GO analysis
ERM
2023-06-01
Last updated: 2023-06-01
Checks: 7 0
Knit directory: Cardiotoxicity/
This reproducible R Markdown analysis was created with workflowr (version 1.7.0). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
Great! Since the R Markdown file has been committed to the Git repository, you know the exact version of the code that produced these results.
Great job! The global environment was empty. Objects defined in the global environment can affect the analysis in your R Markdown file in unknown ways. For reproduciblity it’s best to always run the code in an empty environment.
The command set.seed(20230109) was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.
Great job! Recording the operating system, R version, and package versions is critical for reproducibility.
Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.
Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version 5415215. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish or
wflow_git_commit). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .RData
Ignored: .Rhistory
Ignored: .Rproj.user/
Ignored: analysis/figure/
Ignored: data/41588_2018_171_MOESM3_ESMeQTL_ST2_for paper.csv
Ignored: data/Arr_GWAS.txt
Ignored: data/BC_cell_lines.csv
Ignored: data/CADGWASgene_table.csv
Ignored: data/Clamp_Summary.csv
Ignored: data/Cormotif_24_k1-5_raw.RDS
Ignored: data/DAgostres24.RDS
Ignored: data/DAtable1.csv
Ignored: data/DDEMresp_list.csv
Ignored: data/DDE_reQTL.txt
Ignored: data/DDEresp_list.csv
Ignored: data/DEG-GO/
Ignored: data/DEG_cormotif.RDS
Ignored: data/DF_Plate_Peak.csv
Ignored: data/Da24counts.txt
Ignored: data/Dx24counts.txt
Ignored: data/Dx_reQTL_specific.txt
Ignored: data/Ep24counts.txt
Ignored: data/GOIsig.csv
Ignored: data/GOplots.R
Ignored: data/GTEX_setsimple.csv
Ignored: data/HFGWASgene_table.csv
Ignored: data/Heart_Left_Ventricle.v8.egenes.txt
Ignored: data/Hf_GWAS.txt
Ignored: data/K_cluster
Ignored: data/K_cluster_kisthree.csv
Ignored: data/K_cluster_kistwo.csv
Ignored: data/LDH48hoursdata.csv
Ignored: data/Mt24counts.txt
Ignored: data/RINsamplelist.txt
Ignored: data/Seonane2019supp1.txt
Ignored: data/TOP2Bi-24hoursGO_analysis.csv
Ignored: data/TR24counts.txt
Ignored: data/Top2biresp_cluster24h.csv
Ignored: data/Viabilitylistfull.csv
Ignored: data/allexpressedgenes.txt
Ignored: data/allgenes.txt
Ignored: data/allmatrix.RDS
Ignored: data/avgLD50.RDS
Ignored: data/backGL.txt
Ignored: data/cormotif_3hk1-8.RDS
Ignored: data/cormotif_initalK5.RDS
Ignored: data/cormotif_initialK5.RDS
Ignored: data/cormotif_initialall.RDS
Ignored: data/counts24hours.RDS
Ignored: data/cpmnorm_counts.csv
Ignored: data/cvd_GWAS.txt
Ignored: data/dat_cpm.RDS
Ignored: data/data_outline.txt
Ignored: data/efit2.RDS
Ignored: data/efit2results.RDS
Ignored: data/ensembl_backup.RDS
Ignored: data/ensgtotal.txt
Ignored: data/filenameonly.txt
Ignored: data/filtered_cpm_counts.csv
Ignored: data/filtered_raw_counts.csv
Ignored: data/filtermatrix_x.RDS
Ignored: data/folder_05top/
Ignored: data/gene_corr_frame.RDS
Ignored: data/gene_prob_tran3h.RDS
Ignored: data/gene_probabilityk5.RDS
Ignored: data/gostresTop2bi_ER.RDS
Ignored: data/gostresTop2bi_LR
Ignored: data/gostresTop2bi_LR.RDS
Ignored: data/gostresTop2bi_TI.RDS
Ignored: data/gostrescoNR
Ignored: data/gtex/
Ignored: data/heartgenes.csv
Ignored: data/individualDRCfile.RDS
Ignored: data/individual_LDH48.RDS
Ignored: data/knowfig4.csv
Ignored: data/knowfig5.csv
Ignored: data/knowles56.GMT
Ignored: data/knowlesGMT.GMT
Ignored: data/mymatrix.RDS
Ignored: data/nonresponse_cluster24h.csv
Ignored: data/norm_LDH.csv
Ignored: data/norm_counts.csv
Ignored: data/old_sets/
Ignored: data/plan2plot.png
Ignored: data/raw_counts.csv
Ignored: data/response_cluster24h.csv
Ignored: data/sigVDA24.txt
Ignored: data/sigVDA3.txt
Ignored: data/sigVDX24.txt
Ignored: data/sigVDX3.txt
Ignored: data/sigVEP24.txt
Ignored: data/sigVEP3.txt
Ignored: data/sigVMT24.txt
Ignored: data/sigVMT3.txt
Ignored: data/sigVTR24.txt
Ignored: data/sigVTR3.txt
Ignored: data/siglist.RDS
Ignored: data/table3a.omar
Ignored: data/toplistall.RDS
Ignored: data/tvl24hour.txt
Ignored: data/tvl24hourw.txt
Ignored: data/venn_code.R
Untracked files:
Untracked: .RDataTmp
Untracked: .RDataTmp1
Untracked: .RDataTmp2
Untracked: cormotif_probability_genelist.csv
Untracked: individual-legenddark2.png
Untracked: installed_old.rda
Untracked: motif_ER.txt
Untracked: motif_LR.txt
Untracked: motif_NR.txt
Untracked: motif_TI.txt
Untracked: output/Sup4seoane.csv
Untracked: output/figure_1.Rmd
Untracked: output/output-old/
Untracked: output/plan2plot.png
Untracked: output/plan48ldh.png
Untracked: reneebasecode.R
Unstaged changes:
Modified: analysis/Cormotifcluster_analysis.Rmd
Modified: analysis/DRC_analysis.Rmd
Modified: code/24hour_RNAeval.R
Modified: code/Compare_tnni_ldh.R
Modified: code/eQTLcodes.R
Modified: code/sequencing_info_collection.R
Modified: output/GOI_genelist.txt
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown (analysis/DEG-GO_analysis.Rmd) and
HTML (docs/DEG-GO_analysis.html) files. If you’ve
configured a remote Git repository (see ?wflow_git_remote),
click on the hyperlinks in the table below to view the files as they
were in that past version.
| File | Version | Author | Date | Message |
|---|---|---|---|---|
| Rmd | 5415215 | reneeisnowhere | 2023-06-01 | logging GOIsig changes |
| Rmd | 786c2e2 | reneeisnowhere | 2023-06-01 | logging GOIsig changes |
| Rmd | 6250bc1 | reneeisnowhere | 2023-05-31 | FINALLY fixed the kegg heatmap |
| html | e0702ff | reneeisnowhere | 2023-05-26 | Build site. |
| Rmd | fd12426 | reneeisnowhere | 2023-05-26 | fixcorrelation break |
| html | 00442f9 | reneeisnowhere | 2023-05-26 | Build site. |
| Rmd | d215f0f | reneeisnowhere | 2023-05-26 | updating log2 and adding kegg 24 hour heatmap |
| Rmd | 38e7b3c | reneeisnowhere | 2023-05-26 | adding heatmap |
| Rmd | f3871a5 | reneeisnowhere | 2023-05-26 | updates |
| html | 10393fb | reneeisnowhere | 2023-05-25 | Build site. |
| Rmd | 0c372d0 | reneeisnowhere | 2023-05-25 | update expression correlation |
| html | 5907ad2 | reneeisnowhere | 2023-05-19 | Build site. |
| Rmd | 941b694 | reneeisnowhere | 2023-05-19 | adding corr analysis again |
| html | 860985f | reneeisnowhere | 2023-05-19 | Build site. |
| Rmd | 9f4b03a | reneeisnowhere | 2023-05-19 | adding corr analysis |
| Rmd | d55a810 | reneeisnowhere | 2023-05-18 | working on GWAS and correlation |
| Rmd | 8d87a52 | reneeisnowhere | 2023-05-17 | end of day |
| html | 021e130 | reneeisnowhere | 2023-04-20 | Build site. |
| Rmd | 9d976da | reneeisnowhere | 2023-04-20 | update broken image |
| html | 60af208 | reneeisnowhere | 2023-04-20 | Build site. |
| Rmd | 2b12884 | reneeisnowhere | 2023-04-20 | pheatmap color |
| html | a882f82 | reneeisnowhere | 2023-04-20 | Build site. |
| Rmd | 40ca8e6 | reneeisnowhere | 2023-04-20 | pheatmap color |
| html | 8ad428c | reneeisnowhere | 2023-04-20 | Build site. |
| Rmd | be18119 | reneeisnowhere | 2023-04-20 | updated adj pvalue |
| Rmd | f8eedbf | reneeisnowhere | 2023-04-19 | update after p value to 0.05 |
| html | 56e7c4f | reneeisnowhere | 2023-04-17 | Build site. |
| Rmd | b41cb80 | reneeisnowhere | 2023-04-17 | adding total counts percent graph |
| html | 353fc4a | reneeisnowhere | 2023-04-17 | Build site. |
| Rmd | 457bc7e | reneeisnowhere | 2023-04-17 | updated GO analysis |
| Rmd | 1e2e55e | reneeisnowhere | 2023-04-10 | before final data |
| Rmd | 4e52216 | reneeisnowhere | 2023-03-31 | End of week updates |
GO Analysis
I have created several files from the RNA analysis that contain the significant genes(determined by adj.P.val < 0.05) from each Time and Condition. The names of the files are in the following format: ‘sigV’+Drug(2 letters)+time.
example: ‘sigVDA3.txt’ means this file contains the significant DE genes from the Daunorubicin 3 hour compared to Vehicle Control 3 hour analysis
<environment: R_GlobalEnv>The analysis is based on all genes that passed the rowMeans>0 from the previous page which are about 14084 genes expressed in my RNA-seq data link
All analysis is completed with an adjusted p value of 0.05 This is updated from the 0.1 value I had been using.
2023-04-19 RM
Knowels, et al. mentioned a relationship between transcriptional change
level indicating cardiotoxicity. This may be an observation that
supports that claim as well. ## Daunorubicin
This is analysis on the significantly differentially expressed genes for Daunorubicin by 3 and 24 hours.
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 212 | 1914 | 1.45e-29 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 217 | 1995 | 1.53e-29 |
| GO:BP | GO:0097659 | nucleic acid-templated transcription | 256 | 2684 | 5.18e-28 |
| GO:BP | GO:0006351 | DNA-templated transcription | 256 | 2683 | 5.18e-28 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 249 | 2574 | 1.21e-27 |
| GO:BP | GO:1903506 | regulation of nucleic acid-templated transcription | 249 | 2576 | 1.21e-27 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 256 | 2714 | 1.73e-27 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 249 | 2593 | 2.76e-27 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 262 | 2845 | 2.83e-27 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 271 | 3080 | 9.29e-26 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 263 | 3012 | 2.97e-24 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 262 | 3080 | 5.74e-22 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 260 | 3070 | 2.39e-21 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 265 | 3169 | 2.65e-21 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 262 | 3132 | 6.00e-21 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 261 | 3133 | 2.13e-20 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 264 | 3237 | 3.45e-19 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 283 | 3730 | 4.65e-18 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 306 | 4174 | 7.95e-17 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 276 | 3750 | 6.84e-15 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 312 | 4417 | 2.07e-14 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 305 | 4292 | 2.54e-14 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 87 | 740 | 2.36e-12 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 290 | 4245 | 2.13e-11 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 104 | 1015 | 2.29e-11 |
| GO:BP | GO:1903507 | negative regulation of nucleic acid-templated transcription | 104 | 1017 | 2.43e-11 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 104 | 1026 | 4.60e-11 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 109 | 1119 | 8.53e-11 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 299 | 4539 | 5.91e-10 |
| GO:BP | GO:0009058 | biosynthetic process | 300 | 4590 | 1.83e-09 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 111 | 1209 | 1.98e-09 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 110 | 1214 | 2.76e-09 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 110 | 1239 | 1.24e-08 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 110 | 1280 | 7.73e-08 |
| GO:BP | GO:0010468 | regulation of gene expression | 275 | 3580 | 7.73e-08 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 136 | 1735 | 9.36e-08 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 110 | 1315 | 1.14e-06 |
| GO:BP | GO:1903508 | positive regulation of nucleic acid-templated transcription | 110 | 1315 | 1.14e-06 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 110 | 1322 | 1.40e-06 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 116 | 1441 | 1.56e-06 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 117 | 1507 | 9.90e-06 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 52 | 4617 | 1.07e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 120 | 1564 | 1.44e-05 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 119 | 1602 | 5.22e-05 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 133 | 1849 | 6.29e-05 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 120 | 1604 | 6.29e-05 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 81 | 937 | 9.99e-05 |
| GO:BP | GO:0019222 | regulation of metabolic process | 52 | 5017 | 1.97e-04 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 159 | 2412 | 1.36e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 8 | 67 | 1.54e-03 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 2 | 34 | 1.74e-03 |
| GO:BP | GO:0140467 | integrated stress response signaling | 7 | 35 | 2.02e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 11 | 69 | 2.24e-03 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 23 | 230 | 3.46e-03 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 5 | 84 | 3.64e-03 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 5 | 25 | 3.68e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 22 | 216 | 4.18e-03 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 15 | 128 | 4.59e-03 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 2 | 67 | 4.59e-03 |
| GO:BP | GO:0003162 | atrioventricular node development | 3 | 8 | 4.99e-03 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 15 | 129 | 5.68e-03 |
| GO:BP | GO:0003171 | atrioventricular valve development | 5 | 27 | 5.73e-03 |
| GO:BP | GO:0018076 | N-terminal peptidyl-lysine acetylation | 3 | 4 | 5.73e-03 |
| GO:BP | GO:0021915 | neural tube development | 16 | 146 | 5.73e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 46 | 534 | 5.74e-03 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 2 | 77 | 5.92e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 148 | 2270 | 6.88e-03 |
| GO:BP | GO:0019827 | stem cell population maintenance | 14 | 149 | 8.08e-03 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 44 | 4048 | 8.77e-03 |
| GO:BP | GO:0016070 | RNA metabolic process | 42 | 3600 | 8.83e-03 |
| GO:BP | GO:0045659 | negative regulation of neutrophil differentiation | 1 | 2 | 9.71e-03 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 12 | 100 | 9.71e-03 |
| GO:BP | GO:0045643 | regulation of eosinophil differentiation | 1 | 1 | 9.71e-03 |
| GO:BP | GO:0045645 | positive regulation of eosinophil differentiation | 1 | 1 | 9.71e-03 |
| GO:BP | GO:0060840 | artery development | 11 | 83 | 9.71e-03 |
| GO:BP | GO:0098727 | maintenance of cell number | 14 | 151 | 9.71e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 46 | 551 | 1.03e-02 |
| GO:BP | GO:0030853 | negative regulation of granulocyte differentiation | 2 | 6 | 1.07e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 2 | 118 | 1.12e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 2 | 118 | 1.12e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 12 | 101 | 1.22e-02 |
| GO:BP | GO:0045658 | regulation of neutrophil differentiation | 1 | 2 | 1.34e-02 |
| GO:BP | GO:0090425 | acinar cell differentiation | 3 | 5 | 1.39e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 2 | 152 | 1.42e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 3 | 620 | 1.42e-02 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 10 | 68 | 1.44e-02 |
| GO:BP | GO:0001841 | neural tube formation | 11 | 101 | 1.54e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 2 | 151 | 1.54e-02 |
| GO:BP | GO:0055025 | positive regulation of cardiac muscle tissue development | 1 | 2 | 1.62e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 5 | 123 | 1.62e-02 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 7 | 40 | 1.80e-02 |
| GO:BP | GO:0071772 | response to BMP | 11 | 131 | 1.80e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 11 | 131 | 1.80e-02 |
| GO:BP | GO:0010944 | negative regulation of transcription by competitive promoter binding | 2 | 8 | 1.84e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 8 | 80 | 1.84e-02 |
| GO:BP | GO:0030222 | eosinophil differentiation | 1 | 2 | 1.90e-02 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 6 | 55 | 1.98e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 8 | 56 | 1.98e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 17 | 179 | 2.13e-02 |
| GO:BP | GO:0048636 | positive regulation of muscle organ development | 1 | 3 | 2.13e-02 |
| GO:BP | GO:0045844 | positive regulation of striated muscle tissue development | 1 | 3 | 2.13e-02 |
| GO:BP | GO:0002320 | lymphoid progenitor cell differentiation | 5 | 17 | 2.13e-02 |
| GO:BP | GO:0003183 | mitral valve morphogenesis | 3 | 11 | 2.13e-02 |
| GO:BP | GO:0060430 | lung saccule development | 2 | 7 | 2.13e-02 |
| GO:BP | GO:0006473 | protein acetylation | 15 | 190 | 2.19e-02 |
| GO:BP | GO:0036499 | PERK-mediated unfolded protein response | 4 | 17 | 2.21e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 4 | 75 | 2.28e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 4 | 76 | 2.32e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 4 | 76 | 2.32e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 3 | 45 | 2.34e-02 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 2 | 199 | 2.43e-02 |
| GO:BP | GO:0001823 | mesonephros development | 4 | 77 | 2.44e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 10 | 94 | 2.44e-02 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 166 | 2646 | 2.44e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 5 | 56 | 2.44e-02 |
| GO:BP | GO:0003310 | pancreatic A cell differentiation | 2 | 2 | 2.44e-02 |
| GO:BP | GO:0003174 | mitral valve development | 3 | 12 | 2.44e-02 |
| GO:BP | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 2 | 13 | 2.44e-02 |
| GO:BP | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 2 | 4 | 2.44e-02 |
| GO:BP | GO:0030854 | positive regulation of granulocyte differentiation | 1 | 5 | 2.44e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 5 | 57 | 2.49e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 8 | 60 | 2.60e-02 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 2 | 14 | 2.60e-02 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 6 | 35 | 2.64e-02 |
| GO:BP | GO:1904886 | beta-catenin destruction complex disassembly | 2 | 4 | 2.64e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 3 | 23 | 2.64e-02 |
| GO:BP | GO:0030852 | regulation of granulocyte differentiation | 2 | 11 | 2.77e-02 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 5 | 34 | 2.77e-02 |
| GO:BP | GO:0055024 | regulation of cardiac muscle tissue development | 1 | 3 | 2.81e-02 |
| GO:BP | GO:0030223 | neutrophil differentiation | 1 | 8 | 2.81e-02 |
| GO:BP | GO:0002328 | pro-B cell differentiation | 3 | 10 | 2.86e-02 |
| GO:BP | GO:1904290 | negative regulation of mitotic DNA damage checkpoint | 1 | 1 | 3.05e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 8 | 109 | 3.23e-02 |
| GO:BP | GO:1900034 | regulation of cellular response to heat | 4 | 16 | 3.30e-02 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 3 | 957 | 3.30e-02 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 44 | 4455 | 3.30e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 2 | 279 | 3.33e-02 |
| GO:BP | GO:1902459 | positive regulation of stem cell population maintenance | 6 | 44 | 3.33e-02 |
| GO:BP | GO:0072175 | epithelial tube formation | 12 | 127 | 3.33e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 2 | 310 | 3.37e-02 |
| GO:BP | GO:0014706 | striated muscle tissue development | 19 | 210 | 3.45e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 8 | 58 | 3.51e-02 |
| GO:BP | GO:0010720 | positive regulation of cell development | 2 | 317 | 3.52e-02 |
| GO:BP | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 1 | 7 | 3.55e-02 |
| GO:BP | GO:0005978 | glycogen biosynthetic process | 6 | 39 | 3.61e-02 |
| GO:BP | GO:0009250 | glucan biosynthetic process | 6 | 39 | 3.61e-02 |
| GO:BP | GO:0003170 | heart valve development | 6 | 65 | 3.65e-02 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 18 | 198 | 3.65e-02 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 3 | 1014 | 3.65e-02 |
| GO:BP | GO:1903674 | regulation of cap-dependent translational initiation | 1 | 1 | 3.65e-02 |
| GO:BP | GO:1903676 | positive regulation of cap-dependent translational initiation | 1 | 1 | 3.65e-02 |
| GO:BP | GO:0045622 | regulation of T-helper cell differentiation | 3 | 20 | 3.80e-02 |
| GO:BP | GO:0060509 | type I pneumocyte differentiation | 1 | 8 | 3.80e-02 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 1 | 12 | 3.80e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 5 | 67 | 3.82e-02 |
| GO:BP | GO:0035910 | ascending aorta morphogenesis | 2 | 4 | 3.84e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 19 | 227 | 3.91e-02 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 11 | 116 | 4.08e-02 |
| GO:BP | GO:2000320 | negative regulation of T-helper 17 cell differentiation | 2 | 6 | 4.24e-02 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 22 | 303 | 4.26e-02 |
| GO:BP | GO:0007507 | heart development | 36 | 506 | 4.34e-02 |
| GO:BP | GO:0060325 | face morphogenesis | 5 | 28 | 4.43e-02 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 13 | 4570 | 4.43e-02 |
| GO:BP | GO:0001843 | neural tube closure | 9 | 90 | 4.52e-02 |
| GO:BP | GO:0035904 | aorta development | 7 | 50 | 4.58e-02 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 3 | 1137 | 4.59e-02 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 132 | 2880 | 4.62e-02 |
| GO:BP | GO:0060976 | coronary vasculature development | 6 | 44 | 4.63e-02 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 13 | 4596 | 4.63e-02 |
| GO:BP | GO:0051170 | import into nucleus | 4 | 152 | 4.64e-02 |
| GO:BP | GO:0060606 | tube closure | 9 | 91 | 4.65e-02 |
| GO:BP | GO:0060413 | atrial septum morphogenesis | 3 | 15 | 4.65e-02 |
| GO:BP | GO:2000317 | negative regulation of T-helper 17 type immune response | 2 | 7 | 4.65e-02 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 3 | 65 | 4.65e-02 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 2 | 9 | 4.66e-02 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 2 | 9 | 4.66e-02 |
| GO:BP | GO:2000036 | regulation of stem cell population maintenance | 7 | 62 | 4.69e-02 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 5 | 277 | 4.70e-02 |
| GO:BP | GO:0045649 | regulation of macrophage differentiation | 1 | 17 | 4.70e-02 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 21 | 265 | 4.77e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 2 | 55 | 4.79e-02 |
| GO:BP | GO:0001701 | in utero embryonic development | 28 | 344 | 4.79e-02 |
| GO:BP | GO:0060212 | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1 | 3 | 4.79e-02 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 7 | 44 | 5.10e-02 |
| GO:BP | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 5 | 30 | 5.12e-02 |
| GO:BP | GO:0002521 | leukocyte differentiation | 2 | 382 | 5.12e-02 |
| GO:BP | GO:1903846 | positive regulation of cellular response to transforming growth factor beta stimulus | 5 | 30 | 5.12e-02 |
| GO:BP | GO:0071396 | cellular response to lipid | 2 | 398 | 5.12e-02 |
| GO:BP | GO:0070873 | regulation of glycogen metabolic process | 5 | 28 | 5.12e-02 |
| GO:BP | GO:1904321 | response to forskolin | 1 | 11 | 5.12e-02 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 2 | 10 | 5.12e-02 |
| GO:BP | GO:0003284 | septum primum development | 2 | 5 | 5.12e-02 |
| GO:BP | GO:0018394 | peptidyl-lysine acetylation | 15 | 160 | 5.12e-02 |
| GO:BP | GO:0035905 | ascending aorta development | 2 | 5 | 5.12e-02 |
| GO:BP | GO:0035264 | multicellular organism growth | 13 | 123 | 5.12e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 1 | 25 | 5.12e-02 |
| GO:BP | GO:0035148 | tube formation | 12 | 138 | 5.12e-02 |
| GO:BP | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 1 | 15 | 5.12e-02 |
| GO:BP | GO:0003289 | atrial septum primum morphogenesis | 2 | 5 | 5.12e-02 |
| GO:BP | GO:1904322 | cellular response to forskolin | 1 | 11 | 5.12e-02 |
| GO:BP | GO:0006308 | DNA catabolic process | 4 | 19 | 5.17e-02 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 6 | 32 | 5.17e-02 |
| GO:BP | GO:1902106 | negative regulation of leukocyte differentiation | 4 | 65 | 5.17e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 5 | 50 | 5.17e-02 |
| GO:BP | GO:0043627 | response to estrogen | 3 | 52 | 5.19e-02 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 4 | 33 | 5.19e-02 |
| GO:BP | GO:0072073 | kidney epithelium development | 4 | 112 | 5.19e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 5 | 199 | 5.19e-02 |
| GO:BP | GO:0033484 | intracellular nitric oxide homeostasis | 1 | 3 | 5.24e-02 |
| GO:BP | GO:0019184 | nonribosomal peptide biosynthetic process | 3 | 15 | 5.34e-02 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 13 | 4747 | 5.39e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 18 | 222 | 5.44e-02 |
| GO:BP | GO:0002244 | hematopoietic progenitor cell differentiation | 11 | 109 | 5.47e-02 |
| GO:BP | GO:0045603 | positive regulation of endothelial cell differentiation | 1 | 8 | 5.51e-02 |
| GO:BP | GO:1903707 | negative regulation of hemopoiesis | 4 | 69 | 5.51e-02 |
| GO:BP | GO:1904289 | regulation of mitotic DNA damage checkpoint | 1 | 3 | 5.51e-02 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 3 | 17 | 5.51e-02 |
| GO:BP | GO:0035909 | aorta morphogenesis | 5 | 26 | 5.51e-02 |
| GO:BP | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress | 3 | 10 | 5.51e-02 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 5 | 300 | 5.53e-02 |
| GO:BP | GO:0009950 | dorsal/ventral axis specification | 2 | 9 | 5.53e-02 |
| GO:BP | GO:0060591 | chondroblast differentiation | 2 | 3 | 5.53e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 1 | 13 | 5.53e-02 |
| GO:BP | GO:0060010 | Sertoli cell fate commitment | 1 | 1 | 5.53e-02 |
| GO:BP | GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 2 | 26 | 5.53e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 4 | 124 | 5.54e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 5 | 81 | 5.58e-02 |
| GO:BP | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 3 | 27 | 5.58e-02 |
| GO:BP | GO:1903041 | regulation of chondrocyte hypertrophy | 1 | 1 | 5.58e-02 |
| GO:BP | GO:1903043 | positive regulation of chondrocyte hypertrophy | 1 | 1 | 5.58e-02 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 41 | 616 | 5.63e-02 |
| GO:BP | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 4 | 21 | 5.63e-02 |
| GO:BP | GO:0035729 | cellular response to hepatocyte growth factor stimulus | 1 | 13 | 5.65e-02 |
| GO:BP | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus | 3 | 16 | 5.66e-02 |
| GO:BP | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 4 | 36 | 5.66e-02 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 2 | 19 | 5.68e-02 |
| GO:BP | GO:0006984 | ER-nucleus signaling pathway | 5 | 45 | 5.72e-02 |
| GO:BP | GO:0060324 | face development | 6 | 45 | 5.72e-02 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 3 | 81 | 5.82e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 4 | 36 | 5.87e-02 |
| GO:BP | GO:0090720 | primary adaptive immune response | 1 | 1 | 5.87e-02 |
| GO:BP | GO:0035728 | response to hepatocyte growth factor | 1 | 15 | 5.87e-02 |
| GO:BP | GO:0045210 | FasL biosynthetic process | 1 | 1 | 5.87e-02 |
| GO:BP | GO:0030851 | granulocyte differentiation | 1 | 27 | 5.87e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 2 | 20 | 5.87e-02 |
| GO:BP | GO:0090721 | primary adaptive immune response involving T cells and B cells | 1 | 1 | 5.87e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 11 | 114 | 5.87e-02 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 13 | 4946 | 5.87e-02 |
| GO:BP | GO:0043543 | protein acylation | 15 | 228 | 5.87e-02 |
| GO:BP | GO:0046605 | regulation of centrosome cycle | 4 | 51 | 5.87e-02 |
| GO:BP | GO:0060419 | heart growth | 9 | 72 | 6.01e-02 |
| GO:BP | GO:0033762 | response to glucagon | 1 | 13 | 6.09e-02 |
| GO:BP | GO:0014916 | regulation of lung blood pressure | 2 | 3 | 6.17e-02 |
| GO:BP | GO:0060323 | head morphogenesis | 5 | 33 | 6.22e-02 |
| GO:BP | GO:0021983 | pituitary gland development | 3 | 22 | 6.28e-02 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 1 | 14 | 6.28e-02 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 4 | 36 | 6.28e-02 |
| GO:BP | GO:1903677 | regulation of cap-independent translational initiation | 1 | 3 | 6.35e-02 |
| GO:BP | GO:1903679 | positive regulation of cap-independent translational initiation | 1 | 3 | 6.35e-02 |
| GO:BP | GO:0003205 | cardiac chamber development | 4 | 149 | 6.38e-02 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 3 | 17 | 6.41e-02 |
| GO:BP | GO:0071294 | cellular response to zinc ion | 1 | 15 | 6.41e-02 |
| GO:BP | GO:1900246 | positive regulation of RIG-I signaling pathway | 3 | 7 | 6.48e-02 |
| GO:BP | GO:0061105 | regulation of stomach neuroendocrine cell differentiation | 1 | 1 | 6.64e-02 |
| GO:BP | GO:1904003 | negative regulation of sebum secreting cell proliferation | 1 | 1 | 6.64e-02 |
| GO:BP | GO:0072739 | response to anisomycin | 2 | 4 | 6.64e-02 |
| GO:BP | GO:2000121 | regulation of removal of superoxide radicals | 2 | 6 | 6.64e-02 |
| GO:BP | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1 | 33 | 6.64e-02 |
| GO:BP | GO:2000227 | negative regulation of pancreatic A cell differentiation | 1 | 1 | 6.64e-02 |
| GO:BP | GO:1901863 | positive regulation of muscle tissue development | 1 | 18 | 6.64e-02 |
| GO:BP | GO:2000226 | regulation of pancreatic A cell differentiation | 1 | 1 | 6.64e-02 |
| GO:BP | GO:0045623 | negative regulation of T-helper cell differentiation | 2 | 11 | 6.64e-02 |
| GO:BP | GO:0007613 | memory | 2 | 92 | 6.64e-02 |
| GO:BP | GO:0045977 | positive regulation of mitotic cell cycle, embryonic | 1 | 1 | 6.64e-02 |
| GO:BP | GO:1905934 | negative regulation of cell fate determination | 1 | 1 | 6.64e-02 |
| GO:BP | GO:0061106 | negative regulation of stomach neuroendocrine cell differentiation | 1 | 1 | 6.64e-02 |
| GO:BP | GO:0060284 | regulation of cell development | 2 | 605 | 6.72e-02 |
| GO:BP | GO:0031398 | positive regulation of protein ubiquitination | 3 | 108 | 6.72e-02 |
| GO:BP | GO:0061008 | hepaticobiliary system development | 13 | 112 | 6.72e-02 |
| GO:BP | GO:0045672 | positive regulation of osteoclast differentiation | 1 | 11 | 6.77e-02 |
| GO:BP | GO:0034405 | response to fluid shear stress | 2 | 31 | 6.77e-02 |
| GO:BP | GO:0097676 | histone H3-K36 dimethylation | 2 | 4 | 6.80e-02 |
| GO:BP | GO:0035196 | miRNA processing | 6 | 41 | 6.95e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 1 | 42 | 6.95e-02 |
| GO:BP | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress | 3 | 11 | 6.96e-02 |
| GO:BP | GO:0035880 | embryonic nail plate morphogenesis | 2 | 4 | 7.00e-02 |
| GO:BP | GO:0030225 | macrophage differentiation | 1 | 35 | 7.01e-02 |
| GO:BP | GO:0060479 | lung cell differentiation | 1 | 18 | 7.08e-02 |
| GO:BP | GO:0060487 | lung epithelial cell differentiation | 1 | 18 | 7.08e-02 |
| GO:BP | GO:0071300 | cellular response to retinoic acid | 4 | 49 | 7.15e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 4 | 33 | 7.17e-02 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 28 | 464 | 7.17e-02 |
| GO:BP | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 2 | 5 | 7.19e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 4 | 39 | 7.19e-02 |
| GO:BP | GO:0010664 | negative regulation of striated muscle cell apoptotic process | 4 | 24 | 7.19e-02 |
| GO:BP | GO:0005981 | regulation of glycogen catabolic process | 2 | 4 | 7.33e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 7 | 99 | 7.33e-02 |
| GO:BP | GO:0002190 | cap-independent translational initiation | 1 | 4 | 7.35e-02 |
| GO:BP | GO:2001144 | regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1 | 1 | 7.51e-02 |
| GO:BP | GO:0033993 | response to lipid | 2 | 592 | 7.51e-02 |
| GO:BP | GO:2001145 | negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1 | 1 | 7.51e-02 |
| GO:BP | GO:0032881 | regulation of polysaccharide metabolic process | 5 | 34 | 7.51e-02 |
| GO:BP | GO:0043620 | regulation of DNA-templated transcription in response to stress | 4 | 41 | 7.56e-02 |
| GO:BP | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 1 | 36 | 7.56e-02 |
| GO:BP | GO:1903799 | negative regulation of miRNA processing | 1 | 6 | 7.56e-02 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 5 | 344 | 7.56e-02 |
| GO:BP | GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 5 | 34 | 7.59e-02 |
| GO:BP | GO:0032526 | response to retinoic acid | 5 | 85 | 7.59e-02 |
| GO:BP | GO:0070848 | response to growth factor | 31 | 572 | 7.59e-02 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 5 | 345 | 7.59e-02 |
| GO:BP | GO:0016573 | histone acetylation | 13 | 143 | 7.59e-02 |
| GO:BP | GO:0030279 | negative regulation of ossification | 2 | 25 | 7.59e-02 |
| GO:BP | GO:2000002 | negative regulation of DNA damage checkpoint | 1 | 5 | 7.65e-02 |
| GO:BP | GO:0040018 | positive regulation of multicellular organism growth | 1 | 22 | 7.65e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 2 | 656 | 7.65e-02 |
| GO:BP | GO:0048568 | embryonic organ development | 29 | 316 | 7.73e-02 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 1 | 58 | 7.73e-02 |
| GO:BP | GO:2000319 | regulation of T-helper 17 cell differentiation | 2 | 10 | 7.83e-02 |
| GO:BP | GO:0051141 | negative regulation of NK T cell proliferation | 1 | 1 | 7.86e-02 |
| GO:BP | GO:0090162 | establishment of epithelial cell polarity | 3 | 29 | 7.86e-02 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 2 | 27 | 7.86e-02 |
| GO:BP | GO:1902761 | positive regulation of chondrocyte development | 1 | 1 | 7.94e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 3 | 40 | 7.95e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 8 | 65 | 8.01e-02 |
| GO:BP | GO:0043242 | negative regulation of protein-containing complex disassembly | 2 | 72 | 8.09e-02 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 7 | 50 | 8.22e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 1 | 65 | 8.25e-02 |
| GO:BP | GO:0007352 | zygotic specification of dorsal/ventral axis | 1 | 2 | 8.25e-02 |
| GO:BP | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation | 2 | 14 | 8.27e-02 |
| GO:BP | GO:1904690 | positive regulation of cytoplasmic translational initiation | 1 | 5 | 8.27e-02 |
| GO:BP | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress | 1 | 5 | 8.27e-02 |
| GO:BP | GO:0002383 | immune response in brain or nervous system | 1 | 1 | 8.32e-02 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 11 | 132 | 8.32e-02 |
| GO:BP | GO:0097281 | immune complex formation | 1 | 1 | 8.32e-02 |
| GO:BP | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 3 | 126 | 8.32e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 3 | 40 | 8.32e-02 |
| GO:BP | GO:0003283 | atrial septum development | 3 | 23 | 8.39e-02 |
| GO:BP | GO:0042789 | mRNA transcription by RNA polymerase II | 6 | 45 | 8.49e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 3 | 40 | 8.49e-02 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 3 | 38 | 8.49e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 3 | 40 | 8.49e-02 |
| GO:BP | GO:0046832 | negative regulation of RNA export from nucleus | 1 | 2 | 8.49e-02 |
| GO:BP | GO:0019083 | viral transcription | 6 | 48 | 8.49e-02 |
| GO:BP | GO:0048538 | thymus development | 6 | 35 | 8.49e-02 |
| GO:BP | GO:0060420 | regulation of heart growth | 7 | 50 | 8.50e-02 |
| GO:BP | GO:0009894 | regulation of catabolic process | 48 | 875 | 8.56e-02 |
| GO:BP | GO:0061035 | regulation of cartilage development | 8 | 54 | 8.56e-02 |
| GO:BP | GO:1901983 | regulation of protein acetylation | 6 | 69 | 8.56e-02 |
| GO:BP | GO:0018205 | peptidyl-lysine modification | 19 | 336 | 8.56e-02 |
| GO:BP | GO:0031018 | endocrine pancreas development | 4 | 32 | 8.62e-02 |
| GO:BP | GO:0050793 | regulation of developmental process | 3 | 1835 | 8.62e-02 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 2 | 581 | 8.66e-02 |
| GO:BP | GO:0007595 | lactation | 1 | 32 | 8.66e-02 |
| GO:BP | GO:0000271 | polysaccharide biosynthetic process | 6 | 53 | 8.66e-02 |
| GO:BP | GO:0005979 | regulation of glycogen biosynthetic process | 4 | 25 | 8.68e-02 |
| GO:BP | GO:0010962 | regulation of glucan biosynthetic process | 4 | 25 | 8.68e-02 |
| GO:BP | GO:1901097 | negative regulation of autophagosome maturation | 1 | 5 | 8.68e-02 |
| GO:BP | GO:0006913 | nucleocytoplasmic transport | 13 | 295 | 8.71e-02 |
| GO:BP | GO:0051169 | nuclear transport | 13 | 295 | 8.71e-02 |
| GO:BP | GO:0060428 | lung epithelium development | 1 | 30 | 8.71e-02 |
| GO:BP | GO:0010452 | histone H3-K36 methylation | 2 | 5 | 8.71e-02 |
| GO:BP | GO:1903898 | negative regulation of PERK-mediated unfolded protein response | 2 | 6 | 8.71e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 1 | 76 | 8.76e-02 |
| GO:BP | GO:0043922 | negative regulation by host of viral transcription | 3 | 11 | 8.76e-02 |
| GO:BP | GO:0045661 | regulation of myoblast differentiation | 8 | 61 | 8.79e-02 |
| GO:BP | GO:0071450 | cellular response to oxygen radical | 3 | 19 | 8.85e-02 |
| GO:BP | GO:0071451 | cellular response to superoxide | 3 | 19 | 8.85e-02 |
| GO:BP | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process | 2 | 8 | 8.85e-02 |
| GO:BP | GO:0010835 | regulation of protein ADP-ribosylation | 1 | 9 | 8.86e-02 |
| GO:BP | GO:0018393 | internal peptidyl-lysine acetylation | 13 | 148 | 8.86e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 2 | 18 | 8.86e-02 |
| GO:BP | GO:0045638 | negative regulation of myeloid cell differentiation | 1 | 69 | 8.86e-02 |
| GO:BP | GO:1904688 | regulation of cytoplasmic translational initiation | 1 | 6 | 8.86e-02 |
| GO:BP | GO:1905285 | fibrous ring of heart morphogenesis | 1 | 1 | 8.86e-02 |
| GO:BP | GO:0048352 | paraxial mesoderm structural organization | 1 | 1 | 8.86e-02 |
| GO:BP | GO:1904412 | regulation of cardiac ventricle development | 1 | 1 | 8.86e-02 |
| GO:BP | GO:1904414 | positive regulation of cardiac ventricle development | 1 | 1 | 8.86e-02 |
| GO:BP | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 5 | 56 | 8.86e-02 |
| GO:BP | GO:0048378 | regulation of lateral mesodermal cell fate specification | 1 | 1 | 8.86e-02 |
| GO:BP | GO:0048338 | mesoderm structural organization | 1 | 1 | 8.86e-02 |
| GO:BP | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1 | 89 | 8.86e-02 |
| GO:BP | GO:0001568 | blood vessel development | 36 | 534 | 8.86e-02 |
| GO:BP | GO:1903798 | regulation of miRNA processing | 1 | 10 | 8.86e-02 |
| GO:BP | GO:0048377 | lateral mesodermal cell fate specification | 1 | 1 | 8.86e-02 |
| GO:BP | GO:0021998 | neural plate mediolateral regionalization | 1 | 1 | 8.86e-02 |
| GO:BP | GO:1901861 | regulation of muscle tissue development | 1 | 35 | 8.86e-02 |
| GO:BP | GO:0048372 | lateral mesodermal cell fate commitment | 1 | 1 | 8.86e-02 |
| GO:BP | GO:0061312 | BMP signaling pathway involved in heart development | 2 | 7 | 8.86e-02 |
| GO:BP | GO:0007493 | endodermal cell fate determination | 1 | 1 | 8.89e-02 |
| GO:BP | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 3 | 39 | 8.89e-02 |
| GO:BP | GO:0001949 | sebaceous gland cell differentiation | 1 | 1 | 8.89e-02 |
| GO:BP | GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1 | 12 | 8.89e-02 |
| GO:BP | GO:1904002 | regulation of sebum secreting cell proliferation | 1 | 1 | 8.89e-02 |
| GO:BP | GO:0032912 | negative regulation of transforming growth factor beta2 production | 1 | 2 | 8.89e-02 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 5 | 25 | 8.99e-02 |
| GO:BP | GO:0048286 | lung alveolus development | 1 | 39 | 9.01e-02 |
| GO:BP | GO:0070920 | regulation of regulatory ncRNA processing | 1 | 11 | 9.01e-02 |
| GO:BP | GO:0072071 | kidney interstitial fibroblast differentiation | 1 | 2 | 9.01e-02 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3 | 124 | 9.01e-02 |
| GO:BP | GO:0072141 | renal interstitial fibroblast development | 1 | 2 | 9.01e-02 |
| GO:BP | GO:1905933 | regulation of cell fate determination | 1 | 2 | 9.01e-02 |
| GO:BP | GO:0021870 | Cajal-Retzius cell differentiation | 1 | 2 | 9.01e-02 |
| GO:BP | GO:0061102 | stomach neuroendocrine cell differentiation | 1 | 1 | 9.01e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 3 | 305 | 9.01e-02 |
| GO:BP | GO:0021558 | trochlear nerve development | 1 | 1 | 9.01e-02 |
| GO:BP | GO:0045732 | positive regulation of protein catabolic process | 9 | 192 | 9.18e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 2 | 36 | 9.18e-02 |
| GO:BP | GO:0035998 | 7,8-dihydroneopterin 3’-triphosphate biosynthetic process | 1 | 1 | 9.19e-02 |
| GO:BP | GO:0001944 | vasculature development | 37 | 559 | 9.19e-02 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 9 | 84 | 9.19e-02 |
| GO:BP | GO:0006475 | internal protein amino acid acetylation | 13 | 150 | 9.19e-02 |
| GO:BP | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1 | 13 | 9.19e-02 |
| GO:BP | GO:0010043 | response to zinc ion | 1 | 31 | 9.19e-02 |
| GO:BP | GO:0002191 | cap-dependent translational initiation | 1 | 7 | 9.20e-02 |
| GO:BP | GO:0036492 | eiF2alpha phosphorylation in response to endoplasmic reticulum stress | 1 | 7 | 9.20e-02 |
| GO:BP | GO:0060965 | negative regulation of miRNA-mediated gene silencing | 1 | 10 | 9.20e-02 |
| GO:BP | GO:0045175 | basal protein localization | 1 | 1 | 9.25e-02 |
| GO:BP | GO:0009299 | mRNA transcription | 1 | 50 | 9.25e-02 |
| GO:BP | GO:0045445 | myoblast differentiation | 10 | 90 | 9.25e-02 |
| GO:BP | GO:0060541 | respiratory system development | 4 | 163 | 9.25e-02 |
| GO:BP | GO:0090084 | negative regulation of inclusion body assembly | 1 | 10 | 9.25e-02 |
| GO:BP | GO:0036302 | atrioventricular canal development | 2 | 12 | 9.25e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 3 | 42 | 9.25e-02 |
| GO:BP | GO:2000977 | regulation of forebrain neuron differentiation | 2 | 4 | 9.25e-02 |
| GO:BP | GO:0045601 | regulation of endothelial cell differentiation | 1 | 27 | 9.25e-02 |
| GO:BP | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 3 | 9 | 9.25e-02 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 2 | 442 | 9.26e-02 |
| GO:BP | GO:0001822 | kidney development | 6 | 244 | 9.26e-02 |
| GO:BP | GO:0006309 | apoptotic DNA fragmentation | 3 | 13 | 9.26e-02 |
| GO:BP | GO:1901977 | negative regulation of cell cycle checkpoint | 1 | 8 | 9.26e-02 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 8 | 513 | 9.26e-02 |
| GO:BP | GO:0060149 | negative regulation of post-transcriptional gene silencing | 1 | 11 | 9.26e-02 |
| GO:BP | GO:0060967 | negative regulation of gene silencing by RNA | 1 | 11 | 9.26e-02 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 1 | 35 | 9.26e-02 |
| GO:BP | GO:0008361 | regulation of cell size | 2 | 159 | 9.26e-02 |
| GO:BP | GO:0007614 | short-term memory | 1 | 9 | 9.26e-02 |
| GO:BP | GO:0046639 | negative regulation of alpha-beta T cell differentiation | 2 | 17 | 9.26e-02 |
| GO:BP | GO:1900369 | negative regulation of post-transcriptional gene silencing by RNA | 1 | 11 | 9.26e-02 |
| GO:BP | GO:0060914 | heart formation | 3 | 29 | 9.26e-02 |
| GO:BP | GO:0010507 | negative regulation of autophagy | 8 | 74 | 9.26e-02 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 9 | 85 | 9.26e-02 |
| GO:BP | GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 1 | 103 | 9.26e-02 |
| GO:BP | GO:0021546 | rhombomere development | 2 | 4 | 9.29e-02 |
| GO:BP | GO:0007398 | ectoderm development | 2 | 15 | 9.29e-02 |
| GO:BP | GO:0048468 | cell development | 3 | 1963 | 9.37e-02 |
| GO:BP | GO:0001889 | liver development | 12 | 110 | 9.37e-02 |
| GO:BP | GO:1900036 | positive regulation of cellular response to heat | 1 | 1 | 9.40e-02 |
| GO:BP | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 7 | 86 | 9.40e-02 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 29 | 551 | 9.41e-02 |
| GO:BP | GO:0016570 | histone modification | 29 | 433 | 9.42e-02 |
| GO:BP | GO:0002832 | negative regulation of response to biotic stimulus | 1 | 88 | 9.54e-02 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 5 | 274 | 9.54e-02 |
| GO:BP | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1 | 15 | 9.54e-02 |
| GO:BP | GO:0032240 | negative regulation of nucleobase-containing compound transport | 1 | 3 | 9.54e-02 |
| GO:BP | GO:1901800 | positive regulation of proteasomal protein catabolic process | 1 | 111 | 9.54e-02 |
| GO:BP | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1 | 13 | 9.54e-02 |
| GO:BP | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress | 1 | 8 | 9.54e-02 |
| GO:BP | GO:0009790 | embryo development | 59 | 875 | 9.54e-02 |
| GO:BP | GO:0007172 | signal complex assembly | 1 | 7 | 9.54e-02 |
| GO:BP | GO:0032056 | positive regulation of translation in response to stress | 1 | 8 | 9.54e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 3 | 135 | 9.64e-02 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 2 | 893 | 9.64e-02 |
| GO:BP | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 3 | 50 | 9.65e-02 |
| GO:BP | GO:0035883 | enteroendocrine cell differentiation | 2 | 24 | 9.65e-02 |
| GO:BP | GO:0015074 | DNA integration | 2 | 9 | 9.65e-02 |
| GO:BP | GO:0071636 | positive regulation of transforming growth factor beta production | 2 | 16 | 9.73e-02 |
| GO:BP | GO:0033363 | secretory granule organization | 1 | 50 | 9.84e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 22 | 278 | 9.84e-02 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 4 | 26 | 9.87e-02 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 6 | 482 | 9.93e-02 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 5 | 418 | 9.93e-02 |
| GO:BP | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response | 3 | 16 | 9.96e-02 |
| GO:BP | GO:0072001 | renal system development | 6 | 251 | 9.96e-02 |
| GO:BP | GO:0000303 | response to superoxide | 3 | 21 | 1.00e-01 |
| GO:BP | GO:0001842 | neural fold formation | 2 | 5 | 1.00e-01 |
| GO:BP | GO:0006474 | N-terminal protein amino acid acetylation | 3 | 15 | 1.01e-01 |
| GO:BP | GO:0040014 | regulation of multicellular organism growth | 1 | 53 | 1.02e-01 |
| GO:BP | GO:0006986 | response to unfolded protein | 2 | 128 | 1.02e-01 |
| GO:BP | GO:0003197 | endocardial cushion development | 6 | 46 | 1.02e-01 |
| GO:BP | GO:0006930 | substrate-dependent cell migration, cell extension | 1 | 8 | 1.02e-01 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 1 | 50 | 1.02e-01 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 3 | 113 | 1.03e-01 |
| GO:BP | GO:0048645 | animal organ formation | 4 | 51 | 1.03e-01 |
| GO:BP | GO:2000640 | positive regulation of SREBP signaling pathway | 1 | 2 | 1.03e-01 |
| GO:BP | GO:0051134 | negative regulation of NK T cell activation | 1 | 1 | 1.03e-01 |
| GO:BP | GO:0072539 | T-helper 17 cell differentiation | 2 | 14 | 1.03e-01 |
| GO:BP | GO:0045670 | regulation of osteoclast differentiation | 1 | 38 | 1.03e-01 |
| GO:BP | GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 1 | 127 | 1.04e-01 |
| GO:BP | GO:1902731 | negative regulation of chondrocyte proliferation | 1 | 3 | 1.04e-01 |
| GO:BP | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process | 2 | 10 | 1.05e-01 |
| GO:BP | GO:1901390 | positive regulation of transforming growth factor beta activation | 1 | 3 | 1.05e-01 |
| GO:BP | GO:1990654 | sebum secreting cell proliferation | 1 | 2 | 1.05e-01 |
| GO:BP | GO:0010171 | body morphogenesis | 5 | 45 | 1.05e-01 |
| GO:BP | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1 | 133 | 1.05e-01 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 3 | 17 | 1.05e-01 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 1 | 106 | 1.05e-01 |
| GO:BP | GO:0045727 | positive regulation of translation | 2 | 126 | 1.05e-01 |
| GO:BP | GO:0006109 | regulation of carbohydrate metabolic process | 12 | 144 | 1.05e-01 |
| GO:BP | GO:0110021 | cardiac muscle myoblast proliferation | 1 | 3 | 1.05e-01 |
| GO:BP | GO:0110024 | positive regulation of cardiac muscle myoblast proliferation | 1 | 3 | 1.05e-01 |
| GO:BP | GO:0110022 | regulation of cardiac muscle myoblast proliferation | 1 | 3 | 1.05e-01 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 1 | 110 | 1.06e-01 |
| GO:BP | GO:0000305 | response to oxygen radical | 3 | 22 | 1.06e-01 |
| GO:BP | GO:0051438 | regulation of ubiquitin-protein transferase activity | 2 | 55 | 1.06e-01 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 3 | 50 | 1.06e-01 |
| GO:BP | GO:2000316 | regulation of T-helper 17 type immune response | 2 | 16 | 1.06e-01 |
| GO:BP | GO:2000974 | negative regulation of pro-B cell differentiation | 1 | 2 | 1.06e-01 |
| GO:BP | GO:0046331 | lateral inhibition | 1 | 3 | 1.06e-01 |
| GO:BP | GO:0060164 | regulation of timing of neuron differentiation | 1 | 1 | 1.06e-01 |
| GO:BP | GO:1902870 | negative regulation of amacrine cell differentiation | 1 | 2 | 1.06e-01 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 3 | 2035 | 1.06e-01 |
| GO:BP | GO:2000978 | negative regulation of forebrain neuron differentiation | 1 | 2 | 1.06e-01 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 2 | 21 | 1.06e-01 |
| GO:BP | GO:0030838 | positive regulation of actin filament polymerization | 3 | 39 | 1.06e-01 |
| GO:BP | GO:0021555 | midbrain-hindbrain boundary morphogenesis | 1 | 2 | 1.06e-01 |
| GO:BP | GO:0045168 | cell-cell signaling involved in cell fate commitment | 1 | 3 | 1.06e-01 |
| GO:BP | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 1 | 1 | 1.06e-01 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 3 | 33 | 1.06e-01 |
| GO:BP | GO:1904161 | DNA synthesis involved in UV-damage excision repair | 1 | 2 | 1.07e-01 |
| GO:BP | GO:0060389 | pathway-restricted SMAD protein phosphorylation | 3 | 55 | 1.07e-01 |
| GO:BP | GO:0006968 | cellular defense response | 1 | 15 | 1.08e-01 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 7 | 57 | 1.08e-01 |
| GO:BP | GO:0060669 | embryonic placenta morphogenesis | 4 | 22 | 1.08e-01 |
| GO:BP | GO:0043244 | regulation of protein-containing complex disassembly | 2 | 113 | 1.08e-01 |
| GO:BP | GO:0021536 | diencephalon development | 1 | 41 | 1.08e-01 |
| GO:BP | GO:0010569 | regulation of double-strand break repair via homologous recombination | 6 | 63 | 1.08e-01 |
| GO:BP | GO:0043923 | positive regulation by host of viral transcription | 3 | 18 | 1.08e-01 |
| GO:BP | GO:0021572 | rhombomere 6 development | 1 | 1 | 1.09e-01 |
| GO:BP | GO:0070309 | lens fiber cell morphogenesis | 2 | 5 | 1.09e-01 |
| GO:BP | GO:0035065 | regulation of histone acetylation | 2 | 47 | 1.09e-01 |
| GO:BP | GO:0075732 | viral penetration into host nucleus | 1 | 4 | 1.09e-01 |
| GO:BP | GO:0021599 | abducens nerve formation | 1 | 1 | 1.09e-01 |
| GO:BP | GO:0021598 | abducens nerve morphogenesis | 1 | 1 | 1.09e-01 |
| GO:BP | GO:0044849 | estrous cycle | 1 | 13 | 1.09e-01 |
| GO:BP | GO:0021560 | abducens nerve development | 1 | 1 | 1.09e-01 |
| GO:BP | GO:0001709 | cell fate determination | 2 | 25 | 1.10e-01 |
| GO:BP | GO:0090083 | regulation of inclusion body assembly | 1 | 16 | 1.10e-01 |
| GO:BP | GO:0097719 | neural tissue regeneration | 1 | 1 | 1.10e-01 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 2 | 131 | 1.10e-01 |
| GO:BP | GO:0072359 | circulatory system development | 57 | 884 | 1.10e-01 |
| GO:BP | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 1 | 10 | 1.10e-01 |
| GO:BP | GO:1903897 | regulation of PERK-mediated unfolded protein response | 1 | 10 | 1.10e-01 |
| GO:BP | GO:0030968 | endoplasmic reticulum unfolded protein response | 7 | 70 | 1.10e-01 |
| GO:BP | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation | 1 | 11 | 1.10e-01 |
| GO:BP | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 2 | 16 | 1.11e-01 |
| GO:BP | GO:0062000 | positive regulation of cardiac endothelial to mesenchymal transition | 1 | 1 | 1.11e-01 |
| GO:BP | GO:0061999 | regulation of cardiac endothelial to mesenchymal transition | 1 | 1 | 1.11e-01 |
| GO:BP | GO:0060537 | muscle tissue development | 23 | 343 | 1.11e-01 |
| GO:BP | GO:0002682 | regulation of immune system process | 2 | 877 | 1.11e-01 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 6 | 45 | 1.11e-01 |
| GO:BP | GO:0042636 | negative regulation of hair cycle | 1 | 1 | 1.11e-01 |
| GO:BP | GO:0010721 | negative regulation of cell development | 6 | 191 | 1.12e-01 |
| GO:BP | GO:0006606 | protein import into nucleus | 2 | 147 | 1.12e-01 |
| GO:BP | GO:1990114 | RNA polymerase II core complex assembly | 1 | 1 | 1.12e-01 |
| GO:BP | GO:0046889 | positive regulation of lipid biosynthetic process | 1 | 63 | 1.12e-01 |
| GO:BP | GO:1904574 | negative regulation of selenocysteine insertion sequence binding | 1 | 1 | 1.12e-01 |
| GO:BP | GO:1904573 | regulation of selenocysteine insertion sequence binding | 1 | 1 | 1.12e-01 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 5 | 1074 | 1.12e-01 |
| GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 3 | 15 | 1.12e-01 |
| GO:BP | GO:1904570 | negative regulation of selenocysteine incorporation | 1 | 1 | 1.12e-01 |
| GO:BP | GO:1904572 | negative regulation of mRNA binding | 1 | 1 | 1.12e-01 |
| GO:BP | GO:0072715 | cellular response to selenite ion | 1 | 1 | 1.12e-01 |
| GO:BP | GO:0023057 | negative regulation of signaling | 5 | 1076 | 1.12e-01 |
| GO:BP | GO:0072714 | response to selenite ion | 1 | 1 | 1.12e-01 |
| GO:BP | GO:1904569 | regulation of selenocysteine incorporation | 1 | 1 | 1.12e-01 |
| GO:BP | GO:0003159 | morphogenesis of an endothelium | 3 | 14 | 1.12e-01 |
| GO:BP | GO:0061154 | endothelial tube morphogenesis | 3 | 14 | 1.12e-01 |
| GO:BP | GO:0007254 | JNK cascade | 1 | 138 | 1.12e-01 |
| GO:BP | GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 1 | 160 | 1.12e-01 |
| GO:BP | GO:1903311 | regulation of mRNA metabolic process | 2 | 267 | 1.13e-01 |
| GO:BP | GO:0006468 | protein phosphorylation | 2 | 1167 | 1.13e-01 |
| GO:BP | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 1 | 138 | 1.13e-01 |
| GO:BP | GO:0045607 | regulation of inner ear auditory receptor cell differentiation | 2 | 8 | 1.13e-01 |
| GO:BP | GO:0007589 | body fluid secretion | 1 | 60 | 1.13e-01 |
| GO:BP | GO:2000980 | regulation of inner ear receptor cell differentiation | 2 | 8 | 1.13e-01 |
| GO:BP | GO:0045631 | regulation of mechanoreceptor differentiation | 2 | 8 | 1.13e-01 |
| GO:BP | GO:0035966 | response to topologically incorrect protein | 2 | 150 | 1.13e-01 |
| GO:BP | GO:1901327 | response to tacrolimus | 1 | 1 | 1.13e-01 |
| GO:BP | GO:0030858 | positive regulation of epithelial cell differentiation | 1 | 37 | 1.15e-01 |
| GO:BP | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 4 | 33 | 1.16e-01 |
| GO:BP | GO:0043405 | regulation of MAP kinase activity | 1 | 141 | 1.16e-01 |
| GO:BP | GO:0010991 | negative regulation of SMAD protein complex assembly | 1 | 5 | 1.16e-01 |
| GO:BP | GO:0032885 | regulation of polysaccharide biosynthetic process | 4 | 31 | 1.17e-01 |
| GO:BP | GO:0060486 | club cell differentiation | 1 | 3 | 1.20e-01 |
| GO:BP | GO:0043470 | regulation of carbohydrate catabolic process | 3 | 47 | 1.20e-01 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 3 | 42 | 1.20e-01 |
| GO:BP | GO:0046620 | regulation of organ growth | 8 | 71 | 1.20e-01 |
| GO:BP | GO:0005977 | glycogen metabolic process | 6 | 64 | 1.20e-01 |
| GO:BP | GO:0097306 | cellular response to alcohol | 1 | 70 | 1.21e-01 |
| GO:BP | GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 1 | 1 | 1.21e-01 |
| GO:BP | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 2 | 21 | 1.21e-01 |
| GO:BP | GO:2000759 | regulation of N-terminal peptidyl-lysine acetylation | 1 | 1 | 1.21e-01 |
| GO:BP | GO:0021557 | oculomotor nerve development | 1 | 2 | 1.21e-01 |
| GO:BP | GO:0061136 | regulation of proteasomal protein catabolic process | 1 | 183 | 1.21e-01 |
| GO:BP | GO:2000637 | positive regulation of miRNA-mediated gene silencing | 3 | 15 | 1.21e-01 |
| GO:BP | GO:0034250 | positive regulation of amide metabolic process | 2 | 149 | 1.21e-01 |
| GO:BP | GO:1905457 | negative regulation of lymphoid progenitor cell differentiation | 1 | 3 | 1.21e-01 |
| GO:BP | GO:0045632 | negative regulation of mechanoreceptor differentiation | 1 | 3 | 1.21e-01 |
| GO:BP | GO:2000981 | negative regulation of inner ear receptor cell differentiation | 1 | 3 | 1.21e-01 |
| GO:BP | GO:0009794 | regulation of mitotic cell cycle, embryonic | 1 | 4 | 1.21e-01 |
| GO:BP | GO:0045608 | negative regulation of inner ear auditory receptor cell differentiation | 1 | 3 | 1.21e-01 |
| GO:BP | GO:0045448 | mitotic cell cycle, embryonic | 1 | 4 | 1.21e-01 |
| GO:BP | GO:0001885 | endothelial cell development | 1 | 53 | 1.21e-01 |
| GO:BP | GO:0014861 | regulation of skeletal muscle contraction via regulation of action potential | 1 | 1 | 1.22e-01 |
| GO:BP | GO:0035265 | organ growth | 12 | 131 | 1.22e-01 |
| GO:BP | GO:0042176 | regulation of protein catabolic process | 12 | 331 | 1.23e-01 |
| GO:BP | GO:0001756 | somitogenesis | 7 | 48 | 1.23e-01 |
| GO:BP | GO:0044042 | glucan metabolic process | 6 | 64 | 1.23e-01 |
| GO:BP | GO:0006469 | negative regulation of protein kinase activity | 1 | 179 | 1.23e-01 |
| GO:BP | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1 | 24 | 1.23e-01 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 8 | 74 | 1.23e-01 |
| GO:BP | GO:0033002 | muscle cell proliferation | 1 | 157 | 1.23e-01 |
| GO:BP | GO:0030316 | osteoclast differentiation | 1 | 66 | 1.23e-01 |
| GO:BP | GO:0043377 | negative regulation of CD8-positive, alpha-beta T cell differentiation | 1 | 3 | 1.23e-01 |
| GO:BP | GO:0051066 | dihydrobiopterin metabolic process | 1 | 2 | 1.23e-01 |
| GO:BP | GO:0043041 | amino acid activation for nonribosomal peptide biosynthetic process | 1 | 1 | 1.23e-01 |
| GO:BP | GO:0003415 | chondrocyte hypertrophy | 1 | 6 | 1.23e-01 |
| GO:BP | GO:0061181 | regulation of chondrocyte development | 1 | 4 | 1.23e-01 |
| GO:BP | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization | 1 | 6 | 1.23e-01 |
| GO:BP | GO:0035020 | regulation of Rac protein signal transduction | 2 | 21 | 1.24e-01 |
| GO:BP | GO:0003176 | aortic valve development | 3 | 37 | 1.24e-01 |
| GO:BP | GO:0048729 | tissue morphogenesis | 35 | 504 | 1.24e-01 |
| GO:BP | GO:0071222 | cellular response to lipopolysaccharide | 1 | 110 | 1.24e-01 |
| GO:BP | GO:0035270 | endocrine system development | 3 | 86 | 1.24e-01 |
| GO:BP | GO:0051102 | DNA ligation involved in DNA recombination | 1 | 1 | 1.24e-01 |
| GO:BP | GO:0075713 | establishment of integrated proviral latency | 1 | 1 | 1.24e-01 |
| GO:BP | GO:0061156 | pulmonary artery morphogenesis | 2 | 7 | 1.24e-01 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 2 | 1101 | 1.24e-01 |
| GO:BP | GO:1903788 | positive regulation of glutathione biosynthetic process | 1 | 1 | 1.25e-01 |
| GO:BP | GO:0045444 | fat cell differentiation | 15 | 187 | 1.25e-01 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 2 | 24 | 1.25e-01 |
| GO:BP | GO:0016562 | protein import into peroxisome matrix, receptor recycling | 1 | 7 | 1.25e-01 |
| GO:BP | GO:1901985 | positive regulation of protein acetylation | 4 | 41 | 1.25e-01 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 3 | 129 | 1.25e-01 |
| GO:BP | GO:0002041 | intussusceptive angiogenesis | 1 | 1 | 1.25e-01 |
| GO:BP | GO:0021575 | hindbrain morphogenesis | 2 | 38 | 1.25e-01 |
| GO:BP | GO:0010990 | regulation of SMAD protein complex assembly | 1 | 6 | 1.27e-01 |
| GO:BP | GO:0071219 | cellular response to molecule of bacterial origin | 1 | 114 | 1.27e-01 |
| GO:BP | GO:1901655 | cellular response to ketone | 1 | 86 | 1.27e-01 |
| GO:BP | GO:0060964 | regulation of miRNA-mediated gene silencing | 1 | 25 | 1.27e-01 |
| GO:BP | GO:0070841 | inclusion body assembly | 1 | 22 | 1.27e-01 |
| GO:BP | GO:2000756 | regulation of peptidyl-lysine acetylation | 2 | 57 | 1.27e-01 |
| GO:BP | GO:0070262 | peptidyl-serine dephosphorylation | 1 | 14 | 1.27e-01 |
| GO:BP | GO:0033189 | response to vitamin A | 2 | 12 | 1.27e-01 |
| GO:BP | GO:0010467 | gene expression | 10 | 4587 | 1.28e-01 |
| GO:BP | GO:0060982 | coronary artery morphogenesis | 2 | 8 | 1.28e-01 |
| GO:BP | GO:0060819 | inactivation of X chromosome by genomic imprinting | 1 | 2 | 1.28e-01 |
| GO:BP | GO:0006349 | regulation of gene expression by genomic imprinting | 3 | 14 | 1.28e-01 |
| GO:BP | GO:0035781 | CD86 biosynthetic process | 1 | 2 | 1.28e-01 |
| GO:BP | GO:0007611 | learning or memory | 2 | 202 | 1.28e-01 |
| GO:BP | GO:0033673 | negative regulation of kinase activity | 1 | 197 | 1.29e-01 |
| GO:BP | GO:0031396 | regulation of protein ubiquitination | 3 | 191 | 1.29e-01 |
| GO:BP | GO:0060037 | pharyngeal system development | 2 | 23 | 1.30e-01 |
| GO:BP | GO:1903050 | regulation of proteolysis involved in protein catabolic process | 1 | 214 | 1.30e-01 |
| GO:BP | GO:1990709 | presynaptic active zone organization | 2 | 9 | 1.30e-01 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 7 | 816 | 1.30e-01 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 3 | 395 | 1.30e-01 |
| GO:BP | GO:1900368 | regulation of post-transcriptional gene silencing by RNA | 1 | 27 | 1.30e-01 |
| GO:BP | GO:1900370 | positive regulation of post-transcriptional gene silencing by RNA | 3 | 16 | 1.30e-01 |
| GO:BP | GO:0060534 | trachea cartilage development | 1 | 4 | 1.30e-01 |
| GO:BP | GO:1902217 | erythrocyte apoptotic process | 1 | 1 | 1.30e-01 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 2 | 1223 | 1.30e-01 |
| GO:BP | GO:0016310 | phosphorylation | 2 | 1372 | 1.30e-01 |
| GO:BP | GO:0060148 | positive regulation of post-transcriptional gene silencing | 3 | 16 | 1.30e-01 |
| GO:BP | GO:0045630 | positive regulation of T-helper 2 cell differentiation | 1 | 4 | 1.30e-01 |
| GO:BP | GO:0051403 | stress-activated MAPK cascade | 1 | 190 | 1.30e-01 |
| GO:BP | GO:0120181 | focal adhesion disassembly | 2 | 8 | 1.30e-01 |
| GO:BP | GO:0120180 | cell-substrate junction disassembly | 2 | 8 | 1.30e-01 |
| GO:BP | GO:0043558 | regulation of translational initiation in response to stress | 1 | 16 | 1.30e-01 |
| GO:BP | GO:0140744 | negative regulation of lncRNA transcription | 1 | 2 | 1.31e-01 |
| GO:BP | GO:0110064 | lncRNA catabolic process | 1 | 2 | 1.31e-01 |
| GO:BP | GO:0140742 | lncRNA transcription | 1 | 2 | 1.31e-01 |
| GO:BP | GO:0050863 | regulation of T cell activation | 6 | 216 | 1.31e-01 |
| GO:BP | GO:0140743 | regulation of lncRNA transcription | 1 | 2 | 1.31e-01 |
| GO:BP | GO:0061780 | mitotic cohesin loading | 1 | 1 | 1.31e-01 |
| GO:BP | GO:0035261 | external genitalia morphogenesis | 1 | 1 | 1.31e-01 |
| GO:BP | GO:0060147 | regulation of post-transcriptional gene silencing | 1 | 28 | 1.31e-01 |
| GO:BP | GO:0035295 | tube development | 2 | 821 | 1.32e-01 |
| GO:BP | GO:0031098 | stress-activated protein kinase signaling cascade | 1 | 196 | 1.32e-01 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 4 | 62 | 1.32e-01 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 6 | 2135 | 1.32e-01 |
| GO:BP | GO:0061053 | somite development | 8 | 63 | 1.32e-01 |
| GO:BP | GO:0062094 | stomach development | 1 | 4 | 1.32e-01 |
| GO:BP | GO:0071216 | cellular response to biotic stimulus | 1 | 138 | 1.32e-01 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 7 | 320 | 1.32e-01 |
| GO:BP | GO:0061009 | common bile duct development | 1 | 4 | 1.32e-01 |
| GO:BP | GO:0002085 | inhibition of neuroepithelial cell differentiation | 1 | 4 | 1.32e-01 |
| GO:BP | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay | 2 | 7 | 1.32e-01 |
| GO:BP | GO:0060966 | regulation of gene silencing by RNA | 1 | 29 | 1.32e-01 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 2 | 6 | 1.32e-01 |
| GO:BP | GO:0140290 | peptidyl-serine ADP-deribosylation | 1 | 1 | 1.33e-01 |
| GO:BP | GO:1902902 | negative regulation of autophagosome assembly | 1 | 14 | 1.34e-01 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 1 | 27 | 1.34e-01 |
| GO:BP | GO:0001570 | vasculogenesis | 7 | 67 | 1.37e-01 |
| GO:BP | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 2 | 20 | 1.37e-01 |
| GO:BP | GO:0031953 | negative regulation of protein autophosphorylation | 2 | 9 | 1.38e-01 |
| GO:BP | GO:1905314 | semi-lunar valve development | 3 | 41 | 1.40e-01 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 1 | 102 | 1.40e-01 |
| GO:BP | GO:2001306 | lipoxin B4 biosynthetic process | 1 | 1 | 1.40e-01 |
| GO:BP | GO:0043467 | regulation of generation of precursor metabolites and energy | 7 | 89 | 1.40e-01 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 3 | 58 | 1.40e-01 |
| GO:BP | GO:0035026 | leading edge cell differentiation | 1 | 2 | 1.40e-01 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 4 | 27 | 1.41e-01 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 3 | 48 | 1.41e-01 |
| GO:BP | GO:0006325 | chromatin organization | 35 | 551 | 1.41e-01 |
| GO:BP | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation | 2 | 11 | 1.41e-01 |
| GO:BP | GO:0051348 | negative regulation of transferase activity | 1 | 234 | 1.41e-01 |
| GO:BP | GO:0043589 | skin morphogenesis | 1 | 10 | 1.41e-01 |
| GO:BP | GO:0060290 | transdifferentiation | 2 | 2 | 1.41e-01 |
| GO:BP | GO:0036010 | protein localization to endosome | 3 | 26 | 1.42e-01 |
| GO:BP | GO:0051085 | chaperone cofactor-dependent protein refolding | 1 | 30 | 1.42e-01 |
| GO:BP | GO:0030879 | mammary gland development | 1 | 106 | 1.42e-01 |
| GO:BP | GO:0021503 | neural fold bending | 1 | 1 | 1.42e-01 |
| GO:BP | GO:0048371 | lateral mesodermal cell differentiation | 1 | 2 | 1.42e-01 |
| GO:BP | GO:0090164 | asymmetric Golgi ribbon formation | 1 | 2 | 1.42e-01 |
| GO:BP | GO:1905898 | positive regulation of response to endoplasmic reticulum stress | 3 | 34 | 1.42e-01 |
| GO:BP | GO:0031330 | negative regulation of cellular catabolic process | 13 | 165 | 1.42e-01 |
| GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 3 | 41 | 1.42e-01 |
| GO:BP | GO:0046887 | positive regulation of hormone secretion | 1 | 90 | 1.42e-01 |
| GO:BP | GO:0032915 | positive regulation of transforming growth factor beta2 production | 1 | 3 | 1.42e-01 |
| GO:BP | GO:0002084 | protein depalmitoylation | 2 | 10 | 1.42e-01 |
| GO:BP | GO:0048511 | rhythmic process | 2 | 237 | 1.42e-01 |
| GO:BP | GO:0003290 | atrial septum secundum morphogenesis | 1 | 2 | 1.43e-01 |
| GO:BP | GO:0034421 | post-translational protein acetylation | 1 | 3 | 1.43e-01 |
| GO:BP | GO:0060510 | type II pneumocyte differentiation | 1 | 5 | 1.43e-01 |
| GO:BP | GO:0070315 | G1 to G0 transition involved in cell differentiation | 1 | 4 | 1.43e-01 |
| GO:BP | GO:0032911 | negative regulation of transforming growth factor beta1 production | 1 | 5 | 1.43e-01 |
| GO:BP | GO:0072538 | T-helper 17 type immune response | 2 | 24 | 1.43e-01 |
| GO:BP | GO:0003230 | cardiac atrium development | 3 | 34 | 1.44e-01 |
| GO:BP | GO:0019932 | second-messenger-mediated signaling | 2 | 191 | 1.44e-01 |
| GO:BP | GO:0046661 | male sex differentiation | 6 | 114 | 1.44e-01 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 1 | 227 | 1.44e-01 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 2 | 54 | 1.44e-01 |
| GO:BP | GO:1901096 | regulation of autophagosome maturation | 1 | 16 | 1.44e-01 |
| GO:BP | GO:0007492 | endoderm development | 7 | 65 | 1.44e-01 |
| GO:BP | GO:0045819 | positive regulation of glycogen catabolic process | 1 | 1 | 1.45e-01 |
| GO:BP | GO:0014074 | response to purine-containing compound | 1 | 108 | 1.45e-01 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 3 | 64 | 1.45e-01 |
| GO:BP | GO:2000001 | regulation of DNA damage checkpoint | 1 | 25 | 1.46e-01 |
| GO:BP | GO:0070898 | RNA polymerase III preinitiation complex assembly | 1 | 1 | 1.46e-01 |
| GO:BP | GO:0060795 | cell fate commitment involved in formation of primary germ layer | 2 | 18 | 1.46e-01 |
| GO:BP | GO:0072049 | comma-shaped body morphogenesis | 1 | 4 | 1.46e-01 |
| GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 8 | 91 | 1.46e-01 |
| GO:BP | GO:0050890 | cognition | 2 | 227 | 1.46e-01 |
| GO:BP | GO:1902869 | regulation of amacrine cell differentiation | 1 | 3 | 1.46e-01 |
| GO:BP | GO:0070982 | L-asparagine metabolic process | 1 | 2 | 1.46e-01 |
| GO:BP | GO:0071310 | cellular response to organic substance | 2 | 1399 | 1.47e-01 |
| GO:BP | GO:0060689 | cell differentiation involved in salivary gland development | 1 | 2 | 1.47e-01 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 3 | 55 | 1.47e-01 |
| GO:BP | GO:0030900 | forebrain development | 7 | 281 | 1.47e-01 |
| GO:BP | GO:1902455 | negative regulation of stem cell population maintenance | 3 | 21 | 1.47e-01 |
| GO:BP | GO:0039535 | regulation of RIG-I signaling pathway | 3 | 17 | 1.47e-01 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 1 | 236 | 1.47e-01 |
| GO:BP | GO:0048638 | regulation of developmental growth | 2 | 258 | 1.47e-01 |
| GO:BP | GO:0006356 | regulation of transcription by RNA polymerase I | 5 | 45 | 1.47e-01 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 1 | 108 | 1.47e-01 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 5 | 189 | 1.47e-01 |
| GO:BP | GO:0046599 | regulation of centriole replication | 2 | 21 | 1.48e-01 |
| GO:BP | GO:0048863 | stem cell differentiation | 16 | 197 | 1.48e-01 |
| GO:BP | GO:0046636 | negative regulation of alpha-beta T cell activation | 2 | 25 | 1.49e-01 |
| GO:BP | GO:0006750 | glutathione biosynthetic process | 2 | 13 | 1.49e-01 |
| GO:BP | GO:1903573 | negative regulation of response to endoplasmic reticulum stress | 5 | 41 | 1.49e-01 |
| GO:BP | GO:0048486 | parasympathetic nervous system development | 3 | 12 | 1.49e-01 |
| GO:BP | GO:1990089 | response to nerve growth factor | 3 | 41 | 1.50e-01 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 3 | 67 | 1.50e-01 |
| GO:BP | GO:0060429 | epithelium development | 2 | 850 | 1.50e-01 |
| GO:BP | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1 | 2 | 1.52e-01 |
| GO:BP | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway | 1 | 2 | 1.52e-01 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 5 | 37 | 1.52e-01 |
| GO:BP | GO:0051084 | ‘de novo’ post-translational protein folding | 1 | 35 | 1.52e-01 |
| GO:BP | GO:0048382 | mesendoderm development | 2 | 5 | 1.54e-01 |
| GO:BP | GO:0045647 | negative regulation of erythrocyte differentiation | 2 | 7 | 1.54e-01 |
| GO:BP | GO:0035120 | post-embryonic appendage morphogenesis | 1 | 2 | 1.54e-01 |
| GO:BP | GO:0035128 | post-embryonic forelimb morphogenesis | 1 | 2 | 1.54e-01 |
| GO:BP | GO:0035127 | post-embryonic limb morphogenesis | 1 | 2 | 1.54e-01 |
| GO:BP | GO:0140074 | cardiac endothelial to mesenchymal transition | 1 | 2 | 1.55e-01 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 1 | 90 | 1.57e-01 |
| GO:BP | GO:0032496 | response to lipopolysaccharide | 1 | 178 | 1.57e-01 |
| GO:BP | GO:0001174 | transcriptional start site selection at RNA polymerase II promoter | 1 | 2 | 1.57e-01 |
| GO:BP | GO:0002089 | lens morphogenesis in camera-type eye | 3 | 18 | 1.57e-01 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 6 | 2293 | 1.57e-01 |
| GO:BP | GO:0001173 | DNA-templated transcriptional start site selection | 1 | 2 | 1.57e-01 |
| GO:BP | GO:0010453 | regulation of cell fate commitment | 3 | 26 | 1.58e-01 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 1 | 265 | 1.59e-01 |
| GO:BP | GO:0048732 | gland development | 12 | 318 | 1.59e-01 |
| GO:BP | GO:0046890 | regulation of lipid biosynthetic process | 1 | 134 | 1.60e-01 |
| GO:BP | GO:1905215 | negative regulation of RNA binding | 1 | 2 | 1.60e-01 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 1 | 22 | 1.60e-01 |
| GO:BP | GO:0009798 | axis specification | 7 | 63 | 1.60e-01 |
| GO:BP | GO:0030917 | midbrain-hindbrain boundary development | 1 | 3 | 1.60e-01 |
| GO:BP | GO:0021861 | forebrain radial glial cell differentiation | 1 | 6 | 1.60e-01 |
| GO:BP | GO:0045581 | negative regulation of T cell differentiation | 2 | 27 | 1.61e-01 |
| GO:BP | GO:0010825 | positive regulation of centrosome duplication | 1 | 3 | 1.61e-01 |
| GO:BP | GO:0002237 | response to molecule of bacterial origin | 1 | 187 | 1.61e-01 |
| GO:BP | GO:2000691 | negative regulation of cardiac muscle cell myoblast differentiation | 1 | 1 | 1.61e-01 |
| GO:BP | GO:1990478 | response to ultrasound | 1 | 2 | 1.61e-01 |
| GO:BP | GO:0097198 | histone H3-K36 trimethylation | 1 | 1 | 1.61e-01 |
| GO:BP | GO:0061865 | polarized secretion of basement membrane proteins in epithelium | 1 | 1 | 1.61e-01 |
| GO:BP | GO:0030262 | apoptotic nuclear changes | 3 | 20 | 1.61e-01 |
| GO:BP | GO:0061864 | basement membrane constituent secretion | 1 | 1 | 1.61e-01 |
| GO:BP | GO:0043555 | regulation of translation in response to stress | 1 | 23 | 1.61e-01 |
| GO:BP | GO:1904294 | positive regulation of ERAD pathway | 2 | 16 | 1.61e-01 |
| GO:BP | GO:2000448 | positive regulation of macrophage migration inhibitory factor signaling pathway | 1 | 2 | 1.61e-01 |
| GO:BP | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation | 1 | 1 | 1.61e-01 |
| GO:BP | GO:2001151 | regulation of renal water transport | 1 | 1 | 1.61e-01 |
| GO:BP | GO:2001153 | positive regulation of renal water transport | 1 | 1 | 1.61e-01 |
| GO:BP | GO:0097150 | neuronal stem cell population maintenance | 2 | 21 | 1.61e-01 |
| GO:BP | GO:2000020 | positive regulation of male gonad development | 2 | 4 | 1.61e-01 |
| GO:BP | GO:0008406 | gonad development | 4 | 158 | 1.61e-01 |
| GO:BP | GO:0006542 | glutamine biosynthetic process | 1 | 2 | 1.61e-01 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 1 | 295 | 1.61e-01 |
| GO:BP | GO:1905070 | anterior visceral endoderm cell migration | 1 | 1 | 1.61e-01 |
| GO:BP | GO:0051292 | nuclear pore complex assembly | 1 | 9 | 1.61e-01 |
| GO:BP | GO:0006458 | ‘de novo’ protein folding | 1 | 39 | 1.61e-01 |
| GO:BP | GO:0140067 | peptidyl-lysine butyrylation | 1 | 1 | 1.62e-01 |
| GO:BP | GO:0036268 | swimming | 1 | 1 | 1.62e-01 |
| GO:BP | GO:0061921 | peptidyl-lysine propionylation | 1 | 1 | 1.62e-01 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 1 | 282 | 1.63e-01 |
| GO:BP | GO:0097194 | execution phase of apoptosis | 5 | 53 | 1.63e-01 |
| GO:BP | GO:0003292 | cardiac septum cell differentiation | 1 | 4 | 1.64e-01 |
| GO:BP | GO:1903215 | negative regulation of protein targeting to mitochondrion | 1 | 3 | 1.64e-01 |
| GO:BP | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 3 | 232 | 1.64e-01 |
| GO:BP | GO:0048370 | lateral mesoderm formation | 1 | 3 | 1.64e-01 |
| GO:BP | GO:0060922 | atrioventricular node cell differentiation | 1 | 4 | 1.64e-01 |
| GO:BP | GO:0060928 | atrioventricular node cell development | 1 | 4 | 1.64e-01 |
| GO:BP | GO:0045628 | regulation of T-helper 2 cell differentiation | 1 | 7 | 1.64e-01 |
| GO:BP | GO:0048369 | lateral mesoderm morphogenesis | 1 | 3 | 1.64e-01 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 3 | 100 | 1.64e-01 |
| GO:BP | GO:0086052 | membrane repolarization during SA node cell action potential | 1 | 1 | 1.64e-01 |
| GO:BP | GO:0045778 | positive regulation of ossification | 5 | 40 | 1.64e-01 |
| GO:BP | GO:0086050 | membrane repolarization during bundle of His cell action potential | 1 | 1 | 1.64e-01 |
| GO:BP | GO:0001880 | Mullerian duct regression | 1 | 4 | 1.64e-01 |
| GO:BP | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 2 | 27 | 1.64e-01 |
| GO:BP | GO:0030324 | lung development | 1 | 146 | 1.64e-01 |
| GO:BP | GO:0032197 | retrotransposition | 1 | 4 | 1.64e-01 |
| GO:BP | GO:0045773 | positive regulation of axon extension | 1 | 33 | 1.64e-01 |
| GO:BP | GO:2000176 | positive regulation of pro-T cell differentiation | 1 | 1 | 1.64e-01 |
| GO:BP | GO:2000174 | regulation of pro-T cell differentiation | 1 | 1 | 1.64e-01 |
| GO:BP | GO:0043484 | regulation of RNA splicing | 3 | 164 | 1.64e-01 |
| GO:BP | GO:0030217 | T cell differentiation | 16 | 185 | 1.64e-01 |
| GO:BP | GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1 | 8 | 1.65e-01 |
| GO:BP | GO:0045137 | development of primary sexual characteristics | 4 | 161 | 1.65e-01 |
| GO:BP | GO:1904906 | positive regulation of endothelial cell-matrix adhesion via fibronectin | 1 | 3 | 1.65e-01 |
| GO:BP | GO:0002725 | negative regulation of T cell cytokine production | 1 | 3 | 1.65e-01 |
| GO:BP | GO:0030323 | respiratory tube development | 1 | 150 | 1.66e-01 |
| GO:BP | GO:0006282 | regulation of DNA repair | 14 | 198 | 1.66e-01 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 5 | 1123 | 1.67e-01 |
| GO:BP | GO:0003158 | endothelium development | 1 | 104 | 1.68e-01 |
| GO:BP | GO:2000973 | regulation of pro-B cell differentiation | 1 | 7 | 1.68e-01 |
| GO:BP | GO:0032781 | positive regulation of ATP-dependent activity | 1 | 40 | 1.68e-01 |
| GO:BP | GO:2000979 | positive regulation of forebrain neuron differentiation | 1 | 1 | 1.68e-01 |
| GO:BP | GO:0043049 | otic placode formation | 1 | 1 | 1.68e-01 |
| GO:BP | GO:0051168 | nuclear export | 7 | 150 | 1.68e-01 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 8 | 86 | 1.68e-01 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 5 | 39 | 1.68e-01 |
| GO:BP | GO:0002194 | hepatocyte cell migration | 1 | 1 | 1.68e-01 |
| GO:BP | GO:0006112 | energy reserve metabolic process | 6 | 73 | 1.68e-01 |
| GO:BP | GO:0072050 | S-shaped body morphogenesis | 1 | 5 | 1.68e-01 |
| GO:BP | GO:0061114 | branching involved in pancreas morphogenesis | 1 | 1 | 1.68e-01 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 4 | 809 | 1.68e-01 |
| GO:BP | GO:0072282 | metanephric nephron tubule morphogenesis | 1 | 5 | 1.68e-01 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 4 | 103 | 1.68e-01 |
| GO:BP | GO:0100001 | regulation of skeletal muscle contraction by action potential | 1 | 1 | 1.69e-01 |
| GO:BP | GO:0006929 | substrate-dependent cell migration | 1 | 24 | 1.69e-01 |
| GO:BP | GO:0072740 | cellular response to anisomycin | 1 | 3 | 1.69e-01 |
| GO:BP | GO:0071248 | cellular response to metal ion | 1 | 139 | 1.69e-01 |
| GO:BP | GO:0032102 | negative regulation of response to external stimulus | 1 | 269 | 1.69e-01 |
| GO:BP | GO:0032754 | positive regulation of interleukin-5 production | 1 | 6 | 1.70e-01 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 2 | 31 | 1.70e-01 |
| GO:BP | GO:0050794 | regulation of cellular process | 54 | 7552 | 1.71e-01 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 3 | 13 | 1.71e-01 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 14 | 132 | 1.71e-01 |
| GO:BP | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation | 1 | 6 | 1.71e-01 |
| GO:BP | GO:1904791 | negative regulation of shelterin complex assembly | 1 | 1 | 1.72e-01 |
| GO:BP | GO:0090311 | regulation of protein deacetylation | 5 | 53 | 1.72e-01 |
| GO:BP | GO:0032387 | negative regulation of intracellular transport | 2 | 49 | 1.73e-01 |
| GO:BP | GO:0072752 | cellular response to rapamycin | 1 | 2 | 1.73e-01 |
| GO:BP | GO:0010661 | positive regulation of muscle cell apoptotic process | 2 | 20 | 1.74e-01 |
| GO:BP | GO:0050821 | protein stabilization | 4 | 191 | 1.74e-01 |
| GO:BP | GO:0003285 | septum secundum development | 1 | 3 | 1.74e-01 |
| GO:BP | GO:1902010 | negative regulation of translation in response to endoplasmic reticulum stress | 1 | 1 | 1.74e-01 |
| GO:BP | GO:1901654 | response to ketone | 1 | 147 | 1.74e-01 |
| GO:BP | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 3 | 22 | 1.74e-01 |
| GO:BP | GO:0035054 | embryonic heart tube anterior/posterior pattern specification | 1 | 2 | 1.74e-01 |
| GO:BP | GO:0046822 | regulation of nucleocytoplasmic transport | 4 | 97 | 1.74e-01 |
| GO:BP | GO:1901377 | organic heteropentacyclic compound catabolic process | 1 | 2 | 1.74e-01 |
| GO:BP | GO:1903786 | regulation of glutathione biosynthetic process | 1 | 2 | 1.74e-01 |
| GO:BP | GO:0046223 | aflatoxin catabolic process | 1 | 2 | 1.74e-01 |
| GO:BP | GO:0048565 | digestive tract development | 10 | 92 | 1.74e-01 |
| GO:BP | GO:0043387 | mycotoxin catabolic process | 1 | 2 | 1.74e-01 |
| GO:BP | GO:0007623 | circadian rhythm | 1 | 165 | 1.74e-01 |
| GO:BP | GO:0009407 | toxin catabolic process | 1 | 2 | 1.74e-01 |
| GO:BP | GO:1901388 | regulation of transforming growth factor beta activation | 1 | 8 | 1.74e-01 |
| GO:BP | GO:0060008 | Sertoli cell differentiation | 2 | 15 | 1.74e-01 |
| GO:BP | GO:0070918 | regulatory ncRNA processing | 6 | 47 | 1.75e-01 |
| GO:BP | GO:0051016 | barbed-end actin filament capping | 1 | 21 | 1.75e-01 |
| GO:BP | GO:2000765 | regulation of cytoplasmic translation | 1 | 27 | 1.75e-01 |
| GO:BP | GO:1904668 | positive regulation of ubiquitin protein ligase activity | 1 | 13 | 1.75e-01 |
| GO:BP | GO:0006370 | 7-methylguanosine mRNA capping | 2 | 7 | 1.75e-01 |
| GO:BP | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2 | 25 | 1.75e-01 |
| GO:BP | GO:0075733 | intracellular transport of virus | 1 | 8 | 1.76e-01 |
| GO:BP | GO:0045585 | positive regulation of cytotoxic T cell differentiation | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1 | 53 | 1.76e-01 |
| GO:BP | GO:0048617 | embryonic foregut morphogenesis | 2 | 6 | 1.76e-01 |
| GO:BP | GO:0046601 | positive regulation of centriole replication | 2 | 9 | 1.76e-01 |
| GO:BP | GO:0018272 | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine | 1 | 1 | 1.76e-01 |
| GO:BP | GO:2000120 | positive regulation of sodium-dependent phosphate transport | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0060021 | roof of mouth development | 6 | 71 | 1.76e-01 |
| GO:BP | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2 | 26 | 1.76e-01 |
| GO:BP | GO:1905941 | positive regulation of gonad development | 2 | 4 | 1.76e-01 |
| GO:BP | GO:0016480 | negative regulation of transcription by RNA polymerase III | 1 | 4 | 1.76e-01 |
| GO:BP | GO:0071241 | cellular response to inorganic substance | 8 | 164 | 1.76e-01 |
| GO:BP | GO:0002457 | T cell antigen processing and presentation | 1 | 4 | 1.76e-01 |
| GO:BP | GO:0003266 | regulation of secondary heart field cardioblast proliferation | 1 | 8 | 1.76e-01 |
| GO:BP | GO:2000269 | regulation of fibroblast apoptotic process | 3 | 17 | 1.76e-01 |
| GO:BP | GO:1990737 | response to manganese-induced endoplasmic reticulum stress | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0034333 | adherens junction assembly | 1 | 13 | 1.76e-01 |
| GO:BP | GO:0034599 | cellular response to oxidative stress | 9 | 240 | 1.76e-01 |
| GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 1 | 335 | 1.76e-01 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 29 | 555 | 1.76e-01 |
| GO:BP | GO:0035544 | negative regulation of SNARE complex assembly | 1 | 2 | 1.76e-01 |
| GO:BP | GO:1905671 | regulation of lysosome organization | 1 | 6 | 1.76e-01 |
| GO:BP | GO:0035878 | nail development | 2 | 8 | 1.76e-01 |
| GO:BP | GO:0031016 | pancreas development | 5 | 53 | 1.76e-01 |
| GO:BP | GO:0048869 | cellular developmental process | 3 | 2984 | 1.76e-01 |
| GO:BP | GO:0140468 | HRI-mediated signaling | 1 | 3 | 1.76e-01 |
| GO:BP | GO:2000018 | regulation of male gonad development | 2 | 5 | 1.76e-01 |
| GO:BP | GO:0042110 | T cell activation | 7 | 313 | 1.76e-01 |
| GO:BP | GO:0042246 | tissue regeneration | 5 | 54 | 1.76e-01 |
| GO:BP | GO:0007284 | spermatogonial cell division | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0043277 | apoptotic cell clearance | 2 | 35 | 1.76e-01 |
| GO:BP | GO:0007183 | SMAD protein complex assembly | 1 | 12 | 1.76e-01 |
| GO:BP | GO:0044088 | regulation of vacuole organization | 2 | 50 | 1.76e-01 |
| GO:BP | GO:0044524 | protein sulfhydration | 1 | 1 | 1.76e-01 |
| GO:BP | GO:0032916 | positive regulation of transforming growth factor beta3 production | 1 | 1 | 1.76e-01 |
| GO:BP | GO:0030154 | cell differentiation | 3 | 2958 | 1.76e-01 |
| GO:BP | GO:0061767 | negative regulation of lung blood pressure | 1 | 1 | 1.76e-01 |
| GO:BP | GO:1904904 | regulation of endothelial cell-matrix adhesion via fibronectin | 1 | 3 | 1.76e-01 |
| GO:BP | GO:2000737 | negative regulation of stem cell differentiation | 3 | 24 | 1.76e-01 |
| GO:BP | GO:1905668 | positive regulation of protein localization to endosome | 2 | 13 | 1.76e-01 |
| GO:BP | GO:0045948 | positive regulation of translational initiation | 1 | 23 | 1.76e-01 |
| GO:BP | GO:0090674 | endothelial cell-matrix adhesion via fibronectin | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 1 | 101 | 1.76e-01 |
| GO:BP | GO:0002831 | regulation of response to biotic stimulus | 1 | 293 | 1.76e-01 |
| GO:BP | GO:0000349 | generation of catalytic spliceosome for first transesterification step | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0045943 | positive regulation of transcription by RNA polymerase I | 4 | 34 | 1.76e-01 |
| GO:BP | GO:1901796 | regulation of signal transduction by p53 class mediator | 8 | 101 | 1.76e-01 |
| GO:BP | GO:0016558 | protein import into peroxisome matrix | 1 | 14 | 1.76e-01 |
| GO:BP | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1 | 427 | 1.76e-01 |
| GO:BP | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response | 1 | 29 | 1.76e-01 |
| GO:BP | GO:1902682 | protein localization to pericentric heterochromatin | 1 | 1 | 1.76e-01 |
| GO:BP | GO:0003186 | tricuspid valve morphogenesis | 1 | 5 | 1.77e-01 |
| GO:BP | GO:0071604 | transforming growth factor beta production | 2 | 32 | 1.77e-01 |
| GO:BP | GO:0008584 | male gonad development | 3 | 99 | 1.77e-01 |
| GO:BP | GO:0042661 | regulation of mesodermal cell fate specification | 1 | 4 | 1.77e-01 |
| GO:BP | GO:0048566 | embryonic digestive tract development | 4 | 20 | 1.77e-01 |
| GO:BP | GO:0002683 | negative regulation of immune system process | 1 | 289 | 1.78e-01 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 29 | 462 | 1.79e-01 |
| GO:BP | GO:1901344 | response to leptomycin B | 1 | 1 | 1.79e-01 |
| GO:BP | GO:0072750 | cellular response to leptomycin B | 1 | 1 | 1.79e-01 |
| GO:BP | GO:0046546 | development of primary male sexual characteristics | 3 | 100 | 1.79e-01 |
| GO:BP | GO:0021571 | rhombomere 5 development | 1 | 2 | 1.79e-01 |
| GO:BP | GO:0035284 | brain segmentation | 1 | 2 | 1.79e-01 |
| GO:BP | GO:0046831 | regulation of RNA export from nucleus | 1 | 12 | 1.79e-01 |
| GO:BP | GO:0060713 | labyrinthine layer morphogenesis | 3 | 17 | 1.79e-01 |
| GO:BP | GO:0070306 | lens fiber cell differentiation | 4 | 30 | 1.79e-01 |
| GO:BP | GO:0048733 | sebaceous gland development | 1 | 6 | 1.79e-01 |
| GO:BP | GO:0072710 | response to hydroxyurea | 2 | 11 | 1.79e-01 |
| GO:BP | GO:2000638 | regulation of SREBP signaling pathway | 1 | 7 | 1.79e-01 |
| GO:BP | GO:0051140 | regulation of NK T cell proliferation | 1 | 3 | 1.79e-01 |
| GO:BP | GO:0001113 | transcription open complex formation at RNA polymerase II promoter | 1 | 1 | 1.80e-01 |
| GO:BP | GO:0000956 | nuclear-transcribed mRNA catabolic process | 6 | 120 | 1.80e-01 |
| GO:BP | GO:0061010 | gallbladder development | 1 | 1 | 1.80e-01 |
| GO:BP | GO:0070184 | mitochondrial tyrosyl-tRNA aminoacylation | 1 | 1 | 1.81e-01 |
| GO:BP | GO:0006338 | chromatin remodeling | 22 | 378 | 1.81e-01 |
| GO:BP | GO:0031399 | regulation of protein modification process | 12 | 1173 | 1.81e-01 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 2 | 33 | 1.81e-01 |
| GO:BP | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress | 2 | 18 | 1.81e-01 |
| GO:BP | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 2 | 7 | 1.81e-01 |
| GO:BP | GO:0019430 | removal of superoxide radicals | 2 | 17 | 1.81e-01 |
| GO:BP | GO:0034504 | protein localization to nucleus | 4 | 276 | 1.81e-01 |
| GO:BP | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 1 | 29 | 1.81e-01 |
| GO:BP | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion | 1 | 5 | 1.82e-01 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 3 | 138 | 1.82e-01 |
| GO:BP | GO:0090281 | negative regulation of calcium ion import | 1 | 6 | 1.82e-01 |
| GO:BP | GO:0045620 | negative regulation of lymphocyte differentiation | 2 | 33 | 1.82e-01 |
| GO:BP | GO:0097310 | cap2 mRNA methylation | 1 | 1 | 1.82e-01 |
| GO:BP | GO:0003263 | cardioblast proliferation | 1 | 9 | 1.82e-01 |
| GO:BP | GO:0003264 | regulation of cardioblast proliferation | 1 | 9 | 1.82e-01 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 4 | 144 | 1.82e-01 |
| GO:BP | GO:1900119 | positive regulation of execution phase of apoptosis | 1 | 7 | 1.83e-01 |
| GO:BP | GO:0060716 | labyrinthine layer blood vessel development | 2 | 16 | 1.83e-01 |
| GO:BP | GO:0035601 | protein deacylation | 8 | 116 | 1.84e-01 |
| GO:BP | GO:0072148 | epithelial cell fate commitment | 1 | 9 | 1.84e-01 |
| GO:BP | GO:0032736 | positive regulation of interleukin-13 production | 1 | 7 | 1.84e-01 |
| GO:BP | GO:0030278 | regulation of ossification | 7 | 84 | 1.84e-01 |
| GO:BP | GO:0016579 | protein deubiquitination | 2 | 129 | 1.84e-01 |
| GO:BP | GO:0097305 | response to alcohol | 1 | 159 | 1.84e-01 |
| GO:BP | GO:0046883 | regulation of hormone secretion | 1 | 168 | 1.85e-01 |
| GO:BP | GO:0033301 | cell cycle comprising mitosis without cytokinesis | 1 | 1 | 1.85e-01 |
| GO:BP | GO:0035136 | forelimb morphogenesis | 3 | 21 | 1.85e-01 |
| GO:BP | GO:0018023 | peptidyl-lysine trimethylation | 4 | 33 | 1.85e-01 |
| GO:BP | GO:0046654 | tetrahydrofolate biosynthetic process | 1 | 5 | 1.85e-01 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 5 | 211 | 1.85e-01 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 6 | 665 | 1.86e-01 |
| GO:BP | GO:0061572 | actin filament bundle organization | 3 | 140 | 1.86e-01 |
| GO:BP | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission | 1 | 3 | 1.86e-01 |
| GO:BP | GO:0099578 | regulation of translation at postsynapse, modulating synaptic transmission | 1 | 3 | 1.86e-01 |
| GO:BP | GO:0036090 | cleavage furrow ingression | 1 | 2 | 1.86e-01 |
| GO:BP | GO:0046627 | negative regulation of insulin receptor signaling pathway | 1 | 29 | 1.86e-01 |
| GO:BP | GO:0010575 | positive regulation of vascular endothelial growth factor production | 2 | 18 | 1.86e-01 |
| GO:BP | GO:0035239 | tube morphogenesis | 43 | 663 | 1.86e-01 |
| GO:BP | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2 | 11 | 1.86e-01 |
| GO:BP | GO:0023019 | signal transduction involved in regulation of gene expression | 3 | 14 | 1.86e-01 |
| GO:BP | GO:1903202 | negative regulation of oxidative stress-induced cell death | 3 | 40 | 1.86e-01 |
| GO:BP | GO:0032984 | protein-containing complex disassembly | 2 | 222 | 1.86e-01 |
| GO:BP | GO:0061140 | lung secretory cell differentiation | 1 | 5 | 1.86e-01 |
| GO:BP | GO:0010906 | regulation of glucose metabolic process | 7 | 86 | 1.86e-01 |
| GO:BP | GO:2000257 | regulation of protein activation cascade | 1 | 1 | 1.86e-01 |
| GO:BP | GO:0002820 | negative regulation of adaptive immune response | 2 | 27 | 1.87e-01 |
| GO:BP | GO:0035556 | intracellular signal transduction | 2 | 2065 | 1.87e-01 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 9 | 101 | 1.87e-01 |
| GO:BP | GO:0071630 | nuclear protein quality control by the ubiquitin-proteasome system | 1 | 3 | 1.87e-01 |
| GO:BP | GO:1905666 | regulation of protein localization to endosome | 2 | 14 | 1.88e-01 |
| GO:BP | GO:0090673 | endothelial cell-matrix adhesion | 1 | 4 | 1.88e-01 |
| GO:BP | GO:0035967 | cellular response to topologically incorrect protein | 8 | 111 | 1.88e-01 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 5 | 31 | 1.88e-01 |
| GO:BP | GO:1901751 | leukotriene A4 metabolic process | 1 | 2 | 1.88e-01 |
| GO:BP | GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1 | 3 | 1.88e-01 |
| GO:BP | GO:2000446 | regulation of macrophage migration inhibitory factor signaling pathway | 1 | 3 | 1.88e-01 |
| GO:BP | GO:1901976 | regulation of cell cycle checkpoint | 1 | 45 | 1.88e-01 |
| GO:BP | GO:0010498 | proteasomal protein catabolic process | 1 | 486 | 1.88e-01 |
| GO:BP | GO:2001304 | lipoxin B4 metabolic process | 1 | 1 | 1.88e-01 |
| GO:BP | GO:0098734 | macromolecule depalmitoylation | 2 | 13 | 1.88e-01 |
| GO:BP | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1 | 64 | 1.89e-01 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 30 | 440 | 1.89e-01 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 3 | 36 | 1.90e-01 |
| GO:BP | GO:0072173 | metanephric tubule morphogenesis | 1 | 6 | 1.90e-01 |
| GO:BP | GO:0002376 | immune system process | 2 | 1447 | 1.90e-01 |
| GO:BP | GO:0021903 | rostrocaudal neural tube patterning | 1 | 5 | 1.90e-01 |
| GO:BP | GO:0009452 | 7-methylguanosine RNA capping | 2 | 8 | 1.90e-01 |
| GO:BP | GO:0048505 | regulation of timing of cell differentiation | 1 | 7 | 1.90e-01 |
| GO:BP | GO:0045580 | regulation of T cell differentiation | 12 | 110 | 1.90e-01 |
| GO:BP | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation | 1 | 5 | 1.90e-01 |
| GO:BP | GO:0007275 | multicellular organism development | 3 | 3386 | 1.90e-01 |
| GO:BP | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle | 1 | 2 | 1.90e-01 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 17 | 251 | 1.90e-01 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2 | 43 | 1.90e-01 |
| GO:BP | GO:1900077 | negative regulation of cellular response to insulin stimulus | 1 | 31 | 1.90e-01 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 2 | 1869 | 1.90e-01 |
| GO:BP | GO:0036124 | histone H3-K9 trimethylation | 2 | 9 | 1.90e-01 |
| GO:BP | GO:0007440 | foregut morphogenesis | 2 | 7 | 1.91e-01 |
| GO:BP | GO:0050805 | negative regulation of synaptic transmission | 1 | 35 | 1.91e-01 |
| GO:BP | GO:0006999 | nuclear pore organization | 1 | 14 | 1.91e-01 |
| GO:BP | GO:0003175 | tricuspid valve development | 1 | 6 | 1.92e-01 |
| GO:BP | GO:0021570 | rhombomere 4 development | 1 | 1 | 1.92e-01 |
| GO:BP | GO:0060897 | neural plate regionalization | 1 | 6 | 1.92e-01 |
| GO:BP | GO:0006556 | S-adenosylmethionine biosynthetic process | 1 | 3 | 1.92e-01 |
| GO:BP | GO:0034605 | cellular response to heat | 1 | 51 | 1.92e-01 |
| GO:BP | GO:1900407 | regulation of cellular response to oxidative stress | 4 | 67 | 1.92e-01 |
| GO:BP | GO:1901989 | positive regulation of cell cycle phase transition | 2 | 103 | 1.92e-01 |
| GO:BP | GO:0045815 | transcription initiation-coupled chromatin remodeling | 3 | 26 | 1.92e-01 |
| GO:BP | GO:2000288 | positive regulation of myoblast proliferation | 2 | 9 | 1.92e-01 |
| GO:BP | GO:0032785 | negative regulation of DNA-templated transcription, elongation | 3 | 20 | 1.92e-01 |
| GO:BP | GO:0034620 | cellular response to unfolded protein | 7 | 91 | 1.92e-01 |
| GO:BP | GO:0034968 | histone lysine methylation | 8 | 89 | 1.92e-01 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 2 | 2139 | 1.92e-01 |
| GO:BP | GO:1902373 | negative regulation of mRNA catabolic process | 1 | 57 | 1.92e-01 |
| GO:BP | GO:0032908 | regulation of transforming growth factor beta1 production | 1 | 10 | 1.92e-01 |
| GO:BP | GO:0044334 | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 1 | 2 | 1.92e-01 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 28 | 418 | 1.92e-01 |
| GO:BP | GO:0002759 | regulation of antimicrobial humoral response | 1 | 3 | 1.92e-01 |
| GO:BP | GO:0071635 | negative regulation of transforming growth factor beta production | 1 | 10 | 1.92e-01 |
| GO:BP | GO:0003163 | sinoatrial node development | 1 | 10 | 1.92e-01 |
| GO:BP | GO:0036363 | transforming growth factor beta activation | 1 | 9 | 1.92e-01 |
| GO:BP | GO:0000380 | alternative mRNA splicing, via spliceosome | 1 | 70 | 1.94e-01 |
| GO:BP | GO:1905456 | regulation of lymphoid progenitor cell differentiation | 2 | 10 | 1.94e-01 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 2 | 11 | 1.94e-01 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 2 | 2161 | 1.94e-01 |
| GO:BP | GO:1903724 | positive regulation of centriole elongation | 1 | 5 | 1.95e-01 |
| GO:BP | GO:0030903 | notochord development | 3 | 17 | 1.95e-01 |
| GO:BP | GO:1903532 | positive regulation of secretion by cell | 1 | 199 | 1.96e-01 |
| GO:BP | GO:0010033 | response to organic substance | 2 | 1957 | 1.96e-01 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 4 | 1006 | 1.96e-01 |
| GO:BP | GO:0016242 | negative regulation of macroautophagy | 1 | 34 | 1.96e-01 |
| GO:BP | GO:0007409 | axonogenesis | 2 | 359 | 1.96e-01 |
| GO:BP | GO:0007221 | positive regulation of transcription of Notch receptor target | 1 | 7 | 1.96e-01 |
| GO:BP | GO:0098732 | macromolecule deacylation | 8 | 119 | 1.96e-01 |
| GO:BP | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 1 | 12 | 1.97e-01 |
| GO:BP | GO:0002183 | cytoplasmic translational initiation | 1 | 38 | 1.97e-01 |
| GO:BP | GO:0097084 | vascular associated smooth muscle cell development | 1 | 11 | 1.97e-01 |
| GO:BP | GO:0032239 | regulation of nucleobase-containing compound transport | 1 | 15 | 1.97e-01 |
| GO:BP | GO:0040034 | regulation of development, heterochronic | 1 | 8 | 1.97e-01 |
| GO:BP | GO:0035881 | amacrine cell differentiation | 1 | 3 | 1.97e-01 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 3 | 81 | 1.98e-01 |
| GO:BP | GO:0090076 | relaxation of skeletal muscle | 1 | 3 | 1.98e-01 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 9 | 120 | 1.99e-01 |
| GO:BP | GO:0002830 | positive regulation of type 2 immune response | 1 | 7 | 1.99e-01 |
| GO:BP | GO:0045064 | T-helper 2 cell differentiation | 1 | 10 | 1.99e-01 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 66 | 415 | 1.78e-17 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 15 | 138 | 1.18e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 1 | 77 | 1.47e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 1 | 55 | 1.47e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 1 | 84 | 1.47e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 1 | 77 | 1.47e-01 |
| KEGG | KEGG:04924 | Renin secretion | 1 | 50 | 1.47e-01 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 1 | 41 | 1.47e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 1 | 104 | 1.47e-01 |
| KEGG | KEGG:05224 | Breast cancer | 9 | 117 | 1.47e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 1 | 48 | 1.47e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 1 | 87 | 1.47e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 8 | 84 | 1.47e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 1 | 49 | 1.47e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 1 | 64 | 1.47e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 1 | 78 | 1.47e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 6 | 51 | 1.47e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 1 | 98 | 1.47e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 1 | 95 | 1.47e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 1 | 82 | 1.47e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 1 | 35 | 1.47e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 1 | 103 | 1.47e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 1 | 38 | 1.47e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 1 | 30 | 1.47e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 1 | 69 | 1.47e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 1 | 83 | 1.47e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 1 | 103 | 1.47e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 1 | 87 | 1.47e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 1 | 86 | 1.47e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 1 | 97 | 1.47e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 1 | 128 | 1.50e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 11 | 117 | 1.50e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 1 | 121 | 1.50e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 1 | 136 | 1.52e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 1 | 133 | 1.53e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 1 | 106 | 1.56e-01 |
| KEGG | KEGG:05034 | Alcoholism | 1 | 122 | 1.59e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 1 | 142 | 1.59e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 1 | 180 | 1.59e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 1 | 145 | 1.59e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 1 | 176 | 1.59e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 2 | 4 | 1.59e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 1 | 151 | 1.59e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 10 | 104 | 1.59e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 1 | 172 | 1.59e-01 |
| KEGG | KEGG:04714 | Thermogenesis | 1 | 195 | 1.62e-01 |
| KEGG | KEGG:05020 | Prion disease | 1 | 220 | 1.86e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 11 | 145 | 2.00e-01 |
| KEGG | KEGG:05016 | Huntington disease | 1 | 256 | 2.00e-01 |
Daunorubicin specific genes at 3 hours
How they may relate to 24 hour genes using GO analysis3 hours specifically (see venn below too):
Daunorubicin specific genes at 24 hours
All Daun DEGs adj. p value < 0.05
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0097659 | nucleic acid-templated transcription | 137 | 2684 | 7.33e-10 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 112 | 1991 | 7.33e-10 |
| GO:BP | GO:0006351 | DNA-templated transcription | 137 | 2683 | 7.33e-10 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 108 | 1915 | 7.33e-10 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 137 | 2714 | 1.01e-09 |
| GO:BP | GO:1903506 | regulation of nucleic acid-templated transcription | 132 | 2581 | 1.45e-09 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 148 | 3105 | 1.45e-09 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 132 | 2579 | 1.45e-09 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 140 | 2849 | 1.45e-09 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 132 | 2598 | 1.94e-09 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 149 | 3015 | 1.91e-08 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 144 | 3123 | 1.78e-07 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 145 | 3174 | 2.65e-07 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 141 | 3148 | 5.35e-07 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 139 | 3083 | 5.35e-07 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 140 | 3149 | 1.17e-06 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 143 | 3253 | 1.63e-06 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 150 | 3730 | 1.24e-05 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 169 | 4305 | 1.24e-05 |
| GO:BP | GO:0140467 | integrated stress response signaling | 4 | 34 | 5.91e-04 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 145 | 3758 | 5.91e-04 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 43 | 735 | 9.74e-04 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 166 | 4440 | 1.17e-03 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 162 | 4330 | 1.46e-03 |
| GO:BP | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus | 3 | 18 | 2.72e-03 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 167 | 4465 | 3.49e-03 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 168 | 4537 | 5.88e-03 |
| GO:BP | GO:0034599 | cellular response to oxidative stress | 6 | 239 | 7.97e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 65 | 1304 | 7.97e-03 |
| GO:BP | GO:1903508 | positive regulation of nucleic acid-templated transcription | 65 | 1304 | 7.97e-03 |
| GO:BP | GO:2001020 | regulation of response to DNA damage stimulus | 19 | 292 | 7.97e-03 |
| GO:BP | GO:0009058 | biosynthetic process | 169 | 4595 | 7.97e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 65 | 1311 | 8.55e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 71 | 1499 | 1.00e-02 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 74 | 1571 | 1.00e-02 |
| GO:BP | GO:2000121 | regulation of removal of superoxide radicals | 2 | 6 | 1.02e-02 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 53 | 1115 | 1.02e-02 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 55 | 1215 | 1.28e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 49 | 1009 | 1.29e-02 |
| GO:BP | GO:1903507 | negative regulation of nucleic acid-templated transcription | 49 | 1011 | 1.31e-02 |
| GO:BP | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 3 | 39 | 1.39e-02 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 71 | 1598 | 1.55e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 49 | 1020 | 1.57e-02 |
| GO:BP | GO:0062197 | cellular response to chemical stress | 6 | 290 | 1.62e-02 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 67 | 1431 | 1.77e-02 |
| GO:BP | GO:0036499 | PERK-mediated unfolded protein response | 3 | 17 | 1.77e-02 |
| GO:BP | GO:0043620 | regulation of DNA-templated transcription in response to stress | 3 | 44 | 1.84e-02 |
| GO:BP | GO:2000377 | regulation of reactive oxygen species metabolic process | 5 | 107 | 1.99e-02 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 5 | 195 | 2.15e-02 |
| GO:BP | GO:0034614 | cellular response to reactive oxygen species | 4 | 121 | 3.66e-02 |
| GO:BP | GO:0002244 | hematopoietic progenitor cell differentiation | 4 | 109 | 4.11e-02 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 4 | 132 | 4.22e-02 |
| GO:BP | GO:0006979 | response to oxidative stress | 6 | 349 | 4.73e-02 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 35 | 415 | 2.97e-07 |
[1] 341
Interestingly, Over half of the daunorubicin specific genes are in the
Daunorucin 24 hour group.
When I look at those 187 genes, I do not see a significant enrichment in GO:BP terms, only the KEGG pathway connection to Herpes simplex virus
###Daunorubicin 24 sigDEG
Looking at the Daunorubicin 24 hour geneset using adj. P value of 0.05, I have enrichment in the terms cell cycle and chromosome segregation.
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0000819 | sister chromatid segregation | 72 | 217 | 3.40e-07 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 62 | 179 | 4.74e-07 |
| GO:BP | GO:0000278 | mitotic cell cycle | 185 | 827 | 8.76e-07 |
| GO:BP | GO:0007059 | chromosome segregation | 82 | 369 | 3.20e-06 |
| GO:BP | GO:0140014 | mitotic nuclear division | 78 | 251 | 3.20e-06 |
| GO:BP | GO:0051301 | cell division | 150 | 570 | 3.20e-06 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 167 | 694 | 6.67e-06 |
| GO:BP | GO:0045930 | negative regulation of mitotic cell cycle | 78 | 211 | 1.28e-05 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 144 | 626 | 5.55e-05 |
| GO:BP | GO:0006541 | glutamine metabolic process | 4 | 24 | 9.25e-05 |
| GO:BP | GO:0022402 | cell cycle process | 227 | 1086 | 2.07e-04 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 42 | 139 | 2.07e-04 |
| GO:BP | GO:0000280 | nuclear division | 102 | 344 | 2.07e-04 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 82 | 273 | 2.35e-04 |
| GO:BP | GO:0051726 | regulation of cell cycle | 202 | 956 | 2.75e-04 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 20 | 42 | 3.04e-04 |
| GO:BP | GO:0007052 | mitotic spindle organization | 37 | 129 | 3.50e-04 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 36 | 121 | 3.99e-04 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 110 | 338 | 4.11e-04 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 50 | 183 | 4.24e-04 |
| GO:BP | GO:0051276 | chromosome organization | 135 | 543 | 4.26e-04 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 18 | 52 | 4.26e-04 |
| GO:BP | GO:0007051 | spindle organization | 55 | 188 | 4.62e-04 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 25 | 71 | 4.62e-04 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 32 | 79 | 4.62e-04 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 18 | 54 | 4.62e-04 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 12 | 18 | 4.62e-04 |
| GO:BP | GO:0051225 | spindle assembly | 35 | 120 | 4.62e-04 |
| GO:BP | GO:1903490 | positive regulation of mitotic cytokinesis | 7 | 7 | 4.64e-04 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 42 | 157 | 4.92e-04 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 89 | 273 | 6.73e-04 |
| GO:BP | GO:0048285 | organelle fission | 107 | 388 | 6.73e-04 |
| GO:BP | GO:0006974 | DNA damage response | 193 | 785 | 6.81e-04 |
| GO:BP | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 27 | 88 | 7.25e-04 |
| GO:BP | GO:0007080 | mitotic metaphase plate congression | 18 | 55 | 7.86e-04 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 16 | 46 | 8.14e-04 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 46 | 90 | 1.06e-03 |
| GO:BP | GO:0051255 | spindle midzone assembly | 9 | 12 | 1.12e-03 |
| GO:BP | GO:0051231 | spindle elongation | 9 | 12 | 1.12e-03 |
| GO:BP | GO:0010965 | regulation of mitotic sister chromatid separation | 18 | 58 | 1.12e-03 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 29 | 99 | 1.12e-03 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 16 | 47 | 1.12e-03 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 16 | 47 | 1.12e-03 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 16 | 47 | 1.12e-03 |
| GO:BP | GO:0051256 | mitotic spindle midzone assembly | 8 | 9 | 1.12e-03 |
| GO:BP | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 27 | 89 | 1.12e-03 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 16 | 47 | 1.12e-03 |
| GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 27 | 91 | 1.12e-03 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 27 | 100 | 1.13e-03 |
| GO:BP | GO:0051304 | chromosome separation | 25 | 76 | 1.17e-03 |
| GO:BP | GO:0051310 | metaphase plate congression | 20 | 69 | 1.27e-03 |
| GO:BP | GO:1902412 | regulation of mitotic cytokinesis | 8 | 8 | 1.27e-03 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 17 | 44 | 1.37e-03 |
| GO:BP | GO:0006177 | GMP biosynthetic process | 3 | 13 | 1.37e-03 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 17 | 44 | 1.37e-03 |
| GO:BP | GO:0006167 | AMP biosynthetic process | 3 | 14 | 1.37e-03 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 17 | 44 | 1.37e-03 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 18 | 57 | 1.41e-03 |
| GO:BP | GO:0007049 | cell cycle | 297 | 1529 | 1.41e-03 |
| GO:BP | GO:0009064 | glutamine family amino acid metabolic process | 4 | 60 | 1.41e-03 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 98 | 441 | 1.41e-03 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 16 | 48 | 1.49e-03 |
| GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 27 | 92 | 1.49e-03 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 16 | 48 | 1.49e-03 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 17 | 45 | 1.62e-03 |
| GO:BP | GO:0051306 | mitotic sister chromatid separation | 18 | 61 | 1.62e-03 |
| GO:BP | GO:0000022 | mitotic spindle elongation | 8 | 10 | 1.76e-03 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 76 | 235 | 1.80e-03 |
| GO:BP | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 10 | 69 | 1.84e-03 |
| GO:BP | GO:0006281 | DNA repair | 127 | 534 | 1.92e-03 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 56 | 209 | 2.69e-03 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 17 | 27 | 2.69e-03 |
| GO:BP | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 11 | 21 | 2.93e-03 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 21 | 75 | 3.02e-03 |
| GO:BP | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 3 | 19 | 3.22e-03 |
| GO:BP | GO:0050000 | chromosome localization | 22 | 82 | 3.25e-03 |
| GO:BP | GO:0046060 | dATP metabolic process | 2 | 3 | 3.40e-03 |
| GO:BP | GO:0009127 | purine nucleoside monophosphate biosynthetic process | 3 | 21 | 4.17e-03 |
| GO:BP | GO:0090307 | mitotic spindle assembly | 22 | 70 | 4.19e-03 |
| GO:BP | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 52 | 166 | 4.44e-03 |
| GO:BP | GO:0051783 | regulation of nuclear division | 29 | 116 | 5.53e-03 |
| GO:BP | GO:0046033 | AMP metabolic process | 3 | 22 | 6.65e-03 |
| GO:BP | GO:0060623 | regulation of chromosome condensation | 8 | 11 | 6.77e-03 |
| GO:BP | GO:0000281 | mitotic cytokinesis | 28 | 81 | 6.80e-03 |
| GO:BP | GO:0046037 | GMP metabolic process | 3 | 23 | 7.20e-03 |
| GO:BP | GO:1902423 | regulation of attachment of mitotic spindle microtubules to kinetochore | 6 | 8 | 7.30e-03 |
| GO:BP | GO:1902425 | positive regulation of attachment of mitotic spindle microtubules to kinetochore | 6 | 8 | 7.30e-03 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 79 | 148 | 7.30e-03 |
| GO:BP | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 7 | 11 | 7.83e-03 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 120 | 418 | 8.19e-03 |
| GO:BP | GO:0033044 | regulation of chromosome organization | 56 | 236 | 8.71e-03 |
| GO:BP | GO:0072331 | signal transduction by p53 class mediator | 14 | 161 | 8.71e-03 |
| GO:BP | GO:0044209 | AMP salvage | 2 | 5 | 9.24e-03 |
| GO:BP | GO:0032263 | GMP salvage | 2 | 4 | 9.24e-03 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 68 | 308 | 9.41e-03 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 84 | 391 | 1.01e-02 |
| GO:BP | GO:0051302 | regulation of cell division | 47 | 145 | 1.03e-02 |
| GO:BP | GO:0051383 | kinetochore organization | 11 | 23 | 1.07e-02 |
| GO:BP | GO:0009156 | ribonucleoside monophosphate biosynthetic process | 3 | 30 | 1.24e-02 |
| GO:BP | GO:0009112 | nucleobase metabolic process | 3 | 27 | 1.24e-02 |
| GO:BP | GO:0036166 | phenotypic switching | 5 | 7 | 1.26e-02 |
| GO:BP | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 2 | 6 | 1.28e-02 |
| GO:BP | GO:0010212 | response to ionizing radiation | 39 | 130 | 1.28e-02 |
| GO:BP | GO:0006270 | DNA replication initiation | 15 | 35 | 1.41e-02 |
| GO:BP | GO:0042770 | signal transduction in response to DNA damage | 15 | 178 | 1.65e-02 |
| GO:BP | GO:0046053 | dAMP metabolic process | 2 | 5 | 1.72e-02 |
| GO:BP | GO:0044770 | cell cycle phase transition | 102 | 504 | 1.77e-02 |
| GO:BP | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 6 | 43 | 1.89e-02 |
| GO:BP | GO:0000910 | cytokinesis | 43 | 164 | 1.89e-02 |
| GO:BP | GO:0060236 | regulation of mitotic spindle organization | 9 | 42 | 1.93e-02 |
| GO:BP | GO:0106380 | purine ribonucleotide salvage | 2 | 7 | 2.15e-02 |
| GO:BP | GO:0035878 | nail development | 2 | 8 | 2.15e-02 |
| GO:BP | GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 2 | 8 | 2.15e-02 |
| GO:BP | GO:0006260 | DNA replication | 96 | 255 | 2.15e-02 |
| GO:BP | GO:0009124 | nucleoside monophosphate biosynthetic process | 3 | 37 | 2.16e-02 |
| GO:BP | GO:0009167 | purine ribonucleoside monophosphate metabolic process | 3 | 37 | 2.16e-02 |
| GO:BP | GO:0031570 | DNA integrity checkpoint signaling | 43 | 129 | 2.23e-02 |
| GO:BP | GO:0010332 | response to gamma radiation | 17 | 50 | 2.33e-02 |
| GO:BP | GO:0044774 | mitotic DNA integrity checkpoint signaling | 28 | 85 | 2.33e-02 |
| GO:BP | GO:0046602 | regulation of mitotic centrosome separation | 6 | 8 | 2.33e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 14 | 268 | 2.33e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 14 | 268 | 2.33e-02 |
| GO:BP | GO:0009126 | purine nucleoside monophosphate metabolic process | 3 | 39 | 2.34e-02 |
| GO:BP | GO:1905820 | positive regulation of chromosome separation | 16 | 28 | 2.36e-02 |
| GO:BP | GO:0044786 | cell cycle DNA replication | 12 | 40 | 2.39e-02 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 14 | 36 | 2.63e-02 |
| GO:BP | GO:0046601 | positive regulation of centriole replication | 6 | 9 | 2.66e-02 |
| GO:BP | GO:1902969 | mitotic DNA replication | 9 | 14 | 2.68e-02 |
| GO:BP | GO:1901605 | alpha-amino acid metabolic process | 4 | 151 | 2.68e-02 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 104 | 552 | 2.73e-02 |
| GO:BP | GO:0044837 | actomyosin contractile ring organization | 5 | 7 | 2.89e-02 |
| GO:BP | GO:0090329 | regulation of DNA-templated DNA replication | 24 | 47 | 2.90e-02 |
| GO:BP | GO:0009170 | purine deoxyribonucleoside monophosphate metabolic process | 2 | 7 | 2.92e-02 |
| GO:BP | GO:0090224 | regulation of spindle organization | 9 | 45 | 3.12e-02 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 9 | 81 | 3.14e-02 |
| GO:BP | GO:1905821 | positive regulation of chromosome condensation | 6 | 8 | 3.25e-02 |
| GO:BP | GO:0006284 | base-excision repair | 11 | 44 | 3.31e-02 |
| GO:BP | GO:0009411 | response to UV | 12 | 141 | 3.31e-02 |
| GO:BP | GO:0032261 | purine nucleotide salvage | 2 | 10 | 3.31e-02 |
| GO:BP | GO:0042451 | purine nucleoside biosynthetic process | 2 | 11 | 3.31e-02 |
| GO:BP | GO:0042455 | ribonucleoside biosynthetic process | 2 | 11 | 3.31e-02 |
| GO:BP | GO:0007098 | centrosome cycle | 33 | 127 | 3.31e-02 |
| GO:BP | GO:0046129 | purine ribonucleoside biosynthetic process | 2 | 11 | 3.31e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 8 | 11 | 3.35e-02 |
| GO:BP | GO:0009394 | 2’-deoxyribonucleotide metabolic process | 3 | 35 | 3.35e-02 |
| GO:BP | GO:0009084 | glutamine family amino acid biosynthetic process | 2 | 16 | 3.37e-02 |
| GO:BP | GO:0019692 | deoxyribose phosphate metabolic process | 3 | 36 | 3.52e-02 |
| GO:BP | GO:0009262 | deoxyribonucleotide metabolic process | 3 | 36 | 3.52e-02 |
| GO:BP | GO:1990227 | paranodal junction maintenance | 1 | 2 | 3.79e-02 |
| GO:BP | GO:0019985 | translesion synthesis | 10 | 24 | 3.97e-02 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 65 | 274 | 4.07e-02 |
| GO:BP | GO:0062237 | protein localization to postsynapse | 14 | 39 | 4.10e-02 |
| GO:BP | GO:0046112 | nucleobase biosynthetic process | 2 | 18 | 4.10e-02 |
| GO:BP | GO:0061642 | chemoattraction of axon | 2 | 2 | 4.45e-02 |
| GO:BP | GO:0009161 | ribonucleoside monophosphate metabolic process | 3 | 50 | 4.57e-02 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 10 | 15 | 4.76e-02 |
| GO:BP | GO:0006290 | pyrimidine dimer repair | 1 | 8 | 4.77e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 10 | 36 | 4.77e-02 |
| GO:BP | GO:0033260 | nuclear DNA replication | 9 | 35 | 4.89e-02 |
| GO:BP | GO:0070914 | UV-damage excision repair | 3 | 13 | 4.98e-02 |
| GO:BP | GO:0060444 | branching involved in mammary gland duct morphogenesis | 17 | 20 | 5.01e-02 |
| GO:BP | GO:0000077 | DNA damage checkpoint signaling | 30 | 121 | 5.44e-02 |
| GO:BP | GO:0034404 | nucleobase-containing small molecule biosynthetic process | 2 | 15 | 5.44e-02 |
| GO:BP | GO:0009163 | nucleoside biosynthetic process | 2 | 15 | 5.44e-02 |
| GO:BP | GO:0043101 | purine-containing compound salvage | 2 | 14 | 5.44e-02 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 6 | 28 | 5.47e-02 |
| GO:BP | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 7 | 77 | 5.47e-02 |
| GO:BP | GO:2000060 | positive regulation of ubiquitin-dependent protein catabolic process | 11 | 103 | 5.47e-02 |
| GO:BP | GO:0090235 | regulation of metaphase plate congression | 7 | 13 | 5.82e-02 |
| GO:BP | GO:0032055 | negative regulation of translation in response to stress | 2 | 4 | 5.84e-02 |
| GO:BP | GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 4 | 15 | 5.84e-02 |
| GO:BP | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 8 | 12 | 5.84e-02 |
| GO:BP | GO:0090232 | positive regulation of spindle checkpoint | 8 | 12 | 5.84e-02 |
| GO:BP | GO:0061640 | cytoskeleton-dependent cytokinesis | 31 | 104 | 5.87e-02 |
| GO:BP | GO:0009151 | purine deoxyribonucleotide metabolic process | 2 | 12 | 5.87e-02 |
| GO:BP | GO:0007100 | mitotic centrosome separation | 7 | 13 | 6.18e-02 |
| GO:BP | GO:0071478 | cellular response to radiation | 31 | 156 | 6.18e-02 |
| GO:BP | GO:0000086 | G2/M transition of mitotic cell cycle | 38 | 134 | 6.18e-02 |
| GO:BP | GO:0042148 | strand invasion | 4 | 5 | 6.27e-02 |
| GO:BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4 | 18 | 6.61e-02 |
| GO:BP | GO:0015691 | cadmium ion transport | 4 | 5 | 6.66e-02 |
| GO:BP | GO:0070574 | cadmium ion transmembrane transport | 4 | 5 | 6.66e-02 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 34 | 137 | 6.71e-02 |
| GO:BP | GO:0032467 | positive regulation of cytokinesis | 15 | 33 | 6.71e-02 |
| GO:BP | GO:0043173 | nucleotide salvage | 2 | 15 | 6.97e-02 |
| GO:BP | GO:0006520 | amino acid metabolic process | 4 | 222 | 6.97e-02 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 7 | 40 | 6.97e-02 |
| GO:BP | GO:0099068 | postsynapse assembly | 9 | 32 | 6.97e-02 |
| GO:BP | GO:0044210 | ‘de novo’ CTP biosynthetic process | 1 | 2 | 6.97e-02 |
| GO:BP | GO:0051299 | centrosome separation | 10 | 14 | 7.03e-02 |
| GO:BP | GO:1990170 | stress response to cadmium ion | 2 | 2 | 7.28e-02 |
| GO:BP | GO:0034502 | protein localization to chromosome | 8 | 110 | 7.28e-02 |
| GO:BP | GO:0071585 | detoxification of cadmium ion | 2 | 2 | 7.28e-02 |
| GO:BP | GO:0010825 | positive regulation of centrosome duplication | 1 | 3 | 7.28e-02 |
| GO:BP | GO:0010032 | meiotic chromosome condensation | 4 | 6 | 7.30e-02 |
| GO:BP | GO:1901659 | glycosyl compound biosynthetic process | 2 | 19 | 7.41e-02 |
| GO:BP | GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 31 | 48 | 7.58e-02 |
| GO:BP | GO:0009123 | nucleoside monophosphate metabolic process | 3 | 64 | 7.58e-02 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 21 | 270 | 7.58e-02 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 12 | 34 | 7.61e-02 |
| GO:BP | GO:0048368 | lateral mesoderm development | 2 | 10 | 7.61e-02 |
| GO:BP | GO:0071459 | protein localization to chromosome, centromeric region | 10 | 42 | 7.61e-02 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 23 | 318 | 7.82e-02 |
| GO:BP | GO:0035611 | protein branching point deglutamylation | 1 | 1 | 7.82e-02 |
| GO:BP | GO:0044839 | cell cycle G2/M phase transition | 41 | 149 | 7.82e-02 |
| GO:BP | GO:0006144 | purine nucleobase metabolic process | 2 | 15 | 7.82e-02 |
| GO:BP | GO:0098792 | xenophagy | 9 | 12 | 7.93e-02 |
| GO:BP | GO:0032508 | DNA duplex unwinding | 40 | 74 | 8.09e-02 |
| GO:BP | GO:2001055 | positive regulation of mesenchymal cell apoptotic process | 1 | 2 | 8.09e-02 |
| GO:BP | GO:1903539 | protein localization to postsynaptic membrane | 13 | 38 | 8.09e-02 |
| GO:BP | GO:0051795 | positive regulation of timing of catagen | 1 | 3 | 8.09e-02 |
| GO:BP | GO:2000233 | negative regulation of rRNA processing | 3 | 3 | 8.09e-02 |
| GO:BP | GO:0061912 | selective autophagy | 60 | 90 | 8.09e-02 |
| GO:BP | GO:0007076 | mitotic chromosome condensation | 9 | 19 | 8.09e-02 |
| GO:BP | GO:0006312 | mitotic recombination | 8 | 22 | 8.24e-02 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 26 | 73 | 8.24e-02 |
| GO:BP | GO:0035518 | histone H2A monoubiquitination | 1 | 19 | 8.24e-02 |
| GO:BP | GO:0044818 | mitotic G2/M transition checkpoint | 19 | 50 | 8.35e-02 |
| GO:BP | GO:0071480 | cellular response to gamma radiation | 10 | 29 | 8.35e-02 |
| GO:BP | GO:1900262 | regulation of DNA-directed DNA polymerase activity | 11 | 13 | 8.35e-02 |
| GO:BP | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 28 | 92 | 8.35e-02 |
| GO:BP | GO:1900264 | positive regulation of DNA-directed DNA polymerase activity | 11 | 13 | 8.35e-02 |
| GO:BP | GO:0006259 | DNA metabolic process | 192 | 884 | 8.35e-02 |
| GO:BP | GO:0071479 | cellular response to ionizing radiation | 27 | 68 | 8.39e-02 |
| GO:BP | GO:0072201 | negative regulation of mesenchymal cell proliferation | 5 | 7 | 8.43e-02 |
| GO:BP | GO:1902115 | regulation of organelle assembly | 14 | 186 | 8.43e-02 |
| GO:BP | GO:0034508 | centromere complex assembly | 18 | 28 | 8.44e-02 |
| GO:BP | GO:0034644 | cellular response to UV | 6 | 86 | 8.44e-02 |
| GO:BP | GO:0046128 | purine ribonucleoside metabolic process | 2 | 16 | 8.52e-02 |
| GO:BP | GO:0098698 | postsynaptic specialization assembly | 6 | 23 | 8.62e-02 |
| GO:BP | GO:0006301 | postreplication repair | 13 | 34 | 8.62e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 2 | 84 | 8.86e-02 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 7 | 681 | 8.94e-02 |
| GO:BP | GO:0030174 | regulation of DNA-templated DNA replication initiation | 7 | 14 | 9.17e-02 |
| GO:BP | GO:0099625 | ventricular cardiac muscle cell membrane repolarization | 6 | 21 | 9.18e-02 |
| GO:BP | GO:0097114 | NMDA glutamate receptor clustering | 2 | 5 | 9.18e-02 |
| GO:BP | GO:1902010 | negative regulation of translation in response to endoplasmic reticulum stress | 1 | 1 | 9.18e-02 |
| GO:BP | GO:0051794 | regulation of timing of catagen | 1 | 4 | 9.22e-02 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 12 | 17 | 9.22e-02 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 12 | 17 | 9.22e-02 |
| GO:BP | GO:0044314 | protein K27-linked ubiquitination | 5 | 8 | 9.22e-02 |
| GO:BP | GO:0042637 | catagen | 1 | 4 | 9.22e-02 |
| GO:BP | GO:0097106 | postsynaptic density organization | 7 | 30 | 9.22e-02 |
| GO:BP | GO:0060364 | frontal suture morphogenesis | 1 | 4 | 9.22e-02 |
| GO:BP | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity | 2 | 5 | 9.22e-02 |
| GO:BP | GO:0035880 | embryonic nail plate morphogenesis | 1 | 4 | 9.22e-02 |
| GO:BP | GO:0006189 | ‘de novo’ IMP biosynthetic process | 5 | 6 | 9.22e-02 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 12 | 17 | 9.22e-02 |
| GO:BP | GO:0033554 | cellular response to stress | 58 | 1681 | 9.27e-02 |
| GO:BP | GO:0060169 | negative regulation of adenosine receptor signaling pathway | 1 | 1 | 9.30e-02 |
| GO:BP | GO:1903724 | positive regulation of centriole elongation | 1 | 5 | 9.30e-02 |
| GO:BP | GO:0046111 | xanthine biosynthetic process | 1 | 1 | 9.30e-02 |
| GO:BP | GO:0060407 | negative regulation of penile erection | 1 | 1 | 9.30e-02 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 7 | 696 | 9.36e-02 |
| GO:BP | GO:0032392 | DNA geometric change | 42 | 80 | 9.53e-02 |
| GO:BP | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 4 | 6 | 9.53e-02 |
| GO:BP | GO:0000915 | actomyosin contractile ring assembly | 4 | 6 | 9.53e-02 |
| GO:BP | GO:0006082 | organic acid metabolic process | 7 | 700 | 9.55e-02 |
| GO:BP | GO:0071364 | cellular response to epidermal growth factor stimulus | 11 | 41 | 9.55e-02 |
| GO:BP | GO:0000302 | response to reactive oxygen species | 15 | 160 | 9.58e-02 |
| GO:BP | GO:0035970 | peptidyl-threonine dephosphorylation | 8 | 17 | 9.59e-02 |
| GO:BP | GO:1905832 | positive regulation of spindle assembly | 5 | 7 | 9.59e-02 |
| GO:BP | GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 2 | 18 | 9.59e-02 |
| GO:BP | GO:0006287 | base-excision repair, gap-filling | 4 | 14 | 9.69e-02 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 26 | 464 | 9.69e-02 |
| GO:BP | GO:0106014 | regulation of inflammatory response to wounding | 2 | 4 | 9.69e-02 |
| GO:BP | GO:0071168 | protein localization to chromatin | 6 | 48 | 9.82e-02 |
| GO:BP | GO:0033522 | histone H2A ubiquitination | 1 | 28 | 9.84e-02 |
| GO:BP | GO:0006268 | DNA unwinding involved in DNA replication | 12 | 22 | 9.86e-02 |
| GO:BP | GO:0042542 | response to hydrogen peroxide | 14 | 103 | 9.86e-02 |
| GO:BP | GO:0099633 | protein localization to postsynaptic specialization membrane | 8 | 19 | 9.94e-02 |
| GO:BP | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 14 | 41 | 9.94e-02 |
| GO:BP | GO:0097065 | anterior head development | 6 | 7 | 9.94e-02 |
| GO:BP | GO:0099645 | neurotransmitter receptor localization to postsynaptic specialization membrane | 8 | 19 | 9.94e-02 |
| GO:BP | GO:1902292 | cell cycle DNA replication initiation | 3 | 5 | 1.00e-01 |
| GO:BP | GO:1902975 | mitotic DNA replication initiation | 3 | 5 | 1.00e-01 |
| GO:BP | GO:1902315 | nuclear cell cycle DNA replication initiation | 3 | 5 | 1.00e-01 |
| GO:BP | GO:0048818 | positive regulation of hair follicle maturation | 1 | 5 | 1.02e-01 |
| GO:BP | GO:0006513 | protein monoubiquitination | 2 | 80 | 1.02e-01 |
| GO:BP | GO:0051066 | dihydrobiopterin metabolic process | 2 | 2 | 1.03e-01 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 6 | 25 | 1.03e-01 |
| GO:BP | GO:0010390 | histone monoubiquitination | 1 | 31 | 1.03e-01 |
| GO:BP | GO:0042278 | purine nucleoside metabolic process | 2 | 20 | 1.04e-01 |
| GO:BP | GO:0051095 | regulation of helicase activity | 8 | 12 | 1.04e-01 |
| GO:BP | GO:0031503 | protein-containing complex localization | 46 | 168 | 1.06e-01 |
| GO:BP | GO:0002076 | osteoblast development | 2 | 12 | 1.06e-01 |
| GO:BP | GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 5 | 11 | 1.06e-01 |
| GO:BP | GO:0061724 | lipophagy | 2 | 7 | 1.06e-01 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 8 | 21 | 1.07e-01 |
| GO:BP | GO:0007079 | mitotic chromosome movement towards spindle pole | 3 | 4 | 1.12e-01 |
| GO:BP | GO:1903925 | response to bisphenol A | 3 | 4 | 1.13e-01 |
| GO:BP | GO:0006175 | dATP biosynthetic process | 1 | 1 | 1.13e-01 |
| GO:BP | GO:0061644 | protein localization to CENP-A containing chromatin | 3 | 17 | 1.13e-01 |
| GO:BP | GO:0090427 | activation of meiosis | 1 | 4 | 1.13e-01 |
| GO:BP | GO:0046599 | regulation of centriole replication | 10 | 21 | 1.13e-01 |
| GO:BP | GO:0032792 | negative regulation of CREB transcription factor activity | 1 | 4 | 1.13e-01 |
| GO:BP | GO:1903926 | cellular response to bisphenol A | 3 | 4 | 1.13e-01 |
| GO:BP | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 1 | 1 | 1.13e-01 |
| GO:BP | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process | 1 | 1 | 1.13e-01 |
| GO:BP | GO:1903722 | regulation of centriole elongation | 1 | 7 | 1.13e-01 |
| GO:BP | GO:2000807 | regulation of synaptic vesicle clustering | 5 | 7 | 1.14e-01 |
| GO:BP | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process | 6 | 6 | 1.15e-01 |
| GO:BP | GO:0032954 | regulation of cytokinetic process | 3 | 3 | 1.16e-01 |
| GO:BP | GO:0048340 | paraxial mesoderm morphogenesis | 7 | 9 | 1.17e-01 |
| GO:BP | GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 14 | 35 | 1.17e-01 |
| GO:BP | GO:0023019 | signal transduction involved in regulation of gene expression | 2 | 14 | 1.18e-01 |
| GO:BP | GO:0043094 | cellular metabolic compound salvage | 2 | 25 | 1.18e-01 |
| GO:BP | GO:0006298 | mismatch repair | 4 | 29 | 1.18e-01 |
| GO:BP | GO:0051640 | organelle localization | 92 | 503 | 1.18e-01 |
| GO:BP | GO:0035418 | protein localization to synapse | 18 | 68 | 1.19e-01 |
| GO:BP | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 2 | 9 | 1.19e-01 |
| GO:BP | GO:0061511 | centriole elongation | 1 | 8 | 1.20e-01 |
| GO:BP | GO:0006542 | glutamine biosynthetic process | 1 | 2 | 1.20e-01 |
| GO:BP | GO:0032506 | cytokinetic process | 13 | 39 | 1.21e-01 |
| GO:BP | GO:1904861 | excitatory synapse assembly | 6 | 26 | 1.23e-01 |
| GO:BP | GO:0015936 | coenzyme A metabolic process | 15 | 18 | 1.23e-01 |
| GO:BP | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization | 3 | 7 | 1.23e-01 |
| GO:BP | GO:0060603 | mammary gland duct morphogenesis | 5 | 28 | 1.24e-01 |
| GO:BP | GO:0061312 | BMP signaling pathway involved in heart development | 1 | 7 | 1.24e-01 |
| GO:BP | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2 | 2 | 1.25e-01 |
| GO:BP | GO:0009260 | ribonucleotide biosynthetic process | 4 | 191 | 1.29e-01 |
| GO:BP | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 5 | 15 | 1.30e-01 |
| GO:BP | GO:0035973 | aggrephagy | 2 | 8 | 1.30e-01 |
| GO:BP | GO:0021694 | cerebellar Purkinje cell layer formation | 1 | 12 | 1.31e-01 |
| GO:BP | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 16 | 22 | 1.31e-01 |
| GO:BP | GO:0006979 | response to oxidative stress | 22 | 352 | 1.31e-01 |
| GO:BP | GO:0009439 | cyanate metabolic process | 2 | 2 | 1.31e-01 |
| GO:BP | GO:0009440 | cyanate catabolic process | 2 | 2 | 1.31e-01 |
| GO:BP | GO:0006655 | phosphatidylglycerol biosynthetic process | 9 | 9 | 1.31e-01 |
| GO:BP | GO:0006275 | regulation of DNA replication | 54 | 116 | 1.31e-01 |
| GO:BP | GO:0038101 | sequestering of nodal from receptor via nodal binding | 1 | 1 | 1.33e-01 |
| GO:BP | GO:0016574 | histone ubiquitination | 1 | 46 | 1.33e-01 |
| GO:BP | GO:0042176 | regulation of protein catabolic process | 19 | 331 | 1.33e-01 |
| GO:BP | GO:1901976 | regulation of cell cycle checkpoint | 11 | 45 | 1.34e-01 |
| GO:BP | GO:1901031 | regulation of response to reactive oxygen species | 6 | 28 | 1.34e-01 |
| GO:BP | GO:0090215 | regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity | 4 | 4 | 1.35e-01 |
| GO:BP | GO:0043103 | hypoxanthine salvage | 1 | 2 | 1.35e-01 |
| GO:BP | GO:0002636 | positive regulation of germinal center formation | 1 | 1 | 1.35e-01 |
| GO:BP | GO:0072093 | metanephric renal vesicle formation | 4 | 4 | 1.35e-01 |
| GO:BP | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization | 5 | 16 | 1.35e-01 |
| GO:BP | GO:1901978 | positive regulation of cell cycle checkpoint | 7 | 19 | 1.35e-01 |
| GO:BP | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 19 | 60 | 1.35e-01 |
| GO:BP | GO:0046390 | ribose phosphate biosynthetic process | 4 | 197 | 1.35e-01 |
| GO:BP | GO:0003402 | planar cell polarity pathway involved in axis elongation | 4 | 6 | 1.35e-01 |
| GO:BP | GO:0070256 | negative regulation of mucus secretion | 1 | 2 | 1.35e-01 |
| GO:BP | GO:0030509 | BMP signaling pathway | 2 | 123 | 1.35e-01 |
| GO:BP | GO:0046110 | xanthine metabolic process | 1 | 1 | 1.35e-01 |
| GO:BP | GO:0046061 | dATP catabolic process | 1 | 2 | 1.35e-01 |
| GO:BP | GO:0009314 | response to radiation | 20 | 352 | 1.35e-01 |
| GO:BP | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound | 1 | 8 | 1.35e-01 |
| GO:BP | GO:0051100 | negative regulation of binding | 2 | 135 | 1.35e-01 |
| GO:BP | GO:0044283 | small molecule biosynthetic process | 6 | 425 | 1.35e-01 |
| GO:BP | GO:0045217 | cell-cell junction maintenance | 1 | 13 | 1.35e-01 |
| GO:BP | GO:0072033 | renal vesicle formation | 6 | 8 | 1.35e-01 |
| GO:BP | GO:0046653 | tetrahydrofolate metabolic process | 6 | 14 | 1.39e-01 |
| GO:BP | GO:0044851 | hair cycle phase | 1 | 9 | 1.39e-01 |
| GO:BP | GO:0044848 | biological phase | 1 | 9 | 1.39e-01 |
| GO:BP | GO:1901970 | positive regulation of mitotic sister chromatid separation | 10 | 18 | 1.39e-01 |
| GO:BP | GO:0046341 | CDP-diacylglycerol metabolic process | 12 | 13 | 1.39e-01 |
| GO:BP | GO:0046386 | deoxyribose phosphate catabolic process | 2 | 22 | 1.39e-01 |
| GO:BP | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 13 | 17 | 1.39e-01 |
| GO:BP | GO:0032020 | ISG15-protein conjugation | 1 | 6 | 1.39e-01 |
| GO:BP | GO:0032223 | negative regulation of synaptic transmission, cholinergic | 1 | 1 | 1.39e-01 |
| GO:BP | GO:0007032 | endosome organization | 15 | 92 | 1.39e-01 |
| GO:BP | GO:0042982 | amyloid precursor protein metabolic process | 5 | 69 | 1.39e-01 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 10 | 82 | 1.39e-01 |
| GO:BP | GO:1903052 | positive regulation of proteolysis involved in protein catabolic process | 11 | 127 | 1.39e-01 |
| GO:BP | GO:0045617 | negative regulation of keratinocyte differentiation | 1 | 3 | 1.39e-01 |
| GO:BP | GO:0060088 | auditory receptor cell stereocilium organization | 1 | 9 | 1.39e-01 |
| GO:BP | GO:0009264 | deoxyribonucleotide catabolic process | 2 | 22 | 1.39e-01 |
| GO:BP | GO:0048819 | regulation of hair follicle maturation | 1 | 9 | 1.39e-01 |
| GO:BP | GO:0060363 | cranial suture morphogenesis | 1 | 8 | 1.39e-01 |
| GO:BP | GO:0009119 | ribonucleoside metabolic process | 4 | 23 | 1.39e-01 |
| GO:BP | GO:0036462 | TRAIL-activated apoptotic signaling pathway | 6 | 10 | 1.39e-01 |
| GO:BP | GO:0070849 | response to epidermal growth factor | 11 | 44 | 1.39e-01 |
| GO:BP | GO:0048341 | paraxial mesoderm formation | 5 | 6 | 1.39e-01 |
| GO:BP | GO:0019856 | pyrimidine nucleobase biosynthetic process | 1 | 8 | 1.39e-01 |
| GO:BP | GO:0002097 | tRNA wobble base modification | 12 | 19 | 1.39e-01 |
| GO:BP | GO:0071772 | response to BMP | 2 | 131 | 1.40e-01 |
| GO:BP | GO:0021571 | rhombomere 5 development | 2 | 2 | 1.40e-01 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 11 | 132 | 1.40e-01 |
| GO:BP | GO:0086016 | AV node cell action potential | 7 | 9 | 1.40e-01 |
| GO:BP | GO:0006543 | glutamine catabolic process | 1 | 3 | 1.40e-01 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 2 | 131 | 1.40e-01 |
| GO:BP | GO:0021692 | cerebellar Purkinje cell layer morphogenesis | 1 | 16 | 1.40e-01 |
| GO:BP | GO:0035284 | brain segmentation | 2 | 2 | 1.40e-01 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 7 | 9 | 1.40e-01 |
| GO:BP | GO:0098880 | maintenance of postsynaptic specialization structure | 7 | 9 | 1.40e-01 |
| GO:BP | GO:0009092 | homoserine metabolic process | 4 | 5 | 1.41e-01 |
| GO:BP | GO:0009894 | regulation of catabolic process | 41 | 875 | 1.41e-01 |
| GO:BP | GO:0043570 | maintenance of DNA repeat elements | 2 | 6 | 1.41e-01 |
| GO:BP | GO:0072308 | negative regulation of metanephric nephron tubule epithelial cell differentiation | 1 | 1 | 1.41e-01 |
| GO:BP | GO:0060346 | bone trabecula formation | 1 | 9 | 1.41e-01 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 3 | 440 | 1.41e-01 |
| GO:BP | GO:0043928 | exonucleolytic catabolism of deadenylated mRNA | 2 | 13 | 1.41e-01 |
| GO:BP | GO:0019346 | transsulfuration | 4 | 5 | 1.41e-01 |
| GO:BP | GO:0021591 | ventricular system development | 20 | 29 | 1.41e-01 |
| GO:BP | GO:0098910 | regulation of atrial cardiac muscle cell action potential | 4 | 4 | 1.41e-01 |
| GO:BP | GO:0007062 | sister chromatid cohesion | 6 | 52 | 1.41e-01 |
| GO:BP | GO:0002093 | auditory receptor cell morphogenesis | 1 | 10 | 1.41e-01 |
| GO:BP | GO:0009166 | nucleotide catabolic process | 3 | 69 | 1.44e-01 |
| GO:BP | GO:0097176 | epoxide metabolic process | 3 | 4 | 1.44e-01 |
| GO:BP | GO:0099607 | lateral attachment of mitotic spindle microtubules to kinetochore | 2 | 2 | 1.44e-01 |
| GO:BP | GO:0097113 | AMPA glutamate receptor clustering | 3 | 7 | 1.44e-01 |
| GO:BP | GO:0097688 | glutamate receptor clustering | 3 | 7 | 1.44e-01 |
| GO:BP | GO:0007099 | centriole replication | 3 | 38 | 1.44e-01 |
| GO:BP | GO:0072077 | renal vesicle morphogenesis | 10 | 14 | 1.44e-01 |
| GO:BP | GO:0030953 | astral microtubule organization | 8 | 11 | 1.44e-01 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 2 | 116 | 1.44e-01 |
| GO:BP | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling | 2 | 3 | 1.45e-01 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 42 | 868 | 1.45e-01 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 4 | 194 | 1.45e-01 |
| GO:BP | GO:0060157 | urinary bladder development | 2 | 2 | 1.46e-01 |
| GO:BP | GO:1901607 | alpha-amino acid biosynthetic process | 2 | 59 | 1.49e-01 |
| GO:BP | GO:0061709 | reticulophagy | 14 | 17 | 1.49e-01 |
| GO:BP | GO:0085020 | protein K6-linked ubiquitination | 8 | 9 | 1.50e-01 |
| GO:BP | GO:0097293 | XMP biosynthetic process | 5 | 7 | 1.52e-01 |
| GO:BP | GO:0097294 | ‘de novo’ XMP biosynthetic process | 5 | 7 | 1.52e-01 |
| GO:BP | GO:1990936 | vascular associated smooth muscle cell dedifferentiation | 2 | 2 | 1.52e-01 |
| GO:BP | GO:1905174 | regulation of vascular associated smooth muscle cell dedifferentiation | 2 | 2 | 1.52e-01 |
| GO:BP | GO:0097292 | XMP metabolic process | 5 | 7 | 1.52e-01 |
| GO:BP | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 4 | 76 | 1.52e-01 |
| GO:BP | GO:0090071 | negative regulation of ribosome biogenesis | 3 | 4 | 1.52e-01 |
| GO:BP | GO:0090678 | cell dedifferentiation involved in phenotypic switching | 2 | 2 | 1.52e-01 |
| GO:BP | GO:0018904 | ether metabolic process | 8 | 20 | 1.53e-01 |
| GO:BP | GO:0097091 | synaptic vesicle clustering | 8 | 16 | 1.56e-01 |
| GO:BP | GO:0045828 | positive regulation of isoprenoid metabolic process | 1 | 1 | 1.56e-01 |
| GO:BP | GO:1900054 | positive regulation of retinoic acid biosynthetic process | 1 | 1 | 1.56e-01 |
| GO:BP | GO:0061820 | telomeric D-loop disassembly | 5 | 8 | 1.57e-01 |
| GO:BP | GO:0051798 | positive regulation of hair follicle development | 1 | 9 | 1.57e-01 |
| GO:BP | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 3 | 41 | 1.57e-01 |
| GO:BP | GO:0070212 | protein poly-ADP-ribosylation | 5 | 6 | 1.57e-01 |
| GO:BP | GO:0033043 | regulation of organelle organization | 52 | 1028 | 1.57e-01 |
| GO:BP | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 19 | 62 | 1.57e-01 |
| GO:BP | GO:0086045 | membrane depolarization during AV node cell action potential | 4 | 5 | 1.58e-01 |
| GO:BP | GO:0046101 | hypoxanthine biosynthetic process | 1 | 3 | 1.58e-01 |
| GO:BP | GO:0098869 | cellular oxidant detoxification | 6 | 65 | 1.58e-01 |
| GO:BP | GO:0042454 | ribonucleoside catabolic process | 3 | 12 | 1.58e-01 |
| GO:BP | GO:0046090 | deoxyadenosine metabolic process | 1 | 2 | 1.58e-01 |
| GO:BP | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 29 | 85 | 1.58e-01 |
| GO:BP | GO:0031297 | replication fork processing | 25 | 42 | 1.58e-01 |
| GO:BP | GO:0002227 | innate immune response in mucosa | 2 | 8 | 1.58e-01 |
| GO:BP | GO:0043096 | purine nucleobase salvage | 1 | 3 | 1.58e-01 |
| GO:BP | GO:0006157 | deoxyadenosine catabolic process | 1 | 2 | 1.58e-01 |
| GO:BP | GO:0046103 | inosine biosynthetic process | 1 | 3 | 1.58e-01 |
| GO:BP | GO:0034501 | protein localization to kinetochore | 10 | 18 | 1.59e-01 |
| GO:BP | GO:0032901 | positive regulation of neurotrophin production | 1 | 1 | 1.59e-01 |
| GO:BP | GO:0031571 | mitotic G1 DNA damage checkpoint signaling | 4 | 30 | 1.59e-01 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 12 | 39 | 1.59e-01 |
| GO:BP | GO:1903083 | protein localization to condensed chromosome | 10 | 18 | 1.59e-01 |
| GO:BP | GO:0072719 | cellular response to cisplatin | 4 | 4 | 1.60e-01 |
| GO:BP | GO:0006285 | base-excision repair, AP site formation | 4 | 12 | 1.61e-01 |
| GO:BP | GO:0060117 | auditory receptor cell development | 1 | 14 | 1.61e-01 |
| GO:BP | GO:2001053 | regulation of mesenchymal cell apoptotic process | 1 | 5 | 1.61e-01 |
| GO:BP | GO:0061430 | bone trabecula morphogenesis | 1 | 12 | 1.61e-01 |
| GO:BP | GO:1902414 | protein localization to cell junction | 12 | 93 | 1.62e-01 |
| GO:BP | GO:0007617 | mating behavior | 2 | 21 | 1.63e-01 |
| GO:BP | GO:0098534 | centriole assembly | 3 | 41 | 1.65e-01 |
| GO:BP | GO:0021697 | cerebellar cortex formation | 1 | 22 | 1.65e-01 |
| GO:BP | GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 2 | 2 | 1.65e-01 |
| GO:BP | GO:0008652 | amino acid biosynthetic process | 2 | 64 | 1.65e-01 |
| GO:BP | GO:0034249 | negative regulation of amide metabolic process | 8 | 186 | 1.66e-01 |
| GO:BP | GO:0051865 | protein autoubiquitination | 1 | 75 | 1.66e-01 |
| GO:BP | GO:0051096 | positive regulation of helicase activity | 2 | 7 | 1.66e-01 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 16 | 219 | 1.66e-01 |
| GO:BP | GO:0008315 | G2/MI transition of meiotic cell cycle | 5 | 5 | 1.66e-01 |
| GO:BP | GO:0045683 | negative regulation of epidermis development | 1 | 6 | 1.66e-01 |
| GO:BP | GO:0140013 | meiotic nuclear division | 39 | 120 | 1.66e-01 |
| GO:BP | GO:0086069 | bundle of His cell to Purkinje myocyte communication | 8 | 14 | 1.66e-01 |
| GO:BP | GO:0006289 | nucleotide-excision repair | 1 | 79 | 1.66e-01 |
| GO:BP | GO:1901491 | negative regulation of lymphangiogenesis | 3 | 3 | 1.66e-01 |
| GO:BP | GO:0045605 | negative regulation of epidermal cell differentiation | 1 | 6 | 1.66e-01 |
| GO:BP | GO:0060996 | dendritic spine development | 9 | 80 | 1.66e-01 |
| GO:BP | GO:0090677 | reversible differentiation | 3 | 5 | 1.66e-01 |
| GO:BP | GO:1990709 | presynaptic active zone organization | 5 | 9 | 1.66e-01 |
| GO:BP | GO:0035609 | C-terminal protein deglutamylation | 1 | 2 | 1.67e-01 |
| GO:BP | GO:0044819 | mitotic G1/S transition checkpoint signaling | 4 | 30 | 1.67e-01 |
| GO:BP | GO:0014029 | neural crest formation | 4 | 13 | 1.67e-01 |
| GO:BP | GO:0072525 | pyridine-containing compound biosynthetic process | 4 | 22 | 1.68e-01 |
| GO:BP | GO:0048790 | maintenance of presynaptic active zone structure | 4 | 6 | 1.68e-01 |
| GO:BP | GO:0021680 | cerebellar Purkinje cell layer development | 1 | 24 | 1.69e-01 |
| GO:BP | GO:0000921 | septin ring assembly | 1 | 1 | 1.69e-01 |
| GO:BP | GO:1901751 | leukotriene A4 metabolic process | 2 | 2 | 1.69e-01 |
| GO:BP | GO:0034599 | cellular response to oxidative stress | 9 | 240 | 1.69e-01 |
| GO:BP | GO:1901292 | nucleoside phosphate catabolic process | 3 | 74 | 1.69e-01 |
| GO:BP | GO:0030859 | polarized epithelial cell differentiation | 5 | 19 | 1.69e-01 |
| GO:BP | GO:0030879 | mammary gland development | 2 | 106 | 1.69e-01 |
| GO:BP | GO:1900121 | negative regulation of receptor binding | 1 | 8 | 1.69e-01 |
| GO:BP | GO:0009214 | cyclic nucleotide catabolic process | 2 | 13 | 1.69e-01 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 41 | 135 | 1.71e-01 |
| GO:BP | GO:0048820 | hair follicle maturation | 1 | 15 | 1.71e-01 |
| GO:BP | GO:0046521 | sphingoid catabolic process | 1 | 1 | 1.71e-01 |
| GO:BP | GO:1905364 | regulation of endosomal vesicle fusion | 1 | 1 | 1.71e-01 |
| GO:BP | GO:0097152 | mesenchymal cell apoptotic process | 1 | 7 | 1.71e-01 |
| GO:BP | GO:0110156 | methylguanosine-cap decapping | 2 | 14 | 1.71e-01 |
| GO:BP | GO:0022616 | DNA strand elongation | 11 | 35 | 1.71e-01 |
| GO:BP | GO:0090521 | podocyte cell migration | 2 | 7 | 1.71e-01 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 9 | 26 | 1.71e-01 |
| GO:BP | GO:0009154 | purine ribonucleotide catabolic process | 3 | 40 | 1.71e-01 |
| GO:BP | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential | 3 | 3 | 1.71e-01 |
| GO:BP | GO:1905671 | regulation of lysosome organization | 6 | 6 | 1.71e-01 |
| GO:BP | GO:0050885 | neuromuscular process controlling balance | 5 | 35 | 1.71e-01 |
| GO:BP | GO:0086017 | Purkinje myocyte action potential | 3 | 4 | 1.72e-01 |
| GO:BP | GO:1901490 | regulation of lymphangiogenesis | 4 | 5 | 1.72e-01 |
| GO:BP | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation | 2 | 5 | 1.72e-01 |
| GO:BP | GO:0090231 | regulation of spindle checkpoint | 7 | 19 | 1.72e-01 |
| GO:BP | GO:1903504 | regulation of mitotic spindle checkpoint | 7 | 19 | 1.72e-01 |
| GO:BP | GO:0071897 | DNA biosynthetic process | 66 | 175 | 1.72e-01 |
| GO:BP | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint | 7 | 19 | 1.72e-01 |
| GO:BP | GO:1900176 | negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry | 1 | 1 | 1.73e-01 |
| GO:BP | GO:0140131 | positive regulation of lymphocyte chemotaxis | 4 | 10 | 1.73e-01 |
| GO:BP | GO:1900146 | negative regulation of nodal signaling pathway involved in determination of left/right asymmetry | 1 | 1 | 1.73e-01 |
| GO:BP | GO:0006552 | leucine catabolic process | 6 | 6 | 1.73e-01 |
| GO:BP | GO:0006537 | glutamate biosynthetic process | 1 | 5 | 1.74e-01 |
| GO:BP | GO:0051754 | meiotic sister chromatid cohesion, centromeric | 2 | 4 | 1.74e-01 |
| GO:BP | GO:0071677 | positive regulation of mononuclear cell migration | 8 | 39 | 1.76e-01 |
| GO:BP | GO:0070987 | error-free translesion synthesis | 3 | 5 | 1.76e-01 |
| GO:BP | GO:0002905 | regulation of mature B cell apoptotic process | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 8 | 9 | 1.76e-01 |
| GO:BP | GO:0006154 | adenosine catabolic process | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0051382 | kinetochore assembly | 7 | 18 | 1.76e-01 |
| GO:BP | GO:0006241 | CTP biosynthetic process | 1 | 12 | 1.76e-01 |
| GO:BP | GO:0060167 | regulation of adenosine receptor signaling pathway | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0002901 | mature B cell apoptotic process | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0002906 | negative regulation of mature B cell apoptotic process | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0051418 | microtubule nucleation by microtubule organizing center | 5 | 5 | 1.76e-01 |
| GO:BP | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process | 1 | 4 | 1.76e-01 |
| GO:BP | GO:0034331 | cell junction maintenance | 7 | 40 | 1.76e-01 |
| GO:BP | GO:0051932 | synaptic transmission, GABAergic | 4 | 36 | 1.76e-01 |
| GO:BP | GO:0046124 | purine deoxyribonucleoside catabolic process | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0046100 | hypoxanthine metabolic process | 1 | 3 | 1.76e-01 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 10 | 29 | 1.76e-01 |
| GO:BP | GO:1903546 | protein localization to photoreceptor outer segment | 4 | 5 | 1.76e-01 |
| GO:BP | GO:0046059 | dAMP catabolic process | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0016236 | macroautophagy | 109 | 308 | 1.76e-01 |
| GO:BP | GO:0071482 | cellular response to light stimulus | 6 | 99 | 1.76e-01 |
| GO:BP | GO:0036258 | multivesicular body assembly | 19 | 32 | 1.76e-01 |
| GO:BP | GO:0016024 | CDP-diacylglycerol biosynthetic process | 11 | 12 | 1.76e-01 |
| GO:BP | GO:0035610 | protein side chain deglutamylation | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0072087 | renal vesicle development | 10 | 15 | 1.76e-01 |
| GO:BP | GO:0090222 | centrosome-templated microtubule nucleation | 1 | 2 | 1.76e-01 |
| GO:BP | GO:0097120 | receptor localization to synapse | 15 | 55 | 1.76e-01 |
| GO:BP | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 1 | 14 | 1.76e-01 |
| GO:BP | GO:0045836 | positive regulation of meiotic nuclear division | 1 | 9 | 1.76e-01 |
| GO:BP | GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 11 | 160 | 1.76e-01 |
| GO:BP | GO:0048681 | negative regulation of axon regeneration | 1 | 11 | 1.78e-01 |
| GO:BP | GO:0062197 | cellular response to chemical stress | 10 | 293 | 1.78e-01 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 24 | 45 | 1.78e-01 |
| GO:BP | GO:0006206 | pyrimidine nucleobase metabolic process | 1 | 13 | 1.79e-01 |
| GO:BP | GO:0002027 | regulation of heart rate | 17 | 86 | 1.79e-01 |
| GO:BP | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process | 1 | 13 | 1.79e-01 |
| GO:BP | GO:0010459 | negative regulation of heart rate | 2 | 7 | 1.80e-01 |
| GO:BP | GO:0000076 | DNA replication checkpoint signaling | 9 | 15 | 1.80e-01 |
| GO:BP | GO:0071103 | DNA conformation change | 43 | 87 | 1.81e-01 |
| GO:BP | GO:0090129 | positive regulation of synapse maturation | 1 | 8 | 1.81e-01 |
| GO:BP | GO:0009171 | purine deoxyribonucleoside monophosphate biosynthetic process | 1 | 3 | 1.81e-01 |
| GO:BP | GO:0106381 | purine deoxyribonucleotide salvage | 1 | 3 | 1.81e-01 |
| GO:BP | GO:0006170 | dAMP biosynthetic process | 1 | 3 | 1.81e-01 |
| GO:BP | GO:0099623 | regulation of cardiac muscle cell membrane repolarization | 5 | 20 | 1.81e-01 |
| GO:BP | GO:0106383 | dAMP salvage | 1 | 3 | 1.81e-01 |
| GO:BP | GO:0009165 | nucleotide biosynthetic process | 4 | 240 | 1.81e-01 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 6 | 75 | 1.81e-01 |
| GO:BP | GO:0050974 | detection of mechanical stimulus involved in sensory perception | 1 | 20 | 1.82e-01 |
| GO:BP | GO:0070925 | organelle assembly | 69 | 817 | 1.82e-01 |
| GO:BP | GO:1902065 | response to L-glutamate | 7 | 11 | 1.82e-01 |
| GO:BP | GO:0070571 | negative regulation of neuron projection regeneration | 1 | 12 | 1.82e-01 |
| GO:BP | GO:0046036 | CTP metabolic process | 1 | 14 | 1.82e-01 |
| GO:BP | GO:0001507 | acetylcholine catabolic process in synaptic cleft | 1 | 2 | 1.82e-01 |
| GO:BP | GO:0050686 | negative regulation of mRNA processing | 14 | 25 | 1.82e-01 |
| GO:BP | GO:0035445 | borate transmembrane transport | 1 | 1 | 1.82e-01 |
| GO:BP | GO:0035283 | central nervous system segmentation | 2 | 2 | 1.82e-01 |
| GO:BP | GO:0003094 | glomerular filtration | 7 | 21 | 1.82e-01 |
| GO:BP | GO:0044088 | regulation of vacuole organization | 32 | 50 | 1.82e-01 |
| GO:BP | GO:0019098 | reproductive behavior | 2 | 26 | 1.82e-01 |
| GO:BP | GO:0046713 | borate transport | 1 | 1 | 1.82e-01 |
| GO:BP | GO:0021696 | cerebellar cortex morphogenesis | 1 | 30 | 1.82e-01 |
| GO:BP | GO:1904029 | regulation of cyclin-dependent protein kinase activity | 29 | 88 | 1.82e-01 |
| GO:BP | GO:0006244 | pyrimidine nucleotide catabolic process | 5 | 19 | 1.82e-01 |
| GO:BP | GO:0006220 | pyrimidine nucleotide metabolic process | 7 | 46 | 1.82e-01 |
| GO:BP | GO:1901293 | nucleoside phosphate biosynthetic process | 4 | 241 | 1.82e-01 |
| GO:BP | GO:0060122 | inner ear receptor cell stereocilium organization | 1 | 23 | 1.82e-01 |
| GO:BP | GO:0097094 | craniofacial suture morphogenesis | 1 | 15 | 1.82e-01 |
| GO:BP | GO:0032202 | telomere assembly | 3 | 4 | 1.82e-01 |
| GO:BP | GO:2000678 | negative regulation of transcription regulatory region DNA binding | 1 | 17 | 1.82e-01 |
| GO:BP | GO:1902749 | regulation of cell cycle G2/M phase transition | 28 | 103 | 1.82e-01 |
| GO:BP | GO:0099562 | maintenance of postsynaptic density structure | 5 | 6 | 1.82e-01 |
| GO:BP | GO:0045820 | negative regulation of glycolytic process | 3 | 13 | 1.82e-01 |
| GO:BP | GO:0071230 | cellular response to amino acid stimulus | 2 | 65 | 1.82e-01 |
| GO:BP | GO:1904502 | regulation of lipophagy | 1 | 5 | 1.83e-01 |
| GO:BP | GO:1904504 | positive regulation of lipophagy | 1 | 5 | 1.83e-01 |
| GO:BP | GO:0016567 | protein ubiquitination | 4 | 717 | 1.83e-01 |
| GO:BP | GO:0008592 | regulation of Toll signaling pathway | 3 | 3 | 1.83e-01 |
| GO:BP | GO:0097012 | response to granulocyte macrophage colony-stimulating factor | 2 | 6 | 1.83e-01 |
| GO:BP | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 2 | 6 | 1.83e-01 |
| GO:BP | GO:0031053 | primary miRNA processing | 12 | 16 | 1.83e-01 |
| GO:BP | GO:0006221 | pyrimidine nucleotide biosynthetic process | 11 | 28 | 1.87e-01 |
| GO:BP | GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 1 | 2 | 1.87e-01 |
| GO:BP | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2 | 4 | 1.87e-01 |
| GO:BP | GO:0051797 | regulation of hair follicle development | 1 | 16 | 1.87e-01 |
| GO:BP | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1 | 2 | 1.87e-01 |
| GO:BP | GO:0061001 | regulation of dendritic spine morphogenesis | 5 | 39 | 1.87e-01 |
| GO:BP | GO:0035608 | protein deglutamylation | 1 | 2 | 1.87e-01 |
| GO:BP | GO:0046725 | negative regulation by virus of viral protein levels in host cell | 1 | 2 | 1.87e-01 |
| GO:BP | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 8 | 89 | 1.87e-01 |
| GO:BP | GO:0072273 | metanephric nephron morphogenesis | 12 | 19 | 1.87e-01 |
| GO:BP | GO:0009146 | purine nucleoside triphosphate catabolic process | 1 | 5 | 1.91e-01 |
| GO:BP | GO:0006654 | phosphatidic acid biosynthetic process | 23 | 30 | 1.91e-01 |
| GO:BP | GO:2000479 | regulation of cAMP-dependent protein kinase activity | 7 | 16 | 1.91e-01 |
| GO:BP | GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 8 | 18 | 1.91e-01 |
| GO:BP | GO:0009204 | deoxyribonucleoside triphosphate catabolic process | 1 | 5 | 1.91e-01 |
| GO:BP | GO:0006196 | AMP catabolic process | 1 | 3 | 1.91e-01 |
| GO:BP | GO:0046102 | inosine metabolic process | 1 | 4 | 1.91e-01 |
| GO:BP | GO:0046122 | purine deoxyribonucleoside metabolic process | 1 | 3 | 1.91e-01 |
| GO:BP | GO:2000209 | regulation of anoikis | 11 | 23 | 1.91e-01 |
| GO:BP | GO:0033628 | regulation of cell adhesion mediated by integrin | 4 | 36 | 1.91e-01 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 1 | 17 | 1.92e-01 |
| GO:BP | GO:0045198 | establishment of epithelial cell apical/basal polarity | 5 | 14 | 1.92e-01 |
| GO:BP | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process | 1 | 16 | 1.92e-01 |
| GO:BP | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 2 | 19 | 1.92e-01 |
| GO:BP | GO:0016321 | female meiosis chromosome segregation | 3 | 5 | 1.92e-01 |
| GO:BP | GO:0099622 | cardiac muscle cell membrane repolarization | 6 | 31 | 1.92e-01 |
| GO:BP | GO:0045008 | depyrimidination | 3 | 8 | 1.92e-01 |
| GO:BP | GO:0010651 | negative regulation of cell communication by electrical coupling | 1 | 1 | 1.93e-01 |
| GO:BP | GO:1901845 | negative regulation of cell communication by electrical coupling involved in cardiac conduction | 1 | 1 | 1.93e-01 |
| GO:BP | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1 | 11 | 1.93e-01 |
| GO:BP | GO:1903780 | negative regulation of cardiac conduction | 1 | 1 | 1.93e-01 |
| GO:BP | GO:0110154 | RNA decapping | 2 | 17 | 1.93e-01 |
| GO:BP | GO:0009212 | pyrimidine deoxyribonucleoside triphosphate biosynthetic process | 4 | 4 | 1.93e-01 |
| GO:BP | GO:0046075 | dTTP metabolic process | 4 | 4 | 1.93e-01 |
| GO:BP | GO:0006235 | dTTP biosynthetic process | 4 | 4 | 1.93e-01 |
| GO:BP | GO:0035720 | intraciliary anterograde transport | 3 | 17 | 1.94e-01 |
| GO:BP | GO:0015791 | polyol transmembrane transport | 4 | 6 | 1.95e-01 |
| GO:BP | GO:0021756 | striatum development | 3 | 17 | 1.95e-01 |
| GO:BP | GO:0072697 | protein localization to cell cortex | 6 | 10 | 1.95e-01 |
| GO:BP | GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 13 | 23 | 1.95e-01 |
| GO:BP | GO:0021587 | cerebellum morphogenesis | 1 | 36 | 1.95e-01 |
| GO:BP | GO:0070166 | enamel mineralization | 1 | 11 | 1.95e-01 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 21 | 58 | 1.95e-01 |
| GO:BP | GO:0051298 | centrosome duplication | 7 | 68 | 1.96e-01 |
| GO:BP | GO:0048339 | paraxial mesoderm development | 9 | 15 | 1.96e-01 |
| GO:BP | GO:0044208 | ‘de novo’ AMP biosynthetic process | 4 | 8 | 1.96e-01 |
| GO:BP | GO:1902473 | regulation of protein localization to synapse | 7 | 22 | 1.97e-01 |
| GO:BP | GO:0098911 | regulation of ventricular cardiac muscle cell action potential | 8 | 12 | 1.98e-01 |
| GO:BP | GO:1901565 | organonitrogen compound catabolic process | 50 | 1145 | 1.98e-01 |
| GO:BP | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 6 | 13 | 1.98e-01 |
| GO:BP | GO:0032466 | negative regulation of cytokinesis | 3 | 7 | 1.98e-01 |
| GO:BP | GO:0009116 | nucleoside metabolic process | 2 | 42 | 1.98e-01 |
| GO:BP | GO:2000809 | positive regulation of synaptic vesicle clustering | 2 | 3 | 1.98e-01 |
| GO:BP | GO:0071229 | cellular response to acid chemical | 2 | 71 | 1.98e-01 |
| GO:BP | GO:0009261 | ribonucleotide catabolic process | 3 | 45 | 1.98e-01 |
| GO:BP | GO:0090169 | regulation of spindle assembly | 4 | 32 | 1.98e-01 |
| GO:BP | GO:0036245 | cellular response to menadione | 1 | 2 | 1.99e-01 |
| GO:BP | GO:0098735 | positive regulation of the force of heart contraction | 2 | 4 | 1.99e-01 |
| GO:BP | GO:0045732 | positive regulation of protein catabolic process | 12 | 192 | 2.00e-01 |
| GO:BP | GO:2000271 | positive regulation of fibroblast apoptotic process | 5 | 9 | 2.00e-01 |
| GO:BP | GO:0009164 | nucleoside catabolic process | 3 | 15 | 2.00e-01 |
| GO:BP | GO:1903050 | regulation of proteolysis involved in protein catabolic process | 13 | 214 | 2.00e-01 |
| GO:BP | GO:0007089 | traversing start control point of mitotic cell cycle | 3 | 4 | 2.00e-01 |
| GO:BP | GO:0045870 | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1 | 2 | 2.00e-01 |
| GO:BP | GO:0021575 | hindbrain morphogenesis | 1 | 38 | 2.00e-01 |
| GO:BP | GO:0050905 | neuromuscular process | 6 | 107 | 2.01e-01 |
| GO:BP | GO:1990748 | cellular detoxification | 5 | 76 | 2.01e-01 |
| GO:BP | GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 2 | 4 | 2.01e-01 |
| GO:BP | GO:1903671 | negative regulation of sprouting angiogenesis | 2 | 11 | 2.01e-01 |
| GO:BP | GO:0002385 | mucosal immune response | 2 | 11 | 2.01e-01 |
| GO:BP | GO:0035136 | forelimb morphogenesis | 3 | 21 | 2.02e-01 |
| GO:BP | GO:1904071 | presynaptic active zone assembly | 3 | 4 | 2.02e-01 |
| GO:BP | GO:0002098 | tRNA wobble uridine modification | 10 | 16 | 2.02e-01 |
| GO:BP | GO:0071312 | cellular response to alkaloid | 8 | 29 | 2.02e-01 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2 | 230 | 2.02e-01 |
| GO:BP | GO:0042491 | inner ear auditory receptor cell differentiation | 1 | 29 | 2.02e-01 |
| GO:BP | GO:0045724 | positive regulation of cilium assembly | 4 | 25 | 2.03e-01 |
| GO:BP | GO:0051782 | negative regulation of cell division | 7 | 15 | 2.05e-01 |
| GO:BP | GO:0010458 | exit from mitosis | 20 | 30 | 2.05e-01 |
| GO:BP | GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 3 | 20 | 2.07e-01 |
| GO:BP | GO:0000727 | double-strand break repair via break-induced replication | 6 | 11 | 2.07e-01 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 1 | 23 | 2.07e-01 |
| GO:BP | GO:0009172 | purine deoxyribonucleoside monophosphate catabolic process | 1 | 3 | 2.07e-01 |
| GO:BP | GO:0046121 | deoxyribonucleoside catabolic process | 1 | 4 | 2.07e-01 |
| GO:BP | GO:0046130 | purine ribonucleoside catabolic process | 1 | 5 | 2.07e-01 |
| GO:BP | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway | 3 | 3 | 2.08e-01 |
| GO:BP | GO:0072703 | cellular response to methyl methanesulfonate | 1 | 1 | 2.08e-01 |
| GO:BP | GO:0072702 | response to methyl methanesulfonate | 1 | 1 | 2.08e-01 |
| GO:BP | GO:1903432 | regulation of TORC1 signaling | 27 | 48 | 2.08e-01 |
| GO:BP | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3’-5’ | 5 | 11 | 2.08e-01 |
| GO:BP | GO:0071466 | cellular response to xenobiotic stimulus | 7 | 105 | 2.08e-01 |
| GO:BP | GO:2000269 | regulation of fibroblast apoptotic process | 6 | 17 | 2.08e-01 |
| GO:BP | GO:0008544 | epidermis development | 2 | 210 | 2.08e-01 |
| GO:BP | GO:0060119 | inner ear receptor cell development | 1 | 33 | 2.08e-01 |
| GO:BP | GO:0006195 | purine nucleotide catabolic process | 3 | 48 | 2.08e-01 |
| GO:BP | GO:1903551 | regulation of extracellular exosome assembly | 4 | 6 | 2.09e-01 |
| GO:BP | GO:0097719 | neural tissue regeneration | 1 | 1 | 2.09e-01 |
| GO:BP | GO:0032446 | protein modification by small protein conjugation | 4 | 787 | 2.09e-01 |
| GO:BP | GO:2001189 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1 | 1 | 2.09e-01 |
| GO:BP | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 1 | 8 | 2.09e-01 |
| GO:BP | GO:0060343 | trabecula formation | 1 | 23 | 2.09e-01 |
| GO:BP | GO:2000521 | negative regulation of immunological synapse formation | 1 | 1 | 2.09e-01 |
| GO:BP | GO:0140058 | neuron projection arborization | 7 | 29 | 2.09e-01 |
| GO:BP | GO:0051446 | positive regulation of meiotic cell cycle | 1 | 16 | 2.09e-01 |
| GO:BP | GO:0090069 | regulation of ribosome biogenesis | 3 | 5 | 2.09e-01 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 2 | 8 | 2.09e-01 |
| GO:BP | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 7 | 21 | 2.09e-01 |
| GO:BP | GO:0016188 | synaptic vesicle maturation | 5 | 22 | 2.09e-01 |
| GO:BP | GO:0007589 | body fluid secretion | 2 | 60 | 2.09e-01 |
| GO:BP | GO:0043556 | regulation of translation in response to oxidative stress | 1 | 1 | 2.09e-01 |
| GO:BP | GO:0032938 | negative regulation of translation in response to oxidative stress | 1 | 1 | 2.09e-01 |
| GO:BP | GO:0050435 | amyloid-beta metabolic process | 3 | 48 | 2.10e-01 |
| GO:BP | GO:0036257 | multivesicular body organization | 19 | 33 | 2.10e-01 |
| GO:BP | GO:0010821 | regulation of mitochondrion organization | 26 | 135 | 2.10e-01 |
| GO:BP | GO:0006302 | double-strand break repair | 60 | 271 | 2.10e-01 |
| GO:BP | GO:0042276 | error-prone translesion synthesis | 7 | 11 | 2.10e-01 |
| GO:BP | GO:0060509 | type I pneumocyte differentiation | 5 | 8 | 2.11e-01 |
| GO:BP | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 6 | 94 | 2.11e-01 |
| GO:BP | GO:1901800 | positive regulation of proteasomal protein catabolic process | 9 | 111 | 2.12e-01 |
| GO:BP | GO:0097205 | renal filtration | 7 | 23 | 2.12e-01 |
| GO:BP | GO:0060999 | positive regulation of dendritic spine development | 3 | 33 | 2.12e-01 |
| GO:BP | GO:0021695 | cerebellar cortex development | 1 | 44 | 2.12e-01 |
| GO:BP | GO:0003166 | bundle of His development | 6 | 6 | 2.12e-01 |
| GO:BP | GO:0070242 | thymocyte apoptotic process | 3 | 17 | 2.13e-01 |
| GO:BP | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 4 | 26 | 2.13e-01 |
| GO:BP | GO:0050982 | detection of mechanical stimulus | 1 | 32 | 2.13e-01 |
| GO:BP | GO:0003143 | embryonic heart tube morphogenesis | 6 | 56 | 2.13e-01 |
| GO:BP | GO:1903788 | positive regulation of glutathione biosynthetic process | 1 | 1 | 2.13e-01 |
| GO:BP | GO:0060067 | cervix development | 2 | 2 | 2.13e-01 |
| GO:BP | GO:0044806 | G-quadruplex DNA unwinding | 4 | 7 | 2.13e-01 |
| GO:BP | GO:0006581 | acetylcholine catabolic process | 1 | 3 | 2.13e-01 |
| GO:BP | GO:0061371 | determination of heart left/right asymmetry | 6 | 52 | 2.13e-01 |
| GO:BP | GO:0035115 | embryonic forelimb morphogenesis | 2 | 17 | 2.13e-01 |
| GO:BP | GO:0003416 | endochondral bone growth | 3 | 23 | 2.13e-01 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 13 | 33 | 2.13e-01 |
| GO:BP | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 22 | 72 | 2.13e-01 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 21 | 393 | 2.13e-01 |
| GO:BP | GO:2000121 | regulation of removal of superoxide radicals | 2 | 6 | 2.13e-01 |
| GO:BP | GO:0097186 | amelogenesis | 1 | 14 | 2.13e-01 |
| GO:BP | GO:0098928 | presynaptic signal transduction | 2 | 2 | 2.13e-01 |
| GO:BP | GO:0035116 | embryonic hindlimb morphogenesis | 1 | 17 | 2.13e-01 |
| GO:BP | GO:0003272 | endocardial cushion formation | 1 | 24 | 2.13e-01 |
| GO:BP | GO:1900120 | regulation of receptor binding | 1 | 17 | 2.13e-01 |
| GO:BP | GO:0099526 | presynapse to nucleus signaling pathway | 2 | 2 | 2.13e-01 |
| GO:BP | GO:0034627 | ‘de novo’ NAD biosynthetic process | 2 | 2 | 2.13e-01 |
| GO:BP | GO:0046338 | phosphatidylethanolamine catabolic process | 2 | 4 | 2.13e-01 |
| GO:BP | GO:1901594 | response to capsazepine | 1 | 1 | 2.13e-01 |
| GO:BP | GO:0097150 | neuronal stem cell population maintenance | 12 | 21 | 2.13e-01 |
| GO:BP | GO:0036438 | maintenance of lens transparency | 3 | 6 | 2.14e-01 |
| GO:BP | GO:0044342 | type B pancreatic cell proliferation | 9 | 26 | 2.15e-01 |
| GO:BP | GO:0035315 | hair cell differentiation | 1 | 34 | 2.15e-01 |
| GO:BP | GO:0051656 | establishment of organelle localization | 58 | 378 | 2.15e-01 |
| GO:BP | GO:0002251 | organ or tissue specific immune response | 2 | 13 | 2.15e-01 |
| GO:BP | GO:0044346 | fibroblast apoptotic process | 7 | 23 | 2.15e-01 |
| GO:BP | GO:0042634 | regulation of hair cycle | 1 | 22 | 2.17e-01 |
| GO:BP | GO:0009267 | cellular response to starvation | 11 | 152 | 2.17e-01 |
| GO:BP | GO:1904172 | positive regulation of bleb assembly | 1 | 1 | 2.17e-01 |
| GO:BP | GO:0031106 | septin ring organization | 1 | 2 | 2.17e-01 |
| GO:BP | GO:1904170 | regulation of bleb assembly | 1 | 1 | 2.17e-01 |
| GO:BP | GO:0002949 | tRNA threonylcarbamoyladenosine modification | 3 | 5 | 2.17e-01 |
| GO:BP | GO:0060405 | regulation of penile erection | 1 | 4 | 2.17e-01 |
| GO:BP | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 6 | 7 | 2.17e-01 |
| GO:BP | GO:0072092 | ureteric bud invasion | 3 | 3 | 2.17e-01 |
| GO:BP | GO:2000303 | regulation of ceramide biosynthetic process | 4 | 11 | 2.18e-01 |
| GO:BP | GO:0061643 | chemorepulsion of axon | 2 | 6 | 2.18e-01 |
| GO:BP | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 9 | 25 | 2.19e-01 |
| GO:BP | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 4 | 64 | 2.19e-01 |
| GO:BP | GO:0009153 | purine deoxyribonucleotide biosynthetic process | 1 | 4 | 2.21e-01 |
| GO:BP | GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 1 | 2 | 2.21e-01 |
| GO:BP | GO:0072135 | kidney mesenchymal cell proliferation | 1 | 2 | 2.21e-01 |
| GO:BP | GO:0048789 | cytoskeletal matrix organization at active zone | 1 | 1 | 2.21e-01 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 11 | 36 | 2.21e-01 |
| GO:BP | GO:0097115 | neurexin clustering involved in presynaptic membrane assembly | 1 | 1 | 2.21e-01 |
| GO:BP | GO:0000209 | protein polyubiquitination | 4 | 226 | 2.21e-01 |
| GO:BP | GO:1900745 | positive regulation of p38MAPK cascade | 4 | 22 | 2.22e-01 |
| GO:BP | GO:0140694 | non-membrane-bounded organelle assembly | 80 | 357 | 2.22e-01 |
| GO:BP | GO:0032205 | negative regulation of telomere maintenance | 17 | 33 | 2.23e-01 |
| GO:BP | GO:0035721 | intraciliary retrograde transport | 9 | 14 | 2.23e-01 |
| GO:BP | GO:1905166 | negative regulation of lysosomal protein catabolic process | 1 | 5 | 2.23e-01 |
| GO:BP | GO:0061311 | cell surface receptor signaling pathway involved in heart development | 1 | 25 | 2.23e-01 |
| GO:BP | GO:1904351 | negative regulation of protein catabolic process in the vacuole | 1 | 5 | 2.23e-01 |
| GO:BP | GO:0038109 | Kit signaling pathway | 4 | 4 | 2.23e-01 |
| GO:BP | GO:0010824 | regulation of centrosome duplication | 12 | 44 | 2.23e-01 |
| GO:BP | GO:0036216 | cellular response to stem cell factor stimulus | 4 | 4 | 2.23e-01 |
| GO:BP | GO:0036215 | response to stem cell factor | 4 | 4 | 2.23e-01 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 6 | 82 | 2.23e-01 |
| GO:BP | GO:0048144 | fibroblast proliferation | 8 | 92 | 2.23e-01 |
| GO:BP | GO:0098708 | glucose import across plasma membrane | 3 | 5 | 2.23e-01 |
| GO:BP | GO:0042149 | cellular response to glucose starvation | 5 | 51 | 2.23e-01 |
| GO:BP | GO:0090038 | negative regulation of protein kinase C signaling | 4 | 4 | 2.23e-01 |
| GO:BP | GO:0015750 | pentose transmembrane transport | 2 | 2 | 2.23e-01 |
| GO:BP | GO:0008654 | phospholipid biosynthetic process | 143 | 234 | 2.23e-01 |
| GO:BP | GO:1900108 | negative regulation of nodal signaling pathway | 1 | 2 | 2.23e-01 |
| GO:BP | GO:0000017 | alpha-glucoside transport | 2 | 2 | 2.23e-01 |
| GO:BP | GO:0015756 | fucose transmembrane transport | 2 | 2 | 2.23e-01 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 2 | 265 | 2.23e-01 |
| GO:BP | GO:0009141 | nucleoside triphosphate metabolic process | 3 | 159 | 2.23e-01 |
| GO:BP | GO:0035582 | sequestering of BMP in extracellular matrix | 1 | 2 | 2.23e-01 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 17 | 20 | 2.23e-01 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 21 | 77 | 2.23e-01 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 14 | 158 | 2.24e-01 |
| GO:BP | GO:0097237 | cellular response to toxic substance | 5 | 82 | 2.24e-01 |
| GO:BP | GO:0032049 | cardiolipin biosynthetic process | 7 | 7 | 2.24e-01 |
| GO:BP | GO:1901753 | leukotriene A4 biosynthetic process | 1 | 1 | 2.24e-01 |
| GO:BP | GO:0072523 | purine-containing compound catabolic process | 3 | 53 | 2.24e-01 |
| GO:BP | GO:0003279 | cardiac septum development | 4 | 101 | 2.24e-01 |
| GO:BP | GO:0007064 | mitotic sister chromatid cohesion | 21 | 30 | 2.24e-01 |
| GO:BP | GO:0034505 | tooth mineralization | 1 | 17 | 2.24e-01 |
| GO:BP | GO:0061337 | cardiac conduction | 9 | 88 | 2.24e-01 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 20 | 50 | 2.24e-01 |
| GO:BP | GO:0051043 | regulation of membrane protein ectodomain proteolysis | 1 | 18 | 2.24e-01 |
| GO:BP | GO:0071029 | nuclear ncRNA surveillance | 3 | 7 | 2.24e-01 |
| GO:BP | GO:0106354 | tRNA surveillance | 3 | 7 | 2.24e-01 |
| GO:BP | GO:0051097 | negative regulation of helicase activity | 4 | 5 | 2.24e-01 |
| GO:BP | GO:0000045 | autophagosome assembly | 6 | 103 | 2.24e-01 |
| GO:BP | GO:0051126 | negative regulation of actin nucleation | 2 | 6 | 2.24e-01 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 7 | 106 | 2.24e-01 |
| GO:BP | GO:0090217 | negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity | 3 | 3 | 2.24e-01 |
| GO:BP | GO:0051152 | positive regulation of smooth muscle cell differentiation | 6 | 10 | 2.24e-01 |
| GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 1 | 28 | 2.24e-01 |
| GO:BP | GO:0048642 | negative regulation of skeletal muscle tissue development | 1 | 3 | 2.24e-01 |
| GO:BP | GO:0036376 | sodium ion export across plasma membrane | 3 | 12 | 2.24e-01 |
| GO:BP | GO:0040001 | establishment of mitotic spindle localization | 9 | 36 | 2.24e-01 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 20 | 27 | 2.24e-01 |
| GO:BP | GO:0040020 | regulation of meiotic nuclear division | 1 | 19 | 2.24e-01 |
| GO:BP | GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 3 | 7 | 2.24e-01 |
| GO:BP | GO:0046654 | tetrahydrofolate biosynthetic process | 3 | 5 | 2.24e-01 |
| GO:BP | GO:0002063 | chondrocyte development | 1 | 24 | 2.24e-01 |
| GO:BP | GO:0098868 | bone growth | 1 | 24 | 2.24e-01 |
| GO:BP | GO:0019372 | lipoxygenase pathway | 2 | 5 | 2.24e-01 |
| GO:BP | GO:1901186 | positive regulation of ERBB signaling pathway | 4 | 28 | 2.24e-01 |
| GO:BP | GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 3 | 7 | 2.24e-01 |
| GO:BP | GO:0071505 | response to mycophenolic acid | 2 | 2 | 2.24e-01 |
| GO:BP | GO:1902633 | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process | 3 | 3 | 2.24e-01 |
| GO:BP | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process | 3 | 7 | 2.24e-01 |
| GO:BP | GO:0071506 | cellular response to mycophenolic acid | 2 | 2 | 2.24e-01 |
| GO:BP | GO:1902635 | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process | 3 | 3 | 2.24e-01 |
| GO:BP | GO:0002634 | regulation of germinal center formation | 1 | 6 | 2.24e-01 |
| GO:BP | GO:0006152 | purine nucleoside catabolic process | 1 | 6 | 2.24e-01 |
| GO:BP | GO:0003162 | atrioventricular node development | 6 | 8 | 2.24e-01 |
| GO:BP | GO:0070255 | regulation of mucus secretion | 1 | 6 | 2.24e-01 |
| GO:BP | GO:0042073 | intraciliary transport | 30 | 46 | 2.25e-01 |
| GO:BP | GO:0090657 | telomeric loop disassembly | 5 | 9 | 2.25e-01 |
| GO:BP | GO:0007057 | spindle assembly involved in female meiosis I | 3 | 4 | 2.25e-01 |
| GO:BP | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 2 | 2 | 2.25e-01 |
| GO:BP | GO:0032918 | spermidine acetylation | 2 | 2 | 2.25e-01 |
| GO:BP | GO:0032917 | polyamine acetylation | 2 | 2 | 2.25e-01 |
| GO:BP | GO:1902018 | negative regulation of cilium assembly | 3 | 15 | 2.25e-01 |
| GO:BP | GO:0072283 | metanephric renal vesicle morphogenesis | 8 | 11 | 2.25e-01 |
| GO:BP | GO:0070459 | prolactin secretion | 1 | 4 | 2.25e-01 |
| GO:BP | GO:0072708 | response to sorbitol | 5 | 7 | 2.25e-01 |
| GO:BP | GO:0035845 | photoreceptor cell outer segment organization | 3 | 10 | 2.25e-01 |
| GO:BP | GO:0098754 | detoxification | 10 | 91 | 2.25e-01 |
| GO:BP | GO:0032201 | telomere maintenance via semi-conservative replication | 2 | 8 | 2.25e-01 |
| GO:BP | GO:0035904 | aorta development | 3 | 50 | 2.25e-01 |
| GO:BP | GO:0006551 | leucine metabolic process | 7 | 8 | 2.25e-01 |
| GO:BP | GO:0033082 | regulation of extrathymic T cell differentiation | 1 | 1 | 2.25e-01 |
| GO:BP | GO:0097499 | protein localization to non-motile cilium | 8 | 10 | 2.25e-01 |
| GO:BP | GO:1901623 | regulation of lymphocyte chemotaxis | 4 | 13 | 2.25e-01 |
| GO:BP | GO:0061146 | Peyer’s patch morphogenesis | 3 | 3 | 2.26e-01 |
| GO:BP | GO:0060113 | inner ear receptor cell differentiation | 1 | 47 | 2.27e-01 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 17 | 67 | 2.27e-01 |
| GO:BP | GO:0150011 | regulation of neuron projection arborization | 3 | 14 | 2.27e-01 |
| GO:BP | GO:0048679 | regulation of axon regeneration | 1 | 23 | 2.27e-01 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 5 | 39 | 2.27e-01 |
| GO:BP | GO:0019606 | 2-oxobutyrate catabolic process | 1 | 1 | 2.28e-01 |
| GO:BP | GO:0035137 | hindlimb morphogenesis | 1 | 20 | 2.28e-01 |
| GO:BP | GO:0072202 | cell differentiation involved in metanephros development | 3 | 16 | 2.28e-01 |
| GO:BP | GO:0007143 | female meiotic nuclear division | 13 | 25 | 2.28e-01 |
| GO:BP | GO:0061152 | trachea submucosa development | 2 | 2 | 2.28e-01 |
| GO:BP | GO:0061153 | trachea gland development | 2 | 2 | 2.28e-01 |
| GO:BP | GO:1905064 | negative regulation of vascular associated smooth muscle cell differentiation | 7 | 8 | 2.28e-01 |
| GO:BP | GO:0070231 | T cell apoptotic process | 5 | 39 | 2.29e-01 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 9 | 30 | 2.29e-01 |
| GO:BP | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation | 2 | 2 | 2.29e-01 |
| GO:BP | GO:1900052 | regulation of retinoic acid biosynthetic process | 1 | 3 | 2.29e-01 |
| GO:BP | GO:0003161 | cardiac conduction system development | 1 | 33 | 2.31e-01 |
| GO:BP | GO:0044319 | wound healing, spreading of cells | 1 | 30 | 2.31e-01 |
| GO:BP | GO:0090505 | epiboly involved in wound healing | 1 | 30 | 2.31e-01 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 2 | 278 | 2.31e-01 |
| GO:BP | GO:0010992 | ubiquitin recycling | 7 | 12 | 2.31e-01 |
| GO:BP | GO:0034453 | microtubule anchoring | 3 | 25 | 2.31e-01 |
| GO:BP | GO:0097107 | postsynaptic density assembly | 4 | 16 | 2.31e-01 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 3 | 277 | 2.31e-01 |
| GO:BP | GO:1904997 | regulation of leukocyte adhesion to arterial endothelial cell | 3 | 3 | 2.32e-01 |
| GO:BP | GO:0034475 | U4 snRNA 3’-end processing | 4 | 8 | 2.32e-01 |
| GO:BP | GO:0042490 | mechanoreceptor differentiation | 1 | 49 | 2.35e-01 |
| GO:BP | GO:0031076 | embryonic camera-type eye development | 4 | 28 | 2.35e-01 |
| GO:BP | GO:0090504 | epiboly | 1 | 31 | 2.35e-01 |
| GO:BP | GO:0043954 | cellular component maintenance | 1 | 59 | 2.35e-01 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 4 | 23 | 2.35e-01 |
| GO:BP | GO:0009218 | pyrimidine ribonucleotide metabolic process | 1 | 25 | 2.35e-01 |
| GO:BP | GO:0000255 | allantoin metabolic process | 1 | 4 | 2.35e-01 |
| GO:BP | GO:0048537 | mucosa-associated lymphoid tissue development | 1 | 6 | 2.35e-01 |
| GO:BP | GO:0048541 | Peyer’s patch development | 1 | 6 | 2.35e-01 |
| GO:BP | GO:0030149 | sphingolipid catabolic process | 3 | 26 | 2.35e-01 |
| GO:BP | GO:0002314 | germinal center B cell differentiation | 1 | 3 | 2.35e-01 |
| GO:BP | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 9 | 27 | 2.35e-01 |
| GO:BP | GO:0060058 | positive regulation of apoptotic process involved in mammary gland involution | 2 | 3 | 2.35e-01 |
| GO:BP | GO:1901985 | positive regulation of protein acetylation | 1 | 41 | 2.35e-01 |
| GO:BP | GO:0060057 | apoptotic process involved in mammary gland involution | 2 | 3 | 2.35e-01 |
| GO:BP | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity | 9 | 27 | 2.35e-01 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 21 | 399 | 2.36e-01 |
| GO:BP | GO:1904776 | regulation of protein localization to cell cortex | 5 | 8 | 2.36e-01 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 5 | 72 | 2.36e-01 |
| GO:BP | GO:0032899 | regulation of neurotrophin production | 1 | 2 | 2.36e-01 |
| GO:BP | GO:0060546 | negative regulation of necroptotic process | 10 | 16 | 2.36e-01 |
| GO:BP | GO:0045616 | regulation of keratinocyte differentiation | 1 | 25 | 2.36e-01 |
| GO:BP | GO:0045987 | positive regulation of smooth muscle contraction | 2 | 17 | 2.37e-01 |
| GO:BP | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress | 4 | 8 | 2.37e-01 |
| GO:BP | GO:1903376 | regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 4 | 8 | 2.37e-01 |
| GO:BP | GO:0008063 | Toll signaling pathway | 4 | 6 | 2.37e-01 |
| GO:BP | GO:0006188 | IMP biosynthetic process | 1 | 10 | 2.37e-01 |
| GO:BP | GO:0042245 | RNA repair | 2 | 2 | 2.37e-01 |
| GO:BP | GO:0000132 | establishment of mitotic spindle orientation | 8 | 31 | 2.37e-01 |
| GO:BP | GO:0010820 | positive regulation of T cell chemotaxis | 3 | 7 | 2.37e-01 |
| GO:BP | GO:0071356 | cellular response to tumor necrosis factor | 5 | 155 | 2.37e-01 |
| GO:BP | GO:1902017 | regulation of cilium assembly | 6 | 57 | 2.37e-01 |
| GO:BP | GO:0010225 | response to UV-C | 9 | 13 | 2.37e-01 |
| GO:BP | GO:0070570 | regulation of neuron projection regeneration | 1 | 25 | 2.37e-01 |
| GO:BP | GO:0034656 | nucleobase-containing small molecule catabolic process | 3 | 20 | 2.37e-01 |
| GO:BP | GO:0060453 | regulation of gastric acid secretion | 2 | 8 | 2.37e-01 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 1 | 34 | 2.38e-01 |
| GO:BP | GO:0071280 | cellular response to copper ion | 6 | 18 | 2.38e-01 |
| GO:BP | GO:1903614 | negative regulation of protein tyrosine phosphatase activity | 1 | 3 | 2.38e-01 |
| GO:BP | GO:0090128 | regulation of synapse maturation | 1 | 15 | 2.38e-01 |
| GO:BP | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry | 1 | 2 | 2.38e-01 |
| GO:BP | GO:0090272 | negative regulation of fibroblast growth factor production | 2 | 2 | 2.38e-01 |
| GO:BP | GO:1900175 | regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry | 1 | 2 | 2.38e-01 |
| GO:BP | GO:0071392 | cellular response to estradiol stimulus | 1 | 26 | 2.38e-01 |
| GO:BP | GO:1904613 | cellular response to 2,3,7,8-tetrachlorodibenzodioxine | 1 | 2 | 2.38e-01 |
| GO:BP | GO:1905038 | regulation of membrane lipid metabolic process | 4 | 12 | 2.38e-01 |
| GO:BP | GO:0090153 | regulation of sphingolipid biosynthetic process | 4 | 12 | 2.38e-01 |
| GO:BP | GO:0060775 | planar cell polarity pathway involved in gastrula mediolateral intercalation | 2 | 2 | 2.38e-01 |
| GO:BP | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 7 | 47 | 2.38e-01 |
| GO:BP | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration | 3 | 11 | 2.38e-01 |
| GO:BP | GO:0044572 | [4Fe-4S] cluster assembly | 5 | 5 | 2.38e-01 |
| GO:BP | GO:0006470 | protein dephosphorylation | 2 | 214 | 2.38e-01 |
| GO:BP | GO:2000104 | negative regulation of DNA-templated DNA replication | 5 | 7 | 2.38e-01 |
| GO:BP | GO:0001895 | retina homeostasis | 1 | 44 | 2.38e-01 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 6 | 50 | 2.38e-01 |
| GO:BP | GO:0046605 | regulation of centrosome cycle | 13 | 51 | 2.38e-01 |
| GO:BP | GO:0060031 | mediolateral intercalation | 2 | 2 | 2.38e-01 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 5 | 73 | 2.38e-01 |
| GO:BP | GO:0006915 | apoptotic process | 8 | 1443 | 2.38e-01 |
| GO:BP | GO:2000821 | regulation of grooming behavior | 2 | 3 | 2.38e-01 |
| GO:BP | GO:2000697 | negative regulation of epithelial cell differentiation involved in kidney development | 1 | 3 | 2.38e-01 |
| GO:BP | GO:0018410 | C-terminal protein amino acid modification | 1 | 10 | 2.38e-01 |
| GO:BP | GO:0070266 | necroptotic process | 5 | 32 | 2.38e-01 |
| GO:BP | GO:0006622 | protein targeting to lysosome | 6 | 28 | 2.38e-01 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 20 | 439 | 2.38e-01 |
| GO:BP | GO:0051453 | regulation of intracellular pH | 5 | 65 | 2.38e-01 |
| GO:BP | GO:0007017 | microtubule-based process | 120 | 760 | 2.39e-01 |
| GO:BP | GO:0061525 | hindgut development | 2 | 5 | 2.39e-01 |
| GO:BP | GO:0043377 | negative regulation of CD8-positive, alpha-beta T cell differentiation | 3 | 3 | 2.39e-01 |
| GO:BP | GO:0034476 | U5 snRNA 3’-end processing | 2 | 3 | 2.40e-01 |
| GO:BP | GO:0034473 | U1 snRNA 3’-end processing | 2 | 3 | 2.40e-01 |
| GO:BP | GO:0006110 | regulation of glycolytic process | 5 | 40 | 2.40e-01 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 5 | 73 | 2.41e-01 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 1 | 36 | 2.41e-01 |
| GO:BP | GO:0070244 | negative regulation of thymocyte apoptotic process | 1 | 6 | 2.42e-01 |
| GO:BP | GO:0009155 | purine deoxyribonucleotide catabolic process | 1 | 7 | 2.42e-01 |
| GO:BP | GO:0035641 | locomotory exploration behavior | 3 | 11 | 2.42e-01 |
| GO:BP | GO:0009113 | purine nucleobase biosynthetic process | 1 | 10 | 2.42e-01 |
| GO:BP | GO:0009169 | purine ribonucleoside monophosphate catabolic process | 1 | 7 | 2.42e-01 |
| GO:BP | GO:0002138 | retinoic acid biosynthetic process | 2 | 8 | 2.42e-01 |
| GO:BP | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 4 | 4 | 2.42e-01 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 41 | 113 | 2.42e-01 |
| GO:BP | GO:0051305 | chromosome movement towards spindle pole | 3 | 7 | 2.42e-01 |
| GO:BP | GO:0009128 | purine nucleoside monophosphate catabolic process | 1 | 7 | 2.42e-01 |
| GO:BP | GO:0006362 | transcription elongation by RNA polymerase I | 3 | 4 | 2.42e-01 |
| GO:BP | GO:2000973 | regulation of pro-B cell differentiation | 5 | 7 | 2.42e-01 |
| GO:BP | GO:0071233 | cellular response to leucine | 1 | 10 | 2.42e-01 |
| GO:BP | GO:0110032 | positive regulation of G2/MI transition of meiotic cell cycle | 3 | 3 | 2.42e-01 |
| GO:BP | GO:0051105 | regulation of DNA ligation | 5 | 6 | 2.42e-01 |
| GO:BP | GO:0043200 | response to amino acid | 2 | 95 | 2.42e-01 |
| GO:BP | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress | 1 | 11 | 2.42e-01 |
| GO:BP | GO:1900036 | positive regulation of cellular response to heat | 1 | 1 | 2.42e-01 |
| GO:BP | GO:0006166 | purine ribonucleoside salvage | 1 | 7 | 2.42e-01 |
| GO:BP | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 8 | 16 | 2.42e-01 |
| GO:BP | GO:1903543 | positive regulation of exosomal secretion | 2 | 13 | 2.42e-01 |
| GO:BP | GO:0032230 | positive regulation of synaptic transmission, GABAergic | 2 | 10 | 2.42e-01 |
| GO:BP | GO:0060052 | neurofilament cytoskeleton organization | 7 | 9 | 2.42e-01 |
| GO:BP | GO:0071539 | protein localization to centrosome | 19 | 31 | 2.42e-01 |
| GO:BP | GO:0051098 | regulation of binding | 2 | 317 | 2.42e-01 |
| GO:BP | GO:0072524 | pyridine-containing compound metabolic process | 6 | 72 | 2.43e-01 |
| GO:BP | GO:1902882 | regulation of response to oxidative stress | 7 | 76 | 2.43e-01 |
| GO:BP | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 14 | 22 | 2.43e-01 |
| GO:BP | GO:0097193 | intrinsic apoptotic signaling pathway | 11 | 262 | 2.43e-01 |
| GO:BP | GO:0034312 | diol biosynthetic process | 4 | 20 | 2.44e-01 |
| GO:BP | GO:0051835 | positive regulation of synapse structural plasticity | 2 | 2 | 2.44e-01 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 24 | 459 | 2.44e-01 |
| GO:BP | GO:0032402 | melanosome transport | 6 | 19 | 2.44e-01 |
| GO:BP | GO:0009259 | ribonucleotide metabolic process | 4 | 311 | 2.45e-01 |
| GO:BP | GO:1905037 | autophagosome organization | 6 | 110 | 2.45e-01 |
| GO:BP | GO:0070293 | renal absorption | 5 | 24 | 2.45e-01 |
| GO:BP | GO:1904550 | response to arachidonic acid | 1 | 1 | 2.45e-01 |
| GO:BP | GO:1903436 | regulation of mitotic cytokinetic process | 2 | 2 | 2.45e-01 |
| GO:BP | GO:0043084 | penile erection | 1 | 6 | 2.45e-01 |
| GO:BP | GO:0036337 | Fas signaling pathway | 2 | 5 | 2.45e-01 |
| GO:BP | GO:0009152 | purine ribonucleotide biosynthetic process | 3 | 179 | 2.45e-01 |
| GO:BP | GO:1903995 | regulation of non-membrane spanning protein tyrosine kinase activity | 3 | 3 | 2.45e-01 |
| GO:BP | GO:0043650 | dicarboxylic acid biosynthetic process | 1 | 9 | 2.45e-01 |
| GO:BP | GO:1903438 | positive regulation of mitotic cytokinetic process | 2 | 2 | 2.45e-01 |
| GO:BP | GO:0036486 | ventral trunk neural crest cell migration | 3 | 3 | 2.45e-01 |
| GO:BP | GO:1903553 | positive regulation of extracellular exosome assembly | 3 | 4 | 2.45e-01 |
| GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 1 | 20 | 2.45e-01 |
| GO:BP | GO:0006760 | folic acid-containing compound metabolic process | 7 | 22 | 2.45e-01 |
| GO:BP | GO:1902340 | negative regulation of chromosome condensation | 2 | 2 | 2.45e-01 |
| GO:BP | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process | 8 | 10 | 2.45e-01 |
| GO:BP | GO:0090179 | planar cell polarity pathway involved in neural tube closure | 4 | 12 | 2.45e-01 |
| GO:BP | GO:0009445 | putrescine metabolic process | 2 | 6 | 2.45e-01 |
| GO:BP | GO:0090663 | galanin-activated signaling pathway | 1 | 1 | 2.45e-01 |
| GO:BP | GO:2000403 | positive regulation of lymphocyte migration | 5 | 24 | 2.45e-01 |
| GO:BP | GO:0072528 | pyrimidine-containing compound biosynthetic process | 1 | 33 | 2.45e-01 |
| GO:BP | GO:0097490 | sympathetic neuron projection extension | 4 | 4 | 2.45e-01 |
| GO:BP | GO:1900029 | positive regulation of ruffle assembly | 5 | 12 | 2.45e-01 |
| GO:BP | GO:1902151 | regulation of response to DNA integrity checkpoint signaling | 1 | 1 | 2.45e-01 |
| GO:BP | GO:0010819 | regulation of T cell chemotaxis | 3 | 7 | 2.45e-01 |
| GO:BP | GO:0046385 | deoxyribose phosphate biosynthetic process | 6 | 14 | 2.45e-01 |
| GO:BP | GO:0043328 | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 10 | 16 | 2.45e-01 |
| GO:BP | GO:0052652 | cyclic purine nucleotide metabolic process | 5 | 30 | 2.45e-01 |
| GO:BP | GO:0046340 | diacylglycerol catabolic process | 2 | 3 | 2.45e-01 |
| GO:BP | GO:0009435 | NAD biosynthetic process | 3 | 17 | 2.45e-01 |
| GO:BP | GO:1902145 | regulation of response to cell cycle checkpoint signaling | 1 | 1 | 2.45e-01 |
| GO:BP | GO:0009120 | deoxyribonucleoside metabolic process | 1 | 9 | 2.45e-01 |
| GO:BP | GO:0033089 | positive regulation of T cell differentiation in thymus | 1 | 5 | 2.45e-01 |
| GO:BP | GO:0021544 | subpallium development | 3 | 18 | 2.45e-01 |
| GO:BP | GO:1901657 | glycosyl compound metabolic process | 2 | 62 | 2.45e-01 |
| GO:BP | GO:0090311 | regulation of protein deacetylation | 28 | 53 | 2.45e-01 |
| GO:BP | GO:0001659 | temperature homeostasis | 9 | 132 | 2.45e-01 |
| GO:BP | GO:1905213 | negative regulation of mitotic chromosome condensation | 2 | 2 | 2.45e-01 |
| GO:BP | GO:0006334 | nucleosome assembly | 12 | 80 | 2.45e-01 |
| GO:BP | GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 1 | 6 | 2.45e-01 |
| GO:BP | GO:1902153 | regulation of response to DNA damage checkpoint signaling | 1 | 1 | 2.45e-01 |
| GO:BP | GO:0086054 | bundle of His cell to Purkinje myocyte communication by electrical coupling | 2 | 2 | 2.45e-01 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 2 | 303 | 2.45e-01 |
| GO:BP | GO:0086043 | bundle of His cell action potential | 4 | 6 | 2.45e-01 |
| GO:BP | GO:0071288 | cellular response to mercury ion | 2 | 2 | 2.45e-01 |
| GO:BP | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 32 | 86 | 2.45e-01 |
| GO:BP | GO:0046085 | adenosine metabolic process | 1 | 5 | 2.45e-01 |
| GO:BP | GO:0044281 | small molecule metabolic process | 8 | 1389 | 2.45e-01 |
| GO:BP | GO:1903379 | regulation of mitotic chromosome condensation | 2 | 2 | 2.45e-01 |
| GO:BP | GO:1902608 | positive regulation of large conductance calcium-activated potassium channel activity | 1 | 2 | 2.45e-01 |
| GO:BP | GO:0086028 | bundle of His cell to Purkinje myocyte signaling | 4 | 6 | 2.45e-01 |
| GO:BP | GO:0071307 | cellular response to vitamin K | 1 | 4 | 2.45e-01 |
| GO:BP | GO:1903846 | positive regulation of cellular response to transforming growth factor beta stimulus | 6 | 30 | 2.45e-01 |
| GO:BP | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 6 | 30 | 2.45e-01 |
| GO:BP | GO:0097491 | sympathetic neuron projection guidance | 4 | 4 | 2.45e-01 |
| GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 2 | 31 | 2.45e-01 |
| GO:BP | GO:0035735 | intraciliary transport involved in cilium assembly | 2 | 7 | 2.45e-01 |
| GO:BP | GO:0070647 | protein modification by small protein conjugation or removal | 4 | 898 | 2.45e-01 |
| GO:BP | GO:0009265 | 2’-deoxyribonucleotide biosynthetic process | 6 | 14 | 2.45e-01 |
| GO:BP | GO:0086100 | endothelin receptor signaling pathway | 4 | 9 | 2.45e-01 |
| GO:BP | GO:0140467 | integrated stress response signaling | 9 | 35 | 2.45e-01 |
| GO:BP | GO:0070342 | brown fat cell proliferation | 1 | 1 | 2.45e-01 |
| GO:BP | GO:0000423 | mitophagy | 9 | 37 | 2.45e-01 |
| GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 5 | 45 | 2.45e-01 |
| GO:BP | GO:0009263 | deoxyribonucleotide biosynthetic process | 6 | 14 | 2.45e-01 |
| GO:BP | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway | 2 | 8 | 2.46e-01 |
| GO:BP | GO:0051560 | mitochondrial calcium ion homeostasis | 2 | 23 | 2.46e-01 |
| GO:BP | GO:0019693 | ribose phosphate metabolic process | 4 | 319 | 2.47e-01 |
| GO:BP | GO:0012501 | programmed cell death | 8 | 1479 | 2.47e-01 |
| GO:BP | GO:2000156 | regulation of retrograde vesicle-mediated transport, Golgi to ER | 2 | 2 | 2.48e-01 |
| GO:BP | GO:0032764 | negative regulation of mast cell cytokine production | 3 | 3 | 2.49e-01 |
| GO:BP | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process | 2 | 5 | 2.49e-01 |
| GO:BP | GO:0046136 | positive regulation of vitamin metabolic process | 1 | 2 | 2.49e-01 |
| GO:BP | GO:0060431 | primary lung bud formation | 1 | 2 | 2.49e-01 |
| GO:BP | GO:0046391 | 5-phosphoribose 1-diphosphate metabolic process | 2 | 5 | 2.49e-01 |
| GO:BP | GO:0019747 | regulation of isoprenoid metabolic process | 1 | 4 | 2.49e-01 |
| GO:BP | GO:0072578 | neurotransmitter-gated ion channel clustering | 2 | 12 | 2.50e-01 |
| GO:BP | GO:0090594 | inflammatory response to wounding | 2 | 12 | 2.50e-01 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 3 | 513 | 2.50e-01 |
| GO:BP | GO:0045444 | fat cell differentiation | 18 | 187 | 2.50e-01 |
| GO:BP | GO:0045454 | cell redox homeostasis | 13 | 38 | 2.50e-01 |
| GO:BP | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation | 3 | 5 | 2.50e-01 |
| GO:BP | GO:0046394 | carboxylic acid biosynthetic process | 3 | 223 | 2.50e-01 |
| GO:BP | GO:0045324 | late endosome to vacuole transport | 20 | 36 | 2.50e-01 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 1 | 43 | 2.50e-01 |
| GO:BP | GO:0010649 | regulation of cell communication by electrical coupling | 5 | 17 | 2.50e-01 |
| GO:BP | GO:0045199 | maintenance of epithelial cell apical/basal polarity | 5 | 10 | 2.50e-01 |
| GO:BP | GO:0048570 | notochord morphogenesis | 5 | 9 | 2.50e-01 |
| GO:BP | GO:0035588 | G protein-coupled purinergic receptor signaling pathway | 1 | 8 | 2.50e-01 |
| GO:BP | GO:2000677 | regulation of transcription regulatory region DNA binding | 1 | 43 | 2.50e-01 |
| GO:BP | GO:0097117 | guanylate kinase-associated protein clustering | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0003197 | endocardial cushion development | 1 | 46 | 2.50e-01 |
| GO:BP | GO:1901673 | regulation of mitotic spindle assembly | 3 | 23 | 2.50e-01 |
| GO:BP | GO:0045004 | DNA replication proofreading | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0021768 | nucleus accumbens development | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0008050 | female courtship behavior | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0035494 | SNARE complex disassembly | 3 | 3 | 2.50e-01 |
| GO:BP | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 11 | 31 | 2.50e-01 |
| GO:BP | GO:0051650 | establishment of vesicle localization | 9 | 175 | 2.50e-01 |
| GO:BP | GO:0045196 | establishment or maintenance of neuroblast polarity | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0090737 | telomere maintenance via telomere trimming | 7 | 13 | 2.50e-01 |
| GO:BP | GO:0045200 | establishment of neuroblast polarity | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2 | 18 | 2.50e-01 |
| GO:BP | GO:0090656 | t-circle formation | 7 | 13 | 2.50e-01 |
| GO:BP | GO:0044790 | suppression of viral release by host | 3 | 16 | 2.50e-01 |
| GO:BP | GO:0030592 | DNA ADP-ribosylation | 2 | 3 | 2.50e-01 |
| GO:BP | GO:1900164 | nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0090407 | organophosphate biosynthetic process | 5 | 506 | 2.50e-01 |
| GO:BP | GO:1990253 | cellular response to leucine starvation | 1 | 13 | 2.50e-01 |
| GO:BP | GO:0032898 | neurotrophin production | 3 | 4 | 2.50e-01 |
| GO:BP | GO:1900451 | positive regulation of glutamate receptor signaling pathway | 1 | 2 | 2.50e-01 |
| GO:BP | GO:1902855 | regulation of non-motile cilium assembly | 2 | 10 | 2.50e-01 |
| GO:BP | GO:1904716 | positive regulation of chaperone-mediated autophagy | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0010990 | regulation of SMAD protein complex assembly | 3 | 6 | 2.50e-01 |
| GO:BP | GO:0035024 | negative regulation of Rho protein signal transduction | 8 | 21 | 2.50e-01 |
| GO:BP | GO:0045760 | positive regulation of action potential | 2 | 4 | 2.50e-01 |
| GO:BP | GO:1904717 | regulation of AMPA glutamate receptor clustering | 2 | 4 | 2.50e-01 |
| GO:BP | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell communication | 2 | 6 | 2.50e-01 |
| GO:BP | GO:0015701 | bicarbonate transport | 2 | 19 | 2.50e-01 |
| GO:BP | GO:0007174 | epidermal growth factor catabolic process | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling | 2 | 6 | 2.50e-01 |
| GO:BP | GO:0019363 | pyridine nucleotide biosynthetic process | 3 | 19 | 2.50e-01 |
| GO:BP | GO:1901377 | organic heteropentacyclic compound catabolic process | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0019359 | nicotinamide nucleotide biosynthetic process | 3 | 19 | 2.50e-01 |
| GO:BP | GO:0070997 | neuron death | 17 | 286 | 2.50e-01 |
| GO:BP | GO:1990654 | sebum secreting cell proliferation | 1 | 2 | 2.50e-01 |
| GO:BP | GO:1902525 | regulation of protein monoubiquitination | 5 | 6 | 2.50e-01 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 9 | 28 | 2.50e-01 |
| GO:BP | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 4 | 64 | 2.50e-01 |
| GO:BP | GO:0070254 | mucus secretion | 1 | 8 | 2.50e-01 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 16 | 19 | 2.50e-01 |
| GO:BP | GO:0046223 | aflatoxin catabolic process | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0035089 | establishment of apical/basal cell polarity | 4 | 18 | 2.50e-01 |
| GO:BP | GO:0032401 | establishment of melanosome localization | 6 | 20 | 2.50e-01 |
| GO:BP | GO:1904979 | negative regulation of endosome organization | 1 | 2 | 2.50e-01 |
| GO:BP | GO:1901658 | glycosyl compound catabolic process | 3 | 23 | 2.50e-01 |
| GO:BP | GO:2000520 | regulation of immunological synapse formation | 1 | 2 | 2.50e-01 |
| GO:BP | GO:1904976 | cellular response to bleomycin | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0021549 | cerebellum development | 1 | 78 | 2.50e-01 |
| GO:BP | GO:1904975 | response to bleomycin | 2 | 2 | 2.50e-01 |
| GO:BP | GO:1904955 | planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0001973 | G protein-coupled adenosine receptor signaling pathway | 1 | 8 | 2.50e-01 |
| GO:BP | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity | 6 | 10 | 2.50e-01 |
| GO:BP | GO:0045599 | negative regulation of fat cell differentiation | 1 | 43 | 2.50e-01 |
| GO:BP | GO:0065004 | protein-DNA complex assembly | 33 | 185 | 2.50e-01 |
| GO:BP | GO:0035128 | post-embryonic forelimb morphogenesis | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0072529 | pyrimidine-containing compound catabolic process | 5 | 29 | 2.50e-01 |
| GO:BP | GO:0035127 | post-embryonic limb morphogenesis | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0035120 | post-embryonic appendage morphogenesis | 1 | 2 | 2.50e-01 |
| GO:BP | GO:1900239 | regulation of phenotypic switching | 2 | 3 | 2.50e-01 |
| GO:BP | GO:0070194 | synaptonemal complex disassembly | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0070213 | protein auto-ADP-ribosylation | 2 | 11 | 2.50e-01 |
| GO:BP | GO:0090185 | negative regulation of kidney development | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0035090 | maintenance of apical/basal cell polarity | 5 | 10 | 2.50e-01 |
| GO:BP | GO:1904934 | negative regulation of cell proliferation in midbrain | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0015793 | glycerol transmembrane transport | 2 | 4 | 2.50e-01 |
| GO:BP | GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 1 | 1 | 2.50e-01 |
| GO:BP | GO:1902228 | positive regulation of macrophage colony-stimulating factor signaling pathway | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0099185 | postsynaptic intermediate filament cytoskeleton organization | 3 | 3 | 2.50e-01 |
| GO:BP | GO:0099173 | postsynapse organization | 15 | 155 | 2.50e-01 |
| GO:BP | GO:0060611 | mammary gland fat development | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0016557 | peroxisome membrane biogenesis | 3 | 3 | 2.50e-01 |
| GO:BP | GO:0000492 | box C/D snoRNP assembly | 1 | 10 | 2.50e-01 |
| GO:BP | GO:0033693 | neurofilament bundle assembly | 3 | 3 | 2.50e-01 |
| GO:BP | GO:0000724 | double-strand break repair via homologous recombination | 36 | 149 | 2.50e-01 |
| GO:BP | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 9 | 47 | 2.50e-01 |
| GO:BP | GO:1904024 | negative regulation of glucose catabolic process to lactate via pyruvate | 2 | 3 | 2.50e-01 |
| GO:BP | GO:0036309 | protein localization to M-band | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0009143 | nucleoside triphosphate catabolic process | 1 | 10 | 2.50e-01 |
| GO:BP | GO:0043111 | replication fork arrest | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0001101 | response to acid chemical | 2 | 105 | 2.50e-01 |
| GO:BP | GO:0043149 | stress fiber assembly | 11 | 94 | 2.50e-01 |
| GO:BP | GO:0001325 | formation of extrachromosomal circular DNA | 7 | 13 | 2.50e-01 |
| GO:BP | GO:0006272 | leading strand elongation | 2 | 4 | 2.50e-01 |
| GO:BP | GO:0098925 | retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0036164 | cell-abiotic substrate adhesion | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0060947 | cardiac vascular smooth muscle cell differentiation | 7 | 8 | 2.50e-01 |
| GO:BP | GO:0043174 | nucleoside salvage | 1 | 9 | 2.50e-01 |
| GO:BP | GO:0030010 | establishment of cell polarity | 13 | 134 | 2.50e-01 |
| GO:BP | GO:0036517 | chemoattraction of serotonergic neuron axon | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0009416 | response to light stimulus | 1 | 246 | 2.50e-01 |
| GO:BP | GO:0016053 | organic acid biosynthetic process | 3 | 224 | 2.50e-01 |
| GO:BP | GO:0009187 | cyclic nucleotide metabolic process | 5 | 31 | 2.50e-01 |
| GO:BP | GO:0042023 | DNA endoreduplication | 4 | 5 | 2.50e-01 |
| GO:BP | GO:0030641 | regulation of cellular pH | 5 | 70 | 2.50e-01 |
| GO:BP | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization | 2 | 6 | 2.50e-01 |
| GO:BP | GO:1903786 | regulation of glutathione biosynthetic process | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0039702 | viral budding via host ESCRT complex | 6 | 22 | 2.50e-01 |
| GO:BP | GO:1905366 | negative regulation of intralumenal vesicle formation | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0016260 | selenocysteine biosynthetic process | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0060485 | mesenchyme development | 5 | 249 | 2.50e-01 |
| GO:BP | GO:1905365 | regulation of intralumenal vesicle formation | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0071694 | maintenance of protein location in extracellular region | 1 | 4 | 2.50e-01 |
| GO:BP | GO:0071824 | protein-DNA complex subunit organization | 37 | 204 | 2.50e-01 |
| GO:BP | GO:0106104 | regulation of glutamate receptor clustering | 2 | 4 | 2.50e-01 |
| GO:BP | GO:0046755 | viral budding | 16 | 26 | 2.50e-01 |
| GO:BP | GO:0060542 | regulation of strand invasion | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 1 | 59 | 2.50e-01 |
| GO:BP | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0016102 | diterpenoid biosynthetic process | 2 | 8 | 2.50e-01 |
| GO:BP | GO:0033566 | gamma-tubulin complex localization | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0016446 | somatic hypermutation of immunoglobulin genes | 6 | 11 | 2.50e-01 |
| GO:BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 34 | 101 | 2.50e-01 |
| GO:BP | GO:0009407 | toxin catabolic process | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0071971 | extracellular exosome assembly | 4 | 6 | 2.50e-01 |
| GO:BP | GO:0030308 | negative regulation of cell growth | 3 | 160 | 2.50e-01 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 16 | 279 | 2.50e-01 |
| GO:BP | GO:0060306 | regulation of membrane repolarization | 7 | 28 | 2.50e-01 |
| GO:BP | GO:0043387 | mycotoxin catabolic process | 1 | 2 | 2.50e-01 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 11 | 94 | 2.50e-01 |
| GO:BP | GO:0120034 | positive regulation of plasma membrane bounded cell projection assembly | 6 | 94 | 2.50e-01 |
| GO:BP | GO:0072210 | metanephric nephron development | 11 | 29 | 2.50e-01 |
| GO:BP | GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 3 | 8 | 2.50e-01 |
| GO:BP | GO:0072162 | metanephric mesenchymal cell differentiation | 1 | 3 | 2.50e-01 |
| GO:BP | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0098734 | macromolecule depalmitoylation | 8 | 13 | 2.50e-01 |
| GO:BP | GO:2001170 | negative regulation of ATP biosynthetic process | 2 | 3 | 2.50e-01 |
| GO:BP | GO:0071451 | cellular response to superoxide | 3 | 19 | 2.50e-01 |
| GO:BP | GO:0098530 | positive regulation of strand invasion | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0033058 | directional locomotion | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0033078 | extrathymic T cell differentiation | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 6 | 57 | 2.50e-01 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 33 | 1214 | 2.50e-01 |
| GO:BP | GO:0071450 | cellular response to oxygen radical | 3 | 19 | 2.50e-01 |
| GO:BP | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0051904 | pigment granule transport | 6 | 19 | 2.50e-01 |
| GO:BP | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1 | 3 | 2.50e-01 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 4 | 48 | 2.50e-01 |
| GO:BP | GO:0043392 | negative regulation of DNA binding | 1 | 46 | 2.50e-01 |
| GO:BP | GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0061346 | planar cell polarity pathway involved in heart morphogenesis | 1 | 1 | 2.50e-01 |
| GO:BP | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process | 2 | 2 | 2.50e-01 |
| GO:BP | GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 1 | 1 | 2.50e-01 |
| GO:BP | GO:1903541 | regulation of exosomal secretion | 2 | 15 | 2.50e-01 |
| GO:BP | GO:0034612 | response to tumor necrosis factor | 5 | 172 | 2.50e-01 |
| GO:BP | GO:0046466 | membrane lipid catabolic process | 3 | 30 | 2.51e-01 |
| GO:BP | GO:0009790 | embryo development | 3 | 875 | 2.51e-01 |
| GO:BP | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 8 | 52 | 2.51e-01 |
| GO:BP | GO:0001578 | microtubule bundle formation | 3 | 79 | 2.51e-01 |
| GO:BP | GO:0045794 | negative regulation of cell volume | 2 | 4 | 2.51e-01 |
| GO:BP | GO:1902966 | positive regulation of protein localization to early endosome | 1 | 9 | 2.51e-01 |
| GO:BP | GO:1902965 | regulation of protein localization to early endosome | 1 | 9 | 2.51e-01 |
| GO:BP | GO:0090244 | Wnt signaling pathway involved in somitogenesis | 2 | 5 | 2.51e-01 |
| GO:BP | GO:0014009 | glial cell proliferation | 5 | 40 | 2.52e-01 |
| GO:BP | GO:0051648 | vesicle localization | 11 | 192 | 2.52e-01 |
| GO:BP | GO:0007288 | sperm axoneme assembly | 1 | 20 | 2.52e-01 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 5 | 70 | 2.52e-01 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 19 | 420 | 2.52e-01 |
| GO:BP | GO:0042594 | response to starvation | 3 | 178 | 2.52e-01 |
| GO:BP | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development | 2 | 2 | 2.52e-01 |
| GO:BP | GO:0032042 | mitochondrial DNA metabolic process | 3 | 22 | 2.52e-01 |
| GO:BP | GO:2000785 | regulation of autophagosome assembly | 24 | 44 | 2.52e-01 |
| GO:BP | GO:0060454 | positive regulation of gastric acid secretion | 1 | 2 | 2.52e-01 |
| GO:BP | GO:0051974 | negative regulation of telomerase activity | 4 | 11 | 2.52e-01 |
| GO:BP | GO:0090212 | negative regulation of establishment of blood-brain barrier | 1 | 1 | 2.52e-01 |
| GO:BP | GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 2 | 2 | 2.52e-01 |
| GO:BP | GO:0098704 | carbohydrate import across plasma membrane | 3 | 5 | 2.52e-01 |
| GO:BP | GO:0140271 | hexose import across plasma membrane | 3 | 5 | 2.52e-01 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 22 | 68 | 2.52e-01 |
| GO:BP | GO:0070889 | platelet alpha granule organization | 1 | 2 | 2.52e-01 |
| GO:BP | GO:0003241 | growth involved in heart morphogenesis | 3 | 4 | 2.53e-01 |
| GO:BP | GO:0003273 | cell migration involved in endocardial cushion formation | 3 | 4 | 2.53e-01 |
| GO:BP | GO:0001560 | regulation of cell growth by extracellular stimulus | 3 | 3 | 2.53e-01 |
| GO:BP | GO:0031291 | Ran protein signal transduction | 2 | 3 | 2.53e-01 |
| GO:BP | GO:0032886 | regulation of microtubule-based process | 12 | 217 | 2.54e-01 |
| GO:BP | GO:0045634 | regulation of melanocyte differentiation | 3 | 5 | 2.54e-01 |
| GO:BP | GO:0010643 | cell communication by chemical coupling | 2 | 2 | 2.54e-01 |
| GO:BP | GO:0014839 | myoblast migration involved in skeletal muscle regeneration | 2 | 3 | 2.54e-01 |
| GO:BP | GO:0043201 | response to leucine | 1 | 13 | 2.54e-01 |
| GO:BP | GO:0006303 | double-strand break repair via nonhomologous end joining | 38 | 61 | 2.55e-01 |
| GO:BP | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation | 5 | 7 | 2.55e-01 |
| GO:BP | GO:0035740 | CD8-positive, alpha-beta T cell proliferation | 5 | 7 | 2.55e-01 |
| GO:BP | GO:0055123 | digestive system development | 9 | 100 | 2.55e-01 |
| GO:BP | GO:0070232 | regulation of T cell apoptotic process | 2 | 24 | 2.55e-01 |
| GO:BP | GO:1990182 | exosomal secretion | 9 | 18 | 2.55e-01 |
| GO:BP | GO:2000232 | regulation of rRNA processing | 5 | 16 | 2.55e-01 |
| GO:BP | GO:0000491 | small nucleolar ribonucleoprotein complex assembly | 1 | 12 | 2.55e-01 |
| GO:BP | GO:0032185 | septin cytoskeleton organization | 1 | 4 | 2.55e-01 |
| GO:BP | GO:0046173 | polyol biosynthetic process | 6 | 47 | 2.55e-01 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 4 | 260 | 2.55e-01 |
| GO:BP | GO:0048168 | regulation of neuronal synaptic plasticity | 3 | 42 | 2.55e-01 |
| GO:BP | GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 1 | 8 | 2.55e-01 |
| GO:BP | GO:0002467 | germinal center formation | 1 | 10 | 2.55e-01 |
| GO:BP | GO:0046434 | organophosphate catabolic process | 3 | 113 | 2.56e-01 |
| GO:BP | GO:0034248 | regulation of amide metabolic process | 12 | 424 | 2.56e-01 |
| GO:BP | GO:0045604 | regulation of epidermal cell differentiation | 1 | 39 | 2.56e-01 |
| GO:BP | GO:0046474 | glycerophospholipid biosynthetic process | 117 | 189 | 2.56e-01 |
| GO:BP | GO:0006509 | membrane protein ectodomain proteolysis | 1 | 34 | 2.56e-01 |
| GO:BP | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 2 | 8 | 2.56e-01 |
| GO:BP | GO:0034728 | nucleosome organization | 13 | 98 | 2.56e-01 |
| GO:BP | GO:0046520 | sphingoid biosynthetic process | 2 | 13 | 2.56e-01 |
| GO:BP | GO:0022037 | metencephalon development | 1 | 84 | 2.56e-01 |
| GO:BP | GO:0060900 | embryonic camera-type eye formation | 2 | 8 | 2.56e-01 |
| GO:BP | GO:1901339 | regulation of store-operated calcium channel activity | 3 | 8 | 2.56e-01 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 10 | 2139 | 2.56e-01 |
| GO:BP | GO:0071494 | cellular response to UV-C | 2 | 4 | 2.56e-01 |
| GO:BP | GO:0002011 | morphogenesis of an epithelial sheet | 1 | 52 | 2.56e-01 |
| GO:BP | GO:0046512 | sphingosine biosynthetic process | 2 | 13 | 2.56e-01 |
| GO:BP | GO:0002021 | response to dietary excess | 4 | 22 | 2.56e-01 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 3 | 870 | 2.56e-01 |
| GO:BP | GO:0019048 | modulation by virus of host process | 3 | 5 | 2.56e-01 |
| GO:BP | GO:0071582 | negative regulation of zinc ion transport | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0034402 | recruitment of 3’-end processing factors to RNA polymerase II holoenzyme complex | 1 | 2 | 2.56e-01 |
| GO:BP | GO:0071581 | regulation of zinc ion transmembrane import | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0034080 | CENP-A containing chromatin assembly | 4 | 8 | 2.56e-01 |
| GO:BP | GO:0019054 | modulation by virus of host cellular process | 3 | 5 | 2.56e-01 |
| GO:BP | GO:0046131 | pyrimidine ribonucleoside metabolic process | 2 | 7 | 2.56e-01 |
| GO:BP | GO:0071580 | regulation of zinc ion transmembrane transport | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0046133 | pyrimidine ribonucleoside catabolic process | 2 | 7 | 2.56e-01 |
| GO:BP | GO:0033119 | negative regulation of RNA splicing | 14 | 28 | 2.56e-01 |
| GO:BP | GO:0016540 | protein autoprocessing | 6 | 16 | 2.56e-01 |
| GO:BP | GO:0072527 | pyrimidine-containing compound metabolic process | 8 | 67 | 2.56e-01 |
| GO:BP | GO:0006970 | response to osmotic stress | 7 | 67 | 2.56e-01 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 6 | 59 | 2.56e-01 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 10 | 2161 | 2.56e-01 |
| GO:BP | GO:0046700 | heterocycle catabolic process | 17 | 381 | 2.56e-01 |
| GO:BP | GO:0006995 | cellular response to nitrogen starvation | 4 | 9 | 2.56e-01 |
| GO:BP | GO:0071584 | negative regulation of zinc ion transmembrane import | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0021546 | rhombomere development | 2 | 4 | 2.56e-01 |
| GO:BP | GO:1903954 | positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0042772 | DNA damage response, signal transduction resulting in transcription | 2 | 19 | 2.56e-01 |
| GO:BP | GO:0031122 | cytoplasmic microtubule organization | 31 | 60 | 2.56e-01 |
| GO:BP | GO:2001015 | negative regulation of skeletal muscle cell differentiation | 2 | 3 | 2.56e-01 |
| GO:BP | GO:0009158 | ribonucleoside monophosphate catabolic process | 1 | 10 | 2.56e-01 |
| GO:BP | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 1 | 9 | 2.56e-01 |
| GO:BP | GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 1 | 4 | 2.56e-01 |
| GO:BP | GO:1900107 | regulation of nodal signaling pathway | 1 | 3 | 2.56e-01 |
| GO:BP | GO:0071583 | negative regulation of zinc ion transmembrane transport | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0043157 | response to cation stress | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0060013 | righting reflex | 3 | 6 | 2.56e-01 |
| GO:BP | GO:0009117 | nucleotide metabolic process | 6 | 423 | 2.56e-01 |
| GO:BP | GO:0003170 | heart valve development | 3 | 65 | 2.56e-01 |
| GO:BP | GO:0051491 | positive regulation of filopodium assembly | 1 | 25 | 2.56e-01 |
| GO:BP | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 3 | 23 | 2.56e-01 |
| GO:BP | GO:0044878 | mitotic cytokinesis checkpoint signaling | 2 | 4 | 2.56e-01 |
| GO:BP | GO:0003281 | ventricular septum development | 3 | 69 | 2.56e-01 |
| GO:BP | GO:0051785 | positive regulation of nuclear division | 1 | 38 | 2.56e-01 |
| GO:BP | GO:0032077 | positive regulation of deoxyribonuclease activity | 3 | 5 | 2.56e-01 |
| GO:BP | GO:0032060 | bleb assembly | 2 | 9 | 2.56e-01 |
| GO:BP | GO:0061245 | establishment or maintenance of bipolar cell polarity | 7 | 50 | 2.56e-01 |
| GO:BP | GO:0043562 | cellular response to nitrogen levels | 4 | 9 | 2.56e-01 |
| GO:BP | GO:0003230 | cardiac atrium development | 10 | 34 | 2.56e-01 |
| GO:BP | GO:1904415 | regulation of xenophagy | 6 | 7 | 2.56e-01 |
| GO:BP | GO:1903952 | regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization | 1 | 1 | 2.56e-01 |
| GO:BP | GO:1904417 | positive regulation of xenophagy | 6 | 7 | 2.56e-01 |
| GO:BP | GO:1904612 | response to 2,3,7,8-tetrachlorodibenzodioxine | 1 | 2 | 2.56e-01 |
| GO:BP | GO:0000052 | citrulline metabolic process | 7 | 7 | 2.56e-01 |
| GO:BP | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 1 | 3 | 2.56e-01 |
| GO:BP | GO:1903806 | L-isoleucine import across plasma membrane | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0042364 | water-soluble vitamin biosynthetic process | 2 | 8 | 2.56e-01 |
| GO:BP | GO:1903714 | isoleucine transmembrane transport | 1 | 1 | 2.56e-01 |
| GO:BP | GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 1 | 24 | 2.56e-01 |
| GO:BP | GO:0006620 | post-translational protein targeting to endoplasmic reticulum membrane | 2 | 15 | 2.56e-01 |
| GO:BP | GO:0031990 | mRNA export from nucleus in response to heat stress | 1 | 2 | 2.56e-01 |
| GO:BP | GO:0000301 | retrograde transport, vesicle recycling within Golgi | 6 | 9 | 2.56e-01 |
| GO:BP | GO:1901165 | positive regulation of trophoblast cell migration | 2 | 6 | 2.56e-01 |
| GO:BP | GO:0030903 | notochord development | 9 | 17 | 2.56e-01 |
| GO:BP | GO:0001779 | natural killer cell differentiation | 2 | 18 | 2.56e-01 |
| GO:BP | GO:0090125 | cell-cell adhesion involved in synapse maturation | 1 | 2 | 2.56e-01 |
| GO:BP | GO:0042558 | pteridine-containing compound metabolic process | 8 | 28 | 2.56e-01 |
| GO:BP | GO:0031055 | chromatin remodeling at centromere | 4 | 8 | 2.56e-01 |
| GO:BP | GO:0002903 | negative regulation of B cell apoptotic process | 1 | 11 | 2.56e-01 |
| GO:BP | GO:0044003 | modulation by symbiont of host process | 3 | 5 | 2.56e-01 |
| GO:BP | GO:0035050 | embryonic heart tube development | 6 | 69 | 2.56e-01 |
| GO:BP | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure | 4 | 13 | 2.56e-01 |
| GO:BP | GO:0044068 | modulation by symbiont of host cellular process | 3 | 5 | 2.56e-01 |
| GO:BP | GO:0070243 | regulation of thymocyte apoptotic process | 1 | 11 | 2.56e-01 |
| GO:BP | GO:0019731 | antibacterial humoral response | 2 | 15 | 2.56e-01 |
| GO:BP | GO:0042733 | embryonic digit morphogenesis | 1 | 51 | 2.56e-01 |
| GO:BP | GO:0035088 | establishment or maintenance of apical/basal cell polarity | 7 | 50 | 2.56e-01 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 6 | 90 | 2.56e-01 |
| GO:BP | GO:0009065 | glutamine family amino acid catabolic process | 3 | 20 | 2.56e-01 |
| GO:BP | GO:0050856 | regulation of T cell receptor signaling pathway | 2 | 30 | 2.57e-01 |
| GO:BP | GO:0140290 | peptidyl-serine ADP-deribosylation | 1 | 1 | 2.57e-01 |
| GO:BP | GO:0090162 | establishment of epithelial cell polarity | 5 | 29 | 2.57e-01 |
| GO:BP | GO:0046040 | IMP metabolic process | 1 | 15 | 2.57e-01 |
| GO:BP | GO:0046473 | phosphatidic acid metabolic process | 24 | 32 | 2.57e-01 |
| GO:BP | GO:0044090 | positive regulation of vacuole organization | 11 | 21 | 2.57e-01 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 8 | 116 | 2.57e-01 |
| GO:BP | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1 | 4 | 2.57e-01 |
| GO:BP | GO:1901983 | regulation of protein acetylation | 1 | 69 | 2.57e-01 |
| GO:BP | GO:0071476 | cellular hypotonic response | 6 | 8 | 2.57e-01 |
| GO:BP | GO:0036010 | protein localization to endosome | 17 | 26 | 2.58e-01 |
| GO:BP | GO:0033326 | cerebrospinal fluid secretion | 2 | 3 | 2.58e-01 |
| GO:BP | GO:0008299 | isoprenoid biosynthetic process | 3 | 26 | 2.58e-01 |
| GO:BP | GO:0048850 | hypophysis morphogenesis | 2 | 2 | 2.58e-01 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 5 | 64 | 2.59e-01 |
| GO:BP | GO:0051445 | regulation of meiotic cell cycle | 1 | 45 | 2.59e-01 |
| GO:BP | GO:0008291 | acetylcholine metabolic process | 1 | 3 | 2.59e-01 |
| GO:BP | GO:1900619 | acetate ester metabolic process | 1 | 3 | 2.59e-01 |
| GO:BP | GO:0036297 | interstrand cross-link repair | 10 | 37 | 2.60e-01 |
| GO:BP | GO:1903416 | response to glycoside | 3 | 6 | 2.60e-01 |
| GO:BP | GO:0042471 | ear morphogenesis | 1 | 73 | 2.60e-01 |
| GO:BP | GO:0099606 | microtubule plus-end directed mitotic chromosome migration | 1 | 1 | 2.60e-01 |
| GO:BP | GO:0038202 | TORC1 signaling | 30 | 58 | 2.60e-01 |
| GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 11 | 41 | 2.60e-01 |
| GO:BP | GO:0021599 | abducens nerve formation | 1 | 1 | 2.60e-01 |
| GO:BP | GO:0021598 | abducens nerve morphogenesis | 1 | 1 | 2.60e-01 |
| GO:BP | GO:0021560 | abducens nerve development | 1 | 1 | 2.60e-01 |
| GO:BP | GO:0021572 | rhombomere 6 development | 1 | 1 | 2.60e-01 |
| GO:BP | GO:0072709 | cellular response to sorbitol | 2 | 5 | 2.60e-01 |
| GO:BP | GO:0003336 | corneocyte desquamation | 1 | 1 | 2.60e-01 |
| GO:BP | GO:2001188 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1 | 2 | 2.60e-01 |
| GO:BP | GO:0062099 | negative regulation of programmed necrotic cell death | 10 | 17 | 2.61e-01 |
| GO:BP | GO:0031103 | axon regeneration | 1 | 42 | 2.61e-01 |
| GO:BP | GO:0042391 | regulation of membrane potential | 11 | 293 | 2.61e-01 |
| GO:BP | GO:0051905 | establishment of pigment granule localization | 6 | 20 | 2.61e-01 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 2 | 12 | 2.61e-01 |
| GO:BP | GO:0042822 | pyridoxal phosphate metabolic process | 4 | 4 | 2.61e-01 |
| GO:BP | GO:1904999 | positive regulation of leukocyte adhesion to arterial endothelial cell | 1 | 1 | 2.61e-01 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 4 | 64 | 2.61e-01 |
| GO:BP | GO:0015937 | coenzyme A biosynthetic process | 9 | 11 | 2.62e-01 |
| GO:BP | GO:0045682 | regulation of epidermis development | 1 | 45 | 2.62e-01 |
| GO:BP | GO:1900273 | positive regulation of long-term synaptic potentiation | 2 | 19 | 2.62e-01 |
| GO:BP | GO:0042631 | cellular response to water deprivation | 1 | 1 | 2.62e-01 |
| GO:BP | GO:0070455 | positive regulation of heme biosynthetic process | 3 | 3 | 2.62e-01 |
| GO:BP | GO:1901465 | positive regulation of tetrapyrrole biosynthetic process | 3 | 3 | 2.62e-01 |
| GO:BP | GO:0006753 | nucleoside phosphate metabolic process | 6 | 429 | 2.62e-01 |
| GO:BP | GO:0050862 | positive regulation of T cell receptor signaling pathway | 1 | 11 | 2.63e-01 |
| GO:BP | GO:0099554 | trans-synaptic signaling by soluble gas, modulating synaptic transmission | 2 | 2 | 2.63e-01 |
| GO:BP | GO:0099555 | trans-synaptic signaling by nitric oxide, modulating synaptic transmission | 2 | 2 | 2.63e-01 |
| GO:BP | GO:0035176 | social behavior | 4 | 34 | 2.63e-01 |
| GO:BP | GO:0140450 | protein targeting to Golgi apparatus | 1 | 1 | 2.63e-01 |
| GO:BP | GO:0042126 | nitrate metabolic process | 4 | 4 | 2.64e-01 |
| GO:BP | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling | 2 | 2 | 2.64e-01 |
| GO:BP | GO:1990523 | bone regeneration | 2 | 2 | 2.64e-01 |
| GO:BP | GO:0001561 | fatty acid alpha-oxidation | 2 | 5 | 2.64e-01 |
| GO:BP | GO:0046465 | dolichyl diphosphate metabolic process | 3 | 5 | 2.64e-01 |
| GO:BP | GO:0060429 | epithelium development | 3 | 850 | 2.64e-01 |
| GO:BP | GO:0006489 | dolichyl diphosphate biosynthetic process | 3 | 5 | 2.64e-01 |
| GO:BP | GO:0060040 | retinal bipolar neuron differentiation | 1 | 2 | 2.64e-01 |
| GO:BP | GO:0003093 | regulation of glomerular filtration | 3 | 9 | 2.64e-01 |
| GO:BP | GO:0006043 | glucosamine catabolic process | 2 | 2 | 2.64e-01 |
| GO:BP | GO:0050893 | sensory processing | 4 | 4 | 2.64e-01 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 7 | 83 | 2.64e-01 |
| GO:BP | GO:1902946 | protein localization to early endosome | 1 | 11 | 2.64e-01 |
| GO:BP | GO:0097167 | circadian regulation of translation | 4 | 4 | 2.64e-01 |
| GO:BP | GO:1905165 | regulation of lysosomal protein catabolic process | 1 | 11 | 2.64e-01 |
| GO:BP | GO:0006297 | nucleotide-excision repair, DNA gap filling | 3 | 5 | 2.64e-01 |
| GO:BP | GO:0071695 | anatomical structure maturation | 1 | 48 | 2.64e-01 |
| GO:BP | GO:0060074 | synapse maturation | 1 | 25 | 2.64e-01 |
| GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 1 | 54 | 2.64e-01 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 3 | 22 | 2.65e-01 |
| GO:BP | GO:0070106 | interleukin-27-mediated signaling pathway | 1 | 4 | 2.65e-01 |
| GO:BP | GO:0070278 | extracellular matrix constituent secretion | 4 | 12 | 2.65e-01 |
| GO:BP | GO:0031584 | activation of phospholipase D activity | 2 | 4 | 2.65e-01 |
| GO:BP | GO:0006228 | UTP biosynthetic process | 7 | 8 | 2.65e-01 |
| GO:BP | GO:0043633 | polyadenylation-dependent RNA catabolic process | 3 | 9 | 2.65e-01 |
| GO:BP | GO:0000723 | telomere maintenance | 30 | 142 | 2.65e-01 |
| GO:BP | GO:0000725 | recombinational repair | 74 | 153 | 2.65e-01 |
| GO:BP | GO:0090306 | meiotic spindle assembly | 3 | 8 | 2.65e-01 |
| GO:BP | GO:0045636 | positive regulation of melanocyte differentiation | 1 | 4 | 2.65e-01 |
| GO:BP | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 1 | 4 | 2.65e-01 |
| GO:BP | GO:0001947 | heart looping | 5 | 50 | 2.65e-01 |
| GO:BP | GO:0022614 | membrane to membrane docking | 3 | 5 | 2.65e-01 |
| GO:BP | GO:0071047 | polyadenylation-dependent mRNA catabolic process | 1 | 4 | 2.65e-01 |
| GO:BP | GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 1 | 5 | 2.65e-01 |
| GO:BP | GO:0036295 | cellular response to increased oxygen levels | 5 | 12 | 2.65e-01 |
| GO:BP | GO:2000208 | positive regulation of ribosomal small subunit export from nucleus | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0072698 | protein localization to microtubule cytoskeleton | 33 | 52 | 2.65e-01 |
| GO:BP | GO:0099054 | presynapse assembly | 6 | 39 | 2.65e-01 |
| GO:BP | GO:0016239 | positive regulation of macroautophagy | 36 | 70 | 2.65e-01 |
| GO:BP | GO:0010835 | regulation of protein ADP-ribosylation | 4 | 9 | 2.65e-01 |
| GO:BP | GO:0043470 | regulation of carbohydrate catabolic process | 5 | 47 | 2.65e-01 |
| GO:BP | GO:0072257 | metanephric nephron tubule epithelial cell differentiation | 1 | 5 | 2.65e-01 |
| GO:BP | GO:0035998 | 7,8-dihydroneopterin 3’-triphosphate biosynthetic process | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 34 | 1280 | 2.65e-01 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 6 | 91 | 2.65e-01 |
| GO:BP | GO:0000467 | exonucleolytic trimming to generate mature 3’-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3 | 9 | 2.65e-01 |
| GO:BP | GO:2000202 | positive regulation of ribosomal subunit export from nucleus | 1 | 1 | 2.65e-01 |
| GO:BP | GO:2000199 | positive regulation of ribonucleoprotein complex localization | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0016311 | dephosphorylation | 2 | 284 | 2.65e-01 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 1 | 67 | 2.65e-01 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 5 | 60 | 2.65e-01 |
| GO:BP | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion | 7 | 33 | 2.65e-01 |
| GO:BP | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity | 1 | 3 | 2.65e-01 |
| GO:BP | GO:2000200 | regulation of ribosomal subunit export from nucleus | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 3 | 19 | 2.65e-01 |
| GO:BP | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress | 6 | 7 | 2.65e-01 |
| GO:BP | GO:0010508 | positive regulation of autophagy | 78 | 133 | 2.65e-01 |
| GO:BP | GO:0010616 | negative regulation of cardiac muscle adaptation | 6 | 7 | 2.65e-01 |
| GO:BP | GO:0010942 | positive regulation of cell death | 22 | 441 | 2.65e-01 |
| GO:BP | GO:0001921 | positive regulation of receptor recycling | 9 | 11 | 2.65e-01 |
| GO:BP | GO:0046361 | 2-oxobutyrate metabolic process | 1 | 2 | 2.65e-01 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 12 | 17 | 2.65e-01 |
| GO:BP | GO:0032762 | mast cell cytokine production | 5 | 6 | 2.65e-01 |
| GO:BP | GO:0032763 | regulation of mast cell cytokine production | 5 | 6 | 2.65e-01 |
| GO:BP | GO:0031063 | regulation of histone deacetylation | 20 | 36 | 2.65e-01 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 4 | 112 | 2.65e-01 |
| GO:BP | GO:0046051 | UTP metabolic process | 8 | 10 | 2.65e-01 |
| GO:BP | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0000459 | exonucleolytic trimming involved in rRNA processing | 3 | 9 | 2.65e-01 |
| GO:BP | GO:2000206 | regulation of ribosomal small subunit export from nucleus | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0048596 | embryonic camera-type eye morphogenesis | 3 | 18 | 2.65e-01 |
| GO:BP | GO:0080170 | hydrogen peroxide transmembrane transport | 1 | 1 | 2.65e-01 |
| GO:BP | GO:0033631 | cell-cell adhesion mediated by integrin | 1 | 12 | 2.65e-01 |
| GO:BP | GO:0018216 | peptidyl-arginine methylation | 4 | 15 | 2.65e-01 |
| GO:BP | GO:0003192 | mitral valve formation | 3 | 3 | 2.65e-01 |
| GO:BP | GO:1902807 | negative regulation of cell cycle G1/S phase transition | 4 | 70 | 2.65e-01 |
| GO:BP | GO:1902075 | cellular response to salt | 13 | 142 | 2.65e-01 |
| GO:BP | GO:0010044 | response to aluminum ion | 2 | 5 | 2.65e-01 |
| GO:BP | GO:0072666 | establishment of protein localization to vacuole | 9 | 55 | 2.65e-01 |
| GO:BP | GO:0070131 | positive regulation of mitochondrial translation | 12 | 17 | 2.65e-01 |
| GO:BP | GO:0034655 | nucleobase-containing compound catabolic process | 8 | 358 | 2.65e-01 |
| GO:BP | GO:0043555 | regulation of translation in response to stress | 2 | 23 | 2.65e-01 |
| GO:BP | GO:0014032 | neural crest cell development | 26 | 71 | 2.65e-01 |
| GO:BP | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance | 11 | 16 | 2.65e-01 |
| GO:BP | GO:1901798 | positive regulation of signal transduction by p53 class mediator | 11 | 28 | 2.65e-01 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 4 | 113 | 2.66e-01 |
| GO:BP | GO:0150012 | positive regulation of neuron projection arborization | 2 | 8 | 2.66e-01 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 16 | 295 | 2.66e-01 |
| GO:BP | GO:0061162 | establishment of monopolar cell polarity | 4 | 20 | 2.66e-01 |
| GO:BP | GO:0044282 | small molecule catabolic process | 3 | 271 | 2.67e-01 |
| GO:BP | GO:0061026 | cardiac muscle tissue regeneration | 5 | 6 | 2.68e-01 |
| GO:BP | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 18 | 30 | 2.68e-01 |
| GO:BP | GO:1904888 | cranial skeletal system development | 1 | 51 | 2.70e-01 |
| GO:BP | GO:1905938 | positive regulation of germ cell proliferation | 2 | 2 | 2.70e-01 |
| GO:BP | GO:0032222 | regulation of synaptic transmission, cholinergic | 1 | 3 | 2.70e-01 |
| GO:BP | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1 | 3 | 2.70e-01 |
| GO:BP | GO:2000256 | positive regulation of male germ cell proliferation | 2 | 2 | 2.70e-01 |
| GO:BP | GO:1990646 | cellular response to prolactin | 2 | 2 | 2.70e-01 |
| GO:BP | GO:0086009 | membrane repolarization | 6 | 41 | 2.70e-01 |
| GO:BP | GO:0002690 | positive regulation of leukocyte chemotaxis | 8 | 51 | 2.70e-01 |
| GO:BP | GO:0009581 | detection of external stimulus | 1 | 67 | 2.70e-01 |
| GO:BP | GO:0046073 | dTMP metabolic process | 3 | 7 | 2.70e-01 |
| GO:BP | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential | 3 | 10 | 2.70e-01 |
| GO:BP | GO:0060039 | pericardium development | 8 | 17 | 2.70e-01 |
| GO:BP | GO:0006885 | regulation of pH | 5 | 74 | 2.70e-01 |
| GO:BP | GO:0008219 | cell death | 8 | 1596 | 2.70e-01 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 33 | 1239 | 2.71e-01 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 13 | 102 | 2.72e-01 |
| GO:BP | GO:2000431 | regulation of cytokinesis, actomyosin contractile ring assembly | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0031102 | neuron projection regeneration | 1 | 47 | 2.72e-01 |
| GO:BP | GO:0003097 | renal water transport | 3 | 6 | 2.72e-01 |
| GO:BP | GO:0071569 | protein ufmylation | 4 | 6 | 2.72e-01 |
| GO:BP | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 2 | 15 | 2.72e-01 |
| GO:BP | GO:0070584 | mitochondrion morphogenesis | 6 | 21 | 2.72e-01 |
| GO:BP | GO:1905508 | protein localization to microtubule organizing center | 22 | 33 | 2.72e-01 |
| GO:BP | GO:0045822 | negative regulation of heart contraction | 2 | 17 | 2.72e-01 |
| GO:BP | GO:0009582 | detection of abiotic stimulus | 1 | 68 | 2.72e-01 |
| GO:BP | GO:0098732 | macromolecule deacylation | 55 | 119 | 2.72e-01 |
| GO:BP | GO:1901137 | carbohydrate derivative biosynthetic process | 5 | 544 | 2.72e-01 |
| GO:BP | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | 5 | 89 | 2.72e-01 |
| GO:BP | GO:1900060 | negative regulation of ceramide biosynthetic process | 1 | 5 | 2.72e-01 |
| GO:BP | GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 2 | 6 | 2.72e-01 |
| GO:BP | GO:0061136 | regulation of proteasomal protein catabolic process | 10 | 183 | 2.72e-01 |
| GO:BP | GO:0098900 | regulation of action potential | 14 | 44 | 2.72e-01 |
| GO:BP | GO:0006164 | purine nucleotide biosynthetic process | 3 | 209 | 2.72e-01 |
| GO:BP | GO:0046444 | FMN metabolic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0003283 | atrial septum development | 7 | 23 | 2.72e-01 |
| GO:BP | GO:0045746 | negative regulation of Notch signaling pathway | 1 | 31 | 2.72e-01 |
| GO:BP | GO:0045162 | clustering of voltage-gated sodium channels | 2 | 4 | 2.72e-01 |
| GO:BP | GO:0000303 | response to superoxide | 3 | 21 | 2.72e-01 |
| GO:BP | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway | 15 | 27 | 2.72e-01 |
| GO:BP | GO:0009231 | riboflavin biosynthetic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0021700 | developmental maturation | 2 | 211 | 2.72e-01 |
| GO:BP | GO:0140961 | cellular detoxification of metal ion | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0033320 | UDP-D-xylose biosynthetic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0019362 | pyridine nucleotide metabolic process | 5 | 66 | 2.72e-01 |
| GO:BP | GO:0052648 | ribitol phosphate metabolic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0033319 | UDP-D-xylose metabolic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0051703 | biological process involved in intraspecies interaction between organisms | 4 | 34 | 2.72e-01 |
| GO:BP | GO:0009398 | FMN biosynthetic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0097300 | programmed necrotic cell death | 5 | 39 | 2.72e-01 |
| GO:BP | GO:0052647 | pentitol phosphate metabolic process | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0046496 | nicotinamide nucleotide metabolic process | 5 | 66 | 2.72e-01 |
| GO:BP | GO:0090177 | establishment of planar polarity involved in neural tube closure | 3 | 14 | 2.72e-01 |
| GO:BP | GO:0048873 | homeostasis of number of cells within a tissue | 3 | 24 | 2.72e-01 |
| GO:BP | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | 2 | 3 | 2.72e-01 |
| GO:BP | GO:0080144 | intracellular amino acid homeostasis | 7 | 7 | 2.72e-01 |
| GO:BP | GO:0090037 | positive regulation of protein kinase C signaling | 4 | 7 | 2.72e-01 |
| GO:BP | GO:0048388 | endosomal lumen acidification | 3 | 13 | 2.72e-01 |
| GO:BP | GO:0098957 | anterograde axonal transport of mitochondrion | 1 | 5 | 2.72e-01 |
| GO:BP | GO:1902990 | mitotic telomere maintenance via semi-conservative replication | 1 | 2 | 2.72e-01 |
| GO:BP | GO:0098849 | cellular detoxification of cadmium ion | 1 | 1 | 2.72e-01 |
| GO:BP | GO:0120316 | sperm flagellum assembly | 1 | 26 | 2.72e-01 |
| GO:BP | GO:0010833 | telomere maintenance via telomere lengthening | 29 | 73 | 2.72e-01 |
| GO:BP | GO:0044380 | protein localization to cytoskeleton | 35 | 55 | 2.72e-01 |
| GO:BP | GO:0033387 | putrescine biosynthetic process from ornithine | 1 | 3 | 2.72e-01 |
| GO:BP | GO:0051177 | meiotic sister chromatid cohesion | 8 | 12 | 2.72e-01 |
| GO:BP | GO:0048854 | brain morphogenesis | 9 | 28 | 2.72e-01 |
| GO:BP | GO:0035269 | protein O-linked mannosylation | 5 | 16 | 2.72e-01 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 8 | 97 | 2.72e-01 |
| GO:BP | GO:0033619 | membrane protein proteolysis | 1 | 45 | 2.72e-01 |
| GO:BP | GO:0001880 | Mullerian duct regression | 3 | 4 | 2.72e-01 |
| GO:BP | GO:0046135 | pyrimidine nucleoside catabolic process | 2 | 8 | 2.72e-01 |
| GO:BP | GO:0070932 | histone H3 deacetylation | 8 | 12 | 2.72e-01 |
| GO:BP | GO:0071468 | cellular response to acidic pH | 2 | 10 | 2.72e-01 |
| GO:BP | GO:0140042 | lipid droplet formation | 9 | 12 | 2.72e-01 |
| GO:BP | GO:0045821 | positive regulation of glycolytic process | 1 | 15 | 2.72e-01 |
| GO:BP | GO:0060028 | convergent extension involved in axis elongation | 3 | 6 | 2.72e-01 |
| GO:BP | GO:0006623 | protein targeting to vacuole | 7 | 42 | 2.72e-01 |
| GO:BP | GO:0003254 | regulation of membrane depolarization | 14 | 37 | 2.73e-01 |
| GO:BP | GO:2000786 | positive regulation of autophagosome assembly | 10 | 19 | 2.74e-01 |
| GO:BP | GO:1903613 | regulation of protein tyrosine phosphatase activity | 1 | 4 | 2.74e-01 |
| GO:BP | GO:0086092 | regulation of the force of heart contraction by cardiac conduction | 1 | 2 | 2.74e-01 |
| GO:BP | GO:1903281 | positive regulation of calcium:sodium antiporter activity | 1 | 2 | 2.74e-01 |
| GO:BP | GO:0035581 | sequestering of extracellular ligand from receptor | 1 | 7 | 2.74e-01 |
| GO:BP | GO:0106015 | negative regulation of inflammatory response to wounding | 1 | 2 | 2.74e-01 |
| GO:BP | GO:0010288 | response to lead ion | 7 | 18 | 2.74e-01 |
| GO:BP | GO:0051457 | maintenance of protein location in nucleus | 5 | 22 | 2.75e-01 |
| GO:BP | GO:0017148 | negative regulation of translation | 6 | 165 | 2.75e-01 |
| GO:BP | GO:0002084 | protein depalmitoylation | 6 | 10 | 2.75e-01 |
| GO:BP | GO:0099179 | regulation of synaptic membrane adhesion | 4 | 4 | 2.75e-01 |
| GO:BP | GO:0098719 | sodium ion import across plasma membrane | 4 | 14 | 2.75e-01 |
| GO:BP | GO:0009125 | nucleoside monophosphate catabolic process | 1 | 13 | 2.75e-01 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 1 | 68 | 2.75e-01 |
| GO:BP | GO:0001829 | trophectodermal cell differentiation | 1 | 15 | 2.75e-01 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 8 | 114 | 2.75e-01 |
| GO:BP | GO:0046069 | cGMP catabolic process | 1 | 4 | 2.75e-01 |
| GO:BP | GO:0006833 | water transport | 3 | 10 | 2.75e-01 |
| GO:BP | GO:2000573 | positive regulation of DNA biosynthetic process | 26 | 67 | 2.75e-01 |
| GO:BP | GO:2001301 | lipoxin biosynthetic process | 2 | 2 | 2.75e-01 |
| GO:BP | GO:0032400 | melanosome localization | 6 | 22 | 2.75e-01 |
| GO:BP | GO:0045717 | negative regulation of fatty acid biosynthetic process | 12 | 14 | 2.76e-01 |
| GO:BP | GO:2001012 | mesenchymal cell differentiation involved in renal system development | 1 | 5 | 2.76e-01 |
| GO:BP | GO:0090183 | regulation of kidney development | 3 | 22 | 2.76e-01 |
| GO:BP | GO:0000722 | telomere maintenance via recombination | 4 | 14 | 2.76e-01 |
| GO:BP | GO:0046719 | regulation by virus of viral protein levels in host cell | 1 | 8 | 2.76e-01 |
| GO:BP | GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1 | 5 | 2.76e-01 |
| GO:BP | GO:1904350 | regulation of protein catabolic process in the vacuole | 1 | 13 | 2.76e-01 |
| GO:BP | GO:1905668 | positive regulation of protein localization to endosome | 1 | 13 | 2.76e-01 |
| GO:BP | GO:0006686 | sphingomyelin biosynthetic process | 7 | 11 | 2.76e-01 |
| GO:BP | GO:0097734 | extracellular exosome biogenesis | 2 | 18 | 2.76e-01 |
| GO:BP | GO:0039536 | negative regulation of RIG-I signaling pathway | 2 | 7 | 2.76e-01 |
| GO:BP | GO:0032571 | response to vitamin K | 1 | 5 | 2.76e-01 |
| GO:BP | GO:0035166 | post-embryonic hemopoiesis | 3 | 5 | 2.76e-01 |
| GO:BP | GO:0061757 | leukocyte adhesion to arterial endothelial cell | 3 | 4 | 2.76e-01 |
| GO:BP | GO:0060219 | camera-type eye photoreceptor cell differentiation | 11 | 18 | 2.77e-01 |
| GO:BP | GO:0030902 | hindbrain development | 1 | 114 | 2.77e-01 |
| GO:BP | GO:0060049 | regulation of protein glycosylation | 2 | 10 | 2.77e-01 |
| GO:BP | GO:1903523 | negative regulation of blood circulation | 2 | 18 | 2.77e-01 |
| GO:BP | GO:0014034 | neural crest cell fate commitment | 2 | 4 | 2.77e-01 |
| GO:BP | GO:0042946 | glucoside transport | 3 | 3 | 2.77e-01 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 26 | 44 | 2.77e-01 |
| GO:BP | GO:0008089 | anterograde axonal transport | 6 | 45 | 2.78e-01 |
| GO:BP | GO:0045007 | depurination | 4 | 4 | 2.78e-01 |
| GO:BP | GO:0003164 | His-Purkinje system development | 5 | 7 | 2.78e-01 |
| GO:BP | GO:0034198 | cellular response to amino acid starvation | 8 | 48 | 2.78e-01 |
| GO:BP | GO:1905063 | regulation of vascular associated smooth muscle cell differentiation | 10 | 14 | 2.78e-01 |
| GO:BP | GO:0001843 | neural tube closure | 2 | 90 | 2.78e-01 |
| GO:BP | GO:0060576 | intestinal epithelial cell development | 2 | 11 | 2.78e-01 |
| GO:BP | GO:0036372 | opsin transport | 1 | 2 | 2.78e-01 |
| GO:BP | GO:0001967 | suckling behavior | 1 | 10 | 2.78e-01 |
| GO:BP | GO:2000210 | positive regulation of anoikis | 4 | 6 | 2.79e-01 |
| GO:BP | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate | 2 | 16 | 2.79e-01 |
| GO:BP | GO:0046337 | phosphatidylethanolamine metabolic process | 6 | 19 | 2.79e-01 |
| GO:BP | GO:2000310 | regulation of NMDA receptor activity | 4 | 19 | 2.79e-01 |
| GO:BP | GO:0061339 | establishment or maintenance of monopolar cell polarity | 4 | 20 | 2.79e-01 |
| GO:BP | GO:0016570 | histone modification | 1 | 433 | 2.80e-01 |
| GO:BP | GO:0002566 | somatic diversification of immune receptors via somatic mutation | 6 | 12 | 2.80e-01 |
| GO:BP | GO:0007605 | sensory perception of sound | 1 | 98 | 2.80e-01 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 2 | 418 | 2.80e-01 |
| GO:BP | GO:0060449 | bud elongation involved in lung branching | 1 | 7 | 2.80e-01 |
| GO:BP | GO:0032458 | slow endocytic recycling | 2 | 2 | 2.80e-01 |
| GO:BP | GO:0061485 | memory T cell proliferation | 1 | 1 | 2.80e-01 |
| GO:BP | GO:0043605 | amide catabolic process | 1 | 10 | 2.80e-01 |
| GO:BP | GO:0006218 | uridine catabolic process | 1 | 1 | 2.80e-01 |
| GO:BP | GO:0072522 | purine-containing compound biosynthetic process | 3 | 218 | 2.80e-01 |
| GO:BP | GO:0046108 | uridine metabolic process | 1 | 1 | 2.80e-01 |
| GO:BP | GO:0014886 | transition between slow and fast fiber | 1 | 1 | 2.80e-01 |
| GO:BP | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1 | 2 | 2.80e-01 |
| GO:BP | GO:0031667 | response to nutrient levels | 6 | 353 | 2.80e-01 |
| GO:BP | GO:0090331 | negative regulation of platelet aggregation | 6 | 11 | 2.80e-01 |
| GO:BP | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 10 | 15 | 2.80e-01 |
| GO:BP | GO:0060606 | tube closure | 2 | 91 | 2.80e-01 |
| GO:BP | GO:0046398 | UDP-glucuronate metabolic process | 1 | 2 | 2.80e-01 |
| GO:BP | GO:0007144 | female meiosis I | 6 | 9 | 2.81e-01 |
| GO:BP | GO:0071895 | odontoblast differentiation | 2 | 5 | 2.81e-01 |
| GO:BP | GO:0007595 | lactation | 1 | 32 | 2.81e-01 |
| GO:BP | GO:1905962 | glutamatergic neuron differentiation | 1 | 2 | 2.81e-01 |
| GO:BP | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain | 1 | 2 | 2.81e-01 |
| GO:BP | GO:0060083 | smooth muscle contraction involved in micturition | 1 | 2 | 2.81e-01 |
| GO:BP | GO:0043153 | entrainment of circadian clock by photoperiod | 15 | 27 | 2.81e-01 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 2 | 442 | 2.81e-01 |
| GO:BP | GO:2000406 | positive regulation of T cell migration | 4 | 20 | 2.81e-01 |
| GO:BP | GO:0018200 | peptidyl-glutamic acid modification | 1 | 17 | 2.82e-01 |
| GO:BP | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | 1 | 5 | 2.82e-01 |
| GO:BP | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation | 1 | 1 | 2.82e-01 |
| GO:BP | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 6 | 18 | 2.82e-01 |
| GO:BP | GO:0036497 | eIF2alpha dephosphorylation in response to endoplasmic reticulum stress | 1 | 1 | 2.82e-01 |
| GO:BP | GO:1904668 | positive regulation of ubiquitin protein ligase activity | 7 | 13 | 2.82e-01 |
| GO:BP | GO:0033194 | response to hydroperoxide | 2 | 12 | 2.82e-01 |
| GO:BP | GO:1905443 | regulation of clathrin coat assembly | 1 | 1 | 2.82e-01 |
| GO:BP | GO:1903917 | positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation | 1 | 1 | 2.82e-01 |
| GO:BP | GO:1902074 | response to salt | 21 | 271 | 2.82e-01 |
| GO:BP | GO:1904760 | regulation of myofibroblast differentiation | 3 | 5 | 2.82e-01 |
| GO:BP | GO:1903916 | regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation | 1 | 1 | 2.82e-01 |
| GO:BP | GO:0071955 | recycling endosome to Golgi transport | 1 | 2 | 2.82e-01 |
| GO:BP | GO:1905445 | positive regulation of clathrin coat assembly | 1 | 1 | 2.82e-01 |
| GO:BP | GO:0010609 | mRNA localization resulting in post-transcriptional regulation of gene expression | 1 | 2 | 2.82e-01 |
| GO:BP | GO:0000305 | response to oxygen radical | 3 | 22 | 2.82e-01 |
| GO:BP | GO:0006109 | regulation of carbohydrate metabolic process | 2 | 144 | 2.82e-01 |
| GO:BP | GO:0071732 | cellular response to nitric oxide | 9 | 14 | 2.83e-01 |
| GO:BP | GO:0032462 | regulation of protein homooligomerization | 2 | 4 | 2.83e-01 |
| GO:BP | GO:1904666 | regulation of ubiquitin protein ligase activity | 7 | 26 | 2.83e-01 |
| GO:BP | GO:0008038 | neuron recognition | 2 | 39 | 2.83e-01 |
| GO:BP | GO:0032926 | negative regulation of activin receptor signaling pathway | 1 | 9 | 2.83e-01 |
| GO:BP | GO:1990089 | response to nerve growth factor | 11 | 41 | 2.83e-01 |
| GO:BP | GO:1904747 | positive regulation of apoptotic process involved in development | 4 | 5 | 2.83e-01 |
| GO:BP | GO:1902339 | positive regulation of apoptotic process involved in morphogenesis | 4 | 5 | 2.83e-01 |
| GO:BP | GO:0006878 | intracellular copper ion homeostasis | 4 | 15 | 2.83e-01 |
| GO:BP | GO:0021594 | rhombomere formation | 1 | 1 | 2.83e-01 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 4 | 25 | 2.83e-01 |
| GO:BP | GO:0021595 | rhombomere structural organization | 1 | 1 | 2.83e-01 |
| GO:BP | GO:1901566 | organonitrogen compound biosynthetic process | 7 | 1484 | 2.83e-01 |
| GO:BP | GO:0140112 | extracellular vesicle biogenesis | 10 | 20 | 2.83e-01 |
| GO:BP | GO:0021659 | rhombomere 3 structural organization | 1 | 1 | 2.83e-01 |
| GO:BP | GO:0021660 | rhombomere 3 formation | 1 | 1 | 2.83e-01 |
| GO:BP | GO:2000765 | regulation of cytoplasmic translation | 3 | 27 | 2.83e-01 |
| GO:BP | GO:0021664 | rhombomere 5 morphogenesis | 1 | 1 | 2.83e-01 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 57 | 206 | 2.83e-01 |
| GO:BP | GO:0021666 | rhombomere 5 formation | 1 | 1 | 2.83e-01 |
| GO:BP | GO:0048742 | regulation of skeletal muscle fiber development | 1 | 8 | 2.83e-01 |
| GO:BP | GO:0021665 | rhombomere 5 structural organization | 1 | 1 | 2.83e-01 |
| GO:BP | GO:1901207 | regulation of heart looping | 2 | 2 | 2.83e-01 |
| GO:BP | GO:1905666 | regulation of protein localization to endosome | 1 | 14 | 2.83e-01 |
| GO:BP | GO:0060682 | primary ureteric bud growth | 1 | 1 | 2.83e-01 |
| GO:BP | GO:0032456 | endocytic recycling | 50 | 80 | 2.83e-01 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 29 | 80 | 2.83e-01 |
| GO:BP | GO:1905340 | regulation of protein localization to kinetochore | 3 | 4 | 2.83e-01 |
| GO:BP | GO:0002902 | regulation of B cell apoptotic process | 1 | 15 | 2.83e-01 |
| GO:BP | GO:1905342 | positive regulation of protein localization to kinetochore | 3 | 4 | 2.83e-01 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 14 | 138 | 2.83e-01 |
| GO:BP | GO:0000296 | spermine transport | 1 | 3 | 2.83e-01 |
| GO:BP | GO:1904046 | negative regulation of vascular endothelial growth factor production | 1 | 1 | 2.83e-01 |
| GO:BP | GO:0034389 | lipid droplet organization | 20 | 30 | 2.83e-01 |
| GO:BP | GO:1901796 | regulation of signal transduction by p53 class mediator | 6 | 101 | 2.83e-01 |
| GO:BP | GO:0060080 | inhibitory postsynaptic potential | 1 | 8 | 2.83e-01 |
| GO:BP | GO:0035623 | renal glucose absorption | 2 | 2 | 2.83e-01 |
| GO:BP | GO:1902410 | mitotic cytokinetic process | 14 | 23 | 2.84e-01 |
| GO:BP | GO:0034311 | diol metabolic process | 5 | 26 | 2.84e-01 |
| GO:BP | GO:0090148 | membrane fission | 24 | 44 | 2.84e-01 |
| GO:BP | GO:1901136 | carbohydrate derivative catabolic process | 7 | 137 | 2.85e-01 |
| GO:BP | GO:1900744 | regulation of p38MAPK cascade | 2 | 32 | 2.85e-01 |
| GO:BP | GO:0061909 | autophagosome-lysosome fusion | 6 | 8 | 2.85e-01 |
| GO:BP | GO:0090398 | cellular senescence | 28 | 83 | 2.86e-01 |
| GO:BP | GO:0061157 | mRNA destabilization | 4 | 89 | 2.86e-01 |
| GO:BP | GO:0045933 | positive regulation of muscle contraction | 2 | 32 | 2.86e-01 |
| GO:BP | GO:2000243 | positive regulation of reproductive process | 1 | 54 | 2.86e-01 |
| GO:BP | GO:0046065 | dCTP metabolic process | 1 | 1 | 2.86e-01 |
| GO:BP | GO:0006253 | dCTP catabolic process | 1 | 1 | 2.86e-01 |
| GO:BP | GO:0097338 | response to clozapine | 2 | 2 | 2.86e-01 |
| GO:BP | GO:0032459 | regulation of protein oligomerization | 3 | 6 | 2.87e-01 |
| GO:BP | GO:0043622 | cortical microtubule organization | 3 | 4 | 2.87e-01 |
| GO:BP | GO:0061098 | positive regulation of protein tyrosine kinase activity | 1 | 33 | 2.87e-01 |
| GO:BP | GO:0090155 | negative regulation of sphingolipid biosynthetic process | 1 | 6 | 2.87e-01 |
| GO:BP | GO:0002091 | negative regulation of receptor internalization | 5 | 14 | 2.87e-01 |
| GO:BP | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 1 | 1 | 2.88e-01 |
| GO:BP | GO:1900075 | positive regulation of neuromuscular synaptic transmission | 1 | 2 | 2.88e-01 |
| GO:BP | GO:2000302 | positive regulation of synaptic vesicle exocytosis | 1 | 3 | 2.88e-01 |
| GO:BP | GO:1900073 | regulation of neuromuscular synaptic transmission | 1 | 2 | 2.88e-01 |
| GO:BP | GO:1901503 | ether biosynthetic process | 4 | 11 | 2.88e-01 |
| GO:BP | GO:0036473 | cell death in response to oxidative stress | 19 | 75 | 2.88e-01 |
| GO:BP | GO:0006421 | asparaginyl-tRNA aminoacylation | 3 | 3 | 2.88e-01 |
| GO:BP | GO:0019659 | glucose catabolic process to lactate | 2 | 4 | 2.88e-01 |
| GO:BP | GO:1904023 | regulation of glucose catabolic process to lactate via pyruvate | 2 | 4 | 2.88e-01 |
| GO:BP | GO:0019660 | glycolytic fermentation | 2 | 4 | 2.88e-01 |
| GO:BP | GO:1901003 | negative regulation of fermentation | 2 | 4 | 2.88e-01 |
| GO:BP | GO:0019661 | glucose catabolic process to lactate via pyruvate | 2 | 4 | 2.88e-01 |
| GO:BP | GO:0042790 | nucleolar large rRNA transcription by RNA polymerase I | 12 | 21 | 2.88e-01 |
| GO:BP | GO:0009636 | response to toxic substance | 14 | 158 | 2.89e-01 |
| GO:BP | GO:0043584 | nose development | 2 | 10 | 2.89e-01 |
| GO:BP | GO:0010652 | positive regulation of cell communication by chemical coupling | 1 | 1 | 2.89e-01 |
| GO:BP | GO:0098906 | regulation of Purkinje myocyte action potential | 1 | 1 | 2.89e-01 |
| GO:BP | GO:0010645 | regulation of cell communication by chemical coupling | 1 | 1 | 2.89e-01 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 25 | 377 | 2.89e-01 |
| GO:BP | GO:0014020 | primary neural tube formation | 2 | 94 | 2.89e-01 |
| GO:BP | GO:0007620 | copulation | 1 | 10 | 2.89e-01 |
| GO:BP | GO:1990029 | vasomotion | 1 | 1 | 2.89e-01 |
| GO:BP | GO:2000273 | positive regulation of signaling receptor activity | 1 | 33 | 2.89e-01 |
| GO:BP | GO:0086044 | atrial cardiac muscle cell to AV node cell communication by electrical coupling | 1 | 1 | 2.89e-01 |
| GO:BP | GO:0086055 | Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling | 1 | 1 | 2.89e-01 |
| GO:BP | GO:0048565 | digestive tract development | 8 | 92 | 2.89e-01 |
| GO:BP | GO:0035601 | protein deacylation | 53 | 116 | 2.89e-01 |
| GO:BP | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 13 | 40 | 2.89e-01 |
| GO:BP | GO:1901524 | regulation of mitophagy | 3 | 13 | 2.89e-01 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 3 | 18 | 2.89e-01 |
| GO:BP | GO:0032509 | endosome transport via multivesicular body sorting pathway | 21 | 41 | 2.90e-01 |
| GO:BP | GO:0070507 | regulation of microtubule cytoskeleton organization | 8 | 146 | 2.91e-01 |
| GO:BP | GO:0021889 | olfactory bulb interneuron differentiation | 6 | 7 | 2.91e-01 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 1 | 55 | 2.91e-01 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 5 | 479 | 2.91e-01 |
| GO:BP | GO:0006939 | smooth muscle contraction | 10 | 75 | 2.92e-01 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 4 | 121 | 2.92e-01 |
| GO:BP | GO:0006729 | tetrahydrobiopterin biosynthetic process | 2 | 7 | 2.92e-01 |
| GO:BP | GO:0071932 | replication fork reversal | 4 | 5 | 2.92e-01 |
| GO:BP | GO:0086070 | SA node cell to atrial cardiac muscle cell communication | 6 | 14 | 2.92e-01 |
| GO:BP | GO:0070601 | centromeric sister chromatid cohesion | 2 | 11 | 2.92e-01 |
| GO:BP | GO:1900115 | extracellular regulation of signal transduction | 1 | 9 | 2.92e-01 |
| GO:BP | GO:1900116 | extracellular negative regulation of signal transduction | 1 | 9 | 2.92e-01 |
| GO:BP | GO:0035499 | carnosine biosynthetic process | 1 | 1 | 2.93e-01 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 1 | 112 | 2.93e-01 |
| GO:BP | GO:0044557 | relaxation of smooth muscle | 2 | 9 | 2.93e-01 |
| GO:BP | GO:0097698 | telomere maintenance via base-excision repair | 1 | 1 | 2.93e-01 |
| GO:BP | GO:0106230 | protein depropionylation | 2 | 2 | 2.94e-01 |
| GO:BP | GO:0060995 | cell-cell signaling involved in kidney development | 1 | 1 | 2.94e-01 |
| GO:BP | GO:0061290 | canonical Wnt signaling pathway involved in metanephric kidney development | 1 | 1 | 2.94e-01 |
| GO:BP | GO:0099170 | postsynaptic modulation of chemical synaptic transmission | 3 | 23 | 2.94e-01 |
| GO:BP | GO:0099172 | presynapse organization | 6 | 42 | 2.94e-01 |
| GO:BP | GO:0051875 | pigment granule localization | 6 | 22 | 2.94e-01 |
| GO:BP | GO:0031125 | rRNA 3’-end processing | 3 | 10 | 2.94e-01 |
| GO:BP | GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 6 | 23 | 2.94e-01 |
| GO:BP | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 2 | 2 | 2.94e-01 |
| GO:BP | GO:1900235 | negative regulation of Kit signaling pathway | 2 | 2 | 2.94e-01 |
| GO:BP | GO:0001942 | hair follicle development | 1 | 67 | 2.94e-01 |
| GO:BP | GO:0061289 | Wnt signaling pathway involved in kidney development | 1 | 1 | 2.94e-01 |
| GO:BP | GO:0071051 | polyadenylation-dependent snoRNA 3’-end processing | 6 | 7 | 2.94e-01 |
| GO:BP | GO:1900234 | regulation of Kit signaling pathway | 2 | 2 | 2.94e-01 |
| GO:BP | GO:2001252 | positive regulation of chromosome organization | 32 | 103 | 2.94e-01 |
| GO:BP | GO:0031393 | negative regulation of prostaglandin biosynthetic process | 2 | 2 | 2.94e-01 |
| GO:BP | GO:0009139 | pyrimidine nucleoside diphosphate biosynthetic process | 4 | 6 | 2.94e-01 |
| GO:BP | GO:0010613 | positive regulation of cardiac muscle hypertrophy | 6 | 22 | 2.94e-01 |
| GO:BP | GO:0072204 | cell-cell signaling involved in metanephros development | 1 | 1 | 2.94e-01 |
| GO:BP | GO:0030011 | maintenance of cell polarity | 2 | 16 | 2.94e-01 |
| GO:BP | GO:0045910 | negative regulation of DNA recombination | 3 | 31 | 2.94e-01 |
| GO:BP | GO:1990743 | protein sialylation | 1 | 5 | 2.94e-01 |
| GO:BP | GO:1903929 | primary palate development | 1 | 2 | 2.94e-01 |
| GO:BP | GO:0051877 | pigment granule aggregation in cell center | 1 | 2 | 2.94e-01 |
| GO:BP | GO:0045926 | negative regulation of growth | 3 | 206 | 2.95e-01 |
| GO:BP | GO:0051402 | neuron apoptotic process | 41 | 200 | 2.95e-01 |
| GO:BP | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential | 2 | 3 | 2.95e-01 |
| GO:BP | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 4 | 13 | 2.95e-01 |
| GO:BP | GO:0086048 | membrane depolarization during bundle of His cell action potential | 2 | 3 | 2.95e-01 |
| GO:BP | GO:0021784 | postganglionic parasympathetic fiber development | 1 | 2 | 2.95e-01 |
| GO:BP | GO:0090673 | endothelial cell-matrix adhesion | 1 | 4 | 2.95e-01 |
| GO:BP | GO:0050942 | positive regulation of pigment cell differentiation | 1 | 5 | 2.95e-01 |
| GO:BP | GO:0009396 | folic acid-containing compound biosynthetic process | 3 | 7 | 2.95e-01 |
| GO:BP | GO:0006498 | N-terminal protein lipidation | 4 | 7 | 2.96e-01 |
| GO:BP | GO:0033314 | mitotic DNA replication checkpoint signaling | 4 | 9 | 2.96e-01 |
| GO:BP | GO:0045740 | positive regulation of DNA replication | 6 | 35 | 2.96e-01 |
| GO:BP | GO:0048255 | mRNA stabilization | 4 | 50 | 2.96e-01 |
| GO:BP | GO:0007284 | spermatogonial cell division | 2 | 3 | 2.96e-01 |
| GO:BP | GO:0009611 | response to wounding | 2 | 415 | 2.97e-01 |
| GO:BP | GO:0022404 | molting cycle process | 1 | 69 | 2.97e-01 |
| GO:BP | GO:0022405 | hair cycle process | 1 | 69 | 2.97e-01 |
| GO:BP | GO:0001941 | postsynaptic membrane organization | 4 | 29 | 2.97e-01 |
| GO:BP | GO:0006198 | cAMP catabolic process | 1 | 9 | 2.97e-01 |
| GO:BP | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response | 1 | 2 | 2.97e-01 |
| GO:BP | GO:0002540 | leukotriene production involved in inflammatory response | 1 | 2 | 2.97e-01 |
| GO:BP | GO:0061572 | actin filament bundle organization | 14 | 140 | 2.97e-01 |
| GO:BP | GO:0006278 | RNA-templated DNA biosynthetic process | 25 | 64 | 2.97e-01 |
| GO:BP | GO:0021891 | olfactory bulb interneuron development | 4 | 5 | 2.97e-01 |
| GO:BP | GO:1901525 | negative regulation of mitophagy | 2 | 6 | 2.97e-01 |
| GO:BP | GO:1901656 | glycoside transport | 4 | 5 | 2.97e-01 |
| GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 4 | 38 | 2.97e-01 |
| GO:BP | GO:0018352 | protein-pyridoxal-5-phosphate linkage | 1 | 2 | 2.97e-01 |
| GO:BP | GO:0006540 | glutamate decarboxylation to succinate | 1 | 1 | 2.97e-01 |
| GO:BP | GO:1903542 | negative regulation of exosomal secretion | 1 | 4 | 2.98e-01 |
| GO:BP | GO:0070676 | intralumenal vesicle formation | 1 | 4 | 2.98e-01 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 5 | 66 | 2.98e-01 |
| GO:BP | GO:0035927 | RNA import into mitochondrion | 3 | 4 | 2.98e-01 |
| GO:BP | GO:0046785 | microtubule polymerization | 2 | 84 | 2.98e-01 |
| GO:BP | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis | 3 | 4 | 2.98e-01 |
| GO:BP | GO:1904262 | negative regulation of TORC1 signaling | 1 | 24 | 2.99e-01 |
| GO:BP | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 1 | 16 | 2.99e-01 |
| GO:BP | GO:0072203 | cell proliferation involved in metanephros development | 1 | 8 | 2.99e-01 |
| GO:BP | GO:0055059 | asymmetric neuroblast division | 1 | 6 | 3.00e-01 |
| GO:BP | GO:0003417 | growth plate cartilage development | 2 | 15 | 3.00e-01 |
| GO:BP | GO:0032200 | telomere organization | 34 | 166 | 3.00e-01 |
| GO:BP | GO:0001696 | gastric acid secretion | 2 | 10 | 3.00e-01 |
| GO:BP | GO:0051321 | meiotic cell cycle | 48 | 188 | 3.00e-01 |
| GO:BP | GO:0060544 | regulation of necroptotic process | 13 | 23 | 3.00e-01 |
| GO:BP | GO:0021773 | striatal medium spiny neuron differentiation | 1 | 3 | 3.01e-01 |
| GO:BP | GO:0046490 | isopentenyl diphosphate metabolic process | 1 | 5 | 3.01e-01 |
| GO:BP | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation | 4 | 6 | 3.01e-01 |
| GO:BP | GO:0009240 | isopentenyl diphosphate biosynthetic process | 1 | 5 | 3.01e-01 |
| GO:BP | GO:0051136 | regulation of NK T cell differentiation | 1 | 4 | 3.01e-01 |
| GO:BP | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth | 1 | 2 | 3.01e-01 |
| GO:BP | GO:1902857 | positive regulation of non-motile cilium assembly | 1 | 7 | 3.01e-01 |
| GO:BP | GO:0061014 | positive regulation of mRNA catabolic process | 4 | 93 | 3.01e-01 |
| GO:BP | GO:0050779 | RNA destabilization | 4 | 92 | 3.01e-01 |
| GO:BP | GO:0032691 | negative regulation of interleukin-1 beta production | 2 | 13 | 3.01e-01 |
| GO:BP | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 2 | 18 | 3.01e-01 |
| GO:BP | GO:1904761 | negative regulation of myofibroblast differentiation | 1 | 4 | 3.01e-01 |
| GO:BP | GO:0045951 | positive regulation of mitotic recombination | 1 | 1 | 3.01e-01 |
| GO:BP | GO:1901032 | negative regulation of response to reactive oxygen species | 3 | 13 | 3.01e-01 |
| GO:BP | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death | 3 | 13 | 3.01e-01 |
| GO:BP | GO:0071679 | commissural neuron axon guidance | 7 | 11 | 3.01e-01 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 3 | 69 | 3.02e-01 |
| GO:BP | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 12 | 27 | 3.02e-01 |
| GO:BP | GO:0030575 | nuclear body organization | 3 | 14 | 3.03e-01 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 14 | 21 | 3.03e-01 |
| GO:BP | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 1 | 4 | 3.03e-01 |
| GO:BP | GO:0048839 | inner ear development | 1 | 132 | 3.04e-01 |
| GO:BP | GO:0044771 | meiotic cell cycle phase transition | 6 | 7 | 3.04e-01 |
| GO:BP | GO:0060349 | bone morphogenesis | 1 | 74 | 3.04e-01 |
| GO:BP | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia | 1 | 2 | 3.04e-01 |
| GO:BP | GO:0072175 | epithelial tube formation | 8 | 127 | 3.04e-01 |
| GO:BP | GO:0045216 | cell-cell junction organization | 1 | 153 | 3.04e-01 |
| GO:BP | GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 2 | 2 | 3.04e-01 |
| GO:BP | GO:0051294 | establishment of spindle orientation | 8 | 36 | 3.05e-01 |
| GO:BP | GO:0002232 | leukocyte chemotaxis involved in inflammatory response | 2 | 4 | 3.05e-01 |
| GO:BP | GO:0051489 | regulation of filopodium assembly | 1 | 44 | 3.05e-01 |
| GO:BP | GO:0070295 | renal water absorption | 3 | 5 | 3.05e-01 |
| GO:BP | GO:0090399 | replicative senescence | 2 | 13 | 3.05e-01 |
| GO:BP | GO:0070233 | negative regulation of T cell apoptotic process | 1 | 14 | 3.05e-01 |
| GO:BP | GO:0072224 | metanephric glomerulus development | 5 | 10 | 3.05e-01 |
| GO:BP | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction | 2 | 2 | 3.05e-01 |
| GO:BP | GO:1901862 | negative regulation of muscle tissue development | 2 | 9 | 3.05e-01 |
| GO:BP | GO:0090031 | positive regulation of steroid hormone biosynthetic process | 3 | 5 | 3.05e-01 |
| GO:BP | GO:0000495 | box H/ACA RNA 3’-end processing | 2 | 2 | 3.05e-01 |
| GO:BP | GO:1902683 | regulation of receptor localization to synapse | 5 | 21 | 3.05e-01 |
| GO:BP | GO:0007113 | endomitotic cell cycle | 2 | 3 | 3.05e-01 |
| GO:BP | GO:0007519 | skeletal muscle tissue development | 3 | 129 | 3.05e-01 |
| GO:BP | GO:0034964 | box H/ACA RNA processing | 2 | 2 | 3.05e-01 |
| GO:BP | GO:2000565 | negative regulation of CD8-positive, alpha-beta T cell proliferation | 2 | 2 | 3.05e-01 |
| GO:BP | GO:0006424 | glutamyl-tRNA aminoacylation | 1 | 2 | 3.05e-01 |
| GO:BP | GO:0006433 | prolyl-tRNA aminoacylation | 1 | 2 | 3.05e-01 |
| GO:BP | GO:1904292 | regulation of ERAD pathway | 2 | 22 | 3.05e-01 |
| GO:BP | GO:0007033 | vacuole organization | 8 | 197 | 3.05e-01 |
| GO:BP | GO:0090402 | oncogene-induced cell senescence | 1 | 3 | 3.05e-01 |
| GO:BP | GO:0030034 | microvillar actin bundle assembly | 1 | 1 | 3.05e-01 |
| GO:BP | GO:0000730 | DNA recombinase assembly | 2 | 3 | 3.05e-01 |
| GO:BP | GO:0090735 | DNA repair complex assembly | 2 | 3 | 3.05e-01 |
| GO:BP | GO:0003408 | optic cup formation involved in camera-type eye development | 1 | 1 | 3.05e-01 |
| GO:BP | GO:0090043 | regulation of tubulin deacetylation | 9 | 21 | 3.05e-01 |
| GO:BP | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter | 1 | 1 | 3.05e-01 |
| GO:BP | GO:0010752 | regulation of cGMP-mediated signaling | 2 | 8 | 3.05e-01 |
| GO:BP | GO:1904933 | regulation of cell proliferation in midbrain | 1 | 1 | 3.05e-01 |
| GO:BP | GO:0051885 | positive regulation of timing of anagen | 1 | 2 | 3.05e-01 |
| GO:BP | GO:1905874 | regulation of postsynaptic density organization | 3 | 10 | 3.05e-01 |
| GO:BP | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 2 | 20 | 3.05e-01 |
| GO:BP | GO:0036518 | chemorepulsion of dopaminergic neuron axon | 1 | 2 | 3.05e-01 |
| GO:BP | GO:1905438 | non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation | 1 | 1 | 3.05e-01 |
| GO:BP | GO:0001841 | neural tube formation | 2 | 101 | 3.05e-01 |
| GO:BP | GO:0036515 | serotonergic neuron axon guidance | 1 | 2 | 3.05e-01 |
| GO:BP | GO:0035754 | B cell chemotaxis | 3 | 5 | 3.06e-01 |
| GO:BP | GO:0045912 | negative regulation of carbohydrate metabolic process | 5 | 38 | 3.06e-01 |
| GO:BP | GO:0120163 | negative regulation of cold-induced thermogenesis | 4 | 40 | 3.06e-01 |
| GO:BP | GO:0030261 | chromosome condensation | 12 | 33 | 3.06e-01 |
| GO:BP | GO:2000311 | regulation of AMPA receptor activity | 2 | 15 | 3.06e-01 |
| GO:BP | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress | 1 | 7 | 3.06e-01 |
| GO:BP | GO:0021670 | lateral ventricle development | 5 | 11 | 3.07e-01 |
| GO:BP | GO:0051592 | response to calcium ion | 10 | 113 | 3.07e-01 |
| GO:BP | GO:0035552 | oxidative single-stranded DNA demethylation | 2 | 3 | 3.07e-01 |
| GO:BP | GO:1902045 | negative regulation of Fas signaling pathway | 2 | 2 | 3.08e-01 |
| GO:BP | GO:0051106 | positive regulation of DNA ligation | 4 | 5 | 3.08e-01 |
| GO:BP | GO:0006536 | glutamate metabolic process | 1 | 25 | 3.08e-01 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 4 | 317 | 3.08e-01 |
| GO:BP | GO:0110025 | DNA strand resection involved in replication fork processing | 4 | 7 | 3.08e-01 |
| GO:BP | GO:0060945 | cardiac neuron differentiation | 1 | 1 | 3.08e-01 |
| GO:BP | GO:0062149 | detection of stimulus involved in sensory perception of pain | 2 | 15 | 3.08e-01 |
| GO:BP | GO:0044270 | cellular nitrogen compound catabolic process | 16 | 378 | 3.08e-01 |
| GO:BP | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis | 1 | 1 | 3.08e-01 |
| GO:BP | GO:0010460 | positive regulation of heart rate | 1 | 21 | 3.09e-01 |
| GO:BP | GO:0006666 | 3-keto-sphinganine metabolic process | 1 | 1 | 3.09e-01 |
| GO:BP | GO:0042559 | pteridine-containing compound biosynthetic process | 4 | 12 | 3.09e-01 |
| GO:BP | GO:0043602 | nitrate catabolic process | 1 | 1 | 3.09e-01 |
| GO:BP | GO:0046210 | nitric oxide catabolic process | 1 | 1 | 3.09e-01 |
| GO:BP | GO:0098924 | retrograde trans-synaptic signaling by nitric oxide | 1 | 1 | 3.09e-01 |
| GO:BP | GO:0098923 | retrograde trans-synaptic signaling by soluble gas | 1 | 1 | 3.09e-01 |
| GO:BP | GO:0055086 | nucleobase-containing small molecule metabolic process | 6 | 487 | 3.09e-01 |
| GO:BP | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 1 | 1 | 3.09e-01 |
| GO:BP | GO:0097401 | synaptic vesicle lumen acidification | 3 | 14 | 3.09e-01 |
| GO:BP | GO:0072718 | response to cisplatin | 3 | 6 | 3.09e-01 |
| GO:BP | GO:0097695 | establishment of protein-containing complex localization to telomere | 3 | 3 | 3.09e-01 |
| GO:BP | GO:1905940 | negative regulation of gonad development | 2 | 2 | 3.09e-01 |
| GO:BP | GO:0097694 | establishment of RNA localization to telomere | 3 | 3 | 3.09e-01 |
| GO:BP | GO:0042249 | establishment of planar polarity of embryonic epithelium | 3 | 15 | 3.09e-01 |
| GO:BP | GO:1905463 | negative regulation of DNA duplex unwinding | 3 | 4 | 3.09e-01 |
| GO:BP | GO:0042135 | neurotransmitter catabolic process | 1 | 10 | 3.10e-01 |
| GO:BP | GO:0052040 | modulation by symbiont of host programmed cell death | 3 | 3 | 3.10e-01 |
| GO:BP | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 24 | 47 | 3.10e-01 |
| GO:BP | GO:0008614 | pyridoxine metabolic process | 1 | 2 | 3.10e-01 |
| GO:BP | GO:1902723 | negative regulation of skeletal muscle satellite cell proliferation | 2 | 2 | 3.10e-01 |
| GO:BP | GO:2000242 | negative regulation of reproductive process | 2 | 42 | 3.10e-01 |
| GO:BP | GO:0042823 | pyridoxal phosphate biosynthetic process | 1 | 2 | 3.10e-01 |
| GO:BP | GO:0039526 | modulation by virus of host apoptotic process | 3 | 3 | 3.10e-01 |
| GO:BP | GO:0008615 | pyridoxine biosynthetic process | 1 | 2 | 3.10e-01 |
| GO:BP | GO:0052150 | modulation by symbiont of host apoptotic process | 3 | 3 | 3.10e-01 |
| GO:BP | GO:0048732 | gland development | 3 | 318 | 3.10e-01 |
| GO:BP | GO:0003138 | primary heart field specification | 2 | 3 | 3.10e-01 |
| GO:BP | GO:0047496 | vesicle transport along microtubule | 5 | 41 | 3.10e-01 |
| GO:BP | GO:0048678 | response to axon injury | 1 | 64 | 3.11e-01 |
| GO:BP | GO:0050932 | regulation of pigment cell differentiation | 1 | 6 | 3.11e-01 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 16 | 70 | 3.11e-01 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 31 | 604 | 3.11e-01 |
| GO:BP | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 2 | 41 | 3.12e-01 |
| GO:BP | GO:0006670 | sphingosine metabolic process | 2 | 18 | 3.12e-01 |
| GO:BP | GO:0033211 | adiponectin-activated signaling pathway | 6 | 7 | 3.12e-01 |
| GO:BP | GO:0043488 | regulation of mRNA stability | 8 | 147 | 3.12e-01 |
| GO:BP | GO:1903566 | positive regulation of protein localization to cilium | 5 | 7 | 3.12e-01 |
| GO:BP | GO:1990928 | response to amino acid starvation | 8 | 51 | 3.12e-01 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 10 | 89 | 3.13e-01 |
| GO:BP | GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 5 | 7 | 3.13e-01 |
| GO:BP | GO:0006598 | polyamine catabolic process | 3 | 4 | 3.13e-01 |
| GO:BP | GO:0043276 | anoikis | 12 | 32 | 3.13e-01 |
| GO:BP | GO:0001783 | B cell apoptotic process | 1 | 21 | 3.13e-01 |
| GO:BP | GO:0090210 | regulation of establishment of blood-brain barrier | 1 | 3 | 3.13e-01 |
| GO:BP | GO:0046519 | sphingoid metabolic process | 4 | 19 | 3.13e-01 |
| GO:BP | GO:1905198 | manchette assembly | 4 | 4 | 3.13e-01 |
| GO:BP | GO:0050953 | sensory perception of light stimulus | 1 | 97 | 3.13e-01 |
| GO:BP | GO:1903774 | positive regulation of viral budding via host ESCRT complex | 2 | 3 | 3.13e-01 |
| GO:BP | GO:0010544 | negative regulation of platelet activation | 8 | 17 | 3.13e-01 |
| GO:BP | GO:0014742 | positive regulation of muscle hypertrophy | 6 | 22 | 3.14e-01 |
| GO:BP | GO:1990403 | embryonic brain development | 6 | 13 | 3.14e-01 |
| GO:BP | GO:0009142 | nucleoside triphosphate biosynthetic process | 2 | 111 | 3.14e-01 |
| GO:BP | GO:0070262 | peptidyl-serine dephosphorylation | 10 | 14 | 3.14e-01 |
| GO:BP | GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 4 | 4 | 3.14e-01 |
| GO:BP | GO:0003137 | Notch signaling pathway involved in heart induction | 4 | 4 | 3.14e-01 |
| GO:BP | GO:0035480 | regulation of Notch signaling pathway involved in heart induction | 4 | 4 | 3.14e-01 |
| GO:BP | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration | 2 | 6 | 3.14e-01 |
| GO:BP | GO:0060537 | muscle tissue development | 2 | 343 | 3.14e-01 |
| GO:BP | GO:0030216 | keratinocyte differentiation | 2 | 75 | 3.14e-01 |
| GO:BP | GO:0060173 | limb development | 2 | 142 | 3.14e-01 |
| GO:BP | GO:0030952 | establishment or maintenance of cytoskeleton polarity | 3 | 7 | 3.14e-01 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 21 | 740 | 3.14e-01 |
| GO:BP | GO:0048736 | appendage development | 2 | 142 | 3.14e-01 |
| GO:BP | GO:0002505 | antigen processing and presentation of polysaccharide antigen via MHC class II | 1 | 1 | 3.14e-01 |
| GO:BP | GO:0046754 | viral exocytosis | 1 | 1 | 3.14e-01 |
| GO:BP | GO:0007274 | neuromuscular synaptic transmission | 2 | 14 | 3.14e-01 |
| GO:BP | GO:0007250 | activation of NF-kappaB-inducing kinase activity | 1 | 13 | 3.14e-01 |
| GO:BP | GO:0002747 | antigen processing and presentation following phagocytosis | 1 | 1 | 3.14e-01 |
| GO:BP | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 2 | 12 | 3.15e-01 |
| GO:BP | GO:0009174 | pyrimidine ribonucleoside monophosphate biosynthetic process | 4 | 9 | 3.15e-01 |
| GO:BP | GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 3 | 40 | 3.15e-01 |
| GO:BP | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane | 8 | 10 | 3.15e-01 |
| GO:BP | GO:0030033 | microvillus assembly | 4 | 15 | 3.15e-01 |
| GO:BP | GO:0032011 | ARF protein signal transduction | 3 | 18 | 3.15e-01 |
| GO:BP | GO:0032012 | regulation of ARF protein signal transduction | 3 | 18 | 3.15e-01 |
| GO:BP | GO:0044205 | ‘de novo’ UMP biosynthetic process | 2 | 3 | 3.15e-01 |
| GO:BP | GO:0000002 | mitochondrial genome maintenance | 1 | 29 | 3.15e-01 |
| GO:BP | GO:1905222 | atrioventricular canal morphogenesis | 3 | 4 | 3.15e-01 |
| GO:BP | GO:0099639 | neurotransmitter receptor transport, endosome to plasma membrane | 8 | 10 | 3.15e-01 |
| GO:BP | GO:0035935 | androgen secretion | 1 | 1 | 3.15e-01 |
| GO:BP | GO:2000836 | positive regulation of androgen secretion | 1 | 1 | 3.15e-01 |
| GO:BP | GO:2000834 | regulation of androgen secretion | 1 | 1 | 3.15e-01 |
| GO:BP | GO:0010165 | response to X-ray | 11 | 29 | 3.16e-01 |
| GO:BP | GO:1903955 | positive regulation of protein targeting to mitochondrion | 6 | 30 | 3.16e-01 |
| GO:BP | GO:0045880 | positive regulation of smoothened signaling pathway | 5 | 31 | 3.16e-01 |
| GO:BP | GO:0051694 | pointed-end actin filament capping | 3 | 6 | 3.16e-01 |
| GO:BP | GO:0016114 | terpenoid biosynthetic process | 2 | 12 | 3.16e-01 |
| GO:BP | GO:0002688 | regulation of leukocyte chemotaxis | 9 | 68 | 3.16e-01 |
| GO:BP | GO:0051549 | positive regulation of keratinocyte migration | 1 | 11 | 3.16e-01 |
| GO:BP | GO:0070265 | necrotic cell death | 6 | 53 | 3.16e-01 |
| GO:BP | GO:0007522 | visceral muscle development | 1 | 1 | 3.16e-01 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 30 | 72 | 3.16e-01 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 3 | 26 | 3.16e-01 |
| GO:BP | GO:1905146 | lysosomal protein catabolic process | 1 | 19 | 3.16e-01 |
| GO:BP | GO:0043583 | ear development | 1 | 153 | 3.16e-01 |
| GO:BP | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1 | 3 | 3.16e-01 |
| GO:BP | GO:0006044 | N-acetylglucosamine metabolic process | 1 | 16 | 3.16e-01 |
| GO:BP | GO:0006265 | DNA topological change | 1 | 10 | 3.16e-01 |
| GO:BP | GO:0033081 | regulation of T cell differentiation in thymus | 1 | 16 | 3.16e-01 |
| GO:BP | GO:0003344 | pericardium morphogenesis | 4 | 7 | 3.16e-01 |
| GO:BP | GO:0021856 | hypothalamic tangential migration using cell-axon interactions | 5 | 6 | 3.16e-01 |
| GO:BP | GO:0021828 | gonadotrophin-releasing hormone neuronal migration to the hypothalamus | 5 | 6 | 3.16e-01 |
| GO:BP | GO:1905301 | regulation of macropinocytosis | 3 | 3 | 3.16e-01 |
| GO:BP | GO:1903279 | regulation of calcium:sodium antiporter activity | 1 | 3 | 3.16e-01 |
| GO:BP | GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 4 | 6 | 3.16e-01 |
| GO:BP | GO:0032911 | negative regulation of transforming growth factor beta1 production | 5 | 5 | 3.16e-01 |
| GO:BP | GO:1990261 | pre-mRNA catabolic process | 1 | 1 | 3.17e-01 |
| GO:BP | GO:0070228 | regulation of lymphocyte apoptotic process | 2 | 37 | 3.17e-01 |
| GO:BP | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration | 2 | 3 | 3.17e-01 |
| GO:BP | GO:0048729 | tissue morphogenesis | 2 | 504 | 3.17e-01 |
| GO:BP | GO:0097291 | renal phosphate ion absorption | 1 | 1 | 3.17e-01 |
| GO:BP | GO:0050688 | regulation of defense response to virus | 2 | 63 | 3.17e-01 |
| GO:BP | GO:0034478 | phosphatidylglycerol catabolic process | 1 | 1 | 3.17e-01 |
| GO:BP | GO:0014832 | urinary bladder smooth muscle contraction | 2 | 4 | 3.17e-01 |
| GO:BP | GO:0030865 | cortical cytoskeleton organization | 3 | 55 | 3.17e-01 |
| GO:BP | GO:1905462 | regulation of DNA duplex unwinding | 3 | 7 | 3.17e-01 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 | 100 | 3.17e-01 |
| GO:BP | GO:0001100 | negative regulation of exit from mitosis | 1 | 1 | 3.17e-01 |
| GO:BP | GO:0048703 | embryonic viscerocranium morphogenesis | 1 | 8 | 3.17e-01 |
| GO:BP | GO:1903035 | negative regulation of response to wounding | 1 | 64 | 3.18e-01 |
| GO:BP | GO:0051452 | intracellular pH reduction | 3 | 45 | 3.18e-01 |
| GO:BP | GO:0010754 | negative regulation of cGMP-mediated signaling | 1 | 4 | 3.18e-01 |
| GO:BP | GO:1903762 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | 1 | 2 | 3.18e-01 |
| GO:BP | GO:1905026 | positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential | 1 | 2 | 3.18e-01 |
| GO:BP | GO:1905033 | positive regulation of membrane repolarization during cardiac muscle cell action potential | 1 | 2 | 3.18e-01 |
| GO:BP | GO:0099560 | synaptic membrane adhesion | 4 | 22 | 3.18e-01 |
| GO:BP | GO:0010035 | response to inorganic substance | 28 | 414 | 3.18e-01 |
| GO:BP | GO:0045769 | negative regulation of asymmetric cell division | 1 | 1 | 3.19e-01 |
| GO:BP | GO:0035513 | oxidative RNA demethylation | 3 | 5 | 3.19e-01 |
| GO:BP | GO:0010224 | response to UV-B | 2 | 17 | 3.19e-01 |
| GO:BP | GO:0031175 | neuron projection development | 3 | 780 | 3.19e-01 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 10 | 133 | 3.19e-01 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 3 | 763 | 3.19e-01 |
| GO:BP | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness | 1 | 1 | 3.19e-01 |
| GO:BP | GO:0042633 | hair cycle | 1 | 78 | 3.19e-01 |
| GO:BP | GO:0042303 | molting cycle | 1 | 78 | 3.19e-01 |
| GO:BP | GO:2000080 | negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation | 1 | 1 | 3.19e-01 |
| GO:BP | GO:0031116 | positive regulation of microtubule polymerization | 2 | 31 | 3.19e-01 |
| GO:BP | GO:0060572 | morphogenesis of an epithelial bud | 2 | 11 | 3.19e-01 |
| GO:BP | GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 1 | 1 | 3.19e-01 |
| GO:BP | GO:0042746 | circadian sleep/wake cycle, wakefulness | 1 | 1 | 3.19e-01 |
| GO:BP | GO:0016080 | synaptic vesicle targeting | 1 | 3 | 3.19e-01 |
| GO:BP | GO:0090246 | convergent extension involved in somitogenesis | 1 | 1 | 3.19e-01 |
| GO:BP | GO:0060322 | head development | 12 | 633 | 3.19e-01 |
| GO:BP | GO:0048852 | diencephalon morphogenesis | 2 | 2 | 3.19e-01 |
| GO:BP | GO:0006266 | DNA ligation | 9 | 16 | 3.19e-01 |
| GO:BP | GO:0150018 | basal dendrite development | 3 | 3 | 3.20e-01 |
| GO:BP | GO:0150019 | basal dendrite morphogenesis | 3 | 3 | 3.20e-01 |
| GO:BP | GO:0150020 | basal dendrite arborization | 3 | 3 | 3.20e-01 |
| GO:BP | GO:0072520 | seminiferous tubule development | 9 | 13 | 3.20e-01 |
| GO:BP | GO:0046146 | tetrahydrobiopterin metabolic process | 2 | 7 | 3.20e-01 |
| GO:BP | GO:0007616 | long-term memory | 8 | 31 | 3.20e-01 |
| GO:BP | GO:0106034 | protein maturation by [2Fe-2S] cluster transfer | 1 | 3 | 3.20e-01 |
| GO:BP | GO:0071353 | cellular response to interleukin-4 | 2 | 21 | 3.20e-01 |
| GO:BP | GO:0006222 | UMP biosynthetic process | 2 | 8 | 3.20e-01 |
| GO:BP | GO:0051101 | regulation of DNA binding | 1 | 104 | 3.20e-01 |
| GO:BP | GO:2000379 | positive regulation of reactive oxygen species metabolic process | 9 | 46 | 3.20e-01 |
| GO:BP | GO:0060932 | His-Purkinje system cell differentiation | 4 | 4 | 3.20e-01 |
| GO:BP | GO:0044248 | cellular catabolic process | 6 | 1229 | 3.20e-01 |
| GO:BP | GO:0036211 | protein modification process | 7 | 2901 | 3.20e-01 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 11 | 113 | 3.20e-01 |
| GO:BP | GO:0034976 | response to endoplasmic reticulum stress | 8 | 234 | 3.20e-01 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 19 | 204 | 3.20e-01 |
| GO:BP | GO:2000538 | positive regulation of B cell chemotaxis | 1 | 1 | 3.20e-01 |
| GO:BP | GO:0006400 | tRNA modification | 54 | 90 | 3.20e-01 |
| GO:BP | GO:2000537 | regulation of B cell chemotaxis | 1 | 1 | 3.20e-01 |
| GO:BP | GO:0033599 | regulation of mammary gland epithelial cell proliferation | 10 | 14 | 3.20e-01 |
| GO:BP | GO:0035694 | mitochondrial protein catabolic process | 2 | 6 | 3.20e-01 |
| GO:BP | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 1 | 4 | 3.20e-01 |
| GO:BP | GO:0006305 | DNA alkylation | 1 | 46 | 3.21e-01 |
| GO:BP | GO:0006306 | DNA methylation | 1 | 46 | 3.21e-01 |
| GO:BP | GO:0002313 | mature B cell differentiation involved in immune response | 3 | 17 | 3.21e-01 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 1 | 89 | 3.21e-01 |
| GO:BP | GO:0035695 | mitophagy by induced vacuole formation | 1 | 1 | 3.21e-01 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 1 | 89 | 3.21e-01 |
| GO:BP | GO:0032355 | response to estradiol | 1 | 83 | 3.21e-01 |
| GO:BP | GO:1903966 | monounsaturated fatty acid biosynthetic process | 1 | 2 | 3.21e-01 |
| GO:BP | GO:0009185 | ribonucleoside diphosphate metabolic process | 4 | 27 | 3.21e-01 |
| GO:BP | GO:0018195 | peptidyl-arginine modification | 4 | 18 | 3.21e-01 |
| GO:BP | GO:1904978 | regulation of endosome organization | 1 | 5 | 3.22e-01 |
| GO:BP | GO:0022615 | protein to membrane docking | 1 | 5 | 3.22e-01 |
| GO:BP | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development | 3 | 6 | 3.22e-01 |
| GO:BP | GO:0036005 | response to macrophage colony-stimulating factor | 2 | 8 | 3.22e-01 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 1 | 109 | 3.23e-01 |
| GO:BP | GO:0060856 | establishment of blood-brain barrier | 2 | 9 | 3.23e-01 |
| GO:BP | GO:0048087 | positive regulation of developmental pigmentation | 1 | 7 | 3.23e-01 |
| GO:BP | GO:0032206 | positive regulation of telomere maintenance | 20 | 64 | 3.23e-01 |
| GO:BP | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 4 | 14 | 3.23e-01 |
| GO:BP | GO:0010312 | detoxification of zinc ion | 1 | 1 | 3.23e-01 |
| GO:BP | GO:1990359 | stress response to zinc ion | 1 | 1 | 3.23e-01 |
| GO:BP | GO:0046074 | dTMP catabolic process | 1 | 3 | 3.23e-01 |
| GO:BP | GO:0007042 | lysosomal lumen acidification | 14 | 21 | 3.23e-01 |
| GO:BP | GO:0021894 | cerebral cortex GABAergic interneuron development | 1 | 3 | 3.23e-01 |
| GO:BP | GO:0048863 | stem cell differentiation | 7 | 197 | 3.23e-01 |
| GO:BP | GO:0070227 | lymphocyte apoptotic process | 5 | 56 | 3.24e-01 |
| GO:BP | GO:0030091 | protein repair | 2 | 7 | 3.24e-01 |
| GO:BP | GO:0070301 | cellular response to hydrogen peroxide | 8 | 73 | 3.24e-01 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 10 | 24 | 3.24e-01 |
| GO:BP | GO:0046068 | cGMP metabolic process | 2 | 11 | 3.25e-01 |
| GO:BP | GO:0033499 | galactose catabolic process via UDP-galactose | 2 | 4 | 3.25e-01 |
| GO:BP | GO:0060538 | skeletal muscle organ development | 3 | 139 | 3.25e-01 |
| GO:BP | GO:0001887 | selenium compound metabolic process | 2 | 2 | 3.25e-01 |
| GO:BP | GO:1902513 | regulation of organelle transport along microtubule | 1 | 9 | 3.26e-01 |
| GO:BP | GO:0032091 | negative regulation of protein binding | 1 | 77 | 3.26e-01 |
| GO:BP | GO:2000639 | negative regulation of SREBP signaling pathway | 3 | 3 | 3.26e-01 |
| GO:BP | GO:0051607 | defense response to virus | 2 | 202 | 3.26e-01 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 1 | 99 | 3.26e-01 |
| GO:BP | GO:0022612 | gland morphogenesis | 1 | 98 | 3.26e-01 |
| GO:BP | GO:0140546 | defense response to symbiont | 2 | 202 | 3.27e-01 |
| GO:BP | GO:0072720 | response to dithiothreitol | 2 | 2 | 3.27e-01 |
| GO:BP | GO:0009446 | putrescine biosynthetic process | 1 | 4 | 3.27e-01 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 11 | 357 | 3.27e-01 |
| GO:BP | GO:0051653 | spindle localization | 8 | 52 | 3.28e-01 |
| GO:BP | GO:0098773 | skin epidermis development | 1 | 87 | 3.28e-01 |
| GO:BP | GO:0097324 | melanocyte migration | 3 | 3 | 3.28e-01 |
| GO:BP | GO:0009447 | putrescine catabolic process | 1 | 2 | 3.28e-01 |
| GO:BP | GO:1904948 | midbrain dopaminergic neuron differentiation | 3 | 12 | 3.28e-01 |
| GO:BP | GO:0033484 | intracellular nitric oxide homeostasis | 2 | 3 | 3.28e-01 |
| GO:BP | GO:0048627 | myoblast development | 1 | 3 | 3.28e-01 |
| GO:BP | GO:1905784 | regulation of anaphase-promoting complex-dependent catabolic process | 1 | 4 | 3.28e-01 |
| GO:BP | GO:0002230 | positive regulation of defense response to virus by host | 2 | 23 | 3.28e-01 |
| GO:BP | GO:0042574 | retinal metabolic process | 2 | 11 | 3.28e-01 |
| GO:BP | GO:0031952 | regulation of protein autophosphorylation | 7 | 39 | 3.28e-01 |
| GO:BP | GO:0032770 | positive regulation of monooxygenase activity | 4 | 20 | 3.28e-01 |
| GO:BP | GO:2000241 | regulation of reproductive process | 2 | 128 | 3.29e-01 |
| GO:BP | GO:0099576 | regulation of protein catabolic process at postsynapse, modulating synaptic transmission | 1 | 4 | 3.29e-01 |
| GO:BP | GO:0060707 | trophoblast giant cell differentiation | 5 | 10 | 3.29e-01 |
| GO:BP | GO:0051881 | regulation of mitochondrial membrane potential | 3 | 60 | 3.29e-01 |
| GO:BP | GO:0099550 | trans-synaptic signaling, modulating synaptic transmission | 5 | 10 | 3.29e-01 |
| GO:BP | GO:0038129 | ERBB3 signaling pathway | 4 | 4 | 3.29e-01 |
| GO:BP | GO:0034067 | protein localization to Golgi apparatus | 3 | 27 | 3.29e-01 |
| GO:BP | GO:0072593 | reactive oxygen species metabolic process | 2 | 156 | 3.29e-01 |
| GO:BP | GO:0030576 | Cajal body organization | 2 | 4 | 3.29e-01 |
| GO:BP | GO:0003335 | corneocyte development | 1 | 2 | 3.29e-01 |
| GO:BP | GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 1 | 10 | 3.29e-01 |
| GO:BP | GO:0032902 | nerve growth factor production | 2 | 2 | 3.29e-01 |
| GO:BP | GO:0015680 | protein maturation by copper ion transfer | 2 | 2 | 3.29e-01 |
| GO:BP | GO:0044849 | estrous cycle | 2 | 13 | 3.30e-01 |
| GO:BP | GO:1902527 | positive regulation of protein monoubiquitination | 4 | 5 | 3.30e-01 |
| GO:BP | GO:1904875 | regulation of DNA ligase activity | 2 | 2 | 3.30e-01 |
| GO:BP | GO:0030913 | paranodal junction assembly | 4 | 6 | 3.30e-01 |
| GO:BP | GO:1903518 | positive regulation of single strand break repair | 2 | 2 | 3.30e-01 |
| GO:BP | GO:0097009 | energy homeostasis | 4 | 39 | 3.30e-01 |
| GO:BP | GO:0032057 | negative regulation of translational initiation in response to stress | 1 | 5 | 3.31e-01 |
| GO:BP | GO:1902729 | negative regulation of proteoglycan biosynthetic process | 1 | 1 | 3.31e-01 |
| GO:BP | GO:0032683 | negative regulation of connective tissue growth factor production | 1 | 1 | 3.31e-01 |
| GO:BP | GO:0006596 | polyamine biosynthetic process | 2 | 13 | 3.32e-01 |
| GO:BP | GO:0061512 | protein localization to cilium | 12 | 61 | 3.32e-01 |
| GO:BP | GO:0071462 | cellular response to water stimulus | 1 | 4 | 3.32e-01 |
| GO:BP | GO:0060260 | regulation of transcription initiation by RNA polymerase II | 1 | 69 | 3.32e-01 |
| GO:BP | GO:0044458 | motile cilium assembly | 1 | 45 | 3.32e-01 |
| GO:BP | GO:0043549 | regulation of kinase activity | 6 | 560 | 3.32e-01 |
| GO:BP | GO:1901859 | negative regulation of mitochondrial DNA metabolic process | 1 | 2 | 3.32e-01 |
| GO:BP | GO:0061687 | detoxification of inorganic compound | 3 | 12 | 3.32e-01 |
| GO:BP | GO:0097501 | stress response to metal ion | 3 | 11 | 3.32e-01 |
| GO:BP | GO:0051257 | meiotic spindle midzone assembly | 1 | 2 | 3.32e-01 |
| GO:BP | GO:0032237 | activation of store-operated calcium channel activity | 4 | 5 | 3.32e-01 |
| GO:BP | GO:1901361 | organic cyclic compound catabolic process | 17 | 406 | 3.32e-01 |
| GO:BP | GO:0016259 | selenocysteine metabolic process | 2 | 2 | 3.33e-01 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 14 | 326 | 3.33e-01 |
| GO:BP | GO:0097531 | mast cell migration | 9 | 12 | 3.33e-01 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 2 | 551 | 3.33e-01 |
| GO:BP | GO:0000422 | autophagy of mitochondrion | 10 | 92 | 3.33e-01 |
| GO:BP | GO:0000425 | pexophagy | 1 | 6 | 3.33e-01 |
| GO:BP | GO:0014074 | response to purine-containing compound | 5 | 108 | 3.33e-01 |
| GO:BP | GO:0006895 | Golgi to endosome transport | 10 | 17 | 3.33e-01 |
| GO:BP | GO:0061726 | mitochondrion disassembly | 10 | 92 | 3.33e-01 |
| GO:BP | GO:0002026 | regulation of the force of heart contraction | 8 | 23 | 3.33e-01 |
| GO:BP | GO:1903361 | protein localization to basolateral plasma membrane | 1 | 7 | 3.33e-01 |
| GO:BP | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development | 3 | 5 | 3.33e-01 |
| GO:BP | GO:0060840 | artery development | 3 | 83 | 3.33e-01 |
| GO:BP | GO:0032801 | receptor catabolic process | 9 | 24 | 3.33e-01 |
| GO:BP | GO:1905214 | regulation of RNA binding | 8 | 13 | 3.33e-01 |
| GO:BP | GO:1905215 | negative regulation of RNA binding | 2 | 2 | 3.33e-01 |
| GO:BP | GO:0010889 | regulation of sequestering of triglyceride | 10 | 12 | 3.33e-01 |
| GO:BP | GO:0006183 | GTP biosynthetic process | 7 | 9 | 3.33e-01 |
| GO:BP | GO:1903147 | negative regulation of autophagy of mitochondrion | 2 | 7 | 3.33e-01 |
| GO:BP | GO:0007056 | spindle assembly involved in female meiosis | 3 | 5 | 3.33e-01 |
| GO:BP | GO:0006930 | substrate-dependent cell migration, cell extension | 2 | 8 | 3.33e-01 |
| GO:BP | GO:1990535 | neuron projection maintenance | 4 | 9 | 3.33e-01 |
| GO:BP | GO:0150076 | neuroinflammatory response | 3 | 33 | 3.33e-01 |
| GO:BP | GO:0000160 | phosphorelay signal transduction system | 1 | 1 | 3.33e-01 |
| GO:BP | GO:0060249 | anatomical structure homeostasis | 1 | 170 | 3.34e-01 |
| GO:BP | GO:0001894 | tissue homeostasis | 1 | 170 | 3.34e-01 |
| GO:BP | GO:2000811 | negative regulation of anoikis | 7 | 17 | 3.34e-01 |
| GO:BP | GO:0032292 | peripheral nervous system axon ensheathment | 1 | 25 | 3.34e-01 |
| GO:BP | GO:0060547 | negative regulation of necrotic cell death | 11 | 21 | 3.34e-01 |
| GO:BP | GO:0022011 | myelination in peripheral nervous system | 1 | 25 | 3.34e-01 |
| GO:BP | GO:0051547 | regulation of keratinocyte migration | 1 | 13 | 3.34e-01 |
| GO:BP | GO:0019439 | aromatic compound catabolic process | 8 | 387 | 3.34e-01 |
| GO:BP | GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 1 | 1 | 3.34e-01 |
| GO:BP | GO:0051660 | establishment of centrosome localization | 4 | 8 | 3.34e-01 |
| GO:BP | GO:0043490 | malate-aspartate shuttle | 2 | 4 | 3.35e-01 |
| GO:BP | GO:0043217 | myelin maintenance | 8 | 15 | 3.35e-01 |
| GO:BP | GO:1902037 | negative regulation of hematopoietic stem cell differentiation | 1 | 4 | 3.35e-01 |
| GO:BP | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1 | 5 | 3.35e-01 |
| GO:BP | GO:1901861 | regulation of muscle tissue development | 2 | 35 | 3.35e-01 |
| GO:BP | GO:0075071 | modulation by symbiont of host autophagy | 1 | 1 | 3.35e-01 |
| GO:BP | GO:2000304 | positive regulation of ceramide biosynthetic process | 2 | 5 | 3.35e-01 |
| GO:BP | GO:0042476 | odontogenesis | 1 | 86 | 3.35e-01 |
| GO:BP | GO:0071275 | cellular response to aluminum ion | 1 | 1 | 3.35e-01 |
| GO:BP | GO:2000826 | regulation of heart morphogenesis | 6 | 10 | 3.35e-01 |
| GO:BP | GO:0003207 | cardiac chamber formation | 10 | 14 | 3.35e-01 |
| GO:BP | GO:0010596 | negative regulation of endothelial cell migration | 2 | 40 | 3.35e-01 |
| GO:BP | GO:0039521 | suppression by virus of host autophagy | 1 | 1 | 3.35e-01 |
| GO:BP | GO:0006971 | hypotonic response | 2 | 10 | 3.35e-01 |
| GO:BP | GO:0090154 | positive regulation of sphingolipid biosynthetic process | 2 | 5 | 3.35e-01 |
| GO:BP | GO:0002157 | positive regulation of thyroid hormone mediated signaling pathway | 2 | 3 | 3.35e-01 |
| GO:BP | GO:0048566 | embryonic digestive tract development | 1 | 20 | 3.35e-01 |
| GO:BP | GO:0070245 | positive regulation of thymocyte apoptotic process | 2 | 5 | 3.35e-01 |
| GO:BP | GO:0060400 | negative regulation of growth hormone receptor signaling pathway | 2 | 3 | 3.35e-01 |
| GO:BP | GO:0001782 | B cell homeostasis | 1 | 24 | 3.35e-01 |
| GO:BP | GO:0140321 | suppression of host autophagy | 1 | 1 | 3.35e-01 |
| GO:BP | GO:0007619 | courtship behavior | 2 | 3 | 3.35e-01 |
| GO:BP | GO:1905672 | negative regulation of lysosome organization | 1 | 1 | 3.35e-01 |
| GO:BP | GO:0106070 | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1 | 11 | 3.35e-01 |
| GO:BP | GO:1905775 | negative regulation of DNA helicase activity | 2 | 2 | 3.36e-01 |
| GO:BP | GO:0034727 | piecemeal microautophagy of the nucleus | 7 | 9 | 3.36e-01 |
| GO:BP | GO:0097510 | base-excision repair, AP site formation via deaminated base removal | 1 | 1 | 3.36e-01 |
| GO:BP | GO:0031032 | actomyosin structure organization | 16 | 186 | 3.36e-01 |
| GO:BP | GO:1901995 | positive regulation of meiotic cell cycle phase transition | 3 | 3 | 3.36e-01 |
| GO:BP | GO:0110030 | regulation of G2/MI transition of meiotic cell cycle | 3 | 3 | 3.36e-01 |
| GO:BP | GO:0070945 | neutrophil-mediated killing of gram-negative bacterium | 1 | 2 | 3.36e-01 |
| GO:BP | GO:0072740 | cellular response to anisomycin | 1 | 3 | 3.36e-01 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 16 | 358 | 3.36e-01 |
| GO:BP | GO:0090400 | stress-induced premature senescence | 4 | 7 | 3.36e-01 |
| GO:BP | GO:0160024 | Leydig cell proliferation | 2 | 2 | 3.36e-01 |
| GO:BP | GO:0106049 | regulation of cellular response to osmotic stress | 1 | 10 | 3.36e-01 |
| GO:BP | GO:0099178 | regulation of retrograde trans-synaptic signaling by endocanabinoid | 2 | 3 | 3.37e-01 |
| GO:BP | GO:0000379 | tRNA-type intron splice site recognition and cleavage | 1 | 3 | 3.37e-01 |
| GO:BP | GO:0071321 | cellular response to cGMP | 1 | 7 | 3.37e-01 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 11 | 362 | 3.38e-01 |
| GO:BP | GO:0046208 | spermine catabolic process | 2 | 2 | 3.38e-01 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 12 | 19 | 3.38e-01 |
| GO:BP | GO:0021612 | facial nerve structural organization | 6 | 7 | 3.38e-01 |
| GO:BP | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 2 | 13 | 3.38e-01 |
| GO:BP | GO:0050960 | detection of temperature stimulus involved in thermoception | 1 | 3 | 3.38e-01 |
| GO:BP | GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 24 | 49 | 3.38e-01 |
| GO:BP | GO:0032768 | regulation of monooxygenase activity | 4 | 34 | 3.38e-01 |
| GO:BP | GO:2001153 | positive regulation of renal water transport | 1 | 1 | 3.38e-01 |
| GO:BP | GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 2 | 4 | 3.38e-01 |
| GO:BP | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3 | 7 | 3.38e-01 |
| GO:BP | GO:0006386 | termination of RNA polymerase III transcription | 1 | 1 | 3.38e-01 |
| GO:BP | GO:0003205 | cardiac chamber development | 4 | 149 | 3.38e-01 |
| GO:BP | GO:0006231 | dTMP biosynthetic process | 2 | 4 | 3.38e-01 |
| GO:BP | GO:0038092 | nodal signaling pathway | 1 | 8 | 3.38e-01 |
| GO:BP | GO:1901506 | regulation of acylglycerol transport | 1 | 2 | 3.38e-01 |
| GO:BP | GO:0030656 | regulation of vitamin metabolic process | 1 | 7 | 3.38e-01 |
| GO:BP | GO:0097089 | methyl-branched fatty acid metabolic process | 1 | 3 | 3.38e-01 |
| GO:BP | GO:0036146 | cellular response to mycotoxin | 1 | 1 | 3.38e-01 |
| GO:BP | GO:0034205 | amyloid-beta formation | 2 | 41 | 3.38e-01 |
| GO:BP | GO:2001151 | regulation of renal water transport | 1 | 1 | 3.38e-01 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 12 | 19 | 3.38e-01 |
| GO:BP | GO:0072721 | cellular response to dithiothreitol | 1 | 1 | 3.38e-01 |
| GO:BP | GO:0070328 | triglyceride homeostasis | 1 | 17 | 3.38e-01 |
| GO:BP | GO:0007039 | protein catabolic process in the vacuole | 1 | 22 | 3.38e-01 |
| GO:BP | GO:0035590 | purinergic nucleotide receptor signaling pathway | 1 | 16 | 3.38e-01 |
| GO:BP | GO:0055090 | acylglycerol homeostasis | 1 | 17 | 3.38e-01 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 12 | 19 | 3.38e-01 |
| GO:BP | GO:0046847 | filopodium assembly | 1 | 56 | 3.38e-01 |
| GO:BP | GO:0071470 | cellular response to osmotic stress | 2 | 42 | 3.38e-01 |
| GO:BP | GO:0140018 | regulation of cytoplasmic translational fidelity | 1 | 1 | 3.38e-01 |
| GO:BP | GO:0021685 | cerebellar granular layer structural organization | 1 | 1 | 3.38e-01 |
| GO:BP | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway | 4 | 4 | 3.38e-01 |
| GO:BP | GO:0071502 | cellular response to temperature stimulus | 1 | 2 | 3.38e-01 |
| GO:BP | GO:1905883 | regulation of triglyceride transport | 1 | 2 | 3.38e-01 |
| GO:BP | GO:1905885 | positive regulation of triglyceride transport | 1 | 2 | 3.38e-01 |
| GO:BP | GO:0006304 | DNA modification | 2 | 89 | 3.38e-01 |
| GO:BP | GO:1901508 | positive regulation of acylglycerol transport | 1 | 2 | 3.38e-01 |
| GO:BP | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1 | 4 | 3.38e-01 |
| GO:BP | GO:0038066 | p38MAPK cascade | 2 | 43 | 3.38e-01 |
| GO:BP | GO:0007224 | smoothened signaling pathway | 26 | 124 | 3.39e-01 |
| GO:BP | GO:0090166 | Golgi disassembly | 2 | 6 | 3.39e-01 |
| GO:BP | GO:0014041 | regulation of neuron maturation | 1 | 6 | 3.39e-01 |
| GO:BP | GO:1904439 | negative regulation of iron ion import across plasma membrane | 1 | 1 | 3.39e-01 |
| GO:BP | GO:0006936 | muscle contraction | 8 | 267 | 3.39e-01 |
| GO:BP | GO:0060561 | apoptotic process involved in morphogenesis | 13 | 21 | 3.39e-01 |
| GO:BP | GO:0014849 | ureter smooth muscle contraction | 2 | 2 | 3.39e-01 |
| GO:BP | GO:0070670 | response to interleukin-4 | 2 | 22 | 3.39e-01 |
| GO:BP | GO:0035364 | thymine transport | 1 | 1 | 3.39e-01 |
| GO:BP | GO:0032692 | negative regulation of interleukin-1 production | 2 | 15 | 3.39e-01 |
| GO:BP | GO:0071248 | cellular response to metal ion | 12 | 139 | 3.39e-01 |
| GO:BP | GO:1904798 | positive regulation of core promoter binding | 3 | 4 | 3.39e-01 |
| GO:BP | GO:1903723 | negative regulation of centriole elongation | 1 | 2 | 3.39e-01 |
| GO:BP | GO:0003360 | brainstem development | 3 | 7 | 3.39e-01 |
| GO:BP | GO:0072105 | ureteric peristalsis | 2 | 2 | 3.39e-01 |
| GO:BP | GO:0003431 | growth plate cartilage chondrocyte development | 3 | 5 | 3.39e-01 |
| GO:BP | GO:0002687 | positive regulation of leukocyte migration | 10 | 84 | 3.39e-01 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 4 | 44 | 3.39e-01 |
| GO:BP | GO:0070848 | response to growth factor | 2 | 572 | 3.39e-01 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 1 | 178 | 3.39e-01 |
| GO:BP | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process | 3 | 8 | 3.39e-01 |
| GO:BP | GO:2000772 | regulation of cellular senescence | 15 | 38 | 3.39e-01 |
| GO:BP | GO:0006113 | fermentation | 2 | 5 | 3.39e-01 |
| GO:BP | GO:0031860 | telomeric 3’ overhang formation | 1 | 4 | 3.39e-01 |
| GO:BP | GO:0006940 | regulation of smooth muscle contraction | 2 | 42 | 3.39e-01 |
| GO:BP | GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1 | 102 | 3.39e-01 |
| GO:BP | GO:0007004 | telomere maintenance via telomerase | 24 | 63 | 3.39e-01 |
| GO:BP | GO:0043465 | regulation of fermentation | 2 | 5 | 3.39e-01 |
| GO:BP | GO:0045900 | negative regulation of translational elongation | 4 | 5 | 3.39e-01 |
| GO:BP | GO:0009838 | abscission | 2 | 6 | 3.39e-01 |
| GO:BP | GO:0043063 | intercellular bridge organization | 1 | 1 | 3.39e-01 |
| GO:BP | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway | 4 | 5 | 3.39e-01 |
| GO:BP | GO:0071504 | cellular response to heparin | 3 | 4 | 3.39e-01 |
| GO:BP | GO:0061009 | common bile duct development | 3 | 4 | 3.39e-01 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 4 | 35 | 3.39e-01 |
| GO:BP | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 3 | 4 | 3.39e-01 |
| GO:BP | GO:2001260 | regulation of semaphorin-plexin signaling pathway | 1 | 3 | 3.39e-01 |
| GO:BP | GO:0032620 | interleukin-17 production | 2 | 20 | 3.39e-01 |
| GO:BP | GO:0032660 | regulation of interleukin-17 production | 2 | 20 | 3.39e-01 |
| GO:BP | GO:0015761 | mannose transmembrane transport | 1 | 1 | 3.39e-01 |
| GO:BP | GO:0061205 | paramesonephric duct development | 2 | 4 | 3.39e-01 |
| GO:BP | GO:0010631 | epithelial cell migration | 13 | 252 | 3.39e-01 |
| GO:BP | GO:0015848 | spermidine transport | 1 | 3 | 3.39e-01 |
| GO:BP | GO:0001822 | kidney development | 12 | 244 | 3.39e-01 |
| GO:BP | GO:0060548 | negative regulation of cell death | 38 | 756 | 3.39e-01 |
| GO:BP | GO:1901575 | organic substance catabolic process | 17 | 1712 | 3.39e-01 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 17 | 490 | 3.39e-01 |
| GO:BP | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation | 6 | 7 | 3.39e-01 |
| GO:BP | GO:0043487 | regulation of RNA stability | 4 | 159 | 3.39e-01 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 17 | 490 | 3.39e-01 |
| GO:BP | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron development | 6 | 7 | 3.39e-01 |
| GO:BP | GO:0060166 | olfactory pit development | 1 | 1 | 3.39e-01 |
| GO:BP | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway | 4 | 5 | 3.39e-01 |
| GO:BP | GO:0000320 | re-entry into mitotic cell cycle | 2 | 2 | 3.40e-01 |
| GO:BP | GO:0046600 | negative regulation of centriole replication | 4 | 7 | 3.40e-01 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 19 | 48 | 3.40e-01 |
| GO:BP | GO:2000142 | regulation of DNA-templated transcription initiation | 1 | 76 | 3.40e-01 |
| GO:BP | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 1 | 6 | 3.40e-01 |
| GO:BP | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | 2 | 4 | 3.40e-01 |
| GO:BP | GO:0043923 | positive regulation by host of viral transcription | 5 | 18 | 3.40e-01 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 67 | 251 | 3.41e-01 |
| GO:BP | GO:1904911 | negative regulation of establishment of RNA localization to telomere | 1 | 1 | 3.41e-01 |
| GO:BP | GO:0039689 | negative stranded viral RNA replication | 2 | 3 | 3.41e-01 |
| GO:BP | GO:0086046 | membrane depolarization during SA node cell action potential | 2 | 5 | 3.41e-01 |
| GO:BP | GO:1904913 | regulation of establishment of protein-containing complex localization to telomere | 1 | 1 | 3.41e-01 |
| GO:BP | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein | 8 | 12 | 3.41e-01 |
| GO:BP | GO:1904850 | negative regulation of establishment of protein localization to telomere | 1 | 1 | 3.41e-01 |
| GO:BP | GO:2000171 | negative regulation of dendrite development | 6 | 7 | 3.41e-01 |
| GO:BP | GO:0043489 | RNA stabilization | 4 | 59 | 3.41e-01 |
| GO:BP | GO:1900372 | negative regulation of purine nucleotide biosynthetic process | 2 | 3 | 3.41e-01 |
| GO:BP | GO:0030809 | negative regulation of nucleotide biosynthetic process | 2 | 3 | 3.41e-01 |
| GO:BP | GO:0033627 | cell adhesion mediated by integrin | 4 | 63 | 3.41e-01 |
| GO:BP | GO:1904914 | negative regulation of establishment of protein-containing complex localization to telomere | 1 | 1 | 3.41e-01 |
| GO:BP | GO:2000739 | regulation of mesenchymal stem cell differentiation | 1 | 8 | 3.41e-01 |
| GO:BP | GO:1903579 | negative regulation of ATP metabolic process | 2 | 5 | 3.41e-01 |
| GO:BP | GO:0051781 | positive regulation of cell division | 19 | 64 | 3.41e-01 |
| GO:BP | GO:1904910 | regulation of establishment of RNA localization to telomere | 1 | 1 | 3.41e-01 |
| GO:BP | GO:1904792 | positive regulation of shelterin complex assembly | 1 | 1 | 3.41e-01 |
| GO:BP | GO:0098877 | neurotransmitter receptor transport to plasma membrane | 12 | 17 | 3.41e-01 |
| GO:BP | GO:0007296 | vitellogenesis | 2 | 4 | 3.41e-01 |
| GO:BP | GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2 | 5 | 3.41e-01 |
| GO:BP | GO:0014044 | Schwann cell development | 1 | 28 | 3.41e-01 |
| GO:BP | GO:0002024 | diet induced thermogenesis | 2 | 9 | 3.41e-01 |
| GO:BP | GO:0099171 | presynaptic modulation of chemical synaptic transmission | 2 | 26 | 3.41e-01 |
| GO:BP | GO:0032528 | microvillus organization | 5 | 19 | 3.41e-01 |
| GO:BP | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 1 | 5 | 3.41e-01 |
| GO:BP | GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 2 | 35 | 3.41e-01 |
| GO:BP | GO:1900377 | negative regulation of secondary metabolite biosynthetic process | 2 | 4 | 3.41e-01 |
| GO:BP | GO:0048022 | negative regulation of melanin biosynthetic process | 2 | 4 | 3.41e-01 |
| GO:BP | GO:0031848 | protection from non-homologous end joining at telomere | 5 | 10 | 3.41e-01 |
| GO:BP | GO:0031536 | positive regulation of exit from mitosis | 4 | 4 | 3.41e-01 |
| GO:BP | GO:0046710 | GDP metabolic process | 5 | 10 | 3.42e-01 |
| GO:BP | GO:0002926 | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 3 | 3 | 3.42e-01 |
| GO:BP | GO:0072075 | metanephric mesenchyme development | 1 | 10 | 3.42e-01 |
| GO:BP | GO:0072160 | nephron tubule epithelial cell differentiation | 1 | 12 | 3.42e-01 |
| GO:BP | GO:0097084 | vascular associated smooth muscle cell development | 5 | 11 | 3.42e-01 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 11 | 35 | 3.42e-01 |
| GO:BP | GO:1990953 | intramanchette transport | 1 | 1 | 3.42e-01 |
| GO:BP | GO:0035107 | appendage morphogenesis | 1 | 114 | 3.43e-01 |
| GO:BP | GO:0008090 | retrograde axonal transport | 2 | 19 | 3.43e-01 |
| GO:BP | GO:0036446 | myofibroblast differentiation | 3 | 5 | 3.43e-01 |
| GO:BP | GO:0001738 | morphogenesis of a polarized epithelium | 9 | 88 | 3.43e-01 |
| GO:BP | GO:1904799 | regulation of neuron remodeling | 1 | 1 | 3.43e-01 |
| GO:BP | GO:0072034 | renal vesicle induction | 3 | 3 | 3.43e-01 |
| GO:BP | GO:1904800 | negative regulation of neuron remodeling | 1 | 1 | 3.43e-01 |
| GO:BP | GO:0035108 | limb morphogenesis | 1 | 114 | 3.43e-01 |
| GO:BP | GO:2000173 | negative regulation of branching morphogenesis of a nerve | 1 | 1 | 3.43e-01 |
| GO:BP | GO:0051899 | membrane depolarization | 17 | 60 | 3.43e-01 |
| GO:BP | GO:0050925 | negative regulation of negative chemotaxis | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0017157 | regulation of exocytosis | 6 | 147 | 3.43e-01 |
| GO:BP | GO:1900449 | regulation of glutamate receptor signaling pathway | 1 | 5 | 3.43e-01 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 5 | 51 | 3.43e-01 |
| GO:BP | GO:0061519 | macrophage homeostasis | 1 | 3 | 3.43e-01 |
| GO:BP | GO:0035702 | monocyte homeostasis | 1 | 2 | 3.43e-01 |
| GO:BP | GO:2000766 | negative regulation of cytoplasmic translation | 5 | 7 | 3.43e-01 |
| GO:BP | GO:0048048 | embryonic eye morphogenesis | 3 | 25 | 3.43e-01 |
| GO:BP | GO:0035351 | heme transmembrane transport | 1 | 2 | 3.43e-01 |
| GO:BP | GO:0035999 | tetrahydrofolate interconversion | 3 | 9 | 3.43e-01 |
| GO:BP | GO:0031507 | heterochromatin formation | 1 | 69 | 3.43e-01 |
| GO:BP | GO:0009197 | pyrimidine deoxyribonucleoside diphosphate biosynthetic process | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0045022 | early endosome to late endosome transport | 16 | 40 | 3.43e-01 |
| GO:BP | GO:0042727 | flavin-containing compound biosynthetic process | 1 | 2 | 3.43e-01 |
| GO:BP | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 6 | 18 | 3.43e-01 |
| GO:BP | GO:0001705 | ectoderm formation | 3 | 3 | 3.43e-01 |
| GO:BP | GO:0046072 | dTDP metabolic process | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 2 | 6 | 3.43e-01 |
| GO:BP | GO:0031954 | positive regulation of protein autophosphorylation | 5 | 26 | 3.43e-01 |
| GO:BP | GO:0046077 | dUDP metabolic process | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0006233 | dTDP biosynthetic process | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0055070 | copper ion homeostasis | 4 | 18 | 3.43e-01 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 1 | 101 | 3.43e-01 |
| GO:BP | GO:1904631 | response to glucoside | 1 | 1 | 3.43e-01 |
| GO:BP | GO:0032148 | activation of protein kinase B activity | 10 | 23 | 3.43e-01 |
| GO:BP | GO:0050667 | homocysteine metabolic process | 5 | 11 | 3.43e-01 |
| GO:BP | GO:1905407 | regulation of creatine transmembrane transporter activity | 1 | 2 | 3.43e-01 |
| GO:BP | GO:1905408 | negative regulation of creatine transmembrane transporter activity | 1 | 2 | 3.43e-01 |
| GO:BP | GO:0002931 | response to ischemia | 4 | 46 | 3.43e-01 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 1 | 187 | 3.43e-01 |
| GO:BP | GO:0006227 | dUDP biosynthetic process | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0009196 | pyrimidine deoxyribonucleoside diphosphate metabolic process | 2 | 2 | 3.43e-01 |
| GO:BP | GO:0050807 | regulation of synapse organization | 12 | 184 | 3.44e-01 |
| GO:BP | GO:0060379 | cardiac muscle cell myoblast differentiation | 5 | 11 | 3.44e-01 |
| GO:BP | GO:0016575 | histone deacetylation | 40 | 87 | 3.44e-01 |
| GO:BP | GO:0019934 | cGMP-mediated signaling | 3 | 22 | 3.44e-01 |
| GO:BP | GO:1904896 | ESCRT complex disassembly | 7 | 10 | 3.44e-01 |
| GO:BP | GO:1904903 | ESCRT III complex disassembly | 7 | 10 | 3.44e-01 |
| GO:BP | GO:0060231 | mesenchymal to epithelial transition | 2 | 12 | 3.45e-01 |
| GO:BP | GO:0090132 | epithelium migration | 13 | 252 | 3.45e-01 |
| GO:BP | GO:2000001 | regulation of DNA damage checkpoint | 13 | 25 | 3.45e-01 |
| GO:BP | GO:0071474 | cellular hyperosmotic response | 7 | 13 | 3.45e-01 |
| GO:BP | GO:1901215 | negative regulation of neuron death | 10 | 167 | 3.45e-01 |
| GO:BP | GO:0043542 | endothelial cell migration | 10 | 182 | 3.45e-01 |
| GO:BP | GO:0070814 | hydrogen sulfide biosynthetic process | 3 | 4 | 3.45e-01 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 27 | 1026 | 3.45e-01 |
| GO:BP | GO:1902373 | negative regulation of mRNA catabolic process | 4 | 57 | 3.45e-01 |
| GO:BP | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 4 | 65 | 3.46e-01 |
| GO:BP | GO:0061013 | regulation of mRNA catabolic process | 4 | 161 | 3.46e-01 |
| GO:BP | GO:0050918 | positive chemotaxis | 4 | 40 | 3.46e-01 |
| GO:BP | GO:0038135 | ERBB2-ERBB4 signaling pathway | 3 | 4 | 3.46e-01 |
| GO:BP | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 2 | 15 | 3.46e-01 |
| GO:BP | GO:0046058 | cAMP metabolic process | 3 | 19 | 3.46e-01 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 17 | 495 | 3.47e-01 |
| GO:BP | GO:0034614 | cellular response to reactive oxygen species | 10 | 121 | 3.47e-01 |
| GO:BP | GO:1905116 | positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore | 1 | 1 | 3.47e-01 |
| GO:BP | GO:1901647 | positive regulation of synoviocyte proliferation | 1 | 3 | 3.47e-01 |
| GO:BP | GO:1905115 | regulation of lateral attachment of mitotic spindle microtubules to kinetochore | 1 | 1 | 3.47e-01 |
| GO:BP | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 2 | 20 | 3.47e-01 |
| GO:BP | GO:0002941 | synoviocyte proliferation | 1 | 3 | 3.47e-01 |
| GO:BP | GO:1901645 | regulation of synoviocyte proliferation | 1 | 3 | 3.47e-01 |
| GO:BP | GO:0014901 | satellite cell activation involved in skeletal muscle regeneration | 2 | 3 | 3.47e-01 |
| GO:BP | GO:2000736 | regulation of stem cell differentiation | 3 | 71 | 3.47e-01 |
| GO:BP | GO:1901653 | cellular response to peptide | 79 | 287 | 3.47e-01 |
| GO:BP | GO:0000917 | division septum assembly | 1 | 1 | 3.47e-01 |
| GO:BP | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation | 1 | 2 | 3.47e-01 |
| GO:BP | GO:1903837 | regulation of mRNA 3’-UTR binding | 1 | 1 | 3.47e-01 |
| GO:BP | GO:0007182 | common-partner SMAD protein phosphorylation | 1 | 6 | 3.47e-01 |
| GO:BP | GO:1904100 | positive regulation of protein O-linked glycosylation | 1 | 2 | 3.47e-01 |
| GO:BP | GO:1904098 | regulation of protein O-linked glycosylation | 1 | 2 | 3.47e-01 |
| GO:BP | GO:0036514 | dopaminergic neuron axon guidance | 1 | 3 | 3.47e-01 |
| GO:BP | GO:0003213 | cardiac right atrium morphogenesis | 1 | 2 | 3.47e-01 |
| GO:BP | GO:0030578 | PML body organization | 1 | 6 | 3.47e-01 |
| GO:BP | GO:1903839 | positive regulation of mRNA 3’-UTR binding | 1 | 1 | 3.47e-01 |
| GO:BP | GO:1905359 | protein localization to meiotic spindle | 1 | 1 | 3.47e-01 |
| GO:BP | GO:1903096 | protein localization to meiotic spindle midzone | 1 | 1 | 3.47e-01 |
| GO:BP | GO:0090529 | cell septum assembly | 1 | 1 | 3.47e-01 |
| GO:BP | GO:0046543 | development of secondary female sexual characteristics | 5 | 7 | 3.47e-01 |
| GO:BP | GO:0043651 | linoleic acid metabolic process | 6 | 12 | 3.47e-01 |
| GO:BP | GO:0021540 | corpus callosum morphogenesis | 4 | 5 | 3.47e-01 |
| GO:BP | GO:0032875 | regulation of DNA endoreduplication | 3 | 4 | 3.47e-01 |
| GO:BP | GO:0070229 | negative regulation of lymphocyte apoptotic process | 1 | 23 | 3.47e-01 |
| GO:BP | GO:0008156 | negative regulation of DNA replication | 11 | 19 | 3.47e-01 |
| GO:BP | GO:1905774 | regulation of DNA helicase activity | 2 | 5 | 3.47e-01 |
| GO:BP | GO:0033316 | meiotic spindle assembly checkpoint signaling | 1 | 1 | 3.47e-01 |
| GO:BP | GO:1904938 | planar cell polarity pathway involved in axon guidance | 1 | 3 | 3.47e-01 |
| GO:BP | GO:0097061 | dendritic spine organization | 6 | 67 | 3.47e-01 |
| GO:BP | GO:0035148 | tube formation | 8 | 138 | 3.47e-01 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 1 | 121 | 3.47e-01 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 12 | 341 | 3.47e-01 |
| GO:BP | GO:1904274 | tricellular tight junction assembly | 1 | 1 | 3.47e-01 |
| GO:BP | GO:1903444 | negative regulation of brown fat cell differentiation | 3 | 3 | 3.48e-01 |
| GO:BP | GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1 | 3 | 3.48e-01 |
| GO:BP | GO:0048864 | stem cell development | 26 | 76 | 3.48e-01 |
| GO:BP | GO:2000753 | positive regulation of glucosylceramide catabolic process | 1 | 1 | 3.48e-01 |
| GO:BP | GO:0016054 | organic acid catabolic process | 2 | 187 | 3.48e-01 |
| GO:BP | GO:2000767 | positive regulation of cytoplasmic translation | 1 | 13 | 3.48e-01 |
| GO:BP | GO:1900163 | positive regulation of phospholipid scramblase activity | 1 | 1 | 3.48e-01 |
| GO:BP | GO:2000752 | regulation of glucosylceramide catabolic process | 1 | 1 | 3.48e-01 |
| GO:BP | GO:0002312 | B cell activation involved in immune response | 4 | 57 | 3.48e-01 |
| GO:BP | GO:1901071 | glucosamine-containing compound metabolic process | 1 | 19 | 3.48e-01 |
| GO:BP | GO:0099150 | regulation of postsynaptic specialization assembly | 3 | 12 | 3.48e-01 |
| GO:BP | GO:0045671 | negative regulation of osteoclast differentiation | 5 | 20 | 3.48e-01 |
| GO:BP | GO:0046395 | carboxylic acid catabolic process | 2 | 187 | 3.48e-01 |
| GO:BP | GO:1900161 | regulation of phospholipid scramblase activity | 1 | 1 | 3.48e-01 |
| GO:BP | GO:0034349 | glial cell apoptotic process | 4 | 15 | 3.48e-01 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 13 | 25 | 3.48e-01 |
| GO:BP | GO:0072402 | response to DNA integrity checkpoint signaling | 3 | 8 | 3.48e-01 |
| GO:BP | GO:0072423 | response to DNA damage checkpoint signaling | 3 | 8 | 3.48e-01 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 12 | 342 | 3.48e-01 |
| GO:BP | GO:0072396 | response to cell cycle checkpoint signaling | 3 | 8 | 3.48e-01 |
| GO:BP | GO:0010614 | negative regulation of cardiac muscle hypertrophy | 11 | 26 | 3.48e-01 |
| GO:BP | GO:0046580 | negative regulation of Ras protein signal transduction | 13 | 47 | 3.48e-01 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 1 | 138 | 3.49e-01 |
| GO:BP | GO:0006662 | glycerol ether metabolic process | 5 | 16 | 3.49e-01 |
| GO:BP | GO:0046485 | ether lipid metabolic process | 5 | 16 | 3.49e-01 |
| GO:BP | GO:0072711 | cellular response to hydroxyurea | 4 | 10 | 3.49e-01 |
| GO:BP | GO:0061097 | regulation of protein tyrosine kinase activity | 1 | 65 | 3.49e-01 |
| GO:BP | GO:0045823 | positive regulation of heart contraction | 1 | 32 | 3.50e-01 |
| GO:BP | GO:0002335 | mature B cell differentiation | 1 | 21 | 3.50e-01 |
| GO:BP | GO:0060914 | heart formation | 13 | 29 | 3.50e-01 |
| GO:BP | GO:0090119 | vesicle-mediated cholesterol transport | 2 | 9 | 3.50e-01 |
| GO:BP | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration | 7 | 9 | 3.50e-01 |
| GO:BP | GO:0030837 | negative regulation of actin filament polymerization | 4 | 57 | 3.50e-01 |
| GO:BP | GO:0099548 | trans-synaptic signaling by nitric oxide | 1 | 2 | 3.50e-01 |
| GO:BP | GO:0099543 | trans-synaptic signaling by soluble gas | 1 | 2 | 3.50e-01 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 19 | 73 | 3.51e-01 |
| GO:BP | GO:0060056 | mammary gland involution | 3 | 8 | 3.51e-01 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 3 | 906 | 3.51e-01 |
| GO:BP | GO:0007096 | regulation of exit from mitosis | 3 | 17 | 3.51e-01 |
| GO:BP | GO:0062026 | negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process | 1 | 1 | 3.51e-01 |
| GO:BP | GO:0062025 | regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1 | 1 | 3.51e-01 |
| GO:BP | GO:0010868 | negative regulation of triglyceride biosynthetic process | 2 | 3 | 3.51e-01 |
| GO:BP | GO:0061044 | negative regulation of vascular wound healing | 1 | 4 | 3.51e-01 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 1 | 165 | 3.51e-01 |
| GO:BP | GO:0035265 | organ growth | 1 | 131 | 3.51e-01 |
| GO:BP | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 7 | 17 | 3.51e-01 |
| GO:BP | GO:0034058 | endosomal vesicle fusion | 1 | 10 | 3.51e-01 |
| GO:BP | GO:0000183 | rDNA heterochromatin formation | 2 | 9 | 3.51e-01 |
| GO:BP | GO:0019262 | N-acetylneuraminate catabolic process | 4 | 6 | 3.51e-01 |
| GO:BP | GO:1901628 | positive regulation of postsynaptic membrane organization | 1 | 2 | 3.51e-01 |
| GO:BP | GO:0015798 | myo-inositol transport | 2 | 3 | 3.51e-01 |
| GO:BP | GO:1990166 | protein localization to site of double-strand break | 1 | 5 | 3.51e-01 |
| GO:BP | GO:0060602 | branch elongation of an epithelium | 2 | 14 | 3.51e-01 |
| GO:BP | GO:1990550 | mitochondrial alpha-ketoglutarate transmembrane transport | 1 | 1 | 3.51e-01 |
| GO:BP | GO:0009751 | response to salicylic acid | 1 | 1 | 3.51e-01 |
| GO:BP | GO:0006213 | pyrimidine nucleoside metabolic process | 2 | 16 | 3.51e-01 |
| GO:BP | GO:0000916 | actomyosin contractile ring contraction | 1 | 1 | 3.51e-01 |
| GO:BP | GO:0036213 | contractile ring contraction | 1 | 1 | 3.51e-01 |
| GO:BP | GO:0097049 | motor neuron apoptotic process | 4 | 18 | 3.51e-01 |
| GO:BP | GO:0021979 | hypothalamus cell differentiation | 1 | 8 | 3.51e-01 |
| GO:BP | GO:1903146 | regulation of autophagy of mitochondrion | 5 | 37 | 3.51e-01 |
| GO:BP | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion | 1 | 5 | 3.51e-01 |
| GO:BP | GO:0043412 | macromolecule modification | 7 | 3090 | 3.51e-01 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 20 | 26 | 3.51e-01 |
| GO:BP | GO:0003373 | dynamin family protein polymerization involved in membrane fission | 1 | 2 | 3.51e-01 |
| GO:BP | GO:0072234 | metanephric nephron tubule development | 2 | 14 | 3.51e-01 |
| GO:BP | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process | 6 | 8 | 3.51e-01 |
| GO:BP | GO:0090149 | mitochondrial membrane fission | 1 | 2 | 3.51e-01 |
| GO:BP | GO:0035377 | transepithelial water transport | 2 | 2 | 3.51e-01 |
| GO:BP | GO:1904719 | positive regulation of AMPA glutamate receptor clustering | 1 | 2 | 3.51e-01 |
| GO:BP | GO:0003374 | dynamin family protein polymerization involved in mitochondrial fission | 1 | 2 | 3.51e-01 |
| GO:BP | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion | 1 | 5 | 3.51e-01 |
| GO:BP | GO:0042819 | vitamin B6 biosynthetic process | 1 | 3 | 3.51e-01 |
| GO:BP | GO:0072255 | metanephric glomerular mesangial cell development | 1 | 1 | 3.52e-01 |
| GO:BP | GO:1905176 | positive regulation of vascular associated smooth muscle cell dedifferentiation | 1 | 1 | 3.52e-01 |
| GO:BP | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway | 2 | 3 | 3.52e-01 |
| GO:BP | GO:0050850 | positive regulation of calcium-mediated signaling | 1 | 22 | 3.52e-01 |
| GO:BP | GO:1903524 | positive regulation of blood circulation | 1 | 32 | 3.52e-01 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 83 | 143 | 3.52e-01 |
| GO:BP | GO:1904835 | dorsal root ganglion morphogenesis | 2 | 2 | 3.52e-01 |
| GO:BP | GO:0021649 | vestibulocochlear nerve structural organization | 2 | 2 | 3.52e-01 |
| GO:BP | GO:0007420 | brain development | 11 | 591 | 3.52e-01 |
| GO:BP | GO:0061552 | ganglion morphogenesis | 2 | 2 | 3.52e-01 |
| GO:BP | GO:1903375 | facioacoustic ganglion development | 2 | 2 | 3.52e-01 |
| GO:BP | GO:0031065 | positive regulation of histone deacetylation | 13 | 22 | 3.54e-01 |
| GO:BP | GO:1904748 | regulation of apoptotic process involved in development | 3 | 9 | 3.54e-01 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 6 | 93 | 3.54e-01 |
| GO:BP | GO:0001865 | NK T cell differentiation | 1 | 7 | 3.54e-01 |
| GO:BP | GO:1902337 | regulation of apoptotic process involved in morphogenesis | 3 | 9 | 3.54e-01 |
| GO:BP | GO:0019755 | one-carbon compound transport | 2 | 23 | 3.54e-01 |
| GO:BP | GO:0016233 | telomere capping | 14 | 36 | 3.54e-01 |
| GO:BP | GO:0035825 | homologous recombination | 16 | 43 | 3.54e-01 |
| GO:BP | GO:0070828 | heterochromatin organization | 1 | 77 | 3.54e-01 |
| GO:BP | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation | 2 | 8 | 3.55e-01 |
| GO:BP | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1 | 5 | 3.55e-01 |
| GO:BP | GO:0035329 | hippo signaling | 17 | 41 | 3.55e-01 |
| GO:BP | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication | 4 | 6 | 3.55e-01 |
| GO:BP | GO:1903126 | negative regulation of centriole-centriole cohesion | 1 | 1 | 3.55e-01 |
| GO:BP | GO:0015757 | galactose transmembrane transport | 3 | 4 | 3.56e-01 |
| GO:BP | GO:0018171 | peptidyl-cysteine oxidation | 3 | 3 | 3.56e-01 |
| GO:BP | GO:1904679 | myo-inositol import across plasma membrane | 1 | 1 | 3.56e-01 |
| GO:BP | GO:0047484 | regulation of response to osmotic stress | 1 | 12 | 3.57e-01 |
| GO:BP | GO:0019674 | NAD metabolic process | 3 | 33 | 3.57e-01 |
| GO:BP | GO:0032941 | secretion by tissue | 1 | 25 | 3.57e-01 |
| GO:BP | GO:0019725 | cellular homeostasis | 15 | 569 | 3.57e-01 |
| GO:BP | GO:2000393 | negative regulation of lamellipodium morphogenesis | 2 | 2 | 3.58e-01 |
| GO:BP | GO:2000744 | positive regulation of anterior head development | 2 | 2 | 3.58e-01 |
| GO:BP | GO:2000742 | regulation of anterior head development | 2 | 2 | 3.58e-01 |
| GO:BP | GO:0016237 | lysosomal microautophagy | 8 | 11 | 3.58e-01 |
| GO:BP | GO:2000386 | positive regulation of ovarian follicle development | 2 | 2 | 3.58e-01 |
| GO:BP | GO:0006950 | response to stress | 6 | 2780 | 3.58e-01 |
| GO:BP | GO:0009150 | purine ribonucleotide metabolic process | 3 | 295 | 3.58e-01 |
| GO:BP | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 12 | 32 | 3.58e-01 |
| GO:BP | GO:0019068 | virion assembly | 7 | 35 | 3.58e-01 |
| GO:BP | GO:0006744 | ubiquinone biosynthetic process | 1 | 17 | 3.59e-01 |
| GO:BP | GO:1901663 | quinone biosynthetic process | 1 | 17 | 3.59e-01 |
| GO:BP | GO:0032075 | positive regulation of nuclease activity | 3 | 7 | 3.59e-01 |
| GO:BP | GO:0007020 | microtubule nucleation | 2 | 39 | 3.59e-01 |
| GO:BP | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation | 1 | 1 | 3.59e-01 |
| GO:BP | GO:0048666 | neuron development | 3 | 877 | 3.59e-01 |
| GO:BP | GO:0090383 | phagosome acidification | 1 | 5 | 3.59e-01 |
| GO:BP | GO:0036115 | fatty-acyl-CoA catabolic process | 5 | 6 | 3.59e-01 |
| GO:BP | GO:0015939 | pantothenate metabolic process | 2 | 2 | 3.59e-01 |
| GO:BP | GO:2000002 | negative regulation of DNA damage checkpoint | 1 | 5 | 3.60e-01 |
| GO:BP | GO:0045132 | meiotic chromosome segregation | 19 | 64 | 3.60e-01 |
| GO:BP | GO:0062196 | regulation of lysosome size | 5 | 8 | 3.60e-01 |
| GO:BP | GO:0010886 | positive regulation of cholesterol storage | 4 | 5 | 3.60e-01 |
| GO:BP | GO:0006473 | protein acetylation | 1 | 190 | 3.60e-01 |
| GO:BP | GO:0019184 | nonribosomal peptide biosynthetic process | 4 | 15 | 3.60e-01 |
| GO:BP | GO:0045204 | MAPK export from nucleus | 3 | 3 | 3.60e-01 |
| GO:BP | GO:0031214 | biomineral tissue development | 1 | 111 | 3.60e-01 |
| GO:BP | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction | 4 | 12 | 3.60e-01 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 30 | 809 | 3.60e-01 |
| GO:BP | GO:0021593 | rhombomere morphogenesis | 1 | 1 | 3.60e-01 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 4 | 94 | 3.60e-01 |
| GO:BP | GO:2001311 | lysobisphosphatidic acid metabolic process | 2 | 2 | 3.60e-01 |
| GO:BP | GO:0014040 | positive regulation of Schwann cell differentiation | 1 | 2 | 3.60e-01 |
| GO:BP | GO:0071028 | nuclear mRNA surveillance | 1 | 10 | 3.60e-01 |
| GO:BP | GO:0045814 | negative regulation of gene expression, epigenetic | 1 | 79 | 3.60e-01 |
| GO:BP | GO:0035435 | phosphate ion transmembrane transport | 3 | 12 | 3.60e-01 |
| GO:BP | GO:0014859 | negative regulation of skeletal muscle cell proliferation | 2 | 3 | 3.60e-01 |
| GO:BP | GO:0021658 | rhombomere 3 morphogenesis | 1 | 1 | 3.60e-01 |
| GO:BP | GO:0090130 | tissue migration | 13 | 256 | 3.60e-01 |
| GO:BP | GO:1904161 | DNA synthesis involved in UV-damage excision repair | 2 | 2 | 3.61e-01 |
| GO:BP | GO:0070831 | basement membrane assembly | 2 | 13 | 3.61e-01 |
| GO:BP | GO:0003285 | septum secundum development | 3 | 3 | 3.61e-01 |
| GO:BP | GO:0010038 | response to metal ion | 19 | 264 | 3.61e-01 |
| GO:BP | GO:0072001 | renal system development | 12 | 251 | 3.61e-01 |
| GO:BP | GO:0009414 | response to water deprivation | 1 | 4 | 3.61e-01 |
| GO:BP | GO:0014806 | smooth muscle hyperplasia | 2 | 2 | 3.61e-01 |
| GO:BP | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 8 | 133 | 3.61e-01 |
| GO:BP | GO:0009144 | purine nucleoside triphosphate metabolic process | 2 | 142 | 3.61e-01 |
| GO:BP | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 1 | 138 | 3.61e-01 |
| GO:BP | GO:0051823 | regulation of synapse structural plasticity | 1 | 5 | 3.61e-01 |
| GO:BP | GO:0003085 | negative regulation of systemic arterial blood pressure | 2 | 14 | 3.61e-01 |
| GO:BP | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity | 4 | 9 | 3.61e-01 |
| GO:BP | GO:1905515 | non-motile cilium assembly | 5 | 58 | 3.61e-01 |
| GO:BP | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway | 2 | 4 | 3.61e-01 |
| GO:BP | GO:0042572 | retinol metabolic process | 4 | 24 | 3.61e-01 |
| GO:BP | GO:0042551 | neuron maturation | 6 | 33 | 3.61e-01 |
| GO:BP | GO:0014037 | Schwann cell differentiation | 1 | 34 | 3.62e-01 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 9 | 90 | 3.62e-01 |
| GO:BP | GO:0032352 | positive regulation of hormone metabolic process | 1 | 11 | 3.62e-01 |
| GO:BP | GO:0042267 | natural killer cell mediated cytotoxicity | 2 | 34 | 3.63e-01 |
| GO:BP | GO:0090102 | cochlea development | 9 | 35 | 3.63e-01 |
| GO:BP | GO:0032922 | circadian regulation of gene expression | 4 | 63 | 3.63e-01 |
| GO:BP | GO:0043523 | regulation of neuron apoptotic process | 34 | 167 | 3.63e-01 |
| GO:BP | GO:0070305 | response to cGMP | 1 | 7 | 3.63e-01 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 2 | 742 | 3.63e-01 |
| GO:BP | GO:0060027 | convergent extension involved in gastrulation | 2 | 8 | 3.63e-01 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 12 | 187 | 3.63e-01 |
| GO:BP | GO:1905024 | regulation of membrane repolarization during ventricular cardiac muscle cell action potential | 1 | 2 | 3.63e-01 |
| GO:BP | GO:0009213 | pyrimidine deoxyribonucleoside triphosphate catabolic process | 1 | 2 | 3.63e-01 |
| GO:BP | GO:1901797 | negative regulation of signal transduction by p53 class mediator | 3 | 32 | 3.63e-01 |
| GO:BP | GO:0072347 | response to anesthetic | 1 | 1 | 3.63e-01 |
| GO:BP | GO:0046548 | retinal rod cell development | 3 | 6 | 3.63e-01 |
| GO:BP | GO:0042044 | fluid transport | 3 | 17 | 3.64e-01 |
| GO:BP | GO:1902038 | positive regulation of hematopoietic stem cell differentiation | 1 | 1 | 3.64e-01 |
| GO:BP | GO:0007077 | mitotic nuclear membrane disassembly | 1 | 7 | 3.64e-01 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 7 | 97 | 3.64e-01 |
| GO:BP | GO:0090036 | regulation of protein kinase C signaling | 12 | 14 | 3.64e-01 |
| GO:BP | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 1 | 10 | 3.64e-01 |
| GO:BP | GO:0010559 | regulation of glycoprotein biosynthetic process | 3 | 32 | 3.64e-01 |
| GO:BP | GO:0061462 | protein localization to lysosome | 3 | 46 | 3.64e-01 |
| GO:BP | GO:0097119 | postsynaptic density protein 95 clustering | 2 | 7 | 3.64e-01 |
| GO:BP | GO:0098976 | excitatory chemical synaptic transmission | 1 | 6 | 3.64e-01 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 1 | 407 | 3.64e-01 |
| GO:BP | GO:0072553 | terminal button organization | 1 | 5 | 3.64e-01 |
| GO:BP | GO:0014848 | urinary tract smooth muscle contraction | 2 | 6 | 3.64e-01 |
| GO:BP | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 3 | 4 | 3.64e-01 |
| GO:BP | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway | 1 | 3 | 3.64e-01 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 5 | 115 | 3.64e-01 |
| GO:BP | GO:1900244 | positive regulation of synaptic vesicle endocytosis | 1 | 4 | 3.64e-01 |
| GO:BP | GO:0070509 | calcium ion import | 4 | 37 | 3.65e-01 |
| GO:BP | GO:0019388 | galactose catabolic process | 2 | 5 | 3.65e-01 |
| GO:BP | GO:0099151 | regulation of postsynaptic density assembly | 2 | 9 | 3.65e-01 |
| GO:BP | GO:1990049 | retrograde neuronal dense core vesicle transport | 1 | 4 | 3.65e-01 |
| GO:BP | GO:0033598 | mammary gland epithelial cell proliferation | 15 | 23 | 3.65e-01 |
| GO:BP | GO:0071393 | cellular response to progesterone stimulus | 1 | 5 | 3.65e-01 |
| GO:BP | GO:0031641 | regulation of myelination | 9 | 36 | 3.65e-01 |
| GO:BP | GO:0010799 | regulation of peptidyl-threonine phosphorylation | 3 | 35 | 3.65e-01 |
| GO:BP | GO:0035865 | cellular response to potassium ion | 2 | 9 | 3.65e-01 |
| GO:BP | GO:0046168 | glycerol-3-phosphate catabolic process | 2 | 2 | 3.65e-01 |
| GO:BP | GO:0003266 | regulation of secondary heart field cardioblast proliferation | 4 | 8 | 3.65e-01 |
| GO:BP | GO:0010424 | DNA methylation on cytosine within a CG sequence | 1 | 1 | 3.65e-01 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 3 | 33 | 3.65e-01 |
| GO:BP | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 12 | 33 | 3.65e-01 |
| GO:BP | GO:2001300 | lipoxin metabolic process | 2 | 3 | 3.65e-01 |
| GO:BP | GO:0010970 | transport along microtubule | 13 | 162 | 3.65e-01 |
| GO:BP | GO:0036072 | direct ossification | 1 | 7 | 3.65e-01 |
| GO:BP | GO:0001957 | intramembranous ossification | 1 | 7 | 3.65e-01 |
| GO:BP | GO:0071467 | cellular response to pH | 2 | 16 | 3.65e-01 |
| GO:BP | GO:0034111 | negative regulation of homotypic cell-cell adhesion | 6 | 13 | 3.65e-01 |
| GO:BP | GO:1902742 | apoptotic process involved in development | 18 | 30 | 3.66e-01 |
| GO:BP | GO:0010818 | T cell chemotaxis | 3 | 12 | 3.66e-01 |
| GO:BP | GO:0061956 | penetration of cumulus oophorus | 1 | 1 | 3.66e-01 |
| GO:BP | GO:0071279 | cellular response to cobalt ion | 1 | 4 | 3.66e-01 |
| GO:BP | GO:0099551 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission | 1 | 1 | 3.66e-01 |
| GO:BP | GO:0006041 | glucosamine metabolic process | 2 | 3 | 3.66e-01 |
| GO:BP | GO:0003193 | pulmonary valve formation | 1 | 2 | 3.66e-01 |
| GO:BP | GO:0098905 | regulation of bundle of His cell action potential | 1 | 2 | 3.66e-01 |
| GO:BP | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 2 | 14 | 3.66e-01 |
| GO:BP | GO:1903533 | regulation of protein targeting | 11 | 66 | 3.66e-01 |
| GO:BP | GO:0009649 | entrainment of circadian clock | 16 | 31 | 3.66e-01 |
| GO:BP | GO:0042311 | vasodilation | 5 | 39 | 3.66e-01 |
| GO:BP | GO:0075732 | viral penetration into host nucleus | 3 | 4 | 3.66e-01 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 26 | 1015 | 3.66e-01 |
| GO:BP | GO:1903312 | negative regulation of mRNA metabolic process | 13 | 81 | 3.66e-01 |
| GO:BP | GO:1902170 | cellular response to reactive nitrogen species | 9 | 16 | 3.67e-01 |
| GO:BP | GO:0072739 | response to anisomycin | 1 | 4 | 3.67e-01 |
| GO:BP | GO:0021870 | Cajal-Retzius cell differentiation | 2 | 2 | 3.67e-01 |
| GO:BP | GO:0039694 | viral RNA genome replication | 2 | 27 | 3.67e-01 |
| GO:BP | GO:0051895 | negative regulation of focal adhesion assembly | 6 | 14 | 3.67e-01 |
| GO:BP | GO:0150118 | negative regulation of cell-substrate junction organization | 6 | 14 | 3.67e-01 |
| GO:BP | GO:1903964 | monounsaturated fatty acid metabolic process | 1 | 2 | 3.67e-01 |
| GO:BP | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening | 12 | 26 | 3.67e-01 |
| GO:BP | GO:0006646 | phosphatidylethanolamine biosynthetic process | 7 | 8 | 3.67e-01 |
| GO:BP | GO:0061952 | midbody abscission | 5 | 17 | 3.67e-01 |
| GO:BP | GO:0003330 | regulation of extracellular matrix constituent secretion | 5 | 7 | 3.67e-01 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 24 | 227 | 3.67e-01 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 18 | 69 | 3.67e-01 |
| GO:BP | GO:0032070 | regulation of deoxyribonuclease activity | 6 | 9 | 3.67e-01 |
| GO:BP | GO:1900208 | regulation of cardiolipin metabolic process | 3 | 3 | 3.67e-01 |
| GO:BP | GO:0034199 | activation of protein kinase A activity | 2 | 3 | 3.68e-01 |
| GO:BP | GO:2000270 | negative regulation of fibroblast apoptotic process | 2 | 6 | 3.68e-01 |
| GO:BP | GO:0007498 | mesoderm development | 2 | 89 | 3.68e-01 |
| GO:BP | GO:1903507 | negative regulation of nucleic acid-templated transcription | 26 | 1017 | 3.69e-01 |
| GO:BP | GO:0097601 | retina blood vessel maintenance | 1 | 1 | 3.69e-01 |
| GO:BP | GO:0015755 | fructose transmembrane transport | 3 | 5 | 3.69e-01 |
| GO:BP | GO:0140882 | zinc export across plasma membrane | 1 | 3 | 3.69e-01 |
| GO:BP | GO:0098927 | vesicle-mediated transport between endosomal compartments | 2 | 42 | 3.69e-01 |
| GO:BP | GO:0071579 | regulation of zinc ion transport | 1 | 2 | 3.69e-01 |
| GO:BP | GO:0035082 | axoneme assembly | 2 | 52 | 3.69e-01 |
| GO:BP | GO:0090042 | tubulin deacetylation | 9 | 23 | 3.69e-01 |
| GO:BP | GO:0051684 | maintenance of Golgi location | 3 | 3 | 3.69e-01 |
| GO:BP | GO:0001780 | neutrophil homeostasis | 5 | 16 | 3.69e-01 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 11 | 172 | 3.70e-01 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 1 | 143 | 3.70e-01 |
| GO:BP | GO:0035498 | carnosine metabolic process | 1 | 2 | 3.70e-01 |
| GO:BP | GO:0006283 | transcription-coupled nucleotide-excision repair | 6 | 10 | 3.70e-01 |
| GO:BP | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance | 10 | 14 | 3.70e-01 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 1 | 117 | 3.70e-01 |
| GO:BP | GO:0000706 | meiotic DNA double-strand break processing | 2 | 2 | 3.70e-01 |
| GO:BP | GO:0098703 | calcium ion import across plasma membrane | 2 | 23 | 3.70e-01 |
| GO:BP | GO:0072710 | response to hydroxyurea | 6 | 11 | 3.70e-01 |
| GO:BP | GO:0071498 | cellular response to fluid shear stress | 4 | 19 | 3.70e-01 |
| GO:BP | GO:0080163 | regulation of protein serine/threonine phosphatase activity | 2 | 2 | 3.70e-01 |
| GO:BP | GO:2001306 | lipoxin B4 biosynthetic process | 1 | 1 | 3.70e-01 |
| GO:BP | GO:0014861 | regulation of skeletal muscle contraction via regulation of action potential | 1 | 1 | 3.70e-01 |
| GO:BP | GO:0032876 | negative regulation of DNA endoreduplication | 1 | 1 | 3.70e-01 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 1 | 421 | 3.70e-01 |
| GO:BP | GO:0035928 | rRNA import into mitochondrion | 2 | 3 | 3.70e-01 |
| GO:BP | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle | 2 | 3 | 3.71e-01 |
| GO:BP | GO:0036159 | inner dynein arm assembly | 1 | 8 | 3.71e-01 |
| GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 11 | 194 | 3.71e-01 |
| GO:BP | GO:0072074 | kidney mesenchyme development | 1 | 13 | 3.71e-01 |
| GO:BP | GO:0008593 | regulation of Notch signaling pathway | 1 | 78 | 3.71e-01 |
| GO:BP | GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 1 | 8 | 3.71e-01 |
| GO:BP | GO:0048645 | animal organ formation | 4 | 51 | 3.71e-01 |
| GO:BP | GO:0034498 | early endosome to Golgi transport | 3 | 9 | 3.71e-01 |
| GO:BP | GO:0046222 | aflatoxin metabolic process | 1 | 2 | 3.71e-01 |
| GO:BP | GO:0043385 | mycotoxin metabolic process | 1 | 2 | 3.71e-01 |
| GO:BP | GO:0060677 | ureteric bud elongation | 7 | 7 | 3.71e-01 |
| GO:BP | GO:1901376 | organic heteropentacyclic compound metabolic process | 1 | 2 | 3.71e-01 |
| GO:BP | GO:0006111 | regulation of gluconeogenesis | 1 | 42 | 3.72e-01 |
| GO:BP | GO:0030890 | positive regulation of B cell proliferation | 1 | 26 | 3.72e-01 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 16 | 52 | 3.72e-01 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 6 | 72 | 3.72e-01 |
| GO:BP | GO:0001825 | blastocyst formation | 1 | 37 | 3.72e-01 |
| GO:BP | GO:1904356 | regulation of telomere maintenance via telomere lengthening | 23 | 56 | 3.72e-01 |
| GO:BP | GO:0010991 | negative regulation of SMAD protein complex assembly | 4 | 5 | 3.72e-01 |
| GO:BP | GO:0090522 | vesicle tethering involved in exocytosis | 6 | 9 | 3.72e-01 |
| GO:BP | GO:1900452 | regulation of long-term synaptic depression | 2 | 10 | 3.72e-01 |
| GO:BP | GO:0014824 | artery smooth muscle contraction | 2 | 7 | 3.72e-01 |
| GO:BP | GO:0035234 | ectopic germ cell programmed cell death | 1 | 11 | 3.72e-01 |
| GO:BP | GO:1990505 | mitotic DNA replication maintenance of fidelity | 2 | 2 | 3.72e-01 |
| GO:BP | GO:1902298 | cell cycle DNA replication maintenance of fidelity | 2 | 2 | 3.72e-01 |
| GO:BP | GO:0014816 | skeletal muscle satellite cell differentiation | 3 | 6 | 3.72e-01 |
| GO:BP | GO:1990426 | mitotic recombination-dependent replication fork processing | 2 | 2 | 3.72e-01 |
| GO:BP | GO:0051546 | keratinocyte migration | 1 | 15 | 3.72e-01 |
| GO:BP | GO:0002228 | natural killer cell mediated immunity | 2 | 34 | 3.72e-01 |
| GO:BP | GO:0032228 | regulation of synaptic transmission, GABAergic | 2 | 23 | 3.72e-01 |
| GO:BP | GO:0071709 | membrane assembly | 4 | 53 | 3.72e-01 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 4 | 400 | 3.72e-01 |
| GO:BP | GO:0051697 | protein delipidation | 1 | 5 | 3.72e-01 |
| GO:BP | GO:0099536 | synaptic signaling | 17 | 511 | 3.72e-01 |
| GO:BP | GO:0006743 | ubiquinone metabolic process | 1 | 19 | 3.72e-01 |
| GO:BP | GO:0009650 | UV protection | 2 | 11 | 3.72e-01 |
| GO:BP | GO:1903621 | protein localization to photoreceptor connecting cilium | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 13 | 228 | 3.72e-01 |
| GO:BP | GO:0046627 | negative regulation of insulin receptor signaling pathway | 10 | 29 | 3.72e-01 |
| GO:BP | GO:1905373 | ceramide phosphoethanolamine biosynthetic process | 2 | 2 | 3.72e-01 |
| GO:BP | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1 | 2 | 3.72e-01 |
| GO:BP | GO:0072107 | positive regulation of ureteric bud formation | 1 | 2 | 3.72e-01 |
| GO:BP | GO:0072106 | regulation of ureteric bud formation | 1 | 2 | 3.72e-01 |
| GO:BP | GO:1905371 | ceramide phosphoethanolamine metabolic process | 2 | 2 | 3.72e-01 |
| GO:BP | GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 3 | 21 | 3.72e-01 |
| GO:BP | GO:0006476 | protein deacetylation | 47 | 106 | 3.72e-01 |
| GO:BP | GO:0097428 | protein maturation by iron-sulfur cluster transfer | 3 | 17 | 3.72e-01 |
| GO:BP | GO:0009609 | response to symbiotic bacterium | 1 | 2 | 3.72e-01 |
| GO:BP | GO:0090280 | positive regulation of calcium ion import | 1 | 11 | 3.72e-01 |
| GO:BP | GO:0061865 | polarized secretion of basement membrane proteins in epithelium | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0030219 | megakaryocyte differentiation | 3 | 54 | 3.72e-01 |
| GO:BP | GO:0072220 | metanephric descending thin limb development | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 1 | 429 | 3.72e-01 |
| GO:BP | GO:0072230 | metanephric proximal straight tubule development | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0046688 | response to copper ion | 2 | 29 | 3.72e-01 |
| GO:BP | GO:0006972 | hyperosmotic response | 11 | 19 | 3.72e-01 |
| GO:BP | GO:1905070 | anterior visceral endoderm cell migration | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0000493 | box H/ACA snoRNP assembly | 1 | 2 | 3.72e-01 |
| GO:BP | GO:0061864 | basement membrane constituent secretion | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0032331 | negative regulation of chondrocyte differentiation | 2 | 18 | 3.72e-01 |
| GO:BP | GO:0051664 | nuclear pore localization | 2 | 4 | 3.72e-01 |
| GO:BP | GO:0072022 | descending thin limb development | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0072032 | proximal convoluted tubule segment 2 development | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0009608 | response to symbiont | 1 | 2 | 3.72e-01 |
| GO:BP | GO:2000691 | negative regulation of cardiac muscle cell myoblast differentiation | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0006021 | inositol biosynthetic process | 1 | 3 | 3.72e-01 |
| GO:BP | GO:0070384 | Harderian gland development | 1 | 4 | 3.72e-01 |
| GO:BP | GO:0072232 | metanephric proximal convoluted tubule segment 2 development | 1 | 1 | 3.72e-01 |
| GO:BP | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation | 1 | 1 | 3.72e-01 |
| GO:BP | GO:0001771 | immunological synapse formation | 1 | 7 | 3.72e-01 |
| GO:BP | GO:0032925 | regulation of activin receptor signaling pathway | 1 | 20 | 3.72e-01 |
| GO:BP | GO:0072020 | proximal straight tubule development | 1 | 1 | 3.72e-01 |
| GO:BP | GO:1901660 | calcium ion export | 3 | 3 | 3.72e-01 |
| GO:BP | GO:0034499 | late endosome to Golgi transport | 2 | 5 | 3.73e-01 |
| GO:BP | GO:0021555 | midbrain-hindbrain boundary morphogenesis | 2 | 2 | 3.73e-01 |
| GO:BP | GO:1903753 | negative regulation of p38MAPK cascade | 3 | 5 | 3.73e-01 |
| GO:BP | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 2 | 6 | 3.73e-01 |
| GO:BP | GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1 | 3 | 3.73e-01 |
| GO:BP | GO:0050830 | defense response to Gram-positive bacterium | 2 | 33 | 3.73e-01 |
| GO:BP | GO:0006046 | N-acetylglucosamine catabolic process | 3 | 3 | 3.73e-01 |
| GO:BP | GO:0071403 | cellular response to high density lipoprotein particle stimulus | 3 | 3 | 3.73e-01 |
| GO:BP | GO:0038018 | Wnt receptor catabolic process | 2 | 2 | 3.73e-01 |
| GO:BP | GO:0098532 | histone H3-K27 trimethylation | 1 | 4 | 3.73e-01 |
| GO:BP | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 4 | 8 | 3.73e-01 |
| GO:BP | GO:0006434 | seryl-tRNA aminoacylation | 2 | 2 | 3.74e-01 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 5 | 141 | 3.74e-01 |
| GO:BP | GO:0006269 | DNA replication, synthesis of RNA primer | 2 | 7 | 3.74e-01 |
| GO:BP | GO:0060392 | negative regulation of SMAD protein signal transduction | 7 | 8 | 3.74e-01 |
| GO:BP | GO:1902883 | negative regulation of response to oxidative stress | 3 | 18 | 3.74e-01 |
| GO:BP | GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 1 | 59 | 3.74e-01 |
| GO:BP | GO:0043687 | post-translational protein modification | 1 | 64 | 3.75e-01 |
| GO:BP | GO:0072239 | metanephric glomerulus vasculature development | 3 | 6 | 3.75e-01 |
| GO:BP | GO:0071578 | zinc ion import across plasma membrane | 2 | 6 | 3.75e-01 |
| GO:BP | GO:2000631 | regulation of pre-miRNA processing | 3 | 3 | 3.75e-01 |
| GO:BP | GO:0031109 | microtubule polymerization or depolymerization | 2 | 119 | 3.75e-01 |
| GO:BP | GO:0043041 | amino acid activation for nonribosomal peptide biosynthetic process | 1 | 1 | 3.75e-01 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 3 | 30 | 3.75e-01 |
| GO:BP | GO:0048296 | regulation of isotype switching to IgA isotypes | 1 | 4 | 3.75e-01 |
| GO:BP | GO:1990637 | response to prolactin | 2 | 3 | 3.75e-01 |
| GO:BP | GO:1903997 | positive regulation of non-membrane spanning protein tyrosine kinase activity | 2 | 2 | 3.75e-01 |
| GO:BP | GO:0032007 | negative regulation of TOR signaling | 1 | 47 | 3.75e-01 |
| GO:BP | GO:0086098 | angiotensin-activated signaling pathway involved in heart process | 2 | 3 | 3.75e-01 |
| GO:BP | GO:0051036 | regulation of endosome size | 7 | 13 | 3.76e-01 |
| GO:BP | GO:1905719 | protein localization to perinuclear region of cytoplasm | 1 | 8 | 3.76e-01 |
| GO:BP | GO:0014896 | muscle hypertrophy | 19 | 74 | 3.76e-01 |
| GO:BP | GO:0006534 | cysteine metabolic process | 3 | 11 | 3.76e-01 |
| GO:BP | GO:0007063 | regulation of sister chromatid cohesion | 2 | 18 | 3.76e-01 |
| GO:BP | GO:1990700 | nucleolar chromatin organization | 2 | 10 | 3.76e-01 |
| GO:BP | GO:0001656 | metanephros development | 2 | 64 | 3.76e-01 |
| GO:BP | GO:0034219 | carbohydrate transmembrane transport | 14 | 92 | 3.76e-01 |
| GO:BP | GO:0034421 | post-translational protein acetylation | 3 | 3 | 3.76e-01 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 3 | 37 | 3.76e-01 |
| GO:BP | GO:0071453 | cellular response to oxygen levels | 13 | 144 | 3.77e-01 |
| GO:BP | GO:0019637 | organophosphate metabolic process | 8 | 784 | 3.77e-01 |
| GO:BP | GO:0001919 | regulation of receptor recycling | 1 | 19 | 3.77e-01 |
| GO:BP | GO:0110155 | NAD-cap decapping | 2 | 3 | 3.77e-01 |
| GO:BP | GO:0070495 | negative regulation of thrombin-activated receptor signaling pathway | 3 | 3 | 3.77e-01 |
| GO:BP | GO:0075506 | entry of viral genome into host nucleus through nuclear pore complex via importin | 2 | 2 | 3.77e-01 |
| GO:BP | GO:0055057 | neuroblast division | 4 | 12 | 3.77e-01 |
| GO:BP | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway | 1 | 2 | 3.77e-01 |
| GO:BP | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation | 5 | 5 | 3.77e-01 |
| GO:BP | GO:0070494 | regulation of thrombin-activated receptor signaling pathway | 3 | 3 | 3.77e-01 |
| GO:BP | GO:0001977 | renal system process involved in regulation of blood volume | 3 | 9 | 3.77e-01 |
| GO:BP | GO:2000969 | positive regulation of AMPA receptor activity | 1 | 4 | 3.77e-01 |
| GO:BP | GO:0060763 | mammary duct terminal end bud growth | 1 | 3 | 3.77e-01 |
| GO:BP | GO:0009199 | ribonucleoside triphosphate metabolic process | 1 | 144 | 3.77e-01 |
| GO:BP | GO:1905667 | negative regulation of protein localization to endosome | 1 | 1 | 3.77e-01 |
| GO:BP | GO:0015823 | phenylalanine transport | 2 | 4 | 3.77e-01 |
| GO:BP | GO:1904263 | positive regulation of TORC1 signaling | 12 | 24 | 3.78e-01 |
| GO:BP | GO:0048102 | autophagic cell death | 1 | 6 | 3.78e-01 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 7 | 140 | 3.78e-01 |
| GO:BP | GO:0072497 | mesenchymal stem cell differentiation | 1 | 11 | 3.79e-01 |
| GO:BP | GO:0032365 | intracellular lipid transport | 5 | 42 | 3.79e-01 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 1 | 154 | 3.79e-01 |
| GO:BP | GO:0002686 | negative regulation of leukocyte migration | 1 | 30 | 3.79e-01 |
| GO:BP | GO:0048286 | lung alveolus development | 1 | 39 | 3.79e-01 |
| GO:BP | GO:0097190 | apoptotic signaling pathway | 18 | 494 | 3.79e-01 |
| GO:BP | GO:0060948 | cardiac vascular smooth muscle cell development | 3 | 3 | 3.79e-01 |
| GO:BP | GO:0045722 | positive regulation of gluconeogenesis | 11 | 16 | 3.79e-01 |
| GO:BP | GO:1901342 | regulation of vasculature development | 11 | 206 | 3.79e-01 |
| GO:BP | GO:0014916 | regulation of lung blood pressure | 1 | 3 | 3.79e-01 |
| GO:BP | GO:0106217 | tRNA C3-cytosine methylation | 1 | 2 | 3.80e-01 |
| GO:BP | GO:0050859 | negative regulation of B cell receptor signaling pathway | 1 | 3 | 3.80e-01 |
| GO:BP | GO:0014819 | regulation of skeletal muscle contraction | 1 | 14 | 3.80e-01 |
| GO:BP | GO:1901321 | positive regulation of heart induction | 2 | 4 | 3.81e-01 |
| GO:BP | GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway | 2 | 4 | 3.81e-01 |
| GO:BP | GO:0010621 | negative regulation of transcription by transcription factor localization | 1 | 3 | 3.81e-01 |
| GO:BP | GO:1904778 | positive regulation of protein localization to cell cortex | 3 | 6 | 3.81e-01 |
| GO:BP | GO:0060055 | angiogenesis involved in wound healing | 2 | 25 | 3.81e-01 |
| GO:BP | GO:0051966 | regulation of synaptic transmission, glutamatergic | 3 | 46 | 3.81e-01 |
| GO:BP | GO:0032210 | regulation of telomere maintenance via telomerase | 20 | 49 | 3.81e-01 |
| GO:BP | GO:0051293 | establishment of spindle localization | 17 | 48 | 3.81e-01 |
| GO:BP | GO:1904762 | positive regulation of myofibroblast differentiation | 1 | 1 | 3.81e-01 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 14 | 53 | 3.81e-01 |
| GO:BP | GO:0010738 | regulation of protein kinase A signaling | 1 | 13 | 3.81e-01 |
| GO:BP | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity | 5 | 5 | 3.81e-01 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 15 | 70 | 3.82e-01 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 9 | 23 | 3.82e-01 |
| GO:BP | GO:0014004 | microglia differentiation | 1 | 6 | 3.82e-01 |
| GO:BP | GO:0038146 | chemokine (C-X-C motif) ligand 12 signaling pathway | 4 | 6 | 3.82e-01 |
| GO:BP | GO:0006367 | transcription initiation at RNA polymerase II promoter | 1 | 93 | 3.82e-01 |
| GO:BP | GO:0048070 | regulation of developmental pigmentation | 1 | 11 | 3.82e-01 |
| GO:BP | GO:0120305 | regulation of pigmentation | 1 | 11 | 3.82e-01 |
| GO:BP | GO:0006248 | CMP catabolic process | 1 | 3 | 3.82e-01 |
| GO:BP | GO:0046050 | UMP catabolic process | 1 | 3 | 3.82e-01 |
| GO:BP | GO:0009888 | tissue development | 4 | 1425 | 3.82e-01 |
| GO:BP | GO:0035239 | tube morphogenesis | 2 | 663 | 3.82e-01 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 11 | 207 | 3.83e-01 |
| GO:BP | GO:0061743 | motor learning | 1 | 5 | 3.83e-01 |
| GO:BP | GO:0090063 | positive regulation of microtubule nucleation | 1 | 8 | 3.83e-01 |
| GO:BP | GO:0060068 | vagina development | 3 | 8 | 3.83e-01 |
| GO:BP | GO:0007223 | Wnt signaling pathway, calcium modulating pathway | 4 | 5 | 3.83e-01 |
| GO:BP | GO:0097494 | regulation of vesicle size | 11 | 19 | 3.83e-01 |
| GO:BP | GO:1904782 | negative regulation of NMDA glutamate receptor activity | 2 | 2 | 3.84e-01 |
| GO:BP | GO:0043543 | protein acylation | 1 | 228 | 3.84e-01 |
| GO:BP | GO:0000712 | resolution of meiotic recombination intermediates | 1 | 13 | 3.84e-01 |
| GO:BP | GO:1903932 | regulation of DNA primase activity | 4 | 5 | 3.84e-01 |
| GO:BP | GO:0051767 | nitric-oxide synthase biosynthetic process | 1 | 13 | 3.84e-01 |
| GO:BP | GO:1903934 | positive regulation of DNA primase activity | 4 | 5 | 3.84e-01 |
| GO:BP | GO:1903772 | regulation of viral budding via host ESCRT complex | 2 | 4 | 3.84e-01 |
| GO:BP | GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 1 | 13 | 3.84e-01 |
| GO:BP | GO:0072111 | cell proliferation involved in kidney development | 1 | 17 | 3.84e-01 |
| GO:BP | GO:0006595 | polyamine metabolic process | 2 | 16 | 3.84e-01 |
| GO:BP | GO:0009615 | response to virus | 2 | 275 | 3.84e-01 |
| GO:BP | GO:1901403 | positive regulation of tetrapyrrole metabolic process | 3 | 4 | 3.84e-01 |
| GO:BP | GO:0006722 | triterpenoid metabolic process | 2 | 2 | 3.84e-01 |
| GO:BP | GO:0000956 | nuclear-transcribed mRNA catabolic process | 3 | 120 | 3.84e-01 |
| GO:BP | GO:0061002 | negative regulation of dendritic spine morphogenesis | 1 | 6 | 3.84e-01 |
| GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 4 | 47 | 3.84e-01 |
| GO:BP | GO:0061035 | regulation of cartilage development | 4 | 54 | 3.84e-01 |
| GO:BP | GO:0051216 | cartilage development | 1 | 151 | 3.84e-01 |
| GO:BP | GO:1901203 | positive regulation of extracellular matrix assembly | 2 | 10 | 3.84e-01 |
| GO:BP | GO:0072243 | metanephric nephron epithelium development | 2 | 15 | 3.85e-01 |
| GO:BP | GO:0008088 | axo-dendritic transport | 7 | 73 | 3.85e-01 |
| GO:BP | GO:0072170 | metanephric tubule development | 2 | 15 | 3.85e-01 |
| GO:BP | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 1 | 3 | 3.85e-01 |
| GO:BP | GO:0060686 | negative regulation of prostatic bud formation | 1 | 4 | 3.85e-01 |
| GO:BP | GO:1904322 | cellular response to forskolin | 4 | 11 | 3.85e-01 |
| GO:BP | GO:1904321 | response to forskolin | 4 | 11 | 3.85e-01 |
| GO:BP | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9 | 12 | 3.85e-01 |
| GO:BP | GO:1904293 | negative regulation of ERAD pathway | 1 | 6 | 3.85e-01 |
| GO:BP | GO:0044331 | cell-cell adhesion mediated by cadherin | 17 | 22 | 3.85e-01 |
| GO:BP | GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1 | 27 | 3.85e-01 |
| GO:BP | GO:0032212 | positive regulation of telomere maintenance via telomerase | 11 | 31 | 3.85e-01 |
| GO:BP | GO:1904646 | cellular response to amyloid-beta | 8 | 29 | 3.85e-01 |
| GO:BP | GO:0035268 | protein mannosylation | 5 | 21 | 3.85e-01 |
| GO:BP | GO:0061586 | positive regulation of transcription by transcription factor localization | 1 | 1 | 3.85e-01 |
| GO:BP | GO:0099156 | cell-cell signaling via exosome | 1 | 1 | 3.85e-01 |
| GO:BP | GO:0098801 | regulation of renal system process | 5 | 21 | 3.85e-01 |
| GO:BP | GO:0051725 | protein de-ADP-ribosylation | 3 | 6 | 3.85e-01 |
| GO:BP | GO:0006984 | ER-nucleus signaling pathway | 4 | 45 | 3.85e-01 |
| GO:BP | GO:0009194 | pyrimidine ribonucleoside diphosphate biosynthetic process | 2 | 4 | 3.85e-01 |
| GO:BP | GO:0006225 | UDP biosynthetic process | 2 | 4 | 3.85e-01 |
| GO:BP | GO:0038083 | peptidyl-tyrosine autophosphorylation | 8 | 18 | 3.86e-01 |
| GO:BP | GO:0060383 | positive regulation of DNA strand elongation | 1 | 1 | 3.86e-01 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 7 | 140 | 3.86e-01 |
| GO:BP | GO:0001833 | inner cell mass cell proliferation | 4 | 14 | 3.86e-01 |
| GO:BP | GO:0071577 | zinc ion transmembrane transport | 6 | 21 | 3.86e-01 |
| GO:BP | GO:0019730 | antimicrobial humoral response | 2 | 28 | 3.86e-01 |
| GO:BP | GO:1902178 | fibroblast growth factor receptor apoptotic signaling pathway | 1 | 1 | 3.86e-01 |
| GO:BP | GO:0090316 | positive regulation of intracellular protein transport | 19 | 133 | 3.86e-01 |
| GO:BP | GO:0150037 | regulation of calcium-dependent activation of synaptic vesicle fusion | 1 | 2 | 3.87e-01 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 7 | 3.87e-01 |
| GO:BP | GO:0140039 | cell-cell adhesion in response to extracellular stimulus | 1 | 2 | 3.87e-01 |
| GO:BP | GO:1903034 | regulation of response to wounding | 1 | 121 | 3.87e-01 |
| GO:BP | GO:0048311 | mitochondrion distribution | 1 | 14 | 3.87e-01 |
| GO:BP | GO:0061668 | mitochondrial ribosome assembly | 4 | 8 | 3.88e-01 |
| GO:BP | GO:0042987 | amyloid precursor protein catabolic process | 2 | 53 | 3.88e-01 |
| GO:BP | GO:0045003 | double-strand break repair via synthesis-dependent strand annealing | 5 | 7 | 3.88e-01 |
| GO:BP | GO:0016447 | somatic recombination of immunoglobulin gene segments | 3 | 47 | 3.88e-01 |
| GO:BP | GO:0060047 | heart contraction | 19 | 205 | 3.88e-01 |
| GO:BP | GO:0000212 | meiotic spindle organization | 7 | 14 | 3.88e-01 |
| GO:BP | GO:0021637 | trigeminal nerve structural organization | 3 | 4 | 3.88e-01 |
| GO:BP | GO:0050923 | regulation of negative chemotaxis | 3 | 4 | 3.88e-01 |
| GO:BP | GO:0035640 | exploration behavior | 3 | 21 | 3.88e-01 |
| GO:BP | GO:0030163 | protein catabolic process | 33 | 901 | 3.88e-01 |
| GO:BP | GO:0046886 | positive regulation of hormone biosynthetic process | 4 | 9 | 3.88e-01 |
| GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 2 | 53 | 3.88e-01 |
| GO:BP | GO:0090346 | cellular organofluorine metabolic process | 1 | 1 | 3.88e-01 |
| GO:BP | GO:0009083 | branched-chain amino acid catabolic process | 14 | 21 | 3.88e-01 |
| GO:BP | GO:0090345 | cellular organohalogen metabolic process | 1 | 1 | 3.88e-01 |
| GO:BP | GO:0050691 | regulation of defense response to virus by host | 2 | 30 | 3.88e-01 |
| GO:BP | GO:0016926 | protein desumoylation | 6 | 9 | 3.88e-01 |
| GO:BP | GO:0045110 | intermediate filament bundle assembly | 5 | 6 | 3.88e-01 |
| GO:BP | GO:0021636 | trigeminal nerve morphogenesis | 3 | 4 | 3.88e-01 |
| GO:BP | GO:0071456 | cellular response to hypoxia | 8 | 123 | 3.88e-01 |
| GO:BP | GO:2000504 | positive regulation of blood vessel remodeling | 1 | 1 | 3.88e-01 |
| GO:BP | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway | 1 | 2 | 3.88e-01 |
| GO:BP | GO:0099163 | synaptic signaling by nitric oxide | 1 | 3 | 3.88e-01 |
| GO:BP | GO:0048865 | stem cell fate commitment | 2 | 5 | 3.88e-01 |
| GO:BP | GO:0060243 | negative regulation of cell growth involved in contact inhibition | 1 | 1 | 3.88e-01 |
| GO:BP | GO:0071499 | cellular response to laminar fluid shear stress | 1 | 8 | 3.88e-01 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 131 | 218 | 3.88e-01 |
| GO:BP | GO:2001016 | positive regulation of skeletal muscle cell differentiation | 2 | 5 | 3.88e-01 |
| GO:BP | GO:0051348 | negative regulation of transferase activity | 47 | 234 | 3.88e-01 |
| GO:BP | GO:0000098 | sulfur amino acid catabolic process | 2 | 7 | 3.88e-01 |
| GO:BP | GO:0046967 | cytosol to endoplasmic reticulum transport | 2 | 4 | 3.89e-01 |
| GO:BP | GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1 | 17 | 3.89e-01 |
| GO:BP | GO:0032823 | regulation of natural killer cell differentiation | 1 | 8 | 3.89e-01 |
| GO:BP | GO:1900271 | regulation of long-term synaptic potentiation | 2 | 34 | 3.89e-01 |
| GO:BP | GO:0090161 | Golgi ribbon formation | 7 | 9 | 3.89e-01 |
| GO:BP | GO:0006884 | cell volume homeostasis | 2 | 24 | 3.89e-01 |
| GO:BP | GO:0060916 | mesenchymal cell proliferation involved in lung development | 3 | 5 | 3.89e-01 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 3 | 555 | 3.89e-01 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 8 | 165 | 3.90e-01 |
| GO:BP | GO:0000707 | meiotic DNA recombinase assembly | 1 | 1 | 3.90e-01 |
| GO:BP | GO:0007066 | female meiosis sister chromatid cohesion | 1 | 1 | 3.90e-01 |
| GO:BP | GO:0000050 | urea cycle | 3 | 7 | 3.90e-01 |
| GO:BP | GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 13 | 147 | 3.90e-01 |
| GO:BP | GO:0010447 | response to acidic pH | 2 | 16 | 3.91e-01 |
| GO:BP | GO:0032776 | DNA methylation on cytosine | 2 | 4 | 3.91e-01 |
| GO:BP | GO:0000451 | rRNA 2’-O-methylation | 3 | 3 | 3.91e-01 |
| GO:BP | GO:1990564 | protein polyufmylation | 3 | 5 | 3.91e-01 |
| GO:BP | GO:1990592 | protein K69-linked ufmylation | 3 | 5 | 3.91e-01 |
| GO:BP | GO:1901341 | positive regulation of store-operated calcium channel activity | 2 | 6 | 3.91e-01 |
| GO:BP | GO:2000346 | negative regulation of hepatocyte proliferation | 1 | 3 | 3.92e-01 |
| GO:BP | GO:0030242 | autophagy of peroxisome | 1 | 10 | 3.92e-01 |
| GO:BP | GO:2001205 | negative regulation of osteoclast development | 1 | 2 | 3.92e-01 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 3 | 36 | 3.92e-01 |
| GO:BP | GO:0090520 | sphingolipid mediated signaling pathway | 3 | 11 | 3.92e-01 |
| GO:BP | GO:0033198 | response to ATP | 3 | 24 | 3.92e-01 |
| GO:BP | GO:0021915 | neural tube development | 1 | 146 | 3.92e-01 |
| GO:BP | GO:0008016 | regulation of heart contraction | 52 | 173 | 3.92e-01 |
| GO:BP | GO:0038133 | ERBB2-ERBB3 signaling pathway | 3 | 3 | 3.92e-01 |
| GO:BP | GO:0048672 | positive regulation of collateral sprouting | 4 | 10 | 3.92e-01 |
| GO:BP | GO:0061369 | negative regulation of testicular blood vessel morphogenesis | 1 | 1 | 3.92e-01 |
| GO:BP | GO:2001014 | regulation of skeletal muscle cell differentiation | 4 | 16 | 3.92e-01 |
| GO:BP | GO:0048792 | spontaneous exocytosis of neurotransmitter | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 1 | 198 | 3.92e-01 |
| GO:BP | GO:0042940 | D-amino acid transport | 2 | 5 | 3.92e-01 |
| GO:BP | GO:2000672 | negative regulation of motor neuron apoptotic process | 6 | 10 | 3.92e-01 |
| GO:BP | GO:0044843 | cell cycle G1/S phase transition | 12 | 229 | 3.92e-01 |
| GO:BP | GO:0031948 | positive regulation of glucocorticoid biosynthetic process | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0031945 | positive regulation of glucocorticoid metabolic process | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 11 | 16 | 3.92e-01 |
| GO:BP | GO:0051972 | regulation of telomerase activity | 15 | 45 | 3.92e-01 |
| GO:BP | GO:2000019 | negative regulation of male gonad development | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0044751 | cellular response to human chorionic gonadotropin stimulus | 1 | 2 | 3.92e-01 |
| GO:BP | GO:2000066 | positive regulation of cortisol biosynthetic process | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0034514 | mitochondrial unfolded protein response | 2 | 2 | 3.92e-01 |
| GO:BP | GO:2000180 | negative regulation of androgen biosynthetic process | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 14 | 36 | 3.92e-01 |
| GO:BP | GO:0006817 | phosphate ion transport | 4 | 17 | 3.92e-01 |
| GO:BP | GO:0036503 | ERAD pathway | 4 | 106 | 3.92e-01 |
| GO:BP | GO:0044154 | histone H3-K14 acetylation | 3 | 12 | 3.92e-01 |
| GO:BP | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 1 | 18 | 3.92e-01 |
| GO:BP | GO:0006656 | phosphatidylcholine biosynthetic process | 12 | 25 | 3.92e-01 |
| GO:BP | GO:1904796 | regulation of core promoter binding | 3 | 5 | 3.92e-01 |
| GO:BP | GO:1900407 | regulation of cellular response to oxidative stress | 7 | 67 | 3.92e-01 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 28 | 1119 | 3.92e-01 |
| GO:BP | GO:0007382 | specification of segmental identity, maxillary segment | 1 | 1 | 3.92e-01 |
| GO:BP | GO:0034085 | establishment of sister chromatid cohesion | 8 | 11 | 3.92e-01 |
| GO:BP | GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway | 1 | 38 | 3.92e-01 |
| GO:BP | GO:1905871 | regulation of protein localization to cell leading edge | 1 | 2 | 3.92e-01 |
| GO:BP | GO:0050955 | thermoception | 1 | 3 | 3.92e-01 |
| GO:BP | GO:0086013 | membrane repolarization during cardiac muscle cell action potential | 4 | 18 | 3.92e-01 |
| GO:BP | GO:0003376 | sphingosine-1-phosphate receptor signaling pathway | 1 | 10 | 3.92e-01 |
| GO:BP | GO:0060922 | atrioventricular node cell differentiation | 3 | 4 | 3.93e-01 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 3 | 28 | 3.93e-01 |
| GO:BP | GO:0099188 | postsynaptic cytoskeleton organization | 5 | 14 | 3.93e-01 |
| GO:BP | GO:0003292 | cardiac septum cell differentiation | 3 | 4 | 3.93e-01 |
| GO:BP | GO:0051150 | regulation of smooth muscle cell differentiation | 19 | 28 | 3.93e-01 |
| GO:BP | GO:1904294 | positive regulation of ERAD pathway | 10 | 16 | 3.93e-01 |
| GO:BP | GO:1902306 | negative regulation of sodium ion transmembrane transport | 4 | 10 | 3.93e-01 |
| GO:BP | GO:1901214 | regulation of neuron death | 13 | 246 | 3.93e-01 |
| GO:BP | GO:0060928 | atrioventricular node cell development | 3 | 4 | 3.93e-01 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 1 | 127 | 3.93e-01 |
| GO:BP | GO:0071675 | regulation of mononuclear cell migration | 8 | 71 | 3.93e-01 |
| GO:BP | GO:0016189 | synaptic vesicle to endosome fusion | 1 | 3 | 3.93e-01 |
| GO:BP | GO:0033212 | iron import into cell | 3 | 7 | 3.93e-01 |
| GO:BP | GO:1903313 | positive regulation of mRNA metabolic process | 3 | 121 | 3.93e-01 |
| GO:BP | GO:0060292 | long-term synaptic depression | 3 | 21 | 3.93e-01 |
| GO:BP | GO:1902430 | negative regulation of amyloid-beta formation | 1 | 17 | 3.93e-01 |
| GO:BP | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 3 | 26 | 3.93e-01 |
| GO:BP | GO:0006741 | NADP biosynthetic process | 1 | 2 | 3.93e-01 |
| GO:BP | GO:0031915 | positive regulation of synaptic plasticity | 5 | 6 | 3.93e-01 |
| GO:BP | GO:0001836 | release of cytochrome c from mitochondria | 11 | 47 | 3.93e-01 |
| GO:BP | GO:0032461 | positive regulation of protein oligomerization | 2 | 4 | 3.93e-01 |
| GO:BP | GO:0072173 | metanephric tubule morphogenesis | 3 | 6 | 3.93e-01 |
| GO:BP | GO:0046049 | UMP metabolic process | 2 | 10 | 3.93e-01 |
| GO:BP | GO:1903996 | negative regulation of non-membrane spanning protein tyrosine kinase activity | 1 | 1 | 3.93e-01 |
| GO:BP | GO:0019896 | axonal transport of mitochondrion | 1 | 17 | 3.93e-01 |
| GO:BP | GO:0071839 | apoptotic process in bone marrow cell | 4 | 4 | 3.93e-01 |
| GO:BP | GO:0070102 | interleukin-6-mediated signaling pathway | 10 | 14 | 3.93e-01 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 18 | 27 | 3.93e-01 |
| GO:BP | GO:1990048 | anterograde neuronal dense core vesicle transport | 1 | 4 | 3.93e-01 |
| GO:BP | GO:0090117 | endosome to lysosome transport of low-density lipoprotein particle | 1 | 2 | 3.93e-01 |
| GO:BP | GO:0003129 | heart induction | 4 | 9 | 3.93e-01 |
| GO:BP | GO:0042816 | vitamin B6 metabolic process | 4 | 5 | 3.93e-01 |
| GO:BP | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 1 | 7 | 3.93e-01 |
| GO:BP | GO:0071447 | cellular response to hydroperoxide | 1 | 7 | 3.93e-01 |
| GO:BP | GO:0001649 | osteoblast differentiation | 1 | 179 | 3.93e-01 |
| GO:BP | GO:0014820 | tonic smooth muscle contraction | 2 | 8 | 3.93e-01 |
| GO:BP | GO:0019290 | siderophore biosynthetic process | 1 | 1 | 3.93e-01 |
| GO:BP | GO:2000107 | negative regulation of leukocyte apoptotic process | 1 | 33 | 3.93e-01 |
| GO:BP | GO:0050999 | regulation of nitric-oxide synthase activity | 3 | 25 | 3.93e-01 |
| GO:BP | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process | 3 | 3 | 3.93e-01 |
| GO:BP | GO:0009237 | siderophore metabolic process | 1 | 1 | 3.93e-01 |
| GO:BP | GO:0006003 | fructose 2,6-bisphosphate metabolic process | 1 | 4 | 3.93e-01 |
| GO:BP | GO:1903644 | regulation of chaperone-mediated protein folding | 3 | 3 | 3.93e-01 |
| GO:BP | GO:0034755 | iron ion transmembrane transport | 7 | 16 | 3.93e-01 |
| GO:BP | GO:1904394 | negative regulation of skeletal muscle acetylcholine-gated channel clustering | 1 | 1 | 3.93e-01 |
| GO:BP | GO:0070593 | dendrite self-avoidance | 1 | 11 | 3.93e-01 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 8 | 167 | 3.94e-01 |
| GO:BP | GO:1903434 | negative regulation of constitutive secretory pathway | 1 | 1 | 3.94e-01 |
| GO:BP | GO:1903936 | cellular response to sodium arsenite | 1 | 5 | 3.95e-01 |
| GO:BP | GO:0044030 | regulation of DNA methylation | 4 | 16 | 3.95e-01 |
| GO:BP | GO:0035519 | protein K29-linked ubiquitination | 5 | 6 | 3.95e-01 |
| GO:BP | GO:0019626 | short-chain fatty acid catabolic process | 2 | 6 | 3.95e-01 |
| GO:BP | GO:0006851 | mitochondrial calcium ion transmembrane transport | 1 | 17 | 3.95e-01 |
| GO:BP | GO:0140212 | regulation of long-chain fatty acid import into cell | 3 | 7 | 3.95e-01 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 4 | 23 | 3.95e-01 |
| GO:BP | GO:0032651 | regulation of interleukin-1 beta production | 3 | 48 | 3.95e-01 |
| GO:BP | GO:0032611 | interleukin-1 beta production | 3 | 48 | 3.95e-01 |
| GO:BP | GO:0009597 | detection of virus | 4 | 5 | 3.95e-01 |
| GO:BP | GO:0090168 | Golgi reassembly | 4 | 5 | 3.95e-01 |
| GO:BP | GO:0098974 | postsynaptic actin cytoskeleton organization | 1 | 11 | 3.96e-01 |
| GO:BP | GO:0048844 | artery morphogenesis | 2 | 58 | 3.96e-01 |
| GO:BP | GO:2000974 | negative regulation of pro-B cell differentiation | 2 | 2 | 3.96e-01 |
| GO:BP | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis | 2 | 3 | 3.96e-01 |
| GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 10 | 15 | 3.96e-01 |
| GO:BP | GO:0061436 | establishment of skin barrier | 3 | 18 | 3.96e-01 |
| GO:BP | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 7 | 22 | 3.96e-01 |
| GO:BP | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 1 | 3 | 3.97e-01 |
| GO:BP | GO:0071027 | nuclear RNA surveillance | 3 | 14 | 3.97e-01 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 46 | 174 | 3.97e-01 |
| GO:BP | GO:0032486 | Rap protein signal transduction | 3 | 13 | 3.97e-01 |
| GO:BP | GO:0016078 | tRNA catabolic process | 3 | 14 | 3.97e-01 |
| GO:BP | GO:0051353 | positive regulation of oxidoreductase activity | 9 | 43 | 3.97e-01 |
| GO:BP | GO:0032211 | negative regulation of telomere maintenance via telomerase | 9 | 19 | 3.98e-01 |
| GO:BP | GO:0048568 | embryonic organ development | 1 | 316 | 3.98e-01 |
| GO:BP | GO:0021604 | cranial nerve structural organization | 6 | 8 | 3.98e-01 |
| GO:BP | GO:0003231 | cardiac ventricle development | 3 | 114 | 3.98e-01 |
| GO:BP | GO:0008215 | spermine metabolic process | 3 | 5 | 3.98e-01 |
| GO:BP | GO:0070528 | protein kinase C signaling | 5 | 24 | 3.98e-01 |
| GO:BP | GO:1903402 | regulation of renal phosphate excretion | 1 | 2 | 3.98e-01 |
| GO:BP | GO:0005980 | glycogen catabolic process | 6 | 14 | 3.98e-01 |
| GO:BP | GO:0044722 | renal phosphate excretion | 1 | 2 | 3.98e-01 |
| GO:BP | GO:0006914 | autophagy | 19 | 513 | 3.98e-01 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 1 | 155 | 3.98e-01 |
| GO:BP | GO:0061919 | process utilizing autophagic mechanism | 19 | 513 | 3.98e-01 |
| GO:BP | GO:0032416 | negative regulation of sodium:proton antiporter activity | 1 | 1 | 3.98e-01 |
| GO:BP | GO:0060929 | atrioventricular node cell fate commitment | 2 | 2 | 3.98e-01 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 2 | 665 | 3.98e-01 |
| GO:BP | GO:1903018 | regulation of glycoprotein metabolic process | 3 | 36 | 3.98e-01 |
| GO:BP | GO:0042461 | photoreceptor cell development | 3 | 30 | 3.98e-01 |
| GO:BP | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 6 | 14 | 3.98e-01 |
| GO:BP | GO:0043038 | amino acid activation | 23 | 44 | 3.98e-01 |
| GO:BP | GO:1903670 | regulation of sprouting angiogenesis | 2 | 28 | 3.98e-01 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 3 | 36 | 3.99e-01 |
| GO:BP | GO:0016358 | dendrite development | 13 | 202 | 3.99e-01 |
| GO:BP | GO:1901989 | positive regulation of cell cycle phase transition | 18 | 103 | 3.99e-01 |
| GO:BP | GO:0046753 | non-lytic viral release | 3 | 14 | 3.99e-01 |
| GO:BP | GO:2000106 | regulation of leukocyte apoptotic process | 2 | 57 | 3.99e-01 |
| GO:BP | GO:0048855 | adenohypophysis morphogenesis | 1 | 1 | 3.99e-01 |
| GO:BP | GO:1904381 | Golgi apparatus mannose trimming | 3 | 3 | 3.99e-01 |
| GO:BP | GO:0034729 | histone H3-K79 methylation | 2 | 2 | 3.99e-01 |
| GO:BP | GO:0032048 | cardiolipin metabolic process | 10 | 13 | 4.00e-01 |
| GO:BP | GO:0003064 | regulation of heart rate by hormone | 1 | 2 | 4.00e-01 |
| GO:BP | GO:0046637 | regulation of alpha-beta T cell differentiation | 2 | 38 | 4.00e-01 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 8 | 81 | 4.00e-01 |
| GO:BP | GO:1905031 | regulation of membrane repolarization during cardiac muscle cell action potential | 1 | 3 | 4.00e-01 |
| GO:BP | GO:0060348 | bone development | 1 | 170 | 4.00e-01 |
| GO:BP | GO:0098930 | axonal transport | 6 | 60 | 4.00e-01 |
| GO:BP | GO:0061833 | protein localization to tricellular tight junction | 1 | 2 | 4.01e-01 |
| GO:BP | GO:0033024 | mast cell apoptotic process | 3 | 3 | 4.01e-01 |
| GO:BP | GO:0033025 | regulation of mast cell apoptotic process | 3 | 3 | 4.01e-01 |
| GO:BP | GO:0048290 | isotype switching to IgA isotypes | 1 | 4 | 4.01e-01 |
| GO:BP | GO:0036335 | intestinal stem cell homeostasis | 1 | 3 | 4.01e-01 |
| GO:BP | GO:0061999 | regulation of cardiac endothelial to mesenchymal transition | 1 | 1 | 4.01e-01 |
| GO:BP | GO:1905448 | positive regulation of mitochondrial ATP synthesis coupled electron transport | 1 | 4 | 4.01e-01 |
| GO:BP | GO:0062000 | positive regulation of cardiac endothelial to mesenchymal transition | 1 | 1 | 4.01e-01 |
| GO:BP | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation | 1 | 2 | 4.01e-01 |
| GO:BP | GO:1990314 | cellular response to insulin-like growth factor stimulus | 5 | 8 | 4.01e-01 |
| GO:BP | GO:1903423 | positive regulation of synaptic vesicle recycling | 1 | 6 | 4.01e-01 |
| GO:BP | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification | 1 | 2 | 4.01e-01 |
| GO:BP | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification | 1 | 2 | 4.01e-01 |
| GO:BP | GO:2000041 | negative regulation of planar cell polarity pathway involved in axis elongation | 1 | 2 | 4.01e-01 |
| GO:BP | GO:0046834 | lipid phosphorylation | 1 | 16 | 4.01e-01 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 19 | 49 | 4.01e-01 |
| GO:BP | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification | 1 | 2 | 4.01e-01 |
| GO:BP | GO:0014706 | striated muscle tissue development | 1 | 210 | 4.01e-01 |
| GO:BP | GO:0044343 | canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation | 1 | 1 | 4.01e-01 |
| GO:BP | GO:2000079 | regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation | 1 | 1 | 4.01e-01 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 3 | 47 | 4.01e-01 |
| GO:BP | GO:0048246 | macrophage chemotaxis | 3 | 21 | 4.01e-01 |
| GO:BP | GO:0043507 | positive regulation of JUN kinase activity | 3 | 34 | 4.01e-01 |
| GO:BP | GO:0034472 | snRNA 3’-end processing | 5 | 21 | 4.01e-01 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 5 | 56 | 4.02e-01 |
| GO:BP | GO:0061217 | regulation of mesonephros development | 1 | 2 | 4.02e-01 |
| GO:BP | GO:0060065 | uterus development | 3 | 13 | 4.02e-01 |
| GO:BP | GO:0055011 | atrial cardiac muscle cell differentiation | 3 | 3 | 4.02e-01 |
| GO:BP | GO:0110051 | metabolite repair | 1 | 1 | 4.02e-01 |
| GO:BP | GO:0055014 | atrial cardiac muscle cell development | 3 | 3 | 4.02e-01 |
| GO:BP | GO:0046985 | positive regulation of hemoglobin biosynthetic process | 4 | 6 | 4.02e-01 |
| GO:BP | GO:0019751 | polyol metabolic process | 7 | 82 | 4.02e-01 |
| GO:BP | GO:0070318 | positive regulation of G0 to G1 transition | 1 | 5 | 4.02e-01 |
| GO:BP | GO:0071696 | ectodermal placode development | 7 | 11 | 4.03e-01 |
| GO:BP | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region | 2 | 2 | 4.03e-01 |
| GO:BP | GO:0051053 | negative regulation of DNA metabolic process | 5 | 112 | 4.03e-01 |
| GO:BP | GO:0090335 | regulation of brown fat cell differentiation | 10 | 17 | 4.03e-01 |
| GO:BP | GO:0051898 | negative regulation of protein kinase B signaling | 13 | 36 | 4.03e-01 |
| GO:BP | GO:0003032 | detection of oxygen | 2 | 5 | 4.03e-01 |
| GO:BP | GO:0032543 | mitochondrial translation | 31 | 130 | 4.03e-01 |
| GO:BP | GO:1903205 | regulation of hydrogen peroxide-induced cell death | 3 | 20 | 4.04e-01 |
| GO:BP | GO:1900222 | negative regulation of amyloid-beta clearance | 6 | 7 | 4.04e-01 |
| GO:BP | GO:1905934 | negative regulation of cell fate determination | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 3 | 282 | 4.04e-01 |
| GO:BP | GO:0061106 | negative regulation of stomach neuroendocrine cell differentiation | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0046684 | response to pyrethroid | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0044091 | membrane biogenesis | 4 | 58 | 4.04e-01 |
| GO:BP | GO:0051661 | maintenance of centrosome location | 2 | 6 | 4.04e-01 |
| GO:BP | GO:1902369 | negative regulation of RNA catabolic process | 4 | 69 | 4.04e-01 |
| GO:BP | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 5 | 13 | 4.04e-01 |
| GO:BP | GO:0045618 | positive regulation of keratinocyte differentiation | 10 | 12 | 4.04e-01 |
| GO:BP | GO:0061105 | regulation of stomach neuroendocrine cell differentiation | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0009057 | macromolecule catabolic process | 44 | 1199 | 4.04e-01 |
| GO:BP | GO:0042401 | biogenic amine biosynthetic process | 3 | 24 | 4.04e-01 |
| GO:BP | GO:0006163 | purine nucleotide metabolic process | 9 | 371 | 4.04e-01 |
| GO:BP | GO:2000227 | negative regulation of pancreatic A cell differentiation | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0003357 | noradrenergic neuron differentiation | 2 | 7 | 4.04e-01 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 9 | 39 | 4.04e-01 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 2 | 246 | 4.04e-01 |
| GO:BP | GO:2000226 | regulation of pancreatic A cell differentiation | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0045977 | positive regulation of mitotic cell cycle, embryonic | 1 | 1 | 4.04e-01 |
| GO:BP | GO:0140115 | export across plasma membrane | 1 | 46 | 4.04e-01 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 7 | 100 | 4.04e-01 |
| GO:BP | GO:2000404 | regulation of T cell migration | 4 | 28 | 4.04e-01 |
| GO:BP | GO:2000397 | positive regulation of ubiquitin-dependent endocytosis | 2 | 2 | 4.05e-01 |
| GO:BP | GO:0072014 | proximal tubule development | 1 | 7 | 4.05e-01 |
| GO:BP | GO:0032364 | intracellular oxygen homeostasis | 1 | 6 | 4.05e-01 |
| GO:BP | GO:1903975 | regulation of glial cell migration | 2 | 12 | 4.05e-01 |
| GO:BP | GO:1902415 | regulation of mRNA binding | 6 | 10 | 4.05e-01 |
| GO:BP | GO:2000395 | regulation of ubiquitin-dependent endocytosis | 2 | 2 | 4.05e-01 |
| GO:BP | GO:0009992 | intracellular water homeostasis | 1 | 3 | 4.05e-01 |
| GO:BP | GO:0006417 | regulation of translation | 9 | 370 | 4.05e-01 |
| GO:BP | GO:2000620 | positive regulation of histone H4-K16 acetylation | 2 | 2 | 4.05e-01 |
| GO:BP | GO:0032203 | telomere formation via telomerase | 1 | 1 | 4.05e-01 |
| GO:BP | GO:0034337 | RNA folding | 1 | 1 | 4.05e-01 |
| GO:BP | GO:0048245 | eosinophil chemotaxis | 1 | 5 | 4.05e-01 |
| GO:BP | GO:0060754 | positive regulation of mast cell chemotaxis | 1 | 5 | 4.05e-01 |
| GO:BP | GO:1901626 | regulation of postsynaptic membrane organization | 1 | 2 | 4.05e-01 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 20 | 35 | 4.05e-01 |
| GO:BP | GO:0009175 | pyrimidine ribonucleoside monophosphate catabolic process | 1 | 4 | 4.05e-01 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 37 | 65 | 4.05e-01 |
| GO:BP | GO:0046079 | dUMP catabolic process | 1 | 4 | 4.05e-01 |
| GO:BP | GO:0106027 | neuron projection organization | 6 | 76 | 4.05e-01 |
| GO:BP | GO:0019878 | lysine biosynthetic process via aminoadipic acid | 2 | 2 | 4.05e-01 |
| GO:BP | GO:0051601 | exocyst localization | 4 | 4 | 4.05e-01 |
| GO:BP | GO:0032262 | pyrimidine nucleotide salvage | 1 | 4 | 4.05e-01 |
| GO:BP | GO:0072330 | monocarboxylic acid biosynthetic process | 4 | 145 | 4.05e-01 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 20 | 35 | 4.05e-01 |
| GO:BP | GO:0010138 | pyrimidine ribonucleotide salvage | 1 | 4 | 4.05e-01 |
| GO:BP | GO:0140495 | migracytosis | 1 | 3 | 4.05e-01 |
| GO:BP | GO:0046063 | dCMP metabolic process | 1 | 3 | 4.05e-01 |
| GO:BP | GO:1900247 | regulation of cytoplasmic translational elongation | 7 | 10 | 4.05e-01 |
| GO:BP | GO:0160040 | mitocytosis | 1 | 3 | 4.05e-01 |
| GO:BP | GO:0006249 | dCMP catabolic process | 1 | 3 | 4.05e-01 |
| GO:BP | GO:0032786 | positive regulation of DNA-templated transcription, elongation | 27 | 58 | 4.05e-01 |
| GO:BP | GO:0044206 | UMP salvage | 1 | 4 | 4.05e-01 |
| GO:BP | GO:0009132 | nucleoside diphosphate metabolic process | 4 | 32 | 4.05e-01 |
| GO:BP | GO:0009085 | lysine biosynthetic process | 2 | 2 | 4.05e-01 |
| GO:BP | GO:0003307 | regulation of Wnt signaling pathway involved in heart development | 3 | 7 | 4.05e-01 |
| GO:BP | GO:0032727 | positive regulation of interferon-alpha production | 1 | 17 | 4.05e-01 |
| GO:BP | GO:0035458 | cellular response to interferon-beta | 1 | 15 | 4.05e-01 |
| GO:BP | GO:0070198 | protein localization to chromosome, telomeric region | 10 | 30 | 4.05e-01 |
| GO:BP | GO:2000493 | negative regulation of interleukin-18-mediated signaling pathway | 1 | 1 | 4.07e-01 |
| GO:BP | GO:0051642 | centrosome localization | 17 | 31 | 4.07e-01 |
| GO:BP | GO:0061842 | microtubule organizing center localization | 17 | 31 | 4.07e-01 |
| GO:BP | GO:0019441 | tryptophan catabolic process to kynurenine | 1 | 1 | 4.07e-01 |
| GO:BP | GO:1905898 | positive regulation of response to endoplasmic reticulum stress | 22 | 34 | 4.07e-01 |
| GO:BP | GO:0019240 | citrulline biosynthetic process | 3 | 4 | 4.07e-01 |
| GO:BP | GO:0071277 | cellular response to calcium ion | 6 | 67 | 4.07e-01 |
| GO:BP | GO:0048769 | sarcomerogenesis | 3 | 3 | 4.07e-01 |
| GO:BP | GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 4 | 6 | 4.07e-01 |
| GO:BP | GO:1902389 | ceramide 1-phosphate transport | 2 | 7 | 4.08e-01 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 1 | 107 | 4.08e-01 |
| GO:BP | GO:2000822 | regulation of behavioral fear response | 1 | 7 | 4.08e-01 |
| GO:BP | GO:1901889 | negative regulation of cell junction assembly | 9 | 24 | 4.08e-01 |
| GO:BP | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway | 2 | 4 | 4.08e-01 |
| GO:BP | GO:0043628 | regulatory ncRNA 3’-end processing | 12 | 19 | 4.08e-01 |
| GO:BP | GO:0060073 | micturition | 1 | 2 | 4.08e-01 |
| GO:BP | GO:0043697 | cell dedifferentiation | 2 | 6 | 4.08e-01 |
| GO:BP | GO:0043696 | dedifferentiation | 2 | 6 | 4.08e-01 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 16 | 4955 | 4.08e-01 |
| GO:BP | GO:0062232 | prostanoid catabolic process | 1 | 2 | 4.08e-01 |
| GO:BP | GO:0048147 | negative regulation of fibroblast proliferation | 4 | 31 | 4.08e-01 |
| GO:BP | GO:1905344 | prostaglandin catabolic process | 1 | 2 | 4.08e-01 |
| GO:BP | GO:0006203 | dGTP catabolic process | 2 | 2 | 4.08e-01 |
| GO:BP | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 3 | 3 | 4.08e-01 |
| GO:BP | GO:0070944 | neutrophil-mediated killing of bacterium | 1 | 3 | 4.08e-01 |
| GO:BP | GO:1904425 | negative regulation of GTP binding | 3 | 3 | 4.08e-01 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 1 | 156 | 4.09e-01 |
| GO:BP | GO:0033059 | cellular pigmentation | 10 | 58 | 4.09e-01 |
| GO:BP | GO:0090559 | regulation of membrane permeability | 11 | 64 | 4.09e-01 |
| GO:BP | GO:0072757 | cellular response to camptothecin | 2 | 4 | 4.09e-01 |
| GO:BP | GO:1904407 | positive regulation of nitric oxide metabolic process | 3 | 27 | 4.09e-01 |
| GO:BP | GO:0009070 | serine family amino acid biosynthetic process | 6 | 16 | 4.09e-01 |
| GO:BP | GO:0045578 | negative regulation of B cell differentiation | 3 | 6 | 4.10e-01 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 11 | 27 | 4.10e-01 |
| GO:BP | GO:0072414 | response to mitotic cell cycle checkpoint signaling | 1 | 1 | 4.10e-01 |
| GO:BP | GO:0031099 | regeneration | 1 | 142 | 4.10e-01 |
| GO:BP | GO:0046511 | sphinganine biosynthetic process | 2 | 2 | 4.10e-01 |
| GO:BP | GO:0072432 | response to G1 DNA damage checkpoint signaling | 1 | 1 | 4.10e-01 |
| GO:BP | GO:0009081 | branched-chain amino acid metabolic process | 17 | 26 | 4.10e-01 |
| GO:BP | GO:0003057 | regulation of the force of heart contraction by chemical signal | 3 | 5 | 4.10e-01 |
| GO:BP | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis | 2 | 3 | 4.10e-01 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 2 | 529 | 4.11e-01 |
| GO:BP | GO:0043524 | negative regulation of neuron apoptotic process | 24 | 120 | 4.11e-01 |
| GO:BP | GO:0051081 | nuclear membrane disassembly | 1 | 10 | 4.11e-01 |
| GO:BP | GO:0031441 | negative regulation of mRNA 3’-end processing | 1 | 2 | 4.11e-01 |
| GO:BP | GO:0048308 | organelle inheritance | 10 | 15 | 4.11e-01 |
| GO:BP | GO:0048313 | Golgi inheritance | 10 | 15 | 4.11e-01 |
| GO:BP | GO:0071241 | cellular response to inorganic substance | 30 | 164 | 4.11e-01 |
| GO:BP | GO:0008216 | spermidine metabolic process | 4 | 7 | 4.11e-01 |
| GO:BP | GO:0106074 | aminoacyl-tRNA metabolism involved in translational fidelity | 3 | 11 | 4.11e-01 |
| GO:BP | GO:1904219 | positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity | 1 | 2 | 4.12e-01 |
| GO:BP | GO:1904222 | positive regulation of serine C-palmitoyltransferase activity | 1 | 2 | 4.12e-01 |
| GO:BP | GO:0006657 | CDP-choline pathway | 4 | 6 | 4.12e-01 |
| GO:BP | GO:0043951 | negative regulation of cAMP-mediated signaling | 1 | 10 | 4.12e-01 |
| GO:BP | GO:0062098 | regulation of programmed necrotic cell death | 13 | 26 | 4.12e-01 |
| GO:BP | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity | 1 | 2 | 4.12e-01 |
| GO:BP | GO:0019430 | removal of superoxide radicals | 2 | 17 | 4.12e-01 |
| GO:BP | GO:0071300 | cellular response to retinoic acid | 4 | 49 | 4.12e-01 |
| GO:BP | GO:0032915 | positive regulation of transforming growth factor beta2 production | 2 | 3 | 4.12e-01 |
| GO:BP | GO:0006040 | amino sugar metabolic process | 1 | 33 | 4.12e-01 |
| GO:BP | GO:1905065 | positive regulation of vascular associated smooth muscle cell differentiation | 3 | 6 | 4.12e-01 |
| GO:BP | GO:0010259 | multicellular organism aging | 4 | 16 | 4.12e-01 |
| GO:BP | GO:0035385 | Roundabout signaling pathway | 3 | 5 | 4.12e-01 |
| GO:BP | GO:1904482 | cellular response to tetrahydrofolate | 1 | 1 | 4.12e-01 |
| GO:BP | GO:1904481 | response to tetrahydrofolate | 1 | 1 | 4.12e-01 |
| GO:BP | GO:0036018 | cellular response to erythropoietin | 3 | 4 | 4.12e-01 |
| GO:BP | GO:0009309 | amine biosynthetic process | 3 | 25 | 4.12e-01 |
| GO:BP | GO:0030842 | regulation of intermediate filament depolymerization | 1 | 1 | 4.12e-01 |
| GO:BP | GO:0030844 | positive regulation of intermediate filament depolymerization | 1 | 1 | 4.12e-01 |
| GO:BP | GO:0045106 | intermediate filament depolymerization | 1 | 1 | 4.12e-01 |
| GO:BP | GO:0051338 | regulation of transferase activity | 6 | 679 | 4.12e-01 |
| GO:BP | GO:0045108 | regulation of intermediate filament polymerization or depolymerization | 1 | 1 | 4.12e-01 |
| GO:BP | GO:0099627 | neurotransmitter receptor cycle | 1 | 1 | 4.12e-01 |
| GO:BP | GO:1903311 | regulation of mRNA metabolic process | 5 | 267 | 4.12e-01 |
| GO:BP | GO:0099630 | postsynaptic neurotransmitter receptor cycle | 1 | 1 | 4.12e-01 |
| GO:BP | GO:0046898 | response to cycloheximide | 4 | 4 | 4.12e-01 |
| GO:BP | GO:0042640 | anagen | 1 | 5 | 4.13e-01 |
| GO:BP | GO:2000322 | regulation of glucocorticoid receptor signaling pathway | 2 | 7 | 4.13e-01 |
| GO:BP | GO:0003167 | atrioventricular bundle cell differentiation | 3 | 3 | 4.13e-01 |
| GO:BP | GO:0007035 | vacuolar acidification | 1 | 30 | 4.13e-01 |
| GO:BP | GO:0014038 | regulation of Schwann cell differentiation | 1 | 3 | 4.13e-01 |
| GO:BP | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1 | 4 | 4.13e-01 |
| GO:BP | GO:0060744 | mammary gland branching involved in thelarche | 1 | 5 | 4.13e-01 |
| GO:BP | GO:0042695 | thelarche | 1 | 5 | 4.13e-01 |
| GO:BP | GO:0003007 | heart morphogenesis | 1 | 216 | 4.13e-01 |
| GO:BP | GO:0051107 | negative regulation of DNA ligation | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0010941 | regulation of cell death | 50 | 1219 | 4.13e-01 |
| GO:BP | GO:0045876 | positive regulation of sister chromatid cohesion | 1 | 8 | 4.13e-01 |
| GO:BP | GO:2000401 | regulation of lymphocyte migration | 5 | 41 | 4.13e-01 |
| GO:BP | GO:0007263 | nitric oxide mediated signal transduction | 3 | 20 | 4.13e-01 |
| GO:BP | GO:1901163 | regulation of trophoblast cell migration | 2 | 12 | 4.13e-01 |
| GO:BP | GO:0071421 | manganese ion transmembrane transport | 3 | 7 | 4.13e-01 |
| GO:BP | GO:0050906 | detection of stimulus involved in sensory perception | 1 | 39 | 4.13e-01 |
| GO:BP | GO:0031644 | regulation of nervous system process | 7 | 90 | 4.13e-01 |
| GO:BP | GO:0060751 | branch elongation involved in mammary gland duct branching | 1 | 4 | 4.13e-01 |
| GO:BP | GO:0060029 | convergent extension involved in organogenesis | 1 | 5 | 4.13e-01 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 7 | 111 | 4.13e-01 |
| GO:BP | GO:0001774 | microglial cell activation | 2 | 19 | 4.13e-01 |
| GO:BP | GO:0021534 | cell proliferation in hindbrain | 1 | 12 | 4.13e-01 |
| GO:BP | GO:0034182 | regulation of maintenance of mitotic sister chromatid cohesion | 1 | 8 | 4.13e-01 |
| GO:BP | GO:1904876 | negative regulation of DNA ligase activity | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0006828 | manganese ion transport | 3 | 7 | 4.13e-01 |
| GO:BP | GO:0050872 | white fat cell differentiation | 1 | 15 | 4.13e-01 |
| GO:BP | GO:1903645 | negative regulation of chaperone-mediated protein folding | 2 | 2 | 4.13e-01 |
| GO:BP | GO:0034091 | regulation of maintenance of sister chromatid cohesion | 1 | 8 | 4.13e-01 |
| GO:BP | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 1 | 4 | 4.13e-01 |
| GO:BP | GO:0010046 | response to mycotoxin | 3 | 3 | 4.13e-01 |
| GO:BP | GO:0009826 | unidimensional cell growth | 2 | 3 | 4.13e-01 |
| GO:BP | GO:0046827 | positive regulation of protein export from nucleus | 4 | 15 | 4.13e-01 |
| GO:BP | GO:0006391 | transcription initiation at mitochondrial promoter | 3 | 4 | 4.13e-01 |
| GO:BP | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 5 | 7 | 4.13e-01 |
| GO:BP | GO:0042942 | D-serine transport | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0021930 | cerebellar granule cell precursor proliferation | 1 | 12 | 4.13e-01 |
| GO:BP | GO:0032079 | positive regulation of endodeoxyribonuclease activity | 2 | 4 | 4.13e-01 |
| GO:BP | GO:0003264 | regulation of cardioblast proliferation | 4 | 9 | 4.13e-01 |
| GO:BP | GO:0021924 | cell proliferation in external granule layer | 1 | 12 | 4.13e-01 |
| GO:BP | GO:0051884 | regulation of timing of anagen | 1 | 5 | 4.13e-01 |
| GO:BP | GO:0021569 | rhombomere 3 development | 1 | 2 | 4.13e-01 |
| GO:BP | GO:0097325 | melanocyte proliferation | 1 | 2 | 4.13e-01 |
| GO:BP | GO:0035863 | dITP catabolic process | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0003263 | cardioblast proliferation | 4 | 9 | 4.13e-01 |
| GO:BP | GO:0035847 | uterine epithelium development | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0097379 | dorsal spinal cord interneuron posterior axon guidance | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0035862 | dITP metabolic process | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0035849 | nephric duct elongation | 1 | 1 | 4.13e-01 |
| GO:BP | GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 3 | 4 | 4.13e-01 |
| GO:BP | GO:1901874 | negative regulation of post-translational protein modification | 1 | 4 | 4.13e-01 |
| GO:BP | GO:0044320 | cellular response to leptin stimulus | 2 | 15 | 4.13e-01 |
| GO:BP | GO:1903909 | regulation of receptor clustering | 2 | 12 | 4.13e-01 |
| GO:BP | GO:2000178 | negative regulation of neural precursor cell proliferation | 2 | 21 | 4.13e-01 |
| GO:BP | GO:0042133 | neurotransmitter metabolic process | 1 | 18 | 4.13e-01 |
| GO:BP | GO:0048670 | regulation of collateral sprouting | 9 | 18 | 4.14e-01 |
| GO:BP | GO:1902992 | negative regulation of amyloid precursor protein catabolic process | 1 | 20 | 4.14e-01 |
| GO:BP | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation | 8 | 13 | 4.14e-01 |
| GO:BP | GO:0061635 | regulation of protein complex stability | 1 | 11 | 4.14e-01 |
| GO:BP | GO:0060134 | prepulse inhibition | 1 | 7 | 4.14e-01 |
| GO:BP | GO:1900077 | negative regulation of cellular response to insulin stimulus | 10 | 31 | 4.14e-01 |
| GO:BP | GO:0071287 | cellular response to manganese ion | 1 | 8 | 4.14e-01 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 2 | 541 | 4.14e-01 |
| GO:BP | GO:0034605 | cellular response to heat | 3 | 51 | 4.14e-01 |
| GO:BP | GO:0090009 | primitive streak formation | 3 | 5 | 4.15e-01 |
| GO:BP | GO:0071372 | cellular response to follicle-stimulating hormone stimulus | 2 | 9 | 4.16e-01 |
| GO:BP | GO:2000649 | regulation of sodium ion transmembrane transporter activity | 4 | 44 | 4.16e-01 |
| GO:BP | GO:0044375 | regulation of peroxisome size | 3 | 3 | 4.16e-01 |
| GO:BP | GO:0038138 | ERBB4-ERBB4 signaling pathway | 3 | 3 | 4.17e-01 |
| GO:BP | GO:0015675 | nickel cation transport | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0035444 | nickel cation transmembrane transport | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0015676 | vanadium ion transport | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0007215 | glutamate receptor signaling pathway | 2 | 29 | 4.17e-01 |
| GO:BP | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation | 2 | 25 | 4.17e-01 |
| GO:BP | GO:0017055 | negative regulation of RNA polymerase II transcription preinitiation complex assembly | 2 | 2 | 4.17e-01 |
| GO:BP | GO:0060035 | notochord cell development | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0030954 | astral microtubule nucleation | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0036475 | neuron death in response to oxidative stress | 7 | 28 | 4.17e-01 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 2 | 755 | 4.17e-01 |
| GO:BP | GO:1905936 | regulation of germ cell proliferation | 3 | 5 | 4.17e-01 |
| GO:BP | GO:1904636 | response to ionomycin | 1 | 3 | 4.17e-01 |
| GO:BP | GO:1904637 | cellular response to ionomycin | 1 | 3 | 4.17e-01 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 2 | 16 | 4.17e-01 |
| GO:BP | GO:0016445 | somatic diversification of immunoglobulins | 3 | 53 | 4.17e-01 |
| GO:BP | GO:0006469 | negative regulation of protein kinase activity | 36 | 179 | 4.17e-01 |
| GO:BP | GO:0006825 | copper ion transport | 1 | 13 | 4.17e-01 |
| GO:BP | GO:1903978 | regulation of microglial cell activation | 1 | 9 | 4.17e-01 |
| GO:BP | GO:0010967 | regulation of polyamine biosynthetic process | 2 | 2 | 4.17e-01 |
| GO:BP | GO:0046323 | glucose import | 1 | 53 | 4.17e-01 |
| GO:BP | GO:0060689 | cell differentiation involved in salivary gland development | 2 | 2 | 4.17e-01 |
| GO:BP | GO:0043393 | regulation of protein binding | 1 | 172 | 4.17e-01 |
| GO:BP | GO:1905474 | canonical Wnt signaling pathway involved in stem cell proliferation | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0051415 | microtubule nucleation by interphase microtubule organizing center | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0060064 | Spemann organizer formation at the anterior end of the primitive streak | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0072223 | metanephric glomerular mesangium development | 2 | 3 | 4.17e-01 |
| GO:BP | GO:0010750 | positive regulation of nitric oxide mediated signal transduction | 1 | 4 | 4.17e-01 |
| GO:BP | GO:0051548 | negative regulation of keratinocyte migration | 2 | 2 | 4.17e-01 |
| GO:BP | GO:0032423 | regulation of mismatch repair | 3 | 3 | 4.17e-01 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 33 | 678 | 4.17e-01 |
| GO:BP | GO:0023041 | neuronal signal transduction | 1 | 6 | 4.17e-01 |
| GO:BP | GO:0019075 | virus maturation | 1 | 2 | 4.17e-01 |
| GO:BP | GO:0001759 | organ induction | 2 | 17 | 4.17e-01 |
| GO:BP | GO:0045105 | intermediate filament polymerization or depolymerization | 2 | 2 | 4.17e-01 |
| GO:BP | GO:0015692 | lead ion transport | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0060034 | notochord cell differentiation | 1 | 1 | 4.17e-01 |
| GO:BP | GO:0071318 | cellular response to ATP | 2 | 12 | 4.18e-01 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 40 | 300 | 4.18e-01 |
| GO:BP | GO:0048741 | skeletal muscle fiber development | 1 | 30 | 4.18e-01 |
| GO:BP | GO:0086036 | regulation of cardiac muscle cell membrane potential | 1 | 7 | 4.18e-01 |
| GO:BP | GO:0097104 | postsynaptic membrane assembly | 2 | 8 | 4.18e-01 |
| GO:BP | GO:0030208 | dermatan sulfate biosynthetic process | 2 | 5 | 4.18e-01 |
| GO:BP | GO:0050728 | negative regulation of inflammatory response | 5 | 87 | 4.18e-01 |
| GO:BP | GO:0032933 | SREBP signaling pathway | 9 | 14 | 4.18e-01 |
| GO:BP | GO:1902897 | regulation of postsynaptic density protein 95 clustering | 1 | 2 | 4.19e-01 |
| GO:BP | GO:0009648 | photoperiodism | 15 | 28 | 4.19e-01 |
| GO:BP | GO:0010808 | positive regulation of synaptic vesicle priming | 1 | 1 | 4.19e-01 |
| GO:BP | GO:1903301 | positive regulation of hexokinase activity | 1 | 5 | 4.19e-01 |
| GO:BP | GO:0043456 | regulation of pentose-phosphate shunt | 1 | 6 | 4.19e-01 |
| GO:BP | GO:0009099 | valine biosynthetic process | 2 | 3 | 4.19e-01 |
| GO:BP | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 3 | 17 | 4.19e-01 |
| GO:BP | GO:0031643 | positive regulation of myelination | 4 | 12 | 4.20e-01 |
| GO:BP | GO:0098904 | regulation of AV node cell action potential | 1 | 3 | 4.20e-01 |
| GO:BP | GO:0051054 | positive regulation of DNA metabolic process | 28 | 265 | 4.20e-01 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 11 | 401 | 4.20e-01 |
| GO:BP | GO:2000300 | regulation of synaptic vesicle exocytosis | 2 | 35 | 4.20e-01 |
| GO:BP | GO:0097722 | sperm motility | 1 | 61 | 4.20e-01 |
| GO:BP | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione | 3 | 4 | 4.20e-01 |
| GO:BP | GO:0070943 | neutrophil-mediated killing of symbiont cell | 1 | 3 | 4.20e-01 |
| GO:BP | GO:0010623 | programmed cell death involved in cell development | 1 | 13 | 4.20e-01 |
| GO:BP | GO:0014856 | skeletal muscle cell proliferation | 4 | 14 | 4.20e-01 |
| GO:BP | GO:0140374 | antiviral innate immune response | 13 | 17 | 4.20e-01 |
| GO:BP | GO:1904951 | positive regulation of establishment of protein localization | 1 | 258 | 4.20e-01 |
| GO:BP | GO:0070935 | 3’-UTR-mediated mRNA stabilization | 1 | 19 | 4.20e-01 |
| GO:BP | GO:1903935 | response to sodium arsenite | 1 | 6 | 4.20e-01 |
| GO:BP | GO:0006500 | N-terminal protein palmitoylation | 2 | 3 | 4.20e-01 |
| GO:BP | GO:0030317 | flagellated sperm motility | 1 | 61 | 4.20e-01 |
| GO:BP | GO:0010610 | regulation of mRNA stability involved in response to stress | 3 | 3 | 4.20e-01 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2 | 26 | 4.20e-01 |
| GO:BP | GO:0009097 | isoleucine biosynthetic process | 1 | 2 | 4.20e-01 |
| GO:BP | GO:1901585 | regulation of acid-sensing ion channel activity | 1 | 1 | 4.20e-01 |
| GO:BP | GO:1904181 | positive regulation of membrane depolarization | 3 | 8 | 4.20e-01 |
| GO:BP | GO:1903365 | regulation of fear response | 1 | 8 | 4.20e-01 |
| GO:BP | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 10 | 42 | 4.20e-01 |
| GO:BP | GO:0021855 | hypothalamus cell migration | 5 | 6 | 4.20e-01 |
| GO:BP | GO:0045921 | positive regulation of exocytosis | 3 | 62 | 4.20e-01 |
| GO:BP | GO:0071025 | RNA surveillance | 1 | 16 | 4.21e-01 |
| GO:BP | GO:0036294 | cellular response to decreased oxygen levels | 8 | 131 | 4.21e-01 |
| GO:BP | GO:0003014 | renal system process | 10 | 78 | 4.21e-01 |
| GO:BP | GO:1905456 | regulation of lymphoid progenitor cell differentiation | 5 | 10 | 4.21e-01 |
| GO:BP | GO:0008052 | sensory organ boundary specification | 1 | 1 | 4.21e-01 |
| GO:BP | GO:0021698 | cerebellar cortex structural organization | 1 | 2 | 4.21e-01 |
| GO:BP | GO:0030888 | regulation of B cell proliferation | 1 | 35 | 4.21e-01 |
| GO:BP | GO:0021895 | cerebral cortex neuron differentiation | 3 | 14 | 4.21e-01 |
| GO:BP | GO:0021693 | cerebellar Purkinje cell layer structural organization | 1 | 2 | 4.21e-01 |
| GO:BP | GO:0032787 | monocarboxylic acid metabolic process | 3 | 433 | 4.21e-01 |
| GO:BP | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity | 1 | 23 | 4.21e-01 |
| GO:BP | GO:0061193 | taste bud development | 1 | 1 | 4.21e-01 |
| GO:BP | GO:0060333 | type II interferon-mediated signaling pathway | 1 | 21 | 4.21e-01 |
| GO:BP | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 18 | 35 | 4.21e-01 |
| GO:BP | GO:0045913 | positive regulation of carbohydrate metabolic process | 1 | 60 | 4.21e-01 |
| GO:BP | GO:0010650 | positive regulation of cell communication by electrical coupling | 2 | 3 | 4.21e-01 |
| GO:BP | GO:0033979 | box H/ACA RNA metabolic process | 2 | 3 | 4.21e-01 |
| GO:BP | GO:0010160 | formation of animal organ boundary | 1 | 1 | 4.21e-01 |
| GO:BP | GO:0010830 | regulation of myotube differentiation | 1 | 31 | 4.21e-01 |
| GO:BP | GO:0031120 | snRNA pseudouridine synthesis | 2 | 3 | 4.21e-01 |
| GO:BP | GO:0002328 | pro-B cell differentiation | 5 | 10 | 4.21e-01 |
| GO:BP | GO:0016925 | protein sumoylation | 12 | 59 | 4.21e-01 |
| GO:BP | GO:0140469 | GCN2-mediated signaling | 3 | 3 | 4.21e-01 |
| GO:BP | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells | 1 | 4 | 4.21e-01 |
| GO:BP | GO:0072207 | metanephric epithelium development | 2 | 16 | 4.21e-01 |
| GO:BP | GO:1904044 | response to aldosterone | 3 | 9 | 4.21e-01 |
| GO:BP | GO:0010917 | negative regulation of mitochondrial membrane potential | 1 | 9 | 4.21e-01 |
| GO:BP | GO:0045837 | negative regulation of membrane potential | 1 | 9 | 4.21e-01 |
| GO:BP | GO:0043558 | regulation of translational initiation in response to stress | 2 | 16 | 4.21e-01 |
| GO:BP | GO:0046683 | response to organophosphorus | 4 | 96 | 4.21e-01 |
| GO:BP | GO:0006591 | ornithine metabolic process | 1 | 6 | 4.21e-01 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 13 | 35 | 4.21e-01 |
| GO:BP | GO:0007494 | midgut development | 5 | 7 | 4.21e-01 |
| GO:BP | GO:0097421 | liver regeneration | 5 | 23 | 4.22e-01 |
| GO:BP | GO:0006337 | nucleosome disassembly | 1 | 16 | 4.22e-01 |
| GO:BP | GO:0046165 | alcohol biosynthetic process | 7 | 110 | 4.22e-01 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 3 | 39 | 4.22e-01 |
| GO:BP | GO:0030223 | neutrophil differentiation | 3 | 8 | 4.22e-01 |
| GO:BP | GO:0061448 | connective tissue development | 1 | 208 | 4.22e-01 |
| GO:BP | GO:0030397 | membrane disassembly | 1 | 11 | 4.22e-01 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 27 | 45 | 4.22e-01 |
| GO:BP | GO:0006829 | zinc ion transport | 6 | 23 | 4.22e-01 |
| GO:BP | GO:0021683 | cerebellar granular layer morphogenesis | 2 | 8 | 4.22e-01 |
| GO:BP | GO:0006352 | DNA-templated transcription initiation | 1 | 130 | 4.22e-01 |
| GO:BP | GO:0001906 | cell killing | 3 | 69 | 4.22e-01 |
| GO:BP | GO:0033026 | negative regulation of mast cell apoptotic process | 1 | 1 | 4.22e-01 |
| GO:BP | GO:1903800 | positive regulation of miRNA processing | 3 | 3 | 4.22e-01 |
| GO:BP | GO:0060926 | cardiac pacemaker cell development | 5 | 8 | 4.22e-01 |
| GO:BP | GO:1903898 | negative regulation of PERK-mediated unfolded protein response | 3 | 6 | 4.22e-01 |
| GO:BP | GO:2000773 | negative regulation of cellular senescence | 8 | 19 | 4.22e-01 |
| GO:BP | GO:0095500 | acetylcholine receptor signaling pathway | 1 | 18 | 4.22e-01 |
| GO:BP | GO:0072190 | ureter urothelium development | 3 | 3 | 4.22e-01 |
| GO:BP | GO:0002545 | chronic inflammatory response to non-antigenic stimulus | 1 | 1 | 4.22e-01 |
| GO:BP | GO:0002880 | regulation of chronic inflammatory response to non-antigenic stimulus | 1 | 1 | 4.22e-01 |
| GO:BP | GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 1 | 1 | 4.22e-01 |
| GO:BP | GO:0101030 | tRNA-guanine transglycosylation | 2 | 2 | 4.22e-01 |
| GO:BP | GO:1902068 | regulation of sphingolipid mediated signaling pathway | 1 | 1 | 4.23e-01 |
| GO:BP | GO:0048630 | skeletal muscle tissue growth | 1 | 8 | 4.23e-01 |
| GO:BP | GO:0016050 | vesicle organization | 9 | 320 | 4.23e-01 |
| GO:BP | GO:0062009 | secondary palate development | 6 | 20 | 4.23e-01 |
| GO:BP | GO:0045161 | neuronal ion channel clustering | 2 | 8 | 4.23e-01 |
| GO:BP | GO:1904438 | regulation of iron ion import across plasma membrane | 1 | 1 | 4.24e-01 |
| GO:BP | GO:0061037 | negative regulation of cartilage development | 2 | 23 | 4.24e-01 |
| GO:BP | GO:0015854 | guanine transport | 1 | 2 | 4.24e-01 |
| GO:BP | GO:0044313 | protein K6-linked deubiquitination | 2 | 3 | 4.24e-01 |
| GO:BP | GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling | 12 | 448 | 4.24e-01 |
| GO:BP | GO:0060688 | regulation of morphogenesis of a branching structure | 3 | 36 | 4.24e-01 |
| GO:BP | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway | 1 | 6 | 4.24e-01 |
| GO:BP | GO:0033153 | T cell receptor V(D)J recombination | 2 | 4 | 4.24e-01 |
| GO:BP | GO:0002681 | somatic recombination of T cell receptor gene segments | 2 | 4 | 4.24e-01 |
| GO:BP | GO:0002568 | somatic diversification of T cell receptor genes | 2 | 4 | 4.24e-01 |
| GO:BP | GO:0010968 | regulation of microtubule nucleation | 1 | 11 | 4.24e-01 |
| GO:BP | GO:0021873 | forebrain neuroblast division | 2 | 3 | 4.24e-01 |
| GO:BP | GO:0035344 | hypoxanthine transport | 1 | 2 | 4.24e-01 |
| GO:BP | GO:0001951 | intestinal D-glucose absorption | 2 | 3 | 4.24e-01 |
| GO:BP | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 2 | 6 | 4.24e-01 |
| GO:BP | GO:0033327 | Leydig cell differentiation | 6 | 9 | 4.24e-01 |
| GO:BP | GO:0099111 | microtubule-based transport | 15 | 191 | 4.24e-01 |
| GO:BP | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate | 1 | 1 | 4.25e-01 |
| GO:BP | GO:0048641 | regulation of skeletal muscle tissue development | 1 | 20 | 4.25e-01 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 2 | 41 | 4.25e-01 |
| GO:BP | GO:1903078 | positive regulation of protein localization to plasma membrane | 2 | 50 | 4.25e-01 |
| GO:BP | GO:0090075 | relaxation of muscle | 9 | 29 | 4.25e-01 |
| GO:BP | GO:0070482 | response to oxygen levels | 14 | 272 | 4.25e-01 |
| GO:BP | GO:0070341 | fat cell proliferation | 1 | 10 | 4.25e-01 |
| GO:BP | GO:0030968 | endoplasmic reticulum unfolded protein response | 3 | 70 | 4.25e-01 |
| GO:BP | GO:0052651 | monoacylglycerol catabolic process | 5 | 6 | 4.25e-01 |
| GO:BP | GO:0015707 | nitrite transport | 1 | 1 | 4.26e-01 |
| GO:BP | GO:1904238 | pericyte cell differentiation | 3 | 8 | 4.26e-01 |
| GO:BP | GO:1904354 | negative regulation of telomere capping | 1 | 8 | 4.26e-01 |
| GO:BP | GO:1902685 | positive regulation of receptor localization to synapse | 2 | 3 | 4.26e-01 |
| GO:BP | GO:2000195 | negative regulation of female gonad development | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0033603 | positive regulation of dopamine secretion | 1 | 4 | 4.26e-01 |
| GO:BP | GO:0061734 | parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | 4 | 6 | 4.26e-01 |
| GO:BP | GO:1901977 | negative regulation of cell cycle checkpoint | 1 | 8 | 4.26e-01 |
| GO:BP | GO:0055071 | manganese ion homeostasis | 1 | 2 | 4.26e-01 |
| GO:BP | GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0009173 | pyrimidine ribonucleoside monophosphate metabolic process | 2 | 12 | 4.26e-01 |
| GO:BP | GO:1901875 | positive regulation of post-translational protein modification | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0018215 | protein phosphopantetheinylation | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0006354 | DNA-templated transcription elongation | 53 | 122 | 4.26e-01 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 5 | 154 | 4.26e-01 |
| GO:BP | GO:0030182 | neuron differentiation | 3 | 1061 | 4.26e-01 |
| GO:BP | GO:0006635 | fatty acid beta-oxidation | 1 | 68 | 4.26e-01 |
| GO:BP | GO:0008611 | ether lipid biosynthetic process | 3 | 10 | 4.26e-01 |
| GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 4 | 25 | 4.26e-01 |
| GO:BP | GO:0009730 | detection of carbohydrate stimulus | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0008655 | pyrimidine-containing compound salvage | 1 | 5 | 4.26e-01 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 1 | 36 | 4.26e-01 |
| GO:BP | GO:0009732 | detection of hexose stimulus | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0009749 | response to glucose | 12 | 137 | 4.26e-01 |
| GO:BP | GO:0046504 | glycerol ether biosynthetic process | 3 | 10 | 4.26e-01 |
| GO:BP | GO:0034287 | detection of monosaccharide stimulus | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0046204 | nor-spermidine metabolic process | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0050805 | negative regulation of synaptic transmission | 5 | 35 | 4.26e-01 |
| GO:BP | GO:1905337 | positive regulation of aggrephagy | 2 | 3 | 4.26e-01 |
| GO:BP | GO:0032919 | spermine acetylation | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0032920 | putrescine acetylation | 1 | 1 | 4.26e-01 |
| GO:BP | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 3 | 10 | 4.26e-01 |
| GO:BP | GO:0097384 | cellular lipid biosynthetic process | 3 | 10 | 4.26e-01 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 4 | 71 | 4.26e-01 |
| GO:BP | GO:0051594 | detection of glucose | 1 | 1 | 4.26e-01 |
| GO:BP | GO:1905335 | regulation of aggrephagy | 2 | 3 | 4.26e-01 |
| GO:BP | GO:2000282 | regulation of cellular amino acid biosynthetic process | 3 | 3 | 4.26e-01 |
| GO:BP | GO:0007194 | negative regulation of adenylate cyclase activity | 3 | 13 | 4.26e-01 |
| GO:BP | GO:0032204 | regulation of telomere maintenance | 32 | 96 | 4.26e-01 |
| GO:BP | GO:0007271 | synaptic transmission, cholinergic | 1 | 15 | 4.26e-01 |
| GO:BP | GO:0019228 | neuronal action potential | 1 | 23 | 4.26e-01 |
| GO:BP | GO:0040009 | regulation of growth rate | 1 | 3 | 4.26e-01 |
| GO:BP | GO:0006171 | cAMP biosynthetic process | 3 | 8 | 4.26e-01 |
| GO:BP | GO:0016241 | regulation of macroautophagy | 39 | 151 | 4.26e-01 |
| GO:BP | GO:0044528 | regulation of mitochondrial mRNA stability | 5 | 7 | 4.26e-01 |
| GO:BP | GO:0009437 | carnitine metabolic process | 2 | 11 | 4.26e-01 |
| GO:BP | GO:0002317 | plasma cell differentiation | 1 | 5 | 4.26e-01 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 7 | 203 | 4.26e-01 |
| GO:BP | GO:0090312 | positive regulation of protein deacetylation | 4 | 28 | 4.26e-01 |
| GO:BP | GO:0061364 | apoptotic process involved in luteolysis | 2 | 3 | 4.27e-01 |
| GO:BP | GO:0046697 | decidualization | 6 | 19 | 4.27e-01 |
| GO:BP | GO:0072665 | protein localization to vacuole | 9 | 72 | 4.27e-01 |
| GO:BP | GO:0035290 | trunk segmentation | 3 | 4 | 4.27e-01 |
| GO:BP | GO:0051122 | hepoxilin biosynthetic process | 1 | 5 | 4.27e-01 |
| GO:BP | GO:0071314 | cellular response to cocaine | 2 | 7 | 4.27e-01 |
| GO:BP | GO:0036484 | trunk neural crest cell migration | 3 | 4 | 4.27e-01 |
| GO:BP | GO:0010807 | regulation of synaptic vesicle priming | 1 | 8 | 4.27e-01 |
| GO:BP | GO:0051121 | hepoxilin metabolic process | 1 | 5 | 4.27e-01 |
| GO:BP | GO:0071985 | multivesicular body sorting pathway | 22 | 48 | 4.27e-01 |
| GO:BP | GO:0006999 | nuclear pore organization | 3 | 14 | 4.27e-01 |
| GO:BP | GO:1905839 | negative regulation of telomeric D-loop disassembly | 1 | 2 | 4.27e-01 |
| GO:BP | GO:1905838 | regulation of telomeric D-loop disassembly | 1 | 2 | 4.27e-01 |
| GO:BP | GO:0052646 | alditol phosphate metabolic process | 6 | 10 | 4.27e-01 |
| GO:BP | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential | 1 | 1 | 4.27e-01 |
| GO:BP | GO:1901606 | alpha-amino acid catabolic process | 1 | 63 | 4.27e-01 |
| GO:BP | GO:0061739 | protein lipidation involved in autophagosome assembly | 2 | 3 | 4.27e-01 |
| GO:BP | GO:1905778 | negative regulation of exonuclease activity | 1 | 2 | 4.27e-01 |
| GO:BP | GO:1904199 | positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization | 1 | 1 | 4.27e-01 |
| GO:BP | GO:1905777 | regulation of exonuclease activity | 1 | 2 | 4.27e-01 |
| GO:BP | GO:1903829 | positive regulation of protein localization | 23 | 386 | 4.27e-01 |
| GO:BP | GO:0071573 | shelterin complex assembly | 1 | 2 | 4.27e-01 |
| GO:BP | GO:0009449 | gamma-aminobutyric acid biosynthetic process | 1 | 4 | 4.27e-01 |
| GO:BP | GO:0032214 | negative regulation of telomere maintenance via semi-conservative replication | 1 | 2 | 4.27e-01 |
| GO:BP | GO:0032213 | regulation of telomere maintenance via semi-conservative replication | 1 | 2 | 4.27e-01 |
| GO:BP | GO:0019953 | sexual reproduction | 3 | 631 | 4.27e-01 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 24 | 236 | 4.27e-01 |
| GO:BP | GO:0002269 | leukocyte activation involved in inflammatory response | 2 | 21 | 4.27e-01 |
| GO:BP | GO:0007413 | axonal fasciculation | 1 | 18 | 4.27e-01 |
| GO:BP | GO:1904534 | negative regulation of telomeric loop disassembly | 1 | 2 | 4.27e-01 |
| GO:BP | GO:0106030 | neuron projection fasciculation | 1 | 18 | 4.27e-01 |
| GO:BP | GO:0043648 | dicarboxylic acid metabolic process | 1 | 74 | 4.27e-01 |
| GO:BP | GO:1904790 | regulation of shelterin complex assembly | 1 | 2 | 4.27e-01 |
| GO:BP | GO:0061450 | trophoblast cell migration | 2 | 13 | 4.27e-01 |
| GO:BP | GO:0048671 | negative regulation of collateral sprouting | 5 | 9 | 4.27e-01 |
| GO:BP | GO:1990830 | cellular response to leukemia inhibitory factor | 49 | 84 | 4.27e-01 |
| GO:BP | GO:1902261 | positive regulation of delayed rectifier potassium channel activity | 1 | 5 | 4.27e-01 |
| GO:BP | GO:1990736 | regulation of vascular associated smooth muscle cell membrane depolarization | 1 | 1 | 4.27e-01 |
| GO:BP | GO:1903764 | regulation of potassium ion export across plasma membrane | 3 | 5 | 4.27e-01 |
| GO:BP | GO:0006739 | NADP metabolic process | 6 | 40 | 4.27e-01 |
| GO:BP | GO:0030433 | ubiquitin-dependent ERAD pathway | 6 | 83 | 4.28e-01 |
| GO:BP | GO:0072677 | eosinophil migration | 1 | 7 | 4.28e-01 |
| GO:BP | GO:0097151 | positive regulation of inhibitory postsynaptic potential | 3 | 4 | 4.29e-01 |
| GO:BP | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity | 1 | 6 | 4.29e-01 |
| GO:BP | GO:0042996 | regulation of Golgi to plasma membrane protein transport | 7 | 9 | 4.29e-01 |
| GO:BP | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1 | 11 | 4.29e-01 |
| GO:BP | GO:0060324 | face development | 3 | 45 | 4.29e-01 |
| GO:BP | GO:0003271 | smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 1 | 1 | 4.29e-01 |
| GO:BP | GO:0044550 | secondary metabolite biosynthetic process | 5 | 18 | 4.29e-01 |
| GO:BP | GO:0120077 | angiogenic sprout fusion | 2 | 2 | 4.29e-01 |
| GO:BP | GO:0120078 | cell adhesion involved in sprouting angiogenesis | 2 | 2 | 4.29e-01 |
| GO:BP | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity | 1 | 26 | 4.29e-01 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 1 | 463 | 4.29e-01 |
| GO:BP | GO:1903348 | positive regulation of bicellular tight junction assembly | 4 | 5 | 4.29e-01 |
| GO:BP | GO:0060294 | cilium movement involved in cell motility | 1 | 69 | 4.29e-01 |
| GO:BP | GO:0097105 | presynaptic membrane assembly | 1 | 8 | 4.29e-01 |
| GO:BP | GO:0018277 | protein deamination | 2 | 2 | 4.30e-01 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 16 | 58 | 4.31e-01 |
| GO:BP | GO:1905145 | cellular response to acetylcholine | 1 | 20 | 4.31e-01 |
| GO:BP | GO:0071243 | cellular response to arsenic-containing substance | 9 | 18 | 4.31e-01 |
| GO:BP | GO:0046349 | amino sugar biosynthetic process | 6 | 11 | 4.31e-01 |
| GO:BP | GO:0120041 | positive regulation of macrophage proliferation | 1 | 4 | 4.31e-01 |
| GO:BP | GO:0014740 | negative regulation of muscle hyperplasia | 1 | 1 | 4.31e-01 |
| GO:BP | GO:0032463 | negative regulation of protein homooligomerization | 1 | 2 | 4.31e-01 |
| GO:BP | GO:0042482 | positive regulation of odontogenesis | 1 | 5 | 4.31e-01 |
| GO:BP | GO:1903969 | regulation of response to macrophage colony-stimulating factor | 1 | 3 | 4.31e-01 |
| GO:BP | GO:0032460 | negative regulation of protein oligomerization | 1 | 2 | 4.31e-01 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 6 | 86 | 4.31e-01 |
| GO:BP | GO:0009056 | catabolic process | 19 | 2088 | 4.31e-01 |
| GO:BP | GO:1903972 | regulation of cellular response to macrophage colony-stimulating factor stimulus | 1 | 3 | 4.31e-01 |
| GO:BP | GO:0097154 | GABAergic neuron differentiation | 1 | 5 | 4.31e-01 |
| GO:BP | GO:0021678 | third ventricle development | 3 | 4 | 4.31e-01 |
| GO:BP | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis | 1 | 6 | 4.31e-01 |
| GO:BP | GO:0060442 | branching involved in prostate gland morphogenesis | 2 | 7 | 4.31e-01 |
| GO:BP | GO:0045048 | protein insertion into ER membrane | 1 | 23 | 4.31e-01 |
| GO:BP | GO:0002260 | lymphocyte homeostasis | 1 | 45 | 4.31e-01 |
| GO:BP | GO:0015818 | isoleucine transport | 1 | 5 | 4.31e-01 |
| GO:BP | GO:1904555 | L-proline transmembrane transport | 1 | 5 | 4.31e-01 |
| GO:BP | GO:1903804 | glycine import across plasma membrane | 1 | 4 | 4.31e-01 |
| GO:BP | GO:1905647 | proline import across plasma membrane | 1 | 5 | 4.31e-01 |
| GO:BP | GO:1904271 | L-proline import across plasma membrane | 1 | 5 | 4.31e-01 |
| GO:BP | GO:0032526 | response to retinoic acid | 6 | 85 | 4.32e-01 |
| GO:BP | GO:0042732 | D-xylose metabolic process | 1 | 2 | 4.32e-01 |
| GO:BP | GO:0090618 | DNA clamp unloading | 1 | 2 | 4.32e-01 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 11 | 408 | 4.32e-01 |
| GO:BP | GO:0090216 | positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity | 1 | 1 | 4.32e-01 |
| GO:BP | GO:0046015 | regulation of transcription by glucose | 1 | 6 | 4.32e-01 |
| GO:BP | GO:1902983 | DNA strand elongation involved in mitotic DNA replication | 1 | 1 | 4.32e-01 |
| GO:BP | GO:1902296 | DNA strand elongation involved in cell cycle DNA replication | 1 | 1 | 4.32e-01 |
| GO:BP | GO:0060419 | heart growth | 42 | 72 | 4.32e-01 |
| GO:BP | GO:1902319 | DNA strand elongation involved in nuclear cell cycle DNA replication | 1 | 1 | 4.32e-01 |
| GO:BP | GO:0009251 | glucan catabolic process | 6 | 14 | 4.32e-01 |
| GO:BP | GO:1904889 | regulation of excitatory synapse assembly | 2 | 12 | 4.32e-01 |
| GO:BP | GO:0070778 | L-aspartate transmembrane transport | 3 | 11 | 4.32e-01 |
| GO:BP | GO:0007423 | sensory organ development | 1 | 396 | 4.32e-01 |
| GO:BP | GO:0014904 | myotube cell development | 1 | 34 | 4.32e-01 |
| GO:BP | GO:0090188 | negative regulation of pancreatic juice secretion | 1 | 4 | 4.32e-01 |
| GO:BP | GO:1900242 | regulation of synaptic vesicle endocytosis | 7 | 16 | 4.33e-01 |
| GO:BP | GO:0070383 | DNA cytosine deamination | 1 | 5 | 4.33e-01 |
| GO:BP | GO:0001830 | trophectodermal cell fate commitment | 1 | 1 | 4.33e-01 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 2 | 32 | 4.33e-01 |
| GO:BP | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain | 1 | 8 | 4.33e-01 |
| GO:BP | GO:0003211 | cardiac ventricle formation | 7 | 10 | 4.33e-01 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 5 | 60 | 4.33e-01 |
| GO:BP | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 7 | 10 | 4.34e-01 |
| GO:BP | GO:0001660 | fever generation | 1 | 5 | 4.34e-01 |
| GO:BP | GO:0051000 | positive regulation of nitric-oxide synthase activity | 2 | 14 | 4.34e-01 |
| GO:BP | GO:0016444 | somatic cell DNA recombination | 3 | 55 | 4.35e-01 |
| GO:BP | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 3 | 55 | 4.35e-01 |
| GO:BP | GO:0032647 | regulation of interferon-alpha production | 1 | 19 | 4.35e-01 |
| GO:BP | GO:0032607 | interferon-alpha production | 1 | 19 | 4.35e-01 |
| GO:BP | GO:0045648 | positive regulation of erythrocyte differentiation | 1 | 27 | 4.35e-01 |
| GO:BP | GO:0060789 | hair follicle placode formation | 3 | 5 | 4.35e-01 |
| GO:BP | GO:0042415 | norepinephrine metabolic process | 2 | 7 | 4.35e-01 |
| GO:BP | GO:0003015 | heart process | 19 | 216 | 4.35e-01 |
| GO:BP | GO:0061028 | establishment of endothelial barrier | 12 | 38 | 4.35e-01 |
| GO:BP | GO:0006883 | intracellular sodium ion homeostasis | 3 | 13 | 4.35e-01 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 3 | 1123 | 4.35e-01 |
| GO:BP | GO:0035295 | tube development | 2 | 821 | 4.35e-01 |
| GO:BP | GO:2000120 | positive regulation of sodium-dependent phosphate transport | 1 | 2 | 4.36e-01 |
| GO:BP | GO:1901329 | regulation of odontoblast differentiation | 1 | 2 | 4.36e-01 |
| GO:BP | GO:1905303 | positive regulation of macropinocytosis | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 4 | 10 | 4.36e-01 |
| GO:BP | GO:0035864 | response to potassium ion | 3 | 12 | 4.36e-01 |
| GO:BP | GO:0031126 | sno(s)RNA 3’-end processing | 8 | 12 | 4.36e-01 |
| GO:BP | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion | 4 | 7 | 4.36e-01 |
| GO:BP | GO:0071163 | DNA replication preinitiation complex assembly | 2 | 3 | 4.36e-01 |
| GO:BP | GO:0048843 | negative regulation of axon extension involved in axon guidance | 15 | 26 | 4.36e-01 |
| GO:BP | GO:0032986 | protein-DNA complex disassembly | 1 | 18 | 4.36e-01 |
| GO:BP | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 2 | 21 | 4.36e-01 |
| GO:BP | GO:0014829 | vascular associated smooth muscle contraction | 3 | 20 | 4.36e-01 |
| GO:BP | GO:2001235 | positive regulation of apoptotic signaling pathway | 21 | 108 | 4.36e-01 |
| GO:BP | GO:0042592 | homeostatic process | 26 | 1159 | 4.36e-01 |
| GO:BP | GO:0070129 | regulation of mitochondrial translation | 16 | 26 | 4.36e-01 |
| GO:BP | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0051455 | monopolar spindle attachment to meiosis I kinetochore | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0120094 | negative regulation of peptidyl-lysine crotonylation | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0120093 | regulation of peptidyl-lysine crotonylation | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0061005 | cell differentiation involved in kidney development | 3 | 42 | 4.36e-01 |
| GO:BP | GO:0071787 | endoplasmic reticulum tubular network formation | 3 | 4 | 4.36e-01 |
| GO:BP | GO:0006661 | phosphatidylinositol biosynthetic process | 27 | 119 | 4.36e-01 |
| GO:BP | GO:0150093 | amyloid-beta clearance by transcytosis | 4 | 7 | 4.36e-01 |
| GO:BP | GO:0045054 | constitutive secretory pathway | 3 | 7 | 4.36e-01 |
| GO:BP | GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 15 | 26 | 4.36e-01 |
| GO:BP | GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 6 | 14 | 4.36e-01 |
| GO:BP | GO:1901463 | regulation of tetrapyrrole biosynthetic process | 3 | 7 | 4.36e-01 |
| GO:BP | GO:0044873 | lipoprotein localization to membrane | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0006096 | glycolytic process | 1 | 70 | 4.36e-01 |
| GO:BP | GO:0072673 | lamellipodium morphogenesis | 8 | 17 | 4.36e-01 |
| GO:BP | GO:0048011 | neurotrophin TRK receptor signaling pathway | 1 | 23 | 4.36e-01 |
| GO:BP | GO:1904868 | telomerase catalytic core complex assembly | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0014028 | notochord formation | 2 | 3 | 4.36e-01 |
| GO:BP | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0060685 | regulation of prostatic bud formation | 1 | 5 | 4.36e-01 |
| GO:BP | GO:1903062 | regulation of reverse cholesterol transport | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0042413 | carnitine catabolic process | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0060706 | cell differentiation involved in embryonic placenta development | 11 | 20 | 4.36e-01 |
| GO:BP | GO:0001907 | killing by symbiont of host cells | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0071317 | cellular response to isoquinoline alkaloid | 1 | 2 | 4.36e-01 |
| GO:BP | GO:1904884 | positive regulation of telomerase catalytic core complex assembly | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0071315 | cellular response to morphine | 1 | 2 | 4.36e-01 |
| GO:BP | GO:1904882 | regulation of telomerase catalytic core complex assembly | 2 | 2 | 4.36e-01 |
| GO:BP | GO:1903064 | positive regulation of reverse cholesterol transport | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0071786 | endoplasmic reticulum tubular network organization | 1 | 19 | 4.36e-01 |
| GO:BP | GO:0090381 | regulation of heart induction | 1 | 4 | 4.36e-01 |
| GO:BP | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation | 4 | 6 | 4.36e-01 |
| GO:BP | GO:0090022 | regulation of neutrophil chemotaxis | 3 | 19 | 4.36e-01 |
| GO:BP | GO:0016197 | endosomal transport | 6 | 231 | 4.36e-01 |
| GO:BP | GO:0043588 | skin development | 1 | 175 | 4.36e-01 |
| GO:BP | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade | 1 | 4 | 4.36e-01 |
| GO:BP | GO:0051666 | actin cortical patch localization | 1 | 2 | 4.36e-01 |
| GO:BP | GO:0033668 | suppression by symbiont of host apoptotic process | 2 | 2 | 4.36e-01 |
| GO:BP | GO:1990983 | tRNA demethylation | 1 | 1 | 4.36e-01 |
| GO:BP | GO:0060613 | fat pad development | 1 | 6 | 4.36e-01 |
| GO:BP | GO:0044565 | dendritic cell proliferation | 2 | 3 | 4.36e-01 |
| GO:BP | GO:0052041 | suppression by symbiont of host programmed cell death | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0052042 | induction by symbiont of host programmed cell death | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0052151 | positive regulation by symbiont of host apoptotic process | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0044779 | meiotic spindle checkpoint signaling | 1 | 2 | 4.36e-01 |
| GO:BP | GO:0010907 | positive regulation of glucose metabolic process | 19 | 36 | 4.36e-01 |
| GO:BP | GO:0120222 | regulation of blastocyst development | 2 | 3 | 4.36e-01 |
| GO:BP | GO:0007010 | cytoskeleton organization | 50 | 1226 | 4.36e-01 |
| GO:BP | GO:1902474 | positive regulation of protein localization to synapse | 1 | 6 | 4.36e-01 |
| GO:BP | GO:0070453 | regulation of heme biosynthetic process | 3 | 7 | 4.36e-01 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 29 | 1209 | 4.36e-01 |
| GO:BP | GO:0019051 | induction by virus of host apoptotic process | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0019050 | suppression by virus of host apoptotic process | 2 | 2 | 4.36e-01 |
| GO:BP | GO:0100012 | regulation of heart induction by canonical Wnt signaling pathway | 1 | 4 | 4.36e-01 |
| GO:BP | GO:1901836 | regulation of transcription of nucleolar large rRNA by RNA polymerase I | 8 | 15 | 4.36e-01 |
| GO:BP | GO:0031113 | regulation of microtubule polymerization | 2 | 52 | 4.36e-01 |
| GO:BP | GO:0031128 | developmental induction | 15 | 26 | 4.36e-01 |
| GO:BP | GO:2000466 | negative regulation of glycogen (starch) synthase activity | 2 | 3 | 4.36e-01 |
| GO:BP | GO:1905395 | response to flavonoid | 2 | 2 | 4.37e-01 |
| GO:BP | GO:0046606 | negative regulation of centrosome cycle | 4 | 12 | 4.37e-01 |
| GO:BP | GO:0010826 | negative regulation of centrosome duplication | 4 | 12 | 4.37e-01 |
| GO:BP | GO:0030334 | regulation of cell migration | 1 | 706 | 4.37e-01 |
| GO:BP | GO:0010232 | vascular transport | 1 | 72 | 4.37e-01 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 1 | 72 | 4.37e-01 |
| GO:BP | GO:0062043 | positive regulation of cardiac epithelial to mesenchymal transition | 2 | 9 | 4.37e-01 |
| GO:BP | GO:1900248 | negative regulation of cytoplasmic translational elongation | 2 | 2 | 4.37e-01 |
| GO:BP | GO:1902954 | regulation of early endosome to recycling endosome transport | 1 | 2 | 4.37e-01 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 43 | 1111 | 4.37e-01 |
| GO:BP | GO:0010994 | free ubiquitin chain polymerization | 4 | 8 | 4.37e-01 |
| GO:BP | GO:0043039 | tRNA aminoacylation | 22 | 43 | 4.37e-01 |
| GO:BP | GO:0042159 | lipoprotein catabolic process | 7 | 14 | 4.37e-01 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 3 | 1107 | 4.37e-01 |
| GO:BP | GO:0070813 | hydrogen sulfide metabolic process | 3 | 5 | 4.37e-01 |
| GO:BP | GO:2000754 | regulation of sphingomyelin catabolic process | 1 | 1 | 4.38e-01 |
| GO:BP | GO:0036500 | ATF6-mediated unfolded protein response | 1 | 9 | 4.38e-01 |
| GO:BP | GO:2000755 | positive regulation of sphingomyelin catabolic process | 1 | 1 | 4.38e-01 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 11 | 222 | 4.38e-01 |
| GO:BP | GO:0110113 | positive regulation of lipid transporter activity | 1 | 1 | 4.38e-01 |
| GO:BP | GO:0051591 | response to cAMP | 13 | 66 | 4.38e-01 |
| GO:BP | GO:0033504 | floor plate development | 4 | 8 | 4.38e-01 |
| GO:BP | GO:0098902 | regulation of membrane depolarization during action potential | 4 | 5 | 4.38e-01 |
| GO:BP | GO:0006094 | gluconeogenesis | 1 | 67 | 4.38e-01 |
| GO:BP | GO:0033306 | phytol metabolic process | 2 | 2 | 4.38e-01 |
| GO:BP | GO:1903173 | fatty alcohol metabolic process | 2 | 2 | 4.38e-01 |
| GO:BP | GO:0032874 | positive regulation of stress-activated MAPK cascade | 7 | 96 | 4.38e-01 |
| GO:BP | GO:0061764 | late endosome to lysosome transport via multivesicular body sorting pathway | 2 | 2 | 4.38e-01 |
| GO:BP | GO:0099638 | endosome to plasma membrane protein transport | 2 | 15 | 4.38e-01 |
| GO:BP | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide | 2 | 5 | 4.38e-01 |
| GO:BP | GO:0070942 | neutrophil mediated cytotoxicity | 1 | 4 | 4.38e-01 |
| GO:BP | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 7 | 24 | 4.39e-01 |
| GO:BP | GO:0098760 | response to interleukin-7 | 3 | 12 | 4.39e-01 |
| GO:BP | GO:0098761 | cellular response to interleukin-7 | 3 | 12 | 4.39e-01 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 1 | 13 | 4.39e-01 |
| GO:BP | GO:2001176 | regulation of mediator complex assembly | 1 | 1 | 4.39e-01 |
| GO:BP | GO:0001928 | regulation of exocyst assembly | 1 | 1 | 4.39e-01 |
| GO:BP | GO:0001927 | exocyst assembly | 1 | 1 | 4.39e-01 |
| GO:BP | GO:0060178 | regulation of exocyst localization | 1 | 1 | 4.39e-01 |
| GO:BP | GO:0006451 | translational readthrough | 2 | 10 | 4.39e-01 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 6 | 25 | 4.39e-01 |
| GO:BP | GO:0001514 | selenocysteine incorporation | 2 | 10 | 4.39e-01 |
| GO:BP | GO:0036034 | mediator complex assembly | 1 | 1 | 4.39e-01 |
| GO:BP | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 3 | 9 | 4.39e-01 |
| GO:BP | GO:0045721 | negative regulation of gluconeogenesis | 2 | 12 | 4.39e-01 |
| GO:BP | GO:1904779 | regulation of protein localization to centrosome | 7 | 10 | 4.39e-01 |
| GO:BP | GO:2001178 | positive regulation of mediator complex assembly | 1 | 1 | 4.39e-01 |
| GO:BP | GO:0014846 | esophagus smooth muscle contraction | 1 | 2 | 4.39e-01 |
| GO:BP | GO:0044854 | plasma membrane raft assembly | 1 | 6 | 4.39e-01 |
| GO:BP | GO:0070221 | sulfide oxidation, using sulfide:quinone oxidoreductase | 1 | 3 | 4.39e-01 |
| GO:BP | GO:2000377 | regulation of reactive oxygen species metabolic process | 7 | 108 | 4.39e-01 |
| GO:BP | GO:0072049 | comma-shaped body morphogenesis | 2 | 4 | 4.39e-01 |
| GO:BP | GO:0032379 | positive regulation of intracellular lipid transport | 1 | 4 | 4.39e-01 |
| GO:BP | GO:0008286 | insulin receptor signaling pathway | 32 | 105 | 4.39e-01 |
| GO:BP | GO:0015709 | thiosulfate transport | 1 | 4 | 4.39e-01 |
| GO:BP | GO:0009190 | cyclic nucleotide biosynthetic process | 6 | 14 | 4.39e-01 |
| GO:BP | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus | 2 | 8 | 4.39e-01 |
| GO:BP | GO:0019418 | sulfide oxidation | 1 | 3 | 4.39e-01 |
| GO:BP | GO:0019221 | cytokine-mediated signaling pathway | 1 | 274 | 4.40e-01 |
| GO:BP | GO:0008033 | tRNA processing | 73 | 128 | 4.40e-01 |
| GO:BP | GO:0060285 | cilium-dependent cell motility | 1 | 74 | 4.40e-01 |
| GO:BP | GO:0033197 | response to vitamin E | 2 | 9 | 4.40e-01 |
| GO:BP | GO:0140454 | protein aggregate center assembly | 1 | 1 | 4.40e-01 |
| GO:BP | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response | 5 | 7 | 4.40e-01 |
| GO:BP | GO:0097070 | ductus arteriosus closure | 1 | 2 | 4.40e-01 |
| GO:BP | GO:0046902 | regulation of mitochondrial membrane permeability | 9 | 54 | 4.40e-01 |
| GO:BP | GO:0010469 | regulation of signaling receptor activity | 1 | 107 | 4.40e-01 |
| GO:BP | GO:0001539 | cilium or flagellum-dependent cell motility | 1 | 74 | 4.40e-01 |
| GO:BP | GO:0072521 | purine-containing compound metabolic process | 9 | 390 | 4.40e-01 |
| GO:BP | GO:1903747 | regulation of establishment of protein localization to mitochondrion | 7 | 44 | 4.40e-01 |
| GO:BP | GO:0006020 | inositol metabolic process | 2 | 8 | 4.40e-01 |
| GO:BP | GO:0002023 | reduction of food intake in response to dietary excess | 1 | 2 | 4.40e-01 |
| GO:BP | GO:0070734 | histone H3-K27 methylation | 1 | 9 | 4.41e-01 |
| GO:BP | GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6 | 7 | 4.41e-01 |
| GO:BP | GO:0043048 | dolichyl monophosphate biosynthetic process | 1 | 1 | 4.41e-01 |
| GO:BP | GO:1900141 | regulation of oligodendrocyte apoptotic process | 2 | 2 | 4.41e-01 |
| GO:BP | GO:0071455 | cellular response to hyperoxia | 1 | 5 | 4.41e-01 |
| GO:BP | GO:0035456 | response to interferon-beta | 1 | 22 | 4.41e-01 |
| GO:BP | GO:0034969 | histone arginine methylation | 2 | 8 | 4.41e-01 |
| GO:BP | GO:0021854 | hypothalamus development | 1 | 15 | 4.41e-01 |
| GO:BP | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin | 3 | 16 | 4.41e-01 |
| GO:BP | GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 12 | 46 | 4.41e-01 |
| GO:BP | GO:0007231 | osmosensory signaling pathway | 3 | 3 | 4.41e-01 |
| GO:BP | GO:0034196 | acylglycerol transport | 1 | 4 | 4.41e-01 |
| GO:BP | GO:1905144 | response to acetylcholine | 1 | 22 | 4.41e-01 |
| GO:BP | GO:0032873 | negative regulation of stress-activated MAPK cascade | 12 | 46 | 4.41e-01 |
| GO:BP | GO:0090199 | regulation of release of cytochrome c from mitochondria | 11 | 39 | 4.41e-01 |
| GO:BP | GO:0034197 | triglyceride transport | 1 | 4 | 4.41e-01 |
| GO:BP | GO:0003323 | type B pancreatic cell development | 2 | 19 | 4.41e-01 |
| GO:BP | GO:0016477 | cell migration | 2 | 1081 | 4.41e-01 |
| GO:BP | GO:0060753 | regulation of mast cell chemotaxis | 1 | 7 | 4.41e-01 |
| GO:BP | GO:0048532 | anatomical structure arrangement | 8 | 13 | 4.41e-01 |
| GO:BP | GO:1901723 | negative regulation of cell proliferation involved in kidney development | 1 | 3 | 4.41e-01 |
| GO:BP | GO:0035627 | ceramide transport | 3 | 15 | 4.41e-01 |
| GO:BP | GO:0062111 | zinc ion import into organelle | 2 | 7 | 4.41e-01 |
| GO:BP | GO:0048699 | generation of neurons | 3 | 1119 | 4.41e-01 |
| GO:BP | GO:0034330 | cell junction organization | 2 | 575 | 4.41e-01 |
| GO:BP | GO:0009415 | response to water | 1 | 9 | 4.41e-01 |
| GO:BP | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade | 2 | 5 | 4.41e-01 |
| GO:BP | GO:0071622 | regulation of granulocyte chemotaxis | 4 | 27 | 4.41e-01 |
| GO:BP | GO:0060745 | mammary gland branching involved in pregnancy | 2 | 5 | 4.41e-01 |
| GO:BP | GO:0001832 | blastocyst growth | 5 | 19 | 4.41e-01 |
| GO:BP | GO:0097090 | presynaptic membrane organization | 1 | 8 | 4.41e-01 |
| GO:BP | GO:0006368 | transcription elongation by RNA polymerase II | 46 | 106 | 4.41e-01 |
| GO:BP | GO:1900063 | regulation of peroxisome organization | 1 | 4 | 4.41e-01 |
| GO:BP | GO:1904048 | regulation of spontaneous neurotransmitter secretion | 2 | 2 | 4.42e-01 |
| GO:BP | GO:0072209 | metanephric mesangial cell differentiation | 1 | 1 | 4.42e-01 |
| GO:BP | GO:0046078 | dUMP metabolic process | 1 | 6 | 4.42e-01 |
| GO:BP | GO:0072254 | metanephric glomerular mesangial cell differentiation | 1 | 1 | 4.42e-01 |
| GO:BP | GO:1903905 | positive regulation of establishment of T cell polarity | 1 | 4 | 4.42e-01 |
| GO:BP | GO:0046035 | CMP metabolic process | 1 | 6 | 4.42e-01 |
| GO:BP | GO:0051606 | detection of stimulus | 1 | 110 | 4.42e-01 |
| GO:BP | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 1 | 2 | 4.42e-01 |
| GO:BP | GO:0009178 | pyrimidine deoxyribonucleoside monophosphate catabolic process | 1 | 5 | 4.42e-01 |
| GO:BP | GO:0002894 | positive regulation of type II hypersensitivity | 2 | 3 | 4.42e-01 |
| GO:BP | GO:0031399 | regulation of protein modification process | 3 | 1173 | 4.42e-01 |
| GO:BP | GO:0008356 | asymmetric cell division | 1 | 14 | 4.42e-01 |
| GO:BP | GO:0060708 | spongiotrophoblast differentiation | 2 | 2 | 4.42e-01 |
| GO:BP | GO:0040014 | regulation of multicellular organism growth | 4 | 53 | 4.42e-01 |
| GO:BP | GO:0019319 | hexose biosynthetic process | 1 | 70 | 4.42e-01 |
| GO:BP | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 1 | 6 | 4.42e-01 |
| GO:BP | GO:0051307 | meiotic chromosome separation | 2 | 5 | 4.42e-01 |
| GO:BP | GO:0001798 | positive regulation of type IIa hypersensitivity | 2 | 3 | 4.42e-01 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 44 | 1088 | 4.42e-01 |
| GO:BP | GO:0022406 | membrane docking | 21 | 84 | 4.42e-01 |
| GO:BP | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1 | 6 | 4.42e-01 |
| GO:BP | GO:0050881 | musculoskeletal movement | 2 | 41 | 4.42e-01 |
| GO:BP | GO:0019377 | glycolipid catabolic process | 5 | 12 | 4.42e-01 |
| GO:BP | GO:0043455 | regulation of secondary metabolic process | 3 | 12 | 4.42e-01 |
| GO:BP | GO:0048021 | regulation of melanin biosynthetic process | 3 | 12 | 4.42e-01 |
| GO:BP | GO:1900376 | regulation of secondary metabolite biosynthetic process | 3 | 12 | 4.42e-01 |
| GO:BP | GO:0010890 | positive regulation of sequestering of triglyceride | 6 | 7 | 4.43e-01 |
| GO:BP | GO:0071941 | nitrogen cycle metabolic process | 3 | 7 | 4.43e-01 |
| GO:BP | GO:0009746 | response to hexose | 12 | 138 | 4.43e-01 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 4 | 85 | 4.43e-01 |
| GO:BP | GO:0097503 | sialylation | 1 | 18 | 4.43e-01 |
| GO:BP | GO:0006694 | steroid biosynthetic process | 5 | 121 | 4.43e-01 |
| GO:BP | GO:0009301 | snRNA transcription | 3 | 18 | 4.43e-01 |
| GO:BP | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis | 1 | 3 | 4.43e-01 |
| GO:BP | GO:0070483 | detection of hypoxia | 1 | 2 | 4.43e-01 |
| GO:BP | GO:1905897 | regulation of response to endoplasmic reticulum stress | 3 | 76 | 4.43e-01 |
| GO:BP | GO:0042305 | specification of segmental identity, mandibular segment | 1 | 3 | 4.43e-01 |
| GO:BP | GO:0007613 | memory | 14 | 92 | 4.43e-01 |
| GO:BP | GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | 3 | 12 | 4.43e-01 |
| GO:BP | GO:0086101 | endothelin receptor signaling pathway involved in heart process | 1 | 3 | 4.43e-01 |
| GO:BP | GO:0019627 | urea metabolic process | 3 | 7 | 4.43e-01 |
| GO:BP | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 6 | 10 | 4.43e-01 |
| GO:BP | GO:0034243 | regulation of transcription elongation by RNA polymerase II | 37 | 85 | 4.43e-01 |
| GO:BP | GO:0070493 | thrombin-activated receptor signaling pathway | 1 | 9 | 4.43e-01 |
| GO:BP | GO:0015819 | lysine transport | 2 | 2 | 4.43e-01 |
| GO:BP | GO:0061945 | regulation of protein K48-linked ubiquitination | 2 | 4 | 4.43e-01 |
| GO:BP | GO:0043117 | positive regulation of vascular permeability | 1 | 14 | 4.44e-01 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 42 | 1849 | 4.44e-01 |
| GO:BP | GO:0003096 | renal sodium ion transport | 2 | 10 | 4.44e-01 |
| GO:BP | GO:0000904 | cell morphogenesis involved in differentiation | 1 | 516 | 4.44e-01 |
| GO:BP | GO:0032025 | response to cobalt ion | 3 | 10 | 4.44e-01 |
| GO:BP | GO:0050860 | negative regulation of T cell receptor signaling pathway | 1 | 17 | 4.44e-01 |
| GO:BP | GO:0036336 | dendritic cell migration | 3 | 15 | 4.44e-01 |
| GO:BP | GO:0060676 | ureteric bud formation | 1 | 5 | 4.44e-01 |
| GO:BP | GO:1904232 | regulation of aconitate hydratase activity | 2 | 2 | 4.44e-01 |
| GO:BP | GO:1904234 | positive regulation of aconitate hydratase activity | 2 | 2 | 4.44e-01 |
| GO:BP | GO:0008298 | intracellular mRNA localization | 1 | 11 | 4.44e-01 |
| GO:BP | GO:0000012 | single strand break repair | 6 | 10 | 4.44e-01 |
| GO:BP | GO:0061900 | glial cell activation | 2 | 23 | 4.44e-01 |
| GO:BP | GO:1904862 | inhibitory synapse assembly | 7 | 13 | 4.44e-01 |
| GO:BP | GO:1900365 | positive regulation of mRNA polyadenylation | 3 | 4 | 4.44e-01 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 6 | 91 | 4.44e-01 |
| GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 5 | 51 | 4.44e-01 |
| GO:BP | GO:0070292 | N-acylphosphatidylethanolamine metabolic process | 2 | 5 | 4.44e-01 |
| GO:BP | GO:0032612 | interleukin-1 production | 3 | 56 | 4.44e-01 |
| GO:BP | GO:0007183 | SMAD protein complex assembly | 3 | 12 | 4.44e-01 |
| GO:BP | GO:0032652 | regulation of interleukin-1 production | 3 | 56 | 4.44e-01 |
| GO:BP | GO:0021960 | anterior commissure morphogenesis | 4 | 5 | 4.44e-01 |
| GO:BP | GO:0060980 | cell migration involved in coronary vasculogenesis | 1 | 1 | 4.44e-01 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 11 | 97 | 4.44e-01 |
| GO:BP | GO:1903781 | positive regulation of cardiac conduction | 1 | 1 | 4.44e-01 |
| GO:BP | GO:1903810 | L-histidine import across plasma membrane | 2 | 2 | 4.44e-01 |
| GO:BP | GO:1901726 | negative regulation of histone deacetylase activity | 1 | 2 | 4.44e-01 |
| GO:BP | GO:0006600 | creatine metabolic process | 1 | 3 | 4.44e-01 |
| GO:BP | GO:2000145 | regulation of cell motility | 1 | 742 | 4.44e-01 |
| GO:BP | GO:0150066 | negative regulation of deacetylase activity | 1 | 2 | 4.44e-01 |
| GO:BP | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region | 1 | 13 | 4.44e-01 |
| GO:BP | GO:0032058 | positive regulation of translational initiation in response to stress | 1 | 4 | 4.44e-01 |
| GO:BP | GO:1902308 | regulation of peptidyl-serine dephosphorylation | 1 | 3 | 4.44e-01 |
| GO:BP | GO:1900182 | positive regulation of protein localization to nucleus | 1 | 75 | 4.44e-01 |
| GO:BP | GO:0035733 | hepatic stellate cell activation | 6 | 8 | 4.44e-01 |
| GO:BP | GO:0050808 | synapse organization | 19 | 365 | 4.44e-01 |
| GO:BP | GO:0070842 | aggresome assembly | 3 | 5 | 4.45e-01 |
| GO:BP | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated | 1 | 26 | 4.45e-01 |
| GO:BP | GO:0047497 | mitochondrion transport along microtubule | 1 | 26 | 4.45e-01 |
| GO:BP | GO:0050848 | regulation of calcium-mediated signaling | 1 | 52 | 4.45e-01 |
| GO:BP | GO:0046929 | negative regulation of neurotransmitter secretion | 3 | 6 | 4.45e-01 |
| GO:BP | GO:1990927 | calcium ion regulated lysosome exocytosis | 1 | 3 | 4.45e-01 |
| GO:BP | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 10 | 18 | 4.45e-01 |
| GO:BP | GO:0051438 | regulation of ubiquitin-protein transferase activity | 10 | 55 | 4.45e-01 |
| GO:BP | GO:0140059 | dendrite arborization | 7 | 9 | 4.45e-01 |
| GO:BP | GO:0060441 | epithelial tube branching involved in lung morphogenesis | 1 | 20 | 4.45e-01 |
| GO:BP | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 7 | 98 | 4.45e-01 |
| GO:BP | GO:0006402 | mRNA catabolic process | 4 | 216 | 4.45e-01 |
| GO:BP | GO:0001909 | leukocyte mediated cytotoxicity | 3 | 54 | 4.45e-01 |
| GO:BP | GO:0038130 | ERBB4 signaling pathway | 4 | 6 | 4.45e-01 |
| GO:BP | GO:1904428 | negative regulation of tubulin deacetylation | 3 | 6 | 4.45e-01 |
| GO:BP | GO:0007566 | embryo implantation | 3 | 39 | 4.46e-01 |
| GO:BP | GO:0036113 | very long-chain fatty-acyl-CoA catabolic process | 1 | 1 | 4.46e-01 |
| GO:BP | GO:0061817 | endoplasmic reticulum-plasma membrane tethering | 1 | 5 | 4.46e-01 |
| GO:BP | GO:0014841 | skeletal muscle satellite cell proliferation | 3 | 10 | 4.46e-01 |
| GO:BP | GO:0051657 | maintenance of organelle location | 7 | 11 | 4.46e-01 |
| GO:BP | GO:0044057 | regulation of system process | 26 | 405 | 4.46e-01 |
| GO:BP | GO:0050879 | multicellular organismal movement | 2 | 41 | 4.46e-01 |
| GO:BP | GO:0060221 | retinal rod cell differentiation | 5 | 9 | 4.47e-01 |
| GO:BP | GO:0032700 | negative regulation of interleukin-17 production | 1 | 9 | 4.47e-01 |
| GO:BP | GO:0090650 | cellular response to oxygen-glucose deprivation | 1 | 5 | 4.47e-01 |
| GO:BP | GO:0035434 | copper ion transmembrane transport | 2 | 6 | 4.47e-01 |
| GO:BP | GO:1990823 | response to leukemia inhibitory factor | 49 | 85 | 4.47e-01 |
| GO:BP | GO:0030318 | melanocyte differentiation | 1 | 16 | 4.47e-01 |
| GO:BP | GO:0090262 | regulation of transcription-coupled nucleotide-excision repair | 1 | 1 | 4.47e-01 |
| GO:BP | GO:1903516 | regulation of single strand break repair | 2 | 3 | 4.47e-01 |
| GO:BP | GO:0090385 | phagosome-lysosome fusion | 1 | 12 | 4.47e-01 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 16 | 299 | 4.47e-01 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 9 | 179 | 4.47e-01 |
| GO:BP | GO:0036499 | PERK-mediated unfolded protein response | 2 | 17 | 4.47e-01 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 64 | 241 | 4.47e-01 |
| GO:BP | GO:0097711 | ciliary basal body-plasma membrane docking | 2 | 2 | 4.47e-01 |
| GO:BP | GO:0006576 | biogenic amine metabolic process | 6 | 57 | 4.47e-01 |
| GO:BP | GO:1901006 | ubiquinone-6 biosynthetic process | 1 | 1 | 4.47e-01 |
| GO:BP | GO:1901004 | ubiquinone-6 metabolic process | 1 | 1 | 4.47e-01 |
| GO:BP | GO:0044743 | protein transmembrane import into intracellular organelle | 22 | 36 | 4.47e-01 |
| GO:BP | GO:0055064 | chloride ion homeostasis | 2 | 13 | 4.47e-01 |
| GO:BP | GO:0042994 | cytoplasmic sequestering of transcription factor | 3 | 15 | 4.47e-01 |
| GO:BP | GO:0040029 | epigenetic regulation of gene expression | 1 | 153 | 4.47e-01 |
| GO:BP | GO:0007368 | determination of left/right symmetry | 7 | 97 | 4.47e-01 |
| GO:BP | GO:0035732 | nitric oxide storage | 1 | 1 | 4.47e-01 |
| GO:BP | GO:0060420 | regulation of heart growth | 31 | 50 | 4.47e-01 |
| GO:BP | GO:0010226 | response to lithium ion | 2 | 16 | 4.47e-01 |
| GO:BP | GO:0035235 | ionotropic glutamate receptor signaling pathway | 2 | 14 | 4.47e-01 |
| GO:BP | GO:1990114 | RNA polymerase II core complex assembly | 1 | 1 | 4.47e-01 |
| GO:BP | GO:0002481 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 2 | 2 | 4.47e-01 |
| GO:BP | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 3 | 3 | 4.47e-01 |
| GO:BP | GO:1904261 | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 1 | 5 | 4.47e-01 |
| GO:BP | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis | 1 | 5 | 4.47e-01 |
| GO:BP | GO:1902047 | polyamine transmembrane transport | 1 | 10 | 4.47e-01 |
| GO:BP | GO:2001197 | basement membrane assembly involved in embryonic body morphogenesis | 1 | 5 | 4.47e-01 |
| GO:BP | GO:0006431 | methionyl-tRNA aminoacylation | 2 | 2 | 4.47e-01 |
| GO:BP | GO:0090257 | regulation of muscle system process | 12 | 184 | 4.47e-01 |
| GO:BP | GO:0006566 | threonine metabolic process | 4 | 4 | 4.48e-01 |
| GO:BP | GO:1901392 | regulation of transforming growth factor beta1 activation | 1 | 1 | 4.48e-01 |
| GO:BP | GO:0015919 | peroxisomal membrane transport | 10 | 20 | 4.48e-01 |
| GO:BP | GO:0032329 | serine transport | 2 | 10 | 4.48e-01 |
| GO:BP | GO:1901394 | positive regulation of transforming growth factor beta1 activation | 1 | 1 | 4.48e-01 |
| GO:BP | GO:0090472 | dibasic protein processing | 1 | 1 | 4.48e-01 |
| GO:BP | GO:0090241 | negative regulation of histone H4 acetylation | 2 | 2 | 4.48e-01 |
| GO:BP | GO:0042147 | retrograde transport, endosome to Golgi | 13 | 88 | 4.48e-01 |
| GO:BP | GO:0036316 | SREBP-SCAP complex retention in endoplasmic reticulum | 2 | 2 | 4.48e-01 |
| GO:BP | GO:0046685 | response to arsenic-containing substance | 15 | 30 | 4.48e-01 |
| GO:BP | GO:0039534 | negative regulation of MDA-5 signaling pathway | 1 | 3 | 4.49e-01 |
| GO:BP | GO:0034354 | ‘de novo’ NAD biosynthetic process from tryptophan | 1 | 1 | 4.49e-01 |
| GO:BP | GO:0016559 | peroxisome fission | 7 | 9 | 4.49e-01 |
| GO:BP | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 2 | 8 | 4.49e-01 |
| GO:BP | GO:0097252 | oligodendrocyte apoptotic process | 3 | 4 | 4.49e-01 |
| GO:BP | GO:1900045 | negative regulation of protein K63-linked ubiquitination | 1 | 7 | 4.50e-01 |
| GO:BP | GO:0010561 | negative regulation of glycoprotein biosynthetic process | 2 | 10 | 4.50e-01 |
| GO:BP | GO:0045776 | negative regulation of blood pressure | 4 | 30 | 4.51e-01 |
| GO:BP | GO:0006660 | phosphatidylserine catabolic process | 3 | 3 | 4.51e-01 |
| GO:BP | GO:0038145 | macrophage colony-stimulating factor signaling pathway | 1 | 3 | 4.51e-01 |
| GO:BP | GO:0120040 | regulation of macrophage proliferation | 1 | 4 | 4.51e-01 |
| GO:BP | GO:1904141 | positive regulation of microglial cell migration | 1 | 3 | 4.51e-01 |
| GO:BP | GO:1903569 | positive regulation of protein localization to ciliary membrane | 1 | 1 | 4.51e-01 |
| GO:BP | GO:1901135 | carbohydrate derivative metabolic process | 6 | 843 | 4.51e-01 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 2 | 236 | 4.51e-01 |
| GO:BP | GO:0036474 | cell death in response to hydrogen peroxide | 3 | 23 | 4.51e-01 |
| GO:BP | GO:0016104 | triterpenoid biosynthetic process | 1 | 1 | 4.51e-01 |
| GO:BP | GO:0003401 | axis elongation | 1 | 24 | 4.51e-01 |
| GO:BP | GO:0071361 | cellular response to ethanol | 1 | 9 | 4.52e-01 |
| GO:BP | GO:1904659 | glucose transmembrane transport | 3 | 81 | 4.52e-01 |
| GO:BP | GO:1901166 | neural crest cell migration involved in autonomic nervous system development | 4 | 5 | 4.52e-01 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 3 | 1201 | 4.52e-01 |
| GO:BP | GO:1903765 | negative regulation of potassium ion export across plasma membrane | 1 | 1 | 4.52e-01 |
| GO:BP | GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 4 | 21 | 4.52e-01 |
| GO:BP | GO:1903008 | organelle disassembly | 12 | 137 | 4.52e-01 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 11 | 123 | 4.52e-01 |
| GO:BP | GO:0040012 | regulation of locomotion | 1 | 763 | 4.52e-01 |
| GO:BP | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 10 | 40 | 4.52e-01 |
| GO:BP | GO:0035589 | G protein-coupled purinergic nucleotide receptor signaling pathway | 2 | 4 | 4.52e-01 |
| GO:BP | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 8 | 12 | 4.52e-01 |
| GO:BP | GO:0098926 | postsynaptic signal transduction | 1 | 25 | 4.52e-01 |
| GO:BP | GO:1901254 | positive regulation of intracellular transport of viral material | 1 | 1 | 4.52e-01 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 2 | 49 | 4.52e-01 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 2 | 662 | 4.52e-01 |
| GO:BP | GO:0061951 | establishment of protein localization to plasma membrane | 2 | 59 | 4.52e-01 |
| GO:BP | GO:1902116 | negative regulation of organelle assembly | 7 | 40 | 4.52e-01 |
| GO:BP | GO:1904377 | positive regulation of protein localization to cell periphery | 2 | 57 | 4.52e-01 |
| GO:BP | GO:0007006 | mitochondrial membrane organization | 62 | 114 | 4.53e-01 |
| GO:BP | GO:0043247 | telomere maintenance in response to DNA damage | 3 | 29 | 4.53e-01 |
| GO:BP | GO:0032053 | ciliary basal body organization | 1 | 4 | 4.53e-01 |
| GO:BP | GO:0007029 | endoplasmic reticulum organization | 2 | 83 | 4.53e-01 |
| GO:BP | GO:1905446 | regulation of mitochondrial ATP synthesis coupled electron transport | 1 | 6 | 4.54e-01 |
| GO:BP | GO:1902257 | negative regulation of apoptotic process involved in outflow tract morphogenesis | 1 | 2 | 4.54e-01 |
| GO:BP | GO:0090077 | foam cell differentiation | 1 | 22 | 4.54e-01 |
| GO:BP | GO:0010742 | macrophage derived foam cell differentiation | 1 | 22 | 4.54e-01 |
| GO:BP | GO:0031338 | regulation of vesicle fusion | 1 | 17 | 4.54e-01 |
| GO:BP | GO:0071625 | vocalization behavior | 2 | 13 | 4.54e-01 |
| GO:BP | GO:0090435 | protein localization to nuclear envelope | 1 | 14 | 4.54e-01 |
| GO:BP | GO:1903545 | cellular response to butyrate | 1 | 1 | 4.54e-01 |
| GO:BP | GO:0061772 | xenobiotic transport across blood-nerve barrier | 1 | 1 | 4.54e-01 |
| GO:BP | GO:0061043 | regulation of vascular wound healing | 1 | 9 | 4.54e-01 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 11 | 227 | 4.55e-01 |
| GO:BP | GO:0051409 | response to nitrosative stress | 6 | 10 | 4.55e-01 |
| GO:BP | GO:1902884 | positive regulation of response to oxidative stress | 5 | 9 | 4.55e-01 |
| GO:BP | GO:0043001 | Golgi to plasma membrane protein transport | 22 | 37 | 4.55e-01 |
| GO:BP | GO:0048486 | parasympathetic nervous system development | 2 | 12 | 4.55e-01 |
| GO:BP | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 5 | 9 | 4.55e-01 |
| GO:BP | GO:0001558 | regulation of cell growth | 3 | 357 | 4.55e-01 |
| GO:BP | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation | 5 | 11 | 4.55e-01 |
| GO:BP | GO:0021772 | olfactory bulb development | 12 | 19 | 4.55e-01 |
| GO:BP | GO:0033077 | T cell differentiation in thymus | 1 | 56 | 4.55e-01 |
| GO:BP | GO:0018057 | peptidyl-lysine oxidation | 4 | 5 | 4.55e-01 |
| GO:BP | GO:1903573 | negative regulation of response to endoplasmic reticulum stress | 2 | 41 | 4.56e-01 |
| GO:BP | GO:1903012 | positive regulation of bone development | 1 | 1 | 4.56e-01 |
| GO:BP | GO:1902775 | mitochondrial large ribosomal subunit assembly | 3 | 4 | 4.56e-01 |
| GO:BP | GO:2000638 | regulation of SREBP signaling pathway | 5 | 7 | 4.56e-01 |
| GO:BP | GO:0010002 | cardioblast differentiation | 6 | 15 | 4.56e-01 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3 | 48 | 4.56e-01 |
| GO:BP | GO:0031280 | negative regulation of cyclase activity | 3 | 13 | 4.56e-01 |
| GO:BP | GO:0001736 | establishment of planar polarity | 11 | 70 | 4.56e-01 |
| GO:BP | GO:0045184 | establishment of protein localization | 2 | 1462 | 4.56e-01 |
| GO:BP | GO:0031119 | tRNA pseudouridine synthesis | 1 | 6 | 4.56e-01 |
| GO:BP | GO:0019082 | viral protein processing | 2 | 31 | 4.56e-01 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1 | 105 | 4.56e-01 |
| GO:BP | GO:0071257 | cellular response to electrical stimulus | 4 | 8 | 4.56e-01 |
| GO:BP | GO:0007164 | establishment of tissue polarity | 11 | 70 | 4.56e-01 |
| GO:BP | GO:0043632 | modification-dependent macromolecule catabolic process | 25 | 637 | 4.56e-01 |
| GO:BP | GO:0009063 | amino acid catabolic process | 1 | 78 | 4.56e-01 |
| GO:BP | GO:1903347 | negative regulation of bicellular tight junction assembly | 1 | 3 | 4.56e-01 |
| GO:BP | GO:0034113 | heterotypic cell-cell adhesion | 6 | 37 | 4.56e-01 |
| GO:BP | GO:0090501 | RNA phosphodiester bond hydrolysis | 3 | 136 | 4.56e-01 |
| GO:BP | GO:0019322 | pentose biosynthetic process | 1 | 2 | 4.56e-01 |
| GO:BP | GO:0019520 | aldonic acid metabolic process | 1 | 2 | 4.56e-01 |
| GO:BP | GO:0019521 | D-gluconate metabolic process | 1 | 2 | 4.56e-01 |
| GO:BP | GO:0046177 | D-gluconate catabolic process | 1 | 2 | 4.56e-01 |
| GO:BP | GO:0034486 | vacuolar transmembrane transport | 2 | 3 | 4.56e-01 |
| GO:BP | GO:0046176 | aldonic acid catabolic process | 1 | 2 | 4.56e-01 |
| GO:BP | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 2 | 6 | 4.56e-01 |
| GO:BP | GO:2000348 | regulation of CD40 signaling pathway | 2 | 4 | 4.57e-01 |
| GO:BP | GO:1900543 | negative regulation of purine nucleotide metabolic process | 2 | 6 | 4.57e-01 |
| GO:BP | GO:0032960 | regulation of inositol trisphosphate biosynthetic process | 1 | 4 | 4.57e-01 |
| GO:BP | GO:0031048 | small ncRNA-mediated heterochromatin formation | 2 | 2 | 4.57e-01 |
| GO:BP | GO:0070512 | positive regulation of histone H4-K20 methylation | 1 | 1 | 4.57e-01 |
| GO:BP | GO:2000392 | regulation of lamellipodium morphogenesis | 5 | 10 | 4.57e-01 |
| GO:BP | GO:0035308 | negative regulation of protein dephosphorylation | 3 | 28 | 4.57e-01 |
| GO:BP | GO:0003105 | negative regulation of glomerular filtration | 1 | 3 | 4.57e-01 |
| GO:BP | GO:0098693 | regulation of synaptic vesicle cycle | 8 | 13 | 4.57e-01 |
| GO:BP | GO:0036445 | neuronal stem cell division | 1 | 1 | 4.57e-01 |
| GO:BP | GO:0071295 | cellular response to vitamin | 1 | 22 | 4.57e-01 |
| GO:BP | GO:0016075 | rRNA catabolic process | 1 | 19 | 4.57e-01 |
| GO:BP | GO:0140251 | regulation protein catabolic process at presynapse | 2 | 2 | 4.57e-01 |
| GO:BP | GO:0099540 | trans-synaptic signaling by neuropeptide | 1 | 1 | 4.57e-01 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 1 | 34 | 4.57e-01 |
| GO:BP | GO:0010891 | negative regulation of sequestering of triglyceride | 1 | 5 | 4.57e-01 |
| GO:BP | GO:0046364 | monosaccharide biosynthetic process | 1 | 79 | 4.57e-01 |
| GO:BP | GO:0090103 | cochlea morphogenesis | 2 | 15 | 4.57e-01 |
| GO:BP | GO:0006425 | glutaminyl-tRNA aminoacylation | 1 | 2 | 4.57e-01 |
| GO:BP | GO:0006429 | leucyl-tRNA aminoacylation | 1 | 2 | 4.57e-01 |
| GO:BP | GO:1905608 | positive regulation of presynapse assembly | 1 | 2 | 4.58e-01 |
| GO:BP | GO:0097069 | cellular response to thyroxine stimulus | 2 | 2 | 4.58e-01 |
| GO:BP | GO:0070316 | regulation of G0 to G1 transition | 6 | 34 | 4.58e-01 |
| GO:BP | GO:2000490 | negative regulation of hepatic stellate cell activation | 2 | 2 | 4.58e-01 |
| GO:BP | GO:1904387 | cellular response to L-phenylalanine derivative | 2 | 2 | 4.58e-01 |
| GO:BP | GO:0007219 | Notch signaling pathway | 1 | 146 | 4.58e-01 |
| GO:BP | GO:1903540 | establishment of protein localization to postsynaptic membrane | 11 | 16 | 4.58e-01 |
| GO:BP | GO:0034263 | positive regulation of autophagy in response to ER overload | 1 | 1 | 4.58e-01 |
| GO:BP | GO:1900020 | positive regulation of protein kinase C activity | 1 | 6 | 4.58e-01 |
| GO:BP | GO:0007442 | hindgut morphogenesis | 1 | 4 | 4.58e-01 |
| GO:BP | GO:1900019 | regulation of protein kinase C activity | 1 | 6 | 4.58e-01 |
| GO:BP | GO:0003188 | heart valve formation | 9 | 16 | 4.58e-01 |
| GO:BP | GO:0009408 | response to heat | 4 | 84 | 4.58e-01 |
| GO:BP | GO:0060638 | mesenchymal-epithelial cell signaling | 1 | 4 | 4.58e-01 |
| GO:BP | GO:0010571 | positive regulation of nuclear cell cycle DNA replication | 1 | 6 | 4.58e-01 |
| GO:BP | GO:0045063 | T-helper 1 cell differentiation | 6 | 14 | 4.58e-01 |
| GO:BP | GO:0070257 | positive regulation of mucus secretion | 1 | 4 | 4.58e-01 |
| GO:BP | GO:0001666 | response to hypoxia | 13 | 237 | 4.59e-01 |
| GO:BP | GO:0019538 | protein metabolic process | 8 | 4241 | 4.59e-01 |
| GO:BP | GO:0030238 | male sex determination | 5 | 8 | 4.59e-01 |
| GO:BP | GO:0043255 | regulation of carbohydrate biosynthetic process | 1 | 77 | 4.59e-01 |
| GO:BP | GO:1905232 | cellular response to L-glutamate | 2 | 4 | 4.59e-01 |
| GO:BP | GO:1903429 | regulation of cell maturation | 3 | 13 | 4.59e-01 |
| GO:BP | GO:0045070 | positive regulation of viral genome replication | 1 | 28 | 4.60e-01 |
| GO:BP | GO:0003156 | regulation of animal organ formation | 2 | 20 | 4.60e-01 |
| GO:BP | GO:0051958 | methotrexate transport | 1 | 2 | 4.60e-01 |
| GO:BP | GO:0019227 | neuronal action potential propagation | 2 | 5 | 4.60e-01 |
| GO:BP | GO:0009222 | pyrimidine ribonucleotide catabolic process | 1 | 7 | 4.60e-01 |
| GO:BP | GO:0010737 | protein kinase A signaling | 1 | 23 | 4.60e-01 |
| GO:BP | GO:0009131 | pyrimidine nucleoside monophosphate catabolic process | 1 | 6 | 4.60e-01 |
| GO:BP | GO:0045662 | negative regulation of myoblast differentiation | 12 | 19 | 4.60e-01 |
| GO:BP | GO:0098870 | action potential propagation | 2 | 5 | 4.60e-01 |
| GO:BP | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 3 | 9 | 4.60e-01 |
| GO:BP | GO:0060563 | neuroepithelial cell differentiation | 7 | 22 | 4.60e-01 |
| GO:BP | GO:0016073 | snRNA metabolic process | 8 | 54 | 4.60e-01 |
| GO:BP | GO:1901724 | positive regulation of cell proliferation involved in kidney development | 5 | 8 | 4.60e-01 |
| GO:BP | GO:0018160 | peptidyl-pyrromethane cofactor linkage | 1 | 1 | 4.61e-01 |
| GO:BP | GO:0060059 | embryonic retina morphogenesis in camera-type eye | 2 | 5 | 4.61e-01 |
| GO:BP | GO:0007023 | post-chaperonin tubulin folding pathway | 1 | 6 | 4.62e-01 |
| GO:BP | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration | 1 | 1 | 4.62e-01 |
| GO:BP | GO:2001304 | lipoxin B4 metabolic process | 1 | 1 | 4.62e-01 |
| GO:BP | GO:2000632 | negative regulation of pre-miRNA processing | 2 | 2 | 4.62e-01 |
| GO:BP | GO:0060596 | mammary placode formation | 2 | 2 | 4.62e-01 |
| GO:BP | GO:0090313 | regulation of protein targeting to membrane | 7 | 27 | 4.62e-01 |
| GO:BP | GO:0009110 | vitamin biosynthetic process | 2 | 14 | 4.62e-01 |
| GO:BP | GO:1905072 | cardiac jelly development | 2 | 3 | 4.62e-01 |
| GO:BP | GO:0043116 | negative regulation of vascular permeability | 1 | 16 | 4.62e-01 |
| GO:BP | GO:1901725 | regulation of histone deacetylase activity | 6 | 8 | 4.62e-01 |
| GO:BP | GO:0100001 | regulation of skeletal muscle contraction by action potential | 1 | 1 | 4.62e-01 |
| GO:BP | GO:0030030 | cell projection organization | 3 | 1233 | 4.62e-01 |
| GO:BP | GO:0006892 | post-Golgi vesicle-mediated transport | 57 | 103 | 4.62e-01 |
| GO:BP | GO:0034638 | phosphatidylcholine catabolic process | 2 | 9 | 4.62e-01 |
| GO:BP | GO:0044321 | response to leptin | 2 | 19 | 4.62e-01 |
| GO:BP | GO:0006432 | phenylalanyl-tRNA aminoacylation | 3 | 4 | 4.62e-01 |
| GO:BP | GO:0051610 | serotonin uptake | 1 | 8 | 4.62e-01 |
| GO:BP | GO:0060136 | embryonic process involved in female pregnancy | 1 | 6 | 4.63e-01 |
| GO:BP | GO:0006418 | tRNA aminoacylation for protein translation | 20 | 40 | 4.63e-01 |
| GO:BP | GO:0006309 | apoptotic DNA fragmentation | 4 | 13 | 4.63e-01 |
| GO:BP | GO:0060087 | relaxation of vascular associated smooth muscle | 1 | 7 | 4.63e-01 |
| GO:BP | GO:0031033 | myosin filament organization | 4 | 5 | 4.63e-01 |
| GO:BP | GO:0060532 | bronchus cartilage development | 2 | 2 | 4.63e-01 |
| GO:BP | GO:0006054 | N-acetylneuraminate metabolic process | 6 | 11 | 4.63e-01 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 1 | 222 | 4.63e-01 |
| GO:BP | GO:0061145 | lung smooth muscle development | 2 | 2 | 4.63e-01 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 2 | 81 | 4.63e-01 |
| GO:BP | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex | 4 | 5 | 4.63e-01 |
| GO:BP | GO:0097211 | cellular response to gonadotropin-releasing hormone | 2 | 3 | 4.64e-01 |
| GO:BP | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | 3 | 4 | 4.64e-01 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 1 | 14 | 4.64e-01 |
| GO:BP | GO:1902722 | positive regulation of prolactin secretion | 1 | 1 | 4.64e-01 |
| GO:BP | GO:1900186 | negative regulation of clathrin-dependent endocytosis | 2 | 4 | 4.65e-01 |
| GO:BP | GO:0060398 | regulation of growth hormone receptor signaling pathway | 1 | 5 | 4.65e-01 |
| GO:BP | GO:0006771 | riboflavin metabolic process | 1 | 3 | 4.65e-01 |
| GO:BP | GO:0072282 | metanephric nephron tubule morphogenesis | 1 | 5 | 4.65e-01 |
| GO:BP | GO:0007422 | peripheral nervous system development | 1 | 67 | 4.65e-01 |
| GO:BP | GO:1902866 | regulation of retina development in camera-type eye | 1 | 1 | 4.65e-01 |
| GO:BP | GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4 | 211 | 4.65e-01 |
| GO:BP | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 1 | 1 | 4.66e-01 |
| GO:BP | GO:0032688 | negative regulation of interferon-beta production | 5 | 10 | 4.66e-01 |
| GO:BP | GO:0098939 | dendritic transport of mitochondrion | 1 | 2 | 4.66e-01 |
| GO:BP | GO:0002200 | somatic diversification of immune receptors | 3 | 62 | 4.66e-01 |
| GO:BP | GO:0003174 | mitral valve development | 6 | 12 | 4.66e-01 |
| GO:BP | GO:0016264 | gap junction assembly | 1 | 14 | 4.66e-01 |
| GO:BP | GO:0071044 | histone mRNA catabolic process | 7 | 11 | 4.66e-01 |
| GO:BP | GO:0006089 | lactate metabolic process | 9 | 16 | 4.66e-01 |
| GO:BP | GO:1901873 | regulation of post-translational protein modification | 2 | 6 | 4.67e-01 |
| GO:BP | GO:0038180 | nerve growth factor signaling pathway | 3 | 10 | 4.67e-01 |
| GO:BP | GO:0008645 | hexose transmembrane transport | 3 | 84 | 4.67e-01 |
| GO:BP | GO:0009256 | 10-formyltetrahydrofolate metabolic process | 2 | 6 | 4.67e-01 |
| GO:BP | GO:0072124 | regulation of glomerular mesangial cell proliferation | 7 | 9 | 4.67e-01 |
| GO:BP | GO:0062042 | regulation of cardiac epithelial to mesenchymal transition | 2 | 10 | 4.67e-01 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 24 | 71 | 4.67e-01 |
| GO:BP | GO:0048853 | forebrain morphogenesis | 3 | 7 | 4.67e-01 |
| GO:BP | GO:0035907 | dorsal aorta development | 2 | 8 | 4.67e-01 |
| GO:BP | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission | 1 | 6 | 4.67e-01 |
| GO:BP | GO:0051940 | regulation of catecholamine uptake involved in synaptic transmission | 1 | 6 | 4.67e-01 |
| GO:BP | GO:0014719 | skeletal muscle satellite cell activation | 2 | 5 | 4.67e-01 |
| GO:BP | GO:0071503 | response to heparin | 3 | 5 | 4.67e-01 |
| GO:BP | GO:0021780 | glial cell fate specification | 3 | 3 | 4.67e-01 |
| GO:BP | GO:0072197 | ureter morphogenesis | 3 | 5 | 4.67e-01 |
| GO:BP | GO:0036109 | alpha-linolenic acid metabolic process | 3 | 9 | 4.67e-01 |
| GO:BP | GO:0042758 | long-chain fatty acid catabolic process | 3 | 3 | 4.67e-01 |
| GO:BP | GO:1903894 | regulation of IRE1-mediated unfolded protein response | 5 | 14 | 4.67e-01 |
| GO:BP | GO:0048524 | positive regulation of viral process | 2 | 55 | 4.67e-01 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 4 | 2011 | 4.67e-01 |
| GO:BP | GO:0046380 | N-acetylneuraminate biosynthetic process | 1 | 1 | 4.67e-01 |
| GO:BP | GO:0070544 | histone H3-K36 demethylation | 3 | 5 | 4.67e-01 |
| GO:BP | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 1 | 5 | 4.68e-01 |
| GO:BP | GO:2000671 | regulation of motor neuron apoptotic process | 1 | 12 | 4.68e-01 |
| GO:BP | GO:0003012 | muscle system process | 8 | 334 | 4.68e-01 |
| GO:BP | GO:0006610 | ribosomal protein import into nucleus | 1 | 4 | 4.68e-01 |
| GO:BP | GO:0006404 | RNA import into nucleus | 1 | 4 | 4.68e-01 |
| GO:BP | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade | 7 | 16 | 4.68e-01 |
| GO:BP | GO:0106058 | positive regulation of calcineurin-mediated signaling | 7 | 16 | 4.68e-01 |
| GO:BP | GO:0072080 | nephron tubule development | 4 | 73 | 4.68e-01 |
| GO:BP | GO:1903575 | cornified envelope assembly | 1 | 6 | 4.68e-01 |
| GO:BP | GO:0007495 | visceral mesoderm-endoderm interaction involved in midgut development | 1 | 1 | 4.68e-01 |
| GO:BP | GO:0051309 | female meiosis chromosome separation | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0007283 | spermatogenesis | 2 | 330 | 4.68e-01 |
| GO:BP | GO:0086011 | membrane repolarization during action potential | 3 | 22 | 4.68e-01 |
| GO:BP | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 1 | 30 | 4.68e-01 |
| GO:BP | GO:0072229 | metanephric proximal convoluted tubule development | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0072019 | proximal convoluted tubule development | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0060232 | delamination | 1 | 5 | 4.68e-01 |
| GO:BP | GO:0048261 | negative regulation of receptor-mediated endocytosis | 6 | 25 | 4.68e-01 |
| GO:BP | GO:0061159 | establishment of bipolar cell polarity involved in cell morphogenesis | 1 | 1 | 4.68e-01 |
| GO:BP | GO:0051892 | negative regulation of cardioblast differentiation | 1 | 1 | 4.68e-01 |
| GO:BP | GO:0010664 | negative regulation of striated muscle cell apoptotic process | 2 | 24 | 4.68e-01 |
| GO:BP | GO:0019045 | latent virus replication | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0002087 | regulation of respiratory gaseous exchange by nervous system process | 1 | 8 | 4.68e-01 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 1 | 532 | 4.68e-01 |
| GO:BP | GO:0061000 | negative regulation of dendritic spine development | 1 | 10 | 4.68e-01 |
| GO:BP | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0019046 | release from viral latency | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0010906 | regulation of glucose metabolic process | 1 | 86 | 4.68e-01 |
| GO:BP | GO:2000177 | regulation of neural precursor cell proliferation | 23 | 64 | 4.68e-01 |
| GO:BP | GO:1905454 | negative regulation of myeloid progenitor cell differentiation | 1 | 1 | 4.68e-01 |
| GO:BP | GO:0032464 | positive regulation of protein homooligomerization | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0033630 | positive regulation of cell adhesion mediated by integrin | 1 | 14 | 4.68e-01 |
| GO:BP | GO:0032601 | connective tissue growth factor production | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 5 | 23 | 4.68e-01 |
| GO:BP | GO:0106047 | polyamine deacetylation | 1 | 1 | 4.68e-01 |
| GO:BP | GO:0033962 | P-body assembly | 1 | 20 | 4.68e-01 |
| GO:BP | GO:0071313 | cellular response to caffeine | 5 | 10 | 4.68e-01 |
| GO:BP | GO:1904814 | regulation of protein localization to chromosome, telomeric region | 1 | 15 | 4.68e-01 |
| GO:BP | GO:0001881 | receptor recycling | 1 | 38 | 4.68e-01 |
| GO:BP | GO:0032643 | regulation of connective tissue growth factor production | 1 | 2 | 4.68e-01 |
| GO:BP | GO:0071228 | cellular response to tumor cell | 3 | 4 | 4.68e-01 |
| GO:BP | GO:0001893 | maternal placenta development | 2 | 28 | 4.68e-01 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 7 | 143 | 4.68e-01 |
| GO:BP | GO:0051654 | establishment of mitochondrion localization | 1 | 30 | 4.68e-01 |
| GO:BP | GO:0061072 | iris morphogenesis | 1 | 5 | 4.68e-01 |
| GO:BP | GO:2001045 | negative regulation of integrin-mediated signaling pathway | 1 | 3 | 4.68e-01 |
| GO:BP | GO:0060354 | negative regulation of cell adhesion molecule production | 1 | 5 | 4.68e-01 |
| GO:BP | GO:0048219 | inter-Golgi cisterna vesicle-mediated transport | 1 | 1 | 4.68e-01 |
| GO:BP | GO:2001224 | positive regulation of neuron migration | 11 | 19 | 4.68e-01 |
| GO:BP | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 7 | 10 | 4.68e-01 |
| GO:BP | GO:0106048 | spermidine deacetylation | 1 | 1 | 4.68e-01 |
| GO:BP | GO:0031293 | membrane protein intracellular domain proteolysis | 1 | 10 | 4.68e-01 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 6 | 50 | 4.68e-01 |
| GO:BP | GO:0045925 | positive regulation of female receptivity | 1 | 1 | 4.69e-01 |
| GO:BP | GO:0006538 | glutamate catabolic process | 1 | 7 | 4.69e-01 |
| GO:BP | GO:0009448 | gamma-aminobutyric acid metabolic process | 1 | 6 | 4.69e-01 |
| GO:BP | GO:0035493 | SNARE complex assembly | 13 | 22 | 4.69e-01 |
| GO:BP | GO:0051593 | response to folic acid | 4 | 9 | 4.69e-01 |
| GO:BP | GO:1901563 | response to camptothecin | 2 | 5 | 4.70e-01 |
| GO:BP | GO:0021988 | olfactory lobe development | 1 | 21 | 4.70e-01 |
| GO:BP | GO:0010585 | glutamine secretion | 2 | 2 | 4.70e-01 |
| GO:BP | GO:0006607 | NLS-bearing protein import into nucleus | 3 | 18 | 4.70e-01 |
| GO:BP | GO:0036017 | response to erythropoietin | 3 | 4 | 4.71e-01 |
| GO:BP | GO:0034086 | maintenance of sister chromatid cohesion | 1 | 12 | 4.71e-01 |
| GO:BP | GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1 | 12 | 4.71e-01 |
| GO:BP | GO:1904291 | positive regulation of mitotic DNA damage checkpoint | 1 | 2 | 4.71e-01 |
| GO:BP | GO:0046514 | ceramide catabolic process | 6 | 16 | 4.71e-01 |
| GO:BP | GO:0034260 | negative regulation of GTPase activity | 2 | 29 | 4.71e-01 |
| GO:BP | GO:0006482 | protein demethylation | 12 | 27 | 4.71e-01 |
| GO:BP | GO:0001712 | ectodermal cell fate commitment | 2 | 2 | 4.71e-01 |
| GO:BP | GO:0098920 | retrograde trans-synaptic signaling by lipid | 2 | 4 | 4.71e-01 |
| GO:BP | GO:0034201 | response to oleic acid | 4 | 5 | 4.71e-01 |
| GO:BP | GO:0046457 | prostanoid biosynthetic process | 1 | 19 | 4.71e-01 |
| GO:BP | GO:0071878 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway | 2 | 5 | 4.71e-01 |
| GO:BP | GO:0001516 | prostaglandin biosynthetic process | 1 | 19 | 4.71e-01 |
| GO:BP | GO:0036510 | trimming of terminal mannose on C branch | 1 | 3 | 4.71e-01 |
| GO:BP | GO:0003195 | tricuspid valve formation | 2 | 2 | 4.71e-01 |
| GO:BP | GO:0098921 | retrograde trans-synaptic signaling by endocannabinoid | 2 | 4 | 4.71e-01 |
| GO:BP | GO:0008589 | regulation of smoothened signaling pathway | 10 | 73 | 4.71e-01 |
| GO:BP | GO:0008214 | protein dealkylation | 12 | 27 | 4.71e-01 |
| GO:BP | GO:0048484 | enteric nervous system development | 2 | 7 | 4.71e-01 |
| GO:BP | GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1 | 4 | 4.71e-01 |
| GO:BP | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 10 | 46 | 4.71e-01 |
| GO:BP | GO:0071415 | cellular response to purine-containing compound | 6 | 11 | 4.71e-01 |
| GO:BP | GO:1903464 | negative regulation of mitotic cell cycle DNA replication | 1 | 1 | 4.71e-01 |
| GO:BP | GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 1 | 1 | 4.71e-01 |
| GO:BP | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol | 1 | 3 | 4.71e-01 |
| GO:BP | GO:1902576 | negative regulation of nuclear cell cycle DNA replication | 1 | 1 | 4.71e-01 |
| GO:BP | GO:0003341 | cilium movement | 1 | 97 | 4.71e-01 |
| GO:BP | GO:0016180 | snRNA processing | 5 | 26 | 4.71e-01 |
| GO:BP | GO:0060972 | left/right pattern formation | 7 | 101 | 4.71e-01 |
| GO:BP | GO:0022038 | corpus callosum development | 15 | 20 | 4.72e-01 |
| GO:BP | GO:0035902 | response to immobilization stress | 2 | 16 | 4.72e-01 |
| GO:BP | GO:0060019 | radial glial cell differentiation | 4 | 12 | 4.72e-01 |
| GO:BP | GO:0007286 | spermatid development | 1 | 105 | 4.72e-01 |
| GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 3 | 20 | 4.72e-01 |
| GO:BP | GO:2000808 | negative regulation of synaptic vesicle clustering | 1 | 1 | 4.72e-01 |
| GO:BP | GO:0140029 | exocytic process | 3 | 69 | 4.72e-01 |
| GO:BP | GO:1904627 | response to phorbol 13-acetate 12-myristate | 2 | 4 | 4.72e-01 |
| GO:BP | GO:1904628 | cellular response to phorbol 13-acetate 12-myristate | 2 | 4 | 4.72e-01 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 7 | 54 | 4.72e-01 |
| GO:BP | GO:0042573 | retinoic acid metabolic process | 1 | 12 | 4.72e-01 |
| GO:BP | GO:1990547 | mitochondrial phosphate ion transmembrane transport | 1 | 1 | 4.72e-01 |
| GO:BP | GO:0090135 | actin filament branching | 1 | 1 | 4.73e-01 |
| GO:BP | GO:0036153 | triglyceride acyl-chain remodeling | 1 | 1 | 4.73e-01 |
| GO:BP | GO:0002685 | regulation of leukocyte migration | 12 | 131 | 4.73e-01 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 4 | 1974 | 4.73e-01 |
| GO:BP | GO:1904139 | regulation of microglial cell migration | 1 | 3 | 4.73e-01 |
| GO:BP | GO:1904124 | microglial cell migration | 1 | 3 | 4.73e-01 |
| GO:BP | GO:0061518 | microglial cell proliferation | 1 | 4 | 4.73e-01 |
| GO:BP | GO:0010498 | proteasomal protein catabolic process | 29 | 486 | 4.73e-01 |
| GO:BP | GO:0035891 | exit from host cell | 2 | 28 | 4.73e-01 |
| GO:BP | GO:0019076 | viral release from host cell | 2 | 28 | 4.73e-01 |
| GO:BP | GO:1990918 | double-strand break repair involved in meiotic recombination | 2 | 2 | 4.74e-01 |
| GO:BP | GO:2000394 | positive regulation of lamellipodium morphogenesis | 3 | 6 | 4.74e-01 |
| GO:BP | GO:0032740 | positive regulation of interleukin-17 production | 1 | 12 | 4.74e-01 |
| GO:BP | GO:0051497 | negative regulation of stress fiber assembly | 17 | 23 | 4.74e-01 |
| GO:BP | GO:0006435 | threonyl-tRNA aminoacylation | 1 | 3 | 4.74e-01 |
| GO:BP | GO:0044752 | response to human chorionic gonadotropin | 4 | 5 | 4.74e-01 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 65 | 213 | 4.74e-01 |
| GO:BP | GO:0071423 | malate transmembrane transport | 1 | 5 | 4.74e-01 |
| GO:BP | GO:0003214 | cardiac left ventricle morphogenesis | 6 | 12 | 4.74e-01 |
| GO:BP | GO:0015743 | malate transport | 1 | 5 | 4.74e-01 |
| GO:BP | GO:1901661 | quinone metabolic process | 1 | 32 | 4.74e-01 |
| GO:BP | GO:1902356 | oxaloacetate(2-) transmembrane transport | 1 | 5 | 4.74e-01 |
| GO:BP | GO:1902902 | negative regulation of autophagosome assembly | 8 | 14 | 4.74e-01 |
| GO:BP | GO:0019550 | glutamate catabolic process to aspartate | 2 | 2 | 4.74e-01 |
| GO:BP | GO:0019551 | glutamate catabolic process to 2-oxoglutarate | 2 | 2 | 4.74e-01 |
| GO:BP | GO:0015846 | polyamine transport | 1 | 12 | 4.74e-01 |
| GO:BP | GO:0055111 | ingression involved in gastrulation with mouth forming second | 1 | 1 | 4.74e-01 |
| GO:BP | GO:0070291 | N-acylethanolamine metabolic process | 1 | 4 | 4.74e-01 |
| GO:BP | GO:0045630 | positive regulation of T-helper 2 cell differentiation | 1 | 4 | 4.74e-01 |
| GO:BP | GO:1901290 | succinyl-CoA biosynthetic process | 1 | 1 | 4.74e-01 |
| GO:BP | GO:0051793 | medium-chain fatty acid catabolic process | 2 | 3 | 4.74e-01 |
| GO:BP | GO:0019678 | propionate metabolic process, methylmalonyl pathway | 1 | 1 | 4.74e-01 |
| GO:BP | GO:0048534 | hematopoietic or lymphoid organ development | 1 | 70 | 4.74e-01 |
| GO:BP | GO:0009972 | cytidine deamination | 1 | 6 | 4.74e-01 |
| GO:BP | GO:1904998 | negative regulation of leukocyte adhesion to arterial endothelial cell | 1 | 1 | 4.74e-01 |
| GO:BP | GO:0046087 | cytidine metabolic process | 1 | 6 | 4.74e-01 |
| GO:BP | GO:0006307 | DNA dealkylation involved in DNA repair | 3 | 9 | 4.74e-01 |
| GO:BP | GO:0001570 | vasculogenesis | 18 | 67 | 4.74e-01 |
| GO:BP | GO:0040018 | positive regulation of multicellular organism growth | 2 | 22 | 4.74e-01 |
| GO:BP | GO:0032253 | dense core granule localization | 1 | 7 | 4.74e-01 |
| GO:BP | GO:0030866 | cortical actin cytoskeleton organization | 7 | 35 | 4.74e-01 |
| GO:BP | GO:1900130 | regulation of lipid binding | 1 | 1 | 4.74e-01 |
| GO:BP | GO:1901950 | dense core granule transport | 1 | 7 | 4.74e-01 |
| GO:BP | GO:0046530 | photoreceptor cell differentiation | 3 | 40 | 4.74e-01 |
| GO:BP | GO:0006216 | cytidine catabolic process | 1 | 6 | 4.74e-01 |
| GO:BP | GO:1900131 | negative regulation of lipid binding | 1 | 1 | 4.74e-01 |
| GO:BP | GO:0016554 | cytidine to uridine editing | 1 | 6 | 4.74e-01 |
| GO:BP | GO:0099519 | dense core granule cytoskeletal transport | 1 | 7 | 4.74e-01 |
| GO:BP | GO:0015749 | monosaccharide transmembrane transport | 3 | 85 | 4.74e-01 |
| GO:BP | GO:0030262 | apoptotic nuclear changes | 6 | 20 | 4.74e-01 |
| GO:BP | GO:0007612 | learning | 6 | 115 | 4.74e-01 |
| GO:BP | GO:0006750 | glutathione biosynthetic process | 1 | 13 | 4.74e-01 |
| GO:BP | GO:0006809 | nitric oxide biosynthetic process | 4 | 51 | 4.74e-01 |
| GO:BP | GO:0006511 | ubiquitin-dependent protein catabolic process | 24 | 615 | 4.75e-01 |
| GO:BP | GO:0009062 | fatty acid catabolic process | 1 | 89 | 4.75e-01 |
| GO:BP | GO:0055081 | monoatomic anion homeostasis | 2 | 14 | 4.75e-01 |
| GO:BP | GO:0048232 | male gamete generation | 2 | 343 | 4.75e-01 |
| GO:BP | GO:0061880 | regulation of anterograde axonal transport of mitochondrion | 1 | 1 | 4.75e-01 |
| GO:BP | GO:0061881 | positive regulation of anterograde axonal transport of mitochondrion | 1 | 1 | 4.75e-01 |
| GO:BP | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly | 1 | 2 | 4.75e-01 |
| GO:BP | GO:0071864 | positive regulation of cell proliferation in bone marrow | 2 | 5 | 4.75e-01 |
| GO:BP | GO:1902497 | iron-sulfur cluster transmembrane transport | 1 | 1 | 4.75e-01 |
| GO:BP | GO:0033624 | negative regulation of integrin activation | 2 | 3 | 4.75e-01 |
| GO:BP | GO:1903329 | regulation of iron-sulfur cluster assembly | 1 | 1 | 4.75e-01 |
| GO:BP | GO:1903331 | positive regulation of iron-sulfur cluster assembly | 1 | 1 | 4.75e-01 |
| GO:BP | GO:0140466 | iron-sulfur cluster export from the mitochondrion | 1 | 1 | 4.75e-01 |
| GO:BP | GO:1902031 | regulation of NADP metabolic process | 1 | 8 | 4.75e-01 |
| GO:BP | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein | 1 | 6 | 4.75e-01 |
| GO:BP | GO:0036371 | protein localization to T-tubule | 1 | 2 | 4.75e-01 |
| GO:BP | GO:1904714 | regulation of chaperone-mediated autophagy | 1 | 8 | 4.75e-01 |
| GO:BP | GO:0106089 | negative regulation of cell adhesion involved in sprouting angiogenesis | 1 | 1 | 4.75e-01 |
| GO:BP | GO:0106088 | regulation of cell adhesion involved in sprouting angiogenesis | 1 | 1 | 4.75e-01 |
| GO:BP | GO:0030497 | fatty acid elongation | 4 | 12 | 4.75e-01 |
| GO:BP | GO:0071501 | cellular response to sterol depletion | 8 | 14 | 4.76e-01 |
| GO:BP | GO:0050873 | brown fat cell differentiation | 19 | 41 | 4.76e-01 |
| GO:BP | GO:0032102 | negative regulation of response to external stimulus | 2 | 269 | 4.76e-01 |
| GO:BP | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response | 9 | 13 | 4.76e-01 |
| GO:BP | GO:0042752 | regulation of circadian rhythm | 5 | 97 | 4.76e-01 |
| GO:BP | GO:0034284 | response to monosaccharide | 12 | 142 | 4.76e-01 |
| GO:BP | GO:0048870 | cell motility | 2 | 1182 | 4.76e-01 |
| GO:BP | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 3 | 6 | 4.76e-01 |
| GO:BP | GO:1901081 | negative regulation of relaxation of smooth muscle | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 3 | 93 | 4.76e-01 |
| GO:BP | GO:0032006 | regulation of TOR signaling | 1 | 96 | 4.76e-01 |
| GO:BP | GO:0007416 | synapse assembly | 9 | 152 | 4.76e-01 |
| GO:BP | GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0046292 | formaldehyde metabolic process | 3 | 3 | 4.76e-01 |
| GO:BP | GO:0006273 | lagging strand elongation | 2 | 4 | 4.76e-01 |
| GO:BP | GO:0032286 | central nervous system myelin maintenance | 3 | 3 | 4.76e-01 |
| GO:BP | GO:0045010 | actin nucleation | 3 | 50 | 4.76e-01 |
| GO:BP | GO:0030278 | regulation of ossification | 10 | 84 | 4.76e-01 |
| GO:BP | GO:1903860 | negative regulation of dendrite extension | 2 | 2 | 4.76e-01 |
| GO:BP | GO:2000197 | regulation of ribonucleoprotein complex localization | 1 | 6 | 4.76e-01 |
| GO:BP | GO:0080182 | histone H3-K4 trimethylation | 1 | 16 | 4.76e-01 |
| GO:BP | GO:0031284 | positive regulation of guanylate cyclase activity | 2 | 2 | 4.76e-01 |
| GO:BP | GO:0048515 | spermatid differentiation | 1 | 111 | 4.76e-01 |
| GO:BP | GO:0070086 | ubiquitin-dependent endocytosis | 2 | 4 | 4.76e-01 |
| GO:BP | GO:0046057 | dADP catabolic process | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0021561 | facial nerve development | 5 | 8 | 4.76e-01 |
| GO:BP | GO:0021610 | facial nerve morphogenesis | 5 | 8 | 4.76e-01 |
| GO:BP | GO:0009192 | deoxyribonucleoside diphosphate catabolic process | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0009184 | purine deoxyribonucleoside diphosphate catabolic process | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0051901 | positive regulation of mitochondrial depolarization | 2 | 6 | 4.76e-01 |
| GO:BP | GO:0046067 | dGDP catabolic process | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 3 | 17 | 4.76e-01 |
| GO:BP | GO:0003139 | secondary heart field specification | 3 | 10 | 4.76e-01 |
| GO:BP | GO:0051055 | negative regulation of lipid biosynthetic process | 12 | 46 | 4.76e-01 |
| GO:BP | GO:0098903 | regulation of membrane repolarization during action potential | 1 | 6 | 4.76e-01 |
| GO:BP | GO:0006573 | valine metabolic process | 4 | 7 | 4.76e-01 |
| GO:BP | GO:2001035 | regulation of tongue muscle cell differentiation | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0042264 | peptidyl-aspartic acid hydroxylation | 2 | 2 | 4.76e-01 |
| GO:BP | GO:2001037 | positive regulation of tongue muscle cell differentiation | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0035981 | tongue muscle cell differentiation | 1 | 1 | 4.76e-01 |
| GO:BP | GO:0006853 | carnitine shuttle | 1 | 3 | 4.76e-01 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 1 | 14 | 4.77e-01 |
| GO:BP | GO:0006090 | pyruvate metabolic process | 1 | 93 | 4.77e-01 |
| GO:BP | GO:0098810 | neurotransmitter reuptake | 2 | 21 | 4.77e-01 |
| GO:BP | GO:0051156 | glucose 6-phosphate metabolic process | 4 | 25 | 4.77e-01 |
| GO:BP | GO:0032487 | regulation of Rap protein signal transduction | 1 | 3 | 4.77e-01 |
| GO:BP | GO:1905223 | epicardium morphogenesis | 1 | 2 | 4.77e-01 |
| GO:BP | GO:0016182 | synaptic vesicle budding from endosome | 1 | 1 | 4.77e-01 |
| GO:BP | GO:0001508 | action potential | 11 | 105 | 4.77e-01 |
| GO:BP | GO:1900240 | negative regulation of phenotypic switching | 1 | 2 | 4.77e-01 |
| GO:BP | GO:0070125 | mitochondrial translational elongation | 3 | 4 | 4.77e-01 |
| GO:BP | GO:0006565 | L-serine catabolic process | 4 | 4 | 4.77e-01 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 2 | 104 | 4.77e-01 |
| GO:BP | GO:1905931 | negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching | 1 | 2 | 4.77e-01 |
| GO:BP | GO:0001503 | ossification | 1 | 313 | 4.77e-01 |
| GO:BP | GO:0042430 | indole-containing compound metabolic process | 2 | 8 | 4.77e-01 |
| GO:BP | GO:0051973 | positive regulation of telomerase activity | 10 | 31 | 4.77e-01 |
| GO:BP | GO:1905916 | negative regulation of cell differentiation involved in phenotypic switching | 1 | 2 | 4.77e-01 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 2 | 620 | 4.77e-01 |
| GO:BP | GO:0060612 | adipose tissue development | 9 | 41 | 4.78e-01 |
| GO:BP | GO:0042407 | cristae formation | 2 | 18 | 4.78e-01 |
| GO:BP | GO:0003219 | cardiac right ventricle formation | 2 | 4 | 4.78e-01 |
| GO:BP | GO:2000981 | negative regulation of inner ear receptor cell differentiation | 2 | 3 | 4.78e-01 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 6 | 149 | 4.78e-01 |
| GO:BP | GO:1905457 | negative regulation of lymphoid progenitor cell differentiation | 2 | 3 | 4.78e-01 |
| GO:BP | GO:0045608 | negative regulation of inner ear auditory receptor cell differentiation | 2 | 3 | 4.78e-01 |
| GO:BP | GO:0045632 | negative regulation of mechanoreceptor differentiation | 2 | 3 | 4.78e-01 |
| GO:BP | GO:0000105 | histidine biosynthetic process | 1 | 2 | 4.78e-01 |
| GO:BP | GO:1905331 | negative regulation of morphogenesis of an epithelium | 1 | 6 | 4.78e-01 |
| GO:BP | GO:0010700 | negative regulation of norepinephrine secretion | 2 | 2 | 4.78e-01 |
| GO:BP | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis | 2 | 4 | 4.78e-01 |
| GO:BP | GO:0006310 | DNA recombination | 123 | 257 | 4.78e-01 |
| GO:BP | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process | 1 | 2 | 4.78e-01 |
| GO:BP | GO:0090461 | intracellular glutamate homeostasis | 3 | 4 | 4.78e-01 |
| GO:BP | GO:0033278 | cell proliferation in midbrain | 1 | 4 | 4.78e-01 |
| GO:BP | GO:0060050 | positive regulation of protein glycosylation | 1 | 6 | 4.78e-01 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 32 | 547 | 4.78e-01 |
| GO:BP | GO:0009957 | epidermal cell fate specification | 2 | 4 | 4.78e-01 |
| GO:BP | GO:0051964 | negative regulation of synapse assembly | 1 | 6 | 4.78e-01 |
| GO:BP | GO:1903203 | regulation of oxidative stress-induced neuron death | 6 | 25 | 4.78e-01 |
| GO:BP | GO:1903201 | regulation of oxidative stress-induced cell death | 13 | 56 | 4.78e-01 |
| GO:BP | GO:0046488 | phosphatidylinositol metabolic process | 2 | 140 | 4.78e-01 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 19 | 32 | 4.78e-01 |
| GO:BP | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process | 13 | 19 | 4.78e-01 |
| GO:BP | GO:0060857 | establishment of glial blood-brain barrier | 2 | 2 | 4.78e-01 |
| GO:BP | GO:0061744 | motor behavior | 3 | 17 | 4.78e-01 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 6 | 200 | 4.78e-01 |
| GO:BP | GO:0055129 | L-proline biosynthetic process | 2 | 5 | 4.79e-01 |
| GO:BP | GO:0006561 | proline biosynthetic process | 2 | 5 | 4.79e-01 |
| GO:BP | GO:1905663 | positive regulation of telomerase RNA reverse transcriptase activity | 2 | 2 | 4.79e-01 |
| GO:BP | GO:0006903 | vesicle targeting | 31 | 61 | 4.79e-01 |
| GO:BP | GO:0042779 | tRNA 3’-trailer cleavage | 1 | 3 | 4.79e-01 |
| GO:BP | GO:0006207 | ‘de novo’ pyrimidine nucleobase biosynthetic process | 3 | 6 | 4.79e-01 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 28 | 496 | 4.79e-01 |
| GO:BP | GO:1902958 | positive regulation of mitochondrial electron transport, NADH to ubiquinone | 1 | 3 | 4.79e-01 |
| GO:BP | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 9 | 16 | 4.79e-01 |
| GO:BP | GO:0030046 | parallel actin filament bundle assembly | 2 | 5 | 4.79e-01 |
| GO:BP | GO:1902817 | negative regulation of protein localization to microtubule | 3 | 5 | 4.79e-01 |
| GO:BP | GO:0086018 | SA node cell to atrial cardiac muscle cell signaling | 5 | 12 | 4.79e-01 |
| GO:BP | GO:0034760 | negative regulation of iron ion transmembrane transport | 1 | 2 | 4.79e-01 |
| GO:BP | GO:0001778 | plasma membrane repair | 2 | 28 | 4.79e-01 |
| GO:BP | GO:0086015 | SA node cell action potential | 5 | 12 | 4.79e-01 |
| GO:BP | GO:0070199 | establishment of protein localization to chromosome | 5 | 25 | 4.79e-01 |
| GO:BP | GO:1902816 | regulation of protein localization to microtubule | 3 | 5 | 4.79e-01 |
| GO:BP | GO:1904886 | beta-catenin destruction complex disassembly | 3 | 4 | 4.79e-01 |
| GO:BP | GO:1903214 | regulation of protein targeting to mitochondrion | 6 | 39 | 4.79e-01 |
| GO:BP | GO:0086050 | membrane repolarization during bundle of His cell action potential | 1 | 1 | 4.79e-01 |
| GO:BP | GO:0061564 | axon development | 6 | 398 | 4.79e-01 |
| GO:BP | GO:0036089 | cleavage furrow formation | 2 | 7 | 4.79e-01 |
| GO:BP | GO:0043603 | amide metabolic process | 4 | 993 | 4.79e-01 |
| GO:BP | GO:0034757 | negative regulation of iron ion transport | 1 | 2 | 4.79e-01 |
| GO:BP | GO:0086052 | membrane repolarization during SA node cell action potential | 1 | 1 | 4.79e-01 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 33 | 57 | 4.79e-01 |
| GO:BP | GO:0009605 | response to external stimulus | 8 | 1719 | 4.79e-01 |
| GO:BP | GO:1905450 | negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 2 | 2 | 4.79e-01 |
| GO:BP | GO:1903910 | negative regulation of receptor clustering | 2 | 2 | 4.79e-01 |
| GO:BP | GO:0097396 | response to interleukin-17 | 1 | 13 | 4.79e-01 |
| GO:BP | GO:0007625 | grooming behavior | 2 | 10 | 4.79e-01 |
| GO:BP | GO:0032238 | adenosine transport | 1 | 2 | 4.80e-01 |
| GO:BP | GO:0035751 | regulation of lysosomal lumen pH | 17 | 26 | 4.80e-01 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 2 | 82 | 4.80e-01 |
| GO:BP | GO:0090279 | regulation of calcium ion import | 1 | 24 | 4.80e-01 |
| GO:BP | GO:0030048 | actin filament-based movement | 10 | 112 | 4.80e-01 |
| GO:BP | GO:0090175 | regulation of establishment of planar polarity | 5 | 54 | 4.80e-01 |
| GO:BP | GO:0019395 | fatty acid oxidation | 1 | 93 | 4.80e-01 |
| GO:BP | GO:0060767 | epithelial cell proliferation involved in prostate gland development | 4 | 10 | 4.80e-01 |
| GO:BP | GO:1903202 | negative regulation of oxidative stress-induced cell death | 6 | 40 | 4.80e-01 |
| GO:BP | GO:0055089 | fatty acid homeostasis | 1 | 12 | 4.80e-01 |
| GO:BP | GO:0032367 | intracellular cholesterol transport | 4 | 28 | 4.80e-01 |
| GO:BP | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity | 2 | 20 | 4.81e-01 |
| GO:BP | GO:0106118 | regulation of sterol biosynthetic process | 3 | 16 | 4.81e-01 |
| GO:BP | GO:0045540 | regulation of cholesterol biosynthetic process | 3 | 16 | 4.81e-01 |
| GO:BP | GO:0006294 | nucleotide-excision repair, preincision complex assembly | 1 | 1 | 4.81e-01 |
| GO:BP | GO:0070979 | protein K11-linked ubiquitination | 10 | 29 | 4.82e-01 |
| GO:BP | GO:0106101 | ER-dependent peroxisome localization | 1 | 1 | 4.82e-01 |
| GO:BP | GO:1903943 | regulation of hepatocyte apoptotic process | 4 | 7 | 4.82e-01 |
| GO:BP | GO:0032581 | ER-dependent peroxisome organization | 1 | 1 | 4.82e-01 |
| GO:BP | GO:0032815 | negative regulation of natural killer cell activation | 1 | 3 | 4.82e-01 |
| GO:BP | GO:1900017 | positive regulation of cytokine production involved in inflammatory response | 1 | 15 | 4.82e-01 |
| GO:BP | GO:0046677 | response to antibiotic | 6 | 43 | 4.82e-01 |
| GO:BP | GO:0033564 | anterior/posterior axon guidance | 2 | 4 | 4.82e-01 |
| GO:BP | GO:0003419 | growth plate cartilage chondrocyte proliferation | 1 | 2 | 4.82e-01 |
| GO:BP | GO:0061326 | renal tubule development | 4 | 77 | 4.82e-01 |
| GO:BP | GO:0106035 | protein maturation by [4Fe-4S] cluster transfer | 4 | 7 | 4.82e-01 |
| GO:BP | GO:0016254 | preassembly of GPI anchor in ER membrane | 5 | 8 | 4.82e-01 |
| GO:BP | GO:1990776 | response to angiotensin | 9 | 24 | 4.82e-01 |
| GO:BP | GO:0009895 | negative regulation of catabolic process | 10 | 280 | 4.82e-01 |
| GO:BP | GO:1902044 | regulation of Fas signaling pathway | 1 | 4 | 4.82e-01 |
| GO:BP | GO:0009074 | aromatic amino acid family catabolic process | 2 | 4 | 4.82e-01 |
| GO:BP | GO:1905278 | positive regulation of epithelial tube formation | 1 | 7 | 4.82e-01 |
| GO:BP | GO:1905276 | regulation of epithelial tube formation | 1 | 7 | 4.82e-01 |
| GO:BP | GO:0090675 | intermicrovillar adhesion | 1 | 1 | 4.83e-01 |
| GO:BP | GO:1901617 | organic hydroxy compound biosynthetic process | 10 | 172 | 4.83e-01 |
| GO:BP | GO:0031365 | N-terminal protein amino acid modification | 9 | 28 | 4.83e-01 |
| GO:BP | GO:0042539 | hypotonic salinity response | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0035331 | negative regulation of hippo signaling | 8 | 12 | 4.83e-01 |
| GO:BP | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway | 2 | 17 | 4.83e-01 |
| GO:BP | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 | 25 | 4.83e-01 |
| GO:BP | GO:0042167 | heme catabolic process | 1 | 6 | 4.83e-01 |
| GO:BP | GO:0035544 | negative regulation of SNARE complex assembly | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0001505 | regulation of neurotransmitter levels | 7 | 149 | 4.83e-01 |
| GO:BP | GO:0042100 | B cell proliferation | 1 | 45 | 4.83e-01 |
| GO:BP | GO:0021592 | fourth ventricle development | 1 | 1 | 4.83e-01 |
| GO:BP | GO:0071425 | hematopoietic stem cell proliferation | 3 | 29 | 4.83e-01 |
| GO:BP | GO:0021993 | initiation of neural tube closure | 1 | 1 | 4.83e-01 |
| GO:BP | GO:0051683 | establishment of Golgi localization | 2 | 8 | 4.83e-01 |
| GO:BP | GO:0046149 | pigment catabolic process | 1 | 6 | 4.83e-01 |
| GO:BP | GO:0072141 | renal interstitial fibroblast development | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0071477 | cellular hypotonic salinity response | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0097527 | necroptotic signaling pathway | 1 | 3 | 4.83e-01 |
| GO:BP | GO:0006007 | glucose catabolic process | 2 | 22 | 4.83e-01 |
| GO:BP | GO:0060605 | tube lumen cavitation | 2 | 3 | 4.83e-01 |
| GO:BP | GO:0060920 | cardiac pacemaker cell differentiation | 5 | 9 | 4.83e-01 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 2 | 14 | 4.83e-01 |
| GO:BP | GO:0060662 | salivary gland cavitation | 2 | 3 | 4.83e-01 |
| GO:BP | GO:0010939 | regulation of necrotic cell death | 1 | 38 | 4.83e-01 |
| GO:BP | GO:1905609 | positive regulation of smooth muscle cell-matrix adhesion | 1 | 1 | 4.83e-01 |
| GO:BP | GO:0097374 | sensory neuron axon guidance | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0032912 | negative regulation of transforming growth factor beta2 production | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0051125 | regulation of actin nucleation | 2 | 31 | 4.83e-01 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 5 | 719 | 4.83e-01 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 8 | 179 | 4.83e-01 |
| GO:BP | GO:0072071 | kidney interstitial fibroblast differentiation | 2 | 2 | 4.83e-01 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 11 | 73 | 4.83e-01 |
| GO:BP | GO:0048549 | positive regulation of pinocytosis | 5 | 7 | 4.83e-01 |
| GO:BP | GO:0006631 | fatty acid metabolic process | 2 | 276 | 4.83e-01 |
| GO:BP | GO:0003400 | regulation of COPII vesicle coating | 3 | 3 | 4.83e-01 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 11 | 73 | 4.83e-01 |
| GO:BP | GO:0009886 | post-embryonic animal morphogenesis | 1 | 10 | 4.83e-01 |
| GO:BP | GO:0098917 | retrograde trans-synaptic signaling | 3 | 7 | 4.83e-01 |
| GO:BP | GO:0021785 | branchiomotor neuron axon guidance | 3 | 5 | 4.83e-01 |
| GO:BP | GO:0061469 | regulation of type B pancreatic cell proliferation | 4 | 14 | 4.83e-01 |
| GO:BP | GO:0006098 | pentose-phosphate shunt | 5 | 19 | 4.83e-01 |
| GO:BP | GO:0071731 | response to nitric oxide | 9 | 16 | 4.83e-01 |
| GO:BP | GO:0071697 | ectodermal placode morphogenesis | 6 | 10 | 4.84e-01 |
| GO:BP | GO:0060788 | ectodermal placode formation | 6 | 10 | 4.84e-01 |
| GO:BP | GO:0003002 | regionalization | 1 | 273 | 4.84e-01 |
| GO:BP | GO:0003290 | atrial septum secundum morphogenesis | 2 | 2 | 4.84e-01 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 17 | 340 | 4.84e-01 |
| GO:BP | GO:0050919 | negative chemotaxis | 23 | 42 | 4.84e-01 |
| GO:BP | GO:0051350 | negative regulation of lyase activity | 3 | 15 | 4.84e-01 |
| GO:BP | GO:0001776 | leukocyte homeostasis | 1 | 69 | 4.84e-01 |
| GO:BP | GO:1902977 | mitotic DNA replication preinitiation complex assembly | 1 | 1 | 4.84e-01 |
| GO:BP | GO:0003190 | atrioventricular valve formation | 5 | 8 | 4.84e-01 |
| GO:BP | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway | 2 | 5 | 4.84e-01 |
| GO:BP | GO:0006535 | cysteine biosynthetic process from serine | 1 | 1 | 4.84e-01 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 3 | 1147 | 4.84e-01 |
| GO:BP | GO:0015800 | acidic amino acid transport | 2 | 39 | 4.84e-01 |
| GO:BP | GO:0045006 | DNA deamination | 1 | 9 | 4.84e-01 |
| GO:BP | GO:1904618 | positive regulation of actin binding | 1 | 2 | 4.84e-01 |
| GO:BP | GO:1903223 | positive regulation of oxidative stress-induced neuron death | 1 | 5 | 4.84e-01 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 6 | 85 | 4.84e-01 |
| GO:BP | GO:2001108 | positive regulation of Rho guanyl-nucleotide exchange factor activity | 1 | 2 | 4.84e-01 |
| GO:BP | GO:1905099 | positive regulation of guanyl-nucleotide exchange factor activity | 1 | 2 | 4.84e-01 |
| GO:BP | GO:0006419 | alanyl-tRNA aminoacylation | 2 | 2 | 4.84e-01 |
| GO:BP | GO:1904531 | positive regulation of actin filament binding | 1 | 2 | 4.84e-01 |
| GO:BP | GO:0046726 | positive regulation by virus of viral protein levels in host cell | 3 | 4 | 4.84e-01 |
| GO:BP | GO:0106001 | intestinal hexose absorption | 2 | 3 | 4.85e-01 |
| GO:BP | GO:0032388 | positive regulation of intracellular transport | 23 | 170 | 4.85e-01 |
| GO:BP | GO:0033673 | negative regulation of kinase activity | 38 | 197 | 4.85e-01 |
| GO:BP | GO:0043113 | receptor clustering | 2 | 45 | 4.85e-01 |
| GO:BP | GO:0009855 | determination of bilateral symmetry | 7 | 102 | 4.86e-01 |
| GO:BP | GO:1904533 | regulation of telomeric loop disassembly | 1 | 2 | 4.86e-01 |
| GO:BP | GO:0015770 | sucrose transport | 3 | 4 | 4.86e-01 |
| GO:BP | GO:0015766 | disaccharide transport | 3 | 4 | 4.86e-01 |
| GO:BP | GO:0015772 | oligosaccharide transport | 3 | 4 | 4.86e-01 |
| GO:BP | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 17 | 29 | 4.86e-01 |
| GO:BP | GO:0070286 | axonemal dynein complex assembly | 1 | 20 | 4.86e-01 |
| GO:BP | GO:0001815 | positive regulation of antibody-dependent cellular cytotoxicity | 1 | 1 | 4.86e-01 |
| GO:BP | GO:0035803 | egg coat formation | 2 | 2 | 4.86e-01 |
| GO:BP | GO:2000225 | negative regulation of testosterone biosynthetic process | 1 | 1 | 4.86e-01 |
| GO:BP | GO:0072011 | glomerular endothelium development | 1 | 2 | 4.86e-01 |
| GO:BP | GO:0035287 | head segmentation | 1 | 3 | 4.86e-01 |
| GO:BP | GO:1901401 | regulation of tetrapyrrole metabolic process | 3 | 8 | 4.86e-01 |
| GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 1 | 335 | 4.86e-01 |
| GO:BP | GO:1903210 | podocyte apoptotic process | 1 | 3 | 4.86e-01 |
| GO:BP | GO:0097018 | renal albumin absorption | 1 | 3 | 4.86e-01 |
| GO:BP | GO:0065009 | regulation of molecular function | 4 | 1939 | 4.86e-01 |
| GO:BP | GO:0035289 | posterior head segmentation | 1 | 3 | 4.86e-01 |
| GO:BP | GO:0061158 | 3’-UTR-mediated mRNA destabilization | 10 | 15 | 4.86e-01 |
| GO:BP | GO:0007380 | specification of segmental identity, head | 1 | 3 | 4.86e-01 |
| GO:BP | GO:0032781 | positive regulation of ATP-dependent activity | 2 | 40 | 4.86e-01 |
| GO:BP | GO:0097345 | mitochondrial outer membrane permeabilization | 7 | 35 | 4.86e-01 |
| GO:BP | GO:0030237 | female sex determination | 1 | 1 | 4.86e-01 |
| GO:BP | GO:0042060 | wound healing | 1 | 320 | 4.86e-01 |
| GO:BP | GO:0097492 | sympathetic neuron axon guidance | 1 | 4 | 4.86e-01 |
| GO:BP | GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1 | 62 | 4.86e-01 |
| GO:BP | GO:0035524 | proline transmembrane transport | 3 | 8 | 4.86e-01 |
| GO:BP | GO:0034350 | regulation of glial cell apoptotic process | 6 | 10 | 4.86e-01 |
| GO:BP | GO:0010758 | regulation of macrophage chemotaxis | 2 | 14 | 4.86e-01 |
| GO:BP | GO:0046464 | acylglycerol catabolic process | 3 | 25 | 4.86e-01 |
| GO:BP | GO:0036298 | recombinational interstrand cross-link repair | 1 | 2 | 4.86e-01 |
| GO:BP | GO:0060456 | positive regulation of digestive system process | 1 | 8 | 4.86e-01 |
| GO:BP | GO:0046461 | neutral lipid catabolic process | 3 | 25 | 4.86e-01 |
| GO:BP | GO:0001554 | luteolysis | 3 | 7 | 4.86e-01 |
| GO:BP | GO:0009438 | methylglyoxal metabolic process | 4 | 7 | 4.86e-01 |
| GO:BP | GO:0051603 | proteolysis involved in protein catabolic process | 26 | 706 | 4.86e-01 |
| GO:BP | GO:0045646 | regulation of erythrocyte differentiation | 1 | 39 | 4.86e-01 |
| GO:BP | GO:0021935 | cerebellar granule cell precursor tangential migration | 2 | 2 | 4.86e-01 |
| GO:BP | GO:0045023 | G0 to G1 transition | 6 | 35 | 4.86e-01 |
| GO:BP | GO:0070716 | mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication | 1 | 2 | 4.86e-01 |
| GO:BP | GO:0042365 | water-soluble vitamin catabolic process | 2 | 2 | 4.86e-01 |
| GO:BP | GO:0098885 | modification of postsynaptic actin cytoskeleton | 4 | 10 | 4.86e-01 |
| GO:BP | GO:0044058 | regulation of digestive system process | 3 | 22 | 4.86e-01 |
| GO:BP | GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 1 | 6 | 4.87e-01 |
| GO:BP | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway | 2 | 14 | 4.87e-01 |
| GO:BP | GO:0042436 | indole-containing compound catabolic process | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0006569 | tryptophan catabolic process | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0001956 | positive regulation of neurotransmitter secretion | 1 | 12 | 4.87e-01 |
| GO:BP | GO:0010042 | response to manganese ion | 1 | 15 | 4.87e-01 |
| GO:BP | GO:0061682 | seminal vesicle morphogenesis | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0006839 | mitochondrial transport | 29 | 185 | 4.87e-01 |
| GO:BP | GO:1904192 | regulation of cholangiocyte apoptotic process | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0007072 | positive regulation of transcription involved in exit from mitosis | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0002191 | cap-dependent translational initiation | 5 | 7 | 4.87e-01 |
| GO:BP | GO:0061727 | methylglyoxal catabolic process to lactate | 4 | 5 | 4.87e-01 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 1 | 45 | 4.87e-01 |
| GO:BP | GO:0039654 | fusion of virus membrane with host endosome membrane | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0051596 | methylglyoxal catabolic process | 4 | 5 | 4.87e-01 |
| GO:BP | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 2 | 17 | 4.87e-01 |
| GO:BP | GO:1904193 | negative regulation of cholangiocyte apoptotic process | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0060318 | definitive erythrocyte differentiation | 3 | 4 | 4.87e-01 |
| GO:BP | GO:0015881 | creatine transmembrane transport | 1 | 4 | 4.87e-01 |
| GO:BP | GO:0090270 | regulation of fibroblast growth factor production | 2 | 4 | 4.87e-01 |
| GO:BP | GO:0045980 | negative regulation of nucleotide metabolic process | 2 | 6 | 4.87e-01 |
| GO:BP | GO:0034440 | lipid oxidation | 1 | 94 | 4.87e-01 |
| GO:BP | GO:0090269 | fibroblast growth factor production | 2 | 4 | 4.87e-01 |
| GO:BP | GO:0071409 | cellular response to cycloheximide | 2 | 2 | 4.87e-01 |
| GO:BP | GO:0071225 | cellular response to muramyl dipeptide | 4 | 7 | 4.87e-01 |
| GO:BP | GO:0014043 | negative regulation of neuron maturation | 1 | 2 | 4.87e-01 |
| GO:BP | GO:1902488 | cholangiocyte apoptotic process | 1 | 1 | 4.87e-01 |
| GO:BP | GO:2000584 | negative regulation of platelet-derived growth factor receptor-alpha signaling pathway | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0050774 | negative regulation of dendrite morphogenesis | 2 | 7 | 4.87e-01 |
| GO:BP | GO:0006487 | protein N-linked glycosylation | 1 | 65 | 4.87e-01 |
| GO:BP | GO:0060973 | cell migration involved in heart development | 3 | 20 | 4.87e-01 |
| GO:BP | GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1 | 14 | 4.87e-01 |
| GO:BP | GO:0042181 | ketone biosynthetic process | 1 | 37 | 4.87e-01 |
| GO:BP | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | 4 | 11 | 4.87e-01 |
| GO:BP | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5 | 96 | 4.87e-01 |
| GO:BP | GO:0048297 | negative regulation of isotype switching to IgA isotypes | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0098828 | modulation of inhibitory postsynaptic potential | 3 | 4 | 4.87e-01 |
| GO:BP | GO:0003175 | tricuspid valve development | 4 | 6 | 4.87e-01 |
| GO:BP | GO:0009799 | specification of symmetry | 7 | 103 | 4.87e-01 |
| GO:BP | GO:0070201 | regulation of establishment of protein localization | 1 | 428 | 4.87e-01 |
| GO:BP | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity | 1 | 3 | 4.87e-01 |
| GO:BP | GO:0010935 | regulation of macrophage cytokine production | 3 | 27 | 4.87e-01 |
| GO:BP | GO:0035781 | CD86 biosynthetic process | 2 | 2 | 4.87e-01 |
| GO:BP | GO:0010934 | macrophage cytokine production | 3 | 27 | 4.87e-01 |
| GO:BP | GO:0060633 | negative regulation of transcription initiation by RNA polymerase II | 4 | 6 | 4.87e-01 |
| GO:BP | GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1 | 6 | 4.87e-01 |
| GO:BP | GO:0042983 | amyloid precursor protein biosynthetic process | 1 | 14 | 4.87e-01 |
| GO:BP | GO:1902003 | regulation of amyloid-beta formation | 1 | 33 | 4.87e-01 |
| GO:BP | GO:0010172 | embryonic body morphogenesis | 3 | 11 | 4.87e-01 |
| GO:BP | GO:0014031 | mesenchymal cell development | 4 | 6 | 4.87e-01 |
| GO:BP | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor | 1 | 1 | 4.87e-01 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 15 | 281 | 4.87e-01 |
| GO:BP | GO:0035909 | aorta morphogenesis | 1 | 26 | 4.87e-01 |
| GO:BP | GO:0034351 | negative regulation of glial cell apoptotic process | 5 | 8 | 4.87e-01 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 16 | 54 | 4.87e-01 |
| GO:BP | GO:0050852 | T cell receptor signaling pathway | 2 | 84 | 4.87e-01 |
| GO:BP | GO:0062125 | regulation of mitochondrial gene expression | 17 | 31 | 4.87e-01 |
| GO:BP | GO:0022008 | neurogenesis | 3 | 1294 | 4.87e-01 |
| GO:BP | GO:0098749 | cerebellar neuron development | 2 | 3 | 4.87e-01 |
| GO:BP | GO:0030388 | fructose 1,6-bisphosphate metabolic process | 1 | 6 | 4.87e-01 |
| GO:BP | GO:0019941 | modification-dependent protein catabolic process | 24 | 625 | 4.87e-01 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 1 | 33 | 4.88e-01 |
| GO:BP | GO:0031396 | regulation of protein ubiquitination | 5 | 191 | 4.88e-01 |
| GO:BP | GO:0060397 | growth hormone receptor signaling pathway via JAK-STAT | 5 | 9 | 4.88e-01 |
| GO:BP | GO:0042726 | flavin-containing compound metabolic process | 1 | 4 | 4.88e-01 |
| GO:BP | GO:0014900 | muscle hyperplasia | 2 | 2 | 4.88e-01 |
| GO:BP | GO:1990683 | DNA double-strand break attachment to nuclear envelope | 2 | 2 | 4.88e-01 |
| GO:BP | GO:0006824 | cobalt ion transport | 2 | 5 | 4.88e-01 |
| GO:BP | GO:1905332 | positive regulation of morphogenesis of an epithelium | 2 | 28 | 4.88e-01 |
| GO:BP | GO:0033629 | negative regulation of cell adhesion mediated by integrin | 1 | 10 | 4.88e-01 |
| GO:BP | GO:1903433 | regulation of constitutive secretory pathway | 1 | 2 | 4.88e-01 |
| GO:BP | GO:1904021 | negative regulation of G protein-coupled receptor internalization | 2 | 2 | 4.88e-01 |
| GO:BP | GO:0009082 | branched-chain amino acid biosynthetic process | 1 | 4 | 4.89e-01 |
| GO:BP | GO:2000042 | negative regulation of double-strand break repair via homologous recombination | 9 | 16 | 4.89e-01 |
| GO:BP | GO:1902774 | late endosome to lysosome transport | 11 | 20 | 4.89e-01 |
| GO:BP | GO:0036342 | post-anal tail morphogenesis | 4 | 13 | 4.90e-01 |
| GO:BP | GO:0008037 | cell recognition | 3 | 87 | 4.90e-01 |
| GO:BP | GO:0140214 | positive regulation of long-chain fatty acid import into cell | 2 | 2 | 4.90e-01 |
| GO:BP | GO:0045602 | negative regulation of endothelial cell differentiation | 1 | 7 | 4.90e-01 |
| GO:BP | GO:1902036 | regulation of hematopoietic stem cell differentiation | 1 | 15 | 4.90e-01 |
| GO:BP | GO:0009404 | toxin metabolic process | 1 | 7 | 4.90e-01 |
| GO:BP | GO:0072356 | chromosome passenger complex localization to kinetochore | 1 | 1 | 4.90e-01 |
| GO:BP | GO:0006671 | phytosphingosine metabolic process | 1 | 1 | 4.90e-01 |
| GO:BP | GO:0071602 | phytosphingosine biosynthetic process | 1 | 1 | 4.90e-01 |
| GO:BP | GO:0034031 | ribonucleoside bisphosphate catabolic process | 7 | 11 | 4.90e-01 |
| GO:BP | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2 | 6 | 4.90e-01 |
| GO:BP | GO:0033869 | nucleoside bisphosphate catabolic process | 7 | 11 | 4.90e-01 |
| GO:BP | GO:0034034 | purine nucleoside bisphosphate catabolic process | 7 | 11 | 4.90e-01 |
| GO:BP | GO:0050921 | positive regulation of chemotaxis | 8 | 85 | 4.90e-01 |
| GO:BP | GO:1904375 | regulation of protein localization to cell periphery | 3 | 113 | 4.90e-01 |
| GO:BP | GO:0008340 | determination of adult lifespan | 6 | 16 | 4.90e-01 |
| GO:BP | GO:2000780 | negative regulation of double-strand break repair | 17 | 30 | 4.91e-01 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 2 | 39 | 4.91e-01 |
| GO:BP | GO:0033120 | positive regulation of RNA splicing | 4 | 34 | 4.91e-01 |
| GO:BP | GO:0009268 | response to pH | 2 | 26 | 4.91e-01 |
| GO:BP | GO:0010269 | response to selenium ion | 1 | 8 | 4.91e-01 |
| GO:BP | GO:0098780 | response to mitochondrial depolarisation | 1 | 21 | 4.91e-01 |
| GO:BP | GO:1904442 | negative regulation of thyroid gland epithelial cell proliferation | 1 | 1 | 4.92e-01 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 3 | 1278 | 4.92e-01 |
| GO:BP | GO:1990789 | thyroid gland epithelial cell proliferation | 1 | 1 | 4.92e-01 |
| GO:BP | GO:1903697 | negative regulation of microvillus assembly | 1 | 1 | 4.92e-01 |
| GO:BP | GO:1904441 | regulation of thyroid gland epithelial cell proliferation | 1 | 1 | 4.92e-01 |
| GO:BP | GO:1905843 | regulation of cellular response to gamma radiation | 1 | 1 | 4.92e-01 |
| GO:BP | GO:1903578 | regulation of ATP metabolic process | 4 | 22 | 4.92e-01 |
| GO:BP | GO:2001228 | regulation of response to gamma radiation | 1 | 1 | 4.92e-01 |
| GO:BP | GO:0031640 | killing of cells of another organism | 1 | 10 | 4.92e-01 |
| GO:BP | GO:1901098 | positive regulation of autophagosome maturation | 5 | 6 | 4.92e-01 |
| GO:BP | GO:1902888 | protein localization to astral microtubule | 1 | 1 | 4.92e-01 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 1 | 10 | 4.92e-01 |
| GO:BP | GO:1904781 | positive regulation of protein localization to centrosome | 5 | 7 | 4.92e-01 |
| GO:BP | GO:0016077 | sno(s)RNA catabolic process | 2 | 3 | 4.93e-01 |
| GO:BP | GO:0006012 | galactose metabolic process | 2 | 9 | 4.93e-01 |
| GO:BP | GO:0001834 | trophectodermal cell proliferation | 1 | 2 | 4.93e-01 |
| GO:BP | GO:0001845 | phagolysosome assembly | 1 | 14 | 4.93e-01 |
| GO:BP | GO:1903544 | response to butyrate | 2 | 2 | 4.93e-01 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 1 | 189 | 4.93e-01 |
| GO:BP | GO:0022013 | pallium cell proliferation in forebrain | 1 | 1 | 4.94e-01 |
| GO:BP | GO:0016139 | glycoside catabolic process | 3 | 8 | 4.94e-01 |
| GO:BP | GO:0019321 | pentose metabolic process | 6 | 9 | 4.94e-01 |
| GO:BP | GO:0046634 | regulation of alpha-beta T cell activation | 1 | 58 | 4.94e-01 |
| GO:BP | GO:0006577 | amino-acid betaine metabolic process | 2 | 13 | 4.94e-01 |
| GO:BP | GO:0010720 | positive regulation of cell development | 2 | 317 | 4.94e-01 |
| GO:BP | GO:0010255 | glucose mediated signaling pathway | 1 | 5 | 4.94e-01 |
| GO:BP | GO:0010182 | sugar mediated signaling pathway | 1 | 5 | 4.94e-01 |
| GO:BP | GO:0120187 | positive regulation of protein localization to chromatin | 1 | 3 | 4.94e-01 |
| GO:BP | GO:1900454 | positive regulation of long-term synaptic depression | 1 | 3 | 4.94e-01 |
| GO:BP | GO:0015827 | tryptophan transport | 4 | 6 | 4.94e-01 |
| GO:BP | GO:0009757 | hexose mediated signaling | 1 | 5 | 4.94e-01 |
| GO:BP | GO:0140889 | DNA replication-dependent chromatin disassembly | 2 | 3 | 4.94e-01 |
| GO:BP | GO:0032069 | regulation of nuclease activity | 3 | 17 | 4.94e-01 |
| GO:BP | GO:1905475 | regulation of protein localization to membrane | 26 | 150 | 4.95e-01 |
| GO:BP | GO:0038026 | reelin-mediated signaling pathway | 6 | 9 | 4.95e-01 |
| GO:BP | GO:0000460 | maturation of 5.8S rRNA | 5 | 36 | 4.95e-01 |
| GO:BP | GO:0097355 | protein localization to heterochromatin | 1 | 3 | 4.95e-01 |
| GO:BP | GO:0060723 | regulation of cell proliferation involved in embryonic placenta development | 1 | 1 | 4.95e-01 |
| GO:BP | GO:1902103 | negative regulation of metaphase/anaphase transition of meiotic cell cycle | 1 | 2 | 4.95e-01 |
| GO:BP | GO:0060721 | regulation of spongiotrophoblast cell proliferation | 1 | 1 | 4.95e-01 |
| GO:BP | GO:0032350 | regulation of hormone metabolic process | 1 | 30 | 4.95e-01 |
| GO:BP | GO:1904370 | regulation of protein localization to actin cortical patch | 1 | 1 | 4.95e-01 |
| GO:BP | GO:0030224 | monocyte differentiation | 2 | 26 | 4.95e-01 |
| GO:BP | GO:0044379 | protein localization to actin cortical patch | 1 | 1 | 4.95e-01 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 38 | 1735 | 4.95e-01 |
| GO:BP | GO:1904380 | endoplasmic reticulum mannose trimming | 2 | 14 | 4.95e-01 |
| GO:BP | GO:1903119 | protein localization to actin cytoskeleton | 1 | 1 | 4.95e-01 |
| GO:BP | GO:0000729 | DNA double-strand break processing | 5 | 18 | 4.95e-01 |
| GO:BP | GO:0031443 | fast-twitch skeletal muscle fiber contraction | 1 | 3 | 4.95e-01 |
| GO:BP | GO:0010923 | negative regulation of phosphatase activity | 3 | 30 | 4.95e-01 |
| GO:BP | GO:0043473 | pigmentation | 15 | 92 | 4.95e-01 |
| GO:BP | GO:0060512 | prostate gland morphogenesis | 3 | 21 | 4.95e-01 |
| GO:BP | GO:1904373 | response to kainic acid | 1 | 1 | 4.95e-01 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 13 | 249 | 4.95e-01 |
| GO:BP | GO:1904372 | positive regulation of protein localization to actin cortical patch | 1 | 1 | 4.95e-01 |
| GO:BP | GO:1905133 | negative regulation of meiotic chromosome separation | 1 | 2 | 4.95e-01 |
| GO:BP | GO:1902806 | regulation of cell cycle G1/S phase transition | 7 | 169 | 4.95e-01 |
| GO:BP | GO:0010612 | regulation of cardiac muscle adaptation | 4 | 10 | 4.95e-01 |
| GO:BP | GO:1903242 | regulation of cardiac muscle hypertrophy in response to stress | 4 | 10 | 4.95e-01 |
| GO:BP | GO:0002821 | positive regulation of adaptive immune response | 1 | 66 | 4.95e-01 |
| GO:BP | GO:1902035 | positive regulation of hematopoietic stem cell proliferation | 1 | 7 | 4.95e-01 |
| GO:BP | GO:0039535 | regulation of RIG-I signaling pathway | 2 | 17 | 4.95e-01 |
| GO:BP | GO:0046294 | formaldehyde catabolic process | 2 | 2 | 4.95e-01 |
| GO:BP | GO:1902463 | protein localization to cell leading edge | 2 | 5 | 4.95e-01 |
| GO:BP | GO:0000710 | meiotic mismatch repair | 2 | 2 | 4.95e-01 |
| GO:BP | GO:0040011 | locomotion | 1 | 954 | 4.95e-01 |
| GO:BP | GO:0061107 | seminal vesicle development | 2 | 2 | 4.95e-01 |
| GO:BP | GO:0070203 | regulation of establishment of protein localization to telomere | 4 | 11 | 4.95e-01 |
| GO:BP | GO:0070084 | protein initiator methionine removal | 2 | 4 | 4.95e-01 |
| GO:BP | GO:0031649 | heat generation | 1 | 11 | 4.95e-01 |
| GO:BP | GO:0030900 | forebrain development | 4 | 281 | 4.95e-01 |
| GO:BP | GO:0010761 | fibroblast migration | 13 | 52 | 4.95e-01 |
| GO:BP | GO:0070078 | histone H3-R2 demethylation | 1 | 1 | 4.96e-01 |
| GO:BP | GO:0140074 | cardiac endothelial to mesenchymal transition | 1 | 2 | 4.96e-01 |
| GO:BP | GO:0019433 | triglyceride catabolic process | 2 | 17 | 4.96e-01 |
| GO:BP | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1 | 1 | 4.96e-01 |
| GO:BP | GO:0070079 | histone H4-R3 demethylation | 1 | 1 | 4.96e-01 |
| GO:BP | GO:0009743 | response to carbohydrate | 13 | 161 | 4.96e-01 |
| GO:BP | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication | 1 | 1 | 4.96e-01 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 3 | 266 | 4.96e-01 |
| GO:BP | GO:0060697 | positive regulation of phospholipid catabolic process | 1 | 1 | 4.97e-01 |
| GO:BP | GO:2000278 | regulation of DNA biosynthetic process | 36 | 111 | 4.97e-01 |
| GO:BP | GO:0060009 | Sertoli cell development | 1 | 10 | 4.97e-01 |
| GO:BP | GO:0007158 | neuron cell-cell adhesion | 1 | 13 | 4.97e-01 |
| GO:BP | GO:0042501 | serine phosphorylation of STAT protein | 1 | 9 | 4.97e-01 |
| GO:BP | GO:0006680 | glucosylceramide catabolic process | 1 | 3 | 4.97e-01 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 29 | 616 | 4.97e-01 |
| GO:BP | GO:0000272 | polysaccharide catabolic process | 6 | 14 | 4.97e-01 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 29 | 51 | 4.97e-01 |
| GO:BP | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway | 3 | 3 | 4.97e-01 |
| GO:BP | GO:0023021 | termination of signal transduction | 1 | 3 | 4.97e-01 |
| GO:BP | GO:0044065 | regulation of respiratory system process | 1 | 11 | 4.97e-01 |
| GO:BP | GO:0071865 | regulation of apoptotic process in bone marrow cell | 3 | 3 | 4.97e-01 |
| GO:BP | GO:0071866 | negative regulation of apoptotic process in bone marrow cell | 3 | 3 | 4.97e-01 |
| GO:BP | GO:1904777 | negative regulation of protein localization to cell cortex | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0098725 | symmetric cell division | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0003242 | cardiac chamber ballooning | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0070668 | positive regulation of mast cell proliferation | 2 | 4 | 4.97e-01 |
| GO:BP | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development | 2 | 2 | 4.97e-01 |
| GO:BP | GO:1902034 | negative regulation of hematopoietic stem cell proliferation | 1 | 2 | 4.97e-01 |
| GO:BP | GO:1902767 | isoprenoid biosynthetic process via mevalonate | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 1 | 74 | 4.97e-01 |
| GO:BP | GO:1902262 | apoptotic process involved in blood vessel morphogenesis | 3 | 4 | 4.97e-01 |
| GO:BP | GO:0007584 | response to nutrient | 2 | 109 | 4.97e-01 |
| GO:BP | GO:0097475 | motor neuron migration | 3 | 10 | 4.97e-01 |
| GO:BP | GO:0010142 | farnesyl diphosphate biosynthetic process, mevalonate pathway | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 25 | 427 | 4.97e-01 |
| GO:BP | GO:0072172 | mesonephric tubule formation | 1 | 6 | 4.97e-01 |
| GO:BP | GO:0003182 | coronary sinus valve morphogenesis | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0003178 | coronary sinus valve development | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0001523 | retinoid metabolic process | 5 | 40 | 4.97e-01 |
| GO:BP | GO:0018282 | metal incorporation into metallo-sulfur cluster | 2 | 2 | 4.97e-01 |
| GO:BP | GO:0061551 | trigeminal ganglion development | 3 | 3 | 4.97e-01 |
| GO:BP | GO:0021816 | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 2 | 2 | 4.97e-01 |
| GO:BP | GO:0071166 | ribonucleoprotein complex localization | 1 | 7 | 4.97e-01 |
| GO:BP | GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 6 | 31 | 4.97e-01 |
| GO:BP | GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 1 | 1 | 4.97e-01 |
| GO:BP | GO:1990456 | mitochondrion-endoplasmic reticulum membrane tethering | 3 | 7 | 4.97e-01 |
| GO:BP | GO:1990575 | mitochondrial L-ornithine transmembrane transport | 1 | 2 | 4.97e-01 |
| GO:BP | GO:0018283 | iron incorporation into metallo-sulfur cluster | 2 | 2 | 4.97e-01 |
| GO:BP | GO:0060843 | venous endothelial cell differentiation | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 17 | 31 | 4.97e-01 |
| GO:BP | GO:0030183 | B cell differentiation | 2 | 94 | 4.97e-01 |
| GO:BP | GO:1901993 | regulation of meiotic cell cycle phase transition | 4 | 5 | 4.97e-01 |
| GO:BP | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 2 | 8 | 4.97e-01 |
| GO:BP | GO:2000657 | negative regulation of apolipoprotein binding | 1 | 1 | 4.97e-01 |
| GO:BP | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 2 | 39 | 4.97e-01 |
| GO:BP | GO:2000656 | regulation of apolipoprotein binding | 1 | 1 | 4.97e-01 |
| GO:BP | GO:0062033 | positive regulation of mitotic sister chromatid segregation | 3 | 6 | 4.97e-01 |
| GO:BP | GO:0061713 | anterior neural tube closure | 1 | 2 | 4.97e-01 |
| GO:BP | GO:0021769 | orbitofrontal cortex development | 2 | 2 | 4.97e-01 |
| GO:BP | GO:0001765 | membrane raft assembly | 1 | 9 | 4.97e-01 |
| GO:BP | GO:0050890 | cognition | 11 | 227 | 4.97e-01 |
| GO:BP | GO:1905933 | regulation of cell fate determination | 1 | 2 | 4.98e-01 |
| GO:BP | GO:0007389 | pattern specification process | 1 | 306 | 4.98e-01 |
| GO:BP | GO:1905216 | positive regulation of RNA binding | 5 | 9 | 4.98e-01 |
| GO:BP | GO:0007000 | nucleolus organization | 10 | 17 | 4.98e-01 |
| GO:BP | GO:1903019 | negative regulation of glycoprotein metabolic process | 1 | 12 | 4.98e-01 |
| GO:BP | GO:1901210 | regulation of cardiac chamber formation | 1 | 1 | 4.98e-01 |
| GO:BP | GO:0042462 | eye photoreceptor cell development | 2 | 19 | 4.98e-01 |
| GO:BP | GO:1903141 | negative regulation of establishment of endothelial barrier | 2 | 2 | 4.98e-01 |
| GO:BP | GO:0097533 | cellular stress response to acid chemical | 2 | 2 | 4.98e-01 |
| GO:BP | GO:0003065 | positive regulation of heart rate by epinephrine | 1 | 1 | 4.98e-01 |
| GO:BP | GO:0075733 | intracellular transport of virus | 5 | 8 | 4.98e-01 |
| GO:BP | GO:0015729 | oxaloacetate transport | 1 | 5 | 4.98e-01 |
| GO:BP | GO:0098739 | import across plasma membrane | 20 | 133 | 4.98e-01 |
| GO:BP | GO:0007172 | signal complex assembly | 1 | 7 | 4.98e-01 |
| GO:BP | GO:1901211 | negative regulation of cardiac chamber formation | 1 | 1 | 4.98e-01 |
| GO:BP | GO:0003169 | coronary vein morphogenesis | 2 | 2 | 4.98e-01 |
| GO:BP | GO:1903033 | positive regulation of microtubule plus-end binding | 2 | 2 | 4.98e-01 |
| GO:BP | GO:1901551 | negative regulation of endothelial cell development | 2 | 2 | 4.98e-01 |
| GO:BP | GO:1901208 | negative regulation of heart looping | 1 | 1 | 4.98e-01 |
| GO:BP | GO:0061614 | miRNA transcription | 18 | 57 | 4.98e-01 |
| GO:BP | GO:0021558 | trochlear nerve development | 1 | 1 | 4.98e-01 |
| GO:BP | GO:0035850 | epithelial cell differentiation involved in kidney development | 1 | 35 | 4.98e-01 |
| GO:BP | GO:0062176 | R-loop processing | 4 | 6 | 4.98e-01 |
| GO:BP | GO:0038190 | VEGF-activated neuropilin signaling pathway | 2 | 2 | 4.98e-01 |
| GO:BP | GO:0061102 | stomach neuroendocrine cell differentiation | 1 | 1 | 4.98e-01 |
| GO:BP | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus | 1 | 16 | 4.98e-01 |
| GO:BP | GO:0097532 | stress response to acid chemical | 2 | 2 | 4.98e-01 |
| GO:BP | GO:0045428 | regulation of nitric oxide biosynthetic process | 3 | 38 | 4.98e-01 |
| GO:BP | GO:0098656 | monoatomic anion transmembrane transport | 1 | 71 | 4.98e-01 |
| GO:BP | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization | 1 | 6 | 4.98e-01 |
| GO:BP | GO:0035994 | response to muscle stretch | 3 | 26 | 4.98e-01 |
| GO:BP | GO:1903031 | regulation of microtubule plus-end binding | 2 | 2 | 4.98e-01 |
| GO:BP | GO:0030517 | negative regulation of axon extension | 24 | 41 | 4.98e-01 |
| GO:BP | GO:0071621 | granulocyte chemotaxis | 3 | 53 | 4.98e-01 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 7 | 151 | 4.98e-01 |
| GO:BP | GO:0030150 | protein import into mitochondrial matrix | 12 | 19 | 4.98e-01 |
| GO:BP | GO:0035794 | positive regulation of mitochondrial membrane permeability | 8 | 43 | 4.98e-01 |
| GO:BP | GO:0001824 | blastocyst development | 1 | 94 | 4.98e-01 |
| GO:BP | GO:0006879 | intracellular iron ion homeostasis | 7 | 52 | 4.98e-01 |
| GO:BP | GO:0046824 | positive regulation of nucleocytoplasmic transport | 5 | 51 | 4.98e-01 |
| GO:BP | GO:0045840 | positive regulation of mitotic nuclear division | 13 | 29 | 4.99e-01 |
| GO:BP | GO:0042552 | myelination | 2 | 111 | 4.99e-01 |
| GO:BP | GO:0010823 | negative regulation of mitochondrion organization | 3 | 46 | 4.99e-01 |
| GO:BP | GO:0035963 | cellular response to interleukin-13 | 1 | 1 | 4.99e-01 |
| GO:BP | GO:0071472 | cellular response to salt stress | 5 | 11 | 4.99e-01 |
| GO:BP | GO:0035335 | peptidyl-tyrosine dephosphorylation | 17 | 26 | 4.99e-01 |
| GO:BP | GO:0031670 | cellular response to nutrient | 1 | 31 | 4.99e-01 |
| GO:BP | GO:0002551 | mast cell chemotaxis | 1 | 9 | 4.99e-01 |
| GO:BP | GO:0110022 | regulation of cardiac muscle myoblast proliferation | 2 | 3 | 4.99e-01 |
| GO:BP | GO:0110021 | cardiac muscle myoblast proliferation | 2 | 3 | 4.99e-01 |
| GO:BP | GO:1901390 | positive regulation of transforming growth factor beta activation | 2 | 3 | 4.99e-01 |
| GO:BP | GO:0110024 | positive regulation of cardiac muscle myoblast proliferation | 2 | 3 | 4.99e-01 |
| GO:BP | GO:0099518 | vesicle cytoskeletal trafficking | 5 | 60 | 5.00e-01 |
| GO:BP | GO:0032105 | negative regulation of response to extracellular stimulus | 1 | 7 | 5.00e-01 |
| GO:BP | GO:0032096 | negative regulation of response to food | 1 | 7 | 5.00e-01 |
| GO:BP | GO:0014721 | twitch skeletal muscle contraction | 4 | 5 | 5.00e-01 |
| GO:BP | GO:0032108 | negative regulation of response to nutrient levels | 1 | 7 | 5.00e-01 |
| GO:BP | GO:0003010 | voluntary skeletal muscle contraction | 4 | 5 | 5.00e-01 |
| GO:BP | GO:0033210 | leptin-mediated signaling pathway | 1 | 10 | 5.00e-01 |
| GO:BP | GO:0032099 | negative regulation of appetite | 1 | 7 | 5.00e-01 |
| GO:BP | GO:0110008 | ncRNA deadenylation | 1 | 1 | 5.00e-01 |
| GO:BP | GO:0036015 | response to interleukin-3 | 3 | 6 | 5.00e-01 |
| GO:BP | GO:0036016 | cellular response to interleukin-3 | 3 | 6 | 5.00e-01 |
| GO:BP | GO:0061738 | late endosomal microautophagy | 1 | 3 | 5.00e-01 |
| GO:BP | GO:0061029 | eyelid development in camera-type eye | 3 | 12 | 5.00e-01 |
| GO:BP | GO:0045719 | negative regulation of glycogen biosynthetic process | 3 | 7 | 5.00e-01 |
| GO:BP | GO:0061982 | meiosis I cell cycle process | 35 | 81 | 5.00e-01 |
| GO:BP | GO:0030202 | heparin metabolic process | 2 | 14 | 5.00e-01 |
| GO:BP | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response | 18 | 29 | 5.00e-01 |
| GO:BP | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity | 1 | 10 | 5.00e-01 |
| GO:BP | GO:0050931 | pigment cell differentiation | 1 | 26 | 5.00e-01 |
| GO:BP | GO:2000591 | positive regulation of metanephric mesenchymal cell migration | 1 | 3 | 5.00e-01 |
| GO:BP | GO:0003104 | positive regulation of glomerular filtration | 1 | 3 | 5.00e-01 |
| GO:BP | GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1 | 26 | 5.00e-01 |
| GO:BP | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1 | 3 | 5.00e-01 |
| GO:BP | GO:1900238 | regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1 | 3 | 5.00e-01 |
| GO:BP | GO:0043604 | amide biosynthetic process | 3 | 775 | 5.00e-01 |
| GO:BP | GO:1903903 | regulation of establishment of T cell polarity | 1 | 6 | 5.00e-01 |
| GO:BP | GO:0006636 | unsaturated fatty acid biosynthetic process | 13 | 34 | 5.00e-01 |
| GO:BP | GO:0046456 | icosanoid biosynthetic process | 2 | 29 | 5.00e-01 |
| GO:BP | GO:1905271 | regulation of proton-transporting ATP synthase activity, rotational mechanism | 2 | 3 | 5.00e-01 |
| GO:BP | GO:1905273 | positive regulation of proton-transporting ATP synthase activity, rotational mechanism | 2 | 3 | 5.00e-01 |
| GO:BP | GO:0070143 | mitochondrial alanyl-tRNA aminoacylation | 1 | 1 | 5.00e-01 |
| GO:BP | GO:0031929 | TOR signaling | 1 | 115 | 5.00e-01 |
| GO:BP | GO:1905706 | regulation of mitochondrial ATP synthesis coupled proton transport | 2 | 3 | 5.00e-01 |
| GO:BP | GO:0048369 | lateral mesoderm morphogenesis | 3 | 3 | 5.00e-01 |
| GO:BP | GO:0048370 | lateral mesoderm formation | 3 | 3 | 5.00e-01 |
| GO:BP | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 1 | 1 | 5.01e-01 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 1 | 67 | 5.01e-01 |
| GO:BP | GO:0030210 | heparin biosynthetic process | 1 | 9 | 5.01e-01 |
| GO:BP | GO:0002159 | desmosome assembly | 2 | 3 | 5.02e-01 |
| GO:BP | GO:0071603 | endothelial cell-cell adhesion | 2 | 4 | 5.02e-01 |
| GO:BP | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response | 10 | 16 | 5.02e-01 |
| GO:BP | GO:0031953 | negative regulation of protein autophosphorylation | 1 | 9 | 5.02e-01 |
| GO:BP | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing | 1 | 1 | 5.02e-01 |
| GO:BP | GO:1905090 | negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | 1 | 1 | 5.02e-01 |
| GO:BP | GO:0036149 | phosphatidylinositol acyl-chain remodeling | 2 | 3 | 5.02e-01 |
| GO:BP | GO:2000640 | positive regulation of SREBP signaling pathway | 2 | 2 | 5.02e-01 |
| GO:BP | GO:0051890 | regulation of cardioblast differentiation | 2 | 5 | 5.02e-01 |
| GO:BP | GO:1904058 | positive regulation of sensory perception of pain | 2 | 3 | 5.02e-01 |
| GO:BP | GO:1902915 | negative regulation of protein polyubiquitination | 1 | 9 | 5.02e-01 |
| GO:BP | GO:0003128 | heart field specification | 5 | 16 | 5.02e-01 |
| GO:BP | GO:1900006 | positive regulation of dendrite development | 5 | 14 | 5.02e-01 |
| GO:BP | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway | 1 | 8 | 5.02e-01 |
| GO:BP | GO:1903299 | regulation of hexokinase activity | 1 | 8 | 5.02e-01 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1 | 166 | 5.02e-01 |
| GO:BP | GO:0045542 | positive regulation of cholesterol biosynthetic process | 5 | 7 | 5.02e-01 |
| GO:BP | GO:0007272 | ensheathment of neurons | 2 | 113 | 5.02e-01 |
| GO:BP | GO:0106120 | positive regulation of sterol biosynthetic process | 5 | 7 | 5.02e-01 |
| GO:BP | GO:0060026 | convergent extension | 2 | 14 | 5.02e-01 |
| GO:BP | GO:0045657 | positive regulation of monocyte differentiation | 1 | 7 | 5.02e-01 |
| GO:BP | GO:0031129 | inductive cell-cell signaling | 1 | 1 | 5.02e-01 |
| GO:BP | GO:0008366 | axon ensheathment | 2 | 113 | 5.02e-01 |
| GO:BP | GO:1903232 | melanosome assembly | 10 | 19 | 5.02e-01 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 1 | 302 | 5.02e-01 |
| GO:BP | GO:1903977 | positive regulation of glial cell migration | 1 | 5 | 5.02e-01 |
| GO:BP | GO:0000902 | cell morphogenesis | 1 | 761 | 5.02e-01 |
| GO:BP | GO:0006788 | heme oxidation | 2 | 2 | 5.02e-01 |
| GO:BP | GO:0071707 | immunoglobulin heavy chain V-D-J recombination | 2 | 2 | 5.02e-01 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 22 | 265 | 5.02e-01 |
| GO:BP | GO:1902725 | negative regulation of satellite cell differentiation | 1 | 2 | 5.02e-01 |
| GO:BP | GO:0090669 | telomerase RNA stabilization | 2 | 4 | 5.02e-01 |
| GO:BP | GO:1904273 | L-alanine import across plasma membrane | 3 | 4 | 5.03e-01 |
| GO:BP | GO:0099140 | presynaptic actin cytoskeleton organization | 1 | 1 | 5.03e-01 |
| GO:BP | GO:0099187 | presynaptic cytoskeleton organization | 1 | 1 | 5.03e-01 |
| GO:BP | GO:0007600 | sensory perception | 1 | 269 | 5.03e-01 |
| GO:BP | GO:0071236 | cellular response to antibiotic | 1 | 11 | 5.03e-01 |
| GO:BP | GO:0070417 | cellular response to cold | 1 | 8 | 5.03e-01 |
| GO:BP | GO:0090672 | telomerase RNA localization | 6 | 19 | 5.03e-01 |
| GO:BP | GO:0000469 | cleavage involved in rRNA processing | 1 | 29 | 5.03e-01 |
| GO:BP | GO:0090685 | RNA localization to nucleus | 6 | 19 | 5.03e-01 |
| GO:BP | GO:0050914 | sensory perception of salty taste | 1 | 1 | 5.03e-01 |
| GO:BP | GO:0090671 | telomerase RNA localization to Cajal body | 6 | 19 | 5.03e-01 |
| GO:BP | GO:0048483 | autonomic nervous system development | 4 | 28 | 5.03e-01 |
| GO:BP | GO:0072595 | maintenance of protein localization in organelle | 2 | 39 | 5.03e-01 |
| GO:BP | GO:0060766 | negative regulation of androgen receptor signaling pathway | 6 | 12 | 5.03e-01 |
| GO:BP | GO:0030997 | regulation of centriole-centriole cohesion | 1 | 3 | 5.03e-01 |
| GO:BP | GO:0090670 | RNA localization to Cajal body | 6 | 19 | 5.03e-01 |
| GO:BP | GO:0045339 | farnesyl diphosphate catabolic process | 1 | 1 | 5.03e-01 |
| GO:BP | GO:1902247 | geranylgeranyl diphosphate catabolic process | 1 | 1 | 5.03e-01 |
| GO:BP | GO:0046209 | nitric oxide metabolic process | 4 | 55 | 5.03e-01 |
| GO:BP | GO:1902001 | fatty acid transmembrane transport | 5 | 15 | 5.03e-01 |
| GO:BP | GO:0050655 | dermatan sulfate proteoglycan metabolic process | 3 | 12 | 5.03e-01 |
| GO:BP | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange | 5 | 5 | 5.03e-01 |
| GO:BP | GO:0034087 | establishment of mitotic sister chromatid cohesion | 5 | 7 | 5.03e-01 |
| GO:BP | GO:0055006 | cardiac cell development | 25 | 77 | 5.03e-01 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 3 | 1974 | 5.03e-01 |
| GO:BP | GO:0150077 | regulation of neuroinflammatory response | 1 | 13 | 5.04e-01 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 4 | 20 | 5.04e-01 |
| GO:BP | GO:0030730 | sequestering of triglyceride | 10 | 13 | 5.04e-01 |
| GO:BP | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 1 | 2 | 5.04e-01 |
| GO:BP | GO:0006499 | N-terminal protein myristoylation | 2 | 4 | 5.04e-01 |
| GO:BP | GO:0018377 | protein myristoylation | 2 | 4 | 5.04e-01 |
| GO:BP | GO:0031339 | negative regulation of vesicle fusion | 3 | 3 | 5.04e-01 |
| GO:BP | GO:0034497 | protein localization to phagophore assembly site | 1 | 17 | 5.04e-01 |
| GO:BP | GO:0034620 | cellular response to unfolded protein | 3 | 91 | 5.04e-01 |
| GO:BP | GO:0043550 | regulation of lipid kinase activity | 1 | 43 | 5.04e-01 |
| GO:BP | GO:0030101 | natural killer cell activation | 4 | 42 | 5.04e-01 |
| GO:BP | GO:0038061 | NIK/NF-kappaB signaling | 2 | 86 | 5.04e-01 |
| GO:BP | GO:1900015 | regulation of cytokine production involved in inflammatory response | 2 | 33 | 5.04e-01 |
| GO:BP | GO:0021681 | cerebellar granular layer development | 2 | 11 | 5.04e-01 |
| GO:BP | GO:0048338 | mesoderm structural organization | 1 | 1 | 5.04e-01 |
| GO:BP | GO:1905285 | fibrous ring of heart morphogenesis | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0021998 | neural plate mediolateral regionalization | 1 | 1 | 5.04e-01 |
| GO:BP | GO:1903522 | regulation of blood circulation | 5 | 198 | 5.04e-01 |
| GO:BP | GO:2000655 | negative regulation of cellular response to testosterone stimulus | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0060897 | neural plate regionalization | 3 | 6 | 5.04e-01 |
| GO:BP | GO:0048352 | paraxial mesoderm structural organization | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 2 | 3 | 5.04e-01 |
| GO:BP | GO:0048372 | lateral mesodermal cell fate commitment | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0060515 | prostate field specification | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0048377 | lateral mesodermal cell fate specification | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0060514 | prostate induction | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0048378 | regulation of lateral mesodermal cell fate specification | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0033015 | tetrapyrrole catabolic process | 1 | 7 | 5.04e-01 |
| GO:BP | GO:0032881 | regulation of polysaccharide metabolic process | 12 | 34 | 5.04e-01 |
| GO:BP | GO:0007417 | central nervous system development | 12 | 792 | 5.04e-01 |
| GO:BP | GO:0002885 | positive regulation of hypersensitivity | 3 | 5 | 5.04e-01 |
| GO:BP | GO:1904414 | positive regulation of cardiac ventricle development | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0003306 | Wnt signaling pathway involved in heart development | 3 | 8 | 5.04e-01 |
| GO:BP | GO:0035600 | tRNA methylthiolation | 2 | 2 | 5.04e-01 |
| GO:BP | GO:1904412 | regulation of cardiac ventricle development | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0045670 | regulation of osteoclast differentiation | 7 | 38 | 5.04e-01 |
| GO:BP | GO:0002534 | cytokine production involved in inflammatory response | 2 | 33 | 5.04e-01 |
| GO:BP | GO:0051643 | endoplasmic reticulum localization | 1 | 8 | 5.04e-01 |
| GO:BP | GO:0072329 | monocarboxylic acid catabolic process | 1 | 105 | 5.04e-01 |
| GO:BP | GO:0019102 | male somatic sex determination | 1 | 1 | 5.04e-01 |
| GO:BP | GO:0046426 | negative regulation of receptor signaling pathway via JAK-STAT | 7 | 20 | 5.04e-01 |
| GO:BP | GO:0015911 | long-chain fatty acid import across plasma membrane | 3 | 9 | 5.04e-01 |
| GO:BP | GO:0016049 | cell growth | 3 | 418 | 5.04e-01 |
| GO:BP | GO:0006787 | porphyrin-containing compound catabolic process | 1 | 7 | 5.04e-01 |
| GO:BP | GO:1904220 | regulation of serine C-palmitoyltransferase activity | 1 | 3 | 5.05e-01 |
| GO:BP | GO:0098942 | retrograde trans-synaptic signaling by trans-synaptic protein complex | 2 | 2 | 5.05e-01 |
| GO:BP | GO:0099601 | regulation of neurotransmitter receptor activity | 4 | 40 | 5.05e-01 |
| GO:BP | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress | 1 | 18 | 5.05e-01 |
| GO:BP | GO:0050792 | regulation of viral process | 2 | 122 | 5.05e-01 |
| GO:BP | GO:0006805 | xenobiotic metabolic process | 1 | 56 | 5.05e-01 |
| GO:BP | GO:0150099 | neuron-glial cell signaling | 2 | 4 | 5.05e-01 |
| GO:BP | GO:0090118 | receptor-mediated endocytosis involved in cholesterol transport | 1 | 5 | 5.05e-01 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 5 | 80 | 5.05e-01 |
| GO:BP | GO:0043137 | DNA replication, removal of RNA primer | 2 | 4 | 5.05e-01 |
| GO:BP | GO:0034383 | low-density lipoprotein particle clearance | 1 | 17 | 5.05e-01 |
| GO:BP | GO:2000118 | regulation of sodium-dependent phosphate transport | 1 | 3 | 5.05e-01 |
| GO:BP | GO:0060517 | epithelial cell proliferation involved in prostatic bud elongation | 1 | 1 | 5.05e-01 |
| GO:BP | GO:0006560 | proline metabolic process | 4 | 7 | 5.05e-01 |
| GO:BP | GO:0045647 | negative regulation of erythrocyte differentiation | 1 | 7 | 5.05e-01 |
| GO:BP | GO:0019264 | glycine biosynthetic process from serine | 1 | 2 | 5.05e-01 |
| GO:BP | GO:0060784 | regulation of cell proliferation involved in tissue homeostasis | 1 | 1 | 5.05e-01 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 23 | 55 | 5.06e-01 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 3 | 18 | 5.06e-01 |
| GO:BP | GO:0035750 | protein localization to myelin sheath abaxonal region | 1 | 1 | 5.06e-01 |
| GO:BP | GO:0006941 | striated muscle contraction | 13 | 152 | 5.07e-01 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 6 | 103 | 5.07e-01 |
| GO:BP | GO:0003058 | hormonal regulation of the force of heart contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:2000018 | regulation of male gonad development | 2 | 5 | 5.08e-01 |
| GO:BP | GO:0009932 | cell tip growth | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0072498 | embryonic skeletal joint development | 2 | 10 | 5.08e-01 |
| GO:BP | GO:0051352 | negative regulation of ligase activity | 1 | 2 | 5.08e-01 |
| GO:BP | GO:2000627 | positive regulation of miRNA catabolic process | 1 | 4 | 5.08e-01 |
| GO:BP | GO:2000553 | positive regulation of T-helper 2 cell cytokine production | 1 | 3 | 5.08e-01 |
| GO:BP | GO:0046459 | short-chain fatty acid metabolic process | 1 | 10 | 5.08e-01 |
| GO:BP | GO:1990765 | colon smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0045947 | negative regulation of translational initiation | 1 | 18 | 5.08e-01 |
| GO:BP | GO:1904343 | positive regulation of colon smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0014828 | distal stomach smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 3 | 74 | 5.08e-01 |
| GO:BP | GO:0006695 | cholesterol biosynthetic process | 2 | 46 | 5.08e-01 |
| GO:BP | GO:1902653 | secondary alcohol biosynthetic process | 2 | 46 | 5.08e-01 |
| GO:BP | GO:0097326 | melanocyte adhesion | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0061303 | cornea development in camera-type eye | 1 | 4 | 5.08e-01 |
| GO:BP | GO:0010522 | regulation of calcium ion transport into cytosol | 1 | 10 | 5.08e-01 |
| GO:BP | GO:0120072 | positive regulation of pyloric antrum smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0120071 | regulation of pyloric antrum smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0006264 | mitochondrial DNA replication | 1 | 13 | 5.08e-01 |
| GO:BP | GO:1904341 | regulation of colon smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0120064 | stomach pylorus smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0120063 | stomach smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0120065 | pyloric antrum smooth muscle contraction | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0097378 | dorsal spinal cord interneuron axon guidance | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0032775 | DNA methylation on adenine | 1 | 2 | 5.08e-01 |
| GO:BP | GO:0018872 | arsonoacetate metabolic process | 1 | 1 | 5.08e-01 |
| GO:BP | GO:0032485 | regulation of Ral protein signal transduction | 2 | 3 | 5.08e-01 |
| GO:BP | GO:0097502 | mannosylation | 6 | 32 | 5.08e-01 |
| GO:BP | GO:0048247 | lymphocyte chemotaxis | 4 | 24 | 5.08e-01 |
| GO:BP | GO:0046626 | regulation of insulin receptor signaling pathway | 17 | 53 | 5.08e-01 |
| GO:BP | GO:2001057 | reactive nitrogen species metabolic process | 4 | 56 | 5.08e-01 |
| GO:BP | GO:0030595 | leukocyte chemotaxis | 12 | 115 | 5.08e-01 |
| GO:BP | GO:0042256 | cytosolic ribosome assembly | 1 | 5 | 5.08e-01 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 11 | 104 | 5.09e-01 |
| GO:BP | GO:0035654 | clathrin-coated vesicle cargo loading, AP-3-mediated | 5 | 6 | 5.09e-01 |
| GO:BP | GO:0035652 | clathrin-coated vesicle cargo loading | 5 | 6 | 5.09e-01 |
| GO:BP | GO:2000301 | negative regulation of synaptic vesicle exocytosis | 2 | 4 | 5.09e-01 |
| GO:BP | GO:1901858 | regulation of mitochondrial DNA metabolic process | 1 | 8 | 5.09e-01 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 6 | 110 | 5.09e-01 |
| GO:BP | GO:0045136 | development of secondary sexual characteristics | 1 | 9 | 5.09e-01 |
| GO:BP | GO:0046621 | negative regulation of organ growth | 14 | 27 | 5.09e-01 |
| GO:BP | GO:0060513 | prostatic bud formation | 1 | 8 | 5.09e-01 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 15 | 166 | 5.10e-01 |
| GO:BP | GO:0072073 | kidney epithelium development | 5 | 112 | 5.10e-01 |
| GO:BP | GO:0060765 | regulation of androgen receptor signaling pathway | 10 | 24 | 5.10e-01 |
| GO:BP | GO:0033157 | regulation of intracellular protein transport | 24 | 197 | 5.11e-01 |
| GO:BP | GO:0043434 | response to peptide hormone | 31 | 321 | 5.11e-01 |
| GO:BP | GO:0014860 | neurotransmitter secretion involved in regulation of skeletal muscle contraction | 1 | 1 | 5.11e-01 |
| GO:BP | GO:1902991 | regulation of amyloid precursor protein catabolic process | 1 | 39 | 5.11e-01 |
| GO:BP | GO:0003309 | type B pancreatic cell differentiation | 2 | 22 | 5.11e-01 |
| GO:BP | GO:0048701 | embryonic cranial skeleton morphogenesis | 1 | 31 | 5.11e-01 |
| GO:BP | GO:0048468 | cell development | 3 | 1963 | 5.12e-01 |
| GO:BP | GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 1 | 10 | 5.12e-01 |
| GO:BP | GO:0048266 | behavioral response to pain | 1 | 11 | 5.12e-01 |
| GO:BP | GO:0099532 | synaptic vesicle endosomal processing | 3 | 7 | 5.12e-01 |
| GO:BP | GO:0036120 | cellular response to platelet-derived growth factor stimulus | 6 | 21 | 5.12e-01 |
| GO:BP | GO:0071348 | cellular response to interleukin-11 | 1 | 1 | 5.12e-01 |
| GO:BP | GO:1905605 | positive regulation of blood-brain barrier permeability | 1 | 4 | 5.12e-01 |
| GO:BP | GO:0051029 | rRNA transport | 2 | 5 | 5.12e-01 |
| GO:BP | GO:0051574 | positive regulation of histone H3-K9 methylation | 3 | 5 | 5.12e-01 |
| GO:BP | GO:0032071 | regulation of endodeoxyribonuclease activity | 3 | 7 | 5.12e-01 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 3 | 83 | 5.12e-01 |
| GO:BP | GO:1903712 | cysteine transmembrane transport | 1 | 3 | 5.12e-01 |
| GO:BP | GO:0055113 | epiboly involved in gastrulation with mouth forming second | 1 | 1 | 5.12e-01 |
| GO:BP | GO:0042883 | cysteine transport | 1 | 3 | 5.12e-01 |
| GO:BP | GO:0042262 | DNA protection | 1 | 6 | 5.12e-01 |
| GO:BP | GO:0033864 | positive regulation of NAD(P)H oxidase activity | 1 | 6 | 5.12e-01 |
| GO:BP | GO:0034314 | Arp2/3 complex-mediated actin nucleation | 1 | 40 | 5.12e-01 |
| GO:BP | GO:0051031 | tRNA transport | 4 | 5 | 5.12e-01 |
| GO:BP | GO:0097210 | response to gonadotropin-releasing hormone | 2 | 4 | 5.12e-01 |
| GO:BP | GO:1901740 | negative regulation of myoblast fusion | 2 | 2 | 5.12e-01 |
| GO:BP | GO:0090186 | regulation of pancreatic juice secretion | 1 | 6 | 5.12e-01 |
| GO:BP | GO:0072384 | organelle transport along microtubule | 12 | 84 | 5.12e-01 |
| GO:BP | GO:0010979 | regulation of vitamin D 24-hydroxylase activity | 1 | 1 | 5.12e-01 |
| GO:BP | GO:0061767 | negative regulation of lung blood pressure | 1 | 1 | 5.12e-01 |
| GO:BP | GO:0051340 | regulation of ligase activity | 7 | 11 | 5.12e-01 |
| GO:BP | GO:0010980 | positive regulation of vitamin D 24-hydroxylase activity | 1 | 1 | 5.12e-01 |
| GO:BP | GO:0032916 | positive regulation of transforming growth factor beta3 production | 1 | 1 | 5.12e-01 |
| GO:BP | GO:0048278 | vesicle docking | 12 | 57 | 5.13e-01 |
| GO:BP | GO:1900180 | regulation of protein localization to nucleus | 1 | 117 | 5.13e-01 |
| GO:BP | GO:0007021 | tubulin complex assembly | 1 | 9 | 5.13e-01 |
| GO:BP | GO:0016101 | diterpenoid metabolic process | 5 | 43 | 5.13e-01 |
| GO:BP | GO:0021861 | forebrain radial glial cell differentiation | 2 | 6 | 5.13e-01 |
| GO:BP | GO:2000191 | regulation of fatty acid transport | 3 | 19 | 5.13e-01 |
| GO:BP | GO:0010746 | regulation of long-chain fatty acid import across plasma membrane | 2 | 5 | 5.13e-01 |
| GO:BP | GO:0032696 | negative regulation of interleukin-13 production | 2 | 3 | 5.13e-01 |
| GO:BP | GO:0120158 | positive regulation of collagen catabolic process | 1 | 1 | 5.13e-01 |
| GO:BP | GO:0001885 | endothelial cell development | 6 | 53 | 5.13e-01 |
| GO:BP | GO:0003275 | apoptotic process involved in outflow tract morphogenesis | 1 | 3 | 5.13e-01 |
| GO:BP | GO:1902256 | regulation of apoptotic process involved in outflow tract morphogenesis | 1 | 3 | 5.13e-01 |
| GO:BP | GO:0090322 | regulation of superoxide metabolic process | 2 | 19 | 5.14e-01 |
| GO:BP | GO:0061386 | closure of optic fissure | 2 | 2 | 5.14e-01 |
| GO:BP | GO:0048697 | positive regulation of collateral sprouting in absence of injury | 1 | 1 | 5.14e-01 |
| GO:BP | GO:0099557 | trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission | 2 | 3 | 5.14e-01 |
| GO:BP | GO:0044857 | plasma membrane raft organization | 1 | 9 | 5.14e-01 |
| GO:BP | GO:0034454 | microtubule anchoring at centrosome | 1 | 12 | 5.14e-01 |
| GO:BP | GO:0042753 | positive regulation of circadian rhythm | 1 | 10 | 5.15e-01 |
| GO:BP | GO:0006720 | isoprenoid metabolic process | 6 | 85 | 5.15e-01 |
| GO:BP | GO:0070934 | CRD-mediated mRNA stabilization | 7 | 11 | 5.15e-01 |
| GO:BP | GO:0032530 | regulation of microvillus organization | 4 | 10 | 5.15e-01 |
| GO:BP | GO:0016242 | negative regulation of macroautophagy | 18 | 34 | 5.15e-01 |
| GO:BP | GO:0071362 | cellular response to ether | 1 | 5 | 5.16e-01 |
| GO:BP | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 1 | 6 | 5.16e-01 |
| GO:BP | GO:0015910 | long-chain fatty acid import into peroxisome | 2 | 3 | 5.16e-01 |
| GO:BP | GO:0006896 | Golgi to vacuole transport | 1 | 19 | 5.16e-01 |
| GO:BP | GO:0018158 | protein oxidation | 1 | 12 | 5.16e-01 |
| GO:BP | GO:0090557 | establishment of endothelial intestinal barrier | 3 | 10 | 5.16e-01 |
| GO:BP | GO:0070673 | response to interleukin-18 | 3 | 5 | 5.16e-01 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 24 | 44 | 5.16e-01 |
| GO:BP | GO:0008643 | carbohydrate transport | 4 | 111 | 5.16e-01 |
| GO:BP | GO:0036119 | response to platelet-derived growth factor | 11 | 23 | 5.16e-01 |
| GO:BP | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1 | 27 | 5.16e-01 |
| GO:BP | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol | 2 | 2 | 5.16e-01 |
| GO:BP | GO:0002143 | tRNA wobble position uridine thiolation | 2 | 4 | 5.16e-01 |
| GO:BP | GO:0032252 | secretory granule localization | 1 | 9 | 5.16e-01 |
| GO:BP | GO:2001279 | regulation of unsaturated fatty acid biosynthetic process | 4 | 7 | 5.16e-01 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 8 | 168 | 5.16e-01 |
| GO:BP | GO:1904020 | regulation of G protein-coupled receptor internalization | 3 | 3 | 5.16e-01 |
| GO:BP | GO:0071863 | regulation of cell proliferation in bone marrow | 2 | 6 | 5.16e-01 |
| GO:BP | GO:0006611 | protein export from nucleus | 7 | 55 | 5.16e-01 |
| GO:BP | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1 | 12 | 5.16e-01 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 3 | 1380 | 5.16e-01 |
| GO:BP | GO:0045585 | positive regulation of cytotoxic T cell differentiation | 1 | 2 | 5.16e-01 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 1 | 86 | 5.16e-01 |
| GO:BP | GO:0007018 | microtubule-based movement | 15 | 300 | 5.17e-01 |
| GO:BP | GO:0035330 | regulation of hippo signaling | 3 | 21 | 5.17e-01 |
| GO:BP | GO:0080164 | regulation of nitric oxide metabolic process | 3 | 40 | 5.17e-01 |
| GO:BP | GO:0043506 | regulation of JUN kinase activity | 3 | 49 | 5.17e-01 |
| GO:BP | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine | 1 | 2 | 5.17e-01 |
| GO:BP | GO:2000056 | regulation of Wnt signaling pathway involved in digestive tract morphogenesis | 1 | 1 | 5.17e-01 |
| GO:BP | GO:0032354 | response to follicle-stimulating hormone | 2 | 13 | 5.17e-01 |
| GO:BP | GO:0031444 | slow-twitch skeletal muscle fiber contraction | 2 | 2 | 5.17e-01 |
| GO:BP | GO:2000057 | negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis | 1 | 1 | 5.17e-01 |
| GO:BP | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis | 1 | 1 | 5.17e-01 |
| GO:BP | GO:0046339 | diacylglycerol metabolic process | 15 | 23 | 5.17e-01 |
| GO:BP | GO:0002315 | marginal zone B cell differentiation | 1 | 6 | 5.17e-01 |
| GO:BP | GO:0032959 | inositol trisphosphate biosynthetic process | 1 | 6 | 5.17e-01 |
| GO:BP | GO:0006924 | activation-induced cell death of T cells | 1 | 8 | 5.17e-01 |
| GO:BP | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1 | 8 | 5.17e-01 |
| GO:BP | GO:0051351 | positive regulation of ligase activity | 6 | 9 | 5.17e-01 |
| GO:BP | GO:0042930 | enterobactin transport | 1 | 1 | 5.17e-01 |
| GO:BP | GO:0106072 | negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3 | 8 | 5.17e-01 |
| GO:BP | GO:1904184 | positive regulation of pyruvate dehydrogenase activity | 1 | 3 | 5.17e-01 |
| GO:BP | GO:0016482 | cytosolic transport | 6 | 161 | 5.17e-01 |
| GO:BP | GO:0120322 | lipid modification by small protein conjugation | 1 | 1 | 5.17e-01 |
| GO:BP | GO:0120323 | lipid ubiquitination | 1 | 1 | 5.17e-01 |
| GO:BP | GO:0033292 | T-tubule organization | 5 | 8 | 5.17e-01 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 6 | 214 | 5.17e-01 |
| GO:BP | GO:0021782 | glial cell development | 1 | 84 | 5.17e-01 |
| GO:BP | GO:0051006 | positive regulation of lipoprotein lipase activity | 1 | 4 | 5.17e-01 |
| GO:BP | GO:0010898 | positive regulation of triglyceride catabolic process | 1 | 4 | 5.17e-01 |
| GO:BP | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1 | 12 | 5.17e-01 |
| GO:BP | GO:0072050 | S-shaped body morphogenesis | 2 | 5 | 5.17e-01 |
| GO:BP | GO:0099183 | trans-synaptic signaling by BDNF, modulating synaptic transmission | 1 | 2 | 5.17e-01 |
| GO:BP | GO:2000179 | positive regulation of neural precursor cell proliferation | 9 | 34 | 5.18e-01 |
| GO:BP | GO:0006568 | tryptophan metabolic process | 1 | 3 | 5.18e-01 |
| GO:BP | GO:0045176 | apical protein localization | 1 | 13 | 5.18e-01 |
| GO:BP | GO:0002155 | regulation of thyroid hormone mediated signaling pathway | 2 | 5 | 5.18e-01 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 3 | 85 | 5.18e-01 |
| GO:BP | GO:0045943 | positive regulation of transcription by RNA polymerase I | 18 | 34 | 5.18e-01 |
| GO:BP | GO:0090649 | response to oxygen-glucose deprivation | 1 | 7 | 5.18e-01 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 12 | 43 | 5.18e-01 |
| GO:BP | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle | 1 | 2 | 5.18e-01 |
| GO:BP | GO:0051153 | regulation of striated muscle cell differentiation | 1 | 67 | 5.18e-01 |
| GO:BP | GO:0046717 | acid secretion | 2 | 25 | 5.18e-01 |
| GO:BP | GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1 | 17 | 5.18e-01 |
| GO:BP | GO:0000056 | ribosomal small subunit export from nucleus | 1 | 8 | 5.18e-01 |
| GO:BP | GO:0009135 | purine nucleoside diphosphate metabolic process | 1 | 17 | 5.18e-01 |
| GO:BP | GO:2001204 | regulation of osteoclast development | 1 | 4 | 5.18e-01 |
| GO:BP | GO:0090209 | negative regulation of triglyceride metabolic process | 1 | 7 | 5.18e-01 |
| GO:BP | GO:0061517 | macrophage proliferation | 1 | 7 | 5.19e-01 |
| GO:BP | GO:0002158 | osteoclast proliferation | 1 | 7 | 5.19e-01 |
| GO:BP | GO:0051451 | myoblast migration | 2 | 11 | 5.19e-01 |
| GO:BP | GO:0071374 | cellular response to parathyroid hormone stimulus | 1 | 7 | 5.19e-01 |
| GO:BP | GO:0032366 | intracellular sterol transport | 4 | 30 | 5.19e-01 |
| GO:BP | GO:0006399 | tRNA metabolic process | 27 | 186 | 5.19e-01 |
| GO:BP | GO:0042487 | regulation of odontogenesis of dentin-containing tooth | 1 | 6 | 5.19e-01 |
| GO:BP | GO:0061300 | cerebellum vasculature development | 2 | 2 | 5.19e-01 |
| GO:BP | GO:0060022 | hard palate development | 2 | 5 | 5.19e-01 |
| GO:BP | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 10 | 56 | 5.19e-01 |
| GO:BP | GO:0036359 | renal potassium excretion | 2 | 2 | 5.19e-01 |
| GO:BP | GO:0006592 | ornithine biosynthetic process | 1 | 1 | 5.19e-01 |
| GO:BP | GO:0048302 | regulation of isotype switching to IgG isotypes | 1 | 7 | 5.20e-01 |
| GO:BP | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation | 2 | 2 | 5.20e-01 |
| GO:BP | GO:0060061 | Spemann organizer formation | 2 | 3 | 5.20e-01 |
| GO:BP | GO:1903689 | regulation of wound healing, spreading of epidermal cells | 1 | 8 | 5.20e-01 |
| GO:BP | GO:0009308 | amine metabolic process | 8 | 68 | 5.20e-01 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 5 | 27 | 5.20e-01 |
| GO:BP | GO:0001501 | skeletal system development | 1 | 377 | 5.20e-01 |
| GO:BP | GO:0060301 | positive regulation of cytokine activity | 1 | 1 | 5.20e-01 |
| GO:BP | GO:1905040 | otic placode development | 1 | 1 | 5.20e-01 |
| GO:BP | GO:0060510 | type II pneumocyte differentiation | 4 | 5 | 5.20e-01 |
| GO:BP | GO:1904645 | response to amyloid-beta | 8 | 32 | 5.20e-01 |
| GO:BP | GO:1902378 | VEGF-activated neuropilin signaling pathway involved in axon guidance | 1 | 1 | 5.20e-01 |
| GO:BP | GO:0043647 | inositol phosphate metabolic process | 3 | 35 | 5.20e-01 |
| GO:BP | GO:2001234 | negative regulation of apoptotic signaling pathway | 7 | 194 | 5.20e-01 |
| GO:BP | GO:0007402 | ganglion mother cell fate determination | 1 | 1 | 5.20e-01 |
| GO:BP | GO:0010092 | specification of animal organ identity | 2 | 26 | 5.20e-01 |
| GO:BP | GO:0060819 | inactivation of X chromosome by genomic imprinting | 2 | 2 | 5.20e-01 |
| GO:BP | GO:0071310 | cellular response to organic substance | 2 | 1399 | 5.21e-01 |
| GO:BP | GO:0061042 | vascular wound healing | 2 | 17 | 5.21e-01 |
| GO:BP | GO:1903387 | positive regulation of homophilic cell adhesion | 1 | 1 | 5.21e-01 |
| GO:BP | GO:0046479 | glycosphingolipid catabolic process | 4 | 10 | 5.21e-01 |
| GO:BP | GO:1902426 | deactivation of mitotic spindle assembly checkpoint | 2 | 3 | 5.21e-01 |
| GO:BP | GO:0051589 | negative regulation of neurotransmitter transport | 1 | 8 | 5.21e-01 |
| GO:BP | GO:0090233 | negative regulation of spindle checkpoint | 2 | 3 | 5.21e-01 |
| GO:BP | GO:1905179 | negative regulation of cardiac muscle tissue regeneration | 1 | 2 | 5.21e-01 |
| GO:BP | GO:1905178 | regulation of cardiac muscle tissue regeneration | 1 | 2 | 5.21e-01 |
| GO:BP | GO:0140499 | negative regulation of mitotic spindle assembly checkpoint signaling | 2 | 3 | 5.21e-01 |
| GO:BP | GO:0007635 | chemosensory behavior | 1 | 10 | 5.21e-01 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 6 | 98 | 5.21e-01 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 8 | 115 | 5.21e-01 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 8 | 115 | 5.21e-01 |
| GO:BP | GO:0071169 | establishment of protein localization to chromatin | 1 | 8 | 5.21e-01 |
| GO:BP | GO:0072750 | cellular response to leptomycin B | 1 | 1 | 5.22e-01 |
| GO:BP | GO:1901344 | response to leptomycin B | 1 | 1 | 5.22e-01 |
| GO:BP | GO:0003009 | skeletal muscle contraction | 1 | 31 | 5.22e-01 |
| GO:BP | GO:0034392 | negative regulation of smooth muscle cell apoptotic process | 2 | 6 | 5.22e-01 |
| GO:BP | GO:2001303 | lipoxin A4 biosynthetic process | 1 | 1 | 5.22e-01 |
| GO:BP | GO:0010729 | positive regulation of hydrogen peroxide biosynthetic process | 1 | 3 | 5.22e-01 |
| GO:BP | GO:0001522 | pseudouridine synthesis | 6 | 18 | 5.22e-01 |
| GO:BP | GO:0061458 | reproductive system development | 3 | 215 | 5.22e-01 |
| GO:BP | GO:0009225 | nucleotide-sugar metabolic process | 3 | 35 | 5.22e-01 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 1 | 540 | 5.22e-01 |
| GO:BP | GO:0090076 | relaxation of skeletal muscle | 1 | 3 | 5.23e-01 |
| GO:BP | GO:0043574 | peroxisomal transport | 10 | 22 | 5.23e-01 |
| GO:BP | GO:0035426 | extracellular matrix-cell signaling | 3 | 4 | 5.23e-01 |
| GO:BP | GO:0032814 | regulation of natural killer cell activation | 2 | 20 | 5.23e-01 |
| GO:BP | GO:0090251 | protein localization involved in establishment of planar polarity | 2 | 2 | 5.23e-01 |
| GO:BP | GO:0010766 | negative regulation of sodium ion transport | 4 | 15 | 5.23e-01 |
| GO:BP | GO:0097479 | synaptic vesicle localization | 5 | 50 | 5.23e-01 |
| GO:BP | GO:0006401 | RNA catabolic process | 4 | 256 | 5.23e-01 |
| GO:BP | GO:0006547 | histidine metabolic process | 2 | 5 | 5.23e-01 |
| GO:BP | GO:2000642 | negative regulation of early endosome to late endosome transport | 2 | 2 | 5.23e-01 |
| GO:BP | GO:1905517 | macrophage migration | 3 | 34 | 5.23e-01 |
| GO:BP | GO:0006887 | exocytosis | 8 | 256 | 5.23e-01 |
| GO:BP | GO:0048560 | establishment of anatomical structure orientation | 1 | 2 | 5.24e-01 |
| GO:BP | GO:0017085 | response to insecticide | 1 | 4 | 5.25e-01 |
| GO:BP | GO:0042177 | negative regulation of protein catabolic process | 2 | 100 | 5.25e-01 |
| GO:BP | GO:0034759 | regulation of iron ion transmembrane transport | 1 | 2 | 5.25e-01 |
| GO:BP | GO:0055119 | relaxation of cardiac muscle | 4 | 17 | 5.25e-01 |
| GO:BP | GO:0060271 | cilium assembly | 4 | 292 | 5.25e-01 |
| GO:BP | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity | 2 | 2 | 5.25e-01 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 1 | 221 | 5.25e-01 |
| GO:BP | GO:0015860 | purine nucleoside transmembrane transport | 1 | 3 | 5.25e-01 |
| GO:BP | GO:0019226 | transmission of nerve impulse | 1 | 40 | 5.25e-01 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 30 | 660 | 5.26e-01 |
| GO:BP | GO:1901908 | diadenosine hexaphosphate metabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:1900122 | positive regulation of receptor binding | 5 | 7 | 5.26e-01 |
| GO:BP | GO:1901910 | adenosine 5’-(hexahydrogen pentaphosphate) metabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 5 | 120 | 5.26e-01 |
| GO:BP | GO:0043267 | negative regulation of potassium ion transport | 3 | 21 | 5.26e-01 |
| GO:BP | GO:0071543 | diphosphoinositol polyphosphate metabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:1901911 | adenosine 5’-(hexahydrogen pentaphosphate) catabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:0051792 | medium-chain fatty acid biosynthetic process | 2 | 4 | 5.26e-01 |
| GO:BP | GO:0019085 | early viral transcription | 2 | 2 | 5.26e-01 |
| GO:BP | GO:1901907 | diadenosine pentaphosphate catabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 44 | 140 | 5.26e-01 |
| GO:BP | GO:0042439 | ethanolamine-containing compound metabolic process | 1 | 5 | 5.26e-01 |
| GO:BP | GO:0007207 | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | 2 | 6 | 5.26e-01 |
| GO:BP | GO:1901909 | diadenosine hexaphosphate catabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:1901906 | diadenosine pentaphosphate metabolic process | 2 | 5 | 5.26e-01 |
| GO:BP | GO:0006450 | regulation of translational fidelity | 3 | 16 | 5.26e-01 |
| GO:BP | GO:1902033 | regulation of hematopoietic stem cell proliferation | 3 | 12 | 5.26e-01 |
| GO:BP | GO:0048874 | host-mediated regulation of intestinal microbiota composition | 1 | 2 | 5.26e-01 |
| GO:BP | GO:1905341 | negative regulation of protein localization to kinetochore | 1 | 1 | 5.26e-01 |
| GO:BP | GO:0061622 | glycolytic process through glucose-1-phosphate | 1 | 2 | 5.26e-01 |
| GO:BP | GO:0071262 | regulation of translational initiation in response to starvation | 2 | 2 | 5.26e-01 |
| GO:BP | GO:0071264 | positive regulation of translational initiation in response to starvation | 2 | 2 | 5.26e-01 |
| GO:BP | GO:0046849 | bone remodeling | 4 | 59 | 5.26e-01 |
| GO:BP | GO:0097178 | ruffle assembly | 7 | 37 | 5.26e-01 |
| GO:BP | GO:0019254 | carnitine metabolic process, CoA-linked | 2 | 3 | 5.26e-01 |
| GO:BP | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 1 | 3 | 5.26e-01 |
| GO:BP | GO:0006527 | arginine catabolic process | 1 | 7 | 5.26e-01 |
| GO:BP | GO:0006465 | signal peptide processing | 5 | 13 | 5.26e-01 |
| GO:BP | GO:0071371 | cellular response to gonadotropin stimulus | 3 | 13 | 5.26e-01 |
| GO:BP | GO:0002244 | hematopoietic progenitor cell differentiation | 2 | 109 | 5.27e-01 |
| GO:BP | GO:1903911 | positive regulation of receptor clustering | 1 | 6 | 5.27e-01 |
| GO:BP | GO:1990262 | anti-Mullerian hormone signaling pathway | 1 | 2 | 5.27e-01 |
| GO:BP | GO:0061099 | negative regulation of protein tyrosine kinase activity | 6 | 27 | 5.27e-01 |
| GO:BP | GO:0010749 | regulation of nitric oxide mediated signal transduction | 7 | 10 | 5.27e-01 |
| GO:BP | GO:0048103 | somatic stem cell division | 4 | 10 | 5.27e-01 |
| GO:BP | GO:0030103 | vasopressin secretion | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0003358 | noradrenergic neuron development | 1 | 2 | 5.27e-01 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 13 | 40 | 5.27e-01 |
| GO:BP | GO:0051583 | dopamine uptake involved in synaptic transmission | 1 | 8 | 5.27e-01 |
| GO:BP | GO:1904226 | regulation of glycogen synthase activity, transferring glucose-1-phosphate | 1 | 1 | 5.27e-01 |
| GO:BP | GO:1904227 | negative regulation of glycogen synthase activity, transferring glucose-1-phosphate | 1 | 1 | 5.27e-01 |
| GO:BP | GO:1902951 | negative regulation of dendritic spine maintenance | 1 | 2 | 5.27e-01 |
| GO:BP | GO:0030325 | adrenal gland development | 8 | 22 | 5.27e-01 |
| GO:BP | GO:0071879 | positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0051934 | catecholamine uptake involved in synaptic transmission | 1 | 8 | 5.27e-01 |
| GO:BP | GO:0040007 | growth | 3 | 742 | 5.27e-01 |
| GO:BP | GO:0010905 | negative regulation of UDP-glucose catabolic process | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0032480 | negative regulation of type I interferon production | 10 | 23 | 5.27e-01 |
| GO:BP | GO:0050894 | determination of affect | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0030432 | peristalsis | 1 | 6 | 5.27e-01 |
| GO:BP | GO:0006837 | serotonin transport | 1 | 11 | 5.27e-01 |
| GO:BP | GO:0048312 | intracellular distribution of mitochondria | 1 | 5 | 5.27e-01 |
| GO:BP | GO:0010904 | regulation of UDP-glucose catabolic process | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0016052 | carbohydrate catabolic process | 1 | 120 | 5.27e-01 |
| GO:BP | GO:0006820 | monoatomic anion transport | 1 | 83 | 5.27e-01 |
| GO:BP | GO:0097497 | blood vessel endothelial cell delamination | 1 | 1 | 5.27e-01 |
| GO:BP | GO:1990481 | mRNA pseudouridine synthesis | 6 | 9 | 5.27e-01 |
| GO:BP | GO:0044027 | negative regulation of gene expression via CpG island methylation | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0046084 | adenine biosynthetic process | 1 | 2 | 5.27e-01 |
| GO:BP | GO:1904257 | zinc ion import into Golgi lumen | 1 | 3 | 5.27e-01 |
| GO:BP | GO:1902938 | regulation of intracellular calcium activated chloride channel activity | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1 | 1 | 5.27e-01 |
| GO:BP | GO:0005981 | regulation of glycogen catabolic process | 2 | 4 | 5.27e-01 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 113 | 376 | 5.28e-01 |
| GO:BP | GO:1900027 | regulation of ruffle assembly | 10 | 23 | 5.28e-01 |
| GO:BP | GO:0035914 | skeletal muscle cell differentiation | 13 | 52 | 5.28e-01 |
| GO:BP | GO:0046689 | response to mercury ion | 2 | 7 | 5.28e-01 |
| GO:BP | GO:1905606 | regulation of presynapse assembly | 3 | 25 | 5.28e-01 |
| GO:BP | GO:0030393 | fructoselysine metabolic process | 1 | 1 | 5.28e-01 |
| GO:BP | GO:0001731 | formation of translation preinitiation complex | 3 | 11 | 5.28e-01 |
| GO:BP | GO:2000975 | positive regulation of pro-B cell differentiation | 1 | 1 | 5.28e-01 |
| GO:BP | GO:0070873 | regulation of glycogen metabolic process | 10 | 28 | 5.28e-01 |
| GO:BP | GO:0019367 | fatty acid elongation, saturated fatty acid | 2 | 6 | 5.28e-01 |
| GO:BP | GO:0019368 | fatty acid elongation, unsaturated fatty acid | 2 | 6 | 5.28e-01 |
| GO:BP | GO:0099174 | regulation of presynapse organization | 3 | 25 | 5.28e-01 |
| GO:BP | GO:0061171 | establishment of bipolar cell polarity | 1 | 1 | 5.28e-01 |
| GO:BP | GO:0016322 | neuron remodeling | 2 | 11 | 5.28e-01 |
| GO:BP | GO:1903251 | multi-ciliated epithelial cell differentiation | 2 | 6 | 5.28e-01 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 3 | 122 | 5.28e-01 |
| GO:BP | GO:0008584 | male gonad development | 10 | 99 | 5.28e-01 |
| GO:BP | GO:0031100 | animal organ regeneration | 8 | 47 | 5.28e-01 |
| GO:BP | GO:0006749 | glutathione metabolic process | 2 | 41 | 5.28e-01 |
| GO:BP | GO:1990806 | ligand-gated ion channel signaling pathway | 2 | 20 | 5.28e-01 |
| GO:BP | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1 | 3 | 5.28e-01 |
| GO:BP | GO:0048609 | multicellular organismal reproductive process | 3 | 538 | 5.28e-01 |
| GO:BP | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 4 | 6 | 5.28e-01 |
| GO:BP | GO:0032377 | regulation of intracellular lipid transport | 1 | 7 | 5.28e-01 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 1 | 414 | 5.28e-01 |
| GO:BP | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 2 | 6 | 5.28e-01 |
| GO:BP | GO:0070075 | tear secretion | 1 | 2 | 5.28e-01 |
| GO:BP | GO:0031439 | positive regulation of mRNA cleavage | 1 | 1 | 5.28e-01 |
| GO:BP | GO:0019043 | establishment of viral latency | 1 | 3 | 5.28e-01 |
| GO:BP | GO:0031437 | regulation of mRNA cleavage | 1 | 1 | 5.28e-01 |
| GO:BP | GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 2 | 6 | 5.28e-01 |
| GO:BP | GO:0071871 | response to epinephrine | 1 | 12 | 5.28e-01 |
| GO:BP | GO:0045829 | negative regulation of isotype switching | 2 | 4 | 5.28e-01 |
| GO:BP | GO:0034504 | protein localization to nucleus | 9 | 276 | 5.28e-01 |
| GO:BP | GO:0035378 | carbon dioxide transmembrane transport | 1 | 1 | 5.28e-01 |
| GO:BP | GO:0060284 | regulation of cell development | 4 | 605 | 5.28e-01 |
| GO:BP | GO:1905704 | positive regulation of inhibitory synapse assembly | 1 | 2 | 5.28e-01 |
| GO:BP | GO:0072237 | metanephric proximal tubule development | 1 | 3 | 5.28e-01 |
| GO:BP | GO:0051469 | vesicle fusion with vacuole | 1 | 11 | 5.28e-01 |
| GO:BP | GO:0097320 | plasma membrane tubulation | 3 | 18 | 5.28e-01 |
| GO:BP | GO:0034405 | response to fluid shear stress | 2 | 31 | 5.28e-01 |
| GO:BP | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation | 2 | 5 | 5.28e-01 |
| GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1 | 25 | 5.28e-01 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 3 | 52 | 5.28e-01 |
| GO:BP | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 2 | 29 | 5.28e-01 |
| GO:BP | GO:0007517 | muscle organ development | 3 | 277 | 5.28e-01 |
| GO:BP | GO:0046878 | positive regulation of saliva secretion | 1 | 2 | 5.28e-01 |
| GO:BP | GO:0060353 | regulation of cell adhesion molecule production | 1 | 6 | 5.28e-01 |
| GO:BP | GO:0061763 | multivesicular body-lysosome fusion | 1 | 11 | 5.28e-01 |
| GO:BP | GO:0051939 | gamma-aminobutyric acid import | 1 | 3 | 5.28e-01 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 3 | 89 | 5.29e-01 |
| GO:BP | GO:0072574 | hepatocyte proliferation | 3 | 18 | 5.29e-01 |
| GO:BP | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 4 | 9 | 5.29e-01 |
| GO:BP | GO:0072575 | epithelial cell proliferation involved in liver morphogenesis | 3 | 18 | 5.29e-01 |
| GO:BP | GO:1904386 | response to L-phenylalanine derivative | 4 | 5 | 5.29e-01 |
| GO:BP | GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1 | 4 | 5.29e-01 |
| GO:BP | GO:1905786 | positive regulation of anaphase-promoting complex-dependent catabolic process | 1 | 2 | 5.29e-01 |
| GO:BP | GO:0043414 | macromolecule methylation | 1 | 272 | 5.29e-01 |
| GO:BP | GO:1904152 | regulation of retrograde protein transport, ER to cytosol | 2 | 13 | 5.29e-01 |
| GO:BP | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion | 1 | 1 | 5.30e-01 |
| GO:BP | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation | 3 | 4 | 5.30e-01 |
| GO:BP | GO:0032273 | positive regulation of protein polymerization | 4 | 76 | 5.30e-01 |
| GO:BP | GO:0060004 | reflex | 2 | 9 | 5.31e-01 |
| GO:BP | GO:0006103 | 2-oxoglutarate metabolic process | 1 | 16 | 5.31e-01 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 3 | 1898 | 5.31e-01 |
| GO:BP | GO:0097473 | retinal rod cell apoptotic process | 2 | 2 | 5.31e-01 |
| GO:BP | GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 8 | 18 | 5.31e-01 |
| GO:BP | GO:0015861 | cytidine transport | 1 | 1 | 5.31e-01 |
| GO:BP | GO:0019408 | dolichol biosynthetic process | 1 | 2 | 5.31e-01 |
| GO:BP | GO:0010663 | positive regulation of striated muscle cell apoptotic process | 1 | 12 | 5.31e-01 |
| GO:BP | GO:0001964 | startle response | 1 | 16 | 5.31e-01 |
| GO:BP | GO:0010666 | positive regulation of cardiac muscle cell apoptotic process | 1 | 12 | 5.31e-01 |
| GO:BP | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway | 1 | 7 | 5.31e-01 |
| GO:BP | GO:0030501 | positive regulation of bone mineralization | 6 | 34 | 5.31e-01 |
| GO:BP | GO:0034352 | positive regulation of glial cell apoptotic process | 2 | 2 | 5.31e-01 |
| GO:BP | GO:0009786 | regulation of asymmetric cell division | 1 | 1 | 5.31e-01 |
| GO:BP | GO:0019482 | beta-alanine metabolic process | 1 | 2 | 5.31e-01 |
| GO:BP | GO:0006182 | cGMP biosynthetic process | 1 | 6 | 5.31e-01 |
| GO:BP | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination | 1 | 1 | 5.31e-01 |
| GO:BP | GO:0009069 | serine family amino acid metabolic process | 7 | 30 | 5.31e-01 |
| GO:BP | GO:0042438 | melanin biosynthetic process | 4 | 17 | 5.32e-01 |
| GO:BP | GO:2000446 | regulation of macrophage migration inhibitory factor signaling pathway | 2 | 3 | 5.32e-01 |
| GO:BP | GO:0035691 | macrophage migration inhibitory factor signaling pathway | 2 | 3 | 5.32e-01 |
| GO:BP | GO:0097043 | histone H3-K56 acetylation | 1 | 2 | 5.32e-01 |
| GO:BP | GO:0048291 | isotype switching to IgG isotypes | 1 | 8 | 5.32e-01 |
| GO:BP | GO:0007406 | negative regulation of neuroblast proliferation | 1 | 9 | 5.32e-01 |
| GO:BP | GO:1904289 | regulation of mitotic DNA damage checkpoint | 1 | 3 | 5.32e-01 |
| GO:BP | GO:0001796 | regulation of type IIa hypersensitivity | 2 | 3 | 5.32e-01 |
| GO:BP | GO:0002892 | regulation of type II hypersensitivity | 2 | 3 | 5.32e-01 |
| GO:BP | GO:0048711 | positive regulation of astrocyte differentiation | 4 | 11 | 5.32e-01 |
| GO:BP | GO:0019860 | uracil metabolic process | 1 | 2 | 5.32e-01 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 9 | 62 | 5.32e-01 |
| GO:BP | GO:0007127 | meiosis I | 33 | 77 | 5.32e-01 |
| GO:BP | GO:0045778 | positive regulation of ossification | 7 | 40 | 5.32e-01 |
| GO:BP | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 7 | 38 | 5.32e-01 |
| GO:BP | GO:1901722 | regulation of cell proliferation involved in kidney development | 3 | 11 | 5.33e-01 |
| GO:BP | GO:0002523 | leukocyte migration involved in inflammatory response | 2 | 9 | 5.33e-01 |
| GO:BP | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 2 | 35 | 5.33e-01 |
| GO:BP | GO:0010724 | regulation of definitive erythrocyte differentiation | 2 | 2 | 5.33e-01 |
| GO:BP | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation | 1 | 5 | 5.33e-01 |
| GO:BP | GO:0042749 | regulation of circadian sleep/wake cycle | 1 | 9 | 5.33e-01 |
| GO:BP | GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 1 | 3 | 5.33e-01 |
| GO:BP | GO:0062029 | positive regulation of stress granule assembly | 2 | 2 | 5.33e-01 |
| GO:BP | GO:0090245 | axis elongation involved in somitogenesis | 1 | 4 | 5.33e-01 |
| GO:BP | GO:0046546 | development of primary male sexual characteristics | 10 | 100 | 5.33e-01 |
| GO:BP | GO:1905319 | mesenchymal stem cell migration | 3 | 4 | 5.33e-01 |
| GO:BP | GO:0010722 | regulation of ferrochelatase activity | 1 | 1 | 5.33e-01 |
| GO:BP | GO:0060311 | negative regulation of elastin catabolic process | 1 | 1 | 5.33e-01 |
| GO:BP | GO:0060310 | regulation of elastin catabolic process | 1 | 1 | 5.33e-01 |
| GO:BP | GO:0007276 | gamete generation | 2 | 461 | 5.33e-01 |
| GO:BP | GO:0070189 | kynurenine metabolic process | 1 | 6 | 5.33e-01 |
| GO:BP | GO:1905322 | positive regulation of mesenchymal stem cell migration | 3 | 4 | 5.33e-01 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 5 | 796 | 5.33e-01 |
| GO:BP | GO:0140673 | transcription elongation-coupled chromatin remodeling | 2 | 2 | 5.33e-01 |
| GO:BP | GO:1905320 | regulation of mesenchymal stem cell migration | 3 | 4 | 5.33e-01 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 7 | 54 | 5.33e-01 |
| GO:BP | GO:0010711 | negative regulation of collagen catabolic process | 1 | 1 | 5.33e-01 |
| GO:BP | GO:0060927 | cardiac pacemaker cell fate commitment | 2 | 3 | 5.33e-01 |
| GO:BP | GO:0051341 | regulation of oxidoreductase activity | 5 | 68 | 5.33e-01 |
| GO:BP | GO:0140588 | chromatin looping | 2 | 2 | 5.33e-01 |
| GO:BP | GO:0051728 | cell cycle switching, mitotic to meiotic cell cycle | 1 | 2 | 5.33e-01 |
| GO:BP | GO:0060184 | cell cycle switching | 1 | 2 | 5.33e-01 |
| GO:BP | GO:0051729 | germline cell cycle switching, mitotic to meiotic cell cycle | 1 | 2 | 5.33e-01 |
| GO:BP | GO:0071788 | endoplasmic reticulum tubular network maintenance | 1 | 1 | 5.33e-01 |
| GO:BP | GO:0007507 | heart development | 1 | 506 | 5.33e-01 |
| GO:BP | GO:0050671 | positive regulation of lymphocyte proliferation | 1 | 72 | 5.33e-01 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 8 | 48 | 5.33e-01 |
| GO:BP | GO:0014738 | regulation of muscle hyperplasia | 1 | 1 | 5.34e-01 |
| GO:BP | GO:0010710 | regulation of collagen catabolic process | 2 | 3 | 5.34e-01 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 4 | 9 | 5.34e-01 |
| GO:BP | GO:0019694 | alkanesulfonate metabolic process | 5 | 6 | 5.34e-01 |
| GO:BP | GO:0060309 | elastin catabolic process | 2 | 2 | 5.34e-01 |
| GO:BP | GO:0007220 | Notch receptor processing | 6 | 9 | 5.34e-01 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 1 | 372 | 5.34e-01 |
| GO:BP | GO:0009193 | pyrimidine ribonucleoside diphosphate metabolic process | 1 | 7 | 5.34e-01 |
| GO:BP | GO:0046048 | UDP metabolic process | 1 | 7 | 5.34e-01 |
| GO:BP | GO:0019530 | taurine metabolic process | 5 | 6 | 5.34e-01 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 4 | 9 | 5.34e-01 |
| GO:BP | GO:1904491 | protein localization to ciliary transition zone | 2 | 7 | 5.34e-01 |
| GO:BP | GO:0006633 | fatty acid biosynthetic process | 2 | 104 | 5.34e-01 |
| GO:BP | GO:0014906 | myotube cell development involved in skeletal muscle regeneration | 1 | 1 | 5.34e-01 |
| GO:BP | GO:0072678 | T cell migration | 5 | 38 | 5.34e-01 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 1 | 783 | 5.34e-01 |
| GO:BP | GO:0000038 | very long-chain fatty acid metabolic process | 8 | 27 | 5.34e-01 |
| GO:BP | GO:0019236 | response to pheromone | 1 | 1 | 5.34e-01 |
| GO:BP | GO:0042074 | cell migration involved in gastrulation | 5 | 10 | 5.34e-01 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 7 | 75 | 5.34e-01 |
| GO:BP | GO:0001889 | liver development | 1 | 110 | 5.34e-01 |
| GO:BP | GO:0046452 | dihydrofolate metabolic process | 1 | 3 | 5.35e-01 |
| GO:BP | GO:2000815 | regulation of mRNA stability involved in response to oxidative stress | 2 | 2 | 5.35e-01 |
| GO:BP | GO:1903421 | regulation of synaptic vesicle recycling | 8 | 23 | 5.35e-01 |
| GO:BP | GO:0042754 | negative regulation of circadian rhythm | 1 | 10 | 5.35e-01 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 10 | 129 | 5.35e-01 |
| GO:BP | GO:1904877 | positive regulation of DNA ligase activity | 1 | 1 | 5.35e-01 |
| GO:BP | GO:0055088 | lipid homeostasis | 1 | 115 | 5.35e-01 |
| GO:BP | GO:0002208 | somatic diversification of immunoglobulins involved in immune response | 2 | 39 | 5.35e-01 |
| GO:BP | GO:0045190 | isotype switching | 2 | 39 | 5.35e-01 |
| GO:BP | GO:0002204 | somatic recombination of immunoglobulin genes involved in immune response | 2 | 39 | 5.35e-01 |
| GO:BP | GO:1903093 | regulation of protein K48-linked deubiquitination | 1 | 3 | 5.35e-01 |
| GO:BP | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 2 | 13 | 5.35e-01 |
| GO:BP | GO:0051490 | negative regulation of filopodium assembly | 4 | 6 | 5.35e-01 |
| GO:BP | GO:1900542 | regulation of purine nucleotide metabolic process | 9 | 40 | 5.35e-01 |
| GO:BP | GO:0061365 | positive regulation of triglyceride lipase activity | 1 | 4 | 5.35e-01 |
| GO:BP | GO:0016082 | synaptic vesicle priming | 2 | 16 | 5.35e-01 |
| GO:BP | GO:0071396 | cellular response to lipid | 1 | 398 | 5.36e-01 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 2 | 26 | 5.36e-01 |
| GO:BP | GO:0019720 | Mo-molybdopterin cofactor metabolic process | 4 | 6 | 5.36e-01 |
| GO:BP | GO:0050855 | regulation of B cell receptor signaling pathway | 1 | 11 | 5.36e-01 |
| GO:BP | GO:0032324 | molybdopterin cofactor biosynthetic process | 4 | 6 | 5.36e-01 |
| GO:BP | GO:0043545 | molybdopterin cofactor metabolic process | 4 | 6 | 5.36e-01 |
| GO:BP | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process | 4 | 6 | 5.36e-01 |
| GO:BP | GO:1905267 | endonucleolytic cleavage involved in tRNA processing | 2 | 3 | 5.36e-01 |
| GO:BP | GO:0051189 | prosthetic group metabolic process | 4 | 6 | 5.36e-01 |
| GO:BP | GO:1905552 | positive regulation of protein localization to endoplasmic reticulum | 2 | 2 | 5.36e-01 |
| GO:BP | GO:0039533 | regulation of MDA-5 signaling pathway | 1 | 5 | 5.36e-01 |
| GO:BP | GO:0006081 | cellular aldehyde metabolic process | 3 | 52 | 5.36e-01 |
| GO:BP | GO:0043949 | regulation of cAMP-mediated signaling | 1 | 17 | 5.36e-01 |
| GO:BP | GO:0046620 | regulation of organ growth | 26 | 71 | 5.36e-01 |
| GO:BP | GO:0060425 | lung morphogenesis | 1 | 38 | 5.36e-01 |
| GO:BP | GO:0072715 | cellular response to selenite ion | 1 | 1 | 5.36e-01 |
| GO:BP | GO:0099637 | neurotransmitter receptor transport | 10 | 21 | 5.36e-01 |
| GO:BP | GO:0072714 | response to selenite ion | 1 | 1 | 5.36e-01 |
| GO:BP | GO:1904572 | negative regulation of mRNA binding | 1 | 1 | 5.36e-01 |
| GO:BP | GO:1904570 | negative regulation of selenocysteine incorporation | 1 | 1 | 5.36e-01 |
| GO:BP | GO:0089700 | protein kinase D signaling | 3 | 4 | 5.36e-01 |
| GO:BP | GO:1904569 | regulation of selenocysteine incorporation | 1 | 1 | 5.36e-01 |
| GO:BP | GO:1904573 | regulation of selenocysteine insertion sequence binding | 1 | 1 | 5.36e-01 |
| GO:BP | GO:1904574 | negative regulation of selenocysteine insertion sequence binding | 1 | 1 | 5.36e-01 |
| GO:BP | GO:1902073 | positive regulation of hypoxia-inducible factor-1alpha signaling pathway | 1 | 1 | 5.36e-01 |
| GO:BP | GO:0006740 | NADPH regeneration | 11 | 22 | 5.36e-01 |
| GO:BP | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway | 1 | 1 | 5.36e-01 |
| GO:BP | GO:0032946 | positive regulation of mononuclear cell proliferation | 1 | 75 | 5.37e-01 |
| GO:BP | GO:2001223 | negative regulation of neuron migration | 3 | 8 | 5.37e-01 |
| GO:BP | GO:0008355 | olfactory learning | 2 | 2 | 5.37e-01 |
| GO:BP | GO:0007270 | neuron-neuron synaptic transmission | 4 | 5 | 5.37e-01 |
| GO:BP | GO:0050930 | induction of positive chemotaxis | 1 | 12 | 5.37e-01 |
| GO:BP | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 5 | 25 | 5.37e-01 |
| GO:BP | GO:2000312 | regulation of kainate selective glutamate receptor activity | 1 | 3 | 5.37e-01 |
| GO:BP | GO:0140569 | extraction of mislocalized protein from ER membrane | 1 | 1 | 5.38e-01 |
| GO:BP | GO:0010836 | negative regulation of protein ADP-ribosylation | 2 | 4 | 5.38e-01 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 3 | 59 | 5.38e-01 |
| GO:BP | GO:0036369 | transcription factor catabolic process | 3 | 5 | 5.38e-01 |
| GO:BP | GO:0072098 | anterior/posterior pattern specification involved in kidney development | 2 | 2 | 5.38e-01 |
| GO:BP | GO:0070202 | regulation of establishment of protein localization to chromosome | 4 | 12 | 5.38e-01 |
| GO:BP | GO:0030220 | platelet formation | 1 | 17 | 5.38e-01 |
| GO:BP | GO:0061227 | pattern specification involved in mesonephros development | 2 | 2 | 5.38e-01 |
| GO:BP | GO:0048389 | intermediate mesoderm development | 2 | 2 | 5.38e-01 |
| GO:BP | GO:0071918 | urea transmembrane transport | 1 | 2 | 5.38e-01 |
| GO:BP | GO:0006906 | vesicle fusion | 3 | 104 | 5.38e-01 |
| GO:BP | GO:0061008 | hepaticobiliary system development | 1 | 112 | 5.38e-01 |
| GO:BP | GO:0070837 | dehydroascorbic acid transport | 2 | 6 | 5.38e-01 |
| GO:BP | GO:0140157 | ammonium import across plasma membrane | 1 | 3 | 5.38e-01 |
| GO:BP | GO:0010566 | regulation of ketone biosynthetic process | 4 | 16 | 5.38e-01 |
| GO:BP | GO:0019370 | leukotriene biosynthetic process | 1 | 7 | 5.38e-01 |
| GO:BP | GO:0106227 | peptidyl-lysine glutarylation | 1 | 1 | 5.38e-01 |
| GO:BP | GO:0060971 | embryonic heart tube left/right pattern formation | 3 | 5 | 5.38e-01 |
| GO:BP | GO:0031110 | regulation of microtubule polymerization or depolymerization | 1 | 82 | 5.38e-01 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 2 | 22 | 5.38e-01 |
| GO:BP | GO:0043985 | histone H4-R3 methylation | 4 | 6 | 5.39e-01 |
| GO:BP | GO:0050773 | regulation of dendrite development | 30 | 90 | 5.39e-01 |
| GO:BP | GO:0035305 | negative regulation of dephosphorylation | 1 | 39 | 5.39e-01 |
| GO:BP | GO:0090281 | negative regulation of calcium ion import | 1 | 6 | 5.39e-01 |
| GO:BP | GO:0033169 | histone H3-K9 demethylation | 1 | 5 | 5.39e-01 |
| GO:BP | GO:0032495 | response to muramyl dipeptide | 7 | 15 | 5.39e-01 |
| GO:BP | GO:0060816 | random inactivation of X chromosome | 1 | 2 | 5.39e-01 |
| GO:BP | GO:0140066 | peptidyl-lysine crotonylation | 1 | 2 | 5.39e-01 |
| GO:BP | GO:0043268 | positive regulation of potassium ion transport | 3 | 36 | 5.39e-01 |
| GO:BP | GO:1902811 | positive regulation of skeletal muscle fiber differentiation | 1 | 2 | 5.39e-01 |
| GO:BP | GO:0048024 | regulation of mRNA splicing, via spliceosome | 37 | 96 | 5.39e-01 |
| GO:BP | GO:0090679 | cell differentiation involved in phenotypic switching | 1 | 3 | 5.39e-01 |
| GO:BP | GO:0090088 | regulation of oligopeptide transport | 2 | 2 | 5.39e-01 |
| GO:BP | GO:0099010 | modification of postsynaptic structure | 6 | 17 | 5.39e-01 |
| GO:BP | GO:2000625 | regulation of miRNA catabolic process | 1 | 5 | 5.39e-01 |
| GO:BP | GO:1905930 | regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching | 1 | 3 | 5.39e-01 |
| GO:BP | GO:0046041 | ITP metabolic process | 2 | 2 | 5.39e-01 |
| GO:BP | GO:0097194 | execution phase of apoptosis | 13 | 53 | 5.39e-01 |
| GO:BP | GO:0090089 | regulation of dipeptide transport | 2 | 2 | 5.39e-01 |
| GO:BP | GO:0009756 | carbohydrate mediated signaling | 1 | 6 | 5.39e-01 |
| GO:BP | GO:0051149 | positive regulation of muscle cell differentiation | 16 | 53 | 5.39e-01 |
| GO:BP | GO:1905915 | regulation of cell differentiation involved in phenotypic switching | 1 | 3 | 5.39e-01 |
| GO:BP | GO:0051900 | regulation of mitochondrial depolarization | 5 | 15 | 5.39e-01 |
| GO:BP | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation | 1 | 8 | 5.39e-01 |
| GO:BP | GO:0061090 | positive regulation of sequestering of zinc ion | 1 | 1 | 5.39e-01 |
| GO:BP | GO:2000878 | positive regulation of oligopeptide transport | 2 | 2 | 5.39e-01 |
| GO:BP | GO:0009203 | ribonucleoside triphosphate catabolic process | 2 | 2 | 5.39e-01 |
| GO:BP | GO:2000880 | positive regulation of dipeptide transport | 2 | 2 | 5.39e-01 |
| GO:BP | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential | 3 | 4 | 5.39e-01 |
| GO:BP | GO:0046628 | positive regulation of insulin receptor signaling pathway | 2 | 20 | 5.39e-01 |
| GO:BP | GO:0035655 | interleukin-18-mediated signaling pathway | 2 | 3 | 5.39e-01 |
| GO:BP | GO:0033605 | positive regulation of catecholamine secretion | 1 | 7 | 5.39e-01 |
| GO:BP | GO:0072012 | glomerulus vasculature development | 5 | 22 | 5.39e-01 |
| GO:BP | GO:2001150 | positive regulation of dipeptide transmembrane transport | 2 | 2 | 5.39e-01 |
| GO:BP | GO:0050829 | defense response to Gram-negative bacterium | 2 | 20 | 5.39e-01 |
| GO:BP | GO:0014894 | response to denervation involved in regulation of muscle adaptation | 1 | 8 | 5.39e-01 |
| GO:BP | GO:1905460 | negative regulation of vascular associated smooth muscle cell apoptotic process | 1 | 2 | 5.39e-01 |
| GO:BP | GO:0032481 | positive regulation of type I interferon production | 1 | 45 | 5.39e-01 |
| GO:BP | GO:0002101 | tRNA wobble cytosine modification | 1 | 2 | 5.39e-01 |
| GO:BP | GO:0002182 | cytoplasmic translational elongation | 6 | 12 | 5.39e-01 |
| GO:BP | GO:2001148 | regulation of dipeptide transmembrane transport | 2 | 2 | 5.39e-01 |
| GO:BP | GO:1905420 | vascular associated smooth muscle cell differentiation involved in phenotypic switching | 1 | 3 | 5.39e-01 |
| GO:BP | GO:0140914 | zinc ion import into secretory vesicle | 1 | 1 | 5.39e-01 |
| GO:BP | GO:0140917 | zinc ion import into mitochondrion | 1 | 1 | 5.39e-01 |
| GO:BP | GO:0140915 | zinc ion import into zymogen granule | 1 | 1 | 5.39e-01 |
| GO:BP | GO:0071351 | cellular response to interleukin-18 | 2 | 3 | 5.39e-01 |
| GO:BP | GO:0140916 | zinc ion import into lysosome | 1 | 1 | 5.39e-01 |
| GO:BP | GO:0001946 | lymphangiogenesis | 5 | 12 | 5.40e-01 |
| GO:BP | GO:0022410 | circadian sleep/wake cycle process | 1 | 10 | 5.40e-01 |
| GO:BP | GO:0051590 | positive regulation of neurotransmitter transport | 1 | 16 | 5.40e-01 |
| GO:BP | GO:0007371 | ventral midline determination | 1 | 1 | 5.40e-01 |
| GO:BP | GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 1 | 1 | 5.40e-01 |
| GO:BP | GO:0072036 | mesenchymal to epithelial transition involved in renal vesicle formation | 1 | 1 | 5.40e-01 |
| GO:BP | GO:0034097 | response to cytokine | 1 | 607 | 5.40e-01 |
| GO:BP | GO:0072393 | microtubule anchoring at microtubule organizing center | 1 | 14 | 5.40e-01 |
| GO:BP | GO:0036090 | cleavage furrow ingression | 2 | 2 | 5.40e-01 |
| GO:BP | GO:1901289 | succinyl-CoA catabolic process | 4 | 6 | 5.40e-01 |
| GO:BP | GO:1905533 | negative regulation of leucine import across plasma membrane | 1 | 2 | 5.40e-01 |
| GO:BP | GO:0060358 | negative regulation of leucine import | 1 | 2 | 5.40e-01 |
| GO:BP | GO:0031646 | positive regulation of nervous system process | 6 | 21 | 5.40e-01 |
| GO:BP | GO:0060357 | regulation of leucine import | 1 | 2 | 5.40e-01 |
| GO:BP | GO:0043112 | receptor metabolic process | 1 | 62 | 5.40e-01 |
| GO:BP | GO:0015918 | sterol transport | 3 | 92 | 5.40e-01 |
| GO:BP | GO:0060601 | lateral sprouting from an epithelium | 1 | 10 | 5.40e-01 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 112 | 375 | 5.40e-01 |
| GO:BP | GO:0044785 | metaphase/anaphase transition of meiotic cell cycle | 1 | 2 | 5.40e-01 |
| GO:BP | GO:1990379 | lipid transport across blood-brain barrier | 2 | 6 | 5.40e-01 |
| GO:BP | GO:1905809 | negative regulation of synapse organization | 1 | 8 | 5.40e-01 |
| GO:BP | GO:0034635 | glutathione transport | 6 | 9 | 5.40e-01 |
| GO:BP | GO:0071072 | negative regulation of phospholipid biosynthetic process | 2 | 6 | 5.40e-01 |
| GO:BP | GO:0036525 | protein deglycation | 2 | 2 | 5.40e-01 |
| GO:BP | GO:1905710 | positive regulation of membrane permeability | 2 | 45 | 5.40e-01 |
| GO:BP | GO:1905259 | negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway | 2 | 2 | 5.40e-01 |
| GO:BP | GO:0048845 | venous blood vessel morphogenesis | 3 | 9 | 5.40e-01 |
| GO:BP | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay | 1 | 7 | 5.40e-01 |
| GO:BP | GO:1905132 | regulation of meiotic chromosome separation | 1 | 2 | 5.40e-01 |
| GO:BP | GO:1905258 | regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway | 2 | 2 | 5.40e-01 |
| GO:BP | GO:1901994 | negative regulation of meiotic cell cycle phase transition | 1 | 2 | 5.40e-01 |
| GO:BP | GO:1902102 | regulation of metaphase/anaphase transition of meiotic cell cycle | 1 | 2 | 5.40e-01 |
| GO:BP | GO:0006882 | intracellular zinc ion homeostasis | 5 | 28 | 5.40e-01 |
| GO:BP | GO:0080134 | regulation of response to stress | 2 | 1075 | 5.40e-01 |
| GO:BP | GO:0072009 | nephron epithelium development | 4 | 86 | 5.40e-01 |
| GO:BP | GO:1901307 | positive regulation of spermidine biosynthetic process | 1 | 1 | 5.40e-01 |
| GO:BP | GO:1901304 | regulation of spermidine biosynthetic process | 1 | 1 | 5.40e-01 |
| GO:BP | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway | 5 | 8 | 5.40e-01 |
| GO:BP | GO:0043279 | response to alkaloid | 5 | 68 | 5.40e-01 |
| GO:BP | GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1 | 5 | 5.41e-01 |
| GO:BP | GO:0045041 | protein import into mitochondrial intermembrane space | 2 | 3 | 5.41e-01 |
| GO:BP | GO:0001890 | placenta development | 1 | 117 | 5.41e-01 |
| GO:BP | GO:0001504 | neurotransmitter uptake | 2 | 29 | 5.41e-01 |
| GO:BP | GO:0061502 | early endosome to recycling endosome transport | 1 | 3 | 5.41e-01 |
| GO:BP | GO:1902221 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process | 2 | 3 | 5.41e-01 |
| GO:BP | GO:0006559 | L-phenylalanine catabolic process | 2 | 3 | 5.41e-01 |
| GO:BP | GO:0061824 | cytosolic ciliogenesis | 1 | 1 | 5.41e-01 |
| GO:BP | GO:0106300 | protein-DNA covalent cross-linking repair | 3 | 7 | 5.41e-01 |
| GO:BP | GO:0031269 | pseudopodium assembly | 9 | 14 | 5.41e-01 |
| GO:BP | GO:1902222 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process | 2 | 3 | 5.41e-01 |
| GO:BP | GO:0006558 | L-phenylalanine metabolic process | 2 | 3 | 5.41e-01 |
| GO:BP | GO:1905464 | positive regulation of DNA duplex unwinding | 1 | 3 | 5.41e-01 |
| GO:BP | GO:0009386 | translational attenuation | 1 | 2 | 5.41e-01 |
| GO:BP | GO:1905776 | positive regulation of DNA helicase activity | 1 | 3 | 5.41e-01 |
| GO:BP | GO:0090023 | positive regulation of neutrophil chemotaxis | 2 | 14 | 5.42e-01 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 3 | 195 | 5.42e-01 |
| GO:BP | GO:0110112 | regulation of lipid transporter activity | 1 | 2 | 5.42e-01 |
| GO:BP | GO:0045628 | regulation of T-helper 2 cell differentiation | 1 | 7 | 5.42e-01 |
| GO:BP | GO:1904706 | negative regulation of vascular associated smooth muscle cell proliferation | 15 | 24 | 5.42e-01 |
| GO:BP | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway | 2 | 3 | 5.42e-01 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 3 | 25 | 5.42e-01 |
| GO:BP | GO:0060081 | membrane hyperpolarization | 1 | 7 | 5.42e-01 |
| GO:BP | GO:0042136 | neurotransmitter biosynthetic process | 1 | 5 | 5.42e-01 |
| GO:BP | GO:0019320 | hexose catabolic process | 3 | 32 | 5.42e-01 |
| GO:BP | GO:0016126 | sterol biosynthetic process | 2 | 52 | 5.42e-01 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 82 | 273 | 5.42e-01 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 55 | 257 | 5.42e-01 |
| GO:BP | GO:0097576 | vacuole fusion | 1 | 12 | 5.42e-01 |
| GO:BP | GO:0045445 | myoblast differentiation | 5 | 90 | 5.42e-01 |
| GO:BP | GO:0010936 | negative regulation of macrophage cytokine production | 1 | 7 | 5.43e-01 |
| GO:BP | GO:0031632 | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1 | 4 | 5.43e-01 |
| GO:BP | GO:0090174 | organelle membrane fusion | 3 | 106 | 5.43e-01 |
| GO:BP | GO:0099502 | calcium-dependent activation of synaptic vesicle fusion | 1 | 4 | 5.43e-01 |
| GO:BP | GO:1901634 | positive regulation of synaptic vesicle membrane organization | 1 | 4 | 5.43e-01 |
| GO:BP | GO:0002068 | glandular epithelial cell development | 2 | 28 | 5.43e-01 |
| GO:BP | GO:0006549 | isoleucine metabolic process | 1 | 6 | 5.43e-01 |
| GO:BP | GO:0000348 | mRNA branch site recognition | 1 | 1 | 5.43e-01 |
| GO:BP | GO:0099041 | vesicle tethering to Golgi | 3 | 5 | 5.43e-01 |
| GO:BP | GO:0050961 | detection of temperature stimulus involved in sensory perception | 1 | 12 | 5.43e-01 |
| GO:BP | GO:0006778 | porphyrin-containing compound metabolic process | 2 | 44 | 5.43e-01 |
| GO:BP | GO:0051646 | mitochondrion localization | 1 | 47 | 5.43e-01 |
| GO:BP | GO:0043278 | response to morphine | 2 | 16 | 5.43e-01 |
| GO:BP | GO:0072576 | liver morphogenesis | 3 | 19 | 5.43e-01 |
| GO:BP | GO:0014072 | response to isoquinoline alkaloid | 2 | 16 | 5.43e-01 |
| GO:BP | GO:0046070 | dGTP metabolic process | 2 | 3 | 5.43e-01 |
| GO:BP | GO:0006308 | DNA catabolic process | 1 | 19 | 5.44e-01 |
| GO:BP | GO:0106020 | regulation of vesicle docking | 1 | 2 | 5.44e-01 |
| GO:BP | GO:0002085 | inhibition of neuroepithelial cell differentiation | 2 | 4 | 5.44e-01 |
| GO:BP | GO:0072733 | response to staurosporine | 1 | 3 | 5.44e-01 |
| GO:BP | GO:0072734 | cellular response to staurosporine | 1 | 3 | 5.44e-01 |
| GO:BP | GO:0007386 | compartment pattern specification | 2 | 5 | 5.44e-01 |
| GO:BP | GO:0072144 | glomerular mesangial cell development | 2 | 4 | 5.44e-01 |
| GO:BP | GO:0021603 | cranial nerve formation | 1 | 4 | 5.44e-01 |
| GO:BP | GO:0016553 | base conversion or substitution editing | 1 | 10 | 5.44e-01 |
| GO:BP | GO:0006553 | lysine metabolic process | 2 | 7 | 5.44e-01 |
| GO:BP | GO:0035855 | megakaryocyte development | 1 | 16 | 5.44e-01 |
| GO:BP | GO:0035965 | cardiolipin acyl-chain remodeling | 1 | 4 | 5.44e-01 |
| GO:BP | GO:0005975 | carbohydrate metabolic process | 2 | 433 | 5.44e-01 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 8 | 24 | 5.44e-01 |
| GO:BP | GO:1905794 | response to puromycin | 1 | 1 | 5.44e-01 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 11 | 486 | 5.44e-01 |
| GO:BP | GO:0010822 | positive regulation of mitochondrion organization | 10 | 68 | 5.44e-01 |
| GO:BP | GO:0071422 | succinate transmembrane transport | 1 | 6 | 5.44e-01 |
| GO:BP | GO:0015744 | succinate transport | 1 | 6 | 5.44e-01 |
| GO:BP | GO:1905795 | cellular response to puromycin | 1 | 1 | 5.44e-01 |
| GO:BP | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process | 3 | 4 | 5.44e-01 |
| GO:BP | GO:0061470 | T follicular helper cell differentiation | 2 | 4 | 5.44e-01 |
| GO:BP | GO:0060312 | regulation of blood vessel remodeling | 1 | 4 | 5.45e-01 |
| GO:BP | GO:1904210 | VCP-NPL4-UFD1 AAA ATPase complex assembly | 1 | 1 | 5.45e-01 |
| GO:BP | GO:1904240 | negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly | 1 | 1 | 5.45e-01 |
| GO:BP | GO:1904239 | regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0006880 | intracellular sequestering of iron ion | 3 | 3 | 5.45e-01 |
| GO:BP | GO:0032504 | multicellular organism reproduction | 3 | 556 | 5.45e-01 |
| GO:BP | GO:0001661 | conditioned taste aversion | 1 | 2 | 5.45e-01 |
| GO:BP | GO:0006590 | thyroid hormone generation | 4 | 10 | 5.45e-01 |
| GO:BP | GO:0006667 | sphinganine metabolic process | 2 | 2 | 5.45e-01 |
| GO:BP | GO:0006586 | indolalkylamine metabolic process | 1 | 3 | 5.45e-01 |
| GO:BP | GO:2000050 | regulation of non-canonical Wnt signaling pathway | 11 | 23 | 5.45e-01 |
| GO:BP | GO:0070408 | carbamoyl phosphate metabolic process | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0070409 | carbamoyl phosphate biosynthetic process | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0006693 | prostaglandin metabolic process | 1 | 32 | 5.45e-01 |
| GO:BP | GO:0006692 | prostanoid metabolic process | 1 | 32 | 5.45e-01 |
| GO:BP | GO:1903945 | positive regulation of hepatocyte apoptotic process | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0015779 | glucuronoside transport | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0051866 | general adaptation syndrome | 2 | 4 | 5.45e-01 |
| GO:BP | GO:0046866 | tetraterpenoid transport | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0046867 | carotenoid transport | 1 | 1 | 5.45e-01 |
| GO:BP | GO:0021984 | adenohypophysis development | 3 | 9 | 5.45e-01 |
| GO:BP | GO:0071929 | alpha-tubulin acetylation | 2 | 3 | 5.45e-01 |
| GO:BP | GO:0070649 | formin-nucleated actin cable assembly | 2 | 3 | 5.46e-01 |
| GO:BP | GO:0110009 | formin-nucleated actin cable organization | 2 | 3 | 5.46e-01 |
| GO:BP | GO:1902730 | positive regulation of proteoglycan biosynthetic process | 1 | 4 | 5.46e-01 |
| GO:BP | GO:0007405 | neuroblast proliferation | 3 | 51 | 5.46e-01 |
| GO:BP | GO:0061944 | negative regulation of protein K48-linked ubiquitination | 1 | 2 | 5.46e-01 |
| GO:BP | GO:0071108 | protein K48-linked deubiquitination | 1 | 24 | 5.46e-01 |
| GO:BP | GO:0035962 | response to interleukin-13 | 1 | 1 | 5.46e-01 |
| GO:BP | GO:0008283 | cell population proliferation | 3 | 1378 | 5.47e-01 |
| GO:BP | GO:0032534 | regulation of microvillus assembly | 3 | 6 | 5.47e-01 |
| GO:BP | GO:0071962 | mitotic sister chromatid cohesion, centromeric | 3 | 4 | 5.47e-01 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 6 | 213 | 5.47e-01 |
| GO:BP | GO:0090207 | regulation of triglyceride metabolic process | 3 | 29 | 5.47e-01 |
| GO:BP | GO:0016198 | axon choice point recognition | 3 | 5 | 5.47e-01 |
| GO:BP | GO:0098751 | bone cell development | 2 | 26 | 5.47e-01 |
| GO:BP | GO:0070100 | negative regulation of chemokine-mediated signaling pathway | 3 | 6 | 5.47e-01 |
| GO:BP | GO:0150105 | protein localization to cell-cell junction | 2 | 17 | 5.47e-01 |
| GO:BP | GO:0036302 | atrioventricular canal development | 6 | 12 | 5.47e-01 |
| GO:BP | GO:0000963 | mitochondrial RNA processing | 11 | 20 | 5.47e-01 |
| GO:BP | GO:1901856 | negative regulation of cellular respiration | 1 | 8 | 5.47e-01 |
| GO:BP | GO:0072110 | glomerular mesangial cell proliferation | 7 | 10 | 5.47e-01 |
| GO:BP | GO:0090630 | activation of GTPase activity | 27 | 99 | 5.47e-01 |
| GO:BP | GO:1904556 | L-tryptophan transmembrane transport | 1 | 2 | 5.47e-01 |
| GO:BP | GO:0015824 | proline transport | 2 | 11 | 5.47e-01 |
| GO:BP | GO:0019369 | arachidonic acid metabolic process | 2 | 26 | 5.48e-01 |
| GO:BP | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum | 1 | 2 | 5.48e-01 |
| GO:BP | GO:0036507 | protein demannosylation | 2 | 17 | 5.48e-01 |
| GO:BP | GO:0036508 | protein alpha-1,2-demannosylation | 2 | 17 | 5.48e-01 |
| GO:BP | GO:0098779 | positive regulation of mitophagy in response to mitochondrial depolarization | 5 | 10 | 5.48e-01 |
| GO:BP | GO:0046330 | positive regulation of JNK cascade | 4 | 72 | 5.48e-01 |
| GO:BP | GO:0048012 | hepatocyte growth factor receptor signaling pathway | 7 | 10 | 5.48e-01 |
| GO:BP | GO:0070861 | regulation of protein exit from endoplasmic reticulum | 3 | 22 | 5.48e-01 |
| GO:BP | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 1 | 14 | 5.48e-01 |
| GO:BP | GO:1900127 | positive regulation of hyaluronan biosynthetic process | 1 | 4 | 5.48e-01 |
| GO:BP | GO:0050871 | positive regulation of B cell activation | 1 | 53 | 5.48e-01 |
| GO:BP | GO:0051588 | regulation of neurotransmitter transport | 4 | 70 | 5.48e-01 |
| GO:BP | GO:2000589 | regulation of metanephric mesenchymal cell migration | 1 | 3 | 5.48e-01 |
| GO:BP | GO:0035789 | metanephric mesenchymal cell migration | 1 | 3 | 5.48e-01 |
| GO:BP | GO:1905709 | negative regulation of membrane permeability | 6 | 19 | 5.48e-01 |
| GO:BP | GO:1905673 | positive regulation of lysosome organization | 1 | 1 | 5.48e-01 |
| GO:BP | GO:0097466 | ubiquitin-dependent glycoprotein ERAD pathway | 1 | 5 | 5.49e-01 |
| GO:BP | GO:1904529 | regulation of actin filament binding | 1 | 3 | 5.49e-01 |
| GO:BP | GO:1904382 | mannose trimming involved in glycoprotein ERAD pathway | 1 | 5 | 5.49e-01 |
| GO:BP | GO:0007281 | germ cell development | 1 | 187 | 5.49e-01 |
| GO:BP | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process | 1 | 5 | 5.49e-01 |
| GO:BP | GO:1904426 | positive regulation of GTP binding | 1 | 3 | 5.49e-01 |
| GO:BP | GO:0006140 | regulation of nucleotide metabolic process | 9 | 40 | 5.49e-01 |
| GO:BP | GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 1 | 53 | 5.49e-01 |
| GO:BP | GO:0006084 | acetyl-CoA metabolic process | 1 | 28 | 5.49e-01 |
| GO:BP | GO:0070200 | establishment of protein localization to telomere | 3 | 16 | 5.49e-01 |
| GO:BP | GO:1905603 | regulation of blood-brain barrier permeability | 5 | 6 | 5.49e-01 |
| GO:BP | GO:0006582 | melanin metabolic process | 4 | 18 | 5.49e-01 |
| GO:BP | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1 | 26 | 5.49e-01 |
| GO:BP | GO:0140647 | P450-containing electron transport chain | 1 | 2 | 5.49e-01 |
| GO:BP | GO:0048821 | erythrocyte development | 10 | 30 | 5.49e-01 |
| GO:BP | GO:0051873 | killing by host of symbiont cells | 1 | 5 | 5.49e-01 |
| GO:BP | GO:0016558 | protein import into peroxisome matrix | 7 | 14 | 5.49e-01 |
| GO:BP | GO:0090110 | COPII-coated vesicle cargo loading | 8 | 15 | 5.49e-01 |
| GO:BP | GO:0048589 | developmental growth | 1 | 522 | 5.50e-01 |
| GO:BP | GO:0070193 | synaptonemal complex organization | 1 | 13 | 5.50e-01 |
| GO:BP | GO:0040038 | polar body extrusion after meiotic divisions | 3 | 5 | 5.50e-01 |
| GO:BP | GO:1903589 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1 | 4 | 5.50e-01 |
| GO:BP | GO:0035296 | regulation of tube diameter | 9 | 99 | 5.50e-01 |
| GO:BP | GO:0097746 | blood vessel diameter maintenance | 9 | 99 | 5.50e-01 |
| GO:BP | GO:0045046 | protein import into peroxisome membrane | 3 | 6 | 5.50e-01 |
| GO:BP | GO:1902268 | negative regulation of polyamine transmembrane transport | 1 | 3 | 5.50e-01 |
| GO:BP | GO:0033014 | tetrapyrrole biosynthetic process | 9 | 33 | 5.50e-01 |
| GO:BP | GO:0003183 | mitral valve morphogenesis | 6 | 11 | 5.50e-01 |
| GO:BP | GO:0006779 | porphyrin-containing compound biosynthetic process | 9 | 33 | 5.50e-01 |
| GO:BP | GO:0062036 | sensory perception of hot stimulus | 1 | 1 | 5.50e-01 |
| GO:BP | GO:0120168 | detection of hot stimulus involved in thermoception | 1 | 1 | 5.50e-01 |
| GO:BP | GO:0072028 | nephron morphogenesis | 3 | 62 | 5.50e-01 |
| GO:BP | GO:0071373 | cellular response to luteinizing hormone stimulus | 1 | 5 | 5.50e-01 |
| GO:BP | GO:1903537 | meiotic cell cycle process involved in oocyte maturation | 1 | 5 | 5.50e-01 |
| GO:BP | GO:0006567 | threonine catabolic process | 3 | 3 | 5.51e-01 |
| GO:BP | GO:0032349 | positive regulation of aldosterone biosynthetic process | 1 | 3 | 5.51e-01 |
| GO:BP | GO:0032346 | positive regulation of aldosterone metabolic process | 1 | 3 | 5.51e-01 |
| GO:BP | GO:2000224 | regulation of testosterone biosynthetic process | 1 | 2 | 5.51e-01 |
| GO:BP | GO:0061184 | positive regulation of dermatome development | 1 | 1 | 5.51e-01 |
| GO:BP | GO:0006996 | organelle organization | 62 | 3000 | 5.51e-01 |
| GO:BP | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 2 | 4 | 5.51e-01 |
| GO:BP | GO:0009566 | fertilization | 2 | 93 | 5.51e-01 |
| GO:BP | GO:0021796 | cerebral cortex regionalization | 1 | 2 | 5.51e-01 |
| GO:BP | GO:0010832 | negative regulation of myotube differentiation | 6 | 10 | 5.51e-01 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 2 | 834 | 5.51e-01 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 20 | 893 | 5.51e-01 |
| GO:BP | GO:0000389 | mRNA 3’-splice site recognition | 1 | 6 | 5.51e-01 |
| GO:BP | GO:0030324 | lung development | 2 | 146 | 5.52e-01 |
| GO:BP | GO:0072682 | eosinophil extravasation | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0015698 | inorganic anion transport | 1 | 104 | 5.52e-01 |
| GO:BP | GO:0006699 | bile acid biosynthetic process | 1 | 25 | 5.52e-01 |
| GO:BP | GO:0016255 | attachment of GPI anchor to protein | 3 | 6 | 5.52e-01 |
| GO:BP | GO:0033342 | negative regulation of collagen binding | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0002334 | transitional two stage B cell differentiation | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0098907 | regulation of SA node cell action potential | 3 | 7 | 5.52e-01 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 5 | 23 | 5.52e-01 |
| GO:BP | GO:0140527 | reciprocal homologous recombination | 1 | 36 | 5.52e-01 |
| GO:BP | GO:0003218 | cardiac left ventricle formation | 1 | 2 | 5.52e-01 |
| GO:BP | GO:0048066 | developmental pigmentation | 1 | 36 | 5.52e-01 |
| GO:BP | GO:0036344 | platelet morphogenesis | 1 | 19 | 5.52e-01 |
| GO:BP | GO:0007131 | reciprocal meiotic recombination | 1 | 36 | 5.52e-01 |
| GO:BP | GO:0036093 | germ cell proliferation | 3 | 7 | 5.52e-01 |
| GO:BP | GO:0045879 | negative regulation of smoothened signaling pathway | 4 | 30 | 5.52e-01 |
| GO:BP | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation | 3 | 3 | 5.52e-01 |
| GO:BP | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 5 | 23 | 5.52e-01 |
| GO:BP | GO:0045730 | respiratory burst | 1 | 21 | 5.52e-01 |
| GO:BP | GO:2000194 | regulation of female gonad development | 1 | 4 | 5.52e-01 |
| GO:BP | GO:0048268 | clathrin coat assembly | 1 | 13 | 5.52e-01 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 5 | 23 | 5.52e-01 |
| GO:BP | GO:2000419 | regulation of eosinophil extravasation | 1 | 1 | 5.52e-01 |
| GO:BP | GO:2000420 | negative regulation of eosinophil extravasation | 1 | 1 | 5.52e-01 |
| GO:BP | GO:2000609 | regulation of thyroid hormone generation | 1 | 2 | 5.52e-01 |
| GO:BP | GO:0038173 | interleukin-17A-mediated signaling pathway | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0032885 | regulation of polysaccharide biosynthetic process | 10 | 31 | 5.52e-01 |
| GO:BP | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 4 | 6 | 5.52e-01 |
| GO:BP | GO:0071873 | response to norepinephrine | 1 | 2 | 5.52e-01 |
| GO:BP | GO:0071874 | cellular response to norepinephrine stimulus | 1 | 2 | 5.52e-01 |
| GO:BP | GO:0043972 | histone H3-K23 acetylation | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0110012 | protein localization to P-body | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0010726 | positive regulation of hydrogen peroxide metabolic process | 1 | 4 | 5.52e-01 |
| GO:BP | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 3 | 14 | 5.52e-01 |
| GO:BP | GO:0010359 | regulation of anion channel activity | 4 | 5 | 5.52e-01 |
| GO:BP | GO:0099022 | vesicle tethering | 15 | 31 | 5.52e-01 |
| GO:BP | GO:0035247 | peptidyl-arginine omega-N-methylation | 1 | 3 | 5.52e-01 |
| GO:BP | GO:0031064 | negative regulation of histone deacetylation | 1 | 2 | 5.52e-01 |
| GO:BP | GO:0045653 | negative regulation of megakaryocyte differentiation | 1 | 17 | 5.52e-01 |
| GO:BP | GO:0003158 | endothelium development | 10 | 104 | 5.52e-01 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 17 | 56 | 5.52e-01 |
| GO:BP | GO:0035212 | cell competition in a multicellular organism | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0051141 | negative regulation of NK T cell proliferation | 1 | 1 | 5.52e-01 |
| GO:BP | GO:0032714 | negative regulation of interleukin-5 production | 2 | 2 | 5.52e-01 |
| GO:BP | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress | 1 | 8 | 5.52e-01 |
| GO:BP | GO:0046321 | positive regulation of fatty acid oxidation | 10 | 15 | 5.53e-01 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 5 | 107 | 5.53e-01 |
| GO:BP | GO:0002414 | immunoglobulin transcytosis in epithelial cells | 1 | 2 | 5.53e-01 |
| GO:BP | GO:0090667 | cell chemotaxis to vascular endothelial growth factor | 1 | 1 | 5.53e-01 |
| GO:BP | GO:0090668 | endothelial cell chemotaxis to vascular endothelial growth factor | 1 | 1 | 5.53e-01 |
| GO:BP | GO:0050795 | regulation of behavior | 2 | 39 | 5.53e-01 |
| GO:BP | GO:0046984 | regulation of hemoglobin biosynthetic process | 4 | 8 | 5.53e-01 |
| GO:BP | GO:0048382 | mesendoderm development | 4 | 5 | 5.53e-01 |
| GO:BP | GO:2000454 | positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation | 1 | 1 | 5.54e-01 |
| GO:BP | GO:0033023 | mast cell homeostasis | 3 | 4 | 5.54e-01 |
| GO:BP | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 6 | 37 | 5.54e-01 |
| GO:BP | GO:0032425 | positive regulation of mismatch repair | 2 | 2 | 5.54e-01 |
| GO:BP | GO:0070899 | mitochondrial tRNA wobble uridine modification | 1 | 1 | 5.54e-01 |
| GO:BP | GO:0007611 | learning or memory | 5 | 202 | 5.54e-01 |
| GO:BP | GO:0003332 | negative regulation of extracellular matrix constituent secretion | 2 | 2 | 5.55e-01 |
| GO:BP | GO:0070665 | positive regulation of leukocyte proliferation | 1 | 83 | 5.55e-01 |
| GO:BP | GO:0050685 | positive regulation of mRNA processing | 15 | 30 | 5.55e-01 |
| GO:BP | GO:0000390 | spliceosomal complex disassembly | 2 | 3 | 5.55e-01 |
| GO:BP | GO:0009266 | response to temperature stimulus | 5 | 133 | 5.55e-01 |
| GO:BP | GO:0016266 | O-glycan processing | 1 | 30 | 5.55e-01 |
| GO:BP | GO:0035150 | regulation of tube size | 9 | 99 | 5.55e-01 |
| GO:BP | GO:0032784 | regulation of DNA-templated transcription elongation | 41 | 99 | 5.55e-01 |
| GO:BP | GO:0022414 | reproductive process | 3 | 927 | 5.55e-01 |
| GO:BP | GO:0110135 | Norrin signaling pathway | 2 | 2 | 5.55e-01 |
| GO:BP | GO:0001544 | initiation of primordial ovarian follicle growth | 1 | 1 | 5.55e-01 |
| GO:BP | GO:0008104 | protein localization | 2 | 2129 | 5.55e-01 |
| GO:BP | GO:0002381 | immunoglobulin production involved in immunoglobulin-mediated immune response | 2 | 41 | 5.55e-01 |
| GO:BP | GO:0034770 | histone H4-K20 methylation | 4 | 6 | 5.55e-01 |
| GO:BP | GO:0001826 | inner cell mass cell differentiation | 3 | 5 | 5.56e-01 |
| GO:BP | GO:0015840 | urea transport | 1 | 2 | 5.56e-01 |
| GO:BP | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation | 2 | 9 | 5.56e-01 |
| GO:BP | GO:0071838 | cell proliferation in bone marrow | 2 | 7 | 5.56e-01 |
| GO:BP | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 1 | 6 | 5.56e-01 |
| GO:BP | GO:0051013 | microtubule severing | 1 | 7 | 5.56e-01 |
| GO:BP | GO:0033762 | response to glucagon | 2 | 13 | 5.56e-01 |
| GO:BP | GO:0019233 | sensory perception of pain | 3 | 48 | 5.56e-01 |
| GO:BP | GO:0042745 | circadian sleep/wake cycle | 1 | 11 | 5.56e-01 |
| GO:BP | GO:0090107 | regulation of high-density lipoprotein particle assembly | 1 | 3 | 5.56e-01 |
| GO:BP | GO:2000234 | positive regulation of rRNA processing | 1 | 10 | 5.56e-01 |
| GO:BP | GO:0044782 | cilium organization | 4 | 313 | 5.56e-01 |
| GO:BP | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 3 | 37 | 5.56e-01 |
| GO:BP | GO:0007623 | circadian rhythm | 7 | 165 | 5.56e-01 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 1 | 482 | 5.56e-01 |
| GO:BP | GO:0032259 | methylation | 1 | 313 | 5.57e-01 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 2 | 2138 | 5.57e-01 |
| GO:BP | GO:0002831 | regulation of response to biotic stimulus | 1 | 293 | 5.57e-01 |
| GO:BP | GO:0051154 | negative regulation of striated muscle cell differentiation | 17 | 31 | 5.57e-01 |
| GO:BP | GO:2000756 | regulation of peptidyl-lysine acetylation | 3 | 57 | 5.57e-01 |
| GO:BP | GO:0045002 | double-strand break repair via single-strand annealing | 4 | 7 | 5.57e-01 |
| GO:BP | GO:0006814 | sodium ion transport | 4 | 160 | 5.57e-01 |
| GO:BP | GO:0050775 | positive regulation of dendrite morphogenesis | 16 | 36 | 5.57e-01 |
| GO:BP | GO:0001174 | transcriptional start site selection at RNA polymerase II promoter | 1 | 2 | 5.57e-01 |
| GO:BP | GO:0001173 | DNA-templated transcriptional start site selection | 1 | 2 | 5.57e-01 |
| GO:BP | GO:0070874 | negative regulation of glycogen metabolic process | 3 | 7 | 5.57e-01 |
| GO:BP | GO:0044860 | protein localization to plasma membrane raft | 1 | 4 | 5.58e-01 |
| GO:BP | GO:0035752 | lysosomal lumen pH elevation | 3 | 3 | 5.58e-01 |
| GO:BP | GO:0000003 | reproduction | 3 | 934 | 5.58e-01 |
| GO:BP | GO:0110017 | cap-independent translational initiation of linear mRNA | 1 | 1 | 5.58e-01 |
| GO:BP | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7 | 25 | 5.58e-01 |
| GO:BP | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 3 | 6 | 5.58e-01 |
| GO:BP | GO:0030889 | negative regulation of B cell proliferation | 3 | 9 | 5.58e-01 |
| GO:BP | GO:1902747 | negative regulation of lens fiber cell differentiation | 3 | 5 | 5.58e-01 |
| GO:BP | GO:0002192 | IRES-dependent translational initiation of linear mRNA | 1 | 1 | 5.58e-01 |
| GO:BP | GO:0098967 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane | 3 | 5 | 5.58e-01 |
| GO:BP | GO:0014870 | response to muscle inactivity | 1 | 9 | 5.58e-01 |
| GO:BP | GO:0038154 | interleukin-11-mediated signaling pathway | 2 | 3 | 5.58e-01 |
| GO:BP | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process | 4 | 5 | 5.58e-01 |
| GO:BP | GO:0072137 | condensed mesenchymal cell proliferation | 1 | 2 | 5.58e-01 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 7 | 310 | 5.58e-01 |
| GO:BP | GO:0006659 | phosphatidylserine biosynthetic process | 2 | 4 | 5.58e-01 |
| GO:BP | GO:0099624 | atrial cardiac muscle cell membrane repolarization | 1 | 9 | 5.58e-01 |
| GO:BP | GO:0001959 | regulation of cytokine-mediated signaling pathway | 2 | 117 | 5.58e-01 |
| GO:BP | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 1 | 2 | 5.58e-01 |
| GO:BP | GO:1902622 | regulation of neutrophil migration | 3 | 28 | 5.58e-01 |
| GO:BP | GO:0032754 | positive regulation of interleukin-5 production | 1 | 6 | 5.58e-01 |
| GO:BP | GO:0060086 | circadian temperature homeostasis | 2 | 3 | 5.58e-01 |
| GO:BP | GO:0060413 | atrial septum morphogenesis | 8 | 15 | 5.58e-01 |
| GO:BP | GO:1902359 | Notch signaling pathway involved in somitogenesis | 1 | 2 | 5.58e-01 |
| GO:BP | GO:0014733 | regulation of skeletal muscle adaptation | 3 | 11 | 5.58e-01 |
| GO:BP | GO:1902366 | regulation of Notch signaling pathway involved in somitogenesis | 1 | 2 | 5.58e-01 |
| GO:BP | GO:0060487 | lung epithelial cell differentiation | 6 | 18 | 5.58e-01 |
| GO:BP | GO:1902367 | negative regulation of Notch signaling pathway involved in somitogenesis | 1 | 2 | 5.58e-01 |
| GO:BP | GO:0060479 | lung cell differentiation | 6 | 18 | 5.58e-01 |
| GO:BP | GO:1901327 | response to tacrolimus | 1 | 1 | 5.58e-01 |
| GO:BP | GO:0060761 | negative regulation of response to cytokine stimulus | 1 | 57 | 5.58e-01 |
| GO:BP | GO:0030323 | respiratory tube development | 2 | 150 | 5.58e-01 |
| GO:BP | GO:0014047 | glutamate secretion | 1 | 14 | 5.58e-01 |
| GO:BP | GO:0046951 | ketone body biosynthetic process | 4 | 5 | 5.59e-01 |
| GO:BP | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 5 | 33 | 5.59e-01 |
| GO:BP | GO:2001046 | positive regulation of integrin-mediated signaling pathway | 1 | 13 | 5.59e-01 |
| GO:BP | GO:0035883 | enteroendocrine cell differentiation | 2 | 24 | 5.59e-01 |
| GO:BP | GO:0001701 | in utero embryonic development | 71 | 344 | 5.59e-01 |
| GO:BP | GO:0048265 | response to pain | 2 | 17 | 5.59e-01 |
| GO:BP | GO:0051052 | regulation of DNA metabolic process | 52 | 452 | 5.59e-01 |
| GO:BP | GO:0072680 | extracellular matrix-dependent thymocyte migration | 1 | 1 | 5.59e-01 |
| GO:BP | GO:0038166 | angiotensin-activated signaling pathway | 6 | 10 | 5.59e-01 |
| GO:BP | GO:0038163 | thrombopoietin-mediated signaling pathway | 2 | 3 | 5.59e-01 |
| GO:BP | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay | 1 | 3 | 5.59e-01 |
| GO:BP | GO:0072681 | fibronectin-dependent thymocyte migration | 1 | 1 | 5.59e-01 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 7 | 131 | 5.59e-01 |
| GO:BP | GO:0051048 | negative regulation of secretion | 1 | 111 | 5.59e-01 |
| GO:BP | GO:0060008 | Sertoli cell differentiation | 1 | 15 | 5.59e-01 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 12 | 90 | 5.59e-01 |
| GO:BP | GO:0032765 | positive regulation of mast cell cytokine production | 3 | 3 | 5.59e-01 |
| GO:BP | GO:2000415 | positive regulation of fibronectin-dependent thymocyte migration | 1 | 1 | 5.59e-01 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 8 | 83 | 5.59e-01 |
| GO:BP | GO:0045186 | zonula adherens assembly | 1 | 1 | 5.59e-01 |
| GO:BP | GO:2000413 | regulation of fibronectin-dependent thymocyte migration | 1 | 1 | 5.59e-01 |
| GO:BP | GO:0032967 | positive regulation of collagen biosynthetic process | 4 | 23 | 5.59e-01 |
| GO:BP | GO:0010747 | positive regulation of long-chain fatty acid import across plasma membrane | 1 | 1 | 5.60e-01 |
| GO:BP | GO:0042117 | monocyte activation | 1 | 8 | 5.60e-01 |
| GO:BP | GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1 | 13 | 5.60e-01 |
| GO:BP | GO:1903567 | regulation of protein localization to ciliary membrane | 1 | 2 | 5.60e-01 |
| GO:BP | GO:2000344 | positive regulation of acrosome reaction | 1 | 6 | 5.60e-01 |
| GO:BP | GO:0009249 | protein lipoylation | 4 | 6 | 5.60e-01 |
| GO:BP | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1 | 97 | 5.60e-01 |
| GO:BP | GO:0046661 | male sex differentiation | 11 | 114 | 5.60e-01 |
| GO:BP | GO:0040015 | negative regulation of multicellular organism growth | 1 | 13 | 5.60e-01 |
| GO:BP | GO:0030328 | prenylcysteine catabolic process | 1 | 2 | 5.60e-01 |
| GO:BP | GO:0042335 | cuticle development | 1 | 2 | 5.60e-01 |
| GO:BP | GO:0045638 | negative regulation of myeloid cell differentiation | 4 | 69 | 5.60e-01 |
| GO:BP | GO:0097500 | receptor localization to non-motile cilium | 3 | 4 | 5.60e-01 |
| GO:BP | GO:0032289 | central nervous system myelin formation | 1 | 4 | 5.60e-01 |
| GO:BP | GO:0016577 | histone demethylation | 9 | 21 | 5.60e-01 |
| GO:BP | GO:0000019 | regulation of mitotic recombination | 1 | 5 | 5.60e-01 |
| GO:BP | GO:0030329 | prenylcysteine metabolic process | 1 | 2 | 5.60e-01 |
| GO:BP | GO:0070586 | cell-cell adhesion involved in gastrulation | 3 | 7 | 5.60e-01 |
| GO:BP | GO:0007379 | segment specification | 2 | 14 | 5.60e-01 |
| GO:BP | GO:2000388 | positive regulation of antral ovarian follicle growth | 1 | 1 | 5.60e-01 |
| GO:BP | GO:0001809 | positive regulation of type IV hypersensitivity | 1 | 1 | 5.60e-01 |
| GO:BP | GO:2000387 | regulation of antral ovarian follicle growth | 1 | 1 | 5.60e-01 |
| GO:BP | GO:0021547 | midbrain-hindbrain boundary initiation | 1 | 1 | 5.60e-01 |
| GO:BP | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process | 2 | 3 | 5.60e-01 |
| GO:BP | GO:0021501 | prechordal plate formation | 1 | 1 | 5.60e-01 |
| GO:BP | GO:0003062 | regulation of heart rate by chemical signal | 1 | 6 | 5.61e-01 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 1 | 303 | 5.61e-01 |
| GO:BP | GO:0019470 | 4-hydroxyproline catabolic process | 2 | 4 | 5.61e-01 |
| GO:BP | GO:0019471 | 4-hydroxyproline metabolic process | 2 | 4 | 5.61e-01 |
| GO:BP | GO:0098711 | iron ion import across plasma membrane | 1 | 4 | 5.61e-01 |
| GO:BP | GO:1990708 | conditioned place preference | 1 | 2 | 5.61e-01 |
| GO:BP | GO:0015886 | heme transport | 2 | 9 | 5.61e-01 |
| GO:BP | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone | 1 | 5 | 5.61e-01 |
| GO:BP | GO:0009629 | response to gravity | 2 | 5 | 5.61e-01 |
| GO:BP | GO:1902686 | mitochondrial outer membrane permeabilization involved in programmed cell death | 7 | 40 | 5.61e-01 |
| GO:BP | GO:0042659 | regulation of cell fate specification | 7 | 23 | 5.61e-01 |
| GO:BP | GO:0035553 | oxidative single-stranded RNA demethylation | 1 | 3 | 5.61e-01 |
| GO:BP | GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2 | 21 | 5.61e-01 |
| GO:BP | GO:0015855 | pyrimidine nucleobase transport | 1 | 3 | 5.61e-01 |
| GO:BP | GO:0031034 | myosin filament assembly | 3 | 4 | 5.61e-01 |
| GO:BP | GO:2000641 | regulation of early endosome to late endosome transport | 10 | 17 | 5.61e-01 |
| GO:BP | GO:0071481 | cellular response to X-ray | 4 | 10 | 5.61e-01 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 2 | 18 | 5.61e-01 |
| GO:BP | GO:0033173 | calcineurin-NFAT signaling cascade | 12 | 37 | 5.61e-01 |
| GO:BP | GO:0070350 | regulation of white fat cell proliferation | 1 | 2 | 5.61e-01 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 5 | 190 | 5.61e-01 |
| GO:BP | GO:0006006 | glucose metabolic process | 1 | 151 | 5.61e-01 |
| GO:BP | GO:0002064 | epithelial cell development | 8 | 156 | 5.61e-01 |
| GO:BP | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process | 2 | 3 | 5.61e-01 |
| GO:BP | GO:0015853 | adenine transport | 1 | 5 | 5.61e-01 |
| GO:BP | GO:0033183 | negative regulation of histone ubiquitination | 3 | 4 | 5.61e-01 |
| GO:BP | GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 2 | 21 | 5.61e-01 |
| GO:BP | GO:1902766 | skeletal muscle satellite cell migration | 1 | 2 | 5.61e-01 |
| GO:BP | GO:1901187 | regulation of ephrin receptor signaling pathway | 1 | 2 | 5.61e-01 |
| GO:BP | GO:0061117 | negative regulation of heart growth | 10 | 19 | 5.61e-01 |
| GO:BP | GO:1900034 | regulation of cellular response to heat | 1 | 16 | 5.61e-01 |
| GO:BP | GO:0015862 | uridine transport | 1 | 4 | 5.61e-01 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 2 | 57 | 5.61e-01 |
| GO:BP | GO:0015864 | pyrimidine nucleoside transport | 1 | 4 | 5.61e-01 |
| GO:BP | GO:1901315 | negative regulation of histone H2A K63-linked ubiquitination | 3 | 4 | 5.61e-01 |
| GO:BP | GO:1901314 | regulation of histone H2A K63-linked ubiquitination | 3 | 4 | 5.61e-01 |
| GO:BP | GO:1901838 | positive regulation of transcription of nucleolar large rRNA by RNA polymerase I | 5 | 10 | 5.61e-01 |
| GO:BP | GO:0055022 | negative regulation of cardiac muscle tissue growth | 10 | 19 | 5.61e-01 |
| GO:BP | GO:0070343 | white fat cell proliferation | 1 | 2 | 5.61e-01 |
| GO:BP | GO:0097474 | retinal cone cell apoptotic process | 1 | 1 | 5.62e-01 |
| GO:BP | GO:0072717 | cellular response to actinomycin D | 1 | 4 | 5.62e-01 |
| GO:BP | GO:0097281 | immune complex formation | 1 | 1 | 5.62e-01 |
| GO:BP | GO:0002383 | immune response in brain or nervous system | 1 | 1 | 5.62e-01 |
| GO:BP | GO:0032930 | positive regulation of superoxide anion generation | 4 | 10 | 5.62e-01 |
| GO:BP | GO:0061847 | response to cholecystokinin | 1 | 1 | 5.62e-01 |
| GO:BP | GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 1 | 3 | 5.62e-01 |
| GO:BP | GO:0032095 | regulation of response to food | 1 | 8 | 5.62e-01 |
| GO:BP | GO:0097066 | response to thyroid hormone | 8 | 23 | 5.62e-01 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 4 | 597 | 5.62e-01 |
| GO:BP | GO:1990859 | cellular response to endothelin | 1 | 1 | 5.62e-01 |
| GO:BP | GO:0060526 | prostate glandular acinus morphogenesis | 1 | 3 | 5.62e-01 |
| GO:BP | GO:0010506 | regulation of autophagy | 161 | 313 | 5.62e-01 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 4 | 597 | 5.62e-01 |
| GO:BP | GO:0043266 | regulation of potassium ion transport | 5 | 73 | 5.63e-01 |
| GO:BP | GO:0086103 | G protein-coupled receptor signaling pathway involved in heart process | 4 | 13 | 5.63e-01 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 5 | 60 | 5.63e-01 |
| GO:BP | GO:1905477 | positive regulation of protein localization to membrane | 2 | 84 | 5.63e-01 |
| GO:BP | GO:1903076 | regulation of protein localization to plasma membrane | 2 | 90 | 5.63e-01 |
| GO:BP | GO:2000279 | negative regulation of DNA biosynthetic process | 7 | 34 | 5.63e-01 |
| GO:BP | GO:0045040 | protein insertion into mitochondrial outer membrane | 4 | 15 | 5.63e-01 |
| GO:BP | GO:0007008 | outer mitochondrial membrane organization | 4 | 15 | 5.63e-01 |
| GO:BP | GO:0060992 | response to fungicide | 1 | 4 | 5.64e-01 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 2 | 6 | 5.64e-01 |
| GO:BP | GO:0007565 | female pregnancy | 6 | 122 | 5.64e-01 |
| GO:BP | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis | 6 | 17 | 5.64e-01 |
| GO:BP | GO:1905661 | regulation of telomerase RNA reverse transcriptase activity | 1 | 3 | 5.64e-01 |
| GO:BP | GO:2000064 | regulation of cortisol biosynthetic process | 2 | 7 | 5.64e-01 |
| GO:BP | GO:1904826 | regulation of hydrogen sulfide biosynthetic process | 1 | 1 | 5.64e-01 |
| GO:BP | GO:1990428 | miRNA transport | 1 | 3 | 5.64e-01 |
| GO:BP | GO:1990678 | histone H4-K16 deacetylation | 1 | 1 | 5.64e-01 |
| GO:BP | GO:0010966 | regulation of phosphate transport | 1 | 3 | 5.64e-01 |
| GO:BP | GO:1904828 | positive regulation of hydrogen sulfide biosynthetic process | 1 | 1 | 5.64e-01 |
| GO:BP | GO:2001169 | regulation of ATP biosynthetic process | 3 | 17 | 5.64e-01 |
| GO:BP | GO:0010831 | positive regulation of myotube differentiation | 4 | 10 | 5.64e-01 |
| GO:BP | GO:0060180 | female mating behavior | 2 | 2 | 5.64e-01 |
| GO:BP | GO:0043009 | chordate embryonic development | 5 | 534 | 5.64e-01 |
| GO:BP | GO:0045924 | regulation of female receptivity | 2 | 2 | 5.64e-01 |
| GO:BP | GO:0002154 | thyroid hormone mediated signaling pathway | 2 | 6 | 5.64e-01 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 3 | 44 | 5.64e-01 |
| GO:BP | GO:0010795 | regulation of ubiquinone biosynthetic process | 1 | 2 | 5.64e-01 |
| GO:BP | GO:0046825 | regulation of protein export from nucleus | 3 | 30 | 5.64e-01 |
| GO:BP | GO:0030031 | cell projection assembly | 7 | 469 | 5.65e-01 |
| GO:BP | GO:0009051 | pentose-phosphate shunt, oxidative branch | 1 | 4 | 5.65e-01 |
| GO:BP | GO:0043504 | mitochondrial DNA repair | 4 | 6 | 5.65e-01 |
| GO:BP | GO:0071394 | cellular response to testosterone stimulus | 4 | 11 | 5.65e-01 |
| GO:BP | GO:1904057 | negative regulation of sensory perception of pain | 1 | 1 | 5.65e-01 |
| GO:BP | GO:0015838 | amino-acid betaine transport | 1 | 7 | 5.65e-01 |
| GO:BP | GO:0006929 | substrate-dependent cell migration | 10 | 24 | 5.65e-01 |
| GO:BP | GO:0042868 | antisense RNA metabolic process | 1 | 1 | 5.65e-01 |
| GO:BP | GO:0044571 | [2Fe-2S] cluster assembly | 2 | 11 | 5.65e-01 |
| GO:BP | GO:0071040 | nuclear polyadenylation-dependent antisense transcript catabolic process | 1 | 1 | 5.65e-01 |
| GO:BP | GO:0071041 | antisense RNA transcript catabolic process | 1 | 1 | 5.65e-01 |
| GO:BP | GO:0061053 | somite development | 22 | 63 | 5.65e-01 |
| GO:BP | GO:0031397 | negative regulation of protein ubiquitination | 3 | 76 | 5.66e-01 |
| GO:BP | GO:0060632 | regulation of microtubule-based movement | 1 | 31 | 5.66e-01 |
| GO:BP | GO:0010759 | positive regulation of macrophage chemotaxis | 2 | 9 | 5.66e-01 |
| GO:BP | GO:0045168 | cell-cell signaling involved in cell fate commitment | 1 | 3 | 5.66e-01 |
| GO:BP | GO:2000978 | negative regulation of forebrain neuron differentiation | 1 | 2 | 5.66e-01 |
| GO:BP | GO:0006904 | vesicle docking involved in exocytosis | 1 | 37 | 5.66e-01 |
| GO:BP | GO:0099191 | trans-synaptic signaling by BDNF | 1 | 3 | 5.66e-01 |
| GO:BP | GO:2000737 | negative regulation of stem cell differentiation | 1 | 24 | 5.66e-01 |
| GO:BP | GO:1902870 | negative regulation of amacrine cell differentiation | 1 | 2 | 5.66e-01 |
| GO:BP | GO:0046331 | lateral inhibition | 1 | 3 | 5.66e-01 |
| GO:BP | GO:0060164 | regulation of timing of neuron differentiation | 1 | 1 | 5.66e-01 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 1 | 89 | 5.66e-01 |
| GO:BP | GO:1904182 | regulation of pyruvate dehydrogenase activity | 1 | 4 | 5.66e-01 |
| GO:BP | GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1 | 97 | 5.66e-01 |
| GO:BP | GO:1905584 | outer hair cell apoptotic process | 1 | 2 | 5.66e-01 |
| GO:BP | GO:0032287 | peripheral nervous system myelin maintenance | 3 | 8 | 5.66e-01 |
| GO:BP | GO:0006575 | cellular modified amino acid metabolic process | 18 | 96 | 5.66e-01 |
| GO:BP | GO:0040016 | embryonic cleavage | 2 | 7 | 5.66e-01 |
| GO:BP | GO:0009443 | pyridoxal 5’-phosphate salvage | 1 | 1 | 5.66e-01 |
| GO:BP | GO:2000637 | positive regulation of miRNA-mediated gene silencing | 9 | 15 | 5.66e-01 |
| GO:BP | GO:0007015 | actin filament organization | 13 | 373 | 5.67e-01 |
| GO:BP | GO:0006448 | regulation of translational elongation | 9 | 19 | 5.67e-01 |
| GO:BP | GO:0031442 | positive regulation of mRNA 3’-end processing | 5 | 10 | 5.67e-01 |
| GO:BP | GO:0060021 | roof of mouth development | 4 | 71 | 5.67e-01 |
| GO:BP | GO:0031449 | regulation of slow-twitch skeletal muscle fiber contraction | 1 | 1 | 5.67e-01 |
| GO:BP | GO:0002377 | immunoglobulin production | 3 | 70 | 5.67e-01 |
| GO:BP | GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 2 | 61 | 5.67e-01 |
| GO:BP | GO:0007631 | feeding behavior | 1 | 52 | 5.67e-01 |
| GO:BP | GO:2000635 | negative regulation of primary miRNA processing | 2 | 2 | 5.67e-01 |
| GO:BP | GO:0106004 | tRNA (guanine-N7)-methylation | 1 | 1 | 5.67e-01 |
| GO:BP | GO:0060023 | soft palate development | 1 | 3 | 5.67e-01 |
| GO:BP | GO:2000634 | regulation of primary miRNA processing | 2 | 2 | 5.67e-01 |
| GO:BP | GO:0008334 | histone mRNA metabolic process | 12 | 21 | 5.67e-01 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 7 | 71 | 5.67e-01 |
| GO:BP | GO:0006360 | transcription by RNA polymerase I | 14 | 62 | 5.67e-01 |
| GO:BP | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2 | 86 | 5.67e-01 |
| GO:BP | GO:0034334 | adherens junction maintenance | 4 | 6 | 5.67e-01 |
| GO:BP | GO:0048715 | negative regulation of oligodendrocyte differentiation | 4 | 8 | 5.68e-01 |
| GO:BP | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1 | 7 | 5.68e-01 |
| GO:BP | GO:0044539 | long-chain fatty acid import into cell | 4 | 14 | 5.68e-01 |
| GO:BP | GO:1904797 | negative regulation of core promoter binding | 1 | 1 | 5.68e-01 |
| GO:BP | GO:0090382 | phagosome maturation | 1 | 24 | 5.68e-01 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 2 | 881 | 5.68e-01 |
| GO:BP | GO:0032958 | inositol phosphate biosynthetic process | 2 | 19 | 5.68e-01 |
| GO:BP | GO:0010586 | miRNA metabolic process | 46 | 81 | 5.68e-01 |
| GO:BP | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly | 1 | 3 | 5.69e-01 |
| GO:BP | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1 | 8 | 5.69e-01 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 35 | 114 | 5.69e-01 |
| GO:BP | GO:0038203 | TORC2 signaling | 5 | 12 | 5.69e-01 |
| GO:BP | GO:0043461 | proton-transporting ATP synthase complex assembly | 1 | 8 | 5.69e-01 |
| GO:BP | GO:0098529 | neuromuscular junction development, skeletal muscle fiber | 1 | 1 | 5.69e-01 |
| GO:BP | GO:0045738 | negative regulation of DNA repair | 17 | 32 | 5.69e-01 |
| GO:BP | GO:0046856 | phosphatidylinositol dephosphorylation | 4 | 29 | 5.69e-01 |
| GO:BP | GO:2000977 | regulation of forebrain neuron differentiation | 3 | 4 | 5.69e-01 |
| GO:BP | GO:0000349 | generation of catalytic spliceosome for first transesterification step | 1 | 2 | 5.69e-01 |
| GO:BP | GO:0002100 | tRNA wobble adenosine to inosine editing | 1 | 1 | 5.69e-01 |
| GO:BP | GO:0045945 | positive regulation of transcription by RNA polymerase III | 10 | 19 | 5.69e-01 |
| GO:BP | GO:0007604 | phototransduction, UV | 1 | 1 | 5.69e-01 |
| GO:BP | GO:0032733 | positive regulation of interleukin-10 production | 2 | 16 | 5.69e-01 |
| GO:BP | GO:2000810 | regulation of bicellular tight junction assembly | 6 | 15 | 5.69e-01 |
| GO:BP | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 1 | 1 | 5.69e-01 |
| GO:BP | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel | 3 | 14 | 5.70e-01 |
| GO:BP | GO:0140361 | cyclic-GMP-AMP transmembrane import across plasma membrane | 1 | 4 | 5.70e-01 |
| GO:BP | GO:0060374 | mast cell differentiation | 3 | 4 | 5.70e-01 |
| GO:BP | GO:0001755 | neural crest cell migration | 27 | 49 | 5.70e-01 |
| GO:BP | GO:0070192 | chromosome organization involved in meiotic cell cycle | 10 | 35 | 5.70e-01 |
| GO:BP | GO:0032880 | regulation of protein localization | 1 | 710 | 5.70e-01 |
| GO:BP | GO:0140056 | organelle localization by membrane tethering | 44 | 74 | 5.70e-01 |
| GO:BP | GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 7 | 21 | 5.70e-01 |
| GO:BP | GO:0006446 | regulation of translational initiation | 16 | 73 | 5.70e-01 |
| GO:BP | GO:0044805 | late nucleophagy | 1 | 7 | 5.70e-01 |
| GO:BP | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 6 | 50 | 5.70e-01 |
| GO:BP | GO:0007140 | male meiotic nuclear division | 8 | 27 | 5.70e-01 |
| GO:BP | GO:1902174 | positive regulation of keratinocyte apoptotic process | 1 | 3 | 5.71e-01 |
| GO:BP | GO:0043576 | regulation of respiratory gaseous exchange | 1 | 15 | 5.71e-01 |
| GO:BP | GO:0006548 | histidine catabolic process | 1 | 3 | 5.71e-01 |
| GO:BP | GO:1990386 | mitotic cleavage furrow ingression | 1 | 1 | 5.71e-01 |
| GO:BP | GO:0045580 | regulation of T cell differentiation | 1 | 110 | 5.71e-01 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 1 | 256 | 5.71e-01 |
| GO:BP | GO:0030206 | chondroitin sulfate biosynthetic process | 1 | 17 | 5.71e-01 |
| GO:BP | GO:1902746 | regulation of lens fiber cell differentiation | 4 | 8 | 5.71e-01 |
| GO:BP | GO:1990108 | protein linear deubiquitination | 1 | 3 | 5.71e-01 |
| GO:BP | GO:0043435 | response to corticotropin-releasing hormone | 2 | 3 | 5.71e-01 |
| GO:BP | GO:0071376 | cellular response to corticotropin-releasing hormone stimulus | 2 | 3 | 5.71e-01 |
| GO:BP | GO:1905939 | regulation of gonad development | 4 | 8 | 5.71e-01 |
| GO:BP | GO:0045185 | maintenance of protein location | 1 | 83 | 5.71e-01 |
| GO:BP | GO:0050684 | regulation of mRNA processing | 46 | 127 | 5.71e-01 |
| GO:BP | GO:0043491 | protein kinase B signaling | 1 | 146 | 5.72e-01 |
| GO:BP | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell | 1 | 13 | 5.72e-01 |
| GO:BP | GO:0043666 | regulation of phosphoprotein phosphatase activity | 1 | 47 | 5.72e-01 |
| GO:BP | GO:0051289 | protein homotetramerization | 20 | 42 | 5.72e-01 |
| GO:BP | GO:0009624 | response to nematode | 1 | 4 | 5.72e-01 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 1 | 258 | 5.72e-01 |
| GO:BP | GO:0016062 | adaptation of rhodopsin mediated signaling | 1 | 1 | 5.72e-01 |
| GO:BP | GO:1900044 | regulation of protein K63-linked ubiquitination | 1 | 13 | 5.72e-01 |
| GO:BP | GO:1904003 | negative regulation of sebum secreting cell proliferation | 1 | 1 | 5.72e-01 |
| GO:BP | GO:2000172 | regulation of branching morphogenesis of a nerve | 1 | 3 | 5.72e-01 |
| GO:BP | GO:0010748 | negative regulation of long-chain fatty acid import across plasma membrane | 3 | 4 | 5.72e-01 |
| GO:BP | GO:0097530 | granulocyte migration | 3 | 67 | 5.72e-01 |
| GO:BP | GO:0140213 | negative regulation of long-chain fatty acid import into cell | 3 | 4 | 5.72e-01 |
| GO:BP | GO:0045606 | positive regulation of epidermal cell differentiation | 5 | 16 | 5.72e-01 |
| GO:BP | GO:0071763 | nuclear membrane organization | 2 | 42 | 5.72e-01 |
| GO:BP | GO:1902524 | positive regulation of protein K48-linked ubiquitination | 1 | 2 | 5.72e-01 |
| GO:BP | GO:0030321 | transepithelial chloride transport | 1 | 7 | 5.72e-01 |
| GO:BP | GO:2000819 | regulation of nucleotide-excision repair | 6 | 27 | 5.72e-01 |
| GO:BP | GO:0090238 | positive regulation of arachidonic acid secretion | 1 | 2 | 5.72e-01 |
| GO:BP | GO:0071107 | response to parathyroid hormone | 1 | 9 | 5.72e-01 |
| GO:BP | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 4 | 5 | 5.72e-01 |
| GO:BP | GO:2000551 | regulation of T-helper 2 cell cytokine production | 1 | 3 | 5.72e-01 |
| GO:BP | GO:0035745 | T-helper 2 cell cytokine production | 1 | 3 | 5.72e-01 |
| GO:BP | GO:0048518 | positive regulation of biological process | 4 | 4579 | 5.72e-01 |
| GO:BP | GO:0030097 | hemopoiesis | 14 | 656 | 5.73e-01 |
| GO:BP | GO:0006721 | terpenoid metabolic process | 5 | 50 | 5.73e-01 |
| GO:BP | GO:0014883 | transition between fast and slow fiber | 2 | 7 | 5.73e-01 |
| GO:BP | GO:0060337 | type I interferon-mediated signaling pathway | 1 | 51 | 5.73e-01 |
| GO:BP | GO:1900078 | positive regulation of cellular response to insulin stimulus | 2 | 23 | 5.73e-01 |
| GO:BP | GO:0035967 | cellular response to topologically incorrect protein | 3 | 111 | 5.73e-01 |
| GO:BP | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining | 15 | 25 | 5.73e-01 |
| GO:BP | GO:0009450 | gamma-aminobutyric acid catabolic process | 1 | 2 | 5.73e-01 |
| GO:BP | GO:0031334 | positive regulation of protein-containing complex assembly | 7 | 161 | 5.73e-01 |
| GO:BP | GO:0016074 | sno(s)RNA metabolic process | 5 | 16 | 5.73e-01 |
| GO:BP | GO:0021849 | neuroblast division in subventricular zone | 1 | 3 | 5.73e-01 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 1 | 118 | 5.73e-01 |
| GO:BP | GO:0071681 | cellular response to indole-3-methanol | 2 | 5 | 5.73e-01 |
| GO:BP | GO:0006516 | glycoprotein catabolic process | 2 | 29 | 5.73e-01 |
| GO:BP | GO:1903793 | positive regulation of monoatomic anion transport | 2 | 2 | 5.73e-01 |
| GO:BP | GO:0046105 | thymidine biosynthetic process | 1 | 2 | 5.73e-01 |
| GO:BP | GO:0046890 | regulation of lipid biosynthetic process | 4 | 134 | 5.73e-01 |
| GO:BP | GO:1904448 | regulation of aspartate secretion | 1 | 2 | 5.73e-01 |
| GO:BP | GO:0046120 | deoxyribonucleoside biosynthetic process | 1 | 2 | 5.73e-01 |
| GO:BP | GO:0046126 | pyrimidine deoxyribonucleoside biosynthetic process | 1 | 2 | 5.73e-01 |
| GO:BP | GO:1904450 | positive regulation of aspartate secretion | 1 | 2 | 5.73e-01 |
| GO:BP | GO:0061528 | aspartate secretion | 1 | 2 | 5.73e-01 |
| GO:BP | GO:0098935 | dendritic transport | 2 | 13 | 5.73e-01 |
| GO:BP | GO:0030194 | positive regulation of blood coagulation | 1 | 21 | 5.73e-01 |
| GO:BP | GO:0097202 | activation of cysteine-type endopeptidase activity | 7 | 16 | 5.73e-01 |
| GO:BP | GO:1904685 | positive regulation of metalloendopeptidase activity | 1 | 1 | 5.73e-01 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 1 | 118 | 5.73e-01 |
| GO:BP | GO:0060218 | hematopoietic stem cell differentiation | 3 | 30 | 5.73e-01 |
| GO:BP | GO:0097681 | double-strand break repair via alternative nonhomologous end joining | 3 | 4 | 5.73e-01 |
| GO:BP | GO:1901529 | positive regulation of anion channel activity | 2 | 2 | 5.73e-01 |
| GO:BP | GO:1900048 | positive regulation of hemostasis | 1 | 21 | 5.73e-01 |
| GO:BP | GO:0030917 | midbrain-hindbrain boundary development | 3 | 3 | 5.73e-01 |
| GO:BP | GO:1903961 | positive regulation of anion transmembrane transport | 2 | 2 | 5.73e-01 |
| GO:BP | GO:0060384 | innervation | 3 | 22 | 5.74e-01 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 1 | 301 | 5.74e-01 |
| GO:BP | GO:0046761 | viral budding from plasma membrane | 2 | 13 | 5.74e-01 |
| GO:BP | GO:1903441 | protein localization to ciliary membrane | 7 | 11 | 5.74e-01 |
| GO:BP | GO:0003356 | regulation of cilium beat frequency | 1 | 10 | 5.74e-01 |
| GO:BP | GO:0110011 | regulation of basement membrane organization | 1 | 11 | 5.74e-01 |
| GO:BP | GO:0021740 | principal sensory nucleus of trigeminal nerve development | 1 | 1 | 5.74e-01 |
| GO:BP | GO:0034381 | plasma lipoprotein particle clearance | 1 | 25 | 5.74e-01 |
| GO:BP | GO:0006835 | dicarboxylic acid transport | 10 | 62 | 5.74e-01 |
| GO:BP | GO:0021730 | trigeminal sensory nucleus development | 1 | 1 | 5.74e-01 |
| GO:BP | GO:0048485 | sympathetic nervous system development | 2 | 14 | 5.75e-01 |
| GO:BP | GO:0061302 | smooth muscle cell-matrix adhesion | 2 | 5 | 5.75e-01 |
| GO:BP | GO:0048592 | eye morphogenesis | 6 | 113 | 5.75e-01 |
| GO:BP | GO:0090666 | scaRNA localization to Cajal body | 2 | 5 | 5.76e-01 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 1 | 422 | 5.76e-01 |
| GO:BP | GO:0042304 | regulation of fatty acid biosynthetic process | 8 | 30 | 5.76e-01 |
| GO:BP | GO:0097306 | cellular response to alcohol | 7 | 70 | 5.76e-01 |
| GO:BP | GO:2000020 | positive regulation of male gonad development | 1 | 4 | 5.76e-01 |
| GO:BP | GO:0090309 | positive regulation of DNA methylation-dependent heterochromatin formation | 2 | 12 | 5.76e-01 |
| GO:BP | GO:0071624 | positive regulation of granulocyte chemotaxis | 2 | 14 | 5.76e-01 |
| GO:BP | GO:2000035 | regulation of stem cell division | 5 | 9 | 5.76e-01 |
| GO:BP | GO:0016479 | negative regulation of transcription by RNA polymerase I | 2 | 10 | 5.76e-01 |
| GO:BP | GO:0039529 | RIG-I signaling pathway | 2 | 22 | 5.76e-01 |
| GO:BP | GO:0046826 | negative regulation of protein export from nucleus | 1 | 6 | 5.76e-01 |
| GO:BP | GO:0043144 | sno(s)RNA processing | 8 | 13 | 5.76e-01 |
| GO:BP | GO:0032877 | positive regulation of DNA endoreduplication | 1 | 2 | 5.76e-01 |
| GO:BP | GO:0019086 | late viral transcription | 3 | 4 | 5.76e-01 |
| GO:BP | GO:0034089 | establishment of meiotic sister chromatid cohesion | 3 | 4 | 5.76e-01 |
| GO:BP | GO:1904353 | regulation of telomere capping | 3 | 23 | 5.76e-01 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 6 | 101 | 5.76e-01 |
| GO:BP | GO:0140820 | cytosol to Golgi apparatus transport | 1 | 4 | 5.77e-01 |
| GO:BP | GO:0006564 | L-serine biosynthetic process | 1 | 6 | 5.77e-01 |
| GO:BP | GO:0009791 | post-embryonic development | 2 | 74 | 5.77e-01 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 17 | 323 | 5.77e-01 |
| GO:BP | GO:1901073 | glucosamine-containing compound biosynthetic process | 1 | 2 | 5.77e-01 |
| GO:BP | GO:0006045 | N-acetylglucosamine biosynthetic process | 1 | 2 | 5.77e-01 |
| GO:BP | GO:0051602 | response to electrical stimulus | 2 | 26 | 5.78e-01 |
| GO:BP | GO:0018146 | keratan sulfate biosynthetic process | 5 | 13 | 5.78e-01 |
| GO:BP | GO:0038160 | CXCL12-activated CXCR4 signaling pathway | 2 | 3 | 5.78e-01 |
| GO:BP | GO:0055118 | negative regulation of cardiac muscle contraction | 1 | 4 | 5.78e-01 |
| GO:BP | GO:0070376 | regulation of ERK5 cascade | 1 | 1 | 5.78e-01 |
| GO:BP | GO:0031642 | negative regulation of myelination | 2 | 8 | 5.78e-01 |
| GO:BP | GO:0007610 | behavior | 18 | 436 | 5.78e-01 |
| GO:BP | GO:0006641 | triglyceride metabolic process | 4 | 68 | 5.78e-01 |
| GO:BP | GO:0061440 | kidney vasculature development | 5 | 24 | 5.78e-01 |
| GO:BP | GO:0040008 | regulation of growth | 22 | 501 | 5.78e-01 |
| GO:BP | GO:0061437 | renal system vasculature development | 5 | 24 | 5.78e-01 |
| GO:BP | GO:0031647 | regulation of protein stability | 6 | 290 | 5.78e-01 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 15 | 4245 | 5.78e-01 |
| GO:BP | GO:0001579 | medium-chain fatty acid transport | 1 | 2 | 5.78e-01 |
| GO:BP | GO:0003334 | keratinocyte development | 1 | 8 | 5.78e-01 |
| GO:BP | GO:0010714 | positive regulation of collagen metabolic process | 4 | 24 | 5.78e-01 |
| GO:BP | GO:0075136 | response to host | 1 | 1 | 5.78e-01 |
| GO:BP | GO:1905135 | biotin import across plasma membrane | 1 | 2 | 5.78e-01 |
| GO:BP | GO:0071357 | cellular response to type I interferon | 1 | 52 | 5.78e-01 |
| GO:BP | GO:0052200 | response to host defenses | 1 | 1 | 5.78e-01 |
| GO:BP | GO:0030682 | mitigation of host defenses by symbiont | 1 | 1 | 5.78e-01 |
| GO:BP | GO:0052173 | response to defenses of other organism | 1 | 1 | 5.78e-01 |
| GO:BP | GO:0051258 | protein polymerization | 2 | 241 | 5.78e-01 |
| GO:BP | GO:0051902 | negative regulation of mitochondrial depolarization | 2 | 5 | 5.78e-01 |
| GO:BP | GO:2000254 | regulation of male germ cell proliferation | 2 | 4 | 5.78e-01 |
| GO:BP | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration | 1 | 3 | 5.78e-01 |
| GO:BP | GO:0140861 | DNA repair-dependent chromatin remodeling | 4 | 6 | 5.79e-01 |
| GO:BP | GO:0060759 | regulation of response to cytokine stimulus | 2 | 126 | 5.79e-01 |
| GO:BP | GO:0032745 | positive regulation of interleukin-21 production | 1 | 1 | 5.79e-01 |
| GO:BP | GO:0032625 | interleukin-21 production | 1 | 1 | 5.79e-01 |
| GO:BP | GO:0140627 | ubiquitin-dependent protein catabolic process via the C-end degron rule pathway | 5 | 9 | 5.79e-01 |
| GO:BP | GO:0060352 | cell adhesion molecule production | 1 | 9 | 5.79e-01 |
| GO:BP | GO:0042428 | serotonin metabolic process | 1 | 6 | 5.79e-01 |
| GO:BP | GO:0032665 | regulation of interleukin-21 production | 1 | 1 | 5.79e-01 |
| GO:BP | GO:0005979 | regulation of glycogen biosynthetic process | 8 | 25 | 5.79e-01 |
| GO:BP | GO:0019042 | viral latency | 1 | 4 | 5.79e-01 |
| GO:BP | GO:0030157 | pancreatic juice secretion | 2 | 11 | 5.79e-01 |
| GO:BP | GO:0072488 | ammonium transmembrane transport | 2 | 6 | 5.79e-01 |
| GO:BP | GO:0010962 | regulation of glucan biosynthetic process | 8 | 25 | 5.79e-01 |
| GO:BP | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 5 | 232 | 5.79e-01 |
| GO:BP | GO:0097017 | renal protein absorption | 1 | 5 | 5.79e-01 |
| GO:BP | GO:0042307 | positive regulation of protein import into nucleus | 4 | 32 | 5.79e-01 |
| GO:BP | GO:0016051 | carbohydrate biosynthetic process | 1 | 155 | 5.79e-01 |
| GO:BP | GO:0090403 | oxidative stress-induced premature senescence | 1 | 3 | 5.79e-01 |
| GO:BP | GO:1903959 | regulation of monoatomic anion transmembrane transport | 5 | 6 | 5.79e-01 |
| GO:BP | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1 | 3 | 5.80e-01 |
| GO:BP | GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1 | 3 | 5.80e-01 |
| GO:BP | GO:0071377 | cellular response to glucagon stimulus | 1 | 4 | 5.80e-01 |
| GO:BP | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 6 | 10 | 5.80e-01 |
| GO:BP | GO:0042270 | protection from natural killer cell mediated cytotoxicity | 2 | 5 | 5.80e-01 |
| GO:BP | GO:0097377 | spinal cord interneuron axon guidance | 1 | 1 | 5.80e-01 |
| GO:BP | GO:0035846 | oviduct epithelium development | 1 | 2 | 5.80e-01 |
| GO:BP | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1 | 3 | 5.80e-01 |
| GO:BP | GO:0097477 | lateral motor column neuron migration | 1 | 3 | 5.80e-01 |
| GO:BP | GO:0034661 | ncRNA catabolic process | 1 | 41 | 5.80e-01 |
| GO:BP | GO:0006518 | peptide metabolic process | 10 | 771 | 5.80e-01 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 8 | 19 | 5.80e-01 |
| GO:BP | GO:1905550 | regulation of protein localization to endoplasmic reticulum | 3 | 4 | 5.80e-01 |
| GO:BP | GO:0030258 | lipid modification | 1 | 162 | 5.80e-01 |
| GO:BP | GO:2000143 | negative regulation of DNA-templated transcription initiation | 4 | 6 | 5.80e-01 |
| GO:BP | GO:0006991 | response to sterol depletion | 8 | 16 | 5.80e-01 |
| GO:BP | GO:0007258 | JUN phosphorylation | 1 | 2 | 5.80e-01 |
| GO:BP | GO:2000352 | negative regulation of endothelial cell apoptotic process | 2 | 22 | 5.80e-01 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 2 | 26 | 5.80e-01 |
| GO:BP | GO:0072319 | vesicle uncoating | 2 | 9 | 5.80e-01 |
| GO:BP | GO:1901185 | negative regulation of ERBB signaling pathway | 1 | 30 | 5.81e-01 |
| GO:BP | GO:0019932 | second-messenger-mediated signaling | 4 | 191 | 5.81e-01 |
| GO:BP | GO:0021542 | dentate gyrus development | 4 | 11 | 5.82e-01 |
| GO:BP | GO:0042921 | glucocorticoid receptor signaling pathway | 2 | 13 | 5.82e-01 |
| GO:BP | GO:1902462 | positive regulation of mesenchymal stem cell proliferation | 3 | 4 | 5.82e-01 |
| GO:BP | GO:1902460 | regulation of mesenchymal stem cell proliferation | 3 | 4 | 5.82e-01 |
| GO:BP | GO:0060586 | multicellular organismal-level iron ion homeostasis | 2 | 7 | 5.82e-01 |
| GO:BP | GO:2000458 | regulation of astrocyte chemotaxis | 1 | 1 | 5.82e-01 |
| GO:BP | GO:0032957 | inositol trisphosphate metabolic process | 1 | 10 | 5.82e-01 |
| GO:BP | GO:0036145 | dendritic cell homeostasis | 1 | 2 | 5.82e-01 |
| GO:BP | GO:0035700 | astrocyte chemotaxis | 1 | 1 | 5.82e-01 |
| GO:BP | GO:0035196 | miRNA processing | 22 | 41 | 5.82e-01 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 18 | 816 | 5.82e-01 |
| GO:BP | GO:0001754 | eye photoreceptor cell differentiation | 2 | 30 | 5.82e-01 |
| GO:BP | GO:0006422 | aspartyl-tRNA aminoacylation | 1 | 2 | 5.82e-01 |
| GO:BP | GO:2000360 | negative regulation of binding of sperm to zona pellucida | 2 | 2 | 5.82e-01 |
| GO:BP | GO:0002285 | lymphocyte activation involved in immune response | 5 | 111 | 5.82e-01 |
| GO:BP | GO:1904693 | midbrain morphogenesis | 1 | 3 | 5.82e-01 |
| GO:BP | GO:0070933 | histone H4 deacetylation | 3 | 7 | 5.82e-01 |
| GO:BP | GO:0106028 | neuron projection retraction | 1 | 1 | 5.82e-01 |
| GO:BP | GO:1905458 | positive regulation of lymphoid progenitor cell differentiation | 2 | 3 | 5.82e-01 |
| GO:BP | GO:0036353 | histone H2A-K119 monoubiquitination | 5 | 8 | 5.83e-01 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 6 | 126 | 5.83e-01 |
| GO:BP | GO:1904424 | regulation of GTP binding | 1 | 16 | 5.83e-01 |
| GO:BP | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization | 1 | 1 | 5.83e-01 |
| GO:BP | GO:1903463 | regulation of mitotic cell cycle DNA replication | 1 | 2 | 5.83e-01 |
| GO:BP | GO:1900099 | negative regulation of plasma cell differentiation | 1 | 1 | 5.83e-01 |
| GO:BP | GO:0019742 | pentacyclic triterpenoid metabolic process | 1 | 1 | 5.83e-01 |
| GO:BP | GO:0009303 | rRNA transcription | 14 | 37 | 5.83e-01 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 5 | 551 | 5.83e-01 |
| GO:BP | GO:0060075 | regulation of resting membrane potential | 4 | 6 | 5.83e-01 |
| GO:BP | GO:0055015 | ventricular cardiac muscle cell development | 6 | 10 | 5.83e-01 |
| GO:BP | GO:2000078 | positive regulation of type B pancreatic cell development | 2 | 2 | 5.83e-01 |
| GO:BP | GO:0006338 | chromatin remodeling | 3 | 378 | 5.84e-01 |
| GO:BP | GO:0015961 | diadenosine polyphosphate catabolic process | 2 | 6 | 5.84e-01 |
| GO:BP | GO:0006204 | IMP catabolic process | 3 | 3 | 5.84e-01 |
| GO:BP | GO:0033559 | unsaturated fatty acid metabolic process | 3 | 66 | 5.84e-01 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 7 | 90 | 5.84e-01 |
| GO:BP | GO:2000105 | positive regulation of DNA-templated DNA replication | 1 | 13 | 5.84e-01 |
| GO:BP | GO:0033262 | regulation of nuclear cell cycle DNA replication | 1 | 11 | 5.84e-01 |
| GO:BP | GO:0002819 | regulation of adaptive immune response | 1 | 106 | 5.84e-01 |
| GO:BP | GO:0021761 | limbic system development | 4 | 81 | 5.84e-01 |
| GO:BP | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction | 2 | 8 | 5.85e-01 |
| GO:BP | GO:0097212 | lysosomal membrane organization | 1 | 13 | 5.85e-01 |
| GO:BP | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 8 | 116 | 5.85e-01 |
| GO:BP | GO:0001953 | negative regulation of cell-matrix adhesion | 2 | 26 | 5.85e-01 |
| GO:BP | GO:2000369 | regulation of clathrin-dependent endocytosis | 1 | 18 | 5.85e-01 |
| GO:BP | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 2 | 2 | 5.85e-01 |
| GO:BP | GO:0060701 | negative regulation of ribonuclease activity | 1 | 2 | 5.85e-01 |
| GO:BP | GO:0060702 | negative regulation of endoribonuclease activity | 1 | 2 | 5.85e-01 |
| GO:BP | GO:0050877 | nervous system process | 1 | 634 | 5.85e-01 |
| GO:BP | GO:1900259 | regulation of RNA-dependent RNA polymerase activity | 1 | 1 | 5.85e-01 |
| GO:BP | GO:1900260 | negative regulation of RNA-dependent RNA polymerase activity | 1 | 1 | 5.85e-01 |
| GO:BP | GO:0050810 | regulation of steroid biosynthetic process | 2 | 51 | 5.85e-01 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 5 | 199 | 5.85e-01 |
| GO:BP | GO:1905243 | cellular response to 3,3’,5-triiodo-L-thyronine | 1 | 1 | 5.85e-01 |
| GO:BP | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus | 10 | 49 | 5.85e-01 |
| GO:BP | GO:0006747 | FAD biosynthetic process | 1 | 1 | 5.85e-01 |
| GO:BP | GO:0072388 | flavin adenine dinucleotide biosynthetic process | 1 | 1 | 5.85e-01 |
| GO:BP | GO:0010470 | regulation of gastrulation | 10 | 13 | 5.85e-01 |
| GO:BP | GO:0046443 | FAD metabolic process | 1 | 1 | 5.85e-01 |
| GO:BP | GO:0048210 | Golgi vesicle fusion to target membrane | 3 | 4 | 5.86e-01 |
| GO:BP | GO:0090219 | negative regulation of lipid kinase activity | 5 | 8 | 5.86e-01 |
| GO:BP | GO:0001955 | blood vessel maturation | 2 | 6 | 5.86e-01 |
| GO:BP | GO:0060976 | coronary vasculature development | 1 | 44 | 5.86e-01 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 1 | 12 | 5.86e-01 |
| GO:BP | GO:0010713 | negative regulation of collagen metabolic process | 6 | 8 | 5.86e-01 |
| GO:BP | GO:1905313 | transforming growth factor beta receptor signaling pathway involved in heart development | 1 | 1 | 5.86e-01 |
| GO:BP | GO:0014006 | regulation of microglia differentiation | 1 | 1 | 5.86e-01 |
| GO:BP | GO:1903564 | regulation of protein localization to cilium | 5 | 11 | 5.86e-01 |
| GO:BP | GO:0006900 | vesicle budding from membrane | 2 | 76 | 5.86e-01 |
| GO:BP | GO:0014008 | positive regulation of microglia differentiation | 1 | 1 | 5.86e-01 |
| GO:BP | GO:0060242 | contact inhibition | 5 | 8 | 5.86e-01 |
| GO:BP | GO:1901232 | regulation of convergent extension involved in axis elongation | 1 | 1 | 5.86e-01 |
| GO:BP | GO:0044338 | canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation | 1 | 3 | 5.86e-01 |
| GO:BP | GO:1901229 | regulation of non-canonical Wnt signaling pathway via JNK cascade | 1 | 1 | 5.86e-01 |
| GO:BP | GO:1901231 | positive regulation of non-canonical Wnt signaling pathway via JNK cascade | 1 | 1 | 5.86e-01 |
| GO:BP | GO:0048696 | regulation of collateral sprouting in absence of injury | 1 | 2 | 5.86e-01 |
| GO:BP | GO:0001787 | natural killer cell proliferation | 1 | 6 | 5.86e-01 |
| GO:BP | GO:1901233 | negative regulation of convergent extension involved in axis elongation | 1 | 1 | 5.86e-01 |
| GO:BP | GO:1902416 | positive regulation of mRNA binding | 5 | 8 | 5.86e-01 |
| GO:BP | GO:0003013 | circulatory system process | 2 | 447 | 5.86e-01 |
| GO:BP | GO:0006816 | calcium ion transport | 7 | 269 | 5.86e-01 |
| GO:BP | GO:0042795 | snRNA transcription by RNA polymerase II | 2 | 15 | 5.86e-01 |
| GO:BP | GO:0048207 | vesicle targeting, rough ER to cis-Golgi | 1 | 24 | 5.86e-01 |
| GO:BP | GO:0048208 | COPII vesicle coating | 1 | 24 | 5.86e-01 |
| GO:BP | GO:0014805 | smooth muscle adaptation | 2 | 3 | 5.87e-01 |
| GO:BP | GO:0072695 | regulation of DNA recombination at telomere | 1 | 2 | 5.87e-01 |
| GO:BP | GO:0048239 | negative regulation of DNA recombination at telomere | 1 | 2 | 5.87e-01 |
| GO:BP | GO:0045986 | negative regulation of smooth muscle contraction | 1 | 12 | 5.87e-01 |
| GO:BP | GO:0016048 | detection of temperature stimulus | 1 | 13 | 5.87e-01 |
| GO:BP | GO:0048320 | axial mesoderm formation | 1 | 2 | 5.87e-01 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1 | 81 | 5.87e-01 |
| GO:BP | GO:0060338 | regulation of type I interferon-mediated signaling pathway | 20 | 35 | 5.88e-01 |
| GO:BP | GO:0019449 | L-cysteine catabolic process to hypotaurine | 1 | 1 | 5.88e-01 |
| GO:BP | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1 | 15 | 5.88e-01 |
| GO:BP | GO:0042416 | dopamine biosynthetic process | 1 | 8 | 5.88e-01 |
| GO:BP | GO:0019452 | L-cysteine catabolic process to taurine | 1 | 1 | 5.88e-01 |
| GO:BP | GO:0050820 | positive regulation of coagulation | 1 | 23 | 5.88e-01 |
| GO:BP | GO:0001764 | neuron migration | 7 | 133 | 5.88e-01 |
| GO:BP | GO:0032532 | regulation of microvillus length | 2 | 4 | 5.88e-01 |
| GO:BP | GO:0045583 | regulation of cytotoxic T cell differentiation | 1 | 2 | 5.89e-01 |
| GO:BP | GO:1902307 | positive regulation of sodium ion transmembrane transport | 1 | 17 | 5.89e-01 |
| GO:BP | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 1 | 5 | 5.89e-01 |
| GO:BP | GO:0021707 | cerebellar granule cell differentiation | 1 | 6 | 5.89e-01 |
| GO:BP | GO:0021684 | cerebellar granular layer formation | 1 | 6 | 5.89e-01 |
| GO:BP | GO:0006526 | arginine biosynthetic process | 4 | 4 | 5.89e-01 |
| GO:BP | GO:0010166 | wax metabolic process | 1 | 2 | 5.89e-01 |
| GO:BP | GO:0010025 | wax biosynthetic process | 1 | 2 | 5.89e-01 |
| GO:BP | GO:0097352 | autophagosome maturation | 26 | 55 | 5.89e-01 |
| GO:BP | GO:1990000 | amyloid fibril formation | 1 | 35 | 5.89e-01 |
| GO:BP | GO:0044255 | cellular lipid metabolic process | 3 | 740 | 5.89e-01 |
| GO:BP | GO:0140448 | signaling receptor ligand precursor processing | 1 | 29 | 5.89e-01 |
| GO:BP | GO:0046839 | phospholipid dephosphorylation | 4 | 39 | 5.89e-01 |
| GO:BP | GO:0071139 | resolution of recombination intermediates | 4 | 6 | 5.89e-01 |
| GO:BP | GO:0070306 | lens fiber cell differentiation | 1 | 30 | 5.89e-01 |
| GO:BP | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 3 | 3 | 5.89e-01 |
| GO:BP | GO:0099628 | neurotransmitter receptor diffusion trapping | 1 | 4 | 5.89e-01 |
| GO:BP | GO:0032868 | response to insulin | 53 | 215 | 5.89e-01 |
| GO:BP | GO:0061789 | dense core granule priming | 1 | 1 | 5.89e-01 |
| GO:BP | GO:0010040 | response to iron(II) ion | 1 | 5 | 5.89e-01 |
| GO:BP | GO:0090086 | negative regulation of protein deubiquitination | 3 | 4 | 5.89e-01 |
| GO:BP | GO:0061684 | chaperone-mediated autophagy | 1 | 16 | 5.89e-01 |
| GO:BP | GO:0019249 | lactate biosynthetic process | 3 | 3 | 5.89e-01 |
| GO:BP | GO:0003430 | growth plate cartilage chondrocyte growth | 2 | 3 | 5.89e-01 |
| GO:BP | GO:0032415 | regulation of sodium:proton antiporter activity | 1 | 4 | 5.89e-01 |
| GO:BP | GO:0048806 | genitalia development | 2 | 28 | 5.89e-01 |
| GO:BP | GO:0036465 | synaptic vesicle recycling | 2 | 73 | 5.89e-01 |
| GO:BP | GO:0098953 | receptor diffusion trapping | 1 | 4 | 5.89e-01 |
| GO:BP | GO:0032288 | myelin assembly | 8 | 19 | 5.89e-01 |
| GO:BP | GO:0098970 | postsynaptic neurotransmitter receptor diffusion trapping | 1 | 4 | 5.89e-01 |
| GO:BP | GO:1990966 | ATP generation from poly-ADP-D-ribose | 1 | 4 | 5.89e-01 |
| GO:BP | GO:2000670 | positive regulation of dendritic cell apoptotic process | 1 | 2 | 5.89e-01 |
| GO:BP | GO:0006102 | isocitrate metabolic process | 4 | 6 | 5.90e-01 |
| GO:BP | GO:0150065 | regulation of deacetylase activity | 2 | 10 | 5.90e-01 |
| GO:BP | GO:0007626 | locomotory behavior | 6 | 138 | 5.90e-01 |
| GO:BP | GO:0036151 | phosphatidylcholine acyl-chain remodeling | 1 | 12 | 5.90e-01 |
| GO:BP | GO:0045995 | regulation of embryonic development | 2 | 80 | 5.90e-01 |
| GO:BP | GO:0042045 | epithelial fluid transport | 3 | 7 | 5.90e-01 |
| GO:BP | GO:0018076 | N-terminal peptidyl-lysine acetylation | 1 | 4 | 5.90e-01 |
| GO:BP | GO:1901080 | regulation of relaxation of smooth muscle | 1 | 1 | 5.90e-01 |
| GO:BP | GO:0060541 | respiratory system development | 2 | 163 | 5.90e-01 |
| GO:BP | GO:1902570 | protein localization to nucleolus | 1 | 15 | 5.90e-01 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 5 | 28 | 5.90e-01 |
| GO:BP | GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 1 | 2 | 5.90e-01 |
| GO:BP | GO:0032872 | regulation of stress-activated MAPK cascade | 8 | 154 | 5.90e-01 |
| GO:BP | GO:0036075 | replacement ossification | 4 | 25 | 5.90e-01 |
| GO:BP | GO:0023057 | negative regulation of signaling | 8 | 1076 | 5.90e-01 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 8 | 1074 | 5.90e-01 |
| GO:BP | GO:0001958 | endochondral ossification | 4 | 25 | 5.90e-01 |
| GO:BP | GO:0033013 | tetrapyrrole metabolic process | 2 | 52 | 5.90e-01 |
| GO:BP | GO:0045654 | positive regulation of megakaryocyte differentiation | 2 | 9 | 5.90e-01 |
| GO:BP | GO:0043403 | skeletal muscle tissue regeneration | 5 | 31 | 5.90e-01 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 1 | 55 | 5.90e-01 |
| GO:BP | GO:0040010 | positive regulation of growth rate | 2 | 2 | 5.90e-01 |
| GO:BP | GO:0007530 | sex determination | 6 | 12 | 5.90e-01 |
| GO:BP | GO:0043653 | mitochondrial fragmentation involved in apoptotic process | 1 | 9 | 5.90e-01 |
| GO:BP | GO:0035788 | cell migration involved in metanephros development | 1 | 4 | 5.90e-01 |
| GO:BP | GO:0006855 | xenobiotic transmembrane transport | 2 | 11 | 5.90e-01 |
| GO:BP | GO:0034227 | tRNA thio-modification | 2 | 5 | 5.90e-01 |
| GO:BP | GO:0007031 | peroxisome organization | 14 | 34 | 5.90e-01 |
| GO:BP | GO:0072663 | establishment of protein localization to peroxisome | 9 | 19 | 5.91e-01 |
| GO:BP | GO:0072662 | protein localization to peroxisome | 9 | 19 | 5.91e-01 |
| GO:BP | GO:0006625 | protein targeting to peroxisome | 9 | 19 | 5.91e-01 |
| GO:BP | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 1 | 15 | 5.91e-01 |
| GO:BP | GO:0046503 | glycerolipid catabolic process | 8 | 42 | 5.91e-01 |
| GO:BP | GO:1903726 | negative regulation of phospholipid metabolic process | 2 | 7 | 5.91e-01 |
| GO:BP | GO:0046712 | GDP catabolic process | 1 | 2 | 5.91e-01 |
| GO:BP | GO:0046056 | dADP metabolic process | 1 | 1 | 5.91e-01 |
| GO:BP | GO:0046066 | dGDP metabolic process | 1 | 2 | 5.91e-01 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 3 | 782 | 5.91e-01 |
| GO:BP | GO:0032056 | positive regulation of translation in response to stress | 5 | 8 | 5.92e-01 |
| GO:BP | GO:0042635 | positive regulation of hair cycle | 1 | 1 | 5.92e-01 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 2 | 485 | 5.92e-01 |
| GO:BP | GO:1990009 | retinal cell apoptotic process | 4 | 5 | 5.92e-01 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 2 | 54 | 5.92e-01 |
| GO:BP | GO:0002357 | defense response to tumor cell | 1 | 6 | 5.92e-01 |
| GO:BP | GO:0072537 | fibroblast activation | 7 | 11 | 5.92e-01 |
| GO:BP | GO:0045586 | regulation of gamma-delta T cell differentiation | 2 | 6 | 5.92e-01 |
| GO:BP | GO:0098789 | pre-mRNA cleavage required for polyadenylation | 1 | 12 | 5.92e-01 |
| GO:BP | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation | 1 | 5 | 5.92e-01 |
| GO:BP | GO:0022009 | central nervous system vasculogenesis | 1 | 4 | 5.92e-01 |
| GO:BP | GO:0006901 | vesicle coating | 9 | 36 | 5.92e-01 |
| GO:BP | GO:0021793 | chemorepulsion of branchiomotor axon | 1 | 1 | 5.92e-01 |
| GO:BP | GO:0002184 | cytoplasmic translational termination | 1 | 1 | 5.93e-01 |
| GO:BP | GO:0046686 | response to cadmium ion | 3 | 41 | 5.93e-01 |
| GO:BP | GO:0032008 | positive regulation of TOR signaling | 23 | 43 | 5.93e-01 |
| GO:BP | GO:0002520 | immune system development | 1 | 144 | 5.94e-01 |
| GO:BP | GO:0034340 | response to type I interferon | 1 | 57 | 5.94e-01 |
| GO:BP | GO:0015816 | glycine transport | 2 | 9 | 5.94e-01 |
| GO:BP | GO:1904515 | positive regulation of TORC2 signaling | 2 | 4 | 5.94e-01 |
| GO:BP | GO:0033860 | regulation of NAD(P)H oxidase activity | 1 | 6 | 5.94e-01 |
| GO:BP | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process | 7 | 42 | 5.94e-01 |
| GO:BP | GO:0046851 | negative regulation of bone remodeling | 2 | 9 | 5.94e-01 |
| GO:BP | GO:0042180 | cellular ketone metabolic process | 2 | 158 | 5.94e-01 |
| GO:BP | GO:0016310 | phosphorylation | 7 | 1372 | 5.94e-01 |
| GO:BP | GO:0030644 | intracellular chloride ion homeostasis | 1 | 7 | 5.94e-01 |
| GO:BP | GO:0030002 | intracellular monoatomic anion homeostasis | 1 | 7 | 5.94e-01 |
| GO:BP | GO:0048520 | positive regulation of behavior | 1 | 13 | 5.94e-01 |
| GO:BP | GO:0060341 | regulation of cellular localization | 1 | 798 | 5.94e-01 |
| GO:BP | GO:0042796 | snRNA transcription by RNA polymerase III | 5 | 8 | 5.94e-01 |
| GO:BP | GO:1901523 | icosanoid catabolic process | 1 | 2 | 5.94e-01 |
| GO:BP | GO:1901526 | positive regulation of mitophagy | 1 | 6 | 5.94e-01 |
| GO:BP | GO:0030832 | regulation of actin filament length | 6 | 127 | 5.95e-01 |
| GO:BP | GO:0090314 | positive regulation of protein targeting to membrane | 5 | 22 | 5.95e-01 |
| GO:BP | GO:0033625 | positive regulation of integrin activation | 3 | 6 | 5.95e-01 |
| GO:BP | GO:0097067 | cellular response to thyroid hormone stimulus | 5 | 14 | 5.95e-01 |
| GO:BP | GO:0070234 | positive regulation of T cell apoptotic process | 1 | 8 | 5.95e-01 |
| GO:BP | GO:0006501 | C-terminal protein lipidation | 2 | 6 | 5.95e-01 |
| GO:BP | GO:0060574 | intestinal epithelial cell maturation | 2 | 3 | 5.95e-01 |
| GO:BP | GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 1 | 7 | 5.95e-01 |
| GO:BP | GO:0046031 | ADP metabolic process | 5 | 7 | 5.95e-01 |
| GO:BP | GO:0090315 | negative regulation of protein targeting to membrane | 1 | 5 | 5.95e-01 |
| GO:BP | GO:0014902 | myotube differentiation | 1 | 88 | 5.95e-01 |
| GO:BP | GO:1903626 | positive regulation of DNA catabolic process | 2 | 5 | 5.95e-01 |
| GO:BP | GO:1900142 | negative regulation of oligodendrocyte apoptotic process | 1 | 1 | 5.95e-01 |
| GO:BP | GO:0002265 | astrocyte activation involved in immune response | 2 | 4 | 5.95e-01 |
| GO:BP | GO:2000533 | negative regulation of renal albumin absorption | 1 | 1 | 5.95e-01 |
| GO:BP | GO:0034447 | very-low-density lipoprotein particle clearance | 2 | 4 | 5.95e-01 |
| GO:BP | GO:0098657 | import into cell | 23 | 166 | 5.95e-01 |
| GO:BP | GO:0031054 | pre-miRNA processing | 8 | 14 | 5.96e-01 |
| GO:BP | GO:1905209 | positive regulation of cardiocyte differentiation | 1 | 11 | 5.96e-01 |
| GO:BP | GO:1904528 | positive regulation of microtubule binding | 2 | 6 | 5.96e-01 |
| GO:BP | GO:0060377 | negative regulation of mast cell differentiation | 1 | 1 | 5.96e-01 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 1 | 63 | 5.96e-01 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 3 | 114 | 5.96e-01 |
| GO:BP | GO:0080058 | protein deglutathionylation | 1 | 1 | 5.96e-01 |
| GO:BP | GO:0035246 | peptidyl-arginine N-methylation | 1 | 4 | 5.96e-01 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 4 | 158 | 5.96e-01 |
| GO:BP | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 18 | 39 | 5.96e-01 |
| GO:BP | GO:0051597 | response to methylmercury | 2 | 5 | 5.97e-01 |
| GO:BP | GO:0002446 | neutrophil mediated immunity | 1 | 17 | 5.97e-01 |
| GO:BP | GO:0003168 | Purkinje myocyte differentiation | 1 | 1 | 5.97e-01 |
| GO:BP | GO:1901652 | response to peptide | 35 | 377 | 5.97e-01 |
| GO:BP | GO:0018023 | peptidyl-lysine trimethylation | 1 | 33 | 5.97e-01 |
| GO:BP | GO:0070267 | oncosis | 1 | 1 | 5.97e-01 |
| GO:BP | GO:0033555 | multicellular organismal response to stress | 2 | 57 | 5.97e-01 |
| GO:BP | GO:0060982 | coronary artery morphogenesis | 3 | 8 | 5.97e-01 |
| GO:BP | GO:0098535 | de novo centriole assembly involved in multi-ciliated epithelial cell differentiation | 3 | 4 | 5.98e-01 |
| GO:BP | GO:0097742 | de novo centriole assembly | 3 | 4 | 5.98e-01 |
| GO:BP | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation | 2 | 2 | 5.98e-01 |
| GO:BP | GO:0010996 | response to auditory stimulus | 1 | 16 | 5.98e-01 |
| GO:BP | GO:0010896 | regulation of triglyceride catabolic process | 1 | 7 | 5.99e-01 |
| GO:BP | GO:0006426 | glycyl-tRNA aminoacylation | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0021629 | olfactory nerve structural organization | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0048771 | tissue remodeling | 3 | 114 | 5.99e-01 |
| GO:BP | GO:0051707 | response to other organism | 3 | 820 | 5.99e-01 |
| GO:BP | GO:0070150 | mitochondrial glycyl-tRNA aminoacylation | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0120254 | olefinic compound metabolic process | 6 | 84 | 5.99e-01 |
| GO:BP | GO:1903182 | regulation of SUMO transferase activity | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0006684 | sphingomyelin metabolic process | 8 | 18 | 5.99e-01 |
| GO:BP | GO:1903755 | positive regulation of SUMO transferase activity | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0021602 | cranial nerve morphogenesis | 2 | 16 | 5.99e-01 |
| GO:BP | GO:0051651 | maintenance of location in cell | 4 | 170 | 5.99e-01 |
| GO:BP | GO:0021686 | cerebellar granular layer maturation | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0021933 | radial glia guided migration of cerebellar granule cell | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0072684 | mitochondrial tRNA 3’-trailer cleavage, endonucleolytic | 1 | 1 | 5.99e-01 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 4 | 12 | 5.99e-01 |
| GO:BP | GO:0043207 | response to external biotic stimulus | 3 | 820 | 5.99e-01 |
| GO:BP | GO:0010815 | bradykinin catabolic process | 4 | 6 | 5.99e-01 |
| GO:BP | GO:0050864 | regulation of B cell activation | 1 | 77 | 5.99e-01 |
| GO:BP | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process | 1 | 2 | 5.99e-01 |
| GO:BP | GO:1904893 | negative regulation of receptor signaling pathway via STAT | 7 | 21 | 5.99e-01 |
| GO:BP | GO:0080021 | response to benzoic acid | 1 | 1 | 6.00e-01 |
| GO:BP | GO:0014842 | regulation of skeletal muscle satellite cell proliferation | 2 | 8 | 6.00e-01 |
| GO:BP | GO:1904116 | response to vasopressin | 2 | 5 | 6.00e-01 |
| GO:BP | GO:0061031 | endodermal digestive tract morphogenesis | 1 | 1 | 6.00e-01 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 5 | 461 | 6.00e-01 |
| GO:BP | GO:0046477 | glycosylceramide catabolic process | 2 | 5 | 6.00e-01 |
| GO:BP | GO:1904117 | cellular response to vasopressin | 2 | 5 | 6.00e-01 |
| GO:BP | GO:1902214 | regulation of interleukin-4-mediated signaling pathway | 2 | 2 | 6.00e-01 |
| GO:BP | GO:0007624 | ultradian rhythm | 1 | 2 | 6.00e-01 |
| GO:BP | GO:1901381 | positive regulation of potassium ion transmembrane transport | 2 | 30 | 6.00e-01 |
| GO:BP | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway | 4 | 7 | 6.00e-01 |
| GO:BP | GO:0051205 | protein insertion into membrane | 1 | 62 | 6.00e-01 |
| GO:BP | GO:0010762 | regulation of fibroblast migration | 3 | 37 | 6.00e-01 |
| GO:BP | GO:0051882 | mitochondrial depolarization | 5 | 17 | 6.00e-01 |
| GO:BP | GO:0038003 | G protein-coupled opioid receptor signaling pathway | 1 | 5 | 6.00e-01 |
| GO:BP | GO:0090237 | regulation of arachidonic acid secretion | 1 | 2 | 6.00e-01 |
| GO:BP | GO:0046469 | platelet activating factor metabolic process | 1 | 5 | 6.00e-01 |
| GO:BP | GO:0050951 | sensory perception of temperature stimulus | 1 | 13 | 6.00e-01 |
| GO:BP | GO:0045948 | positive regulation of translational initiation | 2 | 23 | 6.00e-01 |
| GO:BP | GO:0030961 | peptidyl-arginine hydroxylation | 1 | 1 | 6.00e-01 |
| GO:BP | GO:0097350 | neutrophil clearance | 3 | 5 | 6.00e-01 |
| GO:BP | GO:2000182 | regulation of progesterone biosynthetic process | 1 | 3 | 6.00e-01 |
| GO:BP | GO:0003091 | renal water homeostasis | 3 | 13 | 6.00e-01 |
| GO:BP | GO:0006420 | arginyl-tRNA aminoacylation | 2 | 3 | 6.00e-01 |
| GO:BP | GO:0042761 | very long-chain fatty acid biosynthetic process | 5 | 12 | 6.00e-01 |
| GO:BP | GO:0034394 | protein localization to cell surface | 3 | 61 | 6.00e-01 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 8 | 560 | 6.00e-01 |
| GO:BP | GO:0035711 | T-helper 1 cell activation | 2 | 2 | 6.00e-01 |
| GO:BP | GO:0009188 | ribonucleoside diphosphate biosynthetic process | 1 | 8 | 6.00e-01 |
| GO:BP | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 1 | 6 | 6.00e-01 |
| GO:BP | GO:0061966 | establishment of left/right asymmetry | 1 | 3 | 6.00e-01 |
| GO:BP | GO:1905941 | positive regulation of gonad development | 1 | 4 | 6.00e-01 |
| GO:BP | GO:1990134 | epithelial cell apoptotic process involved in palatal shelf morphogenesis | 1 | 1 | 6.00e-01 |
| GO:BP | GO:1903577 | cellular response to L-arginine | 1 | 3 | 6.00e-01 |
| GO:BP | GO:0007506 | gonadal mesoderm development | 1 | 2 | 6.00e-01 |
| GO:BP | GO:0098758 | response to interleukin-8 | 1 | 1 | 6.00e-01 |
| GO:BP | GO:0060160 | negative regulation of dopamine receptor signaling pathway | 1 | 3 | 6.00e-01 |
| GO:BP | GO:0043931 | ossification involved in bone maturation | 1 | 17 | 6.00e-01 |
| GO:BP | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 1 | 2 | 6.00e-01 |
| GO:BP | GO:0090494 | dopamine uptake | 1 | 10 | 6.00e-01 |
| GO:BP | GO:0098759 | cellular response to interleukin-8 | 1 | 1 | 6.00e-01 |
| GO:BP | GO:0009258 | 10-formyltetrahydrofolate catabolic process | 1 | 3 | 6.00e-01 |
| GO:BP | GO:0008637 | apoptotic mitochondrial changes | 16 | 90 | 6.00e-01 |
| GO:BP | GO:0046083 | adenine metabolic process | 1 | 3 | 6.00e-01 |
| GO:BP | GO:1990504 | dense core granule exocytosis | 2 | 7 | 6.00e-01 |
| GO:BP | GO:0032978 | protein insertion into membrane from inner side | 2 | 4 | 6.00e-01 |
| GO:BP | GO:0043030 | regulation of macrophage activation | 1 | 31 | 6.00e-01 |
| GO:BP | GO:0032979 | protein insertion into mitochondrial inner membrane from matrix | 2 | 4 | 6.00e-01 |
| GO:BP | GO:0033151 | V(D)J recombination | 6 | 16 | 6.01e-01 |
| GO:BP | GO:0006506 | GPI anchor biosynthetic process | 5 | 30 | 6.01e-01 |
| GO:BP | GO:0032074 | negative regulation of nuclease activity | 2 | 6 | 6.01e-01 |
| GO:BP | GO:0003150 | muscular septum morphogenesis | 1 | 4 | 6.01e-01 |
| GO:BP | GO:0060486 | club cell differentiation | 2 | 3 | 6.01e-01 |
| GO:BP | GO:0051410 | detoxification of nitrogen compound | 2 | 5 | 6.01e-01 |
| GO:BP | GO:0032736 | positive regulation of interleukin-13 production | 1 | 7 | 6.01e-01 |
| GO:BP | GO:1901741 | positive regulation of myoblast fusion | 1 | 9 | 6.01e-01 |
| GO:BP | GO:0070458 | cellular detoxification of nitrogen compound | 2 | 5 | 6.01e-01 |
| GO:BP | GO:0006066 | alcohol metabolic process | 13 | 265 | 6.01e-01 |
| GO:BP | GO:0070236 | negative regulation of activation-induced cell death of T cells | 2 | 3 | 6.01e-01 |
| GO:BP | GO:1903944 | negative regulation of hepatocyte apoptotic process | 3 | 6 | 6.01e-01 |
| GO:BP | GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 2 | 34 | 6.01e-01 |
| GO:BP | GO:0007601 | visual perception | 2 | 96 | 6.01e-01 |
| GO:BP | GO:0031987 | locomotion involved in locomotory behavior | 5 | 9 | 6.01e-01 |
| GO:BP | GO:0051220 | cytoplasmic sequestering of protein | 3 | 23 | 6.02e-01 |
| GO:BP | GO:0009744 | response to sucrose | 2 | 4 | 6.02e-01 |
| GO:BP | GO:0034285 | response to disaccharide | 2 | 4 | 6.02e-01 |
| GO:BP | GO:0002946 | tRNA C5-cytosine methylation | 2 | 3 | 6.02e-01 |
| GO:BP | GO:0055001 | muscle cell development | 33 | 165 | 6.02e-01 |
| GO:BP | GO:2000510 | positive regulation of dendritic cell chemotaxis | 1 | 3 | 6.02e-01 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 2 | 598 | 6.02e-01 |
| GO:BP | GO:0003186 | tricuspid valve morphogenesis | 3 | 5 | 6.02e-01 |
| GO:BP | GO:0032802 | low-density lipoprotein particle receptor catabolic process | 2 | 5 | 6.02e-01 |
| GO:BP | GO:0018106 | peptidyl-histidine phosphorylation | 1 | 1 | 6.02e-01 |
| GO:BP | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 3 | 18 | 6.02e-01 |
| GO:BP | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 2 | 5 | 6.02e-01 |
| GO:BP | GO:0007097 | nuclear migration | 3 | 23 | 6.02e-01 |
| GO:BP | GO:0032799 | low-density lipoprotein receptor particle metabolic process | 2 | 5 | 6.02e-01 |
| GO:BP | GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 8 | 157 | 6.02e-01 |
| GO:BP | GO:0071711 | basement membrane organization | 2 | 33 | 6.02e-01 |
| GO:BP | GO:1904829 | regulation of aortic smooth muscle cell differentiation | 1 | 2 | 6.02e-01 |
| GO:BP | GO:1904831 | positive regulation of aortic smooth muscle cell differentiation | 1 | 2 | 6.02e-01 |
| GO:BP | GO:0035887 | aortic smooth muscle cell differentiation | 1 | 2 | 6.02e-01 |
| GO:BP | GO:0034982 | mitochondrial protein processing | 4 | 12 | 6.02e-01 |
| GO:BP | GO:0035022 | positive regulation of Rac protein signal transduction | 4 | 5 | 6.02e-01 |
| GO:BP | GO:0010739 | positive regulation of protein kinase A signaling | 1 | 6 | 6.02e-01 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 2 | 31 | 6.02e-01 |
| GO:BP | GO:0007518 | myoblast fate determination | 1 | 1 | 6.02e-01 |
| GO:BP | GO:0003171 | atrioventricular valve development | 13 | 27 | 6.02e-01 |
| GO:BP | GO:0097484 | dendrite extension | 11 | 27 | 6.03e-01 |
| GO:BP | GO:0046184 | aldehyde biosynthetic process | 1 | 14 | 6.03e-01 |
| GO:BP | GO:0044242 | cellular lipid catabolic process | 1 | 170 | 6.03e-01 |
| GO:BP | GO:0019318 | hexose metabolic process | 1 | 185 | 6.03e-01 |
| GO:BP | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 2 | 7 | 6.03e-01 |
| GO:BP | GO:0045472 | response to ether | 1 | 7 | 6.03e-01 |
| GO:BP | GO:0070158 | mitochondrial seryl-tRNA aminoacylation | 1 | 1 | 6.03e-01 |
| GO:BP | GO:0007019 | microtubule depolymerization | 17 | 43 | 6.03e-01 |
| GO:BP | GO:0070460 | thyroid-stimulating hormone secretion | 1 | 2 | 6.03e-01 |
| GO:BP | GO:1904891 | positive regulation of excitatory synapse assembly | 1 | 2 | 6.03e-01 |
| GO:BP | GO:0015828 | tyrosine transport | 1 | 3 | 6.03e-01 |
| GO:BP | GO:0045806 | negative regulation of endocytosis | 1 | 56 | 6.03e-01 |
| GO:BP | GO:0061323 | cell proliferation involved in heart morphogenesis | 6 | 18 | 6.03e-01 |
| GO:BP | GO:0008272 | sulfate transport | 3 | 12 | 6.03e-01 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 2 | 957 | 6.03e-01 |
| GO:BP | GO:0002339 | B cell selection | 2 | 4 | 6.03e-01 |
| GO:BP | GO:0046709 | IDP catabolic process | 1 | 1 | 6.03e-01 |
| GO:BP | GO:0019343 | cysteine biosynthetic process via cystathionine | 1 | 2 | 6.03e-01 |
| GO:BP | GO:0018206 | peptidyl-methionine modification | 4 | 13 | 6.03e-01 |
| GO:BP | GO:0046707 | IDP metabolic process | 1 | 1 | 6.03e-01 |
| GO:BP | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 1 | 1 | 6.03e-01 |
| GO:BP | GO:0032988 | ribonucleoprotein complex disassembly | 4 | 8 | 6.03e-01 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 1 | 132 | 6.04e-01 |
| GO:BP | GO:1904616 | regulation of actin binding | 1 | 3 | 6.04e-01 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 45 | 249 | 6.04e-01 |
| GO:BP | GO:0043649 | dicarboxylic acid catabolic process | 1 | 14 | 6.04e-01 |
| GO:BP | GO:0001545 | primary ovarian follicle growth | 1 | 1 | 6.04e-01 |
| GO:BP | GO:0016031 | tRNA import into mitochondrion | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 4 | 40 | 6.05e-01 |
| GO:BP | GO:0071242 | cellular response to ammonium ion | 1 | 4 | 6.05e-01 |
| GO:BP | GO:0070777 | D-aspartate transport | 1 | 4 | 6.05e-01 |
| GO:BP | GO:0070779 | D-aspartate import across plasma membrane | 1 | 4 | 6.05e-01 |
| GO:BP | GO:0033152 | immunoglobulin V(D)J recombination | 5 | 8 | 6.05e-01 |
| GO:BP | GO:0032639 | TRAIL production | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0001813 | regulation of antibody-dependent cellular cytotoxicity | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0035945 | mitochondrial ncRNA surveillance | 1 | 1 | 6.05e-01 |
| GO:BP | GO:1903457 | lactate catabolic process | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0035946 | mitochondrial mRNA surveillance | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0034699 | response to luteinizing hormone | 1 | 7 | 6.05e-01 |
| GO:BP | GO:0032753 | positive regulation of interleukin-4 production | 2 | 8 | 6.05e-01 |
| GO:BP | GO:2000827 | mitochondrial RNA surveillance | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0046320 | regulation of fatty acid oxidation | 20 | 31 | 6.05e-01 |
| GO:BP | GO:0062014 | negative regulation of small molecule metabolic process | 5 | 71 | 6.05e-01 |
| GO:BP | GO:0099044 | vesicle tethering to endoplasmic reticulum | 1 | 2 | 6.05e-01 |
| GO:BP | GO:0042352 | GDP-L-fucose salvage | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0032730 | positive regulation of interleukin-1 alpha production | 1 | 3 | 6.05e-01 |
| GO:BP | GO:0032679 | regulation of TRAIL production | 1 | 1 | 6.05e-01 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 19 | 67 | 6.05e-01 |
| GO:BP | GO:0002537 | nitric oxide production involved in inflammatory response | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0016094 | polyprenol biosynthetic process | 1 | 3 | 6.05e-01 |
| GO:BP | GO:0061082 | myeloid leukocyte cytokine production | 3 | 38 | 6.05e-01 |
| GO:BP | GO:0050869 | negative regulation of B cell activation | 8 | 19 | 6.05e-01 |
| GO:BP | GO:0031268 | pseudopodium organization | 9 | 14 | 6.05e-01 |
| GO:BP | GO:0043095 | regulation of GTP cyclohydrolase I activity | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5 | 155 | 6.05e-01 |
| GO:BP | GO:0043105 | negative regulation of GTP cyclohydrolase I activity | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0071026 | cytoplasmic RNA surveillance | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0032759 | positive regulation of TRAIL production | 1 | 1 | 6.05e-01 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 4 | 348 | 6.05e-01 |
| GO:BP | GO:0034696 | response to prostaglandin F | 1 | 2 | 6.05e-01 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 13 | 31 | 6.05e-01 |
| GO:BP | GO:0031958 | corticosteroid receptor signaling pathway | 2 | 14 | 6.05e-01 |
| GO:BP | GO:0014003 | oligodendrocyte development | 3 | 27 | 6.05e-01 |
| GO:BP | GO:0003348 | cardiac endothelial cell differentiation | 2 | 4 | 6.05e-01 |
| GO:BP | GO:0061183 | regulation of dermatome development | 1 | 2 | 6.05e-01 |
| GO:BP | GO:0016476 | regulation of embryonic cell shape | 2 | 3 | 6.05e-01 |
| GO:BP | GO:0006848 | pyruvate transport | 1 | 5 | 6.05e-01 |
| GO:BP | GO:0072716 | response to actinomycin D | 1 | 5 | 6.05e-01 |
| GO:BP | GO:1904667 | negative regulation of ubiquitin protein ligase activity | 2 | 11 | 6.05e-01 |
| GO:BP | GO:0002548 | monocyte chemotaxis | 1 | 22 | 6.05e-01 |
| GO:BP | GO:2000193 | positive regulation of fatty acid transport | 2 | 11 | 6.05e-01 |
| GO:BP | GO:0021943 | formation of radial glial scaffolds | 1 | 3 | 6.05e-01 |
| GO:BP | GO:0046604 | positive regulation of mitotic centrosome separation | 1 | 3 | 6.05e-01 |
| GO:BP | GO:0060956 | endocardial cell differentiation | 2 | 4 | 6.05e-01 |
| GO:BP | GO:1901475 | pyruvate transmembrane transport | 1 | 5 | 6.05e-01 |
| GO:BP | GO:0045589 | regulation of regulatory T cell differentiation | 10 | 21 | 6.05e-01 |
| GO:BP | GO:0061054 | dermatome development | 1 | 2 | 6.05e-01 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 6 | 462 | 6.05e-01 |
| GO:BP | GO:0072143 | mesangial cell development | 2 | 5 | 6.05e-01 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 1 | 36 | 6.05e-01 |
| GO:BP | GO:0072008 | glomerular mesangial cell differentiation | 2 | 4 | 6.05e-01 |
| GO:BP | GO:0014807 | regulation of somitogenesis | 2 | 3 | 6.05e-01 |
| GO:BP | GO:1903801 | L-leucine import across plasma membrane | 3 | 5 | 6.06e-01 |
| GO:BP | GO:0098713 | leucine import across plasma membrane | 3 | 5 | 6.06e-01 |
| GO:BP | GO:1990961 | xenobiotic detoxification by transmembrane export across the plasma membrane | 4 | 7 | 6.06e-01 |
| GO:BP | GO:0098787 | mRNA cleavage involved in mRNA processing | 1 | 13 | 6.06e-01 |
| GO:BP | GO:1905521 | regulation of macrophage migration | 2 | 24 | 6.06e-01 |
| GO:BP | GO:0033604 | negative regulation of catecholamine secretion | 3 | 6 | 6.06e-01 |
| GO:BP | GO:1904055 | negative regulation of cholangiocyte proliferation | 1 | 1 | 6.06e-01 |
| GO:BP | GO:0018335 | protein succinylation | 2 | 4 | 6.07e-01 |
| GO:BP | GO:0106077 | histone succinylation | 2 | 4 | 6.07e-01 |
| GO:BP | GO:0010728 | regulation of hydrogen peroxide biosynthetic process | 1 | 5 | 6.07e-01 |
| GO:BP | GO:0009299 | mRNA transcription | 10 | 50 | 6.07e-01 |
| GO:BP | GO:1903636 | regulation of protein insertion into mitochondrial outer membrane | 1 | 1 | 6.07e-01 |
| GO:BP | GO:1903638 | positive regulation of protein insertion into mitochondrial outer membrane | 1 | 1 | 6.07e-01 |
| GO:BP | GO:0002296 | T-helper 1 cell lineage commitment | 1 | 3 | 6.07e-01 |
| GO:BP | GO:0032682 | negative regulation of chemokine production | 5 | 12 | 6.07e-01 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 5 | 28 | 6.07e-01 |
| GO:BP | GO:0008045 | motor neuron axon guidance | 2 | 25 | 6.07e-01 |
| GO:BP | GO:0090030 | regulation of steroid hormone biosynthetic process | 4 | 15 | 6.07e-01 |
| GO:BP | GO:0006463 | steroid hormone receptor complex assembly | 1 | 1 | 6.07e-01 |
| GO:BP | GO:0034230 | enkephalin processing | 1 | 1 | 6.07e-01 |
| GO:BP | GO:0051496 | positive regulation of stress fiber assembly | 14 | 47 | 6.07e-01 |
| GO:BP | GO:0022412 | cellular process involved in reproduction in multicellular organism | 1 | 252 | 6.07e-01 |
| GO:BP | GO:0009607 | response to biotic stimulus | 3 | 850 | 6.07e-01 |
| GO:BP | GO:0001788 | antibody-dependent cellular cytotoxicity | 2 | 2 | 6.07e-01 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 9 | 29 | 6.07e-01 |
| GO:BP | GO:0035542 | regulation of SNARE complex assembly | 7 | 13 | 6.07e-01 |
| GO:BP | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 2 | 5 | 6.08e-01 |
| GO:BP | GO:0061698 | protein deglutarylation | 1 | 2 | 6.08e-01 |
| GO:BP | GO:0036048 | protein desuccinylation | 1 | 2 | 6.08e-01 |
| GO:BP | GO:0036049 | peptidyl-lysine desuccinylation | 1 | 2 | 6.08e-01 |
| GO:BP | GO:0034122 | negative regulation of toll-like receptor signaling pathway | 1 | 13 | 6.08e-01 |
| GO:BP | GO:0014854 | response to inactivity | 1 | 11 | 6.08e-01 |
| GO:BP | GO:0007005 | mitochondrion organization | 13 | 500 | 6.08e-01 |
| GO:BP | GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 1 | 8 | 6.08e-01 |
| GO:BP | GO:0042481 | regulation of odontogenesis | 1 | 10 | 6.08e-01 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 14 | 35 | 6.08e-01 |
| GO:BP | GO:0002532 | production of molecular mediator involved in inflammatory response | 2 | 49 | 6.08e-01 |
| GO:BP | GO:0051702 | biological process involved in interaction with symbiont | 3 | 78 | 6.08e-01 |
| GO:BP | GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 11 | 37 | 6.08e-01 |
| GO:BP | GO:0033700 | phospholipid efflux | 1 | 9 | 6.08e-01 |
| GO:BP | GO:0048680 | positive regulation of axon regeneration | 1 | 8 | 6.08e-01 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 2 | 993 | 6.08e-01 |
| GO:BP | GO:2000345 | regulation of hepatocyte proliferation | 2 | 13 | 6.08e-01 |
| GO:BP | GO:0070986 | left/right axis specification | 1 | 13 | 6.08e-01 |
| GO:BP | GO:0015959 | diadenosine polyphosphate metabolic process | 5 | 8 | 6.08e-01 |
| GO:BP | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 3 | 9 | 6.08e-01 |
| GO:BP | GO:0099093 | calcium export from the mitochondrion | 1 | 2 | 6.08e-01 |
| GO:BP | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway | 7 | 9 | 6.08e-01 |
| GO:BP | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis | 1 | 2 | 6.08e-01 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 2 | 994 | 6.08e-01 |
| GO:BP | GO:0031392 | regulation of prostaglandin biosynthetic process | 3 | 6 | 6.08e-01 |
| GO:BP | GO:1902510 | regulation of apoptotic DNA fragmentation | 2 | 8 | 6.08e-01 |
| GO:BP | GO:0015803 | branched-chain amino acid transport | 1 | 14 | 6.08e-01 |
| GO:BP | GO:0042219 | cellular modified amino acid catabolic process | 7 | 16 | 6.08e-01 |
| GO:BP | GO:1904872 | regulation of telomerase RNA localization to Cajal body | 5 | 18 | 6.09e-01 |
| GO:BP | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 2 | 3 | 6.09e-01 |
| GO:BP | GO:0051147 | regulation of muscle cell differentiation | 1 | 118 | 6.09e-01 |
| GO:BP | GO:0031645 | negative regulation of nervous system process | 3 | 9 | 6.09e-01 |
| GO:BP | GO:0032344 | regulation of aldosterone metabolic process | 2 | 8 | 6.09e-01 |
| GO:BP | GO:0042976 | activation of Janus kinase activity | 1 | 7 | 6.09e-01 |
| GO:BP | GO:0032347 | regulation of aldosterone biosynthetic process | 2 | 8 | 6.09e-01 |
| GO:BP | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering | 1 | 4 | 6.09e-01 |
| GO:BP | GO:0006508 | proteolysis | 2 | 1318 | 6.09e-01 |
| GO:BP | GO:0032808 | lacrimal gland development | 4 | 5 | 6.09e-01 |
| GO:BP | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity | 1 | 3 | 6.10e-01 |
| GO:BP | GO:0090493 | catecholamine uptake | 1 | 11 | 6.10e-01 |
| GO:BP | GO:2001044 | regulation of integrin-mediated signaling pathway | 2 | 20 | 6.10e-01 |
| GO:BP | GO:0051580 | regulation of neurotransmitter uptake | 1 | 15 | 6.10e-01 |
| GO:BP | GO:0071680 | response to indole-3-methanol | 4 | 6 | 6.10e-01 |
| GO:BP | GO:2000758 | positive regulation of peptidyl-lysine acetylation | 1 | 31 | 6.10e-01 |
| GO:BP | GO:0042759 | long-chain fatty acid biosynthetic process | 1 | 14 | 6.10e-01 |
| GO:BP | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 4 | 7 | 6.10e-01 |
| GO:BP | GO:0043973 | histone H3-K4 acetylation | 1 | 1 | 6.10e-01 |
| GO:BP | GO:2001212 | regulation of vasculogenesis | 1 | 13 | 6.10e-01 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 3 | 97 | 6.10e-01 |
| GO:BP | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death | 4 | 5 | 6.10e-01 |
| GO:BP | GO:0070926 | regulation of ATP:ADP antiporter activity | 1 | 1 | 6.10e-01 |
| GO:BP | GO:0006626 | protein targeting to mitochondrion | 53 | 100 | 6.10e-01 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 2 | 517 | 6.10e-01 |
| GO:BP | GO:0140053 | mitochondrial gene expression | 36 | 162 | 6.10e-01 |
| GO:BP | GO:0048525 | negative regulation of viral process | 1 | 64 | 6.10e-01 |
| GO:BP | GO:0033182 | regulation of histone ubiquitination | 4 | 6 | 6.10e-01 |
| GO:BP | GO:0010529 | negative regulation of transposition | 1 | 14 | 6.10e-01 |
| GO:BP | GO:0010528 | regulation of transposition | 1 | 14 | 6.10e-01 |
| GO:BP | GO:0032072 | regulation of restriction endodeoxyribonuclease activity | 1 | 1 | 6.10e-01 |
| GO:BP | GO:0006335 | DNA replication-dependent chromatin assembly | 2 | 6 | 6.10e-01 |
| GO:BP | GO:1903442 | response to lipoic acid | 1 | 1 | 6.10e-01 |
| GO:BP | GO:2000074 | regulation of type B pancreatic cell development | 3 | 8 | 6.10e-01 |
| GO:BP | GO:0036255 | response to methylamine | 1 | 1 | 6.10e-01 |
| GO:BP | GO:0060534 | trachea cartilage development | 4 | 4 | 6.10e-01 |
| GO:BP | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 17 | 40 | 6.10e-01 |
| GO:BP | GO:0000350 | generation of catalytic spliceosome for second transesterification step | 1 | 2 | 6.10e-01 |
| GO:BP | GO:0030643 | intracellular phosphate ion homeostasis | 3 | 5 | 6.10e-01 |
| GO:BP | GO:0043500 | muscle adaptation | 19 | 90 | 6.10e-01 |
| GO:BP | GO:0008206 | bile acid metabolic process | 1 | 34 | 6.10e-01 |
| GO:BP | GO:0061301 | cerebellum vasculature morphogenesis | 1 | 1 | 6.10e-01 |
| GO:BP | GO:0003415 | chondrocyte hypertrophy | 4 | 6 | 6.11e-01 |
| GO:BP | GO:0006769 | nicotinamide metabolic process | 1 | 1 | 6.11e-01 |
| GO:BP | GO:1901509 | regulation of endothelial tube morphogenesis | 3 | 3 | 6.11e-01 |
| GO:BP | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding | 1 | 1 | 6.11e-01 |
| GO:BP | GO:0033036 | macromolecule localization | 2 | 2450 | 6.11e-01 |
| GO:BP | GO:0018197 | peptidyl-aspartic acid modification | 3 | 5 | 6.11e-01 |
| GO:BP | GO:1900114 | positive regulation of histone H3-K9 trimethylation | 1 | 2 | 6.11e-01 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 14 | 276 | 6.12e-01 |
| GO:BP | GO:0072177 | mesonephric duct development | 2 | 7 | 6.12e-01 |
| GO:BP | GO:1905870 | positive regulation of 3’-UTR-mediated mRNA stabilization | 1 | 4 | 6.12e-01 |
| GO:BP | GO:0051155 | positive regulation of striated muscle cell differentiation | 2 | 31 | 6.12e-01 |
| GO:BP | GO:0035922 | foramen ovale closure | 1 | 1 | 6.12e-01 |
| GO:BP | GO:0061550 | cranial ganglion development | 3 | 4 | 6.12e-01 |
| GO:BP | GO:0000959 | mitochondrial RNA metabolic process | 25 | 50 | 6.12e-01 |
| GO:BP | GO:0099542 | trans-synaptic signaling by endocannabinoid | 2 | 6 | 6.12e-01 |
| GO:BP | GO:0099541 | trans-synaptic signaling by lipid | 2 | 6 | 6.12e-01 |
| GO:BP | GO:0036306 | embryonic heart tube elongation | 1 | 1 | 6.12e-01 |
| GO:BP | GO:0140706 | protein-containing complex localization to centriolar satellite | 1 | 1 | 6.12e-01 |
| GO:BP | GO:0060577 | pulmonary vein morphogenesis | 1 | 1 | 6.12e-01 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 31 | 95 | 6.12e-01 |
| GO:BP | GO:0046365 | monosaccharide catabolic process | 3 | 38 | 6.12e-01 |
| GO:BP | GO:0002051 | osteoblast fate commitment | 2 | 2 | 6.13e-01 |
| GO:BP | GO:1902358 | sulfate transmembrane transport | 2 | 11 | 6.13e-01 |
| GO:BP | GO:0097577 | sequestering of iron ion | 1 | 3 | 6.13e-01 |
| GO:BP | GO:1990792 | cellular response to glial cell derived neurotrophic factor | 1 | 1 | 6.13e-01 |
| GO:BP | GO:0009224 | CMP biosynthetic process | 1 | 3 | 6.13e-01 |
| GO:BP | GO:0045747 | positive regulation of Notch signaling pathway | 24 | 37 | 6.13e-01 |
| GO:BP | GO:1990790 | response to glial cell derived neurotrophic factor | 1 | 1 | 6.13e-01 |
| GO:BP | GO:0051260 | protein homooligomerization | 11 | 136 | 6.13e-01 |
| GO:BP | GO:0032197 | retrotransposition | 3 | 4 | 6.13e-01 |
| GO:BP | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1 | 13 | 6.13e-01 |
| GO:BP | GO:0051960 | regulation of nervous system development | 1 | 357 | 6.13e-01 |
| GO:BP | GO:0060135 | maternal process involved in female pregnancy | 7 | 41 | 6.13e-01 |
| GO:BP | GO:1904447 | folate import across plasma membrane | 1 | 4 | 6.13e-01 |
| GO:BP | GO:0060755 | negative regulation of mast cell chemotaxis | 1 | 1 | 6.13e-01 |
| GO:BP | GO:1905755 | protein localization to cytoplasmic microtubule | 1 | 2 | 6.14e-01 |
| GO:BP | GO:1902889 | protein localization to spindle microtubule | 1 | 2 | 6.14e-01 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 1 | 252 | 6.14e-01 |
| GO:BP | GO:1903897 | regulation of PERK-mediated unfolded protein response | 1 | 10 | 6.14e-01 |
| GO:BP | GO:1904015 | cellular response to serotonin | 1 | 1 | 6.14e-01 |
| GO:BP | GO:1904014 | response to serotonin | 1 | 1 | 6.14e-01 |
| GO:BP | GO:0010757 | negative regulation of plasminogen activation | 5 | 7 | 6.14e-01 |
| GO:BP | GO:0048511 | rhythmic process | 9 | 237 | 6.14e-01 |
| GO:BP | GO:0042538 | hyperosmotic salinity response | 4 | 8 | 6.14e-01 |
| GO:BP | GO:0030316 | osteoclast differentiation | 4 | 66 | 6.14e-01 |
| GO:BP | GO:0097370 | protein O-GlcNAcylation via threonine | 1 | 1 | 6.14e-01 |
| GO:BP | GO:0045920 | negative regulation of exocytosis | 1 | 26 | 6.14e-01 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 5 | 230 | 6.15e-01 |
| GO:BP | GO:0006893 | Golgi to plasma membrane transport | 32 | 60 | 6.15e-01 |
| GO:BP | GO:0050821 | protein stabilization | 4 | 191 | 6.15e-01 |
| GO:BP | GO:0060696 | regulation of phospholipid catabolic process | 3 | 5 | 6.15e-01 |
| GO:BP | GO:0035780 | CD80 biosynthetic process | 1 | 1 | 6.15e-01 |
| GO:BP | GO:0016203 | muscle attachment | 1 | 1 | 6.15e-01 |
| GO:BP | GO:2001302 | lipoxin A4 metabolic process | 1 | 2 | 6.15e-01 |
| GO:BP | GO:0036035 | osteoclast development | 1 | 10 | 6.15e-01 |
| GO:BP | GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 3 | 7 | 6.15e-01 |
| GO:BP | GO:0046471 | phosphatidylglycerol metabolic process | 3 | 23 | 6.15e-01 |
| GO:BP | GO:0017182 | peptidyl-diphthamide metabolic process | 3 | 7 | 6.15e-01 |
| GO:BP | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1 | 2 | 6.15e-01 |
| GO:BP | GO:0060024 | rhythmic synaptic transmission | 2 | 3 | 6.15e-01 |
| GO:BP | GO:0120179 | adherens junction disassembly | 1 | 1 | 6.15e-01 |
| GO:BP | GO:0007292 | female gamete generation | 25 | 103 | 6.15e-01 |
| GO:BP | GO:0090386 | phagosome maturation involved in apoptotic cell clearance | 1 | 2 | 6.15e-01 |
| GO:BP | GO:0090387 | phagolysosome assembly involved in apoptotic cell clearance | 1 | 2 | 6.15e-01 |
| GO:BP | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion | 2 | 3 | 6.15e-01 |
| GO:BP | GO:0033993 | response to lipid | 1 | 592 | 6.15e-01 |
| GO:BP | GO:0034308 | primary alcohol metabolic process | 5 | 61 | 6.15e-01 |
| GO:BP | GO:0060046 | regulation of acrosome reaction | 1 | 8 | 6.15e-01 |
| GO:BP | GO:0015712 | hexose phosphate transport | 1 | 3 | 6.16e-01 |
| GO:BP | GO:0015760 | glucose-6-phosphate transport | 1 | 3 | 6.16e-01 |
| GO:BP | GO:0031114 | regulation of microtubule depolymerization | 12 | 31 | 6.16e-01 |
| GO:BP | GO:0008406 | gonad development | 2 | 158 | 6.16e-01 |
| GO:BP | GO:0060092 | regulation of synaptic transmission, glycinergic | 1 | 1 | 6.16e-01 |
| GO:BP | GO:0140719 | constitutive heterochromatin formation | 5 | 10 | 6.16e-01 |
| GO:BP | GO:0061087 | positive regulation of histone H3-K27 methylation | 1 | 4 | 6.16e-01 |
| GO:BP | GO:0070537 | histone H2A K63-linked deubiquitination | 2 | 8 | 6.16e-01 |
| GO:BP | GO:0006468 | protein phosphorylation | 4 | 1167 | 6.16e-01 |
| GO:BP | GO:0032098 | regulation of appetite | 1 | 8 | 6.16e-01 |
| GO:BP | GO:1904376 | negative regulation of protein localization to cell periphery | 7 | 23 | 6.16e-01 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 5 | 63 | 6.16e-01 |
| GO:BP | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2 | 3 | 6.16e-01 |
| GO:BP | GO:0060720 | spongiotrophoblast cell proliferation | 1 | 2 | 6.16e-01 |
| GO:BP | GO:0060722 | cell proliferation involved in embryonic placenta development | 1 | 2 | 6.16e-01 |
| GO:BP | GO:0050927 | positive regulation of positive chemotaxis | 2 | 20 | 6.16e-01 |
| GO:BP | GO:0031648 | protein destabilization | 2 | 45 | 6.16e-01 |
| GO:BP | GO:0051394 | regulation of nerve growth factor receptor activity | 1 | 1 | 6.16e-01 |
| GO:BP | GO:1905532 | regulation of leucine import across plasma membrane | 1 | 3 | 6.16e-01 |
| GO:BP | GO:0035067 | negative regulation of histone acetylation | 6 | 9 | 6.16e-01 |
| GO:BP | GO:0090214 | spongiotrophoblast layer developmental growth | 1 | 2 | 6.16e-01 |
| GO:BP | GO:0006579 | amino-acid betaine catabolic process | 1 | 1 | 6.16e-01 |
| GO:BP | GO:1900826 | negative regulation of membrane depolarization during cardiac muscle cell action potential | 1 | 1 | 6.16e-01 |
| GO:BP | GO:0060299 | negative regulation of sarcomere organization | 1 | 1 | 6.16e-01 |
| GO:BP | GO:1903547 | regulation of growth hormone activity | 1 | 2 | 6.16e-01 |
| GO:BP | GO:0008306 | associative learning | 3 | 65 | 6.16e-01 |
| GO:BP | GO:0038009 | regulation of signal transduction by receptor internalization | 1 | 1 | 6.16e-01 |
| GO:BP | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter | 6 | 12 | 6.16e-01 |
| GO:BP | GO:0071043 | CUT metabolic process | 1 | 5 | 6.16e-01 |
| GO:BP | GO:0071034 | CUT catabolic process | 1 | 5 | 6.16e-01 |
| GO:BP | GO:0042593 | glucose homeostasis | 1 | 168 | 6.17e-01 |
| GO:BP | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 3 | 78 | 6.17e-01 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 3 | 26 | 6.17e-01 |
| GO:BP | GO:0001702 | gastrulation with mouth forming second | 4 | 21 | 6.17e-01 |
| GO:BP | GO:0006505 | GPI anchor metabolic process | 5 | 31 | 6.17e-01 |
| GO:BP | GO:0042246 | tissue regeneration | 9 | 54 | 6.17e-01 |
| GO:BP | GO:0032409 | regulation of transporter activity | 5 | 211 | 6.17e-01 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 3 | 1914 | 6.17e-01 |
| GO:BP | GO:0051385 | response to mineralocorticoid | 5 | 25 | 6.17e-01 |
| GO:BP | GO:0030225 | macrophage differentiation | 2 | 35 | 6.17e-01 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 1 | 35 | 6.17e-01 |
| GO:BP | GO:1904692 | positive regulation of type B pancreatic cell proliferation | 1 | 2 | 6.17e-01 |
| GO:BP | GO:0042918 | alkanesulfonate transport | 2 | 6 | 6.17e-01 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 2 | 1869 | 6.17e-01 |
| GO:BP | GO:0015734 | taurine transport | 2 | 6 | 6.17e-01 |
| GO:BP | GO:0002318 | myeloid progenitor cell differentiation | 3 | 7 | 6.17e-01 |
| GO:BP | GO:0033500 | carbohydrate homeostasis | 1 | 169 | 6.17e-01 |
| GO:BP | GO:1903859 | regulation of dendrite extension | 8 | 17 | 6.17e-01 |
| GO:BP | GO:0019464 | glycine decarboxylation via glycine cleavage system | 3 | 3 | 6.17e-01 |
| GO:BP | GO:0030205 | dermatan sulfate metabolic process | 2 | 9 | 6.17e-01 |
| GO:BP | GO:0052779 | amino disaccharide metabolic process | 2 | 9 | 6.17e-01 |
| GO:BP | GO:0006690 | icosanoid metabolic process | 3 | 60 | 6.18e-01 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 4 | 1248 | 6.18e-01 |
| GO:BP | GO:0060197 | cloacal septation | 1 | 2 | 6.18e-01 |
| GO:BP | GO:0051938 | L-glutamate import | 1 | 25 | 6.18e-01 |
| GO:BP | GO:0070445 | regulation of oligodendrocyte progenitor proliferation | 1 | 5 | 6.18e-01 |
| GO:BP | GO:0070444 | oligodendrocyte progenitor proliferation | 1 | 5 | 6.18e-01 |
| GO:BP | GO:0035995 | detection of muscle stretch | 1 | 7 | 6.18e-01 |
| GO:BP | GO:0033567 | DNA replication, Okazaki fragment processing | 1 | 2 | 6.18e-01 |
| GO:BP | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 1 | 20 | 6.18e-01 |
| GO:BP | GO:0031272 | regulation of pseudopodium assembly | 7 | 11 | 6.18e-01 |
| GO:BP | GO:0031274 | positive regulation of pseudopodium assembly | 7 | 11 | 6.18e-01 |
| GO:BP | GO:0045655 | regulation of monocyte differentiation | 1 | 13 | 6.18e-01 |
| GO:BP | GO:1903751 | negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide | 1 | 3 | 6.18e-01 |
| GO:BP | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide | 1 | 3 | 6.18e-01 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 3 | 2646 | 6.18e-01 |
| GO:BP | GO:0051458 | corticotropin secretion | 2 | 4 | 6.18e-01 |
| GO:BP | GO:1903367 | positive regulation of fear response | 2 | 4 | 6.18e-01 |
| GO:BP | GO:0060389 | pathway-restricted SMAD protein phosphorylation | 6 | 55 | 6.18e-01 |
| GO:BP | GO:0072660 | maintenance of protein location in plasma membrane | 1 | 2 | 6.18e-01 |
| GO:BP | GO:0090156 | intracellular sphingolipid homeostasis | 1 | 5 | 6.18e-01 |
| GO:BP | GO:0072658 | maintenance of protein location in membrane | 1 | 2 | 6.18e-01 |
| GO:BP | GO:0061091 | regulation of phospholipid translocation | 1 | 5 | 6.18e-01 |
| GO:BP | GO:0006678 | glucosylceramide metabolic process | 1 | 5 | 6.18e-01 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 5 | 130 | 6.18e-01 |
| GO:BP | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 | 2 | 6.18e-01 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 2 | 109 | 6.18e-01 |
| GO:BP | GO:0000709 | meiotic joint molecule formation | 1 | 1 | 6.19e-01 |
| GO:BP | GO:0046777 | protein autophosphorylation | 23 | 188 | 6.19e-01 |
| GO:BP | GO:0030162 | regulation of proteolysis | 1 | 535 | 6.19e-01 |
| GO:BP | GO:0060252 | positive regulation of glial cell proliferation | 5 | 14 | 6.19e-01 |
| GO:BP | GO:0072079 | nephron tubule formation | 1 | 12 | 6.19e-01 |
| GO:BP | GO:1901698 | response to nitrogen compound | 3 | 830 | 6.19e-01 |
| GO:BP | GO:0036261 | 7-methylguanosine cap hypermethylation | 5 | 8 | 6.19e-01 |
| GO:BP | GO:0006563 | L-serine metabolic process | 7 | 10 | 6.19e-01 |
| GO:BP | GO:0000708 | meiotic strand invasion | 1 | 1 | 6.19e-01 |
| GO:BP | GO:0010774 | meiotic strand invasion involved in reciprocal meiotic recombination | 1 | 1 | 6.19e-01 |
| GO:BP | GO:0008203 | cholesterol metabolic process | 2 | 101 | 6.19e-01 |
| GO:BP | GO:0039530 | MDA-5 signaling pathway | 1 | 8 | 6.19e-01 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 1 | 640 | 6.19e-01 |
| GO:BP | GO:0071320 | cellular response to cAMP | 6 | 41 | 6.19e-01 |
| GO:BP | GO:0030540 | female genitalia development | 3 | 14 | 6.19e-01 |
| GO:BP | GO:0021516 | dorsal spinal cord development | 1 | 7 | 6.19e-01 |
| GO:BP | GO:1903352 | L-ornithine transmembrane transport | 1 | 4 | 6.19e-01 |
| GO:BP | GO:1904923 | regulation of autophagy of mitochondrion in response to mitochondrial depolarization | 8 | 15 | 6.19e-01 |
| GO:BP | GO:0045338 | farnesyl diphosphate metabolic process | 2 | 5 | 6.19e-01 |
| GO:BP | GO:1902859 | propionyl-CoA catabolic process | 1 | 2 | 6.19e-01 |
| GO:BP | GO:0071140 | resolution of mitotic recombination intermediates | 1 | 2 | 6.19e-01 |
| GO:BP | GO:0019389 | glucuronoside metabolic process | 1 | 2 | 6.19e-01 |
| GO:BP | GO:0019391 | glucuronoside catabolic process | 1 | 2 | 6.19e-01 |
| GO:BP | GO:1904557 | L-alanine transmembrane transport | 3 | 4 | 6.19e-01 |
| GO:BP | GO:0070977 | bone maturation | 1 | 19 | 6.19e-01 |
| GO:BP | GO:1903849 | positive regulation of aorta morphogenesis | 1 | 2 | 6.19e-01 |
| GO:BP | GO:0003252 | negative regulation of cell proliferation involved in heart valve morphogenesis | 1 | 2 | 6.19e-01 |
| GO:BP | GO:0021944 | neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration | 1 | 1 | 6.19e-01 |
| GO:BP | GO:1903847 | regulation of aorta morphogenesis | 1 | 2 | 6.19e-01 |
| GO:BP | GO:1901072 | glucosamine-containing compound catabolic process | 4 | 5 | 6.19e-01 |
| GO:BP | GO:0045337 | farnesyl diphosphate biosynthetic process | 1 | 3 | 6.19e-01 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 51 | 1137 | 6.19e-01 |
| GO:BP | GO:0030593 | neutrophil chemotaxis | 2 | 39 | 6.19e-01 |
| GO:BP | GO:0051450 | myoblast proliferation | 1 | 17 | 6.20e-01 |
| GO:BP | GO:0071528 | tRNA re-export from nucleus | 1 | 1 | 6.20e-01 |
| GO:BP | GO:0030201 | heparan sulfate proteoglycan metabolic process | 2 | 11 | 6.21e-01 |
| GO:BP | GO:1902731 | negative regulation of chondrocyte proliferation | 1 | 3 | 6.21e-01 |
| GO:BP | GO:0002069 | columnar/cuboidal epithelial cell maturation | 5 | 9 | 6.21e-01 |
| GO:BP | GO:0030185 | nitric oxide transport | 1 | 2 | 6.21e-01 |
| GO:BP | GO:0030521 | androgen receptor signaling pathway | 12 | 39 | 6.22e-01 |
| GO:BP | GO:0035563 | positive regulation of chromatin binding | 3 | 12 | 6.22e-01 |
| GO:BP | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 5 | 13 | 6.22e-01 |
| GO:BP | GO:0010919 | regulation of inositol phosphate biosynthetic process | 1 | 6 | 6.22e-01 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 1 | 198 | 6.22e-01 |
| GO:BP | GO:0072675 | osteoclast fusion | 1 | 5 | 6.22e-01 |
| GO:BP | GO:1904355 | positive regulation of telomere capping | 2 | 14 | 6.22e-01 |
| GO:BP | GO:0007521 | muscle cell fate determination | 1 | 2 | 6.22e-01 |
| GO:BP | GO:0045835 | negative regulation of meiotic nuclear division | 2 | 5 | 6.22e-01 |
| GO:BP | GO:0046007 | negative regulation of activated T cell proliferation | 2 | 8 | 6.22e-01 |
| GO:BP | GO:0035910 | ascending aorta morphogenesis | 1 | 4 | 6.22e-01 |
| GO:BP | GO:1903306 | negative regulation of regulated secretory pathway | 6 | 14 | 6.22e-01 |
| GO:BP | GO:1905691 | lipid droplet disassembly | 4 | 7 | 6.22e-01 |
| GO:BP | GO:1901016 | regulation of potassium ion transmembrane transporter activity | 3 | 45 | 6.22e-01 |
| GO:BP | GO:2000725 | regulation of cardiac muscle cell differentiation | 1 | 14 | 6.22e-01 |
| GO:BP | GO:0016320 | endoplasmic reticulum membrane fusion | 1 | 2 | 6.22e-01 |
| GO:BP | GO:0009794 | regulation of mitotic cell cycle, embryonic | 1 | 4 | 6.22e-01 |
| GO:BP | GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 1 | 12 | 6.22e-01 |
| GO:BP | GO:0030041 | actin filament polymerization | 6 | 134 | 6.22e-01 |
| GO:BP | GO:0071557 | histone H3-K27 demethylation | 1 | 2 | 6.22e-01 |
| GO:BP | GO:0045448 | mitotic cell cycle, embryonic | 1 | 4 | 6.22e-01 |
| GO:BP | GO:0021557 | oculomotor nerve development | 1 | 2 | 6.22e-01 |
| GO:BP | GO:0045137 | development of primary sexual characteristics | 2 | 161 | 6.22e-01 |
| GO:BP | GO:0046326 | positive regulation of glucose import | 1 | 26 | 6.22e-01 |
| GO:BP | GO:2000644 | regulation of receptor catabolic process | 3 | 9 | 6.22e-01 |
| GO:BP | GO:0006107 | oxaloacetate metabolic process | 5 | 7 | 6.22e-01 |
| GO:BP | GO:0007041 | lysosomal transport | 9 | 115 | 6.22e-01 |
| GO:BP | GO:1905578 | regulation of ERBB3 signaling pathway | 1 | 1 | 6.22e-01 |
| GO:BP | GO:0036296 | response to increased oxygen levels | 6 | 25 | 6.22e-01 |
| GO:BP | GO:1905580 | positive regulation of ERBB3 signaling pathway | 1 | 1 | 6.22e-01 |
| GO:BP | GO:1900112 | regulation of histone H3-K9 trimethylation | 2 | 5 | 6.22e-01 |
| GO:BP | GO:0051573 | negative regulation of histone H3-K9 methylation | 2 | 5 | 6.22e-01 |
| GO:BP | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell | 1 | 16 | 6.23e-01 |
| GO:BP | GO:0090370 | negative regulation of cholesterol efflux | 1 | 3 | 6.23e-01 |
| GO:BP | GO:0035795 | negative regulation of mitochondrial membrane permeability | 5 | 17 | 6.23e-01 |
| GO:BP | GO:0002432 | granuloma formation | 1 | 1 | 6.23e-01 |
| GO:BP | GO:0060382 | regulation of DNA strand elongation | 3 | 16 | 6.24e-01 |
| GO:BP | GO:0009988 | cell-cell recognition | 1 | 32 | 6.24e-01 |
| GO:BP | GO:0009093 | cysteine catabolic process | 2 | 3 | 6.24e-01 |
| GO:BP | GO:0046439 | L-cysteine metabolic process | 2 | 3 | 6.24e-01 |
| GO:BP | GO:0045631 | regulation of mechanoreceptor differentiation | 6 | 8 | 6.24e-01 |
| GO:BP | GO:0045927 | positive regulation of growth | 7 | 199 | 6.24e-01 |
| GO:BP | GO:0045607 | regulation of inner ear auditory receptor cell differentiation | 6 | 8 | 6.24e-01 |
| GO:BP | GO:0061088 | regulation of sequestering of zinc ion | 2 | 4 | 6.24e-01 |
| GO:BP | GO:2000980 | regulation of inner ear receptor cell differentiation | 6 | 8 | 6.24e-01 |
| GO:BP | GO:0032927 | positive regulation of activin receptor signaling pathway | 1 | 7 | 6.24e-01 |
| GO:BP | GO:1990786 | cellular response to dsDNA | 1 | 2 | 6.24e-01 |
| GO:BP | GO:0021536 | diencephalon development | 1 | 41 | 6.24e-01 |
| GO:BP | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 2 | 12 | 6.24e-01 |
| GO:BP | GO:1902808 | positive regulation of cell cycle G1/S phase transition | 8 | 52 | 6.24e-01 |
| GO:BP | GO:1990784 | response to dsDNA | 1 | 2 | 6.24e-01 |
| GO:BP | GO:0019448 | L-cysteine catabolic process | 2 | 3 | 6.24e-01 |
| GO:BP | GO:0046794 | transport of virus | 9 | 19 | 6.24e-01 |
| GO:BP | GO:0009750 | response to fructose | 1 | 3 | 6.24e-01 |
| GO:BP | GO:0097332 | response to antipsychotic drug | 1 | 2 | 6.24e-01 |
| GO:BP | GO:0061101 | neuroendocrine cell differentiation | 3 | 9 | 6.24e-01 |
| GO:BP | GO:2000489 | regulation of hepatic stellate cell activation | 4 | 6 | 6.24e-01 |
| GO:BP | GO:0006702 | androgen biosynthetic process | 2 | 4 | 6.24e-01 |
| GO:BP | GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 1 | 40 | 6.24e-01 |
| GO:BP | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 3 | 9 | 6.24e-01 |
| GO:BP | GO:0043966 | histone H3 acetylation | 7 | 59 | 6.24e-01 |
| GO:BP | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 3 | 86 | 6.24e-01 |
| GO:BP | GO:0001657 | ureteric bud development | 3 | 75 | 6.24e-01 |
| GO:BP | GO:0060993 | kidney morphogenesis | 3 | 73 | 6.24e-01 |
| GO:BP | GO:0045069 | regulation of viral genome replication | 1 | 64 | 6.24e-01 |
| GO:BP | GO:0015742 | alpha-ketoglutarate transport | 1 | 3 | 6.25e-01 |
| GO:BP | GO:0005996 | monosaccharide metabolic process | 1 | 209 | 6.25e-01 |
| GO:BP | GO:0001770 | establishment of natural killer cell polarity | 1 | 1 | 6.26e-01 |
| GO:BP | GO:0140354 | lipid import into cell | 1 | 15 | 6.26e-01 |
| GO:BP | GO:1901160 | primary amino compound metabolic process | 1 | 8 | 6.26e-01 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 2 | 1014 | 6.26e-01 |
| GO:BP | GO:0010955 | negative regulation of protein processing | 6 | 19 | 6.26e-01 |
| GO:BP | GO:1905476 | negative regulation of protein localization to membrane | 7 | 29 | 6.26e-01 |
| GO:BP | GO:0030808 | regulation of nucleotide biosynthetic process | 6 | 25 | 6.26e-01 |
| GO:BP | GO:0034756 | regulation of iron ion transport | 1 | 4 | 6.26e-01 |
| GO:BP | GO:0019060 | intracellular transport of viral protein in host cell | 1 | 2 | 6.26e-01 |
| GO:BP | GO:0097720 | calcineurin-mediated signaling | 12 | 38 | 6.26e-01 |
| GO:BP | GO:0009950 | dorsal/ventral axis specification | 2 | 9 | 6.26e-01 |
| GO:BP | GO:1903318 | negative regulation of protein maturation | 6 | 19 | 6.26e-01 |
| GO:BP | GO:1905857 | positive regulation of pentose-phosphate shunt | 2 | 3 | 6.26e-01 |
| GO:BP | GO:0035787 | cell migration involved in kidney development | 1 | 5 | 6.26e-01 |
| GO:BP | GO:1900371 | regulation of purine nucleotide biosynthetic process | 6 | 25 | 6.26e-01 |
| GO:BP | GO:0046643 | regulation of gamma-delta T cell activation | 2 | 6 | 6.26e-01 |
| GO:BP | GO:0030581 | symbiont intracellular protein transport in host | 1 | 2 | 6.26e-01 |
| GO:BP | GO:0030488 | tRNA methylation | 19 | 42 | 6.26e-01 |
| GO:BP | GO:0015810 | aspartate transmembrane transport | 3 | 16 | 6.26e-01 |
| GO:BP | GO:0046533 | negative regulation of photoreceptor cell differentiation | 2 | 3 | 6.26e-01 |
| GO:BP | GO:0045819 | positive regulation of glycogen catabolic process | 1 | 1 | 6.26e-01 |
| GO:BP | GO:0072174 | metanephric tubule formation | 2 | 3 | 6.26e-01 |
| GO:BP | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway | 2 | 3 | 6.26e-01 |
| GO:BP | GO:1901642 | nucleoside transmembrane transport | 1 | 6 | 6.26e-01 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 1 | 126 | 6.26e-01 |
| GO:BP | GO:2000492 | regulation of interleukin-18-mediated signaling pathway | 1 | 1 | 6.26e-01 |
| GO:BP | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 2 | 3 | 6.26e-01 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 1 | 67 | 6.26e-01 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 8 | 233 | 6.26e-01 |
| GO:BP | GO:0001828 | inner cell mass cellular morphogenesis | 1 | 2 | 6.26e-01 |
| GO:BP | GO:0060020 | Bergmann glial cell differentiation | 4 | 9 | 6.26e-01 |
| GO:BP | GO:0001827 | inner cell mass cell fate commitment | 1 | 2 | 6.26e-01 |
| GO:BP | GO:0072382 | minus-end-directed vesicle transport along microtubule | 1 | 1 | 6.27e-01 |
| GO:BP | GO:1901678 | iron coordination entity transport | 4 | 11 | 6.27e-01 |
| GO:BP | GO:1905089 | regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | 1 | 2 | 6.27e-01 |
| GO:BP | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation | 1 | 6 | 6.27e-01 |
| GO:BP | GO:0070230 | positive regulation of lymphocyte apoptotic process | 1 | 10 | 6.27e-01 |
| GO:BP | GO:0015938 | coenzyme A catabolic process | 2 | 3 | 6.28e-01 |
| GO:BP | GO:0044580 | butyryl-CoA catabolic process | 2 | 3 | 6.28e-01 |
| GO:BP | GO:0046889 | positive regulation of lipid biosynthetic process | 1 | 63 | 6.28e-01 |
| GO:BP | GO:0060385 | axonogenesis involved in innervation | 1 | 7 | 6.28e-01 |
| GO:BP | GO:0043462 | regulation of ATP-dependent activity | 2 | 63 | 6.28e-01 |
| GO:BP | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 1 | 36 | 6.28e-01 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 5 | 32 | 6.28e-01 |
| GO:BP | GO:0016042 | lipid catabolic process | 5 | 225 | 6.28e-01 |
| GO:BP | GO:1901492 | positive regulation of lymphangiogenesis | 1 | 2 | 6.28e-01 |
| GO:BP | GO:0071674 | mononuclear cell migration | 9 | 102 | 6.28e-01 |
| GO:BP | GO:0002052 | positive regulation of neuroblast proliferation | 7 | 19 | 6.28e-01 |
| GO:BP | GO:0061034 | olfactory bulb mitral cell layer development | 1 | 2 | 6.28e-01 |
| GO:BP | GO:0031118 | rRNA pseudouridine synthesis | 3 | 10 | 6.28e-01 |
| GO:BP | GO:1904851 | positive regulation of establishment of protein localization to telomere | 3 | 10 | 6.28e-01 |
| GO:BP | GO:0001662 | behavioral fear response | 1 | 29 | 6.28e-01 |
| GO:BP | GO:0006106 | fumarate metabolic process | 2 | 3 | 6.28e-01 |
| GO:BP | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response | 1 | 1 | 6.28e-01 |
| GO:BP | GO:0021934 | hindbrain tangential cell migration | 3 | 3 | 6.28e-01 |
| GO:BP | GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 2 | 5 | 6.28e-01 |
| GO:BP | GO:0010033 | response to organic substance | 2 | 1957 | 6.28e-01 |
| GO:BP | GO:0050926 | regulation of positive chemotaxis | 2 | 20 | 6.28e-01 |
| GO:BP | GO:0006532 | aspartate biosynthetic process | 2 | 2 | 6.28e-01 |
| GO:BP | GO:0032570 | response to progesterone | 1 | 27 | 6.28e-01 |
| GO:BP | GO:0140060 | axon arborization | 1 | 1 | 6.28e-01 |
| GO:BP | GO:0070572 | positive regulation of neuron projection regeneration | 1 | 8 | 6.28e-01 |
| GO:BP | GO:0032908 | regulation of transforming growth factor beta1 production | 7 | 10 | 6.28e-01 |
| GO:BP | GO:0006412 | translation | 2 | 646 | 6.29e-01 |
| GO:BP | GO:0033623 | regulation of integrin activation | 4 | 11 | 6.29e-01 |
| GO:BP | GO:0072164 | mesonephric tubule development | 3 | 76 | 6.29e-01 |
| GO:BP | GO:1901423 | response to benzene | 1 | 1 | 6.29e-01 |
| GO:BP | GO:1904710 | positive regulation of granulosa cell apoptotic process | 1 | 1 | 6.29e-01 |
| GO:BP | GO:0046687 | response to chromate | 1 | 1 | 6.29e-01 |
| GO:BP | GO:1901655 | cellular response to ketone | 2 | 86 | 6.29e-01 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 3 | 76 | 6.29e-01 |
| GO:BP | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | 1 | 1 | 6.29e-01 |
| GO:BP | GO:0031117 | positive regulation of microtubule depolymerization | 2 | 4 | 6.29e-01 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 2 | 86 | 6.29e-01 |
| GO:BP | GO:0071247 | cellular response to chromate | 1 | 1 | 6.29e-01 |
| GO:BP | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1 | 53 | 6.29e-01 |
| GO:BP | GO:0060931 | sinoatrial node cell development | 2 | 4 | 6.29e-01 |
| GO:BP | GO:1905396 | cellular response to flavonoid | 1 | 1 | 6.29e-01 |
| GO:BP | GO:0033385 | geranylgeranyl diphosphate metabolic process | 1 | 2 | 6.29e-01 |
| GO:BP | GO:0048668 | collateral sprouting | 3 | 25 | 6.29e-01 |
| GO:BP | GO:1904045 | cellular response to aldosterone | 1 | 5 | 6.29e-01 |
| GO:BP | GO:0061025 | membrane fusion | 4 | 137 | 6.29e-01 |
| GO:BP | GO:0044703 | multi-organism reproductive process | 6 | 131 | 6.29e-01 |
| GO:BP | GO:0050727 | regulation of inflammatory response | 11 | 212 | 6.29e-01 |
| GO:BP | GO:0031348 | negative regulation of defense response | 1 | 159 | 6.29e-01 |
| GO:BP | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 12 | 203 | 6.29e-01 |
| GO:BP | GO:0002939 | tRNA N1-guanine methylation | 2 | 3 | 6.29e-01 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 1 | 129 | 6.29e-01 |
| GO:BP | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 6 | 12 | 6.29e-01 |
| GO:BP | GO:1901837 | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I | 1 | 4 | 6.29e-01 |
| GO:BP | GO:1990264 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 2 | 4 | 6.29e-01 |
| GO:BP | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 1 | 2 | 6.29e-01 |
| GO:BP | GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 1 | 1 | 6.29e-01 |
| GO:BP | GO:0035227 | regulation of glutamate-cysteine ligase activity | 1 | 1 | 6.29e-01 |
| GO:BP | GO:0035282 | segmentation | 7 | 75 | 6.29e-01 |
| GO:BP | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 1 | 2 | 6.29e-01 |
| GO:BP | GO:0098937 | anterograde dendritic transport | 1 | 9 | 6.29e-01 |
| GO:BP | GO:0016081 | synaptic vesicle docking | 2 | 9 | 6.30e-01 |
| GO:BP | GO:0032606 | type I interferon production | 1 | 76 | 6.30e-01 |
| GO:BP | GO:0046513 | ceramide biosynthetic process | 1 | 53 | 6.30e-01 |
| GO:BP | GO:0031282 | regulation of guanylate cyclase activity | 2 | 3 | 6.30e-01 |
| GO:BP | GO:0032479 | regulation of type I interferon production | 1 | 76 | 6.30e-01 |
| GO:BP | GO:0140888 | interferon-mediated signaling pathway | 1 | 67 | 6.30e-01 |
| GO:BP | GO:1903426 | regulation of reactive oxygen species biosynthetic process | 4 | 29 | 6.30e-01 |
| GO:BP | GO:0000055 | ribosomal large subunit export from nucleus | 3 | 8 | 6.30e-01 |
| GO:BP | GO:1904180 | negative regulation of membrane depolarization | 2 | 6 | 6.30e-01 |
| GO:BP | GO:0035337 | fatty-acyl-CoA metabolic process | 9 | 31 | 6.30e-01 |
| GO:BP | GO:0046458 | hexadecanal metabolic process | 1 | 1 | 6.30e-01 |
| GO:BP | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 1 | 1 | 6.30e-01 |
| GO:BP | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway | 1 | 1 | 6.30e-01 |
| GO:BP | GO:0050832 | defense response to fungus | 1 | 14 | 6.30e-01 |
| GO:BP | GO:0051570 | regulation of histone H3-K9 methylation | 4 | 11 | 6.30e-01 |
| GO:BP | GO:0042474 | middle ear morphogenesis | 2 | 13 | 6.30e-01 |
| GO:BP | GO:0010769 | regulation of cell morphogenesis involved in differentiation | 11 | 37 | 6.30e-01 |
| GO:BP | GO:0018993 | somatic sex determination | 1 | 1 | 6.31e-01 |
| GO:BP | GO:0045720 | negative regulation of integrin biosynthetic process | 1 | 1 | 6.31e-01 |
| GO:BP | GO:2000654 | regulation of cellular response to testosterone stimulus | 1 | 2 | 6.31e-01 |
| GO:BP | GO:0042595 | behavioral response to starvation | 1 | 1 | 6.31e-01 |
| GO:BP | GO:0048016 | inositol phosphate-mediated signaling | 14 | 45 | 6.31e-01 |
| GO:BP | GO:0051339 | regulation of lyase activity | 6 | 39 | 6.31e-01 |
| GO:BP | GO:0000958 | mitochondrial mRNA catabolic process | 2 | 3 | 6.32e-01 |
| GO:BP | GO:0009250 | glucan biosynthetic process | 18 | 39 | 6.32e-01 |
| GO:BP | GO:0015916 | fatty-acyl-CoA transport | 1 | 2 | 6.32e-01 |
| GO:BP | GO:0005978 | glycogen biosynthetic process | 18 | 39 | 6.32e-01 |
| GO:BP | GO:1901337 | thioester transport | 1 | 2 | 6.32e-01 |
| GO:BP | GO:1903059 | regulation of protein lipidation | 1 | 11 | 6.32e-01 |
| GO:BP | GO:0021615 | glossopharyngeal nerve morphogenesis | 2 | 2 | 6.32e-01 |
| GO:BP | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway | 9 | 31 | 6.32e-01 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 1 | 144 | 6.32e-01 |
| GO:BP | GO:0048199 | vesicle targeting, to, from or within Golgi | 1 | 31 | 6.33e-01 |
| GO:BP | GO:0008217 | regulation of blood pressure | 12 | 115 | 6.33e-01 |
| GO:BP | GO:0003177 | pulmonary valve development | 9 | 22 | 6.33e-01 |
| GO:BP | GO:0002209 | behavioral defense response | 1 | 30 | 6.33e-01 |
| GO:BP | GO:0006986 | response to unfolded protein | 3 | 128 | 6.33e-01 |
| GO:BP | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 3 | 5 | 6.33e-01 |
| GO:BP | GO:1900143 | positive regulation of oligodendrocyte apoptotic process | 1 | 1 | 6.33e-01 |
| GO:BP | GO:0055078 | sodium ion homeostasis | 4 | 26 | 6.33e-01 |
| GO:BP | GO:0060042 | retina morphogenesis in camera-type eye | 9 | 40 | 6.33e-01 |
| GO:BP | GO:0018992 | germ-line sex determination | 1 | 2 | 6.33e-01 |
| GO:BP | GO:0014036 | neural crest cell fate specification | 1 | 1 | 6.33e-01 |
| GO:BP | GO:0007542 | primary sex determination, germ-line | 1 | 2 | 6.33e-01 |
| GO:BP | GO:0006959 | humoral immune response | 2 | 80 | 6.33e-01 |
| GO:BP | GO:0060516 | primary prostatic bud elongation | 1 | 1 | 6.33e-01 |
| GO:BP | GO:0019100 | male germ-line sex determination | 1 | 2 | 6.33e-01 |
| GO:BP | GO:1902930 | regulation of alcohol biosynthetic process | 2 | 33 | 6.33e-01 |
| GO:BP | GO:0042636 | negative regulation of hair cycle | 1 | 1 | 6.33e-01 |
| GO:BP | GO:0080120 | CAAX-box protein maturation | 1 | 3 | 6.33e-01 |
| GO:BP | GO:1904864 | negative regulation of beta-catenin-TCF complex assembly | 1 | 2 | 6.33e-01 |
| GO:BP | GO:1904863 | regulation of beta-catenin-TCF complex assembly | 1 | 2 | 6.33e-01 |
| GO:BP | GO:0033273 | response to vitamin | 1 | 61 | 6.33e-01 |
| GO:BP | GO:0044341 | sodium-dependent phosphate transport | 1 | 4 | 6.33e-01 |
| GO:BP | GO:0035622 | intrahepatic bile duct development | 1 | 2 | 6.33e-01 |
| GO:BP | GO:0002735 | positive regulation of myeloid dendritic cell cytokine production | 1 | 6 | 6.33e-01 |
| GO:BP | GO:0015693 | magnesium ion transport | 9 | 17 | 6.33e-01 |
| GO:BP | GO:0002372 | myeloid dendritic cell cytokine production | 1 | 6 | 6.33e-01 |
| GO:BP | GO:0002733 | regulation of myeloid dendritic cell cytokine production | 1 | 6 | 6.33e-01 |
| GO:BP | GO:0009133 | nucleoside diphosphate biosynthetic process | 7 | 11 | 6.33e-01 |
| GO:BP | GO:0007212 | dopamine receptor signaling pathway | 6 | 27 | 6.33e-01 |
| GO:BP | GO:0035279 | miRNA-mediated gene silencing by mRNA destabilization | 1 | 3 | 6.34e-01 |
| GO:BP | GO:0017156 | calcium-ion regulated exocytosis | 17 | 46 | 6.34e-01 |
| GO:BP | GO:1905302 | negative regulation of macropinocytosis | 1 | 1 | 6.34e-01 |
| GO:BP | GO:1904050 | positive regulation of spontaneous neurotransmitter secretion | 1 | 1 | 6.34e-01 |
| GO:BP | GO:0010526 | retrotransposon silencing | 1 | 3 | 6.34e-01 |
| GO:BP | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 1 | 1 | 6.34e-01 |
| GO:BP | GO:1902216 | positive regulation of interleukin-4-mediated signaling pathway | 1 | 1 | 6.34e-01 |
| GO:BP | GO:1901380 | negative regulation of potassium ion transmembrane transport | 2 | 18 | 6.34e-01 |
| GO:BP | GO:0090394 | negative regulation of excitatory postsynaptic potential | 3 | 8 | 6.34e-01 |
| GO:BP | GO:0048284 | organelle fusion | 3 | 135 | 6.34e-01 |
| GO:BP | GO:1990074 | polyuridylation-dependent mRNA catabolic process | 2 | 3 | 6.34e-01 |
| GO:BP | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1 | 3 | 6.34e-01 |
| GO:BP | GO:0045603 | positive regulation of endothelial cell differentiation | 3 | 8 | 6.34e-01 |
| GO:BP | GO:1902809 | regulation of skeletal muscle fiber differentiation | 1 | 4 | 6.34e-01 |
| GO:BP | GO:0034653 | retinoic acid catabolic process | 1 | 1 | 6.34e-01 |
| GO:BP | GO:0016103 | diterpenoid catabolic process | 1 | 1 | 6.34e-01 |
| GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 25 | 91 | 6.34e-01 |
| GO:BP | GO:0070536 | protein K63-linked deubiquitination | 9 | 33 | 6.34e-01 |
| GO:BP | GO:0035350 | FAD transmembrane transport | 1 | 2 | 6.35e-01 |
| GO:BP | GO:0015880 | coenzyme A transport | 1 | 2 | 6.35e-01 |
| GO:BP | GO:0015883 | FAD transport | 1 | 2 | 6.35e-01 |
| GO:BP | GO:0080121 | AMP transport | 1 | 2 | 6.35e-01 |
| GO:BP | GO:0071106 | adenosine 3’,5’-bisphosphate transmembrane transport | 1 | 2 | 6.35e-01 |
| GO:BP | GO:0035349 | coenzyme A transmembrane transport | 1 | 2 | 6.35e-01 |
| GO:BP | GO:0043388 | positive regulation of DNA binding | 7 | 44 | 6.35e-01 |
| GO:BP | GO:0035873 | lactate transmembrane transport | 1 | 5 | 6.35e-01 |
| GO:BP | GO:0015727 | lactate transport | 1 | 5 | 6.35e-01 |
| GO:BP | GO:0090140 | regulation of mitochondrial fission | 4 | 28 | 6.35e-01 |
| GO:BP | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 7 | 12 | 6.35e-01 |
| GO:BP | GO:0051447 | negative regulation of meiotic cell cycle | 2 | 9 | 6.36e-01 |
| GO:BP | GO:0060148 | positive regulation of post-transcriptional gene silencing | 9 | 16 | 6.36e-01 |
| GO:BP | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion | 3 | 12 | 6.36e-01 |
| GO:BP | GO:0018202 | peptidyl-histidine modification | 6 | 11 | 6.36e-01 |
| GO:BP | GO:0045064 | T-helper 2 cell differentiation | 1 | 10 | 6.36e-01 |
| GO:BP | GO:0032488 | Cdc42 protein signal transduction | 1 | 10 | 6.36e-01 |
| GO:BP | GO:0018364 | peptidyl-glutamine methylation | 1 | 4 | 6.36e-01 |
| GO:BP | GO:0060155 | platelet dense granule organization | 11 | 23 | 6.36e-01 |
| GO:BP | GO:0008015 | blood circulation | 31 | 374 | 6.36e-01 |
| GO:BP | GO:0097376 | interneuron axon guidance | 1 | 1 | 6.36e-01 |
| GO:BP | GO:0090116 | C-5 methylation of cytosine | 1 | 3 | 6.36e-01 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 3 | 1995 | 6.36e-01 |
| GO:BP | GO:0002830 | positive regulation of type 2 immune response | 1 | 7 | 6.36e-01 |
| GO:BP | GO:1900370 | positive regulation of post-transcriptional gene silencing by RNA | 9 | 16 | 6.36e-01 |
| GO:BP | GO:0072278 | metanephric comma-shaped body morphogenesis | 1 | 3 | 6.36e-01 |
| GO:BP | GO:0036364 | transforming growth factor beta1 activation | 1 | 1 | 6.36e-01 |
| GO:BP | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 2 | 5 | 6.36e-01 |
| GO:BP | GO:2000645 | negative regulation of receptor catabolic process | 1 | 3 | 6.36e-01 |
| GO:BP | GO:0031347 | regulation of defense response | 10 | 448 | 6.36e-01 |
| GO:BP | GO:0097476 | spinal cord motor neuron migration | 1 | 3 | 6.36e-01 |
| GO:BP | GO:0010814 | substance P catabolic process | 2 | 3 | 6.36e-01 |
| GO:BP | GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 2 | 5 | 6.36e-01 |
| GO:BP | GO:0046475 | glycerophospholipid catabolic process | 4 | 21 | 6.36e-01 |
| GO:BP | GO:0046081 | dUTP catabolic process | 1 | 1 | 6.36e-01 |
| GO:BP | GO:0046080 | dUTP metabolic process | 1 | 1 | 6.36e-01 |
| GO:BP | GO:2000508 | regulation of dendritic cell chemotaxis | 1 | 3 | 6.36e-01 |
| GO:BP | GO:0060896 | neural plate pattern specification | 3 | 8 | 6.36e-01 |
| GO:BP | GO:0032194 | ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate | 1 | 1 | 6.36e-01 |
| GO:BP | GO:0042371 | vitamin K biosynthetic process | 1 | 1 | 6.36e-01 |
| GO:BP | GO:0099152 | regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane | 2 | 3 | 6.36e-01 |
| GO:BP | GO:0009234 | menaquinone biosynthetic process | 1 | 1 | 6.36e-01 |
| GO:BP | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 3 | 6 | 6.36e-01 |
| GO:BP | GO:1903811 | L-asparagine import across plasma membrane | 1 | 1 | 6.37e-01 |
| GO:BP | GO:0098781 | ncRNA transcription | 14 | 61 | 6.37e-01 |
| GO:BP | GO:0055024 | regulation of cardiac muscle tissue development | 1 | 3 | 6.37e-01 |
| GO:BP | GO:0032196 | transposition | 1 | 17 | 6.37e-01 |
| GO:BP | GO:0051891 | positive regulation of cardioblast differentiation | 2 | 4 | 6.37e-01 |
| GO:BP | GO:1903937 | response to acrylamide | 1 | 1 | 6.37e-01 |
| GO:BP | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway | 1 | 4 | 6.37e-01 |
| GO:BP | GO:0006383 | transcription by RNA polymerase III | 5 | 54 | 6.37e-01 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 5 | 126 | 6.37e-01 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 6 | 11 | 6.37e-01 |
| GO:BP | GO:0050851 | antigen receptor-mediated signaling pathway | 1 | 106 | 6.37e-01 |
| GO:BP | GO:0034436 | glycoprotein transport | 2 | 3 | 6.38e-01 |
| GO:BP | GO:0010560 | positive regulation of glycoprotein biosynthetic process | 2 | 15 | 6.38e-01 |
| GO:BP | GO:0070859 | positive regulation of bile acid biosynthetic process | 2 | 3 | 6.38e-01 |
| GO:BP | GO:0016562 | protein import into peroxisome matrix, receptor recycling | 3 | 7 | 6.38e-01 |
| GO:BP | GO:1904253 | positive regulation of bile acid metabolic process | 2 | 3 | 6.38e-01 |
| GO:BP | GO:0048385 | regulation of retinoic acid receptor signaling pathway | 1 | 13 | 6.38e-01 |
| GO:BP | GO:1901223 | negative regulation of NIK/NF-kappaB signaling | 4 | 21 | 6.38e-01 |
| GO:BP | GO:1902215 | negative regulation of interleukin-4-mediated signaling pathway | 1 | 1 | 6.38e-01 |
| GO:BP | GO:1902233 | negative regulation of positive thymic T cell selection | 1 | 1 | 6.38e-01 |
| GO:BP | GO:0097398 | cellular response to interleukin-17 | 4 | 12 | 6.38e-01 |
| GO:BP | GO:1902206 | negative regulation of interleukin-2-mediated signaling pathway | 1 | 1 | 6.38e-01 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 7 | 1006 | 6.38e-01 |
| GO:BP | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling | 9 | 12 | 6.38e-01 |
| GO:BP | GO:0048371 | lateral mesodermal cell differentiation | 2 | 2 | 6.38e-01 |
| GO:BP | GO:0030327 | prenylated protein catabolic process | 1 | 3 | 6.38e-01 |
| GO:BP | GO:0000455 | enzyme-directed rRNA pseudouridine synthesis | 2 | 6 | 6.38e-01 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 1 | 60 | 6.38e-01 |
| GO:BP | GO:0014852 | regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction | 1 | 2 | 6.38e-01 |
| GO:BP | GO:1902205 | regulation of interleukin-2-mediated signaling pathway | 1 | 1 | 6.38e-01 |
| GO:BP | GO:0070076 | histone lysine demethylation | 8 | 20 | 6.38e-01 |
| GO:BP | GO:0006689 | ganglioside catabolic process | 2 | 5 | 6.39e-01 |
| GO:BP | GO:0010272 | response to silver ion | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0097188 | dentin mineralization | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0071105 | response to interleukin-11 | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis | 1 | 3 | 6.39e-01 |
| GO:BP | GO:0016199 | axon midline choice point recognition | 2 | 3 | 6.39e-01 |
| GO:BP | GO:0009098 | leucine biosynthetic process | 1 | 2 | 6.39e-01 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 2 | 88 | 6.39e-01 |
| GO:BP | GO:1901252 | regulation of intracellular transport of viral material | 1 | 2 | 6.39e-01 |
| GO:BP | GO:0072046 | establishment of planar polarity involved in nephron morphogenesis | 1 | 1 | 6.39e-01 |
| GO:BP | GO:1901175 | lycopene metabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:1901176 | lycopene catabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0031000 | response to caffeine | 2 | 13 | 6.39e-01 |
| GO:BP | GO:0060359 | response to ammonium ion | 1 | 5 | 6.39e-01 |
| GO:BP | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 2 | 3 | 6.39e-01 |
| GO:BP | GO:1901388 | regulation of transforming growth factor beta activation | 2 | 8 | 6.39e-01 |
| GO:BP | GO:0044419 | biological process involved in interspecies interaction between organisms | 3 | 963 | 6.39e-01 |
| GO:BP | GO:0062172 | lutein catabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0097068 | response to thyroxine | 3 | 4 | 6.39e-01 |
| GO:BP | GO:0031167 | rRNA methylation | 12 | 24 | 6.39e-01 |
| GO:BP | GO:0035585 | calcium-mediated signaling using extracellular calcium source | 1 | 2 | 6.39e-01 |
| GO:BP | GO:0070564 | positive regulation of vitamin D receptor signaling pathway | 1 | 5 | 6.39e-01 |
| GO:BP | GO:1900453 | negative regulation of long-term synaptic depression | 1 | 3 | 6.39e-01 |
| GO:BP | GO:0071283 | cellular response to iron(III) ion | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0062170 | lutein metabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0016124 | xanthophyll catabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0140009 | L-aspartate import across plasma membrane | 1 | 5 | 6.39e-01 |
| GO:BP | GO:0006282 | regulation of DNA repair | 21 | 198 | 6.39e-01 |
| GO:BP | GO:0016118 | carotenoid catabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0008065 | establishment of blood-nerve barrier | 2 | 3 | 6.39e-01 |
| GO:BP | GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 2 | 5 | 6.39e-01 |
| GO:BP | GO:1901826 | zeaxanthin catabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process | 3 | 16 | 6.39e-01 |
| GO:BP | GO:0016110 | tetraterpenoid catabolic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0042116 | macrophage activation | 2 | 57 | 6.39e-01 |
| GO:BP | GO:1903703 | enterocyte differentiation | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0043525 | positive regulation of neuron apoptotic process | 2 | 41 | 6.39e-01 |
| GO:BP | GO:0045344 | negative regulation of MHC class I biosynthetic process | 1 | 1 | 6.39e-01 |
| GO:BP | GO:0006768 | biotin metabolic process | 2 | 3 | 6.39e-01 |
| GO:BP | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 10 | 32 | 6.39e-01 |
| GO:BP | GO:0007398 | ectoderm development | 3 | 15 | 6.40e-01 |
| GO:BP | GO:0019080 | viral gene expression | 2 | 96 | 6.40e-01 |
| GO:BP | GO:0043043 | peptide biosynthetic process | 2 | 666 | 6.40e-01 |
| GO:BP | GO:0003278 | apoptotic process involved in heart morphogenesis | 1 | 6 | 6.40e-01 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 6 | 4292 | 6.40e-01 |
| GO:BP | GO:0021627 | olfactory nerve morphogenesis | 2 | 3 | 6.40e-01 |
| GO:BP | GO:0051148 | negative regulation of muscle cell differentiation | 28 | 52 | 6.40e-01 |
| GO:BP | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis | 1 | 3 | 6.40e-01 |
| GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 2 | 43 | 6.40e-01 |
| GO:BP | GO:1905381 | negative regulation of snRNA transcription by RNA polymerase II | 1 | 1 | 6.40e-01 |
| GO:BP | GO:1904746 | negative regulation of apoptotic process involved in development | 1 | 3 | 6.40e-01 |
| GO:BP | GO:0071712 | ER-associated misfolded protein catabolic process | 1 | 12 | 6.40e-01 |
| GO:BP | GO:0045830 | positive regulation of isotype switching | 1 | 19 | 6.40e-01 |
| GO:BP | GO:1901303 | negative regulation of cargo loading into COPII-coated vesicle | 1 | 1 | 6.40e-01 |
| GO:BP | GO:0050793 | regulation of developmental process | 3 | 1835 | 6.40e-01 |
| GO:BP | GO:0021502 | neural fold elevation formation | 1 | 3 | 6.40e-01 |
| GO:BP | GO:1902652 | secondary alcohol metabolic process | 2 | 108 | 6.40e-01 |
| GO:BP | GO:1905168 | positive regulation of double-strand break repair via homologous recombination | 5 | 35 | 6.40e-01 |
| GO:BP | GO:1901216 | positive regulation of neuron death | 3 | 70 | 6.40e-01 |
| GO:BP | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation | 1 | 2 | 6.40e-01 |
| GO:BP | GO:0035624 | receptor transactivation | 1 | 3 | 6.41e-01 |
| GO:BP | GO:0032811 | negative regulation of epinephrine secretion | 1 | 2 | 6.41e-01 |
| GO:BP | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process | 1 | 2 | 6.41e-01 |
| GO:BP | GO:0032928 | regulation of superoxide anion generation | 4 | 11 | 6.41e-01 |
| GO:BP | GO:0006691 | leukotriene metabolic process | 1 | 12 | 6.41e-01 |
| GO:BP | GO:0009617 | response to bacterium | 4 | 321 | 6.41e-01 |
| GO:BP | GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 1 | 7 | 6.41e-01 |
| GO:BP | GO:1903576 | response to L-arginine | 1 | 3 | 6.41e-01 |
| GO:BP | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process | 2 | 3 | 6.41e-01 |
| GO:BP | GO:0043248 | proteasome assembly | 1 | 13 | 6.41e-01 |
| GO:BP | GO:1900864 | mitochondrial RNA modification | 5 | 9 | 6.42e-01 |
| GO:BP | GO:0070900 | mitochondrial tRNA modification | 5 | 9 | 6.42e-01 |
| GO:BP | GO:0031018 | endocrine pancreas development | 2 | 32 | 6.42e-01 |
| GO:BP | GO:0140192 | regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process | 1 | 3 | 6.42e-01 |
| GO:BP | GO:0048319 | axial mesoderm morphogenesis | 1 | 3 | 6.42e-01 |
| GO:BP | GO:0140199 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process | 1 | 3 | 6.42e-01 |
| GO:BP | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1 | 16 | 6.42e-01 |
| GO:BP | GO:2000124 | regulation of endocannabinoid signaling pathway | 1 | 3 | 6.42e-01 |
| GO:BP | GO:0051481 | negative regulation of cytosolic calcium ion concentration | 5 | 9 | 6.43e-01 |
| GO:BP | GO:2000779 | regulation of double-strand break repair | 16 | 121 | 6.43e-01 |
| GO:BP | GO:1903010 | regulation of bone development | 1 | 6 | 6.43e-01 |
| GO:BP | GO:0032507 | maintenance of protein location in cell | 2 | 58 | 6.44e-01 |
| GO:BP | GO:0045065 | cytotoxic T cell differentiation | 1 | 2 | 6.44e-01 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 5 | 41 | 6.44e-01 |
| GO:BP | GO:0006356 | regulation of transcription by RNA polymerase I | 8 | 45 | 6.44e-01 |
| GO:BP | GO:0140754 | reorganization of cellular membranes to establish viral sites of replication | 1 | 1 | 6.44e-01 |
| GO:BP | GO:0015808 | L-alanine transport | 6 | 9 | 6.44e-01 |
| GO:BP | GO:0007034 | vacuolar transport | 11 | 149 | 6.44e-01 |
| GO:BP | GO:1904205 | negative regulation of skeletal muscle hypertrophy | 1 | 1 | 6.44e-01 |
| GO:BP | GO:0006409 | tRNA export from nucleus | 2 | 3 | 6.44e-01 |
| GO:BP | GO:0007588 | excretion | 1 | 18 | 6.44e-01 |
| GO:BP | GO:0045725 | positive regulation of glycogen biosynthetic process | 1 | 12 | 6.44e-01 |
| GO:BP | GO:0001823 | mesonephros development | 3 | 77 | 6.44e-01 |
| GO:BP | GO:0034983 | peptidyl-lysine deacetylation | 3 | 8 | 6.45e-01 |
| GO:BP | GO:0006627 | protein processing involved in protein targeting to mitochondrion | 2 | 6 | 6.45e-01 |
| GO:BP | GO:2001222 | regulation of neuron migration | 9 | 38 | 6.45e-01 |
| GO:BP | GO:0010001 | glial cell differentiation | 2 | 170 | 6.45e-01 |
| GO:BP | GO:0036155 | acylglycerol acyl-chain remodeling | 2 | 2 | 6.45e-01 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1 | 128 | 6.45e-01 |
| GO:BP | GO:0045342 | MHC class II biosynthetic process | 5 | 12 | 6.46e-01 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 9 | 70 | 6.46e-01 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 21 | 665 | 6.46e-01 |
| GO:BP | GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1 | 2 | 6.46e-01 |
| GO:BP | GO:0071548 | response to dexamethasone | 1 | 36 | 6.46e-01 |
| GO:BP | GO:0010915 | regulation of very-low-density lipoprotein particle clearance | 1 | 2 | 6.46e-01 |
| GO:BP | GO:2000230 | negative regulation of pancreatic stellate cell proliferation | 1 | 1 | 6.46e-01 |
| GO:BP | GO:0033353 | S-adenosylmethionine cycle | 2 | 7 | 6.46e-01 |
| GO:BP | GO:0099538 | synaptic signaling via neuropeptide | 1 | 2 | 6.46e-01 |
| GO:BP | GO:0051004 | regulation of lipoprotein lipase activity | 1 | 11 | 6.46e-01 |
| GO:BP | GO:0048799 | animal organ maturation | 1 | 20 | 6.46e-01 |
| GO:BP | GO:0010763 | positive regulation of fibroblast migration | 2 | 15 | 6.46e-01 |
| GO:BP | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 3 | 5 | 6.46e-01 |
| GO:BP | GO:0001756 | somitogenesis | 16 | 48 | 6.46e-01 |
| GO:BP | GO:0071391 | cellular response to estrogen stimulus | 10 | 15 | 6.46e-01 |
| GO:BP | GO:2000535 | regulation of entry of bacterium into host cell | 1 | 6 | 6.46e-01 |
| GO:BP | GO:0016191 | synaptic vesicle uncoating | 4 | 7 | 6.46e-01 |
| GO:BP | GO:0070602 | regulation of centromeric sister chromatid cohesion | 2 | 4 | 6.47e-01 |
| GO:BP | GO:0043129 | surfactant homeostasis | 1 | 12 | 6.47e-01 |
| GO:BP | GO:0007387 | anterior compartment pattern formation | 1 | 1 | 6.47e-01 |
| GO:BP | GO:0007388 | posterior compartment specification | 1 | 1 | 6.47e-01 |
| GO:BP | GO:0033750 | ribosome localization | 1 | 15 | 6.47e-01 |
| GO:BP | GO:0009067 | aspartate family amino acid biosynthetic process | 10 | 18 | 6.47e-01 |
| GO:BP | GO:0010866 | regulation of triglyceride biosynthetic process | 1 | 19 | 6.47e-01 |
| GO:BP | GO:0014728 | regulation of the force of skeletal muscle contraction | 1 | 3 | 6.47e-01 |
| GO:BP | GO:0071542 | dopaminergic neuron differentiation | 3 | 20 | 6.47e-01 |
| GO:BP | GO:1903527 | positive regulation of membrane tubulation | 2 | 3 | 6.47e-01 |
| GO:BP | GO:0033079 | immature T cell proliferation | 2 | 7 | 6.47e-01 |
| GO:BP | GO:0033080 | immature T cell proliferation in thymus | 2 | 7 | 6.47e-01 |
| GO:BP | GO:1902624 | positive regulation of neutrophil migration | 2 | 21 | 6.47e-01 |
| GO:BP | GO:0000054 | ribosomal subunit export from nucleus | 1 | 15 | 6.47e-01 |
| GO:BP | GO:1903209 | positive regulation of oxidative stress-induced cell death | 1 | 13 | 6.47e-01 |
| GO:BP | GO:0010043 | response to zinc ion | 4 | 31 | 6.47e-01 |
| GO:BP | GO:0002327 | immature B cell differentiation | 5 | 11 | 6.47e-01 |
| GO:BP | GO:0001768 | establishment of T cell polarity | 2 | 10 | 6.47e-01 |
| GO:BP | GO:0010921 | regulation of phosphatase activity | 1 | 65 | 6.47e-01 |
| GO:BP | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production | 1 | 5 | 6.47e-01 |
| GO:BP | GO:0097341 | zymogen inhibition | 2 | 5 | 6.47e-01 |
| GO:BP | GO:0097340 | inhibition of cysteine-type endopeptidase activity | 2 | 5 | 6.47e-01 |
| GO:BP | GO:0050687 | negative regulation of defense response to virus | 2 | 30 | 6.47e-01 |
| GO:BP | GO:0014862 | regulation of skeletal muscle contraction by chemo-mechanical energy conversion | 1 | 3 | 6.47e-01 |
| GO:BP | GO:0035767 | endothelial cell chemotaxis | 15 | 23 | 6.47e-01 |
| GO:BP | GO:0010883 | regulation of lipid storage | 2 | 39 | 6.47e-01 |
| GO:BP | GO:0071635 | negative regulation of transforming growth factor beta production | 6 | 10 | 6.47e-01 |
| GO:BP | GO:0043983 | histone H4-K12 acetylation | 4 | 7 | 6.47e-01 |
| GO:BP | GO:0070637 | pyridine nucleoside metabolic process | 1 | 1 | 6.47e-01 |
| GO:BP | GO:0046495 | nicotinamide riboside metabolic process | 1 | 1 | 6.47e-01 |
| GO:BP | GO:0006738 | nicotinamide riboside catabolic process | 1 | 1 | 6.47e-01 |
| GO:BP | GO:0070638 | pyridine nucleoside catabolic process | 1 | 1 | 6.47e-01 |
| GO:BP | GO:0033523 | histone H2B ubiquitination | 5 | 10 | 6.47e-01 |
| GO:BP | GO:0048872 | homeostasis of number of cells | 2 | 228 | 6.48e-01 |
| GO:BP | GO:1902847 | regulation of neuronal signal transduction | 1 | 1 | 6.48e-01 |
| GO:BP | GO:1905868 | regulation of 3’-UTR-mediated mRNA stabilization | 1 | 5 | 6.48e-01 |
| GO:BP | GO:1902998 | positive regulation of neurofibrillary tangle assembly | 1 | 1 | 6.48e-01 |
| GO:BP | GO:0033275 | actin-myosin filament sliding | 5 | 11 | 6.48e-01 |
| GO:BP | GO:0050812 | regulation of acyl-CoA biosynthetic process | 3 | 5 | 6.48e-01 |
| GO:BP | GO:1905590 | fibronectin fibril organization | 1 | 1 | 6.48e-01 |
| GO:BP | GO:0046293 | formaldehyde biosynthetic process | 1 | 1 | 6.48e-01 |
| GO:BP | GO:0021932 | hindbrain radial glia guided cell migration | 4 | 8 | 6.48e-01 |
| GO:BP | GO:0060216 | definitive hemopoiesis | 8 | 18 | 6.48e-01 |
| GO:BP | GO:1902267 | regulation of polyamine transmembrane transport | 1 | 5 | 6.48e-01 |
| GO:BP | GO:0050916 | sensory perception of sweet taste | 3 | 3 | 6.48e-01 |
| GO:BP | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate | 2 | 4 | 6.48e-01 |
| GO:BP | GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 2 | 44 | 6.48e-01 |
| GO:BP | GO:0031946 | regulation of glucocorticoid biosynthetic process | 2 | 9 | 6.48e-01 |
| GO:BP | GO:0031453 | positive regulation of heterochromatin formation | 2 | 15 | 6.48e-01 |
| GO:BP | GO:0120263 | positive regulation of heterochromatin organization | 2 | 15 | 6.48e-01 |
| GO:BP | GO:0046660 | female sex differentiation | 17 | 91 | 6.48e-01 |
| GO:BP | GO:0070294 | renal sodium ion absorption | 1 | 9 | 6.48e-01 |
| GO:BP | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 1 | 10 | 6.48e-01 |
| GO:BP | GO:0097102 | endothelial tip cell fate specification | 1 | 2 | 6.48e-01 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 1 | 141 | 6.48e-01 |
| GO:BP | GO:0071921 | cohesin loading | 2 | 3 | 6.48e-01 |
| GO:BP | GO:0061441 | renal artery morphogenesis | 1 | 2 | 6.48e-01 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 7 | 4617 | 6.49e-01 |
| GO:BP | GO:0060126 | somatotropin secreting cell differentiation | 1 | 2 | 6.49e-01 |
| GO:BP | GO:0070729 | cyclic nucleotide transport | 1 | 6 | 6.49e-01 |
| GO:BP | GO:1903790 | guanine nucleotide transmembrane transport | 1 | 5 | 6.49e-01 |
| GO:BP | GO:1903393 | positive regulation of adherens junction organization | 1 | 2 | 6.49e-01 |
| GO:BP | GO:0051168 | nuclear export | 11 | 150 | 6.49e-01 |
| GO:BP | GO:0044795 | trans-Golgi network to recycling endosome transport | 1 | 1 | 6.49e-01 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 1 | 129 | 6.49e-01 |
| GO:BP | GO:0042339 | keratan sulfate metabolic process | 5 | 15 | 6.49e-01 |
| GO:BP | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport | 3 | 4 | 6.49e-01 |
| GO:BP | GO:1905602 | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 1 | 2 | 6.49e-01 |
| GO:BP | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation | 3 | 5 | 6.50e-01 |
| GO:BP | GO:0060319 | primitive erythrocyte differentiation | 3 | 4 | 6.50e-01 |
| GO:BP | GO:0048704 | embryonic skeletal system morphogenesis | 1 | 55 | 6.50e-01 |
| GO:BP | GO:0099118 | microtubule-based protein transport | 1 | 14 | 6.50e-01 |
| GO:BP | GO:0098840 | protein transport along microtubule | 1 | 14 | 6.50e-01 |
| GO:BP | GO:1901340 | negative regulation of store-operated calcium channel activity | 1 | 1 | 6.50e-01 |
| GO:BP | GO:0005977 | glycogen metabolic process | 19 | 64 | 6.50e-01 |
| GO:BP | GO:0042744 | hydrogen peroxide catabolic process | 1 | 12 | 6.50e-01 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 1 | 157 | 6.50e-01 |
| GO:BP | GO:0015822 | ornithine transport | 1 | 5 | 6.50e-01 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 12 | 42 | 6.50e-01 |
| GO:BP | GO:1903512 | phytanic acid metabolic process | 1 | 2 | 6.50e-01 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 74 | 3625 | 6.50e-01 |
| GO:BP | GO:0090205 | positive regulation of cholesterol metabolic process | 5 | 12 | 6.50e-01 |
| GO:BP | GO:2001233 | regulation of apoptotic signaling pathway | 12 | 307 | 6.50e-01 |
| GO:BP | GO:0051151 | negative regulation of smooth muscle cell differentiation | 9 | 14 | 6.51e-01 |
| GO:BP | GO:0033572 | transferrin transport | 4 | 8 | 6.51e-01 |
| GO:BP | GO:0007026 | negative regulation of microtubule depolymerization | 2 | 27 | 6.51e-01 |
| GO:BP | GO:1900364 | negative regulation of mRNA polyadenylation | 1 | 1 | 6.51e-01 |
| GO:BP | GO:0002280 | monocyte activation involved in immune response | 1 | 1 | 6.51e-01 |
| GO:BP | GO:1900181 | negative regulation of protein localization to nucleus | 2 | 28 | 6.51e-01 |
| GO:BP | GO:1903818 | positive regulation of voltage-gated potassium channel activity | 1 | 11 | 6.51e-01 |
| GO:BP | GO:0007344 | pronuclear fusion | 1 | 1 | 6.51e-01 |
| GO:BP | GO:2000250 | negative regulation of actin cytoskeleton reorganization | 1 | 1 | 6.51e-01 |
| GO:BP | GO:0000380 | alternative mRNA splicing, via spliceosome | 32 | 70 | 6.51e-01 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 20 | 4539 | 6.51e-01 |
| GO:BP | GO:0000741 | karyogamy | 1 | 1 | 6.51e-01 |
| GO:BP | GO:0036498 | IRE1-mediated unfolded protein response | 7 | 19 | 6.51e-01 |
| GO:BP | GO:0034250 | positive regulation of amide metabolic process | 3 | 149 | 6.51e-01 |
| GO:BP | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation | 1 | 6 | 6.51e-01 |
| GO:BP | GO:0042780 | tRNA 3’-end processing | 1 | 7 | 6.51e-01 |
| GO:BP | GO:0060525 | prostate glandular acinus development | 5 | 5 | 6.51e-01 |
| GO:BP | GO:0051645 | Golgi localization | 7 | 14 | 6.51e-01 |
| GO:BP | GO:0002678 | positive regulation of chronic inflammatory response | 1 | 1 | 6.52e-01 |
| GO:BP | GO:0021879 | forebrain neuron differentiation | 1 | 23 | 6.52e-01 |
| GO:BP | GO:0051403 | stress-activated MAPK cascade | 9 | 190 | 6.52e-01 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 2 | 1149 | 6.52e-01 |
| GO:BP | GO:0002943 | tRNA dihydrouridine synthesis | 2 | 4 | 6.52e-01 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 3 | 104 | 6.52e-01 |
| GO:BP | GO:0015740 | C4-dicarboxylate transport | 4 | 24 | 6.52e-01 |
| GO:BP | GO:0099643 | signal release from synapse | 3 | 104 | 6.52e-01 |
| GO:BP | GO:0150045 | regulation of synaptic signaling by nitric oxide | 1 | 1 | 6.52e-01 |
| GO:BP | GO:1901799 | negative regulation of proteasomal protein catabolic process | 6 | 47 | 6.52e-01 |
| GO:BP | GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1 | 1 | 6.52e-01 |
| GO:BP | GO:0048104 | establishment of body hair or bristle planar orientation | 1 | 3 | 6.52e-01 |
| GO:BP | GO:1902455 | negative regulation of stem cell population maintenance | 3 | 21 | 6.52e-01 |
| GO:BP | GO:0048105 | establishment of body hair planar orientation | 1 | 3 | 6.52e-01 |
| GO:BP | GO:0021541 | ammon gyrus development | 1 | 1 | 6.52e-01 |
| GO:BP | GO:0021510 | spinal cord development | 6 | 59 | 6.52e-01 |
| GO:BP | GO:0032497 | detection of lipopolysaccharide | 2 | 2 | 6.52e-01 |
| GO:BP | GO:0007399 | nervous system development | 3 | 1904 | 6.52e-01 |
| GO:BP | GO:2001198 | regulation of dendritic cell differentiation | 1 | 8 | 6.53e-01 |
| GO:BP | GO:0009912 | auditory receptor cell fate commitment | 3 | 4 | 6.53e-01 |
| GO:BP | GO:0060120 | inner ear receptor cell fate commitment | 3 | 4 | 6.53e-01 |
| GO:BP | GO:0032755 | positive regulation of interleukin-6 production | 3 | 56 | 6.53e-01 |
| GO:BP | GO:0050915 | sensory perception of sour taste | 1 | 4 | 6.53e-01 |
| GO:BP | GO:0072383 | plus-end-directed vesicle transport along microtubule | 2 | 6 | 6.53e-01 |
| GO:BP | GO:0035583 | sequestering of TGFbeta in extracellular matrix | 1 | 3 | 6.53e-01 |
| GO:BP | GO:1902480 | protein localization to mitotic spindle | 1 | 1 | 6.53e-01 |
| GO:BP | GO:0061960 | regulation of heme oxygenase activity | 1 | 1 | 6.53e-01 |
| GO:BP | GO:0090151 | establishment of protein localization to mitochondrial membrane | 8 | 38 | 6.53e-01 |
| GO:BP | GO:0010661 | positive regulation of muscle cell apoptotic process | 1 | 20 | 6.53e-01 |
| GO:BP | GO:0015804 | neutral amino acid transport | 6 | 43 | 6.53e-01 |
| GO:BP | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 1 | 3 | 6.53e-01 |
| GO:BP | GO:0017196 | N-terminal peptidyl-methionine acetylation | 2 | 8 | 6.53e-01 |
| GO:BP | GO:0031529 | ruffle organization | 16 | 45 | 6.53e-01 |
| GO:BP | GO:0003412 | establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis | 1 | 1 | 6.53e-01 |
| GO:BP | GO:0034030 | ribonucleoside bisphosphate biosynthetic process | 11 | 49 | 6.54e-01 |
| GO:BP | GO:0033866 | nucleoside bisphosphate biosynthetic process | 11 | 49 | 6.54e-01 |
| GO:BP | GO:1901739 | regulation of myoblast fusion | 1 | 12 | 6.54e-01 |
| GO:BP | GO:0036444 | calcium import into the mitochondrion | 1 | 12 | 6.54e-01 |
| GO:BP | GO:0046865 | terpenoid transport | 2 | 3 | 6.54e-01 |
| GO:BP | GO:0045988 | negative regulation of striated muscle contraction | 2 | 7 | 6.54e-01 |
| GO:BP | GO:0046864 | isoprenoid transport | 2 | 3 | 6.54e-01 |
| GO:BP | GO:0051292 | nuclear pore complex assembly | 4 | 9 | 6.54e-01 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 4 | 58 | 6.54e-01 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 | 124 | 6.54e-01 |
| GO:BP | GO:0034033 | purine nucleoside bisphosphate biosynthetic process | 11 | 49 | 6.54e-01 |
| GO:BP | GO:0030539 | male genitalia development | 1 | 13 | 6.54e-01 |
| GO:BP | GO:0010133 | proline catabolic process to glutamate | 1 | 2 | 6.54e-01 |
| GO:BP | GO:0032780 | negative regulation of ATP-dependent activity | 10 | 18 | 6.54e-01 |
| GO:BP | GO:1990758 | mitotic sister chromatid biorientation | 1 | 1 | 6.54e-01 |
| GO:BP | GO:0016125 | sterol metabolic process | 2 | 111 | 6.54e-01 |
| GO:BP | GO:1902595 | regulation of DNA replication origin binding | 1 | 2 | 6.54e-01 |
| GO:BP | GO:0032650 | regulation of interleukin-1 alpha production | 1 | 4 | 6.54e-01 |
| GO:BP | GO:0032610 | interleukin-1 alpha production | 1 | 4 | 6.54e-01 |
| GO:BP | GO:0044357 | regulation of rRNA stability | 1 | 1 | 6.54e-01 |
| GO:BP | GO:0018344 | protein geranylgeranylation | 1 | 6 | 6.54e-01 |
| GO:BP | GO:0010265 | SCF complex assembly | 1 | 2 | 6.54e-01 |
| GO:BP | GO:1902374 | regulation of rRNA catabolic process | 1 | 1 | 6.54e-01 |
| GO:BP | GO:0042402 | cellular biogenic amine catabolic process | 1 | 13 | 6.54e-01 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 1 | 748 | 6.55e-01 |
| GO:BP | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body | 4 | 15 | 6.55e-01 |
| GO:BP | GO:0035372 | protein localization to microtubule | 10 | 18 | 6.55e-01 |
| GO:BP | GO:0006525 | arginine metabolic process | 1 | 13 | 6.55e-01 |
| GO:BP | GO:0150032 | positive regulation of protein localization to lysosome | 1 | 2 | 6.55e-01 |
| GO:BP | GO:0055093 | response to hyperoxia | 1 | 18 | 6.55e-01 |
| GO:BP | GO:0021508 | floor plate formation | 1 | 3 | 6.55e-01 |
| GO:BP | GO:2000615 | regulation of histone H3-K9 acetylation | 2 | 7 | 6.55e-01 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 2 | 1133 | 6.55e-01 |
| GO:BP | GO:0042130 | negative regulation of T cell proliferation | 9 | 38 | 6.55e-01 |
| GO:BP | GO:0007267 | cell-cell signaling | 26 | 1138 | 6.55e-01 |
| GO:BP | GO:0002309 | T cell proliferation involved in immune response | 1 | 3 | 6.55e-01 |
| GO:BP | GO:0031623 | receptor internalization | 1 | 95 | 6.55e-01 |
| GO:BP | GO:0035821 | modulation of process of another organism | 3 | 5 | 6.55e-01 |
| GO:BP | GO:0071500 | cellular response to nitrosative stress | 2 | 6 | 6.56e-01 |
| GO:BP | GO:2000679 | positive regulation of transcription regulatory region DNA binding | 5 | 18 | 6.56e-01 |
| GO:BP | GO:0043977 | histone H2A-K5 acetylation | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0042665 | regulation of ectodermal cell fate specification | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0043980 | histone H2B-K12 acetylation | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0038001 | paracrine signaling | 1 | 3 | 6.56e-01 |
| GO:BP | GO:0042596 | fear response | 1 | 32 | 6.56e-01 |
| GO:BP | GO:0080111 | DNA demethylation | 1 | 23 | 6.56e-01 |
| GO:BP | GO:0006258 | UDP-glucose catabolic process | 1 | 2 | 6.56e-01 |
| GO:BP | GO:0045661 | regulation of myoblast differentiation | 3 | 61 | 6.56e-01 |
| GO:BP | GO:0014821 | phasic smooth muscle contraction | 1 | 12 | 6.56e-01 |
| GO:BP | GO:0045649 | regulation of macrophage differentiation | 1 | 17 | 6.56e-01 |
| GO:BP | GO:2000723 | negative regulation of cardiac vascular smooth muscle cell differentiation | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0072007 | mesangial cell differentiation | 1 | 5 | 6.56e-01 |
| GO:BP | GO:0006554 | lysine catabolic process | 1 | 6 | 6.56e-01 |
| GO:BP | GO:1900125 | regulation of hyaluronan biosynthetic process | 1 | 6 | 6.56e-01 |
| GO:BP | GO:1903939 | regulation of TORC2 signaling | 2 | 5 | 6.56e-01 |
| GO:BP | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1 | 3 | 6.56e-01 |
| GO:BP | GO:0001715 | ectodermal cell fate specification | 1 | 1 | 6.56e-01 |
| GO:BP | GO:1902896 | terminal web assembly | 1 | 2 | 6.56e-01 |
| GO:BP | GO:2000077 | negative regulation of type B pancreatic cell development | 1 | 2 | 6.56e-01 |
| GO:BP | GO:0030502 | negative regulation of bone mineralization | 1 | 10 | 6.56e-01 |
| GO:BP | GO:0006574 | valine catabolic process | 2 | 4 | 6.56e-01 |
| GO:BP | GO:0015825 | L-serine transport | 1 | 7 | 6.56e-01 |
| GO:BP | GO:0042666 | negative regulation of ectodermal cell fate specification | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0045887 | positive regulation of synaptic assembly at neuromuscular junction | 1 | 1 | 6.56e-01 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0007351 | tripartite regional subdivision | 1 | 10 | 6.56e-01 |
| GO:BP | GO:0008595 | anterior/posterior axis specification, embryo | 1 | 10 | 6.56e-01 |
| GO:BP | GO:0071642 | positive regulation of macrophage inflammatory protein 1 alpha production | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0015677 | copper ion import | 1 | 5 | 6.56e-01 |
| GO:BP | GO:0000018 | regulation of DNA recombination | 3 | 101 | 6.56e-01 |
| GO:BP | GO:0009235 | cobalamin metabolic process | 5 | 8 | 6.56e-01 |
| GO:BP | GO:0000023 | maltose metabolic process | 1 | 2 | 6.56e-01 |
| GO:BP | GO:0031398 | positive regulation of protein ubiquitination | 2 | 108 | 6.56e-01 |
| GO:BP | GO:0061718 | glucose catabolic process to pyruvate | 1 | 15 | 6.56e-01 |
| GO:BP | GO:1903333 | negative regulation of protein folding | 2 | 4 | 6.56e-01 |
| GO:BP | GO:0061621 | canonical glycolysis | 1 | 15 | 6.56e-01 |
| GO:BP | GO:0070875 | positive regulation of glycogen metabolic process | 1 | 13 | 6.56e-01 |
| GO:BP | GO:0006735 | NADH regeneration | 1 | 15 | 6.56e-01 |
| GO:BP | GO:0051641 | cellular localization | 2 | 2810 | 6.56e-01 |
| GO:BP | GO:1990046 | stress-induced mitochondrial fusion | 1 | 2 | 6.56e-01 |
| GO:BP | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 1 | 10 | 6.56e-01 |
| GO:BP | GO:0043586 | tongue development | 5 | 15 | 6.56e-01 |
| GO:BP | GO:0033235 | positive regulation of protein sumoylation | 2 | 12 | 6.56e-01 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 2 | 24 | 6.56e-01 |
| GO:BP | GO:0090143 | nucleoid organization | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 6 | 135 | 6.56e-01 |
| GO:BP | GO:0090144 | mitochondrial nucleoid organization | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0060718 | chorionic trophoblast cell differentiation | 2 | 5 | 6.56e-01 |
| GO:BP | GO:0038159 | C-X-C chemokine receptor CXCR4 signaling pathway | 2 | 4 | 6.56e-01 |
| GO:BP | GO:2000543 | positive regulation of gastrulation | 4 | 5 | 6.56e-01 |
| GO:BP | GO:0072359 | circulatory system development | 1 | 884 | 6.56e-01 |
| GO:BP | GO:0140051 | positive regulation of endocardial cushion to mesenchymal transition | 1 | 1 | 6.56e-01 |
| GO:BP | GO:2000800 | regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | 1 | 1 | 6.56e-01 |
| GO:BP | GO:2000802 | positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0140049 | regulation of endocardial cushion to mesenchymal transition | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0034772 | histone H4-K20 dimethylation | 1 | 2 | 6.56e-01 |
| GO:BP | GO:0072236 | metanephric loop of Henle development | 1 | 3 | 6.56e-01 |
| GO:BP | GO:1905764 | regulation of protection from non-homologous end joining at telomere | 2 | 3 | 6.56e-01 |
| GO:BP | GO:0015878 | biotin transport | 1 | 3 | 6.56e-01 |
| GO:BP | GO:0031627 | telomeric loop formation | 1 | 2 | 6.56e-01 |
| GO:BP | GO:0044706 | multi-multicellular organism process | 6 | 135 | 6.56e-01 |
| GO:BP | GO:0045763 | negative regulation of cellular amino acid metabolic process | 2 | 2 | 6.56e-01 |
| GO:BP | GO:1905765 | negative regulation of protection from non-homologous end joining at telomere | 2 | 3 | 6.56e-01 |
| GO:BP | GO:0010828 | positive regulation of glucose transmembrane transport | 1 | 31 | 6.56e-01 |
| GO:BP | GO:0043620 | regulation of DNA-templated transcription in response to stress | 1 | 41 | 6.56e-01 |
| GO:BP | GO:0061819 | telomeric DNA-containing double minutes formation | 2 | 3 | 6.56e-01 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 3 | 2880 | 6.56e-01 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 14 | 33 | 6.56e-01 |
| GO:BP | GO:0030389 | fructosamine metabolic process | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0090152 | establishment of protein localization to mitochondrial membrane involved in mitochondrial fission | 1 | 1 | 6.56e-01 |
| GO:BP | GO:0042797 | tRNA transcription by RNA polymerase III | 1 | 7 | 6.57e-01 |
| GO:BP | GO:1990542 | mitochondrial transmembrane transport | 7 | 39 | 6.57e-01 |
| GO:BP | GO:1900221 | regulation of amyloid-beta clearance | 1 | 13 | 6.57e-01 |
| GO:BP | GO:0010764 | negative regulation of fibroblast migration | 1 | 9 | 6.57e-01 |
| GO:BP | GO:0006099 | tricarboxylic acid cycle | 18 | 30 | 6.57e-01 |
| GO:BP | GO:0019748 | secondary metabolic process | 2 | 34 | 6.57e-01 |
| GO:BP | GO:1905702 | regulation of inhibitory synapse assembly | 1 | 3 | 6.57e-01 |
| GO:BP | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis | 1 | 1 | 6.58e-01 |
| GO:BP | GO:1905453 | regulation of myeloid progenitor cell differentiation | 1 | 1 | 6.58e-01 |
| GO:BP | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1 | 5 | 6.58e-01 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 10 | 17 | 6.58e-01 |
| GO:BP | GO:0050847 | progesterone receptor signaling pathway | 5 | 9 | 6.58e-01 |
| GO:BP | GO:0071691 | cardiac muscle thin filament assembly | 1 | 3 | 6.58e-01 |
| GO:BP | GO:0031340 | positive regulation of vesicle fusion | 1 | 9 | 6.58e-01 |
| GO:BP | GO:1903382 | negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 1 | 2 | 6.59e-01 |
| GO:BP | GO:1903394 | protein localization to kinetochore involved in kinetochore assembly | 1 | 1 | 6.59e-01 |
| GO:BP | GO:1905281 | positive regulation of retrograde transport, endosome to Golgi | 1 | 2 | 6.59e-01 |
| GO:BP | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin | 1 | 8 | 6.59e-01 |
| GO:BP | GO:1903381 | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine | 2 | 5 | 6.59e-01 |
| GO:BP | GO:0009229 | thiamine diphosphate biosynthetic process | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0042724 | thiamine-containing compound biosynthetic process | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0032825 | positive regulation of natural killer cell differentiation | 4 | 7 | 6.59e-01 |
| GO:BP | GO:0021999 | neural plate anterior/posterior regionalization | 1 | 5 | 6.59e-01 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 5 | 82 | 6.59e-01 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 4 | 102 | 6.59e-01 |
| GO:BP | GO:1902528 | regulation of protein linear polyubiquitination | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0021537 | telencephalon development | 54 | 201 | 6.59e-01 |
| GO:BP | GO:0060193 | positive regulation of lipase activity | 4 | 34 | 6.59e-01 |
| GO:BP | GO:1902530 | positive regulation of protein linear polyubiquitination | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0060245 | detection of cell density | 5 | 9 | 6.59e-01 |
| GO:BP | GO:0055107 | Golgi to secretory granule transport | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0060939 | epicardium-derived cardiac fibroblast cell development | 2 | 3 | 6.59e-01 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 2 | 35 | 6.59e-01 |
| GO:BP | GO:0060938 | epicardium-derived cardiac fibroblast cell differentiation | 2 | 3 | 6.59e-01 |
| GO:BP | GO:0061140 | lung secretory cell differentiation | 1 | 5 | 6.59e-01 |
| GO:BP | GO:1905636 | positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 1 | 5 | 6.59e-01 |
| GO:BP | GO:0048861 | leukemia inhibitory factor signaling pathway | 2 | 6 | 6.59e-01 |
| GO:BP | GO:0046189 | phenol-containing compound biosynthetic process | 2 | 28 | 6.59e-01 |
| GO:BP | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process | 4 | 14 | 6.59e-01 |
| GO:BP | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib | 3 | 5 | 6.59e-01 |
| GO:BP | GO:0043467 | regulation of generation of precursor metabolites and energy | 4 | 89 | 6.59e-01 |
| GO:BP | GO:2001113 | negative regulation of cellular response to hepatocyte growth factor stimulus | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0031330 | negative regulation of cellular catabolic process | 5 | 165 | 6.59e-01 |
| GO:BP | GO:0001802 | type III hypersensitivity | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0001803 | regulation of type III hypersensitivity | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0010587 | miRNA catabolic process | 5 | 10 | 6.59e-01 |
| GO:BP | GO:0051944 | positive regulation of catecholamine uptake involved in synaptic transmission | 2 | 2 | 6.59e-01 |
| GO:BP | GO:0042820 | vitamin B6 catabolic process | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0090336 | positive regulation of brown fat cell differentiation | 5 | 11 | 6.59e-01 |
| GO:BP | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0032361 | pyridoxal phosphate catabolic process | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0009395 | phospholipid catabolic process | 6 | 37 | 6.59e-01 |
| GO:BP | GO:0035437 | maintenance of protein localization in endoplasmic reticulum | 6 | 11 | 6.59e-01 |
| GO:BP | GO:0006801 | superoxide metabolic process | 11 | 42 | 6.59e-01 |
| GO:BP | GO:0001805 | positive regulation of type III hypersensitivity | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0021986 | habenula development | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0036138 | peptidyl-histidine hydroxylation | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in hemopoiesis | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0051046 | regulation of secretion | 10 | 418 | 6.59e-01 |
| GO:BP | GO:0006836 | neurotransmitter transport | 4 | 138 | 6.59e-01 |
| GO:BP | GO:0016095 | polyprenol catabolic process | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0006644 | phospholipid metabolic process | 1 | 316 | 6.59e-01 |
| GO:BP | GO:0034477 | U6 snRNA 3’-end processing | 1 | 2 | 6.59e-01 |
| GO:BP | GO:0071701 | regulation of MAPK export from nucleus | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0009106 | lipoate metabolic process | 1 | 1 | 6.59e-01 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 1 | 60 | 6.59e-01 |
| GO:BP | GO:0009107 | lipoate biosynthetic process | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0021513 | spinal cord dorsal/ventral patterning | 1 | 7 | 6.59e-01 |
| GO:BP | GO:0021538 | epithalamus development | 1 | 1 | 6.59e-01 |
| GO:BP | GO:0034105 | positive regulation of tissue remodeling | 1 | 4 | 6.59e-01 |
| GO:BP | GO:1902259 | regulation of delayed rectifier potassium channel activity | 1 | 12 | 6.59e-01 |
| GO:BP | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission | 2 | 2 | 6.59e-01 |
| GO:BP | GO:0001806 | type IV hypersensitivity | 2 | 2 | 6.59e-01 |
| GO:BP | GO:2000359 | regulation of binding of sperm to zona pellucida | 2 | 2 | 6.59e-01 |
| GO:BP | GO:0061890 | positive regulation of astrocyte activation | 1 | 1 | 6.59e-01 |
| GO:BP | GO:1902512 | positive regulation of apoptotic DNA fragmentation | 1 | 4 | 6.60e-01 |
| GO:BP | GO:0003274 | endocardial cushion fusion | 1 | 5 | 6.60e-01 |
| GO:BP | GO:2000003 | positive regulation of DNA damage checkpoint | 1 | 6 | 6.60e-01 |
| GO:BP | GO:0106056 | regulation of calcineurin-mediated signaling | 10 | 32 | 6.60e-01 |
| GO:BP | GO:0035304 | regulation of protein dephosphorylation | 1 | 75 | 6.60e-01 |
| GO:BP | GO:1904587 | response to glycoprotein | 1 | 5 | 6.60e-01 |
| GO:BP | GO:0048294 | negative regulation of isotype switching to IgE isotypes | 1 | 2 | 6.60e-01 |
| GO:BP | GO:0010884 | positive regulation of lipid storage | 7 | 18 | 6.60e-01 |
| GO:BP | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 4 | 123 | 6.60e-01 |
| GO:BP | GO:0072006 | nephron development | 4 | 117 | 6.60e-01 |
| GO:BP | GO:0035912 | dorsal aorta morphogenesis | 4 | 6 | 6.60e-01 |
| GO:BP | GO:0018345 | protein palmitoylation | 2 | 30 | 6.60e-01 |
| GO:BP | GO:0034959 | endothelin maturation | 1 | 1 | 6.60e-01 |
| GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 16 | 54 | 6.60e-01 |
| GO:BP | GO:0021987 | cerebral cortex development | 50 | 101 | 6.60e-01 |
| GO:BP | GO:0010816 | calcitonin catabolic process | 1 | 1 | 6.60e-01 |
| GO:BP | GO:0106134 | positive regulation of cardiac muscle cell contraction | 1 | 1 | 6.60e-01 |
| GO:BP | GO:0036466 | synaptic vesicle recycling via endosome | 3 | 4 | 6.60e-01 |
| GO:BP | GO:0035964 | COPI-coated vesicle budding | 1 | 6 | 6.60e-01 |
| GO:BP | GO:0048200 | Golgi transport vesicle coating | 1 | 6 | 6.60e-01 |
| GO:BP | GO:0048205 | COPI coating of Golgi vesicle | 1 | 6 | 6.60e-01 |
| GO:BP | GO:1903624 | regulation of DNA catabolic process | 2 | 10 | 6.60e-01 |
| GO:BP | GO:0070498 | interleukin-1-mediated signaling pathway | 4 | 20 | 6.60e-01 |
| GO:BP | GO:0031077 | post-embryonic camera-type eye development | 3 | 7 | 6.60e-01 |
| GO:BP | GO:0090160 | Golgi to lysosome transport | 6 | 10 | 6.60e-01 |
| GO:BP | GO:1902336 | positive regulation of retinal ganglion cell axon guidance | 2 | 2 | 6.60e-01 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 1 | 311 | 6.60e-01 |
| GO:BP | GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1 | 3 | 6.61e-01 |
| GO:BP | GO:0033087 | negative regulation of immature T cell proliferation | 1 | 3 | 6.61e-01 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 8 | 14 | 6.61e-01 |
| GO:BP | GO:1904585 | response to putrescine | 1 | 1 | 6.61e-01 |
| GO:BP | GO:0034329 | cell junction assembly | 25 | 344 | 6.61e-01 |
| GO:BP | GO:0060313 | negative regulation of blood vessel remodeling | 1 | 2 | 6.61e-01 |
| GO:BP | GO:0046745 | viral capsid secondary envelopment | 1 | 1 | 6.61e-01 |
| GO:BP | GO:1990828 | hepatocyte dedifferentiation | 1 | 1 | 6.61e-01 |
| GO:BP | GO:1904586 | cellular response to putrescine | 1 | 1 | 6.61e-01 |
| GO:BP | GO:0090136 | epithelial cell-cell adhesion | 8 | 16 | 6.61e-01 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 4 | 1101 | 6.61e-01 |
| GO:BP | GO:0003407 | neural retina development | 10 | 48 | 6.61e-01 |
| GO:BP | GO:0042104 | positive regulation of activated T cell proliferation | 1 | 13 | 6.61e-01 |
| GO:BP | GO:0072337 | modified amino acid transport | 5 | 35 | 6.61e-01 |
| GO:BP | GO:0099158 | regulation of recycling endosome localization within postsynapse | 1 | 1 | 6.61e-01 |
| GO:BP | GO:0071672 | negative regulation of smooth muscle cell chemotaxis | 1 | 2 | 6.61e-01 |
| GO:BP | GO:1905242 | response to 3,3’,5-triiodo-L-thyronine | 1 | 1 | 6.61e-01 |
| GO:BP | GO:0099527 | postsynapse to nucleus signaling pathway | 1 | 6 | 6.61e-01 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 6 | 4417 | 6.61e-01 |
| GO:BP | GO:1903430 | negative regulation of cell maturation | 1 | 4 | 6.61e-01 |
| GO:BP | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway | 1 | 7 | 6.62e-01 |
| GO:BP | GO:0030838 | positive regulation of actin filament polymerization | 2 | 39 | 6.62e-01 |
| GO:BP | GO:1903608 | protein localization to cytoplasmic stress granule | 1 | 7 | 6.62e-01 |
| GO:BP | GO:1901143 | insulin catabolic process | 1 | 3 | 6.62e-01 |
| GO:BP | GO:0008333 | endosome to lysosome transport | 6 | 63 | 6.62e-01 |
| GO:BP | GO:0034773 | histone H4-K20 trimethylation | 3 | 5 | 6.62e-01 |
| GO:BP | GO:0005976 | polysaccharide metabolic process | 8 | 80 | 6.62e-01 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 9 | 25 | 6.62e-01 |
| GO:BP | GO:0030854 | positive regulation of granulocyte differentiation | 3 | 5 | 6.62e-01 |
| GO:BP | GO:0045165 | cell fate commitment | 4 | 155 | 6.62e-01 |
| GO:BP | GO:1903020 | positive regulation of glycoprotein metabolic process | 2 | 17 | 6.62e-01 |
| GO:BP | GO:0009620 | response to fungus | 1 | 22 | 6.62e-01 |
| GO:BP | GO:1901096 | regulation of autophagosome maturation | 9 | 16 | 6.62e-01 |
| GO:BP | GO:0009310 | amine catabolic process | 1 | 14 | 6.62e-01 |
| GO:BP | GO:0072429 | response to intra-S DNA damage checkpoint signaling | 1 | 4 | 6.62e-01 |
| GO:BP | GO:0036285 | SAGA complex assembly | 1 | 1 | 6.62e-01 |
| GO:BP | GO:1904431 | positive regulation of t-circle formation | 1 | 3 | 6.62e-01 |
| GO:BP | GO:0070585 | protein localization to mitochondrion | 64 | 123 | 6.62e-01 |
| GO:BP | GO:0006004 | fucose metabolic process | 2 | 10 | 6.62e-01 |
| GO:BP | GO:0060003 | copper ion export | 1 | 2 | 6.63e-01 |
| GO:BP | GO:0045739 | positive regulation of DNA repair | 5 | 120 | 6.63e-01 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 4 | 27 | 6.63e-01 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 4 | 163 | 6.63e-01 |
| GO:BP | GO:0106091 | glial cell projection elongation | 1 | 2 | 6.63e-01 |
| GO:BP | GO:0120192 | tight junction assembly | 4 | 47 | 6.63e-01 |
| GO:BP | GO:0052472 | modulation by host of symbiont transcription | 1 | 2 | 6.63e-01 |
| GO:BP | GO:1902440 | protein localization to mitotic spindle pole body | 1 | 1 | 6.63e-01 |
| GO:BP | GO:0002713 | negative regulation of B cell mediated immunity | 4 | 9 | 6.64e-01 |
| GO:BP | GO:0002890 | negative regulation of immunoglobulin mediated immune response | 4 | 9 | 6.64e-01 |
| GO:BP | GO:0048513 | animal organ development | 2 | 2189 | 6.64e-01 |
| GO:BP | GO:2000435 | negative regulation of protein neddylation | 1 | 4 | 6.64e-01 |
| GO:BP | GO:2000436 | positive regulation of protein neddylation | 1 | 5 | 6.64e-01 |
| GO:BP | GO:0044042 | glucan metabolic process | 19 | 64 | 6.64e-01 |
| GO:BP | GO:0032634 | interleukin-5 production | 1 | 8 | 6.64e-01 |
| GO:BP | GO:0050884 | neuromuscular process controlling posture | 1 | 12 | 6.64e-01 |
| GO:BP | GO:0045624 | positive regulation of T-helper cell differentiation | 1 | 11 | 6.64e-01 |
| GO:BP | GO:0062094 | stomach development | 1 | 4 | 6.64e-01 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 1 | 8 | 6.64e-01 |
| GO:BP | GO:0035905 | ascending aorta development | 1 | 5 | 6.64e-01 |
| GO:BP | GO:0007500 | mesodermal cell fate determination | 1 | 2 | 6.64e-01 |
| GO:BP | GO:1905512 | regulation of short-term synaptic potentiation | 1 | 1 | 6.64e-01 |
| GO:BP | GO:0070317 | negative regulation of G0 to G1 transition | 1 | 5 | 6.64e-01 |
| GO:BP | GO:0098886 | modification of dendritic spine | 1 | 2 | 6.64e-01 |
| GO:BP | GO:1905513 | negative regulation of short-term synaptic potentiation | 1 | 1 | 6.64e-01 |
| GO:BP | GO:0010952 | positive regulation of peptidase activity | 4 | 135 | 6.64e-01 |
| GO:BP | GO:0001767 | establishment of lymphocyte polarity | 2 | 11 | 6.64e-01 |
| GO:BP | GO:0045601 | regulation of endothelial cell differentiation | 2 | 27 | 6.64e-01 |
| GO:BP | GO:1902910 | positive regulation of melanosome transport | 1 | 1 | 6.64e-01 |
| GO:BP | GO:0060901 | regulation of hair cycle by canonical Wnt signaling pathway | 1 | 1 | 6.64e-01 |
| GO:BP | GO:0051796 | negative regulation of timing of catagen | 1 | 1 | 6.64e-01 |
| GO:BP | GO:0072168 | specification of anterior mesonephric tubule identity | 1 | 1 | 6.65e-01 |
| GO:BP | GO:1901077 | regulation of relaxation of muscle | 2 | 8 | 6.65e-01 |
| GO:BP | GO:0072167 | specification of mesonephric tubule identity | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0071907 | determination of digestive tract left/right asymmetry | 3 | 5 | 6.65e-01 |
| GO:BP | GO:0072165 | anterior mesonephric tubule development | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0072169 | specification of posterior mesonephric tubule identity | 1 | 1 | 6.65e-01 |
| GO:BP | GO:1902605 | heterotrimeric G-protein complex assembly | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0097039 | protein linear polyubiquitination | 2 | 5 | 6.65e-01 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 1 | 71 | 6.65e-01 |
| GO:BP | GO:0072259 | metanephric interstitial fibroblast development | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0072258 | metanephric interstitial fibroblast differentiation | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0072184 | renal vesicle progenitor cell differentiation | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0034104 | negative regulation of tissue remodeling | 2 | 13 | 6.65e-01 |
| GO:BP | GO:0099514 | synaptic vesicle cytoskeletal transport | 2 | 16 | 6.65e-01 |
| GO:BP | GO:0071346 | cellular response to type II interferon | 1 | 69 | 6.65e-01 |
| GO:BP | GO:0051235 | maintenance of location | 5 | 260 | 6.65e-01 |
| GO:BP | GO:0051176 | positive regulation of sulfur metabolic process | 2 | 5 | 6.65e-01 |
| GO:BP | GO:1903676 | positive regulation of cap-dependent translational initiation | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress | 5 | 10 | 6.65e-01 |
| GO:BP | GO:0006364 | rRNA processing | 6 | 221 | 6.65e-01 |
| GO:BP | GO:0048490 | anterograde synaptic vesicle transport | 2 | 16 | 6.65e-01 |
| GO:BP | GO:1903674 | regulation of cap-dependent translational initiation | 1 | 1 | 6.65e-01 |
| GO:BP | GO:0099517 | synaptic vesicle transport along microtubule | 2 | 16 | 6.65e-01 |
| GO:BP | GO:0060545 | positive regulation of necroptotic process | 1 | 4 | 6.65e-01 |
| GO:BP | GO:0045659 | negative regulation of neutrophil differentiation | 1 | 2 | 6.65e-01 |
| GO:BP | GO:0001974 | blood vessel remodeling | 4 | 32 | 6.65e-01 |
| GO:BP | GO:1905604 | negative regulation of blood-brain barrier permeability | 2 | 2 | 6.65e-01 |
| GO:BP | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 1 | 2 | 6.65e-01 |
| GO:BP | GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 1 | 5 | 6.65e-01 |
| GO:BP | GO:0003016 | respiratory system process | 1 | 30 | 6.65e-01 |
| GO:BP | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway | 1 | 1 | 6.65e-01 |
| GO:BP | GO:2001145 | negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1 | 1 | 6.66e-01 |
| GO:BP | GO:2001144 | regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1 | 1 | 6.66e-01 |
| GO:BP | GO:0071475 | cellular hyperosmotic salinity response | 2 | 6 | 6.66e-01 |
| GO:BP | GO:1905269 | positive regulation of chromatin organization | 2 | 15 | 6.66e-01 |
| GO:BP | GO:0042168 | heme metabolic process | 9 | 40 | 6.66e-01 |
| GO:BP | GO:0140568 | extraction of mislocalized protein from membrane | 1 | 2 | 6.66e-01 |
| GO:BP | GO:0007512 | adult heart development | 7 | 9 | 6.66e-01 |
| GO:BP | GO:1904429 | regulation of t-circle formation | 2 | 5 | 6.66e-01 |
| GO:BP | GO:0060010 | Sertoli cell fate commitment | 1 | 1 | 6.66e-01 |
| GO:BP | GO:0021675 | nerve development | 5 | 57 | 6.66e-01 |
| GO:BP | GO:0009058 | biosynthetic process | 20 | 4590 | 6.66e-01 |
| GO:BP | GO:0014812 | muscle cell migration | 7 | 76 | 6.66e-01 |
| GO:BP | GO:0060191 | regulation of lipase activity | 5 | 52 | 6.66e-01 |
| GO:BP | GO:0007141 | male meiosis I | 4 | 15 | 6.66e-01 |
| GO:BP | GO:1904507 | positive regulation of telomere maintenance in response to DNA damage | 7 | 14 | 6.66e-01 |
| GO:BP | GO:0006517 | protein deglycosylation | 2 | 25 | 6.66e-01 |
| GO:BP | GO:0014857 | regulation of skeletal muscle cell proliferation | 2 | 10 | 6.66e-01 |
| GO:BP | GO:0045684 | positive regulation of epidermis development | 5 | 20 | 6.66e-01 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 3 | 62 | 6.66e-01 |
| GO:BP | GO:0072655 | establishment of protein localization to mitochondrion | 61 | 118 | 6.66e-01 |
| GO:BP | GO:0001568 | blood vessel development | 7 | 534 | 6.66e-01 |
| GO:BP | GO:0003008 | system process | 1 | 1189 | 6.66e-01 |
| GO:BP | GO:0030070 | insulin processing | 2 | 6 | 6.66e-01 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 2 | 100 | 6.66e-01 |
| GO:BP | GO:0016076 | snRNA catabolic process | 2 | 5 | 6.66e-01 |
| GO:BP | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1 | 11 | 6.67e-01 |
| GO:BP | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 1 | 8 | 6.67e-01 |
| GO:BP | GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1 | 2 | 6.67e-01 |
| GO:BP | GO:0090226 | regulation of microtubule nucleation by Ran protein signal transduction | 1 | 1 | 6.67e-01 |
| GO:BP | GO:0009397 | folic acid-containing compound catabolic process | 1 | 1 | 6.67e-01 |
| GO:BP | GO:0061298 | retina vasculature development in camera-type eye | 2 | 14 | 6.67e-01 |
| GO:BP | GO:0042560 | pteridine-containing compound catabolic process | 1 | 1 | 6.67e-01 |
| GO:BP | GO:0046657 | folic acid catabolic process | 1 | 1 | 6.67e-01 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 3070 | 6.67e-01 |
| GO:BP | GO:0060558 | regulation of calcidiol 1-monooxygenase activity | 1 | 2 | 6.67e-01 |
| GO:BP | GO:0002090 | regulation of receptor internalization | 4 | 49 | 6.67e-01 |
| GO:BP | GO:0090181 | regulation of cholesterol metabolic process | 1 | 29 | 6.67e-01 |
| GO:BP | GO:2000467 | positive regulation of glycogen (starch) synthase activity | 2 | 4 | 6.67e-01 |
| GO:BP | GO:0010668 | ectodermal cell differentiation | 1 | 5 | 6.67e-01 |
| GO:BP | GO:0048280 | vesicle fusion with Golgi apparatus | 1 | 8 | 6.67e-01 |
| GO:BP | GO:0017062 | respiratory chain complex III assembly | 2 | 10 | 6.67e-01 |
| GO:BP | GO:0006116 | NADH oxidation | 2 | 4 | 6.67e-01 |
| GO:BP | GO:0030852 | regulation of granulocyte differentiation | 6 | 11 | 6.67e-01 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 1 | 154 | 6.67e-01 |
| GO:BP | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process | 1 | 2 | 6.67e-01 |
| GO:BP | GO:0042403 | thyroid hormone metabolic process | 4 | 11 | 6.67e-01 |
| GO:BP | GO:0034551 | mitochondrial respiratory chain complex III assembly | 2 | 10 | 6.67e-01 |
| GO:BP | GO:1901142 | insulin metabolic process | 3 | 11 | 6.67e-01 |
| GO:BP | GO:0002445 | type II hypersensitivity | 2 | 3 | 6.67e-01 |
| GO:BP | GO:0001794 | type IIa hypersensitivity | 2 | 3 | 6.67e-01 |
| GO:BP | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 5 | 19 | 6.67e-01 |
| GO:BP | GO:0021978 | telencephalon regionalization | 1 | 4 | 6.67e-01 |
| GO:BP | GO:0070050 | neuron cellular homeostasis | 4 | 46 | 6.67e-01 |
| GO:BP | GO:0070836 | caveola assembly | 2 | 4 | 6.67e-01 |
| GO:BP | GO:0031115 | negative regulation of microtubule polymerization | 7 | 13 | 6.67e-01 |
| GO:BP | GO:0034114 | regulation of heterotypic cell-cell adhesion | 2 | 13 | 6.67e-01 |
| GO:BP | GO:0031579 | membrane raft organization | 2 | 19 | 6.67e-01 |
| GO:BP | GO:0030490 | maturation of SSU-rRNA | 3 | 54 | 6.67e-01 |
| GO:BP | GO:1903044 | protein localization to membrane raft | 1 | 8 | 6.68e-01 |
| GO:BP | GO:0035261 | external genitalia morphogenesis | 1 | 1 | 6.68e-01 |
| GO:BP | GO:1903077 | negative regulation of protein localization to plasma membrane | 5 | 21 | 6.68e-01 |
| GO:BP | GO:0061780 | mitotic cohesin loading | 1 | 1 | 6.68e-01 |
| GO:BP | GO:1901373 | lipid hydroperoxide transport | 1 | 1 | 6.68e-01 |
| GO:BP | GO:0033365 | protein localization to organelle | 23 | 859 | 6.68e-01 |
| GO:BP | GO:0000154 | rRNA modification | 18 | 35 | 6.68e-01 |
| GO:BP | GO:0060037 | pharyngeal system development | 2 | 23 | 6.68e-01 |
| GO:BP | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity | 1 | 1 | 6.68e-01 |
| GO:BP | GO:0000041 | transition metal ion transport | 10 | 71 | 6.68e-01 |
| GO:BP | GO:0032965 | regulation of collagen biosynthetic process | 8 | 30 | 6.69e-01 |
| GO:BP | GO:0060716 | labyrinthine layer blood vessel development | 5 | 16 | 6.69e-01 |
| GO:BP | GO:0160025 | sensory perception of itch | 1 | 1 | 6.69e-01 |
| GO:BP | GO:2000843 | regulation of testosterone secretion | 1 | 2 | 6.69e-01 |
| GO:BP | GO:0160023 | sneeze reflex | 1 | 1 | 6.69e-01 |
| GO:BP | GO:2000845 | positive regulation of testosterone secretion | 1 | 2 | 6.69e-01 |
| GO:BP | GO:2000626 | negative regulation of miRNA catabolic process | 1 | 1 | 6.69e-01 |
| GO:BP | GO:0140235 | RNA polyadenylation at postsynapse | 1 | 1 | 6.69e-01 |
| GO:BP | GO:0035936 | testosterone secretion | 1 | 2 | 6.69e-01 |
| GO:BP | GO:0070175 | positive regulation of enamel mineralization | 1 | 2 | 6.69e-01 |
| GO:BP | GO:1900210 | positive regulation of cardiolipin metabolic process | 1 | 1 | 6.70e-01 |
| GO:BP | GO:0006998 | nuclear envelope organization | 2 | 57 | 6.70e-01 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 10 | 23 | 6.70e-01 |
| GO:BP | GO:0048569 | post-embryonic animal organ development | 4 | 15 | 6.70e-01 |
| GO:BP | GO:0043249 | erythrocyte maturation | 2 | 12 | 6.70e-01 |
| GO:BP | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1 | 9 | 6.70e-01 |
| GO:BP | GO:0015821 | methionine transport | 1 | 4 | 6.70e-01 |
| GO:BP | GO:0048132 | female germ-line stem cell asymmetric division | 1 | 1 | 6.70e-01 |
| GO:BP | GO:0030217 | T cell differentiation | 1 | 185 | 6.70e-01 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 1 | 157 | 6.70e-01 |
| GO:BP | GO:0018095 | protein polyglutamylation | 1 | 9 | 6.70e-01 |
| GO:BP | GO:2000833 | positive regulation of steroid hormone secretion | 1 | 6 | 6.70e-01 |
| GO:BP | GO:0034698 | response to gonadotropin | 2 | 19 | 6.70e-01 |
| GO:BP | GO:0051103 | DNA ligation involved in DNA repair | 3 | 5 | 6.71e-01 |
| GO:BP | GO:0033313 | meiotic cell cycle checkpoint signaling | 1 | 6 | 6.71e-01 |
| GO:BP | GO:0060907 | positive regulation of macrophage cytokine production | 1 | 18 | 6.71e-01 |
| GO:BP | GO:2000465 | regulation of glycogen (starch) synthase activity | 1 | 8 | 6.71e-01 |
| GO:BP | GO:0046203 | spermidine catabolic process | 1 | 2 | 6.71e-01 |
| GO:BP | GO:2000108 | positive regulation of leukocyte apoptotic process | 4 | 18 | 6.71e-01 |
| GO:BP | GO:0097048 | dendritic cell apoptotic process | 2 | 7 | 6.71e-01 |
| GO:BP | GO:2000668 | regulation of dendritic cell apoptotic process | 2 | 7 | 6.71e-01 |
| GO:BP | GO:0043297 | apical junction assembly | 12 | 51 | 6.72e-01 |
| GO:BP | GO:0048731 | system development | 3 | 2901 | 6.72e-01 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 2 | 49 | 6.72e-01 |
| GO:BP | GO:0031652 | positive regulation of heat generation | 2 | 4 | 6.72e-01 |
| GO:BP | GO:0032717 | negative regulation of interleukin-8 production | 1 | 12 | 6.72e-01 |
| GO:BP | GO:0008053 | mitochondrial fusion | 11 | 28 | 6.72e-01 |
| GO:BP | GO:0009100 | glycoprotein metabolic process | 8 | 316 | 6.72e-01 |
| GO:BP | GO:0034463 | 90S preribosome assembly | 1 | 1 | 6.72e-01 |
| GO:BP | GO:0046835 | carbohydrate phosphorylation | 2 | 21 | 6.72e-01 |
| GO:BP | GO:0032966 | negative regulation of collagen biosynthetic process | 5 | 7 | 6.72e-01 |
| GO:BP | GO:2000764 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis | 1 | 1 | 6.72e-01 |
| GO:BP | GO:2000763 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process | 1 | 1 | 6.72e-01 |
| GO:BP | GO:2001262 | positive regulation of semaphorin-plexin signaling pathway | 1 | 1 | 6.72e-01 |
| GO:BP | GO:0035844 | cloaca development | 1 | 3 | 6.72e-01 |
| GO:BP | GO:1904897 | regulation of hepatic stellate cell proliferation | 1 | 1 | 6.72e-01 |
| GO:BP | GO:0071527 | semaphorin-plexin signaling pathway involved in outflow tract morphogenesis | 1 | 1 | 6.72e-01 |
| GO:BP | GO:1990922 | hepatic stellate cell proliferation | 1 | 1 | 6.72e-01 |
| GO:BP | GO:1904899 | positive regulation of hepatic stellate cell proliferation | 1 | 1 | 6.72e-01 |
| GO:BP | GO:0006325 | chromatin organization | 1 | 551 | 6.73e-01 |
| GO:BP | GO:0097623 | potassium ion export across plasma membrane | 4 | 10 | 6.73e-01 |
| GO:BP | GO:1903435 | positive regulation of constitutive secretory pathway | 1 | 1 | 6.73e-01 |
| GO:BP | GO:0071922 | regulation of cohesin loading | 1 | 2 | 6.73e-01 |
| GO:BP | GO:1901835 | positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA | 1 | 1 | 6.73e-01 |
| GO:BP | GO:1904246 | negative regulation of polynucleotide adenylyltransferase activity | 1 | 1 | 6.73e-01 |
| GO:BP | GO:1901834 | regulation of deadenylation-independent decapping of nuclear-transcribed mRNA | 1 | 1 | 6.73e-01 |
| GO:BP | GO:0030001 | metal ion transport | 12 | 562 | 6.73e-01 |
| GO:BP | GO:0007497 | posterior midgut development | 1 | 2 | 6.73e-01 |
| GO:BP | GO:1902600 | proton transmembrane transport | 2 | 111 | 6.73e-01 |
| GO:BP | GO:0033031 | positive regulation of neutrophil apoptotic process | 1 | 3 | 6.73e-01 |
| GO:BP | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 4 | 6 | 6.73e-01 |
| GO:BP | GO:0043010 | camera-type eye development | 4 | 236 | 6.73e-01 |
| GO:BP | GO:0031098 | stress-activated protein kinase signaling cascade | 9 | 196 | 6.73e-01 |
| GO:BP | GO:0030505 | inorganic diphosphate transport | 1 | 3 | 6.73e-01 |
| GO:BP | GO:0032616 | interleukin-13 production | 1 | 10 | 6.73e-01 |
| GO:BP | GO:0006685 | sphingomyelin catabolic process | 1 | 6 | 6.73e-01 |
| GO:BP | GO:0032656 | regulation of interleukin-13 production | 1 | 10 | 6.73e-01 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2 | 48 | 6.73e-01 |
| GO:BP | GO:0061017 | hepatoblast differentiation | 1 | 1 | 6.73e-01 |
| GO:BP | GO:1905711 | response to phosphatidylethanolamine | 1 | 1 | 6.73e-01 |
| GO:BP | GO:0038128 | ERBB2 signaling pathway | 9 | 14 | 6.73e-01 |
| GO:BP | GO:1903598 | positive regulation of gap junction assembly | 2 | 7 | 6.73e-01 |
| GO:BP | GO:0006379 | mRNA cleavage | 1 | 19 | 6.73e-01 |
| GO:BP | GO:0006863 | purine nucleobase transport | 1 | 7 | 6.73e-01 |
| GO:BP | GO:0015858 | nucleoside transport | 1 | 8 | 6.73e-01 |
| GO:BP | GO:0010888 | negative regulation of lipid storage | 1 | 16 | 6.73e-01 |
| GO:BP | GO:0071926 | endocannabinoid signaling pathway | 2 | 5 | 6.73e-01 |
| GO:BP | GO:0019218 | regulation of steroid metabolic process | 2 | 69 | 6.74e-01 |
| GO:BP | GO:1902022 | L-lysine transport | 1 | 6 | 6.74e-01 |
| GO:BP | GO:1903401 | L-lysine transmembrane transport | 1 | 6 | 6.74e-01 |
| GO:BP | GO:1901843 | positive regulation of high voltage-gated calcium channel activity | 2 | 4 | 6.74e-01 |
| GO:BP | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1 | 8 | 6.74e-01 |
| GO:BP | GO:0001971 | negative regulation of activation of membrane attack complex | 1 | 1 | 6.74e-01 |
| GO:BP | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 9 | 17 | 6.74e-01 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 10 | 438 | 6.74e-01 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 1 | 162 | 6.74e-01 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 1 | 484 | 6.74e-01 |
| GO:BP | GO:1901632 | regulation of synaptic vesicle membrane organization | 1 | 8 | 6.74e-01 |
| GO:BP | GO:1900081 | regulation of arginine catabolic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0006766 | vitamin metabolic process | 1 | 73 | 6.74e-01 |
| GO:BP | GO:1900082 | negative regulation of arginine catabolic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0033241 | regulation of amine catabolic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:2000283 | negative regulation of amino acid biosynthetic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0098736 | negative regulation of the force of heart contraction | 1 | 1 | 6.74e-01 |
| GO:BP | GO:1903248 | regulation of citrulline biosynthetic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:1903249 | negative regulation of citrulline biosynthetic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0033242 | negative regulation of amine catabolic process | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0061108 | seminal vesicle epithelium development | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0071397 | cellular response to cholesterol | 1 | 11 | 6.74e-01 |
| GO:BP | GO:0007040 | lysosome organization | 3 | 88 | 6.74e-01 |
| GO:BP | GO:0080171 | lytic vacuole organization | 3 | 88 | 6.74e-01 |
| GO:BP | GO:0030218 | erythrocyte differentiation | 1 | 107 | 6.74e-01 |
| GO:BP | GO:0032782 | bile acid secretion | 1 | 5 | 6.74e-01 |
| GO:BP | GO:0065008 | regulation of biological quality | 41 | 2102 | 6.74e-01 |
| GO:BP | GO:1901654 | response to ketone | 3 | 147 | 6.74e-01 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 4 | 4099 | 6.74e-01 |
| GO:BP | GO:0042628 | mating plug formation | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0009306 | protein secretion | 2 | 262 | 6.74e-01 |
| GO:BP | GO:0002732 | positive regulation of dendritic cell cytokine production | 3 | 8 | 6.74e-01 |
| GO:BP | GO:0070375 | ERK5 cascade | 1 | 3 | 6.74e-01 |
| GO:BP | GO:1905523 | positive regulation of macrophage migration | 2 | 13 | 6.74e-01 |
| GO:BP | GO:0001682 | tRNA 5’-leader removal | 7 | 13 | 6.74e-01 |
| GO:BP | GO:0032835 | glomerulus development | 9 | 54 | 6.74e-01 |
| GO:BP | GO:0043363 | nucleate erythrocyte differentiation | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0002574 | thrombocyte differentiation | 1 | 1 | 6.74e-01 |
| GO:BP | GO:0045066 | regulatory T cell differentiation | 10 | 22 | 6.74e-01 |
| GO:BP | GO:0050819 | negative regulation of coagulation | 5 | 38 | 6.74e-01 |
| GO:BP | GO:0008585 | female gonad development | 24 | 77 | 6.74e-01 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 1 | 68 | 6.75e-01 |
| GO:BP | GO:0006783 | heme biosynthetic process | 7 | 30 | 6.75e-01 |
| GO:BP | GO:0018125 | peptidyl-cysteine methylation | 1 | 2 | 6.75e-01 |
| GO:BP | GO:0032370 | positive regulation of lipid transport | 5 | 58 | 6.75e-01 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 5 | 169 | 6.75e-01 |
| GO:BP | GO:2000010 | positive regulation of protein localization to cell surface | 1 | 16 | 6.75e-01 |
| GO:BP | GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway | 17 | 61 | 6.75e-01 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 2 | 262 | 6.75e-01 |
| GO:BP | GO:2000633 | positive regulation of pre-miRNA processing | 1 | 1 | 6.75e-01 |
| GO:BP | GO:0051295 | establishment of meiotic spindle localization | 1 | 4 | 6.75e-01 |
| GO:BP | GO:0007411 | axon guidance | 2 | 185 | 6.75e-01 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 2 | 50 | 6.75e-01 |
| GO:BP | GO:0045932 | negative regulation of muscle contraction | 1 | 20 | 6.75e-01 |
| GO:BP | GO:0060457 | negative regulation of digestive system process | 1 | 7 | 6.75e-01 |
| GO:BP | GO:0051204 | protein insertion into mitochondrial membrane | 7 | 34 | 6.76e-01 |
| GO:BP | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 5 | 10 | 6.76e-01 |
| GO:BP | GO:1904970 | brush border assembly | 1 | 2 | 6.76e-01 |
| GO:BP | GO:0035543 | positive regulation of SNARE complex assembly | 1 | 1 | 6.76e-01 |
| GO:BP | GO:1903284 | positive regulation of glutathione peroxidase activity | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0032633 | interleukin-4 production | 2 | 14 | 6.76e-01 |
| GO:BP | GO:0007409 | axonogenesis | 4 | 359 | 6.76e-01 |
| GO:BP | GO:0035771 | interleukin-4-mediated signaling pathway | 2 | 4 | 6.76e-01 |
| GO:BP | GO:0043508 | negative regulation of JUN kinase activity | 4 | 13 | 6.76e-01 |
| GO:BP | GO:0016256 | N-glycan processing to lysosome | 1 | 2 | 6.76e-01 |
| GO:BP | GO:0001963 | synaptic transmission, dopaminergic | 1 | 16 | 6.76e-01 |
| GO:BP | GO:0015920 | lipopolysaccharide transport | 1 | 1 | 6.76e-01 |
| GO:BP | GO:1903285 | positive regulation of hydrogen peroxide catabolic process | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0051585 | negative regulation of dopamine uptake involved in synaptic transmission | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway | 1 | 2 | 6.76e-01 |
| GO:BP | GO:0071514 | genomic imprinting | 1 | 9 | 6.76e-01 |
| GO:BP | GO:0051945 | negative regulation of catecholamine uptake involved in synaptic transmission | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0001408 | guanine nucleotide transport | 1 | 6 | 6.76e-01 |
| GO:BP | GO:0051622 | negative regulation of norepinephrine uptake | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0035669 | TRAM-dependent toll-like receptor 4 signaling pathway | 1 | 2 | 6.76e-01 |
| GO:BP | GO:0015850 | organic hydroxy compound transport | 5 | 174 | 6.76e-01 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1 | 1836 | 6.76e-01 |
| GO:BP | GO:0098838 | folate transmembrane transport | 1 | 6 | 6.76e-01 |
| GO:BP | GO:0032673 | regulation of interleukin-4 production | 2 | 14 | 6.76e-01 |
| GO:BP | GO:0032104 | regulation of response to extracellular stimulus | 1 | 19 | 6.76e-01 |
| GO:BP | GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 5 | 8 | 6.76e-01 |
| GO:BP | GO:0032107 | regulation of response to nutrient levels | 1 | 19 | 6.76e-01 |
| GO:BP | GO:0000413 | protein peptidyl-prolyl isomerization | 6 | 26 | 6.76e-01 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 8 | 179 | 6.76e-01 |
| GO:BP | GO:0097485 | neuron projection guidance | 2 | 186 | 6.76e-01 |
| GO:BP | GO:0060066 | oviduct development | 1 | 4 | 6.76e-01 |
| GO:BP | GO:1904992 | positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0021535 | cell migration in hindbrain | 8 | 12 | 6.76e-01 |
| GO:BP | GO:0090114 | COPII-coated vesicle budding | 1 | 40 | 6.76e-01 |
| GO:BP | GO:0045672 | positive regulation of osteoclast differentiation | 1 | 11 | 6.76e-01 |
| GO:BP | GO:0097283 | keratinocyte apoptotic process | 1 | 5 | 6.76e-01 |
| GO:BP | GO:0048240 | sperm capacitation | 1 | 7 | 6.76e-01 |
| GO:BP | GO:1904990 | regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway | 1 | 1 | 6.76e-01 |
| GO:BP | GO:1902172 | regulation of keratinocyte apoptotic process | 1 | 5 | 6.76e-01 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 4 | 3132 | 6.76e-01 |
| GO:BP | GO:0061620 | glycolytic process through glucose-6-phosphate | 1 | 17 | 6.76e-01 |
| GO:BP | GO:0045143 | homologous chromosome segregation | 14 | 34 | 6.76e-01 |
| GO:BP | GO:0010171 | body morphogenesis | 16 | 45 | 6.76e-01 |
| GO:BP | GO:1903570 | regulation of protein kinase D signaling | 1 | 1 | 6.76e-01 |
| GO:BP | GO:1903572 | positive regulation of protein kinase D signaling | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0002575 | basophil chemotaxis | 1 | 1 | 6.76e-01 |
| GO:BP | GO:0031440 | regulation of mRNA 3’-end processing | 2 | 22 | 6.76e-01 |
| GO:BP | GO:0035441 | cell migration involved in vasculogenesis | 2 | 4 | 6.77e-01 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 1 | 168 | 6.77e-01 |
| GO:BP | GO:0032713 | negative regulation of interleukin-4 production | 3 | 5 | 6.77e-01 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 5 | 3750 | 6.77e-01 |
| GO:BP | GO:0110096 | cellular response to aldehyde | 4 | 10 | 6.77e-01 |
| GO:BP | GO:0002070 | epithelial cell maturation | 8 | 16 | 6.77e-01 |
| GO:BP | GO:0001569 | branching involved in blood vessel morphogenesis | 3 | 29 | 6.78e-01 |
| GO:BP | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity | 1 | 3 | 6.78e-01 |
| GO:BP | GO:1902645 | tertiary alcohol biosynthetic process | 2 | 8 | 6.78e-01 |
| GO:BP | GO:0006050 | mannosamine metabolic process | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1 | 28 | 6.78e-01 |
| GO:BP | GO:0045087 | innate immune response | 7 | 488 | 6.78e-01 |
| GO:BP | GO:0021825 | substrate-dependent cerebral cortex tangential migration | 1 | 2 | 6.78e-01 |
| GO:BP | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter | 1 | 4 | 6.78e-01 |
| GO:BP | GO:0045652 | regulation of megakaryocyte differentiation | 1 | 33 | 6.78e-01 |
| GO:BP | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0006051 | N-acetylmannosamine metabolic process | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0035065 | regulation of histone acetylation | 2 | 47 | 6.78e-01 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 4 | 3133 | 6.78e-01 |
| GO:BP | GO:0021827 | postnatal olfactory bulb interneuron migration | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0106016 | positive regulation of inflammatory response to wounding | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0030282 | bone mineralization | 13 | 82 | 6.78e-01 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 4 | 94 | 6.78e-01 |
| GO:BP | GO:0019344 | cysteine biosynthetic process | 1 | 3 | 6.78e-01 |
| GO:BP | GO:0034651 | cortisol biosynthetic process | 2 | 8 | 6.78e-01 |
| GO:BP | GO:1903334 | positive regulation of protein folding | 1 | 2 | 6.78e-01 |
| GO:BP | GO:0061085 | regulation of histone H3-K27 methylation | 1 | 4 | 6.78e-01 |
| GO:BP | GO:0043418 | homocysteine catabolic process | 1 | 3 | 6.78e-01 |
| GO:BP | GO:0071896 | protein localization to adherens junction | 3 | 6 | 6.78e-01 |
| GO:BP | GO:1900076 | regulation of cellular response to insulin stimulus | 13 | 56 | 6.78e-01 |
| GO:BP | GO:0035728 | response to hepatocyte growth factor | 9 | 15 | 6.78e-01 |
| GO:BP | GO:0036492 | eiF2alpha phosphorylation in response to endoplasmic reticulum stress | 4 | 7 | 6.78e-01 |
| GO:BP | GO:0016561 | protein import into peroxisome matrix, translocation | 2 | 3 | 6.78e-01 |
| GO:BP | GO:0042669 | regulation of inner ear auditory receptor cell fate specification | 1 | 1 | 6.78e-01 |
| GO:BP | GO:0032353 | negative regulation of hormone biosynthetic process | 2 | 8 | 6.78e-01 |
| GO:BP | GO:0033227 | dsRNA transport | 2 | 2 | 6.78e-01 |
| GO:BP | GO:0015801 | aromatic amino acid transport | 6 | 11 | 6.79e-01 |
| GO:BP | GO:0007548 | sex differentiation | 2 | 191 | 6.79e-01 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 1 | 189 | 6.79e-01 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 1 | 199 | 6.79e-01 |
| GO:BP | GO:0035510 | DNA dealkylation | 1 | 28 | 6.79e-01 |
| GO:BP | GO:0050714 | positive regulation of protein secretion | 1 | 100 | 6.79e-01 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 8 | 24 | 6.80e-01 |
| GO:BP | GO:0007350 | blastoderm segmentation | 2 | 17 | 6.80e-01 |
| GO:BP | GO:0001556 | oocyte maturation | 2 | 22 | 6.80e-01 |
| GO:BP | GO:0060760 | positive regulation of response to cytokine stimulus | 2 | 49 | 6.80e-01 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 1 | 701 | 6.80e-01 |
| GO:BP | GO:0070534 | protein K63-linked ubiquitination | 2 | 52 | 6.80e-01 |
| GO:BP | GO:0021511 | spinal cord patterning | 1 | 9 | 6.80e-01 |
| GO:BP | GO:0008300 | isoprenoid catabolic process | 2 | 5 | 6.80e-01 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 43 | 180 | 6.80e-01 |
| GO:BP | GO:0048073 | regulation of eye pigmentation | 1 | 2 | 6.80e-01 |
| GO:BP | GO:0051764 | actin crosslink formation | 5 | 10 | 6.80e-01 |
| GO:BP | GO:0036506 | maintenance of unfolded protein | 1 | 3 | 6.80e-01 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 11 | 517 | 6.80e-01 |
| GO:BP | GO:0061549 | sympathetic ganglion development | 3 | 6 | 6.80e-01 |
| GO:BP | GO:0038029 | epidermal growth factor receptor signaling pathway via MAPK cascade | 1 | 1 | 6.80e-01 |
| GO:BP | GO:1904378 | maintenance of unfolded protein involved in ERAD pathway | 1 | 3 | 6.80e-01 |
| GO:BP | GO:0051001 | negative regulation of nitric-oxide synthase activity | 1 | 6 | 6.80e-01 |
| GO:BP | GO:0002519 | natural killer cell tolerance induction | 1 | 1 | 6.80e-01 |
| GO:BP | GO:0071294 | cellular response to zinc ion | 3 | 15 | 6.80e-01 |
| GO:BP | GO:0006742 | NADP catabolic process | 1 | 3 | 6.80e-01 |
| GO:BP | GO:0060837 | blood vessel endothelial cell differentiation | 3 | 10 | 6.80e-01 |
| GO:BP | GO:0051259 | protein complex oligomerization | 5 | 185 | 6.80e-01 |
| GO:BP | GO:0019677 | NAD catabolic process | 1 | 3 | 6.80e-01 |
| GO:BP | GO:0071765 | nuclear inner membrane organization | 1 | 1 | 6.81e-01 |
| GO:BP | GO:0009304 | tRNA transcription | 1 | 8 | 6.81e-01 |
| GO:BP | GO:0030916 | otic vesicle formation | 4 | 6 | 6.81e-01 |
| GO:BP | GO:0044349 | DNA excision | 1 | 1 | 6.81e-01 |
| GO:BP | GO:0000718 | nucleotide-excision repair, DNA damage removal | 1 | 1 | 6.81e-01 |
| GO:BP | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation | 1 | 4 | 6.81e-01 |
| GO:BP | GO:0030301 | cholesterol transport | 2 | 80 | 6.81e-01 |
| GO:BP | GO:0097712 | vesicle targeting, trans-Golgi to periciliary membrane compartment | 1 | 1 | 6.82e-01 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 6 | 37 | 6.82e-01 |
| GO:BP | GO:1903741 | negative regulation of phosphatidate phosphatase activity | 1 | 1 | 6.83e-01 |
| GO:BP | GO:1903730 | regulation of phosphatidate phosphatase activity | 1 | 1 | 6.83e-01 |
| GO:BP | GO:0048669 | collateral sprouting in absence of injury | 1 | 4 | 6.83e-01 |
| GO:BP | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation | 1 | 4 | 6.83e-01 |
| GO:BP | GO:0006982 | response to lipid hydroperoxide | 2 | 2 | 6.83e-01 |
| GO:BP | GO:0043060 | meiotic metaphase I plate congression | 1 | 1 | 6.83e-01 |
| GO:BP | GO:0006983 | ER overload response | 4 | 12 | 6.84e-01 |
| GO:BP | GO:2000417 | negative regulation of eosinophil migration | 1 | 1 | 6.84e-01 |
| GO:BP | GO:0045903 | positive regulation of translational fidelity | 1 | 1 | 6.84e-01 |
| GO:BP | GO:0048512 | circadian behavior | 1 | 30 | 6.84e-01 |
| GO:BP | GO:0060741 | prostate gland stromal morphogenesis | 1 | 2 | 6.84e-01 |
| GO:BP | GO:2001288 | positive regulation of caveolin-mediated endocytosis | 2 | 3 | 6.84e-01 |
| GO:BP | GO:1990266 | neutrophil migration | 2 | 52 | 6.84e-01 |
| GO:BP | GO:0061061 | muscle structure development | 1 | 546 | 6.84e-01 |
| GO:BP | GO:0090410 | malonate catabolic process | 1 | 1 | 6.84e-01 |
| GO:BP | GO:0000821 | regulation of arginine metabolic process | 2 | 3 | 6.84e-01 |
| GO:BP | GO:1990390 | protein K33-linked ubiquitination | 1 | 2 | 6.84e-01 |
| GO:BP | GO:0002344 | B cell affinity maturation | 1 | 2 | 6.84e-01 |
| GO:BP | GO:0002332 | transitional stage B cell differentiation | 1 | 2 | 6.84e-01 |
| GO:BP | GO:0002343 | peripheral B cell selection | 1 | 2 | 6.84e-01 |
| GO:BP | GO:0030858 | positive regulation of epithelial cell differentiation | 9 | 37 | 6.84e-01 |
| GO:BP | GO:0033341 | regulation of collagen binding | 1 | 2 | 6.84e-01 |
| GO:BP | GO:0007418 | ventral midline development | 2 | 4 | 6.84e-01 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3 | 118 | 6.85e-01 |
| GO:BP | GO:0021702 | cerebellar Purkinje cell differentiation | 5 | 10 | 6.85e-01 |
| GO:BP | GO:0072385 | minus-end-directed organelle transport along microtubule | 3 | 5 | 6.85e-01 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 2 | 172 | 6.85e-01 |
| GO:BP | GO:0021872 | forebrain generation of neurons | 1 | 29 | 6.85e-01 |
| GO:BP | GO:2000351 | regulation of endothelial cell apoptotic process | 1 | 35 | 6.85e-01 |
| GO:BP | GO:0031056 | regulation of histone modification | 14 | 125 | 6.85e-01 |
| GO:BP | GO:0006891 | intra-Golgi vesicle-mediated transport | 1 | 33 | 6.85e-01 |
| GO:BP | GO:0097006 | regulation of plasma lipoprotein particle levels | 1 | 45 | 6.85e-01 |
| GO:BP | GO:0051134 | negative regulation of NK T cell activation | 1 | 1 | 6.85e-01 |
| GO:BP | GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 1 | 47 | 6.86e-01 |
| GO:BP | GO:2000774 | positive regulation of cellular senescence | 3 | 9 | 6.86e-01 |
| GO:BP | GO:0010637 | negative regulation of mitochondrial fusion | 4 | 8 | 6.86e-01 |
| GO:BP | GO:1901622 | positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 1 | 1 | 6.86e-01 |
| GO:BP | GO:0009072 | aromatic amino acid metabolic process | 2 | 12 | 6.86e-01 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 6 | 295 | 6.86e-01 |
| GO:BP | GO:0015964 | diadenosine triphosphate catabolic process | 1 | 1 | 6.86e-01 |
| GO:BP | GO:0015962 | diadenosine triphosphate metabolic process | 1 | 1 | 6.86e-01 |
| GO:BP | GO:1900623 | regulation of monocyte aggregation | 2 | 3 | 6.86e-01 |
| GO:BP | GO:1900625 | positive regulation of monocyte aggregation | 2 | 3 | 6.86e-01 |
| GO:BP | GO:0051562 | negative regulation of mitochondrial calcium ion concentration | 1 | 2 | 6.86e-01 |
| GO:BP | GO:0071902 | positive regulation of protein serine/threonine kinase activity | 1 | 135 | 6.86e-01 |
| GO:BP | GO:0032613 | interleukin-10 production | 2 | 24 | 6.86e-01 |
| GO:BP | GO:0051647 | nucleus localization | 2 | 28 | 6.86e-01 |
| GO:BP | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation | 1 | 1 | 6.86e-01 |
| GO:BP | GO:0036292 | DNA rewinding | 1 | 1 | 6.86e-01 |
| GO:BP | GO:2000452 | regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation | 1 | 1 | 6.86e-01 |
| GO:BP | GO:0032653 | regulation of interleukin-10 production | 2 | 24 | 6.86e-01 |
| GO:BP | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation | 1 | 1 | 6.86e-01 |
| GO:BP | GO:1903225 | negative regulation of endodermal cell differentiation | 2 | 3 | 6.86e-01 |
| GO:BP | GO:0043922 | negative regulation by host of viral transcription | 2 | 11 | 6.87e-01 |
| GO:BP | GO:0070911 | global genome nucleotide-excision repair | 1 | 2 | 6.87e-01 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 9 | 403 | 6.87e-01 |
| GO:BP | GO:0042354 | L-fucose metabolic process | 2 | 4 | 6.87e-01 |
| GO:BP | GO:0036116 | long-chain fatty-acyl-CoA catabolic process | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0007221 | positive regulation of transcription of Notch receptor target | 3 | 7 | 6.87e-01 |
| GO:BP | GO:0001192 | maintenance of transcriptional fidelity during transcription elongation | 1 | 1 | 6.87e-01 |
| GO:BP | GO:1900535 | palmitic acid biosynthetic process | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0008626 | granzyme-mediated apoptotic signaling pathway | 1 | 1 | 6.87e-01 |
| GO:BP | GO:1990791 | dorsal root ganglion development | 3 | 6 | 6.87e-01 |
| GO:BP | GO:1904925 | positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization | 7 | 14 | 6.87e-01 |
| GO:BP | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process | 1 | 2 | 6.87e-01 |
| GO:BP | GO:0032897 | negative regulation of viral transcription | 1 | 15 | 6.87e-01 |
| GO:BP | GO:0001193 | maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0043970 | histone H3-K9 acetylation | 2 | 8 | 6.87e-01 |
| GO:BP | GO:0050428 | 3’-phosphoadenosine 5’-phosphosulfate biosynthetic process | 1 | 2 | 6.87e-01 |
| GO:BP | GO:1900533 | palmitic acid metabolic process | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0071919 | G-quadruplex DNA formation | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0000103 | sulfate assimilation | 1 | 2 | 6.87e-01 |
| GO:BP | GO:0007435 | salivary gland morphogenesis | 3 | 25 | 6.87e-01 |
| GO:BP | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway | 6 | 15 | 6.87e-01 |
| GO:BP | GO:0003056 | regulation of vascular associated smooth muscle contraction | 3 | 8 | 6.87e-01 |
| GO:BP | GO:0030204 | chondroitin sulfate metabolic process | 1 | 28 | 6.87e-01 |
| GO:BP | GO:0002883 | regulation of hypersensitivity | 3 | 5 | 6.87e-01 |
| GO:BP | GO:0090330 | regulation of platelet aggregation | 3 | 21 | 6.87e-01 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 2 | 963 | 6.87e-01 |
| GO:BP | GO:0032596 | protein transport into membrane raft | 2 | 4 | 6.87e-01 |
| GO:BP | GO:0034101 | erythrocyte homeostasis | 1 | 114 | 6.87e-01 |
| GO:BP | GO:2000659 | regulation of interleukin-1-mediated signaling pathway | 4 | 4 | 6.87e-01 |
| GO:BP | GO:0051391 | tRNA acetylation | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0071688 | striated muscle myosin thick filament assembly | 2 | 3 | 6.87e-01 |
| GO:BP | GO:0009210 | pyrimidine ribonucleoside triphosphate catabolic process | 1 | 1 | 6.87e-01 |
| GO:BP | GO:1903766 | positive regulation of potassium ion export across plasma membrane | 1 | 3 | 6.87e-01 |
| GO:BP | GO:1904812 | rRNA acetylation involved in maturation of SSU-rRNA | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0035281 | pre-miRNA export from nucleus | 1 | 2 | 6.87e-01 |
| GO:BP | GO:0031062 | positive regulation of histone methylation | 11 | 36 | 6.87e-01 |
| GO:BP | GO:0032484 | Ral protein signal transduction | 2 | 5 | 6.87e-01 |
| GO:BP | GO:0110010 | basolateral protein secretion | 2 | 3 | 6.87e-01 |
| GO:BP | GO:1990882 | rRNA acetylation | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0046052 | UTP catabolic process | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0040031 | snRNA modification | 2 | 7 | 6.87e-01 |
| GO:BP | GO:1990884 | RNA acetylation | 1 | 1 | 6.87e-01 |
| GO:BP | GO:0061015 | snRNA import into nucleus | 1 | 2 | 6.87e-01 |
| GO:BP | GO:0030241 | skeletal muscle myosin thick filament assembly | 2 | 3 | 6.87e-01 |
| GO:BP | GO:0006254 | CTP catabolic process | 1 | 1 | 6.87e-01 |
| GO:BP | GO:1903650 | negative regulation of cytoplasmic transport | 2 | 3 | 6.87e-01 |
| GO:BP | GO:1904505 | regulation of telomere maintenance in response to DNA damage | 9 | 17 | 6.87e-01 |
| GO:BP | GO:0046655 | folic acid metabolic process | 2 | 14 | 6.88e-01 |
| GO:BP | GO:0042742 | defense response to bacterium | 2 | 95 | 6.88e-01 |
| GO:BP | GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 2 | 27 | 6.88e-01 |
| GO:BP | GO:0016240 | autophagosome membrane docking | 3 | 7 | 6.88e-01 |
| GO:BP | GO:0048148 | behavioral response to cocaine | 3 | 9 | 6.88e-01 |
| GO:BP | GO:0061198 | fungiform papilla formation | 1 | 3 | 6.88e-01 |
| GO:BP | GO:0006997 | nucleus organization | 4 | 126 | 6.88e-01 |
| GO:BP | GO:0009451 | RNA modification | 43 | 162 | 6.88e-01 |
| GO:BP | GO:0061615 | glycolytic process through fructose-6-phosphate | 1 | 17 | 6.88e-01 |
| GO:BP | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death | 2 | 3 | 6.88e-01 |
| GO:BP | GO:1901687 | glutathione derivative biosynthetic process | 1 | 3 | 6.88e-01 |
| GO:BP | GO:1901685 | glutathione derivative metabolic process | 1 | 3 | 6.88e-01 |
| GO:BP | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response | 1 | 5 | 6.88e-01 |
| GO:BP | GO:0099040 | ceramide translocation | 1 | 2 | 6.88e-01 |
| GO:BP | GO:0035966 | response to topologically incorrect protein | 3 | 150 | 6.88e-01 |
| GO:BP | GO:0003163 | sinoatrial node development | 4 | 10 | 6.88e-01 |
| GO:BP | GO:0031038 | myosin II filament organization | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0070988 | demethylation | 4 | 52 | 6.89e-01 |
| GO:BP | GO:0043519 | regulation of myosin II filament organization | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0051709 | regulation of killing of cells of another organism | 2 | 3 | 6.89e-01 |
| GO:BP | GO:0043252 | sodium-independent organic anion transport | 1 | 4 | 6.89e-01 |
| GO:BP | GO:0031468 | nuclear membrane reassembly | 1 | 24 | 6.89e-01 |
| GO:BP | GO:0072706 | response to sodium dodecyl sulfate | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 | 38 | 6.89e-01 |
| GO:BP | GO:0072707 | cellular response to sodium dodecyl sulfate | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0060921 | sinoatrial node cell differentiation | 2 | 5 | 6.89e-01 |
| GO:BP | GO:0021750 | vestibular nucleus development | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 1 | 6 | 6.89e-01 |
| GO:BP | GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 1 | 6 | 6.89e-01 |
| GO:BP | GO:0140718 | facultative heterochromatin formation | 4 | 35 | 6.89e-01 |
| GO:BP | GO:0006639 | acylglycerol metabolic process | 4 | 92 | 6.89e-01 |
| GO:BP | GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 20 | 39 | 6.89e-01 |
| GO:BP | GO:0099149 | regulation of postsynaptic neurotransmitter receptor internalization | 5 | 11 | 6.89e-01 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 2 | 99 | 6.89e-01 |
| GO:BP | GO:0070989 | oxidative demethylation | 4 | 10 | 6.89e-01 |
| GO:BP | GO:0010839 | negative regulation of keratinocyte proliferation | 1 | 19 | 6.89e-01 |
| GO:BP | GO:0035037 | sperm entry | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 9 | 114 | 6.89e-01 |
| GO:BP | GO:0010719 | negative regulation of epithelial to mesenchymal transition | 8 | 29 | 6.89e-01 |
| GO:BP | GO:0006101 | citrate metabolic process | 3 | 5 | 6.89e-01 |
| GO:BP | GO:0019518 | L-threonine catabolic process to glycine | 1 | 1 | 6.89e-01 |
| GO:BP | GO:1905528 | positive regulation of Golgi lumen acidification | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0019284 | L-methionine salvage from S-adenosylmethionine | 1 | 3 | 6.89e-01 |
| GO:BP | GO:1902019 | regulation of cilium-dependent cell motility | 1 | 12 | 6.89e-01 |
| GO:BP | GO:0060295 | regulation of cilium movement involved in cell motility | 1 | 12 | 6.89e-01 |
| GO:BP | GO:0035063 | nuclear speck organization | 2 | 3 | 6.89e-01 |
| GO:BP | GO:0090298 | negative regulation of mitochondrial DNA replication | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0006288 | base-excision repair, DNA ligation | 1 | 1 | 6.89e-01 |
| GO:BP | GO:0006606 | protein import into nucleus | 13 | 147 | 6.90e-01 |
| GO:BP | GO:0042158 | lipoprotein biosynthetic process | 14 | 92 | 6.90e-01 |
| GO:BP | GO:0002331 | pre-B cell allelic exclusion | 1 | 2 | 6.90e-01 |
| GO:BP | GO:1990478 | response to ultrasound | 1 | 2 | 6.90e-01 |
| GO:BP | GO:0036250 | peroxisome transport along microtubule | 1 | 1 | 6.90e-01 |
| GO:BP | GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 4 | 16 | 6.90e-01 |
| GO:BP | GO:2000448 | positive regulation of macrophage migration inhibitory factor signaling pathway | 1 | 2 | 6.90e-01 |
| GO:BP | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway | 5 | 9 | 6.90e-01 |
| GO:BP | GO:0006953 | acute-phase response | 1 | 18 | 6.90e-01 |
| GO:BP | GO:0006651 | diacylglycerol biosynthetic process | 4 | 7 | 6.90e-01 |
| GO:BP | GO:0071344 | diphosphate metabolic process | 1 | 2 | 6.90e-01 |
| GO:BP | GO:0042537 | benzene-containing compound metabolic process | 1 | 14 | 6.90e-01 |
| GO:BP | GO:0090208 | positive regulation of triglyceride metabolic process | 1 | 18 | 6.91e-01 |
| GO:BP | GO:1904251 | regulation of bile acid metabolic process | 1 | 9 | 6.91e-01 |
| GO:BP | GO:0009812 | flavonoid metabolic process | 1 | 4 | 6.91e-01 |
| GO:BP | GO:0033027 | positive regulation of mast cell apoptotic process | 1 | 1 | 6.91e-01 |
| GO:BP | GO:0046039 | GTP metabolic process | 10 | 21 | 6.91e-01 |
| GO:BP | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission | 1 | 1 | 6.91e-01 |
| GO:BP | GO:0009226 | nucleotide-sugar biosynthetic process | 7 | 19 | 6.92e-01 |
| GO:BP | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 1 | 6 | 6.92e-01 |
| GO:BP | GO:0032793 | positive regulation of CREB transcription factor activity | 3 | 15 | 6.92e-01 |
| GO:BP | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | 1 | 1 | 6.92e-01 |
| GO:BP | GO:0043413 | macromolecule glycosylation | 1 | 187 | 6.92e-01 |
| GO:BP | GO:0033344 | cholesterol efflux | 2 | 40 | 6.92e-01 |
| GO:BP | GO:0006486 | protein glycosylation | 1 | 187 | 6.92e-01 |
| GO:BP | GO:2000781 | positive regulation of double-strand break repair | 10 | 79 | 6.92e-01 |
| GO:BP | GO:0007622 | rhythmic behavior | 1 | 32 | 6.92e-01 |
| GO:BP | GO:0019852 | L-ascorbic acid metabolic process | 1 | 9 | 6.92e-01 |
| GO:BP | GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 2 | 3 | 6.92e-01 |
| GO:BP | GO:1901334 | lactone metabolic process | 1 | 9 | 6.92e-01 |
| GO:BP | GO:1905634 | regulation of protein localization to chromatin | 1 | 8 | 6.92e-01 |
| GO:BP | GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 2 | 15 | 6.93e-01 |
| GO:BP | GO:0061308 | cardiac neural crest cell development involved in heart development | 2 | 15 | 6.93e-01 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 15 | 62 | 6.93e-01 |
| GO:BP | GO:0003165 | Purkinje myocyte development | 2 | 3 | 6.93e-01 |
| GO:BP | GO:0071449 | cellular response to lipid hydroperoxide | 1 | 1 | 6.93e-01 |
| GO:BP | GO:0023056 | positive regulation of signaling | 2 | 1256 | 6.93e-01 |
| GO:BP | GO:0035635 | entry of bacterium into host cell | 1 | 8 | 6.93e-01 |
| GO:BP | GO:0006638 | neutral lipid metabolic process | 4 | 93 | 6.93e-01 |
| GO:BP | GO:0006767 | water-soluble vitamin metabolic process | 3 | 49 | 6.93e-01 |
| GO:BP | GO:0160007 | glutathione import into mitochondrion | 1 | 1 | 6.93e-01 |
| GO:BP | GO:0042789 | mRNA transcription by RNA polymerase II | 1 | 45 | 6.93e-01 |
| GO:BP | GO:2000643 | positive regulation of early endosome to late endosome transport | 4 | 7 | 6.93e-01 |
| GO:BP | GO:0017126 | nucleologenesis | 1 | 2 | 6.93e-01 |
| GO:BP | GO:1900079 | regulation of arginine biosynthetic process | 1 | 1 | 6.93e-01 |
| GO:BP | GO:0090384 | phagosome-lysosome docking | 1 | 1 | 6.93e-01 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 2 | 1255 | 6.93e-01 |
| GO:BP | GO:0071386 | cellular response to corticosterone stimulus | 1 | 1 | 6.93e-01 |
| GO:BP | GO:0071636 | positive regulation of transforming growth factor beta production | 5 | 16 | 6.93e-01 |
| GO:BP | GO:0006782 | protoporphyrinogen IX biosynthetic process | 2 | 9 | 6.93e-01 |
| GO:BP | GO:0071400 | cellular response to oleic acid | 2 | 3 | 6.93e-01 |
| GO:BP | GO:2000368 | positive regulation of acrosomal vesicle exocytosis | 1 | 2 | 6.93e-01 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 1 | 106 | 6.93e-01 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 12 | 168 | 6.94e-01 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 49 | 294 | 6.94e-01 |
| GO:BP | GO:0007568 | aging | 9 | 115 | 6.94e-01 |
| GO:BP | GO:0001944 | vasculature development | 7 | 559 | 6.94e-01 |
| GO:BP | GO:2000474 | regulation of opioid receptor signaling pathway | 1 | 2 | 6.94e-01 |
| GO:BP | GO:1900373 | positive regulation of purine nucleotide biosynthetic process | 3 | 12 | 6.94e-01 |
| GO:BP | GO:0017145 | stem cell division | 8 | 26 | 6.94e-01 |
| GO:BP | GO:0030810 | positive regulation of nucleotide biosynthetic process | 3 | 12 | 6.94e-01 |
| GO:BP | GO:0044828 | negative regulation by host of viral genome replication | 1 | 7 | 6.94e-01 |
| GO:BP | GO:0098542 | defense response to other organism | 2 | 608 | 6.94e-01 |
| GO:BP | GO:0055002 | striated muscle cell development | 2 | 67 | 6.94e-01 |
| GO:BP | GO:0003235 | sinus venosus development | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0061795 | Golgi lumen acidification | 1 | 13 | 6.94e-01 |
| GO:BP | GO:0038097 | positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0009713 | catechol-containing compound biosynthetic process | 1 | 11 | 6.94e-01 |
| GO:BP | GO:0006713 | glucocorticoid catabolic process | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0003236 | sinus venosus morphogenesis | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0043032 | positive regulation of macrophage activation | 1 | 12 | 6.94e-01 |
| GO:BP | GO:0003260 | cardioblast migration | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0042664 | negative regulation of endodermal cell fate specification | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0070368 | positive regulation of hepatocyte differentiation | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0060975 | cardioblast migration to the midline involved in heart field formation | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0032474 | otolith morphogenesis | 1 | 3 | 6.94e-01 |
| GO:BP | GO:0003259 | cardioblast anterior-lateral migration | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 6 | 31 | 6.94e-01 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 7 | 160 | 6.94e-01 |
| GO:BP | GO:0097529 | myeloid leukocyte migration | 7 | 120 | 6.94e-01 |
| GO:BP | GO:0015851 | nucleobase transport | 1 | 7 | 6.94e-01 |
| GO:BP | GO:0003318 | cell migration to the midline involved in heart development | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0042423 | catecholamine biosynthetic process | 1 | 11 | 6.94e-01 |
| GO:BP | GO:0009444 | pyruvate oxidation | 1 | 1 | 6.94e-01 |
| GO:BP | GO:1900378 | positive regulation of secondary metabolite biosynthetic process | 1 | 7 | 6.94e-01 |
| GO:BP | GO:2000648 | positive regulation of stem cell proliferation | 2 | 31 | 6.94e-01 |
| GO:BP | GO:0120127 | response to zinc ion starvation | 3 | 6 | 6.94e-01 |
| GO:BP | GO:2000065 | negative regulation of cortisol biosynthetic process | 1 | 4 | 6.94e-01 |
| GO:BP | GO:0032348 | negative regulation of aldosterone biosynthetic process | 1 | 4 | 6.94e-01 |
| GO:BP | GO:0072189 | ureter development | 5 | 10 | 6.94e-01 |
| GO:BP | GO:0048023 | positive regulation of melanin biosynthetic process | 1 | 7 | 6.94e-01 |
| GO:BP | GO:0032345 | negative regulation of aldosterone metabolic process | 1 | 4 | 6.94e-01 |
| GO:BP | GO:1905069 | allantois development | 1 | 4 | 6.94e-01 |
| GO:BP | GO:0034224 | cellular response to zinc ion starvation | 3 | 6 | 6.94e-01 |
| GO:BP | GO:0072109 | glomerular mesangium development | 6 | 13 | 6.94e-01 |
| GO:BP | GO:0061343 | cell adhesion involved in heart morphogenesis | 1 | 6 | 6.94e-01 |
| GO:BP | GO:0045056 | transcytosis | 8 | 17 | 6.94e-01 |
| GO:BP | GO:0060490 | lateral sprouting involved in lung morphogenesis | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0007621 | negative regulation of female receptivity | 1 | 1 | 6.94e-01 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2 | 78 | 6.94e-01 |
| GO:BP | GO:0048878 | chemical homeostasis | 13 | 676 | 6.95e-01 |
| GO:BP | GO:0030850 | prostate gland development | 3 | 35 | 6.95e-01 |
| GO:BP | GO:1901897 | regulation of relaxation of cardiac muscle | 1 | 5 | 6.95e-01 |
| GO:BP | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway | 1 | 1 | 6.95e-01 |
| GO:BP | GO:1903830 | magnesium ion transmembrane transport | 8 | 16 | 6.95e-01 |
| GO:BP | GO:0062100 | positive regulation of programmed necrotic cell death | 1 | 5 | 6.95e-01 |
| GO:BP | GO:0042748 | circadian sleep/wake cycle, non-REM sleep | 1 | 3 | 6.95e-01 |
| GO:BP | GO:0035685 | helper T cell diapedesis | 1 | 2 | 6.95e-01 |
| GO:BP | GO:1990839 | response to endothelin | 1 | 2 | 6.95e-01 |
| GO:BP | GO:0098661 | inorganic anion transmembrane transport | 2 | 66 | 6.95e-01 |
| GO:BP | GO:0007007 | inner mitochondrial membrane organization | 19 | 40 | 6.95e-01 |
| GO:BP | GO:0010849 | regulation of proton-transporting ATPase activity, rotational mechanism | 1 | 1 | 6.95e-01 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 1 | 132 | 6.95e-01 |
| GO:BP | GO:0002579 | positive regulation of antigen processing and presentation | 2 | 3 | 6.95e-01 |
| GO:BP | GO:0051568 | histone H3-K4 methylation | 1 | 57 | 6.95e-01 |
| GO:BP | GO:0072676 | lymphocyte migration | 5 | 59 | 6.95e-01 |
| GO:BP | GO:1904338 | regulation of dopaminergic neuron differentiation | 1 | 7 | 6.95e-01 |
| GO:BP | GO:0051930 | regulation of sensory perception of pain | 1 | 13 | 6.95e-01 |
| GO:BP | GO:0051931 | regulation of sensory perception | 1 | 13 | 6.95e-01 |
| GO:BP | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron | 1 | 2 | 6.95e-01 |
| GO:BP | GO:0033689 | negative regulation of osteoblast proliferation | 1 | 10 | 6.95e-01 |
| GO:BP | GO:0003226 | right ventricular compact myocardium morphogenesis | 1 | 1 | 6.95e-01 |
| GO:BP | GO:0051503 | adenine nucleotide transport | 3 | 23 | 6.96e-01 |
| GO:BP | GO:1903883 | positive regulation of interleukin-17-mediated signaling pathway | 1 | 1 | 6.96e-01 |
| GO:BP | GO:1903881 | regulation of interleukin-17-mediated signaling pathway | 1 | 1 | 6.96e-01 |
| GO:BP | GO:1903886 | positive regulation of chemokine (C-C motif) ligand 20 production | 1 | 1 | 6.96e-01 |
| GO:BP | GO:0036392 | chemokine (C-C motif) ligand 20 production | 1 | 1 | 6.96e-01 |
| GO:BP | GO:1903884 | regulation of chemokine (C-C motif) ligand 20 production | 1 | 1 | 6.96e-01 |
| GO:BP | GO:0007014 | actin ubiquitination | 1 | 1 | 6.96e-01 |
| GO:BP | GO:0034462 | small-subunit processome assembly | 2 | 3 | 6.96e-01 |
| GO:BP | GO:0032000 | positive regulation of fatty acid beta-oxidation | 2 | 9 | 6.96e-01 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 4 | 65 | 6.96e-01 |
| GO:BP | GO:0034975 | protein folding in endoplasmic reticulum | 1 | 10 | 6.96e-01 |
| GO:BP | GO:0071347 | cellular response to interleukin-1 | 6 | 64 | 6.96e-01 |
| GO:BP | GO:1905799 | regulation of intraciliary retrograde transport | 1 | 2 | 6.96e-01 |
| GO:BP | GO:0042670 | retinal cone cell differentiation | 3 | 6 | 6.96e-01 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 3 | 151 | 6.96e-01 |
| GO:BP | GO:0046356 | acetyl-CoA catabolic process | 1 | 3 | 6.96e-01 |
| GO:BP | GO:0034341 | response to type II interferon | 1 | 83 | 6.96e-01 |
| GO:BP | GO:1904568 | cellular response to wortmannin | 1 | 2 | 6.96e-01 |
| GO:BP | GO:1904567 | response to wortmannin | 1 | 2 | 6.96e-01 |
| GO:BP | GO:1900276 | regulation of proteinase activated receptor activity | 1 | 1 | 6.96e-01 |
| GO:BP | GO:1900737 | negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway | 1 | 1 | 6.96e-01 |
| GO:BP | GO:1903999 | negative regulation of eating behavior | 1 | 1 | 6.96e-01 |
| GO:BP | GO:0003421 | growth plate cartilage axis specification | 1 | 1 | 6.96e-01 |
| GO:BP | GO:1903403 | negative regulation of renal phosphate excretion | 1 | 1 | 6.96e-01 |
| GO:BP | GO:0003249 | cell proliferation involved in heart valve morphogenesis | 1 | 3 | 6.96e-01 |
| GO:BP | GO:0003250 | regulation of cell proliferation involved in heart valve morphogenesis | 1 | 3 | 6.96e-01 |
| GO:BP | GO:1903721 | positive regulation of I-kappaB phosphorylation | 1 | 5 | 6.97e-01 |
| GO:BP | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development | 1 | 2 | 6.97e-01 |
| GO:BP | GO:0060672 | epithelial cell morphogenesis involved in placental branching | 1 | 2 | 6.97e-01 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 4 | 3237 | 6.97e-01 |
| GO:BP | GO:0000957 | mitochondrial RNA catabolic process | 3 | 6 | 6.97e-01 |
| GO:BP | GO:0022027 | interkinetic nuclear migration | 2 | 4 | 6.97e-01 |
| GO:BP | GO:1903893 | positive regulation of ATF6-mediated unfolded protein response | 1 | 1 | 6.97e-01 |
| GO:BP | GO:1903054 | negative regulation of extracellular matrix organization | 3 | 6 | 6.97e-01 |
| GO:BP | GO:0006493 | protein O-linked glycosylation | 1 | 69 | 6.97e-01 |
| GO:BP | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 2 | 126 | 6.97e-01 |
| GO:BP | GO:0006423 | cysteinyl-tRNA aminoacylation | 1 | 2 | 6.97e-01 |
| GO:BP | GO:0090027 | negative regulation of monocyte chemotaxis | 1 | 4 | 6.97e-01 |
| GO:BP | GO:1902914 | regulation of protein polyubiquitination | 1 | 23 | 6.97e-01 |
| GO:BP | GO:1903867 | extraembryonic membrane development | 4 | 11 | 6.97e-01 |
| GO:BP | GO:0048842 | positive regulation of axon extension involved in axon guidance | 2 | 6 | 6.97e-01 |
| GO:BP | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3 | 13 | 6.97e-01 |
| GO:BP | GO:0071037 | nuclear polyadenylation-dependent snRNA catabolic process | 1 | 2 | 6.97e-01 |
| GO:BP | GO:0071039 | nuclear polyadenylation-dependent CUT catabolic process | 1 | 2 | 6.97e-01 |
| GO:BP | GO:0045792 | negative regulation of cell size | 2 | 9 | 6.97e-01 |
| GO:BP | GO:0090646 | mitochondrial tRNA processing | 6 | 12 | 6.97e-01 |
| GO:BP | GO:0071036 | nuclear polyadenylation-dependent snoRNA catabolic process | 1 | 2 | 6.97e-01 |
| GO:BP | GO:0031509 | subtelomeric heterochromatin formation | 3 | 7 | 6.97e-01 |
| GO:BP | GO:0070661 | leukocyte proliferation | 1 | 188 | 6.97e-01 |
| GO:BP | GO:0072526 | pyridine-containing compound catabolic process | 4 | 7 | 6.97e-01 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 1 | 110 | 6.97e-01 |
| GO:BP | GO:0003406 | retinal pigment epithelium development | 1 | 4 | 6.98e-01 |
| GO:BP | GO:0072674 | multinuclear osteoclast differentiation | 1 | 6 | 6.98e-01 |
| GO:BP | GO:0044804 | autophagy of nucleus | 10 | 18 | 6.98e-01 |
| GO:BP | GO:0051572 | negative regulation of histone H3-K4 methylation | 1 | 4 | 6.98e-01 |
| GO:BP | GO:0060268 | negative regulation of respiratory burst | 2 | 4 | 6.98e-01 |
| GO:BP | GO:0002320 | lymphoid progenitor cell differentiation | 6 | 17 | 6.98e-01 |
| GO:BP | GO:0002071 | glandular epithelial cell maturation | 3 | 7 | 6.98e-01 |
| GO:BP | GO:0006127 | glycerophosphate shuttle | 1 | 2 | 6.98e-01 |
| GO:BP | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway | 3 | 11 | 6.98e-01 |
| GO:BP | GO:0006104 | succinyl-CoA metabolic process | 5 | 9 | 6.98e-01 |
| GO:BP | GO:0000053 | argininosuccinate metabolic process | 1 | 1 | 6.98e-01 |
| GO:BP | GO:1902869 | regulation of amacrine cell differentiation | 1 | 3 | 6.98e-01 |
| GO:BP | GO:0120193 | tight junction organization | 4 | 52 | 6.98e-01 |
| GO:BP | GO:0010725 | regulation of primitive erythrocyte differentiation | 1 | 1 | 6.98e-01 |
| GO:BP | GO:0016183 | synaptic vesicle coating | 3 | 4 | 6.98e-01 |
| GO:BP | GO:0048608 | reproductive structure development | 2 | 212 | 6.98e-01 |
| GO:BP | GO:0007213 | G protein-coupled acetylcholine receptor signaling pathway | 4 | 14 | 6.98e-01 |
| GO:BP | GO:0035854 | eosinophil fate commitment | 1 | 1 | 6.98e-01 |
| GO:BP | GO:0051047 | positive regulation of secretion | 5 | 215 | 6.98e-01 |
| GO:BP | GO:1990679 | histone H4-K12 deacetylation | 1 | 1 | 6.98e-01 |
| GO:BP | GO:1905770 | regulation of mesodermal cell differentiation | 4 | 6 | 6.99e-01 |
| GO:BP | GO:0060592 | mammary gland formation | 4 | 6 | 6.99e-01 |
| GO:BP | GO:0019079 | viral genome replication | 1 | 101 | 6.99e-01 |
| GO:BP | GO:1904153 | negative regulation of retrograde protein transport, ER to cytosol | 1 | 9 | 6.99e-01 |
| GO:BP | GO:0031104 | dendrite regeneration | 1 | 1 | 6.99e-01 |
| GO:BP | GO:0045191 | regulation of isotype switching | 1 | 27 | 6.99e-01 |
| GO:BP | GO:0006497 | protein lipidation | 27 | 89 | 6.99e-01 |
| GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 1 | 18 | 6.99e-01 |
| GO:BP | GO:1903307 | positive regulation of regulated secretory pathway | 1 | 32 | 6.99e-01 |
| GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 3 | 17 | 6.99e-01 |
| GO:BP | GO:0070481 | nuclear-transcribed mRNA catabolic process, non-stop decay | 1 | 1 | 6.99e-01 |
| GO:BP | GO:1903744 | positive regulation of anterograde synaptic vesicle transport | 1 | 2 | 6.99e-01 |
| GO:BP | GO:0008582 | regulation of synaptic assembly at neuromuscular junction | 3 | 4 | 6.99e-01 |
| GO:BP | GO:0140239 | postsynaptic endocytosis | 3 | 17 | 6.99e-01 |
| GO:BP | GO:1902805 | positive regulation of synaptic vesicle transport | 1 | 2 | 6.99e-01 |
| GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 1 | 18 | 6.99e-01 |
| GO:BP | GO:0014724 | regulation of twitch skeletal muscle contraction | 1 | 3 | 6.99e-01 |
| GO:BP | GO:0070651 | nonfunctional rRNA decay | 1 | 1 | 6.99e-01 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 4 | 3012 | 6.99e-01 |
| GO:BP | GO:0042760 | very long-chain fatty acid catabolic process | 2 | 5 | 6.99e-01 |
| GO:BP | GO:0060674 | placenta blood vessel development | 6 | 26 | 6.99e-01 |
| GO:BP | GO:0051123 | RNA polymerase II preinitiation complex assembly | 7 | 54 | 6.99e-01 |
| GO:BP | GO:0110095 | cellular detoxification of aldehyde | 3 | 5 | 6.99e-01 |
| GO:BP | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 1 | 151 | 6.99e-01 |
| GO:BP | GO:0042118 | endothelial cell activation | 3 | 7 | 6.99e-01 |
| GO:BP | GO:0140249 | protein catabolic process at postsynapse | 1 | 2 | 7.00e-01 |
| GO:BP | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 1 | 2 | 7.00e-01 |
| GO:BP | GO:0140246 | protein catabolic process at synapse | 1 | 2 | 7.00e-01 |
| GO:BP | GO:0099533 | positive regulation of presynaptic cytosolic calcium concentration | 1 | 1 | 7.00e-01 |
| GO:BP | GO:0034121 | regulation of toll-like receptor signaling pathway | 1 | 19 | 7.00e-01 |
| GO:BP | GO:0072386 | plus-end-directed organelle transport along microtubule | 2 | 7 | 7.00e-01 |
| GO:BP | GO:1990036 | calcium ion import into sarcoplasmic reticulum | 3 | 4 | 7.00e-01 |
| GO:BP | GO:0060033 | anatomical structure regression | 6 | 11 | 7.00e-01 |
| GO:BP | GO:0060681 | branch elongation involved in ureteric bud branching | 3 | 3 | 7.00e-01 |
| GO:BP | GO:0019083 | viral transcription | 6 | 48 | 7.00e-01 |
| GO:BP | GO:0045141 | meiotic telomere clustering | 1 | 5 | 7.00e-01 |
| GO:BP | GO:0001892 | embryonic placenta development | 18 | 71 | 7.00e-01 |
| GO:BP | GO:0036124 | histone H3-K9 trimethylation | 3 | 9 | 7.00e-01 |
| GO:BP | GO:0021897 | forebrain astrocyte development | 2 | 2 | 7.01e-01 |
| GO:BP | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 4 | 4 | 7.01e-01 |
| GO:BP | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 3 | 5 | 7.01e-01 |
| GO:BP | GO:0042113 | B cell activation | 1 | 170 | 7.01e-01 |
| GO:BP | GO:0046348 | amino sugar catabolic process | 5 | 9 | 7.01e-01 |
| GO:BP | GO:1901222 | regulation of NIK/NF-kappaB signaling | 1 | 65 | 7.01e-01 |
| GO:BP | GO:0021896 | forebrain astrocyte differentiation | 2 | 2 | 7.01e-01 |
| GO:BP | GO:0002337 | B-1a B cell differentiation | 1 | 2 | 7.01e-01 |
| GO:BP | GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 2 | 3 | 7.01e-01 |
| GO:BP | GO:0051571 | positive regulation of histone H3-K4 methylation | 9 | 20 | 7.01e-01 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 2 | 1223 | 7.01e-01 |
| GO:BP | GO:0007084 | mitotic nuclear membrane reassembly | 1 | 9 | 7.01e-01 |
| GO:BP | GO:0101024 | mitotic nuclear membrane organization | 1 | 9 | 7.01e-01 |
| GO:BP | GO:0009589 | detection of UV | 1 | 2 | 7.01e-01 |
| GO:BP | GO:0038020 | insulin receptor recycling | 2 | 4 | 7.01e-01 |
| GO:BP | GO:0061304 | retinal blood vessel morphogenesis | 3 | 5 | 7.01e-01 |
| GO:BP | GO:0032695 | negative regulation of interleukin-12 production | 1 | 6 | 7.01e-01 |
| GO:BP | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 5 | 37 | 7.01e-01 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 4 | 124 | 7.01e-01 |
| GO:BP | GO:0001575 | globoside metabolic process | 1 | 2 | 7.01e-01 |
| GO:BP | GO:1903048 | regulation of acetylcholine-gated cation channel activity | 1 | 1 | 7.01e-01 |
| GO:BP | GO:0010421 | hydrogen peroxide-mediated programmed cell death | 2 | 11 | 7.01e-01 |
| GO:BP | GO:0071389 | cellular response to mineralocorticoid stimulus | 4 | 9 | 7.01e-01 |
| GO:BP | GO:0031179 | peptide modification | 1 | 4 | 7.01e-01 |
| GO:BP | GO:1903049 | negative regulation of acetylcholine-gated cation channel activity | 1 | 1 | 7.01e-01 |
| GO:BP | GO:0001576 | globoside biosynthetic process | 1 | 2 | 7.01e-01 |
| GO:BP | GO:0051127 | positive regulation of actin nucleation | 2 | 14 | 7.02e-01 |
| GO:BP | GO:1905772 | positive regulation of mesodermal cell differentiation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0038116 | chemokine (C-C motif) ligand 21 signaling pathway | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0072577 | endothelial cell apoptotic process | 1 | 40 | 7.02e-01 |
| GO:BP | GO:0046324 | regulation of glucose import | 1 | 41 | 7.02e-01 |
| GO:BP | GO:0030500 | regulation of bone mineralization | 3 | 53 | 7.02e-01 |
| GO:BP | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1905449 | regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 3 | 5 | 7.02e-01 |
| GO:BP | GO:1903167 | regulation of pyrroline-5-carboxylate reductase activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0072192 | ureter epithelial cell differentiation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0042440 | pigment metabolic process | 10 | 60 | 7.02e-01 |
| GO:BP | GO:2000825 | positive regulation of androgen receptor activity | 3 | 5 | 7.02e-01 |
| GO:BP | GO:0030035 | microspike assembly | 3 | 5 | 7.02e-01 |
| GO:BP | GO:0060567 | negative regulation of termination of DNA-templated transcription | 1 | 2 | 7.02e-01 |
| GO:BP | GO:2000144 | positive regulation of DNA-templated transcription initiation | 31 | 65 | 7.02e-01 |
| GO:BP | GO:2000111 | positive regulation of macrophage apoptotic process | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0010899 | regulation of phosphatidylcholine catabolic process | 2 | 3 | 7.02e-01 |
| GO:BP | GO:0018198 | peptidyl-cysteine modification | 22 | 41 | 7.02e-01 |
| GO:BP | GO:0045727 | positive regulation of translation | 1 | 126 | 7.02e-01 |
| GO:BP | GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903200 | positive regulation of L-dopa decarboxylase activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903073 | negative regulation of death-inducing signaling complex assembly | 1 | 1 | 7.02e-01 |
| GO:BP | GO:2000805 | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0035272 | exocrine system development | 4 | 34 | 7.02e-01 |
| GO:BP | GO:0097264 | self proteolysis | 2 | 7 | 7.02e-01 |
| GO:BP | GO:0032525 | somite rostral/caudal axis specification | 2 | 7 | 7.02e-01 |
| GO:BP | GO:0006546 | glycine catabolic process | 3 | 3 | 7.02e-01 |
| GO:BP | GO:0048041 | focal adhesion assembly | 3 | 81 | 7.02e-01 |
| GO:BP | GO:0090194 | negative regulation of glomerulus development | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0097238 | cellular response to methylglyoxal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0030154 | cell differentiation | 3 | 2958 | 7.02e-01 |
| GO:BP | GO:0032608 | interferon-beta production | 15 | 43 | 7.02e-01 |
| GO:BP | GO:0072377 | blood coagulation, common pathway | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0033240 | positive regulation of amine metabolic process | 5 | 7 | 7.02e-01 |
| GO:BP | GO:0090239 | regulation of histone H4 acetylation | 5 | 10 | 7.02e-01 |
| GO:BP | GO:0048242 | epinephrine secretion | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0045214 | sarcomere organization | 19 | 43 | 7.02e-01 |
| GO:BP | GO:0046359 | butyrate catabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0045915 | positive regulation of catecholamine metabolic process | 4 | 6 | 7.02e-01 |
| GO:BP | GO:1903198 | regulation of L-dopa decarboxylase activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0046836 | glycolipid transport | 1 | 7 | 7.02e-01 |
| GO:BP | GO:0010159 | specification of animal organ position | 2 | 2 | 7.02e-01 |
| GO:BP | GO:1903178 | positive regulation of tyrosine 3-monooxygenase activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0033366 | protein localization to secretory granule | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0001949 | sebaceous gland cell differentiation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0060152 | microtubule-based peroxisome localization | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0060151 | peroxisome localization | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1903176 | regulation of tyrosine 3-monooxygenase activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0046134 | pyrimidine nucleoside biosynthetic process | 1 | 4 | 7.02e-01 |
| GO:BP | GO:0031123 | RNA 3’-end processing | 2 | 100 | 7.02e-01 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 7 | 351 | 7.02e-01 |
| GO:BP | GO:0010565 | regulation of cellular ketone metabolic process | 1 | 98 | 7.02e-01 |
| GO:BP | GO:0002934 | desmosome organization | 3 | 9 | 7.02e-01 |
| GO:BP | GO:0033383 | geranyl diphosphate metabolic process | 1 | 3 | 7.02e-01 |
| GO:BP | GO:2000284 | positive regulation of amino acid biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0033505 | floor plate morphogenesis | 1 | 3 | 7.02e-01 |
| GO:BP | GO:0034213 | quinolinate catabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903122 | negative regulation of TRAIL-activated apoptotic signaling pathway | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1904867 | protein localization to Cajal body | 3 | 12 | 7.02e-01 |
| GO:BP | GO:1903043 | positive regulation of chondrocyte hypertrophy | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 12 | 563 | 7.02e-01 |
| GO:BP | GO:0014843 | growth factor dependent regulation of skeletal muscle satellite cell proliferation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1903184 | L-dopa metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903168 | positive regulation of pyrroline-5-carboxylate reductase activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0055020 | positive regulation of cardiac muscle fiber development | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0033602 | negative regulation of dopamine secretion | 3 | 4 | 7.02e-01 |
| GO:BP | GO:1904736 | negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1904735 | regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0046295 | glycolate biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1904733 | negative regulation of electron transfer activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0055018 | regulation of cardiac muscle fiber development | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0060235 | lens induction in camera-type eye | 2 | 3 | 7.02e-01 |
| GO:BP | GO:0097468 | programmed cell death in response to reactive oxygen species | 7 | 12 | 7.02e-01 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 55 | 277 | 7.02e-01 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 1 | 211 | 7.02e-01 |
| GO:BP | GO:1901964 | positive regulation of cell proliferation involved in outflow tract morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1905426 | positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1901494 | regulation of cysteine metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0140924 | L-kynurenine transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0014060 | regulation of epinephrine secretion | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1905424 | regulation of Wnt-mediated midbrain dopaminergic neuron differentiation | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0015782 | CMP-N-acetylneuraminate transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0015789 | UDP-N-acetylgalactosamine transmembrane transport | 2 | 4 | 7.02e-01 |
| GO:BP | GO:0002726 | positive regulation of T cell cytokine production | 1 | 14 | 7.02e-01 |
| GO:BP | GO:0015797 | mannitol transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903041 | regulation of chondrocyte hypertrophy | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0034775 | glutathione transmembrane transport | 4 | 7 | 7.02e-01 |
| GO:BP | GO:0060503 | bud dilation involved in lung branching | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0015787 | UDP-glucuronic acid transmembrane transport | 2 | 4 | 7.02e-01 |
| GO:BP | GO:0032092 | positive regulation of protein binding | 3 | 78 | 7.02e-01 |
| GO:BP | GO:0046885 | regulation of hormone biosynthetic process | 5 | 21 | 7.02e-01 |
| GO:BP | GO:1904022 | positive regulation of G protein-coupled receptor internalization | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0015724 | formate transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903185 | L-dopa biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0045964 | positive regulation of dopamine metabolic process | 4 | 6 | 7.02e-01 |
| GO:BP | GO:0042063 | gliogenesis | 1 | 235 | 7.02e-01 |
| GO:BP | GO:0015735 | uronic acid transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0015736 | hexuronate transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0015738 | glucuronate transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0060323 | head morphogenesis | 12 | 33 | 7.02e-01 |
| GO:BP | GO:1903189 | glyoxal metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903190 | glyoxal catabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0009994 | oocyte differentiation | 7 | 39 | 7.02e-01 |
| GO:BP | GO:1903195 | regulation of L-dopa biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1904430 | negative regulation of t-circle formation | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0010569 | regulation of double-strand break repair via homologous recombination | 8 | 63 | 7.02e-01 |
| GO:BP | GO:1903197 | positive regulation of L-dopa biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0045726 | positive regulation of integrin biosynthetic process | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1904002 | regulation of sebum secreting cell proliferation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1990442 | intrinsic apoptotic signaling pathway in response to nitrosative stress | 2 | 3 | 7.02e-01 |
| GO:BP | GO:0120191 | negative regulation of termination of RNA polymerase II transcription | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1902748 | positive regulation of lens fiber cell differentiation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0021563 | glossopharyngeal nerve development | 2 | 3 | 7.02e-01 |
| GO:BP | GO:2000004 | regulation of metanephric S-shaped body morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036150 | phosphatidylserine acyl-chain remodeling | 1 | 7 | 7.02e-01 |
| GO:BP | GO:0050764 | regulation of phagocytosis | 1 | 57 | 7.02e-01 |
| GO:BP | GO:2000006 | regulation of metanephric comma-shaped body morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0061756 | leukocyte adhesion to vascular endothelial cell | 1 | 27 | 7.02e-01 |
| GO:BP | GO:0071893 | BMP signaling pathway involved in nephric duct formation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036367 | light adaption | 1 | 3 | 7.02e-01 |
| GO:BP | GO:0035633 | maintenance of blood-brain barrier | 2 | 26 | 7.02e-01 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 4 | 2890 | 7.02e-01 |
| GO:BP | GO:1990034 | calcium ion export across plasma membrane | 4 | 6 | 7.02e-01 |
| GO:BP | GO:0002440 | production of molecular mediator of immune response | 6 | 135 | 7.02e-01 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 1 | 55 | 7.02e-01 |
| GO:BP | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1 | 161 | 7.02e-01 |
| GO:BP | GO:1903072 | regulation of death-inducing signaling complex assembly | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0106046 | guanine deglycation, glyoxal removal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0106045 | guanine deglycation, methylglyoxal removal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0106044 | guanine deglycation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 9 | 142 | 7.02e-01 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 2 | 57 | 7.02e-01 |
| GO:BP | GO:0021954 | central nervous system neuron development | 1 | 61 | 7.02e-01 |
| GO:BP | GO:0048599 | oocyte development | 6 | 38 | 7.02e-01 |
| GO:BP | GO:0001525 | angiogenesis | 28 | 390 | 7.02e-01 |
| GO:BP | GO:0007493 | endodermal cell fate determination | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 3 | 42 | 7.02e-01 |
| GO:BP | GO:0006562 | proline catabolic process | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1903405 | protein localization to nuclear body | 3 | 12 | 7.02e-01 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 7 | 64 | 7.02e-01 |
| GO:BP | GO:0071550 | death-inducing signaling complex assembly | 2 | 3 | 7.02e-01 |
| GO:BP | GO:0038002 | endocrine signaling | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036531 | glutathione deglycation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036530 | protein deglycation, methylglyoxal removal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036529 | protein deglycation, glyoxal removal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0048706 | embryonic skeletal system development | 1 | 78 | 7.02e-01 |
| GO:BP | GO:0002352 | B cell negative selection | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0036528 | peptidyl-lysine deglycation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036527 | peptidyl-arginine deglycation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0070085 | glycosylation | 1 | 202 | 7.02e-01 |
| GO:BP | GO:0070235 | regulation of activation-induced cell death of T cells | 2 | 3 | 7.02e-01 |
| GO:BP | GO:0006580 | ethanolamine metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0140041 | cellular detoxification of methylglyoxal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 13 | 67 | 7.02e-01 |
| GO:BP | GO:0042874 | D-glucuronate transmembrane transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0006193 | ITP catabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1900113 | negative regulation of histone H3-K9 trimethylation | 1 | 3 | 7.02e-01 |
| GO:BP | GO:0016132 | brassinosteroid biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0016131 | brassinosteroid metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0016129 | phytosteroid biosynthetic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0016128 | phytosteroid metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036471 | cellular response to glyoxal | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0070099 | regulation of chemokine-mediated signaling pathway | 3 | 8 | 7.02e-01 |
| GO:BP | GO:0036526 | peptidyl-cysteine deglycation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0005997 | xylulose metabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0036037 | CD8-positive, alpha-beta T cell activation | 8 | 15 | 7.02e-01 |
| GO:BP | GO:0048391 | intermediate mesoderm formation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0061151 | BMP signaling pathway involved in renal system segmentation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0072096 | negative regulation of branch elongation involved in ureteric bud branching | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0006954 | inflammatory response | 12 | 429 | 7.02e-01 |
| GO:BP | GO:0061155 | pulmonary artery endothelial tube morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0061150 | renal system segmentation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0048390 | intermediate mesoderm morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0032648 | regulation of interferon-beta production | 15 | 43 | 7.02e-01 |
| GO:BP | GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0048392 | intermediate mesodermal cell differentiation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0072099 | anterior/posterior pattern specification involved in ureteric bud development | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0042492 | gamma-delta T cell differentiation | 2 | 7 | 7.02e-01 |
| GO:BP | GO:0021983 | pituitary gland development | 5 | 22 | 7.02e-01 |
| GO:BP | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 2 | 7 | 7.02e-01 |
| GO:BP | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 2 | 12 | 7.02e-01 |
| GO:BP | GO:0071332 | cellular response to fructose stimulus | 2 | 2 | 7.02e-01 |
| GO:BP | GO:0072100 | specification of ureteric bud anterior/posterior symmetry | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0061141 | lung ciliated cell differentiation | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0097050 | type B pancreatic cell apoptotic process | 3 | 7 | 7.02e-01 |
| GO:BP | GO:1905949 | negative regulation of calcium ion import across plasma membrane | 1 | 4 | 7.02e-01 |
| GO:BP | GO:0030302 | deoxynucleotide transport | 1 | 1 | 7.02e-01 |
| GO:BP | GO:0046949 | fatty-acyl-CoA biosynthetic process | 5 | 20 | 7.02e-01 |
| GO:BP | GO:2000525 | positive regulation of T cell costimulation | 1 | 2 | 7.02e-01 |
| GO:BP | GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 3 | 15 | 7.02e-01 |
| GO:BP | GO:0065002 | intracellular protein transmembrane transport | 27 | 52 | 7.02e-01 |
| GO:BP | GO:0016036 | cellular response to phosphate starvation | 1 | 2 | 7.02e-01 |
| GO:BP | GO:1901615 | organic hydroxy compound metabolic process | 18 | 376 | 7.02e-01 |
| GO:BP | GO:0032342 | aldosterone biosynthetic process | 2 | 9 | 7.02e-01 |
| GO:BP | GO:2001136 | negative regulation of endocytic recycling | 1 | 1 | 7.02e-01 |
| GO:BP | GO:1903140 | regulation of establishment of endothelial barrier | 1 | 12 | 7.02e-01 |
| GO:BP | GO:1901550 | regulation of endothelial cell development | 1 | 12 | 7.02e-01 |
| GO:BP | GO:0071492 | cellular response to UV-A | 1 | 8 | 7.02e-01 |
| GO:BP | GO:0031943 | regulation of glucocorticoid metabolic process | 2 | 11 | 7.02e-01 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 11 | 540 | 7.02e-01 |
| GO:BP | GO:0038034 | signal transduction in absence of ligand | 2 | 52 | 7.03e-01 |
| GO:BP | GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 2 | 52 | 7.03e-01 |
| GO:BP | GO:0002176 | male germ cell proliferation | 2 | 6 | 7.03e-01 |
| GO:BP | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | 4 | 7 | 7.03e-01 |
| GO:BP | GO:0048869 | cellular developmental process | 3 | 2984 | 7.03e-01 |
| GO:BP | GO:1990773 | matrix metallopeptidase secretion | 1 | 5 | 7.03e-01 |
| GO:BP | GO:1904464 | regulation of matrix metallopeptidase secretion | 1 | 5 | 7.03e-01 |
| GO:BP | GO:0030049 | muscle filament sliding | 4 | 10 | 7.03e-01 |
| GO:BP | GO:1904837 | beta-catenin-TCF complex assembly | 1 | 3 | 7.04e-01 |
| GO:BP | GO:0007538 | primary sex determination | 1 | 2 | 7.04e-01 |
| GO:BP | GO:0003176 | aortic valve development | 15 | 37 | 7.04e-01 |
| GO:BP | GO:0007431 | salivary gland development | 3 | 26 | 7.04e-01 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 12 | 40 | 7.04e-01 |
| GO:BP | GO:0019064 | fusion of virus membrane with host plasma membrane | 2 | 4 | 7.04e-01 |
| GO:BP | GO:0046877 | regulation of saliva secretion | 1 | 3 | 7.04e-01 |
| GO:BP | GO:0039663 | membrane fusion involved in viral entry into host cell | 2 | 4 | 7.04e-01 |
| GO:BP | GO:0120181 | focal adhesion disassembly | 1 | 8 | 7.05e-01 |
| GO:BP | GO:0120180 | cell-substrate junction disassembly | 1 | 8 | 7.05e-01 |
| GO:BP | GO:1903672 | positive regulation of sprouting angiogenesis | 1 | 14 | 7.05e-01 |
| GO:BP | GO:0034720 | histone H3-K4 demethylation | 1 | 5 | 7.05e-01 |
| GO:BP | GO:0009180 | purine ribonucleoside diphosphate biosynthetic process | 3 | 4 | 7.05e-01 |
| GO:BP | GO:0006172 | ADP biosynthetic process | 3 | 4 | 7.05e-01 |
| GO:BP | GO:1905430 | cellular response to glycine | 1 | 2 | 7.05e-01 |
| GO:BP | GO:0045833 | negative regulation of lipid metabolic process | 1 | 72 | 7.05e-01 |
| GO:BP | GO:0032438 | melanosome organization | 4 | 36 | 7.05e-01 |
| GO:BP | GO:0050863 | regulation of T cell activation | 1 | 216 | 7.05e-01 |
| GO:BP | GO:0002698 | negative regulation of immune effector process | 1 | 59 | 7.05e-01 |
| GO:BP | GO:0035551 | protein initiator methionine removal involved in protein maturation | 1 | 3 | 7.05e-01 |
| GO:BP | GO:0019222 | regulation of metabolic process | 7 | 5017 | 7.05e-01 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 18 | 120 | 7.05e-01 |
| GO:BP | GO:0030263 | apoptotic chromosome condensation | 1 | 4 | 7.05e-01 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 1 | 18 | 7.05e-01 |
| GO:BP | GO:0003099 | positive regulation of the force of heart contraction by chemical signal | 1 | 2 | 7.05e-01 |
| GO:BP | GO:0000294 | nuclear-transcribed mRNA catabolic process, RNase MRP-dependent | 1 | 2 | 7.05e-01 |
| GO:BP | GO:1903358 | regulation of Golgi organization | 2 | 17 | 7.05e-01 |
| GO:BP | GO:0048496 | maintenance of animal organ identity | 1 | 4 | 7.05e-01 |
| GO:BP | GO:0061370 | testosterone biosynthetic process | 1 | 3 | 7.06e-01 |
| GO:BP | GO:0010518 | positive regulation of phospholipase activity | 3 | 27 | 7.06e-01 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 5 | 19 | 7.06e-01 |
| GO:BP | GO:0034244 | negative regulation of transcription elongation by RNA polymerase II | 5 | 17 | 7.06e-01 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 6 | 30 | 7.07e-01 |
| GO:BP | GO:0006097 | glyoxylate cycle | 1 | 2 | 7.07e-01 |
| GO:BP | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus | 2 | 2 | 7.07e-01 |
| GO:BP | GO:1904347 | regulation of small intestine smooth muscle contraction | 1 | 1 | 7.07e-01 |
| GO:BP | GO:1904349 | positive regulation of small intestine smooth muscle contraction | 1 | 1 | 7.07e-01 |
| GO:BP | GO:0036303 | lymph vessel morphogenesis | 5 | 17 | 7.07e-01 |
| GO:BP | GO:0035502 | metanephric part of ureteric bud development | 1 | 3 | 7.07e-01 |
| GO:BP | GO:0072284 | metanephric S-shaped body morphogenesis | 1 | 4 | 7.07e-01 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 19 | 320 | 7.07e-01 |
| GO:BP | GO:0051290 | protein heterotetramerization | 4 | 12 | 7.07e-01 |
| GO:BP | GO:0045898 | regulation of RNA polymerase II transcription preinitiation complex assembly | 1 | 7 | 7.07e-01 |
| GO:BP | GO:0099039 | sphingolipid translocation | 2 | 4 | 7.07e-01 |
| GO:BP | GO:0006672 | ceramide metabolic process | 1 | 80 | 7.07e-01 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 1 | 37 | 7.07e-01 |
| GO:BP | GO:0008209 | androgen metabolic process | 5 | 16 | 7.07e-01 |
| GO:BP | GO:0048194 | Golgi vesicle budding | 4 | 10 | 7.07e-01 |
| GO:BP | GO:0072584 | caveolin-mediated endocytosis | 3 | 9 | 7.07e-01 |
| GO:BP | GO:0006621 | protein retention in ER lumen | 4 | 8 | 7.07e-01 |
| GO:BP | GO:0070071 | proton-transporting two-sector ATPase complex assembly | 1 | 15 | 7.08e-01 |
| GO:BP | GO:0097400 | interleukin-17-mediated signaling pathway | 3 | 8 | 7.08e-01 |
| GO:BP | GO:0019371 | cyclooxygenase pathway | 2 | 7 | 7.08e-01 |
| GO:BP | GO:2001293 | malonyl-CoA metabolic process | 3 | 6 | 7.08e-01 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 4 | 3080 | 7.08e-01 |
| GO:BP | GO:0051412 | response to corticosterone | 5 | 10 | 7.08e-01 |
| GO:BP | GO:0051091 | positive regulation of DNA-binding transcription factor activity | 14 | 199 | 7.08e-01 |
| GO:BP | GO:0048632 | negative regulation of skeletal muscle tissue growth | 1 | 1 | 7.08e-01 |
| GO:BP | GO:0002115 | store-operated calcium entry | 2 | 15 | 7.08e-01 |
| GO:BP | GO:0034516 | response to vitamin B6 | 1 | 1 | 7.08e-01 |
| GO:BP | GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 1 | 31 | 7.08e-01 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 4 | 116 | 7.09e-01 |
| GO:BP | GO:0051349 | positive regulation of lyase activity | 6 | 23 | 7.09e-01 |
| GO:BP | GO:0046329 | negative regulation of JNK cascade | 7 | 36 | 7.09e-01 |
| GO:BP | GO:1900028 | negative regulation of ruffle assembly | 2 | 4 | 7.09e-01 |
| GO:BP | GO:0051170 | import into nucleus | 13 | 152 | 7.10e-01 |
| GO:BP | GO:0099525 | presynaptic dense core vesicle exocytosis | 2 | 4 | 7.10e-01 |
| GO:BP | GO:1905912 | regulation of calcium ion export across plasma membrane | 2 | 4 | 7.10e-01 |
| GO:BP | GO:1905913 | negative regulation of calcium ion export across plasma membrane | 2 | 4 | 7.10e-01 |
| GO:BP | GO:1904179 | positive regulation of adipose tissue development | 2 | 6 | 7.10e-01 |
| GO:BP | GO:0015711 | organic anion transport | 1 | 264 | 7.11e-01 |
| GO:BP | GO:0015847 | putrescine transport | 2 | 2 | 7.11e-01 |
| GO:BP | GO:1904772 | response to tetrachloromethane | 2 | 4 | 7.11e-01 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 32 | 691 | 7.11e-01 |
| GO:BP | GO:0071305 | cellular response to vitamin D | 2 | 14 | 7.11e-01 |
| GO:BP | GO:0045629 | negative regulation of T-helper 2 cell differentiation | 1 | 3 | 7.11e-01 |
| GO:BP | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 1 | 162 | 7.11e-01 |
| GO:BP | GO:1990167 | protein K27-linked deubiquitination | 2 | 3 | 7.11e-01 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 5 | 275 | 7.12e-01 |
| GO:BP | GO:1901569 | fatty acid derivative catabolic process | 1 | 10 | 7.12e-01 |
| GO:BP | GO:0021551 | central nervous system morphogenesis | 1 | 2 | 7.12e-01 |
| GO:BP | GO:0097155 | fasciculation of sensory neuron axon | 1 | 3 | 7.12e-01 |
| GO:BP | GO:0030043 | actin filament fragmentation | 2 | 4 | 7.13e-01 |
| GO:BP | GO:0010273 | detoxification of copper ion | 1 | 8 | 7.13e-01 |
| GO:BP | GO:1990169 | stress response to copper ion | 1 | 8 | 7.13e-01 |
| GO:BP | GO:0038134 | ERBB2-EGFR signaling pathway | 1 | 6 | 7.13e-01 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 1 | 43 | 7.13e-01 |
| GO:BP | GO:0032907 | transforming growth factor beta3 production | 1 | 3 | 7.13e-01 |
| GO:BP | GO:0032910 | regulation of transforming growth factor beta3 production | 1 | 3 | 7.13e-01 |
| GO:BP | GO:0010457 | centriole-centriole cohesion | 6 | 14 | 7.13e-01 |
| GO:BP | GO:0060699 | regulation of endoribonuclease activity | 1 | 4 | 7.13e-01 |
| GO:BP | GO:0046545 | development of primary female sexual characteristics | 14 | 79 | 7.13e-01 |
| GO:BP | GO:1990145 | maintenance of translational fidelity | 1 | 2 | 7.13e-01 |
| GO:BP | GO:1903902 | positive regulation of viral life cycle | 4 | 19 | 7.13e-01 |
| GO:BP | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity | 1 | 14 | 7.13e-01 |
| GO:BP | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1 | 3 | 7.13e-01 |
| GO:BP | GO:0033189 | response to vitamin A | 2 | 12 | 7.13e-01 |
| GO:BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 2 | 17 | 7.13e-01 |
| GO:BP | GO:1905664 | regulation of calcium ion import across plasma membrane | 2 | 8 | 7.13e-01 |
| GO:BP | GO:0072560 | type B pancreatic cell maturation | 1 | 2 | 7.13e-01 |
| GO:BP | GO:0071888 | macrophage apoptotic process | 5 | 9 | 7.13e-01 |
| GO:BP | GO:0060717 | chorion development | 3 | 8 | 7.13e-01 |
| GO:BP | GO:1900126 | negative regulation of hyaluronan biosynthetic process | 1 | 2 | 7.13e-01 |
| GO:BP | GO:2000416 | regulation of eosinophil migration | 2 | 2 | 7.13e-01 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 13 | 632 | 7.13e-01 |
| GO:BP | GO:0072387 | flavin adenine dinucleotide metabolic process | 1 | 2 | 7.13e-01 |
| GO:BP | GO:0034214 | protein hexamerization | 2 | 9 | 7.14e-01 |
| GO:BP | GO:0008354 | germ cell migration | 1 | 6 | 7.14e-01 |
| GO:BP | GO:1903204 | negative regulation of oxidative stress-induced neuron death | 2 | 19 | 7.15e-01 |
| GO:BP | GO:0048203 | vesicle targeting, trans-Golgi to endosome | 1 | 2 | 7.15e-01 |
| GO:BP | GO:0019432 | triglyceride biosynthetic process | 10 | 31 | 7.15e-01 |
| GO:BP | GO:0038192 | gastric inhibitory peptide signaling pathway | 1 | 1 | 7.15e-01 |
| GO:BP | GO:0090248 | cell migration involved in somitogenic axis elongation | 1 | 2 | 7.15e-01 |
| GO:BP | GO:0090249 | regulation of cell migration involved in somitogenic axis elongation | 1 | 2 | 7.15e-01 |
| GO:BP | GO:0050672 | negative regulation of lymphocyte proliferation | 10 | 46 | 7.16e-01 |
| GO:BP | GO:0090308 | regulation of DNA methylation-dependent heterochromatin formation | 2 | 16 | 7.16e-01 |
| GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1 | 29 | 7.16e-01 |
| GO:BP | GO:0010796 | regulation of multivesicular body size | 1 | 2 | 7.16e-01 |
| GO:BP | GO:1902744 | negative regulation of lamellipodium organization | 2 | 4 | 7.16e-01 |
| GO:BP | GO:0060325 | face morphogenesis | 10 | 28 | 7.16e-01 |
| GO:BP | GO:0060712 | spongiotrophoblast layer development | 3 | 11 | 7.16e-01 |
| GO:BP | GO:2000354 | regulation of ovarian follicle development | 2 | 5 | 7.16e-01 |
| GO:BP | GO:1902836 | positive regulation of proline import across plasma membrane | 1 | 2 | 7.16e-01 |
| GO:BP | GO:1902834 | regulation of proline import across plasma membrane | 1 | 2 | 7.16e-01 |
| GO:BP | GO:1905735 | regulation of L-proline import across plasma membrane | 1 | 2 | 7.16e-01 |
| GO:BP | GO:1905737 | positive regulation of L-proline import across plasma membrane | 1 | 2 | 7.16e-01 |
| GO:BP | GO:0070881 | regulation of proline transport | 1 | 2 | 7.16e-01 |
| GO:BP | GO:0009966 | regulation of signal transduction | 3 | 2285 | 7.16e-01 |
| GO:BP | GO:0070309 | lens fiber cell morphogenesis | 1 | 5 | 7.16e-01 |
| GO:BP | GO:0048133 | male germ-line stem cell asymmetric division | 1 | 1 | 7.17e-01 |
| GO:BP | GO:0015865 | purine nucleotide transport | 3 | 23 | 7.17e-01 |
| GO:BP | GO:0019541 | propionate metabolic process | 1 | 2 | 7.17e-01 |
| GO:BP | GO:0034397 | telomere localization | 1 | 5 | 7.17e-01 |
| GO:BP | GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1 | 26 | 7.17e-01 |
| GO:BP | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation | 1 | 5 | 7.17e-01 |
| GO:BP | GO:0090303 | positive regulation of wound healing | 1 | 45 | 7.17e-01 |
| GO:BP | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production | 1 | 2 | 7.17e-01 |
| GO:BP | GO:0002714 | positive regulation of B cell mediated immunity | 1 | 26 | 7.17e-01 |
| GO:BP | GO:1905207 | regulation of cardiocyte differentiation | 1 | 22 | 7.17e-01 |
| GO:BP | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 2 | 9 | 7.17e-01 |
| GO:BP | GO:0097164 | ammonium ion metabolic process | 1 | 14 | 7.17e-01 |
| GO:BP | GO:0009101 | glycoprotein biosynthetic process | 8 | 252 | 7.18e-01 |
| GO:BP | GO:0080009 | mRNA methylation | 1 | 16 | 7.18e-01 |
| GO:BP | GO:0061515 | myeloid cell development | 4 | 57 | 7.18e-01 |
| GO:BP | GO:0050665 | hydrogen peroxide biosynthetic process | 2 | 11 | 7.18e-01 |
| GO:BP | GO:0048213 | Golgi vesicle prefusion complex stabilization | 1 | 2 | 7.18e-01 |
| GO:BP | GO:0140962 | multicellular organismal-level chemical homeostasis | 2 | 34 | 7.18e-01 |
| GO:BP | GO:1901570 | fatty acid derivative biosynthetic process | 1 | 33 | 7.18e-01 |
| GO:BP | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum | 1 | 10 | 7.18e-01 |
| GO:BP | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 9 | 23 | 7.18e-01 |
| GO:BP | GO:0072318 | clathrin coat disassembly | 4 | 8 | 7.19e-01 |
| GO:BP | GO:0030851 | granulocyte differentiation | 13 | 27 | 7.19e-01 |
| GO:BP | GO:0001743 | lens placode formation | 1 | 2 | 7.19e-01 |
| GO:BP | GO:0046619 | lens placode formation involved in camera-type eye formation | 1 | 2 | 7.19e-01 |
| GO:BP | GO:0031060 | regulation of histone methylation | 5 | 47 | 7.19e-01 |
| GO:BP | GO:0019532 | oxalate transport | 1 | 5 | 7.19e-01 |
| GO:BP | GO:0060426 | lung vasculature development | 1 | 3 | 7.20e-01 |
| GO:BP | GO:0021781 | glial cell fate commitment | 3 | 5 | 7.20e-01 |
| GO:BP | GO:1903900 | regulation of viral life cycle | 1 | 101 | 7.20e-01 |
| GO:BP | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential | 3 | 6 | 7.20e-01 |
| GO:BP | GO:2000757 | negative regulation of peptidyl-lysine acetylation | 7 | 13 | 7.20e-01 |
| GO:BP | GO:0070662 | mast cell proliferation | 2 | 6 | 7.20e-01 |
| GO:BP | GO:0015891 | siderophore transport | 1 | 2 | 7.20e-01 |
| GO:BP | GO:0070666 | regulation of mast cell proliferation | 2 | 6 | 7.20e-01 |
| GO:BP | GO:0045346 | regulation of MHC class II biosynthetic process | 8 | 11 | 7.20e-01 |
| GO:BP | GO:0006629 | lipid metabolic process | 3 | 994 | 7.20e-01 |
| GO:BP | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway | 1 | 10 | 7.20e-01 |
| GO:BP | GO:1904527 | negative regulation of microtubule binding | 1 | 2 | 7.21e-01 |
| GO:BP | GO:1902511 | negative regulation of apoptotic DNA fragmentation | 1 | 2 | 7.21e-01 |
| GO:BP | GO:0045348 | positive regulation of MHC class II biosynthetic process | 6 | 8 | 7.21e-01 |
| GO:BP | GO:0032076 | negative regulation of deoxyribonuclease activity | 1 | 1 | 7.21e-01 |
| GO:BP | GO:0050868 | negative regulation of T cell activation | 1 | 67 | 7.21e-01 |
| GO:BP | GO:0051867 | general adaptation syndrome, behavioral process | 1 | 3 | 7.21e-01 |
| GO:BP | GO:0048193 | Golgi vesicle transport | 6 | 285 | 7.21e-01 |
| GO:BP | GO:0045453 | bone resorption | 1 | 40 | 7.21e-01 |
| GO:BP | GO:0051230 | spindle disassembly | 1 | 2 | 7.21e-01 |
| GO:BP | GO:0043984 | histone H4-K16 acetylation | 6 | 14 | 7.21e-01 |
| GO:BP | GO:0051228 | mitotic spindle disassembly | 1 | 2 | 7.21e-01 |
| GO:BP | GO:0060326 | cell chemotaxis | 15 | 162 | 7.21e-01 |
| GO:BP | GO:0048753 | pigment granule organization | 4 | 37 | 7.21e-01 |
| GO:BP | GO:0032836 | glomerular basement membrane development | 2 | 9 | 7.22e-01 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 2 | 61 | 7.22e-01 |
| GO:BP | GO:0021527 | spinal cord association neuron differentiation | 2 | 3 | 7.22e-01 |
| GO:BP | GO:0009181 | purine ribonucleoside diphosphate catabolic process | 2 | 4 | 7.22e-01 |
| GO:BP | GO:0009137 | purine nucleoside diphosphate catabolic process | 2 | 4 | 7.22e-01 |
| GO:BP | GO:0048755 | branching morphogenesis of a nerve | 1 | 8 | 7.22e-01 |
| GO:BP | GO:1903719 | regulation of I-kappaB phosphorylation | 1 | 6 | 7.22e-01 |
| GO:BP | GO:0046449 | creatinine metabolic process | 1 | 2 | 7.22e-01 |
| GO:BP | GO:0000101 | sulfur amino acid transport | 2 | 10 | 7.23e-01 |
| GO:BP | GO:0050891 | multicellular organismal-level water homeostasis | 3 | 16 | 7.23e-01 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 4 | 114 | 7.23e-01 |
| GO:BP | GO:0050900 | leukocyte migration | 1 | 209 | 7.23e-01 |
| GO:BP | GO:0010520 | regulation of reciprocal meiotic recombination | 1 | 2 | 7.23e-01 |
| GO:BP | GO:0030148 | sphingolipid biosynthetic process | 1 | 88 | 7.23e-01 |
| GO:BP | GO:0070268 | cornification | 1 | 2 | 7.23e-01 |
| GO:BP | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 3 | 11 | 7.23e-01 |
| GO:BP | GO:0010845 | positive regulation of reciprocal meiotic recombination | 1 | 2 | 7.23e-01 |
| GO:BP | GO:0098528 | skeletal muscle fiber differentiation | 1 | 5 | 7.23e-01 |
| GO:BP | GO:0061073 | ciliary body morphogenesis | 1 | 3 | 7.23e-01 |
| GO:BP | GO:0002861 | regulation of inflammatory response to antigenic stimulus | 1 | 24 | 7.23e-01 |
| GO:BP | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment | 1 | 1 | 7.23e-01 |
| GO:BP | GO:0045055 | regulated exocytosis | 4 | 155 | 7.23e-01 |
| GO:BP | GO:0042088 | T-helper 1 type immune response | 7 | 26 | 7.23e-01 |
| GO:BP | GO:0048548 | regulation of pinocytosis | 6 | 11 | 7.23e-01 |
| GO:BP | GO:0031061 | negative regulation of histone methylation | 3 | 9 | 7.23e-01 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 6 | 116 | 7.23e-01 |
| GO:BP | GO:0042692 | muscle cell differentiation | 80 | 324 | 7.24e-01 |
| GO:BP | GO:0010878 | cholesterol storage | 2 | 16 | 7.24e-01 |
| GO:BP | GO:0021644 | vagus nerve morphogenesis | 1 | 1 | 7.24e-01 |
| GO:BP | GO:0006665 | sphingolipid metabolic process | 3 | 131 | 7.24e-01 |
| GO:BP | GO:0097101 | blood vessel endothelial cell fate specification | 1 | 3 | 7.24e-01 |
| GO:BP | GO:0060846 | blood vessel endothelial cell fate commitment | 1 | 3 | 7.24e-01 |
| GO:BP | GO:2000252 | negative regulation of feeding behavior | 2 | 2 | 7.24e-01 |
| GO:BP | GO:0010453 | regulation of cell fate commitment | 9 | 26 | 7.25e-01 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 1 | 199 | 7.25e-01 |
| GO:BP | GO:0051138 | positive regulation of NK T cell differentiation | 1 | 3 | 7.25e-01 |
| GO:BP | GO:0048625 | myoblast fate commitment | 2 | 4 | 7.25e-01 |
| GO:BP | GO:0009712 | catechol-containing compound metabolic process | 3 | 30 | 7.25e-01 |
| GO:BP | GO:0006584 | catecholamine metabolic process | 3 | 30 | 7.25e-01 |
| GO:BP | GO:0015884 | folic acid transport | 1 | 7 | 7.25e-01 |
| GO:BP | GO:1903385 | regulation of homophilic cell adhesion | 1 | 3 | 7.25e-01 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 7 | 29 | 7.25e-01 |
| GO:BP | GO:0006413 | translational initiation | 2 | 116 | 7.25e-01 |
| GO:BP | GO:0030072 | peptide hormone secretion | 1 | 166 | 7.25e-01 |
| GO:BP | GO:0051897 | positive regulation of protein kinase B signaling | 3 | 79 | 7.25e-01 |
| GO:BP | GO:0006427 | histidyl-tRNA aminoacylation | 1 | 2 | 7.25e-01 |
| GO:BP | GO:1905581 | positive regulation of low-density lipoprotein particle clearance | 1 | 2 | 7.25e-01 |
| GO:BP | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering | 1 | 2 | 7.25e-01 |
| GO:BP | GO:0050746 | regulation of lipoprotein metabolic process | 1 | 15 | 7.25e-01 |
| GO:BP | GO:0048702 | embryonic neurocranium morphogenesis | 1 | 7 | 7.25e-01 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 2 | 45 | 7.25e-01 |
| GO:BP | GO:0010875 | positive regulation of cholesterol efflux | 1 | 23 | 7.26e-01 |
| GO:BP | GO:0060018 | astrocyte fate commitment | 2 | 2 | 7.26e-01 |
| GO:BP | GO:1903332 | regulation of protein folding | 3 | 8 | 7.26e-01 |
| GO:BP | GO:0072289 | metanephric nephron tubule formation | 2 | 2 | 7.26e-01 |
| GO:BP | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 3 | 4 | 7.26e-01 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 1 | 234 | 7.26e-01 |
| GO:BP | GO:0032945 | negative regulation of mononuclear cell proliferation | 10 | 46 | 7.26e-01 |
| GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1 | 25 | 7.26e-01 |
| GO:BP | GO:1903305 | regulation of regulated secretory pathway | 2 | 89 | 7.26e-01 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 8 | 391 | 7.26e-01 |
| GO:BP | GO:0045039 | protein insertion into mitochondrial inner membrane | 2 | 13 | 7.26e-01 |
| GO:BP | GO:0035810 | positive regulation of urine volume | 1 | 10 | 7.26e-01 |
| GO:BP | GO:0055025 | positive regulation of cardiac muscle tissue development | 1 | 2 | 7.27e-01 |
| GO:BP | GO:0044070 | regulation of monoatomic anion transport | 7 | 12 | 7.27e-01 |
| GO:BP | GO:2000532 | regulation of renal albumin absorption | 1 | 1 | 7.27e-01 |
| GO:BP | GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 12 | 227 | 7.27e-01 |
| GO:BP | GO:0097368 | establishment of Sertoli cell barrier | 2 | 3 | 7.27e-01 |
| GO:BP | GO:0140468 | HRI-mediated signaling | 1 | 3 | 7.27e-01 |
| GO:BP | GO:0099116 | tRNA 5’-end processing | 8 | 16 | 7.28e-01 |
| GO:BP | GO:1905349 | ciliary transition zone assembly | 1 | 2 | 7.28e-01 |
| GO:BP | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation | 1 | 9 | 7.28e-01 |
| GO:BP | GO:0044691 | tooth eruption | 3 | 5 | 7.28e-01 |
| GO:BP | GO:0010753 | positive regulation of cGMP-mediated signaling | 1 | 3 | 7.28e-01 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 4 | 3169 | 7.28e-01 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 7 | 105 | 7.28e-01 |
| GO:BP | GO:0003343 | septum transversum development | 1 | 2 | 7.28e-01 |
| GO:BP | GO:0006474 | N-terminal protein amino acid acetylation | 2 | 15 | 7.28e-01 |
| GO:BP | GO:0003350 | pulmonary myocardium development | 1 | 2 | 7.28e-01 |
| GO:BP | GO:0003342 | proepicardium development | 1 | 2 | 7.28e-01 |
| GO:BP | GO:0006047 | UDP-N-acetylglucosamine metabolic process | 5 | 13 | 7.29e-01 |
| GO:BP | GO:0032536 | regulation of cell projection size | 3 | 8 | 7.29e-01 |
| GO:BP | GO:1902498 | regulation of protein autoubiquitination | 3 | 5 | 7.29e-01 |
| GO:BP | GO:1901679 | nucleotide transmembrane transport | 2 | 18 | 7.29e-01 |
| GO:BP | GO:0046544 | development of secondary male sexual characteristics | 1 | 1 | 7.29e-01 |
| GO:BP | GO:0036363 | transforming growth factor beta activation | 2 | 9 | 7.29e-01 |
| GO:BP | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 1 | 10 | 7.29e-01 |
| GO:BP | GO:0051461 | positive regulation of corticotropin secretion | 1 | 2 | 7.29e-01 |
| GO:BP | GO:0009651 | response to salt stress | 1 | 18 | 7.29e-01 |
| GO:BP | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 1 | 18 | 7.29e-01 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 10 | 98 | 7.29e-01 |
| GO:BP | GO:0007528 | neuromuscular junction development | 6 | 39 | 7.29e-01 |
| GO:BP | GO:0031144 | proteasome localization | 1 | 2 | 7.29e-01 |
| GO:BP | GO:0071360 | cellular response to exogenous dsRNA | 5 | 14 | 7.29e-01 |
| GO:BP | GO:0046618 | xenobiotic export from cell | 4 | 8 | 7.29e-01 |
| GO:BP | GO:0032482 | Rab protein signal transduction | 3 | 19 | 7.29e-01 |
| GO:BP | GO:0070168 | negative regulation of biomineral tissue development | 1 | 19 | 7.29e-01 |
| GO:BP | GO:0002181 | cytoplasmic translation | 1 | 156 | 7.29e-01 |
| GO:BP | GO:2001137 | positive regulation of endocytic recycling | 1 | 7 | 7.29e-01 |
| GO:BP | GO:0033131 | regulation of glucokinase activity | 4 | 7 | 7.29e-01 |
| GO:BP | GO:0015960 | diadenosine polyphosphate biosynthetic process | 1 | 2 | 7.29e-01 |
| GO:BP | GO:0015965 | diadenosine tetraphosphate metabolic process | 1 | 2 | 7.29e-01 |
| GO:BP | GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1 | 2 | 7.29e-01 |
| GO:BP | GO:2000793 | cell proliferation involved in heart valve development | 2 | 4 | 7.29e-01 |
| GO:BP | GO:0090500 | endocardial cushion to mesenchymal transition | 2 | 4 | 7.29e-01 |
| GO:BP | GO:0050996 | positive regulation of lipid catabolic process | 1 | 16 | 7.29e-01 |
| GO:BP | GO:1903850 | regulation of cristae formation | 2 | 4 | 7.29e-01 |
| GO:BP | GO:0046903 | secretion | 2 | 645 | 7.29e-01 |
| GO:BP | GO:0045213 | neurotransmitter receptor metabolic process | 1 | 2 | 7.29e-01 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 7 | 373 | 7.29e-01 |
| GO:BP | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus | 6 | 9 | 7.29e-01 |
| GO:BP | GO:0046782 | regulation of viral transcription | 1 | 19 | 7.29e-01 |
| GO:BP | GO:0002790 | peptide secretion | 1 | 170 | 7.29e-01 |
| GO:BP | GO:0006913 | nucleocytoplasmic transport | 6 | 295 | 7.30e-01 |
| GO:BP | GO:0035303 | regulation of dephosphorylation | 1 | 105 | 7.30e-01 |
| GO:BP | GO:0034414 | tRNA 3’-trailer cleavage, endonucleolytic | 1 | 2 | 7.30e-01 |
| GO:BP | GO:1904694 | negative regulation of vascular associated smooth muscle contraction | 1 | 3 | 7.30e-01 |
| GO:BP | GO:0017158 | regulation of calcium ion-dependent exocytosis | 10 | 29 | 7.30e-01 |
| GO:BP | GO:0051169 | nuclear transport | 6 | 295 | 7.30e-01 |
| GO:BP | GO:1902803 | regulation of synaptic vesicle transport | 2 | 5 | 7.30e-01 |
| GO:BP | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation | 1 | 2 | 7.30e-01 |
| GO:BP | GO:1902858 | propionyl-CoA metabolic process | 2 | 4 | 7.30e-01 |
| GO:BP | GO:1902269 | positive regulation of polyamine transmembrane transport | 1 | 2 | 7.30e-01 |
| GO:BP | GO:2001294 | malonyl-CoA catabolic process | 2 | 4 | 7.30e-01 |
| GO:BP | GO:1901880 | negative regulation of protein depolymerization | 2 | 64 | 7.30e-01 |
| GO:BP | GO:0043378 | positive regulation of CD8-positive, alpha-beta T cell differentiation | 2 | 2 | 7.30e-01 |
| GO:BP | GO:0006572 | tyrosine catabolic process | 1 | 2 | 7.30e-01 |
| GO:BP | GO:0006479 | protein methylation | 2 | 160 | 7.30e-01 |
| GO:BP | GO:0000028 | ribosomal small subunit assembly | 9 | 18 | 7.30e-01 |
| GO:BP | GO:0036315 | cellular response to sterol | 1 | 14 | 7.30e-01 |
| GO:BP | GO:0008213 | protein alkylation | 2 | 160 | 7.30e-01 |
| GO:BP | GO:0003351 | epithelial cilium movement involved in extracellular fluid movement | 1 | 29 | 7.30e-01 |
| GO:BP | GO:0006024 | glycosaminoglycan biosynthetic process | 2 | 60 | 7.30e-01 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 1 | 140 | 7.30e-01 |
| GO:BP | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 3 | 5 | 7.30e-01 |
| GO:BP | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 1 | 2 | 7.30e-01 |
| GO:BP | GO:0010793 | regulation of mRNA export from nucleus | 1 | 5 | 7.30e-01 |
| GO:BP | GO:0006533 | aspartate catabolic process | 2 | 2 | 7.30e-01 |
| GO:BP | GO:1901379 | regulation of potassium ion transmembrane transport | 8 | 64 | 7.30e-01 |
| GO:BP | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 1 | 10 | 7.31e-01 |
| GO:BP | GO:0150031 | regulation of protein localization to lysosome | 1 | 3 | 7.31e-01 |
| GO:BP | GO:0061045 | negative regulation of wound healing | 6 | 51 | 7.31e-01 |
| GO:BP | GO:0090218 | positive regulation of lipid kinase activity | 5 | 25 | 7.31e-01 |
| GO:BP | GO:0018175 | protein nucleotidylation | 1 | 2 | 7.31e-01 |
| GO:BP | GO:1902024 | L-histidine transport | 2 | 4 | 7.31e-01 |
| GO:BP | GO:1902688 | regulation of NAD metabolic process | 1 | 1 | 7.31e-01 |
| GO:BP | GO:0018117 | protein adenylylation | 1 | 2 | 7.31e-01 |
| GO:BP | GO:0007252 | I-kappaB phosphorylation | 2 | 14 | 7.31e-01 |
| GO:BP | GO:0015829 | valine transport | 2 | 4 | 7.31e-01 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 6 | 612 | 7.31e-01 |
| GO:BP | GO:0015817 | histidine transport | 2 | 4 | 7.31e-01 |
| GO:BP | GO:0010712 | regulation of collagen metabolic process | 21 | 34 | 7.31e-01 |
| GO:BP | GO:0090184 | positive regulation of kidney development | 3 | 9 | 7.31e-01 |
| GO:BP | GO:0060192 | negative regulation of lipase activity | 1 | 13 | 7.31e-01 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 1 | 279 | 7.31e-01 |
| GO:BP | GO:1902949 | positive regulation of tau-protein kinase activity | 1 | 6 | 7.32e-01 |
| GO:BP | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 16 | 59 | 7.32e-01 |
| GO:BP | GO:0090141 | positive regulation of mitochondrial fission | 1 | 21 | 7.32e-01 |
| GO:BP | GO:0043485 | endosome to pigment granule transport | 3 | 9 | 7.32e-01 |
| GO:BP | GO:0035646 | endosome to melanosome transport | 3 | 9 | 7.32e-01 |
| GO:BP | GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 1 | 25 | 7.32e-01 |
| GO:BP | GO:1901099 | negative regulation of signal transduction in absence of ligand | 1 | 25 | 7.32e-01 |
| GO:BP | GO:0048757 | pigment granule maturation | 3 | 9 | 7.32e-01 |
| GO:BP | GO:0001676 | long-chain fatty acid metabolic process | 19 | 65 | 7.32e-01 |
| GO:BP | GO:0009227 | nucleotide-sugar catabolic process | 1 | 3 | 7.32e-01 |
| GO:BP | GO:1902081 | negative regulation of calcium ion import into sarcoplasmic reticulum | 1 | 1 | 7.33e-01 |
| GO:BP | GO:0006029 | proteoglycan metabolic process | 2 | 77 | 7.33e-01 |
| GO:BP | GO:0071276 | cellular response to cadmium ion | 2 | 24 | 7.33e-01 |
| GO:BP | GO:0070830 | bicellular tight junction assembly | 10 | 43 | 7.33e-01 |
| GO:BP | GO:0051582 | positive regulation of neurotransmitter uptake | 3 | 4 | 7.33e-01 |
| GO:BP | GO:0010893 | positive regulation of steroid biosynthetic process | 9 | 15 | 7.33e-01 |
| GO:BP | GO:0003149 | membranous septum morphogenesis | 1 | 8 | 7.33e-01 |
| GO:BP | GO:0046148 | pigment biosynthetic process | 7 | 48 | 7.33e-01 |
| GO:BP | GO:0045959 | negative regulation of complement activation, classical pathway | 2 | 4 | 7.34e-01 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 1 | 937 | 7.34e-01 |
| GO:BP | GO:0060764 | cell-cell signaling involved in mammary gland development | 1 | 1 | 7.34e-01 |
| GO:BP | GO:1990120 | messenger ribonucleoprotein complex assembly | 1 | 3 | 7.34e-01 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 5 | 294 | 7.34e-01 |
| GO:BP | GO:0015844 | monoamine transport | 2 | 45 | 7.34e-01 |
| GO:BP | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 1 | 52 | 7.34e-01 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 32 | 55 | 7.34e-01 |
| GO:BP | GO:0007440 | foregut morphogenesis | 3 | 7 | 7.34e-01 |
| GO:BP | GO:0055075 | potassium ion homeostasis | 3 | 22 | 7.34e-01 |
| GO:BP | GO:0034766 | negative regulation of monoatomic ion transmembrane transport | 7 | 70 | 7.34e-01 |
| GO:BP | GO:0006865 | amino acid transport | 2 | 102 | 7.35e-01 |
| GO:BP | GO:0006398 | mRNA 3’-end processing by stem-loop binding and cleavage | 3 | 7 | 7.35e-01 |
| GO:BP | GO:0048477 | oogenesis | 3 | 64 | 7.35e-01 |
| GO:BP | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway | 3 | 4 | 7.35e-01 |
| GO:BP | GO:0060414 | aorta smooth muscle tissue morphogenesis | 1 | 4 | 7.35e-01 |
| GO:BP | GO:1904028 | positive regulation of collagen fibril organization | 1 | 4 | 7.35e-01 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 12 | 40 | 7.35e-01 |
| GO:BP | GO:0032094 | response to food | 1 | 22 | 7.35e-01 |
| GO:BP | GO:2000738 | positive regulation of stem cell differentiation | 5 | 17 | 7.35e-01 |
| GO:BP | GO:1905314 | semi-lunar valve development | 16 | 41 | 7.35e-01 |
| GO:BP | GO:0035020 | regulation of Rac protein signal transduction | 11 | 21 | 7.36e-01 |
| GO:BP | GO:0033280 | response to vitamin D | 3 | 24 | 7.36e-01 |
| GO:BP | GO:1901727 | positive regulation of histone deacetylase activity | 3 | 5 | 7.36e-01 |
| GO:BP | GO:0070633 | transepithelial transport | 3 | 24 | 7.36e-01 |
| GO:BP | GO:0001654 | eye development | 4 | 272 | 7.36e-01 |
| GO:BP | GO:0008347 | glial cell migration | 2 | 47 | 7.36e-01 |
| GO:BP | GO:0090660 | cerebrospinal fluid circulation | 1 | 9 | 7.36e-01 |
| GO:BP | GO:0070173 | regulation of enamel mineralization | 1 | 2 | 7.36e-01 |
| GO:BP | GO:0015697 | quaternary ammonium group transport | 1 | 17 | 7.36e-01 |
| GO:BP | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 4 | 20 | 7.36e-01 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 31 | 53 | 7.36e-01 |
| GO:BP | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2 | 4 | 7.36e-01 |
| GO:BP | GO:0046032 | ADP catabolic process | 1 | 2 | 7.36e-01 |
| GO:BP | GO:0060737 | prostate gland morphogenetic growth | 2 | 2 | 7.36e-01 |
| GO:BP | GO:0000027 | ribosomal large subunit assembly | 6 | 23 | 7.36e-01 |
| GO:BP | GO:0007028 | cytoplasm organization | 2 | 8 | 7.36e-01 |
| GO:BP | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process | 1 | 2 | 7.36e-01 |
| GO:BP | GO:0072350 | tricarboxylic acid metabolic process | 7 | 13 | 7.37e-01 |
| GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 2 | 6 | 7.37e-01 |
| GO:BP | GO:0006658 | phosphatidylserine metabolic process | 2 | 21 | 7.37e-01 |
| GO:BP | GO:0099074 | mitochondrion to lysosome transport | 1 | 3 | 7.37e-01 |
| GO:BP | GO:0032351 | negative regulation of hormone metabolic process | 2 | 10 | 7.37e-01 |
| GO:BP | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1 | 3 | 7.37e-01 |
| GO:BP | GO:0099075 | mitochondrion-derived vesicle mediated transport | 1 | 3 | 7.37e-01 |
| GO:BP | GO:0010636 | positive regulation of mitochondrial fusion | 1 | 2 | 7.37e-01 |
| GO:BP | GO:0042698 | ovulation cycle | 2 | 54 | 7.37e-01 |
| GO:BP | GO:1902283 | negative regulation of primary amine oxidase activity | 1 | 1 | 7.37e-01 |
| GO:BP | GO:0061055 | myotome development | 2 | 2 | 7.37e-01 |
| GO:BP | GO:0034650 | cortisol metabolic process | 2 | 9 | 7.37e-01 |
| GO:BP | GO:0046813 | receptor-mediated virion attachment to host cell | 1 | 6 | 7.37e-01 |
| GO:BP | GO:0006705 | mineralocorticoid biosynthetic process | 2 | 9 | 7.37e-01 |
| GO:BP | GO:0006002 | fructose 6-phosphate metabolic process | 2 | 8 | 7.37e-01 |
| GO:BP | GO:0033363 | secretory granule organization | 1 | 50 | 7.38e-01 |
| GO:BP | GO:0046373 | L-arabinose metabolic process | 1 | 1 | 7.38e-01 |
| GO:BP | GO:0031591 | wybutosine biosynthetic process | 2 | 4 | 7.38e-01 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 3 | 2412 | 7.38e-01 |
| GO:BP | GO:0019566 | arabinose metabolic process | 1 | 1 | 7.38e-01 |
| GO:BP | GO:0031590 | wybutosine metabolic process | 2 | 4 | 7.38e-01 |
| GO:BP | GO:0045475 | locomotor rhythm | 3 | 13 | 7.38e-01 |
| GO:BP | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum | 2 | 2 | 7.38e-01 |
| GO:BP | GO:1904606 | fat cell apoptotic process | 1 | 1 | 7.38e-01 |
| GO:BP | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1 | 15 | 7.38e-01 |
| GO:BP | GO:1904649 | regulation of fat cell apoptotic process | 1 | 1 | 7.38e-01 |
| GO:BP | GO:1903971 | positive regulation of response to macrophage colony-stimulating factor | 1 | 1 | 7.38e-01 |
| GO:BP | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c | 1 | 7 | 7.38e-01 |
| GO:BP | GO:0070562 | regulation of vitamin D receptor signaling pathway | 1 | 9 | 7.38e-01 |
| GO:BP | GO:0019364 | pyridine nucleotide catabolic process | 1 | 4 | 7.38e-01 |
| GO:BP | GO:1903974 | positive regulation of cellular response to macrophage colony-stimulating factor stimulus | 1 | 1 | 7.38e-01 |
| GO:BP | GO:0008202 | steroid metabolic process | 3 | 204 | 7.38e-01 |
| GO:BP | GO:0032707 | negative regulation of interleukin-23 production | 1 | 2 | 7.38e-01 |
| GO:BP | GO:0019882 | antigen processing and presentation | 1 | 69 | 7.38e-01 |
| GO:BP | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation | 1 | 2 | 7.38e-01 |
| GO:BP | GO:0098908 | regulation of neuronal action potential | 1 | 3 | 7.38e-01 |
| GO:BP | GO:0014059 | regulation of dopamine secretion | 1 | 22 | 7.38e-01 |
| GO:BP | GO:0002521 | leukocyte differentiation | 7 | 382 | 7.39e-01 |
| GO:BP | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 4 | 6 | 7.39e-01 |
| GO:BP | GO:1903651 | positive regulation of cytoplasmic transport | 3 | 11 | 7.39e-01 |
| GO:BP | GO:0010635 | regulation of mitochondrial fusion | 3 | 11 | 7.39e-01 |
| GO:BP | GO:0042273 | ribosomal large subunit biogenesis | 1 | 73 | 7.39e-01 |
| GO:BP | GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 1 | 5 | 7.39e-01 |
| GO:BP | GO:1903409 | reactive oxygen species biosynthetic process | 3 | 36 | 7.39e-01 |
| GO:BP | GO:0031944 | negative regulation of glucocorticoid metabolic process | 1 | 5 | 7.39e-01 |
| GO:BP | GO:0010813 | neuropeptide catabolic process | 2 | 4 | 7.39e-01 |
| GO:BP | GO:0035584 | calcium-mediated signaling using intracellular calcium source | 2 | 14 | 7.39e-01 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 15 | 59 | 7.40e-01 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 15 | 59 | 7.40e-01 |
| GO:BP | GO:1905274 | regulation of modification of postsynaptic actin cytoskeleton | 1 | 4 | 7.40e-01 |
| GO:BP | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 1 | 26 | 7.40e-01 |
| GO:BP | GO:1900104 | regulation of hyaluranon cable assembly | 1 | 3 | 7.40e-01 |
| GO:BP | GO:1900106 | positive regulation of hyaluranon cable assembly | 1 | 3 | 7.40e-01 |
| GO:BP | GO:0046379 | extracellular polysaccharide metabolic process | 1 | 2 | 7.40e-01 |
| GO:BP | GO:0045226 | extracellular polysaccharide biosynthetic process | 1 | 2 | 7.40e-01 |
| GO:BP | GO:0036118 | hyaluranon cable assembly | 1 | 3 | 7.40e-01 |
| GO:BP | GO:0071398 | cellular response to fatty acid | 9 | 25 | 7.40e-01 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 1 | 74 | 7.40e-01 |
| GO:BP | GO:0046716 | muscle cell cellular homeostasis | 10 | 21 | 7.40e-01 |
| GO:BP | GO:0071284 | cellular response to lead ion | 1 | 4 | 7.40e-01 |
| GO:BP | GO:0002524 | hypersensitivity | 4 | 7 | 7.40e-01 |
| GO:BP | GO:1905551 | negative regulation of protein localization to endoplasmic reticulum | 1 | 2 | 7.40e-01 |
| GO:BP | GO:0010608 | post-transcriptional regulation of gene expression | 2 | 468 | 7.40e-01 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 1 | 108 | 7.40e-01 |
| GO:BP | GO:0150063 | visual system development | 4 | 273 | 7.40e-01 |
| GO:BP | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2 | 19 | 7.40e-01 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 1 | 260 | 7.40e-01 |
| GO:BP | GO:0015695 | organic cation transport | 1 | 34 | 7.40e-01 |
| GO:BP | GO:2000439 | positive regulation of monocyte extravasation | 2 | 3 | 7.40e-01 |
| GO:BP | GO:1904231 | positive regulation of succinate dehydrogenase activity | 1 | 2 | 7.41e-01 |
| GO:BP | GO:0055091 | phospholipid homeostasis | 1 | 12 | 7.41e-01 |
| GO:BP | GO:1904229 | regulation of succinate dehydrogenase activity | 1 | 2 | 7.41e-01 |
| GO:BP | GO:0010716 | negative regulation of extracellular matrix disassembly | 1 | 2 | 7.41e-01 |
| GO:BP | GO:0045793 | positive regulation of cell size | 1 | 11 | 7.41e-01 |
| GO:BP | GO:0006545 | glycine biosynthetic process | 1 | 4 | 7.42e-01 |
| GO:BP | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition | 2 | 3 | 7.42e-01 |
| GO:BP | GO:0022411 | cellular component disassembly | 12 | 427 | 7.42e-01 |
| GO:BP | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway | 1 | 2 | 7.42e-01 |
| GO:BP | GO:0071716 | leukotriene transport | 3 | 5 | 7.42e-01 |
| GO:BP | GO:0001541 | ovarian follicle development | 7 | 41 | 7.43e-01 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1 | 4953 | 7.43e-01 |
| GO:BP | GO:0000096 | sulfur amino acid metabolic process | 3 | 27 | 7.43e-01 |
| GO:BP | GO:0097168 | mesenchymal stem cell proliferation | 3 | 4 | 7.43e-01 |
| GO:BP | GO:0032635 | interleukin-6 production | 4 | 86 | 7.43e-01 |
| GO:BP | GO:0032675 | regulation of interleukin-6 production | 4 | 86 | 7.43e-01 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 6 | 152 | 7.43e-01 |
| GO:BP | GO:1903826 | L-arginine transmembrane transport | 2 | 12 | 7.43e-01 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 1 | 4048 | 7.43e-01 |
| GO:BP | GO:0090240 | positive regulation of histone H4 acetylation | 3 | 6 | 7.43e-01 |
| GO:BP | GO:1990086 | lens fiber cell apoptotic process | 1 | 3 | 7.43e-01 |
| GO:BP | GO:1901000 | regulation of response to salt stress | 1 | 4 | 7.43e-01 |
| GO:BP | GO:0015802 | basic amino acid transport | 10 | 17 | 7.43e-01 |
| GO:BP | GO:0036228 | protein localization to nuclear inner membrane | 1 | 3 | 7.43e-01 |
| GO:BP | GO:1900069 | regulation of cellular hyperosmotic salinity response | 1 | 4 | 7.43e-01 |
| GO:BP | GO:0007275 | multicellular organism development | 3 | 3386 | 7.43e-01 |
| GO:BP | GO:0099105 | ion channel modulating, G protein-coupled receptor signaling pathway | 1 | 7 | 7.43e-01 |
| GO:BP | GO:0021578 | hindbrain maturation | 2 | 4 | 7.43e-01 |
| GO:BP | GO:0043484 | regulation of RNA splicing | 45 | 164 | 7.43e-01 |
| GO:BP | GO:0099509 | regulation of presynaptic cytosolic calcium ion concentration | 1 | 10 | 7.43e-01 |
| GO:BP | GO:0009753 | response to jasmonic acid | 2 | 3 | 7.44e-01 |
| GO:BP | GO:0071395 | cellular response to jasmonic acid stimulus | 2 | 3 | 7.44e-01 |
| GO:BP | GO:1903599 | positive regulation of autophagy of mitochondrion | 1 | 13 | 7.44e-01 |
| GO:BP | GO:0006072 | glycerol-3-phosphate metabolic process | 3 | 7 | 7.44e-01 |
| GO:BP | GO:0007341 | penetration of zona pellucida | 1 | 4 | 7.44e-01 |
| GO:BP | GO:0042310 | vasoconstriction | 4 | 51 | 7.45e-01 |
| GO:BP | GO:1900118 | negative regulation of execution phase of apoptosis | 3 | 6 | 7.45e-01 |
| GO:BP | GO:1905208 | negative regulation of cardiocyte differentiation | 6 | 11 | 7.45e-01 |
| GO:BP | GO:0002679 | respiratory burst involved in defense response | 4 | 7 | 7.45e-01 |
| GO:BP | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity | 1 | 6 | 7.45e-01 |
| GO:BP | GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 1 | 59 | 7.45e-01 |
| GO:BP | GO:0015833 | peptide transport | 1 | 179 | 7.45e-01 |
| GO:BP | GO:0036071 | N-glycan fucosylation | 1 | 3 | 7.45e-01 |
| GO:BP | GO:0014046 | dopamine secretion | 1 | 23 | 7.45e-01 |
| GO:BP | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 2 | 4 | 7.45e-01 |
| GO:BP | GO:0042398 | cellular modified amino acid biosynthetic process | 1 | 26 | 7.45e-01 |
| GO:BP | GO:0051051 | negative regulation of transport | 1 | 318 | 7.46e-01 |
| GO:BP | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process | 3 | 12 | 7.46e-01 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 3 | 2574 | 7.46e-01 |
| GO:BP | GO:0097343 | ripoptosome assembly | 1 | 2 | 7.46e-01 |
| GO:BP | GO:1901026 | ripoptosome assembly involved in necroptotic process | 1 | 2 | 7.46e-01 |
| GO:BP | GO:1903506 | regulation of nucleic acid-templated transcription | 3 | 2576 | 7.46e-01 |
| GO:BP | GO:2000426 | negative regulation of apoptotic cell clearance | 1 | 1 | 7.46e-01 |
| GO:BP | GO:0030449 | regulation of complement activation | 1 | 11 | 7.46e-01 |
| GO:BP | GO:0045163 | clustering of voltage-gated potassium channels | 1 | 2 | 7.46e-01 |
| GO:BP | GO:1903861 | positive regulation of dendrite extension | 6 | 15 | 7.46e-01 |
| GO:BP | GO:0016137 | glycoside metabolic process | 4 | 16 | 7.47e-01 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 6 | 64 | 7.47e-01 |
| GO:BP | GO:0006858 | extracellular transport | 1 | 32 | 7.47e-01 |
| GO:BP | GO:0099578 | regulation of translation at postsynapse, modulating synaptic transmission | 1 | 3 | 7.47e-01 |
| GO:BP | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission | 1 | 3 | 7.47e-01 |
| GO:BP | GO:0006812 | monoatomic cation transport | 13 | 669 | 7.47e-01 |
| GO:BP | GO:0045658 | regulation of neutrophil differentiation | 1 | 2 | 7.47e-01 |
| GO:BP | GO:0042541 | hemoglobin biosynthetic process | 5 | 13 | 7.47e-01 |
| GO:BP | GO:1990399 | epithelium regeneration | 1 | 2 | 7.47e-01 |
| GO:BP | GO:0071616 | acyl-CoA biosynthetic process | 8 | 38 | 7.47e-01 |
| GO:BP | GO:0045016 | mitochondrial magnesium ion transmembrane transport | 1 | 2 | 7.47e-01 |
| GO:BP | GO:1905041 | regulation of epithelium regeneration | 1 | 2 | 7.47e-01 |
| GO:BP | GO:0035384 | thioester biosynthetic process | 8 | 38 | 7.47e-01 |
| GO:BP | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1 | 33 | 7.47e-01 |
| GO:BP | GO:0043654 | recognition of apoptotic cell | 2 | 4 | 7.47e-01 |
| GO:BP | GO:0048015 | phosphatidylinositol-mediated signaling | 1 | 123 | 7.48e-01 |
| GO:BP | GO:0090234 | regulation of kinetochore assembly | 1 | 3 | 7.48e-01 |
| GO:BP | GO:0002190 | cap-independent translational initiation | 2 | 4 | 7.48e-01 |
| GO:BP | GO:0070542 | response to fatty acid | 2 | 43 | 7.48e-01 |
| GO:BP | GO:0050994 | regulation of lipid catabolic process | 2 | 38 | 7.48e-01 |
| GO:BP | GO:1904892 | regulation of receptor signaling pathway via STAT | 1 | 54 | 7.48e-01 |
| GO:BP | GO:0042701 | progesterone secretion | 2 | 3 | 7.48e-01 |
| GO:BP | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 2 | 19 | 7.49e-01 |
| GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 1 | 20 | 7.49e-01 |
| GO:BP | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 2 | 19 | 7.49e-01 |
| GO:BP | GO:0061041 | regulation of wound healing | 2 | 95 | 7.49e-01 |
| GO:BP | GO:0002384 | hepatic immune response | 1 | 1 | 7.49e-01 |
| GO:BP | GO:0048880 | sensory system development | 4 | 275 | 7.49e-01 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 9 | 17 | 7.49e-01 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 12 | 40 | 7.49e-01 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 12 | 40 | 7.49e-01 |
| GO:BP | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion | 2 | 5 | 7.49e-01 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 7 | 418 | 7.49e-01 |
| GO:BP | GO:0050818 | regulation of coagulation | 6 | 55 | 7.50e-01 |
| GO:BP | GO:0060644 | mammary gland epithelial cell differentiation | 1 | 14 | 7.50e-01 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 3 | 2593 | 7.50e-01 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 3 | 91 | 7.50e-01 |
| GO:BP | GO:0050708 | regulation of protein secretion | 10 | 185 | 7.50e-01 |
| GO:BP | GO:0006023 | aminoglycan biosynthetic process | 2 | 63 | 7.50e-01 |
| GO:BP | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 1 | 9 | 7.50e-01 |
| GO:BP | GO:0032386 | regulation of intracellular transport | 30 | 292 | 7.50e-01 |
| GO:BP | GO:0002457 | T cell antigen processing and presentation | 2 | 4 | 7.51e-01 |
| GO:BP | GO:0035264 | multicellular organism growth | 8 | 123 | 7.51e-01 |
| GO:BP | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1 | 16 | 7.51e-01 |
| GO:BP | GO:0060406 | positive regulation of penile erection | 1 | 3 | 7.51e-01 |
| GO:BP | GO:0016115 | terpenoid catabolic process | 1 | 4 | 7.51e-01 |
| GO:BP | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process | 1 | 3 | 7.51e-01 |
| GO:BP | GO:0070344 | regulation of fat cell proliferation | 4 | 9 | 7.51e-01 |
| GO:BP | GO:0045728 | respiratory burst after phagocytosis | 1 | 2 | 7.51e-01 |
| GO:BP | GO:0045071 | negative regulation of viral genome replication | 1 | 37 | 7.51e-01 |
| GO:BP | GO:0003159 | morphogenesis of an endothelium | 3 | 14 | 7.51e-01 |
| GO:BP | GO:0061154 | endothelial tube morphogenesis | 3 | 14 | 7.51e-01 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 1 | 222 | 7.52e-01 |
| GO:BP | GO:0021586 | pons maturation | 1 | 1 | 7.52e-01 |
| GO:BP | GO:0021722 | superior olivary nucleus maturation | 1 | 1 | 7.52e-01 |
| GO:BP | GO:0021522 | spinal cord motor neuron differentiation | 1 | 18 | 7.52e-01 |
| GO:BP | GO:0021718 | superior olivary nucleus development | 1 | 1 | 7.52e-01 |
| GO:BP | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly | 1 | 7 | 7.52e-01 |
| GO:BP | GO:0016340 | calcium-dependent cell-matrix adhesion | 1 | 2 | 7.52e-01 |
| GO:BP | GO:0061086 | negative regulation of histone H3-K27 methylation | 1 | 2 | 7.52e-01 |
| GO:BP | GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 1 | 2 | 7.53e-01 |
| GO:BP | GO:0008039 | synaptic target recognition | 1 | 2 | 7.53e-01 |
| GO:BP | GO:0060168 | positive regulation of adenosine receptor signaling pathway | 1 | 1 | 7.53e-01 |
| GO:BP | GO:0046597 | negative regulation of viral entry into host cell | 1 | 14 | 7.53e-01 |
| GO:BP | GO:0060264 | regulation of respiratory burst involved in inflammatory response | 2 | 3 | 7.53e-01 |
| GO:BP | GO:1903596 | regulation of gap junction assembly | 5 | 8 | 7.53e-01 |
| GO:BP | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 25 | 153 | 7.54e-01 |
| GO:BP | GO:0007228 | positive regulation of hh target transcription factor activity | 1 | 2 | 7.54e-01 |
| GO:BP | GO:0007227 | signal transduction downstream of smoothened | 1 | 2 | 7.54e-01 |
| GO:BP | GO:0003352 | regulation of cilium movement | 1 | 17 | 7.54e-01 |
| GO:BP | GO:0060438 | trachea development | 4 | 13 | 7.54e-01 |
| GO:BP | GO:0048017 | inositol lipid-mediated signaling | 1 | 126 | 7.54e-01 |
| GO:BP | GO:0051851 | modulation by host of symbiont process | 12 | 68 | 7.54e-01 |
| GO:BP | GO:0043007 | maintenance of rDNA | 1 | 2 | 7.54e-01 |
| GO:BP | GO:0035726 | common myeloid progenitor cell proliferation | 4 | 5 | 7.54e-01 |
| GO:BP | GO:0060713 | labyrinthine layer morphogenesis | 5 | 17 | 7.55e-01 |
| GO:BP | GO:0046501 | protoporphyrinogen IX metabolic process | 2 | 11 | 7.55e-01 |
| GO:BP | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway | 1 | 1 | 7.55e-01 |
| GO:BP | GO:0030007 | intracellular potassium ion homeostasis | 2 | 11 | 7.55e-01 |
| GO:BP | GO:0046104 | thymidine metabolic process | 1 | 5 | 7.55e-01 |
| GO:BP | GO:0009409 | response to cold | 9 | 41 | 7.55e-01 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 8 | 382 | 7.55e-01 |
| GO:BP | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 1 | 5 | 7.55e-01 |
| GO:BP | GO:0051695 | actin filament uncapping | 1 | 2 | 7.55e-01 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 9 | 23 | 7.55e-01 |
| GO:BP | GO:0035094 | response to nicotine | 1 | 28 | 7.55e-01 |
| GO:BP | GO:0051222 | positive regulation of protein transport | 27 | 242 | 7.55e-01 |
| GO:BP | GO:0032382 | positive regulation of intracellular sterol transport | 2 | 3 | 7.55e-01 |
| GO:BP | GO:0032385 | positive regulation of intracellular cholesterol transport | 2 | 3 | 7.55e-01 |
| GO:BP | GO:0032879 | regulation of localization | 1 | 1555 | 7.55e-01 |
| GO:BP | GO:0043271 | negative regulation of monoatomic ion transport | 9 | 90 | 7.55e-01 |
| GO:BP | GO:0030193 | regulation of blood coagulation | 1 | 50 | 7.56e-01 |
| GO:BP | GO:1903286 | regulation of potassium ion import | 3 | 8 | 7.56e-01 |
| GO:BP | GO:0051050 | positive regulation of transport | 31 | 667 | 7.56e-01 |
| GO:BP | GO:0048014 | Tie signaling pathway | 2 | 3 | 7.56e-01 |
| GO:BP | GO:0071322 | cellular response to carbohydrate stimulus | 10 | 105 | 7.56e-01 |
| GO:BP | GO:0090164 | asymmetric Golgi ribbon formation | 1 | 2 | 7.56e-01 |
| GO:BP | GO:0006085 | acetyl-CoA biosynthetic process | 1 | 16 | 7.56e-01 |
| GO:BP | GO:1990858 | cellular response to lectin | 1 | 11 | 7.56e-01 |
| GO:BP | GO:1990840 | response to lectin | 1 | 11 | 7.56e-01 |
| GO:BP | GO:0010501 | RNA secondary structure unwinding | 4 | 8 | 7.56e-01 |
| GO:BP | GO:1902004 | positive regulation of amyloid-beta formation | 8 | 17 | 7.56e-01 |
| GO:BP | GO:0002223 | stimulatory C-type lectin receptor signaling pathway | 1 | 11 | 7.56e-01 |
| GO:BP | GO:0060965 | negative regulation of miRNA-mediated gene silencing | 6 | 10 | 7.57e-01 |
| GO:BP | GO:0016072 | rRNA metabolic process | 6 | 258 | 7.57e-01 |
| GO:BP | GO:0099011 | neuronal dense core vesicle exocytosis | 1 | 4 | 7.57e-01 |
| GO:BP | GO:0006637 | acyl-CoA metabolic process | 1 | 71 | 7.57e-01 |
| GO:BP | GO:0072300 | positive regulation of metanephric glomerulus development | 1 | 1 | 7.57e-01 |
| GO:BP | GO:0072298 | regulation of metanephric glomerulus development | 1 | 1 | 7.57e-01 |
| GO:BP | GO:0010468 | regulation of gene expression | 5 | 3580 | 7.57e-01 |
| GO:BP | GO:0014042 | positive regulation of neuron maturation | 1 | 3 | 7.57e-01 |
| GO:BP | GO:0035383 | thioester metabolic process | 1 | 71 | 7.57e-01 |
| GO:BP | GO:0072216 | positive regulation of metanephros development | 1 | 1 | 7.57e-01 |
| GO:BP | GO:0031124 | mRNA 3’-end processing | 2 | 58 | 7.57e-01 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 5 | 4174 | 7.57e-01 |
| GO:BP | GO:1902692 | regulation of neuroblast proliferation | 4 | 28 | 7.57e-01 |
| GO:BP | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 2 | 7 | 7.57e-01 |
| GO:BP | GO:0050765 | negative regulation of phagocytosis | 11 | 15 | 7.57e-01 |
| GO:BP | GO:0060215 | primitive hemopoiesis | 3 | 7 | 7.58e-01 |
| GO:BP | GO:0001542 | ovulation from ovarian follicle | 2 | 8 | 7.58e-01 |
| GO:BP | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 1 | 16 | 7.58e-01 |
| GO:BP | GO:0002828 | regulation of type 2 immune response | 1 | 15 | 7.58e-01 |
| GO:BP | GO:0002074 | extraocular skeletal muscle development | 1 | 2 | 7.58e-01 |
| GO:BP | GO:0051965 | positive regulation of synapse assembly | 1 | 44 | 7.58e-01 |
| GO:BP | GO:0038172 | interleukin-33-mediated signaling pathway | 1 | 1 | 7.58e-01 |
| GO:BP | GO:0061188 | negative regulation of rDNA heterochromatin formation | 1 | 2 | 7.58e-01 |
| GO:BP | GO:0061187 | regulation of rDNA heterochromatin formation | 1 | 2 | 7.58e-01 |
| GO:BP | GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 2 | 5 | 7.58e-01 |
| GO:BP | GO:0045347 | negative regulation of MHC class II biosynthetic process | 1 | 3 | 7.58e-01 |
| GO:BP | GO:0071359 | cellular response to dsRNA | 6 | 18 | 7.58e-01 |
| GO:BP | GO:0007130 | synaptonemal complex assembly | 7 | 10 | 7.58e-01 |
| GO:BP | GO:0098728 | germline stem cell asymmetric division | 2 | 2 | 7.58e-01 |
| GO:BP | GO:0002719 | negative regulation of cytokine production involved in immune response | 1 | 16 | 7.58e-01 |
| GO:BP | GO:0030100 | regulation of endocytosis | 2 | 211 | 7.58e-01 |
| GO:BP | GO:0042078 | germ-line stem cell division | 2 | 2 | 7.58e-01 |
| GO:BP | GO:0098722 | asymmetric stem cell division | 2 | 2 | 7.58e-01 |
| GO:BP | GO:0023035 | CD40 signaling pathway | 2 | 11 | 7.58e-01 |
| GO:BP | GO:0001905 | activation of membrane attack complex | 1 | 2 | 7.58e-01 |
| GO:BP | GO:0001969 | regulation of activation of membrane attack complex | 1 | 2 | 7.58e-01 |
| GO:BP | GO:0002088 | lens development in camera-type eye | 1 | 57 | 7.58e-01 |
| GO:BP | GO:1903036 | positive regulation of response to wounding | 1 | 55 | 7.59e-01 |
| GO:BP | GO:0030195 | negative regulation of blood coagulation | 4 | 34 | 7.59e-01 |
| GO:BP | GO:1905382 | positive regulation of snRNA transcription by RNA polymerase II | 1 | 3 | 7.59e-01 |
| GO:BP | GO:0014075 | response to amine | 1 | 34 | 7.59e-01 |
| GO:BP | GO:0044794 | positive regulation by host of viral process | 3 | 20 | 7.59e-01 |
| GO:BP | GO:2001027 | negative regulation of endothelial cell chemotaxis | 1 | 2 | 7.59e-01 |
| GO:BP | GO:0060820 | inactivation of X chromosome by heterochromatin formation | 1 | 1 | 7.59e-01 |
| GO:BP | GO:0070920 | regulation of regulatory ncRNA processing | 7 | 11 | 7.59e-01 |
| GO:BP | GO:0021553 | olfactory nerve development | 4 | 5 | 7.59e-01 |
| GO:BP | GO:0071420 | cellular response to histamine | 3 | 4 | 7.59e-01 |
| GO:BP | GO:0050962 | detection of light stimulus involved in sensory perception | 1 | 9 | 7.59e-01 |
| GO:BP | GO:0050908 | detection of light stimulus involved in visual perception | 1 | 9 | 7.59e-01 |
| GO:BP | GO:1905653 | positive regulation of artery morphogenesis | 2 | 5 | 7.59e-01 |
| GO:BP | GO:1905651 | regulation of artery morphogenesis | 2 | 5 | 7.59e-01 |
| GO:BP | GO:0090170 | regulation of Golgi inheritance | 1 | 4 | 7.60e-01 |
| GO:BP | GO:0055003 | cardiac myofibril assembly | 8 | 19 | 7.60e-01 |
| GO:BP | GO:0014831 | gastro-intestinal system smooth muscle contraction | 1 | 5 | 7.60e-01 |
| GO:BP | GO:0016032 | viral process | 3 | 344 | 7.60e-01 |
| GO:BP | GO:0043587 | tongue morphogenesis | 2 | 7 | 7.60e-01 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 1 | 229 | 7.61e-01 |
| GO:BP | GO:0035356 | intracellular triglyceride homeostasis | 3 | 5 | 7.61e-01 |
| GO:BP | GO:0044381 | glucose import in response to insulin stimulus | 1 | 4 | 7.61e-01 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 31 | 631 | 7.61e-01 |
| GO:BP | GO:0002718 | regulation of cytokine production involved in immune response | 3 | 70 | 7.61e-01 |
| GO:BP | GO:0043474 | pigment metabolic process involved in pigmentation | 1 | 3 | 7.61e-01 |
| GO:BP | GO:0060465 | pharynx development | 1 | 3 | 7.61e-01 |
| GO:BP | GO:0002367 | cytokine production involved in immune response | 3 | 70 | 7.61e-01 |
| GO:BP | GO:0048009 | insulin-like growth factor receptor signaling pathway | 3 | 42 | 7.61e-01 |
| GO:BP | GO:1902732 | positive regulation of chondrocyte proliferation | 2 | 5 | 7.62e-01 |
| GO:BP | GO:0048859 | formation of anatomical boundary | 1 | 3 | 7.62e-01 |
| GO:BP | GO:1904237 | positive regulation of substrate-dependent cell migration, cell attachment to substrate | 1 | 3 | 7.62e-01 |
| GO:BP | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate | 1 | 3 | 7.62e-01 |
| GO:BP | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 4 | 21 | 7.62e-01 |
| GO:BP | GO:0046833 | positive regulation of RNA export from nucleus | 2 | 5 | 7.62e-01 |
| GO:BP | GO:0043967 | histone H4 acetylation | 27 | 57 | 7.62e-01 |
| GO:BP | GO:0061484 | hematopoietic stem cell homeostasis | 3 | 20 | 7.62e-01 |
| GO:BP | GO:1900046 | regulation of hemostasis | 1 | 50 | 7.62e-01 |
| GO:BP | GO:2001213 | negative regulation of vasculogenesis | 1 | 1 | 7.62e-01 |
| GO:BP | GO:0008542 | visual learning | 1 | 37 | 7.62e-01 |
| GO:BP | GO:1904580 | regulation of intracellular mRNA localization | 2 | 4 | 7.62e-01 |
| GO:BP | GO:0051262 | protein tetramerization | 2 | 64 | 7.63e-01 |
| GO:BP | GO:1905524 | negative regulation of protein autoubiquitination | 1 | 2 | 7.63e-01 |
| GO:BP | GO:0007009 | plasma membrane organization | 12 | 116 | 7.63e-01 |
| GO:BP | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase | 2 | 4 | 7.63e-01 |
| GO:BP | GO:0046639 | negative regulation of alpha-beta T cell differentiation | 9 | 17 | 7.63e-01 |
| GO:BP | GO:0002683 | negative regulation of immune system process | 1 | 289 | 7.63e-01 |
| GO:BP | GO:0035802 | adrenal cortex formation | 1 | 1 | 7.63e-01 |
| GO:BP | GO:0070141 | response to UV-A | 1 | 11 | 7.63e-01 |
| GO:BP | GO:0042554 | superoxide anion generation | 6 | 20 | 7.63e-01 |
| GO:BP | GO:0046006 | regulation of activated T cell proliferation | 1 | 21 | 7.63e-01 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1 | 2065 | 7.63e-01 |
| GO:BP | GO:0001188 | RNA polymerase I preinitiation complex assembly | 2 | 9 | 7.63e-01 |
| GO:BP | GO:0034163 | regulation of toll-like receptor 9 signaling pathway | 4 | 6 | 7.64e-01 |
| GO:BP | GO:0006000 | fructose metabolic process | 1 | 10 | 7.64e-01 |
| GO:BP | GO:0035455 | response to interferon-alpha | 9 | 16 | 7.64e-01 |
| GO:BP | GO:0061669 | spontaneous neurotransmitter secretion | 2 | 5 | 7.64e-01 |
| GO:BP | GO:0015074 | DNA integration | 4 | 9 | 7.64e-01 |
| GO:BP | GO:0044829 | positive regulation by host of viral genome replication | 3 | 10 | 7.65e-01 |
| GO:BP | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 3 | 21 | 7.65e-01 |
| GO:BP | GO:0055095 | lipoprotein particle mediated signaling | 1 | 3 | 7.65e-01 |
| GO:BP | GO:0055096 | low-density lipoprotein particle mediated signaling | 1 | 3 | 7.65e-01 |
| GO:BP | GO:0046822 | regulation of nucleocytoplasmic transport | 6 | 97 | 7.65e-01 |
| GO:BP | GO:0051236 | establishment of RNA localization | 45 | 147 | 7.65e-01 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 56 | 204 | 7.65e-01 |
| GO:BP | GO:0034371 | chylomicron remodeling | 1 | 1 | 7.65e-01 |
| GO:BP | GO:0034390 | smooth muscle cell apoptotic process | 1 | 15 | 7.65e-01 |
| GO:BP | GO:0034391 | regulation of smooth muscle cell apoptotic process | 1 | 15 | 7.65e-01 |
| GO:BP | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration | 1 | 2 | 7.65e-01 |
| GO:BP | GO:1904526 | regulation of microtubule binding | 2 | 10 | 7.65e-01 |
| GO:BP | GO:0060669 | embryonic placenta morphogenesis | 6 | 22 | 7.65e-01 |
| GO:BP | GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 2 | 5 | 7.65e-01 |
| GO:BP | GO:0060670 | branching involved in labyrinthine layer morphogenesis | 3 | 10 | 7.65e-01 |
| GO:BP | GO:0045494 | photoreceptor cell maintenance | 1 | 27 | 7.65e-01 |
| GO:BP | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway | 8 | 15 | 7.65e-01 |
| GO:BP | GO:0002604 | regulation of dendritic cell antigen processing and presentation | 2 | 5 | 7.65e-01 |
| GO:BP | GO:0002757 | immune response-activating signaling pathway | 1 | 230 | 7.66e-01 |
| GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 1 | 55 | 7.66e-01 |
| GO:BP | GO:0045723 | positive regulation of fatty acid biosynthetic process | 3 | 12 | 7.66e-01 |
| GO:BP | GO:0030878 | thyroid gland development | 3 | 17 | 7.66e-01 |
| GO:BP | GO:0006351 | DNA-templated transcription | 3 | 2683 | 7.66e-01 |
| GO:BP | GO:1904506 | negative regulation of telomere maintenance in response to DNA damage | 2 | 3 | 7.66e-01 |
| GO:BP | GO:0043011 | myeloid dendritic cell differentiation | 1 | 10 | 7.66e-01 |
| GO:BP | GO:0097659 | nucleic acid-templated transcription | 3 | 2684 | 7.66e-01 |
| GO:BP | GO:0072583 | clathrin-dependent endocytosis | 1 | 43 | 7.66e-01 |
| GO:BP | GO:0042221 | response to chemical | 2 | 2559 | 7.66e-01 |
| GO:BP | GO:0042255 | ribosome assembly | 14 | 56 | 7.66e-01 |
| GO:BP | GO:0002940 | tRNA N2-guanine methylation | 1 | 4 | 7.66e-01 |
| GO:BP | GO:0043501 | skeletal muscle adaptation | 1 | 19 | 7.66e-01 |
| GO:BP | GO:1901857 | positive regulation of cellular respiration | 1 | 11 | 7.66e-01 |
| GO:BP | GO:1900098 | regulation of plasma cell differentiation | 1 | 2 | 7.66e-01 |
| GO:BP | GO:0006703 | estrogen biosynthetic process | 2 | 6 | 7.66e-01 |
| GO:BP | GO:0072599 | establishment of protein localization to endoplasmic reticulum | 2 | 53 | 7.67e-01 |
| GO:BP | GO:0005513 | detection of calcium ion | 4 | 12 | 7.67e-01 |
| GO:BP | GO:0006403 | RNA localization | 55 | 182 | 7.67e-01 |
| GO:BP | GO:0032527 | protein exit from endoplasmic reticulum | 1 | 43 | 7.67e-01 |
| GO:BP | GO:0006349 | regulation of gene expression by genomic imprinting | 8 | 14 | 7.67e-01 |
| GO:BP | GO:0048469 | cell maturation | 2 | 108 | 7.68e-01 |
| GO:BP | GO:0016226 | iron-sulfur cluster assembly | 3 | 29 | 7.68e-01 |
| GO:BP | GO:0032769 | negative regulation of monooxygenase activity | 1 | 8 | 7.68e-01 |
| GO:BP | GO:0070922 | RISC complex assembly | 3 | 9 | 7.68e-01 |
| GO:BP | GO:1903327 | negative regulation of tRNA metabolic process | 1 | 2 | 7.68e-01 |
| GO:BP | GO:0090206 | negative regulation of cholesterol metabolic process | 2 | 5 | 7.68e-01 |
| GO:BP | GO:0042473 | outer ear morphogenesis | 3 | 5 | 7.68e-01 |
| GO:BP | GO:0036416 | tRNA stabilization | 1 | 2 | 7.68e-01 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 2 | 50 | 7.68e-01 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 1 | 295 | 7.68e-01 |
| GO:BP | GO:0014015 | positive regulation of gliogenesis | 3 | 45 | 7.68e-01 |
| GO:BP | GO:0106119 | negative regulation of sterol biosynthetic process | 2 | 5 | 7.68e-01 |
| GO:BP | GO:0140447 | cytokine precursor processing | 1 | 1 | 7.68e-01 |
| GO:BP | GO:0032341 | aldosterone metabolic process | 2 | 10 | 7.68e-01 |
| GO:BP | GO:0036415 | regulation of tRNA stability | 1 | 2 | 7.68e-01 |
| GO:BP | GO:0031650 | regulation of heat generation | 2 | 7 | 7.68e-01 |
| GO:BP | GO:1902370 | regulation of tRNA catabolic process | 1 | 2 | 7.68e-01 |
| GO:BP | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2 | 13 | 7.68e-01 |
| GO:BP | GO:0045940 | positive regulation of steroid metabolic process | 11 | 20 | 7.68e-01 |
| GO:BP | GO:0060936 | cardiac fibroblast cell development | 2 | 4 | 7.68e-01 |
| GO:BP | GO:0060935 | cardiac fibroblast cell differentiation | 2 | 4 | 7.68e-01 |
| GO:BP | GO:0031163 | metallo-sulfur cluster assembly | 3 | 29 | 7.68e-01 |
| GO:BP | GO:1903326 | regulation of tRNA metabolic process | 1 | 2 | 7.68e-01 |
| GO:BP | GO:0045541 | negative regulation of cholesterol biosynthetic process | 2 | 5 | 7.68e-01 |
| GO:BP | GO:0035457 | cellular response to interferon-alpha | 5 | 7 | 7.68e-01 |
| GO:BP | GO:1902371 | negative regulation of tRNA catabolic process | 1 | 2 | 7.68e-01 |
| GO:BP | GO:0006112 | energy reserve metabolic process | 18 | 73 | 7.68e-01 |
| GO:BP | GO:0021532 | neural tube patterning | 5 | 31 | 7.69e-01 |
| GO:BP | GO:0070172 | positive regulation of tooth mineralization | 1 | 2 | 7.69e-01 |
| GO:BP | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1 | 11 | 7.69e-01 |
| GO:BP | GO:1901841 | regulation of high voltage-gated calcium channel activity | 1 | 12 | 7.69e-01 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 1 | 4455 | 7.69e-01 |
| GO:BP | GO:0000271 | polysaccharide biosynthetic process | 2 | 53 | 7.69e-01 |
| GO:BP | GO:1900047 | negative regulation of hemostasis | 4 | 34 | 7.69e-01 |
| GO:BP | GO:0075525 | viral translational termination-reinitiation | 1 | 5 | 7.69e-01 |
| GO:BP | GO:0016571 | histone methylation | 11 | 117 | 7.70e-01 |
| GO:BP | GO:0035747 | natural killer cell chemotaxis | 2 | 3 | 7.70e-01 |
| GO:BP | GO:0019509 | L-methionine salvage from methylthioadenosine | 2 | 5 | 7.70e-01 |
| GO:BP | GO:0060267 | positive regulation of respiratory burst | 2 | 3 | 7.70e-01 |
| GO:BP | GO:0006701 | progesterone biosynthetic process | 1 | 5 | 7.70e-01 |
| GO:BP | GO:0021747 | cochlear nucleus development | 1 | 3 | 7.70e-01 |
| GO:BP | GO:0045687 | positive regulation of glial cell differentiation | 2 | 28 | 7.71e-01 |
| GO:BP | GO:0051541 | elastin metabolic process | 2 | 5 | 7.71e-01 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 2 | 108 | 7.71e-01 |
| GO:BP | GO:1902559 | 3’-phospho-5’-adenylyl sulfate transmembrane transport | 1 | 2 | 7.71e-01 |
| GO:BP | GO:1902558 | 5’-adenylyl sulfate transmembrane transport | 1 | 2 | 7.71e-01 |
| GO:BP | GO:0048172 | regulation of short-term neuronal synaptic plasticity | 1 | 9 | 7.71e-01 |
| GO:BP | GO:0046963 | 3’-phosphoadenosine 5’-phosphosulfate transport | 1 | 2 | 7.71e-01 |
| GO:BP | GO:0030279 | negative regulation of ossification | 2 | 25 | 7.71e-01 |
| GO:BP | GO:0030970 | retrograde protein transport, ER to cytosol | 2 | 28 | 7.71e-01 |
| GO:BP | GO:2001286 | regulation of caveolin-mediated endocytosis | 3 | 5 | 7.71e-01 |
| GO:BP | GO:1903513 | endoplasmic reticulum to cytosol transport | 2 | 28 | 7.71e-01 |
| GO:BP | GO:0043585 | nose morphogenesis | 1 | 3 | 7.71e-01 |
| GO:BP | GO:1990959 | eosinophil homeostasis | 1 | 2 | 7.71e-01 |
| GO:BP | GO:0033133 | positive regulation of glucokinase activity | 2 | 4 | 7.71e-01 |
| GO:BP | GO:0055085 | transmembrane transport | 20 | 998 | 7.71e-01 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 3 | 2714 | 7.71e-01 |
| GO:BP | GO:1901537 | positive regulation of DNA demethylation | 1 | 7 | 7.71e-01 |
| GO:BP | GO:2000192 | negative regulation of fatty acid transport | 4 | 7 | 7.71e-01 |
| GO:BP | GO:0022600 | digestive system process | 2 | 54 | 7.71e-01 |
| GO:BP | GO:0006406 | mRNA export from nucleus | 1 | 59 | 7.71e-01 |
| GO:BP | GO:2000546 | positive regulation of endothelial cell chemotaxis to fibroblast growth factor | 1 | 3 | 7.71e-01 |
| GO:BP | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor | 1 | 3 | 7.71e-01 |
| GO:BP | GO:0050896 | response to stimulus | 3 | 5770 | 7.71e-01 |
| GO:BP | GO:0038189 | neuropilin signaling pathway | 2 | 4 | 7.72e-01 |
| GO:BP | GO:0045981 | positive regulation of nucleotide metabolic process | 3 | 16 | 7.72e-01 |
| GO:BP | GO:0071380 | cellular response to prostaglandin E stimulus | 1 | 14 | 7.72e-01 |
| GO:BP | GO:1900544 | positive regulation of purine nucleotide metabolic process | 3 | 16 | 7.72e-01 |
| GO:BP | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell | 1 | 2 | 7.72e-01 |
| GO:BP | GO:1902669 | positive regulation of axon guidance | 2 | 3 | 7.72e-01 |
| GO:BP | GO:0051028 | mRNA transport | 35 | 117 | 7.72e-01 |
| GO:BP | GO:1990926 | short-term synaptic potentiation | 2 | 4 | 7.72e-01 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 12 | 23 | 7.72e-01 |
| GO:BP | GO:2000674 | regulation of type B pancreatic cell apoptotic process | 2 | 6 | 7.72e-01 |
| GO:BP | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1 | 2 | 7.72e-01 |
| GO:BP | GO:0043406 | positive regulation of MAP kinase activity | 3 | 82 | 7.72e-01 |
| GO:BP | GO:0034110 | regulation of homotypic cell-cell adhesion | 3 | 26 | 7.72e-01 |
| GO:BP | GO:0072156 | distal tubule morphogenesis | 1 | 3 | 7.72e-01 |
| GO:BP | GO:0021648 | vestibulocochlear nerve morphogenesis | 2 | 3 | 7.72e-01 |
| GO:BP | GO:1903532 | positive regulation of secretion by cell | 4 | 199 | 7.72e-01 |
| GO:BP | GO:0033029 | regulation of neutrophil apoptotic process | 1 | 5 | 7.72e-01 |
| GO:BP | GO:0090598 | male anatomical structure morphogenesis | 1 | 2 | 7.72e-01 |
| GO:BP | GO:0048808 | male genitalia morphogenesis | 1 | 2 | 7.72e-01 |
| GO:BP | GO:0006642 | triglyceride mobilization | 1 | 3 | 7.72e-01 |
| GO:BP | GO:0042048 | olfactory behavior | 5 | 7 | 7.72e-01 |
| GO:BP | GO:0000097 | sulfur amino acid biosynthetic process | 3 | 14 | 7.72e-01 |
| GO:BP | GO:0060297 | regulation of sarcomere organization | 3 | 7 | 7.72e-01 |
| GO:BP | GO:0090158 | endoplasmic reticulum membrane organization | 3 | 14 | 7.72e-01 |
| GO:BP | GO:0035697 | CD8-positive, alpha-beta T cell extravasation | 1 | 1 | 7.72e-01 |
| GO:BP | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation | 1 | 1 | 7.72e-01 |
| GO:BP | GO:2000409 | positive regulation of T cell extravasation | 1 | 2 | 7.72e-01 |
| GO:BP | GO:0000266 | mitochondrial fission | 4 | 38 | 7.73e-01 |
| GO:BP | GO:0043407 | negative regulation of MAP kinase activity | 25 | 50 | 7.73e-01 |
| GO:BP | GO:0042743 | hydrogen peroxide metabolic process | 1 | 29 | 7.73e-01 |
| GO:BP | GO:0044827 | modulation by host of viral genome replication | 5 | 21 | 7.73e-01 |
| GO:BP | GO:0033002 | muscle cell proliferation | 1 | 157 | 7.73e-01 |
| GO:BP | GO:0035617 | stress granule disassembly | 2 | 5 | 7.73e-01 |
| GO:BP | GO:1990173 | protein localization to nucleoplasm | 3 | 14 | 7.73e-01 |
| GO:BP | GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1 | 34 | 7.73e-01 |
| GO:BP | GO:0045591 | positive regulation of regulatory T cell differentiation | 5 | 14 | 7.73e-01 |
| GO:BP | GO:0033633 | negative regulation of cell-cell adhesion mediated by integrin | 1 | 2 | 7.73e-01 |
| GO:BP | GO:0006363 | termination of RNA polymerase I transcription | 1 | 4 | 7.73e-01 |
| GO:BP | GO:0071218 | cellular response to misfolded protein | 1 | 23 | 7.73e-01 |
| GO:BP | GO:0046460 | neutral lipid biosynthetic process | 15 | 36 | 7.73e-01 |
| GO:BP | GO:0043171 | peptide catabolic process | 9 | 16 | 7.73e-01 |
| GO:BP | GO:0043029 | T cell homeostasis | 8 | 27 | 7.73e-01 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 3 | 344 | 7.73e-01 |
| GO:BP | GO:0046463 | acylglycerol biosynthetic process | 15 | 36 | 7.73e-01 |
| GO:BP | GO:0043242 | negative regulation of protein-containing complex disassembly | 2 | 72 | 7.73e-01 |
| GO:BP | GO:0034968 | histone lysine methylation | 2 | 89 | 7.73e-01 |
| GO:BP | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 2 | 4 | 7.73e-01 |
| GO:BP | GO:0008361 | regulation of cell size | 15 | 159 | 7.73e-01 |
| GO:BP | GO:0030450 | regulation of complement activation, classical pathway | 2 | 4 | 7.74e-01 |
| GO:BP | GO:0061868 | hepatic stellate cell migration | 1 | 2 | 7.74e-01 |
| GO:BP | GO:0061869 | regulation of hepatic stellate cell migration | 1 | 2 | 7.74e-01 |
| GO:BP | GO:0051234 | establishment of localization | 2 | 3433 | 7.74e-01 |
| GO:BP | GO:0061870 | positive regulation of hepatic stellate cell migration | 1 | 2 | 7.74e-01 |
| GO:BP | GO:0070723 | response to cholesterol | 1 | 16 | 7.74e-01 |
| GO:BP | GO:1904880 | response to hydrogen sulfide | 1 | 3 | 7.74e-01 |
| GO:BP | GO:0071806 | protein transmembrane transport | 24 | 62 | 7.74e-01 |
| GO:BP | GO:0072193 | ureter smooth muscle cell differentiation | 1 | 2 | 7.74e-01 |
| GO:BP | GO:0072191 | ureter smooth muscle development | 1 | 2 | 7.74e-01 |
| GO:BP | GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 1 | 4 | 7.74e-01 |
| GO:BP | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1 | 5 | 7.74e-01 |
| GO:BP | GO:1990834 | response to odorant | 1 | 3 | 7.74e-01 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 3 | 345 | 7.74e-01 |
| GO:BP | GO:0002639 | positive regulation of immunoglobulin production | 1 | 30 | 7.74e-01 |
| GO:BP | GO:0097680 | double-strand break repair via classical nonhomologous end joining | 1 | 6 | 7.74e-01 |
| GO:BP | GO:0061299 | retina vasculature morphogenesis in camera-type eye | 5 | 7 | 7.75e-01 |
| GO:BP | GO:0051954 | positive regulation of amine transport | 1 | 26 | 7.75e-01 |
| GO:BP | GO:0072010 | glomerular epithelium development | 2 | 18 | 7.75e-01 |
| GO:BP | GO:0046950 | cellular ketone body metabolic process | 2 | 7 | 7.75e-01 |
| GO:BP | GO:0002720 | positive regulation of cytokine production involved in immune response | 2 | 49 | 7.75e-01 |
| GO:BP | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1 | 3 | 7.75e-01 |
| GO:BP | GO:1903422 | negative regulation of synaptic vesicle recycling | 1 | 2 | 7.75e-01 |
| GO:BP | GO:0033206 | meiotic cytokinesis | 1 | 7 | 7.75e-01 |
| GO:BP | GO:0051384 | response to glucocorticoid | 2 | 93 | 7.75e-01 |
| GO:BP | GO:0030240 | skeletal muscle thin filament assembly | 3 | 6 | 7.75e-01 |
| GO:BP | GO:0070535 | histone H2A K63-linked ubiquitination | 3 | 6 | 7.75e-01 |
| GO:BP | GO:1905429 | response to glycine | 1 | 2 | 7.76e-01 |
| GO:BP | GO:0016056 | rhodopsin mediated signaling pathway | 3 | 6 | 7.76e-01 |
| GO:BP | GO:0006730 | one-carbon metabolic process | 4 | 29 | 7.76e-01 |
| GO:BP | GO:1903300 | negative regulation of hexokinase activity | 2 | 3 | 7.76e-01 |
| GO:BP | GO:0060585 | positive regulation of prostaglandin-endoperoxide synthase activity | 1 | 2 | 7.76e-01 |
| GO:BP | GO:0033132 | negative regulation of glucokinase activity | 2 | 3 | 7.76e-01 |
| GO:BP | GO:0051026 | chiasma assembly | 1 | 3 | 7.76e-01 |
| GO:BP | GO:1904683 | regulation of metalloendopeptidase activity | 2 | 6 | 7.76e-01 |
| GO:BP | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity | 1 | 2 | 7.76e-01 |
| GO:BP | GO:0014826 | vein smooth muscle contraction | 1 | 3 | 7.76e-01 |
| GO:BP | GO:0042306 | regulation of protein import into nucleus | 3 | 51 | 7.76e-01 |
| GO:BP | GO:0035352 | NAD transmembrane transport | 1 | 3 | 7.76e-01 |
| GO:BP | GO:0045588 | positive regulation of gamma-delta T cell differentiation | 1 | 4 | 7.76e-01 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 1 | 4570 | 7.76e-01 |
| GO:BP | GO:0090317 | negative regulation of intracellular protein transport | 3 | 37 | 7.77e-01 |
| GO:BP | GO:0038162 | erythropoietin-mediated signaling pathway | 1 | 2 | 7.77e-01 |
| GO:BP | GO:1990770 | small intestine smooth muscle contraction | 1 | 1 | 7.77e-01 |
| GO:BP | GO:0046959 | habituation | 2 | 5 | 7.77e-01 |
| GO:BP | GO:0048793 | pronephros development | 1 | 5 | 7.77e-01 |
| GO:BP | GO:0043045 | DNA methylation involved in embryo development | 1 | 7 | 7.77e-01 |
| GO:BP | GO:1905459 | regulation of vascular associated smooth muscle cell apoptotic process | 1 | 9 | 7.77e-01 |
| GO:BP | GO:1905288 | vascular associated smooth muscle cell apoptotic process | 1 | 9 | 7.77e-01 |
| GO:BP | GO:0021903 | rostrocaudal neural tube patterning | 2 | 5 | 7.78e-01 |
| GO:BP | GO:0001547 | antral ovarian follicle growth | 3 | 5 | 7.78e-01 |
| GO:BP | GO:0006226 | dUMP biosynthetic process | 1 | 2 | 7.78e-01 |
| GO:BP | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 2 | 7 | 7.79e-01 |
| GO:BP | GO:0071352 | cellular response to interleukin-2 | 1 | 2 | 7.79e-01 |
| GO:BP | GO:0032483 | regulation of Rab protein signal transduction | 1 | 7 | 7.79e-01 |
| GO:BP | GO:0002764 | immune response-regulating signaling pathway | 1 | 242 | 7.79e-01 |
| GO:BP | GO:0038110 | interleukin-2-mediated signaling pathway | 1 | 2 | 7.79e-01 |
| GO:BP | GO:0001678 | intracellular glucose homeostasis | 7 | 110 | 7.79e-01 |
| GO:BP | GO:2000487 | positive regulation of glutamine transport | 1 | 2 | 7.79e-01 |
| GO:BP | GO:1903713 | asparagine transmembrane transport | 1 | 1 | 7.79e-01 |
| GO:BP | GO:0051365 | cellular response to potassium ion starvation | 1 | 1 | 7.79e-01 |
| GO:BP | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH | 1 | 1 | 7.79e-01 |
| GO:BP | GO:0060841 | venous blood vessel development | 2 | 13 | 7.79e-01 |
| GO:BP | GO:0036378 | calcitriol biosynthetic process from calciol | 2 | 2 | 7.79e-01 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 1 | 4596 | 7.79e-01 |
| GO:BP | GO:0051099 | positive regulation of binding | 5 | 150 | 7.80e-01 |
| GO:BP | GO:0072535 | tumor necrosis factor (ligand) superfamily member 11 production | 1 | 1 | 7.80e-01 |
| GO:BP | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1 | 2 | 7.80e-01 |
| GO:BP | GO:0015812 | gamma-aminobutyric acid transport | 1 | 11 | 7.80e-01 |
| GO:BP | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1 | 2 | 7.80e-01 |
| GO:BP | GO:2000412 | positive regulation of thymocyte migration | 1 | 1 | 7.80e-01 |
| GO:BP | GO:2000307 | regulation of tumor necrosis factor (ligand) superfamily member 11 production | 1 | 1 | 7.80e-01 |
| GO:BP | GO:0018002 | N-terminal peptidyl-glutamic acid acetylation | 1 | 2 | 7.80e-01 |
| GO:BP | GO:0017190 | N-terminal peptidyl-aspartic acid acetylation | 1 | 2 | 7.80e-01 |
| GO:BP | GO:0060290 | transdifferentiation | 2 | 2 | 7.80e-01 |
| GO:BP | GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 2 | 119 | 7.80e-01 |
| GO:BP | GO:1900272 | negative regulation of long-term synaptic potentiation | 1 | 8 | 7.80e-01 |
| GO:BP | GO:1902950 | regulation of dendritic spine maintenance | 1 | 7 | 7.80e-01 |
| GO:BP | GO:0072348 | sulfur compound transport | 4 | 39 | 7.80e-01 |
| GO:BP | GO:0099563 | modification of synaptic structure | 6 | 24 | 7.80e-01 |
| GO:BP | GO:0051250 | negative regulation of lymphocyte activation | 1 | 90 | 7.81e-01 |
| GO:BP | GO:2000353 | positive regulation of endothelial cell apoptotic process | 1 | 13 | 7.81e-01 |
| GO:BP | GO:0046185 | aldehyde catabolic process | 5 | 12 | 7.81e-01 |
| GO:BP | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway | 1 | 2 | 7.81e-01 |
| GO:BP | GO:0060416 | response to growth hormone | 1 | 25 | 7.81e-01 |
| GO:BP | GO:0043409 | negative regulation of MAPK cascade | 39 | 145 | 7.81e-01 |
| GO:BP | GO:2000367 | regulation of acrosomal vesicle exocytosis | 1 | 3 | 7.82e-01 |
| GO:BP | GO:0001807 | regulation of type IV hypersensitivity | 1 | 1 | 7.82e-01 |
| GO:BP | GO:0006550 | isoleucine catabolic process | 1 | 4 | 7.82e-01 |
| GO:BP | GO:0051459 | regulation of corticotropin secretion | 1 | 3 | 7.82e-01 |
| GO:BP | GO:0035483 | gastric emptying | 1 | 2 | 7.82e-01 |
| GO:BP | GO:0097354 | prenylation | 1 | 10 | 7.82e-01 |
| GO:BP | GO:0018342 | protein prenylation | 1 | 10 | 7.82e-01 |
| GO:BP | GO:0038183 | bile acid signaling pathway | 1 | 3 | 7.82e-01 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 12 | 58 | 7.82e-01 |
| GO:BP | GO:0045875 | negative regulation of sister chromatid cohesion | 1 | 5 | 7.82e-01 |
| GO:BP | GO:1904437 | positive regulation of transferrin receptor binding | 1 | 2 | 7.82e-01 |
| GO:BP | GO:0070561 | vitamin D receptor signaling pathway | 1 | 10 | 7.82e-01 |
| GO:BP | GO:1904432 | regulation of ferrous iron binding | 1 | 2 | 7.82e-01 |
| GO:BP | GO:0043305 | negative regulation of mast cell degranulation | 2 | 2 | 7.82e-01 |
| GO:BP | GO:0023051 | regulation of signaling | 3 | 2565 | 7.82e-01 |
| GO:BP | GO:0051935 | glutamate reuptake | 2 | 4 | 7.82e-01 |
| GO:BP | GO:0044830 | modulation by host of viral RNA genome replication | 1 | 6 | 7.82e-01 |
| GO:BP | GO:0016119 | carotene metabolic process | 1 | 1 | 7.82e-01 |
| GO:BP | GO:0016121 | carotene catabolic process | 1 | 1 | 7.82e-01 |
| GO:BP | GO:0016122 | xanthophyll metabolic process | 1 | 1 | 7.82e-01 |
| GO:BP | GO:0072531 | pyrimidine-containing compound transmembrane transport | 1 | 9 | 7.82e-01 |
| GO:BP | GO:0010310 | regulation of hydrogen peroxide metabolic process | 1 | 14 | 7.82e-01 |
| GO:BP | GO:0001938 | positive regulation of endothelial cell proliferation | 3 | 74 | 7.82e-01 |
| GO:BP | GO:1901825 | zeaxanthin metabolic process | 1 | 1 | 7.82e-01 |
| GO:BP | GO:0070345 | negative regulation of fat cell proliferation | 2 | 5 | 7.82e-01 |
| GO:BP | GO:0030199 | collagen fibril organization | 1 | 56 | 7.82e-01 |
| GO:BP | GO:0046549 | retinal cone cell development | 2 | 5 | 7.82e-01 |
| GO:BP | GO:0006952 | defense response | 4 | 944 | 7.82e-01 |
| GO:BP | GO:1904434 | positive regulation of ferrous iron binding | 1 | 2 | 7.82e-01 |
| GO:BP | GO:0046247 | terpene catabolic process | 1 | 1 | 7.82e-01 |
| GO:BP | GO:1904435 | regulation of transferrin receptor binding | 1 | 2 | 7.82e-01 |
| GO:BP | GO:0046879 | hormone secretion | 1 | 210 | 7.83e-01 |
| GO:BP | GO:0045911 | positive regulation of DNA recombination | 7 | 57 | 7.83e-01 |
| GO:BP | GO:0003157 | endocardium development | 3 | 9 | 7.83e-01 |
| GO:BP | GO:1901301 | regulation of cargo loading into COPII-coated vesicle | 1 | 2 | 7.83e-01 |
| GO:BP | GO:0050798 | activated T cell proliferation | 1 | 25 | 7.83e-01 |
| GO:BP | GO:0007197 | adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | 1 | 3 | 7.83e-01 |
| GO:BP | GO:0001553 | luteinization | 4 | 10 | 7.83e-01 |
| GO:BP | GO:0090032 | negative regulation of steroid hormone biosynthetic process | 1 | 6 | 7.83e-01 |
| GO:BP | GO:0035054 | embryonic heart tube anterior/posterior pattern specification | 1 | 2 | 7.83e-01 |
| GO:BP | GO:0010646 | regulation of cell communication | 3 | 2573 | 7.83e-01 |
| GO:BP | GO:0002544 | chronic inflammatory response | 1 | 6 | 7.83e-01 |
| GO:BP | GO:0006700 | C21-steroid hormone biosynthetic process | 3 | 17 | 7.84e-01 |
| GO:BP | GO:0030213 | hyaluronan biosynthetic process | 1 | 10 | 7.84e-01 |
| GO:BP | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration | 1 | 12 | 7.84e-01 |
| GO:BP | GO:0045843 | negative regulation of striated muscle tissue development | 4 | 5 | 7.84e-01 |
| GO:BP | GO:0019348 | dolichol metabolic process | 4 | 22 | 7.84e-01 |
| GO:BP | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway | 2 | 40 | 7.84e-01 |
| GO:BP | GO:1903056 | regulation of melanosome organization | 1 | 2 | 7.84e-01 |
| GO:BP | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 2 | 7 | 7.84e-01 |
| GO:BP | GO:0097240 | chromosome attachment to the nuclear envelope | 1 | 3 | 7.84e-01 |
| GO:BP | GO:0035684 | helper T cell extravasation | 1 | 3 | 7.84e-01 |
| GO:BP | GO:0048561 | establishment of animal organ orientation | 1 | 1 | 7.84e-01 |
| GO:BP | GO:0048241 | epinephrine transport | 1 | 4 | 7.84e-01 |
| GO:BP | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation | 3 | 4 | 7.84e-01 |
| GO:BP | GO:0032119 | sequestering of zinc ion | 2 | 5 | 7.85e-01 |
| GO:BP | GO:0030422 | siRNA processing | 1 | 7 | 7.85e-01 |
| GO:BP | GO:0021766 | hippocampus development | 2 | 62 | 7.85e-01 |
| GO:BP | GO:0035504 | regulation of myosin light chain kinase activity | 1 | 1 | 7.85e-01 |
| GO:BP | GO:0035505 | positive regulation of myosin light chain kinase activity | 1 | 1 | 7.85e-01 |
| GO:BP | GO:0007632 | visual behavior | 1 | 41 | 7.85e-01 |
| GO:BP | GO:1903649 | regulation of cytoplasmic transport | 6 | 25 | 7.85e-01 |
| GO:BP | GO:0016973 | poly(A)+ mRNA export from nucleus | 2 | 15 | 7.85e-01 |
| GO:BP | GO:0006811 | monoatomic ion transport | 15 | 775 | 7.85e-01 |
| GO:BP | GO:0018201 | peptidyl-glycine modification | 1 | 4 | 7.85e-01 |
| GO:BP | GO:0097028 | dendritic cell differentiation | 2 | 23 | 7.86e-01 |
| GO:BP | GO:0014858 | positive regulation of skeletal muscle cell proliferation | 1 | 2 | 7.87e-01 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 3 | 46 | 7.87e-01 |
| GO:BP | GO:0038016 | insulin receptor internalization | 1 | 3 | 7.87e-01 |
| GO:BP | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | 1 | 3 | 7.87e-01 |
| GO:BP | GO:2000009 | negative regulation of protein localization to cell surface | 2 | 12 | 7.87e-01 |
| GO:BP | GO:0120009 | intermembrane lipid transfer | 4 | 43 | 7.87e-01 |
| GO:BP | GO:0042755 | eating behavior | 1 | 16 | 7.87e-01 |
| GO:BP | GO:0038095 | Fc-epsilon receptor signaling pathway | 1 | 17 | 7.88e-01 |
| GO:BP | GO:1904204 | regulation of skeletal muscle hypertrophy | 1 | 1 | 7.88e-01 |
| GO:BP | GO:0070103 | regulation of interleukin-6-mediated signaling pathway | 2 | 4 | 7.88e-01 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 3 | 122 | 7.88e-01 |
| GO:BP | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade | 7 | 14 | 7.88e-01 |
| GO:BP | GO:0106057 | negative regulation of calcineurin-mediated signaling | 7 | 14 | 7.88e-01 |
| GO:BP | GO:0110091 | negative regulation of hippocampal neuron apoptotic process | 1 | 2 | 7.88e-01 |
| GO:BP | GO:1990258 | histone glutamine methylation | 1 | 2 | 7.88e-01 |
| GO:BP | GO:0033233 | regulation of protein sumoylation | 3 | 22 | 7.89e-01 |
| GO:BP | GO:0046676 | negative regulation of insulin secretion | 2 | 28 | 7.89e-01 |
| GO:BP | GO:0045210 | FasL biosynthetic process | 1 | 1 | 7.89e-01 |
| GO:BP | GO:0051454 | intracellular pH elevation | 4 | 4 | 7.89e-01 |
| GO:BP | GO:0070476 | rRNA (guanine-N7)-methylation | 1 | 2 | 7.89e-01 |
| GO:BP | GO:0048488 | synaptic vesicle endocytosis | 1 | 63 | 7.89e-01 |
| GO:BP | GO:0010543 | regulation of platelet activation | 4 | 32 | 7.89e-01 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 2 | 1555 | 7.90e-01 |
| GO:BP | GO:0097402 | neuroblast migration | 1 | 2 | 7.90e-01 |
| GO:BP | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway | 1 | 3 | 7.90e-01 |
| GO:BP | GO:0072343 | pancreatic stellate cell proliferation | 1 | 1 | 7.90e-01 |
| GO:BP | GO:0051953 | negative regulation of amine transport | 4 | 15 | 7.90e-01 |
| GO:BP | GO:0060694 | regulation of cholesterol transporter activity | 1 | 1 | 7.90e-01 |
| GO:BP | GO:1904597 | negative regulation of connective tissue replacement involved in inflammatory response wound healing | 1 | 1 | 7.90e-01 |
| GO:BP | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing | 1 | 1 | 7.90e-01 |
| GO:BP | GO:0015909 | long-chain fatty acid transport | 3 | 38 | 7.90e-01 |
| GO:BP | GO:1905204 | negative regulation of connective tissue replacement | 1 | 1 | 7.90e-01 |
| GO:BP | GO:1901097 | negative regulation of autophagosome maturation | 2 | 5 | 7.90e-01 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 19 | 97 | 7.90e-01 |
| GO:BP | GO:0033085 | negative regulation of T cell differentiation in thymus | 1 | 5 | 7.90e-01 |
| GO:BP | GO:0048708 | astrocyte differentiation | 1 | 58 | 7.90e-01 |
| GO:BP | GO:1900223 | positive regulation of amyloid-beta clearance | 1 | 5 | 7.90e-01 |
| GO:BP | GO:1901558 | response to metformin | 1 | 1 | 7.90e-01 |
| GO:BP | GO:0071306 | cellular response to vitamin E | 1 | 2 | 7.90e-01 |
| GO:BP | GO:2000229 | regulation of pancreatic stellate cell proliferation | 1 | 1 | 7.90e-01 |
| GO:BP | GO:0009086 | methionine biosynthetic process | 5 | 10 | 7.91e-01 |
| GO:BP | GO:1903742 | regulation of anterograde synaptic vesicle transport | 1 | 3 | 7.91e-01 |
| GO:BP | GO:0071333 | cellular response to glucose stimulus | 6 | 93 | 7.91e-01 |
| GO:BP | GO:0002724 | regulation of T cell cytokine production | 1 | 18 | 7.91e-01 |
| GO:BP | GO:0070948 | regulation of neutrophil mediated cytotoxicity | 1 | 2 | 7.91e-01 |
| GO:BP | GO:0035307 | positive regulation of protein dephosphorylation | 7 | 36 | 7.91e-01 |
| GO:BP | GO:0044273 | sulfur compound catabolic process | 2 | 31 | 7.91e-01 |
| GO:BP | GO:1904780 | negative regulation of protein localization to centrosome | 1 | 2 | 7.91e-01 |
| GO:BP | GO:0010517 | regulation of phospholipase activity | 3 | 37 | 7.91e-01 |
| GO:BP | GO:0009136 | purine nucleoside diphosphate biosynthetic process | 3 | 5 | 7.91e-01 |
| GO:BP | GO:0002369 | T cell cytokine production | 1 | 18 | 7.91e-01 |
| GO:BP | GO:1903525 | regulation of membrane tubulation | 2 | 5 | 7.91e-01 |
| GO:BP | GO:0009313 | oligosaccharide catabolic process | 3 | 11 | 7.91e-01 |
| GO:BP | GO:0006149 | deoxyinosine catabolic process | 1 | 1 | 7.91e-01 |
| GO:BP | GO:0006148 | inosine catabolic process | 1 | 1 | 7.91e-01 |
| GO:BP | GO:0046094 | deoxyinosine metabolic process | 1 | 1 | 7.91e-01 |
| GO:BP | GO:0007264 | small GTPase mediated signal transduction | 63 | 421 | 7.91e-01 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 1 | 4747 | 7.91e-01 |
| GO:BP | GO:0034418 | urate biosynthetic process | 1 | 2 | 7.91e-01 |
| GO:BP | GO:0006862 | nucleotide transport | 3 | 28 | 7.91e-01 |
| GO:BP | GO:1905380 | regulation of snRNA transcription by RNA polymerase II | 2 | 4 | 7.91e-01 |
| GO:BP | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 1 | 35 | 7.91e-01 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 3 | 2845 | 7.91e-01 |
| GO:BP | GO:0019065 | receptor-mediated endocytosis of virus by host cell | 2 | 9 | 7.91e-01 |
| GO:BP | GO:0009914 | hormone transport | 1 | 215 | 7.91e-01 |
| GO:BP | GO:0070664 | negative regulation of leukocyte proliferation | 10 | 51 | 7.91e-01 |
| GO:BP | GO:0015867 | ATP transport | 3 | 9 | 7.92e-01 |
| GO:BP | GO:0046931 | pore complex assembly | 7 | 19 | 7.92e-01 |
| GO:BP | GO:1902996 | regulation of neurofibrillary tangle assembly | 1 | 2 | 7.92e-01 |
| GO:BP | GO:1901998 | toxin transport | 2 | 37 | 7.92e-01 |
| GO:BP | GO:0000961 | negative regulation of mitochondrial RNA catabolic process | 1 | 2 | 7.92e-01 |
| GO:BP | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 3 | 5 | 7.92e-01 |
| GO:BP | GO:0035523 | protein K29-linked deubiquitination | 1 | 4 | 7.92e-01 |
| GO:BP | GO:1905035 | negative regulation of antifungal innate immune response | 1 | 2 | 7.92e-01 |
| GO:BP | GO:1903901 | negative regulation of viral life cycle | 1 | 17 | 7.92e-01 |
| GO:BP | GO:0031290 | retinal ganglion cell axon guidance | 6 | 13 | 7.92e-01 |
| GO:BP | GO:0055062 | phosphate ion homeostasis | 1 | 8 | 7.93e-01 |
| GO:BP | GO:0019915 | lipid storage | 8 | 66 | 7.93e-01 |
| GO:BP | GO:0060847 | endothelial cell fate specification | 1 | 3 | 7.93e-01 |
| GO:BP | GO:0060300 | regulation of cytokine activity | 1 | 3 | 7.93e-01 |
| GO:BP | GO:0071205 | protein localization to juxtaparanode region of axon | 2 | 3 | 7.93e-01 |
| GO:BP | GO:0033030 | negative regulation of neutrophil apoptotic process | 1 | 1 | 7.93e-01 |
| GO:BP | GO:1990737 | response to manganese-induced endoplasmic reticulum stress | 1 | 3 | 7.93e-01 |
| GO:BP | GO:0045762 | positive regulation of adenylate cyclase activity | 4 | 19 | 7.93e-01 |
| GO:BP | GO:0043982 | histone H4-K8 acetylation | 7 | 16 | 7.93e-01 |
| GO:BP | GO:0043981 | histone H4-K5 acetylation | 7 | 16 | 7.93e-01 |
| GO:BP | GO:0061357 | positive regulation of Wnt protein secretion | 1 | 4 | 7.93e-01 |
| GO:BP | GO:0051788 | response to misfolded protein | 1 | 25 | 7.93e-01 |
| GO:BP | GO:0016560 | protein import into peroxisome matrix, docking | 2 | 3 | 7.93e-01 |
| GO:BP | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly | 1 | 1 | 7.93e-01 |
| GO:BP | GO:0015813 | L-glutamate transmembrane transport | 3 | 19 | 7.94e-01 |
| GO:BP | GO:1905600 | regulation of receptor-mediated endocytosis involved in cholesterol transport | 1 | 3 | 7.94e-01 |
| GO:BP | GO:0010256 | endomembrane system organization | 7 | 496 | 7.94e-01 |
| GO:BP | GO:0060183 | apelin receptor signaling pathway | 1 | 1 | 7.94e-01 |
| GO:BP | GO:0018958 | phenol-containing compound metabolic process | 11 | 61 | 7.94e-01 |
| GO:BP | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway | 1 | 6 | 7.95e-01 |
| GO:BP | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway | 1 | 2 | 7.95e-01 |
| GO:BP | GO:0008212 | mineralocorticoid metabolic process | 2 | 10 | 7.95e-01 |
| GO:BP | GO:0034309 | primary alcohol biosynthetic process | 2 | 12 | 7.95e-01 |
| GO:BP | GO:0060330 | regulation of response to type II interferon | 6 | 12 | 7.95e-01 |
| GO:BP | GO:0060334 | regulation of type II interferon-mediated signaling pathway | 6 | 12 | 7.95e-01 |
| GO:BP | GO:0046467 | membrane lipid biosynthetic process | 1 | 124 | 7.95e-01 |
| GO:BP | GO:0032447 | protein urmylation | 1 | 4 | 7.95e-01 |
| GO:BP | GO:0140238 | presynaptic endocytosis | 1 | 65 | 7.95e-01 |
| GO:BP | GO:0060174 | limb bud formation | 5 | 10 | 7.95e-01 |
| GO:BP | GO:0035021 | negative regulation of Rac protein signal transduction | 2 | 4 | 7.96e-01 |
| GO:BP | GO:0035811 | negative regulation of urine volume | 1 | 2 | 7.96e-01 |
| GO:BP | GO:0070669 | response to interleukin-2 | 3 | 3 | 7.96e-01 |
| GO:BP | GO:0006346 | DNA methylation-dependent heterochromatin formation | 5 | 22 | 7.96e-01 |
| GO:BP | GO:0002673 | regulation of acute inflammatory response | 1 | 21 | 7.96e-01 |
| GO:BP | GO:1905050 | positive regulation of metallopeptidase activity | 3 | 5 | 7.96e-01 |
| GO:BP | GO:0045329 | carnitine biosynthetic process | 2 | 3 | 7.96e-01 |
| GO:BP | GO:1990544 | mitochondrial ATP transmembrane transport | 2 | 4 | 7.96e-01 |
| GO:BP | GO:0045590 | negative regulation of regulatory T cell differentiation | 1 | 3 | 7.96e-01 |
| GO:BP | GO:0140021 | mitochondrial ADP transmembrane transport | 2 | 4 | 7.96e-01 |
| GO:BP | GO:0060749 | mammary gland alveolus development | 5 | 13 | 7.96e-01 |
| GO:BP | GO:0061377 | mammary gland lobule development | 5 | 13 | 7.96e-01 |
| GO:BP | GO:0033034 | positive regulation of myeloid cell apoptotic process | 2 | 6 | 7.96e-01 |
| GO:BP | GO:0021997 | neural plate axis specification | 1 | 2 | 7.97e-01 |
| GO:BP | GO:0032305 | positive regulation of icosanoid secretion | 1 | 8 | 7.97e-01 |
| GO:BP | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 3 | 35 | 7.97e-01 |
| GO:BP | GO:0046054 | dGMP metabolic process | 2 | 2 | 7.97e-01 |
| GO:BP | GO:1901879 | regulation of protein depolymerization | 2 | 78 | 7.97e-01 |
| GO:BP | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 3 | 9 | 7.97e-01 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 1 | 13 | 7.97e-01 |
| GO:BP | GO:1900117 | regulation of execution phase of apoptosis | 5 | 13 | 7.98e-01 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 8 | 51 | 7.98e-01 |
| GO:BP | GO:0034143 | regulation of toll-like receptor 4 signaling pathway | 3 | 15 | 7.98e-01 |
| GO:BP | GO:0046167 | glycerol-3-phosphate biosynthetic process | 1 | 2 | 7.98e-01 |
| GO:BP | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 2 | 5 | 7.98e-01 |
| GO:BP | GO:0002322 | B cell proliferation involved in immune response | 2 | 3 | 7.98e-01 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 29 | 50 | 7.98e-01 |
| GO:BP | GO:0007585 | respiratory gaseous exchange by respiratory system | 1 | 49 | 7.99e-01 |
| GO:BP | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering | 1 | 9 | 7.99e-01 |
| GO:BP | GO:0051693 | actin filament capping | 1 | 34 | 7.99e-01 |
| GO:BP | GO:1905954 | positive regulation of lipid localization | 5 | 75 | 7.99e-01 |
| GO:BP | GO:0001818 | negative regulation of cytokine production | 3 | 165 | 8.00e-01 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 1 | 4946 | 8.00e-01 |
| GO:BP | GO:0051567 | histone H3-K9 methylation | 7 | 18 | 8.00e-01 |
| GO:BP | GO:0007614 | short-term memory | 5 | 9 | 8.00e-01 |
| GO:BP | GO:0098964 | anterograde dendritic transport of messenger ribonucleoprotein complex | 1 | 2 | 8.00e-01 |
| GO:BP | GO:0006359 | regulation of transcription by RNA polymerase III | 2 | 30 | 8.00e-01 |
| GO:BP | GO:0010912 | positive regulation of isomerase activity | 2 | 5 | 8.00e-01 |
| GO:BP | GO:0010911 | regulation of isomerase activity | 2 | 5 | 8.00e-01 |
| GO:BP | GO:1903489 | positive regulation of lactation | 1 | 1 | 8.00e-01 |
| GO:BP | GO:0034375 | high-density lipoprotein particle remodeling | 2 | 11 | 8.00e-01 |
| GO:BP | GO:0045923 | positive regulation of fatty acid metabolic process | 5 | 26 | 8.00e-01 |
| GO:BP | GO:0071331 | cellular response to hexose stimulus | 6 | 94 | 8.00e-01 |
| GO:BP | GO:1904958 | positive regulation of midbrain dopaminergic neuron differentiation | 1 | 3 | 8.00e-01 |
| GO:BP | GO:2000669 | negative regulation of dendritic cell apoptotic process | 1 | 5 | 8.01e-01 |
| GO:BP | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 1 | 104 | 8.01e-01 |
| GO:BP | GO:2000288 | positive regulation of myoblast proliferation | 2 | 9 | 8.01e-01 |
| GO:BP | GO:0060462 | lung lobe development | 1 | 4 | 8.01e-01 |
| GO:BP | GO:0002253 | activation of immune response | 1 | 272 | 8.01e-01 |
| GO:BP | GO:0001781 | neutrophil apoptotic process | 1 | 5 | 8.01e-01 |
| GO:BP | GO:0001510 | RNA methylation | 36 | 87 | 8.01e-01 |
| GO:BP | GO:0060463 | lung lobe morphogenesis | 1 | 4 | 8.01e-01 |
| GO:BP | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity | 3 | 4 | 8.01e-01 |
| GO:BP | GO:0050917 | sensory perception of umami taste | 3 | 3 | 8.01e-01 |
| GO:BP | GO:0015807 | L-amino acid transport | 1 | 65 | 8.01e-01 |
| GO:BP | GO:0046832 | negative regulation of RNA export from nucleus | 1 | 2 | 8.01e-01 |
| GO:BP | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 1 | 9 | 8.01e-01 |
| GO:BP | GO:0061197 | fungiform papilla morphogenesis | 1 | 4 | 8.01e-01 |
| GO:BP | GO:0021871 | forebrain regionalization | 1 | 8 | 8.01e-01 |
| GO:BP | GO:0009071 | serine family amino acid catabolic process | 8 | 10 | 8.01e-01 |
| GO:BP | GO:0051005 | negative regulation of lipoprotein lipase activity | 3 | 4 | 8.01e-01 |
| GO:BP | GO:0140250 | regulation protein catabolic process at synapse | 2 | 5 | 8.01e-01 |
| GO:BP | GO:1904594 | regulation of termination of RNA polymerase II transcription | 1 | 3 | 8.01e-01 |
| GO:BP | GO:2000804 | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1 | 3 | 8.01e-01 |
| GO:BP | GO:0030846 | termination of RNA polymerase II transcription, poly(A)-coupled | 1 | 3 | 8.01e-01 |
| GO:BP | GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 5 | 12 | 8.01e-01 |
| GO:BP | GO:0042110 | T cell activation | 1 | 313 | 8.01e-01 |
| GO:BP | GO:0051030 | snRNA transport | 3 | 6 | 8.02e-01 |
| GO:BP | GO:0006668 | sphinganine-1-phosphate metabolic process | 1 | 2 | 8.02e-01 |
| GO:BP | GO:0044793 | negative regulation by host of viral process | 1 | 10 | 8.02e-01 |
| GO:BP | GO:0035988 | chondrocyte proliferation | 3 | 18 | 8.02e-01 |
| GO:BP | GO:0030309 | poly-N-acetyllactosamine metabolic process | 2 | 6 | 8.02e-01 |
| GO:BP | GO:2000722 | regulation of cardiac vascular smooth muscle cell differentiation | 1 | 2 | 8.02e-01 |
| GO:BP | GO:0061027 | umbilical cord development | 1 | 2 | 8.02e-01 |
| GO:BP | GO:0036304 | umbilical cord morphogenesis | 1 | 2 | 8.02e-01 |
| GO:BP | GO:0106071 | positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1 | 3 | 8.02e-01 |
| GO:BP | GO:0072176 | nephric duct development | 2 | 12 | 8.03e-01 |
| GO:BP | GO:0000578 | embryonic axis specification | 1 | 26 | 8.03e-01 |
| GO:BP | GO:0031016 | pancreas development | 2 | 53 | 8.03e-01 |
| GO:BP | GO:0070972 | protein localization to endoplasmic reticulum | 2 | 78 | 8.03e-01 |
| GO:BP | GO:0015868 | purine ribonucleotide transport | 2 | 19 | 8.03e-01 |
| GO:BP | GO:0051284 | positive regulation of sequestering of calcium ion | 1 | 13 | 8.03e-01 |
| GO:BP | GO:0021543 | pallium development | 34 | 139 | 8.03e-01 |
| GO:BP | GO:0009631 | cold acclimation | 1 | 2 | 8.03e-01 |
| GO:BP | GO:0040019 | positive regulation of embryonic development | 3 | 17 | 8.03e-01 |
| GO:BP | GO:0071671 | regulation of smooth muscle cell chemotaxis | 2 | 4 | 8.03e-01 |
| GO:BP | GO:1903292 | protein localization to Golgi membrane | 1 | 4 | 8.03e-01 |
| GO:BP | GO:0045104 | intermediate filament cytoskeleton organization | 1 | 39 | 8.03e-01 |
| GO:BP | GO:0002252 | immune effector process | 4 | 318 | 8.03e-01 |
| GO:BP | GO:0031930 | mitochondria-nucleus signaling pathway | 1 | 2 | 8.04e-01 |
| GO:BP | GO:0002329 | pre-B cell differentiation | 1 | 4 | 8.04e-01 |
| GO:BP | GO:1903109 | positive regulation of mitochondrial transcription | 1 | 2 | 8.04e-01 |
| GO:BP | GO:0061003 | positive regulation of dendritic spine morphogenesis | 8 | 17 | 8.04e-01 |
| GO:BP | GO:0002536 | respiratory burst involved in inflammatory response | 2 | 4 | 8.04e-01 |
| GO:BP | GO:1905908 | positive regulation of amyloid fibril formation | 2 | 5 | 8.04e-01 |
| GO:BP | GO:0006850 | mitochondrial pyruvate transmembrane transport | 1 | 2 | 8.04e-01 |
| GO:BP | GO:0038065 | collagen-activated signaling pathway | 1 | 13 | 8.04e-01 |
| GO:BP | GO:0072070 | loop of Henle development | 1 | 8 | 8.04e-01 |
| GO:BP | GO:0045779 | negative regulation of bone resorption | 1 | 7 | 8.04e-01 |
| GO:BP | GO:0051639 | actin filament network formation | 1 | 7 | 8.04e-01 |
| GO:BP | GO:1905203 | regulation of connective tissue replacement | 3 | 5 | 8.04e-01 |
| GO:BP | GO:0000960 | regulation of mitochondrial RNA catabolic process | 2 | 5 | 8.04e-01 |
| GO:BP | GO:0030029 | actin filament-based process | 6 | 687 | 8.04e-01 |
| GO:BP | GO:0003084 | positive regulation of systemic arterial blood pressure | 1 | 7 | 8.04e-01 |
| GO:BP | GO:0042426 | choline catabolic process | 1 | 3 | 8.04e-01 |
| GO:BP | GO:0043371 | negative regulation of CD4-positive, alpha-beta T cell differentiation | 7 | 14 | 8.04e-01 |
| GO:BP | GO:1900369 | negative regulation of post-transcriptional gene silencing by RNA | 6 | 11 | 8.05e-01 |
| GO:BP | GO:0036476 | neuron death in response to hydrogen peroxide | 3 | 5 | 8.05e-01 |
| GO:BP | GO:0032972 | regulation of muscle filament sliding speed | 1 | 2 | 8.05e-01 |
| GO:BP | GO:1903207 | regulation of hydrogen peroxide-induced neuron death | 3 | 5 | 8.05e-01 |
| GO:BP | GO:0036301 | macrophage colony-stimulating factor production | 1 | 2 | 8.05e-01 |
| GO:BP | GO:0060149 | negative regulation of post-transcriptional gene silencing | 6 | 11 | 8.05e-01 |
| GO:BP | GO:0060967 | negative regulation of gene silencing by RNA | 6 | 11 | 8.05e-01 |
| GO:BP | GO:1903208 | negative regulation of hydrogen peroxide-induced neuron death | 3 | 5 | 8.05e-01 |
| GO:BP | GO:1901033 | positive regulation of response to reactive oxygen species | 1 | 6 | 8.05e-01 |
| GO:BP | GO:1901256 | regulation of macrophage colony-stimulating factor production | 1 | 2 | 8.05e-01 |
| GO:BP | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death | 1 | 6 | 8.05e-01 |
| GO:BP | GO:0007603 | phototransduction, visible light | 4 | 9 | 8.05e-01 |
| GO:BP | GO:0051598 | meiotic recombination checkpoint signaling | 1 | 2 | 8.05e-01 |
| GO:BP | GO:0045103 | intermediate filament-based process | 1 | 40 | 8.06e-01 |
| GO:BP | GO:0007340 | acrosome reaction | 1 | 20 | 8.06e-01 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 1 | 196 | 8.06e-01 |
| GO:BP | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 2 | 24 | 8.06e-01 |
| GO:BP | GO:0021884 | forebrain neuron development | 10 | 16 | 8.07e-01 |
| GO:BP | GO:0010874 | regulation of cholesterol efflux | 7 | 31 | 8.07e-01 |
| GO:BP | GO:0042357 | thiamine diphosphate metabolic process | 1 | 2 | 8.07e-01 |
| GO:BP | GO:0010985 | negative regulation of lipoprotein particle clearance | 2 | 6 | 8.07e-01 |
| GO:BP | GO:0042762 | regulation of sulfur metabolic process | 4 | 12 | 8.07e-01 |
| GO:BP | GO:0002407 | dendritic cell chemotaxis | 1 | 9 | 8.07e-01 |
| GO:BP | GO:0098795 | global gene silencing by mRNA cleavage | 1 | 4 | 8.08e-01 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 48 | 300 | 8.08e-01 |
| GO:BP | GO:0042129 | regulation of T cell proliferation | 1 | 95 | 8.08e-01 |
| GO:BP | GO:0061647 | histone H3-K9 modification | 4 | 23 | 8.08e-01 |
| GO:BP | GO:0006437 | tyrosyl-tRNA aminoacylation | 1 | 2 | 8.08e-01 |
| GO:BP | GO:0050992 | dimethylallyl diphosphate biosynthetic process | 1 | 2 | 8.09e-01 |
| GO:BP | GO:2001112 | regulation of cellular response to hepatocyte growth factor stimulus | 1 | 1 | 8.09e-01 |
| GO:BP | GO:0050729 | positive regulation of inflammatory response | 6 | 75 | 8.09e-01 |
| GO:BP | GO:0060667 | branch elongation involved in salivary gland morphogenesis | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0071326 | cellular response to monosaccharide stimulus | 6 | 95 | 8.09e-01 |
| GO:BP | GO:0032785 | negative regulation of DNA-templated transcription, elongation | 5 | 20 | 8.09e-01 |
| GO:BP | GO:0051291 | protein heterooligomerization | 1 | 21 | 8.09e-01 |
| GO:BP | GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development | 1 | 1 | 8.09e-01 |
| GO:BP | GO:0060595 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0060915 | mesenchymal cell differentiation involved in lung development | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0050993 | dimethylallyl diphosphate metabolic process | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0060615 | mammary gland bud formation | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0021847 | ventricular zone neuroblast division | 1 | 1 | 8.09e-01 |
| GO:BP | GO:0110077 | vesicle-mediated intercellular transport | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0046645 | positive regulation of gamma-delta T cell activation | 1 | 4 | 8.09e-01 |
| GO:BP | GO:0031247 | actin rod assembly | 1 | 2 | 8.09e-01 |
| GO:BP | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity | 1 | 2 | 8.09e-01 |
| GO:BP | GO:0015908 | fatty acid transport | 5 | 58 | 8.10e-01 |
| GO:BP | GO:0045622 | regulation of T-helper cell differentiation | 1 | 20 | 8.10e-01 |
| GO:BP | GO:0042092 | type 2 immune response | 1 | 19 | 8.10e-01 |
| GO:BP | GO:0036066 | protein O-linked fucosylation | 2 | 5 | 8.10e-01 |
| GO:BP | GO:0051659 | maintenance of mitochondrion location | 1 | 2 | 8.10e-01 |
| GO:BP | GO:0010507 | negative regulation of autophagy | 37 | 74 | 8.10e-01 |
| GO:BP | GO:1901264 | carbohydrate derivative transport | 6 | 63 | 8.10e-01 |
| GO:BP | GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1 | 2 | 8.10e-01 |
| GO:BP | GO:2000864 | regulation of estradiol secretion | 1 | 2 | 8.10e-01 |
| GO:BP | GO:1902082 | positive regulation of calcium ion import into sarcoplasmic reticulum | 1 | 1 | 8.10e-01 |
| GO:BP | GO:0014888 | striated muscle adaptation | 13 | 40 | 8.10e-01 |
| GO:BP | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction | 1 | 2 | 8.10e-01 |
| GO:BP | GO:0035938 | estradiol secretion | 1 | 2 | 8.10e-01 |
| GO:BP | GO:1903116 | positive regulation of actin filament-based movement | 1 | 2 | 8.10e-01 |
| GO:BP | GO:0090084 | negative regulation of inclusion body assembly | 1 | 10 | 8.10e-01 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 23 | 539 | 8.10e-01 |
| GO:BP | GO:1990822 | basic amino acid transmembrane transport | 2 | 14 | 8.10e-01 |
| GO:BP | GO:0060923 | cardiac muscle cell fate commitment | 3 | 7 | 8.10e-01 |
| GO:BP | GO:2001138 | regulation of phospholipid transport | 1 | 12 | 8.10e-01 |
| GO:BP | GO:1903727 | positive regulation of phospholipid metabolic process | 1 | 9 | 8.10e-01 |
| GO:BP | GO:0032594 | protein transport within lipid bilayer | 2 | 6 | 8.10e-01 |
| GO:BP | GO:0006544 | glycine metabolic process | 2 | 10 | 8.11e-01 |
| GO:BP | GO:1903715 | regulation of aerobic respiration | 4 | 28 | 8.11e-01 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 4 | 45 | 8.11e-01 |
| GO:BP | GO:0048243 | norepinephrine secretion | 2 | 5 | 8.11e-01 |
| GO:BP | GO:0014061 | regulation of norepinephrine secretion | 2 | 5 | 8.11e-01 |
| GO:BP | GO:0086023 | adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process | 3 | 6 | 8.11e-01 |
| GO:BP | GO:1903597 | negative regulation of gap junction assembly | 1 | 1 | 8.11e-01 |
| GO:BP | GO:0060177 | regulation of angiotensin metabolic process | 1 | 1 | 8.11e-01 |
| GO:BP | GO:0030516 | regulation of axon extension | 21 | 84 | 8.11e-01 |
| GO:BP | GO:0060336 | negative regulation of type II interferon-mediated signaling pathway | 3 | 6 | 8.11e-01 |
| GO:BP | GO:0002246 | wound healing involved in inflammatory response | 3 | 6 | 8.11e-01 |
| GO:BP | GO:0060331 | negative regulation of response to type II interferon | 3 | 6 | 8.11e-01 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 1 | 296 | 8.11e-01 |
| GO:BP | GO:1903373 | positive regulation of endoplasmic reticulum tubular network organization | 1 | 4 | 8.12e-01 |
| GO:BP | GO:0097242 | amyloid-beta clearance | 1 | 27 | 8.12e-01 |
| GO:BP | GO:0002387 | immune response in gut-associated lymphoid tissue | 1 | 1 | 8.12e-01 |
| GO:BP | GO:0002449 | lymphocyte mediated immunity | 2 | 142 | 8.12e-01 |
| GO:BP | GO:1905867 | epididymis development | 2 | 2 | 8.12e-01 |
| GO:BP | GO:0150094 | amyloid-beta clearance by cellular catabolic process | 1 | 7 | 8.12e-01 |
| GO:BP | GO:0099590 | neurotransmitter receptor internalization | 3 | 19 | 8.12e-01 |
| GO:BP | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 2 | 4 | 8.12e-01 |
| GO:BP | GO:0001709 | cell fate determination | 5 | 25 | 8.12e-01 |
| GO:BP | GO:0002395 | immune response in nasopharyngeal-associated lymphoid tissue | 1 | 1 | 8.12e-01 |
| GO:BP | GO:0010887 | negative regulation of cholesterol storage | 4 | 9 | 8.12e-01 |
| GO:BP | GO:0019835 | cytolysis | 1 | 6 | 8.12e-01 |
| GO:BP | GO:0021570 | rhombomere 4 development | 1 | 1 | 8.12e-01 |
| GO:BP | GO:0048505 | regulation of timing of cell differentiation | 2 | 7 | 8.12e-01 |
| GO:BP | GO:0002702 | positive regulation of production of molecular mediator of immune response | 3 | 77 | 8.12e-01 |
| GO:BP | GO:1990402 | embryonic liver development | 1 | 3 | 8.12e-01 |
| GO:BP | GO:0006414 | translational elongation | 8 | 65 | 8.12e-01 |
| GO:BP | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 2 | 4 | 8.12e-01 |
| GO:BP | GO:0050777 | negative regulation of immune response | 1 | 111 | 8.12e-01 |
| GO:BP | GO:0060251 | regulation of glial cell proliferation | 7 | 26 | 8.12e-01 |
| GO:BP | GO:0014732 | skeletal muscle atrophy | 3 | 5 | 8.13e-01 |
| GO:BP | GO:0015871 | choline transport | 3 | 6 | 8.13e-01 |
| GO:BP | GO:0035459 | vesicle cargo loading | 3 | 27 | 8.13e-01 |
| GO:BP | GO:0140352 | export from cell | 14 | 611 | 8.13e-01 |
| GO:BP | GO:0032291 | axon ensheathment in central nervous system | 1 | 12 | 8.13e-01 |
| GO:BP | GO:0022010 | central nervous system myelination | 1 | 12 | 8.13e-01 |
| GO:BP | GO:0050882 | voluntary musculoskeletal movement | 2 | 7 | 8.13e-01 |
| GO:BP | GO:0001913 | T cell mediated cytotoxicity | 1 | 22 | 8.13e-01 |
| GO:BP | GO:1903508 | positive regulation of nucleic acid-templated transcription | 1 | 1315 | 8.13e-01 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 1 | 1315 | 8.13e-01 |
| GO:BP | GO:0098814 | spontaneous synaptic transmission | 3 | 10 | 8.13e-01 |
| GO:BP | GO:0010574 | regulation of vascular endothelial growth factor production | 2 | 20 | 8.13e-01 |
| GO:BP | GO:0071988 | protein localization to spindle pole body | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0032761 | positive regulation of lymphotoxin A production | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0090085 | regulation of protein deubiquitination | 1 | 12 | 8.14e-01 |
| GO:BP | GO:0070781 | response to biotin | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0032681 | regulation of lymphotoxin A production | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0035729 | cellular response to hepatocyte growth factor stimulus | 7 | 13 | 8.14e-01 |
| GO:BP | GO:0032641 | lymphotoxin A production | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0021628 | olfactory nerve formation | 1 | 2 | 8.14e-01 |
| GO:BP | GO:1905461 | positive regulation of vascular associated smooth muscle cell apoptotic process | 3 | 7 | 8.14e-01 |
| GO:BP | GO:0032914 | positive regulation of transforming growth factor beta1 production | 1 | 6 | 8.14e-01 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 1 | 1322 | 8.14e-01 |
| GO:BP | GO:0048318 | axial mesoderm development | 1 | 6 | 8.14e-01 |
| GO:BP | GO:0071868 | cellular response to monoamine stimulus | 2 | 60 | 8.14e-01 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 1 | 100 | 8.14e-01 |
| GO:BP | GO:0035470 | positive regulation of vascular wound healing | 2 | 4 | 8.14e-01 |
| GO:BP | GO:0071870 | cellular response to catecholamine stimulus | 2 | 60 | 8.14e-01 |
| GO:BP | GO:0070307 | lens fiber cell development | 4 | 11 | 8.14e-01 |
| GO:BP | GO:0003310 | pancreatic A cell differentiation | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0072530 | purine-containing compound transmembrane transport | 2 | 20 | 8.14e-01 |
| GO:BP | GO:0042886 | amide transport | 1 | 235 | 8.14e-01 |
| GO:BP | GO:1902224 | ketone body metabolic process | 2 | 7 | 8.14e-01 |
| GO:BP | GO:0046016 | positive regulation of transcription by glucose | 2 | 3 | 8.14e-01 |
| GO:BP | GO:0031281 | positive regulation of cyclase activity | 5 | 23 | 8.14e-01 |
| GO:BP | GO:0021533 | cell differentiation in hindbrain | 1 | 18 | 8.14e-01 |
| GO:BP | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 1 | 20 | 8.14e-01 |
| GO:BP | GO:0006415 | translational termination | 5 | 17 | 8.14e-01 |
| GO:BP | GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0072208 | metanephric smooth muscle tissue development | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0048686 | regulation of sprouting of injured axon | 1 | 1 | 8.14e-01 |
| GO:BP | GO:1902908 | regulation of melanosome transport | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0071600 | otic vesicle morphogenesis | 4 | 8 | 8.14e-01 |
| GO:BP | GO:0071358 | cellular response to type III interferon | 1 | 4 | 8.14e-01 |
| GO:BP | GO:0002475 | antigen processing and presentation via MHC class Ib | 5 | 8 | 8.14e-01 |
| GO:BP | GO:0072185 | metanephric cap development | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0006605 | protein targeting | 8 | 307 | 8.14e-01 |
| GO:BP | GO:0072186 | metanephric cap morphogenesis | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0048688 | negative regulation of sprouting of injured axon | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0048690 | regulation of axon extension involved in regeneration | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0048692 | negative regulation of axon extension involved in regeneration | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0071493 | cellular response to UV-B | 2 | 11 | 8.14e-01 |
| GO:BP | GO:0032771 | regulation of tyrosinase activity | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0038196 | type III interferon-mediated signaling pathway | 1 | 4 | 8.14e-01 |
| GO:BP | GO:0032773 | positive regulation of tyrosinase activity | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0048817 | negative regulation of hair follicle maturation | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0072166 | posterior mesonephric tubule development | 1 | 1 | 8.14e-01 |
| GO:BP | GO:0050658 | RNA transport | 43 | 144 | 8.14e-01 |
| GO:BP | GO:0050657 | nucleic acid transport | 43 | 144 | 8.14e-01 |
| GO:BP | GO:0072112 | podocyte differentiation | 1 | 17 | 8.14e-01 |
| GO:BP | GO:0061318 | renal filtration cell differentiation | 1 | 17 | 8.14e-01 |
| GO:BP | GO:0070315 | G1 to G0 transition involved in cell differentiation | 2 | 4 | 8.14e-01 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 8 | 65 | 8.14e-01 |
| GO:BP | GO:2000870 | regulation of progesterone secretion | 1 | 1 | 8.14e-01 |
| GO:BP | GO:1903803 | L-glutamine import across plasma membrane | 2 | 4 | 8.14e-01 |
| GO:BP | GO:0010669 | epithelial structure maintenance | 1 | 15 | 8.14e-01 |
| GO:BP | GO:0120261 | regulation of heterochromatin organization | 2 | 22 | 8.14e-01 |
| GO:BP | GO:0060478 | acrosomal vesicle exocytosis | 1 | 5 | 8.14e-01 |
| GO:BP | GO:0031445 | regulation of heterochromatin formation | 2 | 22 | 8.14e-01 |
| GO:BP | GO:0032376 | positive regulation of cholesterol transport | 1 | 30 | 8.14e-01 |
| GO:BP | GO:0051569 | regulation of histone H3-K4 methylation | 11 | 26 | 8.14e-01 |
| GO:BP | GO:0019216 | regulation of lipid metabolic process | 2 | 250 | 8.14e-01 |
| GO:BP | GO:0034032 | purine nucleoside bisphosphate metabolic process | 1 | 92 | 8.14e-01 |
| GO:BP | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 1 | 5 | 8.14e-01 |
| GO:BP | GO:0033875 | ribonucleoside bisphosphate metabolic process | 1 | 92 | 8.14e-01 |
| GO:BP | GO:0032373 | positive regulation of sterol transport | 1 | 30 | 8.14e-01 |
| GO:BP | GO:0033865 | nucleoside bisphosphate metabolic process | 1 | 92 | 8.14e-01 |
| GO:BP | GO:0022400 | regulation of rhodopsin mediated signaling pathway | 2 | 5 | 8.14e-01 |
| GO:BP | GO:0062207 | regulation of pattern recognition receptor signaling pathway | 4 | 68 | 8.14e-01 |
| GO:BP | GO:0006529 | asparagine biosynthetic process | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 1 | 17 | 8.14e-01 |
| GO:BP | GO:0045922 | negative regulation of fatty acid metabolic process | 17 | 25 | 8.14e-01 |
| GO:BP | GO:0090230 | regulation of centromere complex assembly | 1 | 4 | 8.14e-01 |
| GO:BP | GO:2001214 | positive regulation of vasculogenesis | 1 | 9 | 8.14e-01 |
| GO:BP | GO:0034159 | regulation of toll-like receptor 8 signaling pathway | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0034161 | positive regulation of toll-like receptor 8 signaling pathway | 1 | 2 | 8.14e-01 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 4 | 3730 | 8.14e-01 |
| GO:BP | GO:0001711 | endodermal cell fate commitment | 4 | 9 | 8.15e-01 |
| GO:BP | GO:1903625 | negative regulation of DNA catabolic process | 1 | 3 | 8.15e-01 |
| GO:BP | GO:0035162 | embryonic hemopoiesis | 7 | 19 | 8.15e-01 |
| GO:BP | GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 4 | 8 | 8.15e-01 |
| GO:BP | GO:2001295 | malonyl-CoA biosynthetic process | 1 | 2 | 8.15e-01 |
| GO:BP | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | 2 | 4 | 8.15e-01 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 4 | 113 | 8.15e-01 |
| GO:BP | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production | 5 | 10 | 8.15e-01 |
| GO:BP | GO:0072567 | chemokine (C-X-C motif) ligand 2 production | 5 | 10 | 8.15e-01 |
| GO:BP | GO:0070897 | transcription preinitiation complex assembly | 1 | 67 | 8.16e-01 |
| GO:BP | GO:0032303 | regulation of icosanoid secretion | 1 | 9 | 8.16e-01 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 11 | 31 | 8.16e-01 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 14 | 50 | 8.16e-01 |
| GO:BP | GO:1900425 | negative regulation of defense response to bacterium | 1 | 4 | 8.16e-01 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 1 | 116 | 8.16e-01 |
| GO:BP | GO:0032905 | transforming growth factor beta1 production | 7 | 11 | 8.17e-01 |
| GO:BP | GO:0072338 | lactam metabolic process | 1 | 2 | 8.17e-01 |
| GO:BP | GO:0034063 | stress granule assembly | 10 | 28 | 8.17e-01 |
| GO:BP | GO:0061792 | secretory granule maturation | 1 | 3 | 8.17e-01 |
| GO:BP | GO:1905413 | regulation of dense core granule exocytosis | 1 | 2 | 8.17e-01 |
| GO:BP | GO:1990502 | dense core granule maturation | 1 | 3 | 8.17e-01 |
| GO:BP | GO:0030835 | negative regulation of actin filament depolymerization | 1 | 37 | 8.17e-01 |
| GO:BP | GO:2000251 | positive regulation of actin cytoskeleton reorganization | 4 | 14 | 8.17e-01 |
| GO:BP | GO:0036314 | response to sterol | 1 | 19 | 8.17e-01 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 3 | 77 | 8.17e-01 |
| GO:BP | GO:0006909 | phagocytosis | 3 | 148 | 8.17e-01 |
| GO:BP | GO:0021545 | cranial nerve development | 2 | 31 | 8.18e-01 |
| GO:BP | GO:0061010 | gallbladder development | 1 | 1 | 8.18e-01 |
| GO:BP | GO:0045053 | protein retention in Golgi apparatus | 1 | 5 | 8.18e-01 |
| GO:BP | GO:0070126 | mitochondrial translational termination | 1 | 4 | 8.18e-01 |
| GO:BP | GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 1 | 28 | 8.18e-01 |
| GO:BP | GO:0021564 | vagus nerve development | 1 | 2 | 8.18e-01 |
| GO:BP | GO:0001842 | neural fold formation | 1 | 5 | 8.18e-01 |
| GO:BP | GO:0002712 | regulation of B cell mediated immunity | 1 | 39 | 8.18e-01 |
| GO:BP | GO:0015872 | dopamine transport | 1 | 29 | 8.18e-01 |
| GO:BP | GO:0070358 | actin polymerization-dependent cell motility | 1 | 6 | 8.18e-01 |
| GO:BP | GO:0002889 | regulation of immunoglobulin mediated immune response | 1 | 39 | 8.18e-01 |
| GO:BP | GO:1903630 | regulation of aminoacyl-tRNA ligase activity | 1 | 2 | 8.18e-01 |
| GO:BP | GO:0051561 | positive regulation of mitochondrial calcium ion concentration | 5 | 11 | 8.18e-01 |
| GO:BP | GO:0032929 | negative regulation of superoxide anion generation | 1 | 1 | 8.18e-01 |
| GO:BP | GO:1902362 | melanocyte apoptotic process | 1 | 1 | 8.19e-01 |
| GO:BP | GO:0043476 | pigment accumulation | 3 | 11 | 8.19e-01 |
| GO:BP | GO:0043482 | cellular pigment accumulation | 3 | 11 | 8.19e-01 |
| GO:BP | GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 2 | 2 | 8.19e-01 |
| GO:BP | GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 2 | 4 | 8.19e-01 |
| GO:BP | GO:0090290 | positive regulation of osteoclast proliferation | 1 | 1 | 8.19e-01 |
| GO:BP | GO:1903942 | positive regulation of respiratory gaseous exchange | 1 | 1 | 8.19e-01 |
| GO:BP | GO:0007218 | neuropeptide signaling pathway | 1 | 36 | 8.19e-01 |
| GO:BP | GO:0120229 | protein localization to motile cilium | 2 | 4 | 8.19e-01 |
| GO:BP | GO:0050709 | negative regulation of protein secretion | 3 | 44 | 8.19e-01 |
| GO:BP | GO:0061113 | pancreas morphogenesis | 1 | 3 | 8.19e-01 |
| GO:BP | GO:0006114 | glycerol biosynthetic process | 2 | 3 | 8.19e-01 |
| GO:BP | GO:0019401 | alditol biosynthetic process | 2 | 3 | 8.19e-01 |
| GO:BP | GO:0048137 | spermatocyte division | 1 | 1 | 8.19e-01 |
| GO:BP | GO:1901568 | fatty acid derivative metabolic process | 1 | 48 | 8.19e-01 |
| GO:BP | GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 2 | 4 | 8.20e-01 |
| GO:BP | GO:0046532 | regulation of photoreceptor cell differentiation | 3 | 4 | 8.20e-01 |
| GO:BP | GO:2000491 | positive regulation of hepatic stellate cell activation | 1 | 4 | 8.20e-01 |
| GO:BP | GO:2000831 | regulation of steroid hormone secretion | 1 | 13 | 8.20e-01 |
| GO:BP | GO:0002281 | macrophage activation involved in immune response | 5 | 8 | 8.20e-01 |
| GO:BP | GO:0046541 | saliva secretion | 1 | 4 | 8.20e-01 |
| GO:BP | GO:0061975 | articular cartilage development | 1 | 3 | 8.20e-01 |
| GO:BP | GO:2000257 | regulation of protein activation cascade | 1 | 1 | 8.20e-01 |
| GO:BP | GO:0001698 | gastrin-induced gastric acid secretion | 1 | 1 | 8.20e-01 |
| GO:BP | GO:0045844 | positive regulation of striated muscle tissue development | 1 | 3 | 8.20e-01 |
| GO:BP | GO:0009452 | 7-methylguanosine RNA capping | 4 | 8 | 8.20e-01 |
| GO:BP | GO:0032892 | positive regulation of organic acid transport | 2 | 27 | 8.20e-01 |
| GO:BP | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 1 | 15 | 8.20e-01 |
| GO:BP | GO:0006408 | snRNA export from nucleus | 2 | 4 | 8.20e-01 |
| GO:BP | GO:0048636 | positive regulation of muscle organ development | 1 | 3 | 8.20e-01 |
| GO:BP | GO:0008295 | spermidine biosynthetic process | 1 | 3 | 8.20e-01 |
| GO:BP | GO:0010829 | negative regulation of glucose transmembrane transport | 1 | 14 | 8.20e-01 |
| GO:BP | GO:2001256 | regulation of store-operated calcium entry | 1 | 11 | 8.20e-01 |
| GO:BP | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 1 | 40 | 8.21e-01 |
| GO:BP | GO:0002695 | negative regulation of leukocyte activation | 1 | 105 | 8.21e-01 |
| GO:BP | GO:0043335 | protein unfolding | 1 | 5 | 8.21e-01 |
| GO:BP | GO:0060375 | regulation of mast cell differentiation | 1 | 2 | 8.21e-01 |
| GO:BP | GO:0070995 | NADPH oxidation | 2 | 3 | 8.21e-01 |
| GO:BP | GO:2001074 | regulation of metanephric ureteric bud development | 1 | 1 | 8.21e-01 |
| GO:BP | GO:2001076 | positive regulation of metanephric ureteric bud development | 1 | 1 | 8.21e-01 |
| GO:BP | GO:0071869 | response to catecholamine | 2 | 62 | 8.21e-01 |
| GO:BP | GO:0071867 | response to monoamine | 2 | 62 | 8.21e-01 |
| GO:BP | GO:0060484 | lung-associated mesenchyme development | 1 | 5 | 8.21e-01 |
| GO:BP | GO:0061032 | visceral serous pericardium development | 1 | 1 | 8.21e-01 |
| GO:BP | GO:0051775 | response to redox state | 1 | 12 | 8.21e-01 |
| GO:BP | GO:0060347 | heart trabecula formation | 6 | 13 | 8.22e-01 |
| GO:BP | GO:0046322 | negative regulation of fatty acid oxidation | 4 | 12 | 8.22e-01 |
| GO:BP | GO:0032375 | negative regulation of cholesterol transport | 1 | 5 | 8.22e-01 |
| GO:BP | GO:0032372 | negative regulation of sterol transport | 1 | 5 | 8.22e-01 |
| GO:BP | GO:0055005 | ventricular cardiac myofibril assembly | 1 | 3 | 8.22e-01 |
| GO:BP | GO:0018026 | peptidyl-lysine monomethylation | 4 | 11 | 8.22e-01 |
| GO:BP | GO:1904245 | regulation of polynucleotide adenylyltransferase activity | 1 | 2 | 8.22e-01 |
| GO:BP | GO:2000347 | positive regulation of hepatocyte proliferation | 5 | 9 | 8.22e-01 |
| GO:BP | GO:0035799 | ureter maturation | 1 | 1 | 8.22e-01 |
| GO:BP | GO:2000987 | positive regulation of behavioral fear response | 1 | 3 | 8.22e-01 |
| GO:BP | GO:0045113 | regulation of integrin biosynthetic process | 1 | 2 | 8.22e-01 |
| GO:BP | GO:0060455 | negative regulation of gastric acid secretion | 1 | 3 | 8.22e-01 |
| GO:BP | GO:1900194 | negative regulation of oocyte maturation | 1 | 2 | 8.22e-01 |
| GO:BP | GO:0003383 | apical constriction | 2 | 4 | 8.22e-01 |
| GO:BP | GO:0006677 | glycosylceramide metabolic process | 1 | 13 | 8.22e-01 |
| GO:BP | GO:1905123 | regulation of glucosylceramidase activity | 1 | 2 | 8.22e-01 |
| GO:BP | GO:0072089 | stem cell proliferation | 3 | 84 | 8.22e-01 |
| GO:BP | GO:0032264 | IMP salvage | 2 | 4 | 8.23e-01 |
| GO:BP | GO:0009073 | aromatic amino acid family biosynthetic process | 2 | 3 | 8.23e-01 |
| GO:BP | GO:0007165 | signal transduction | 5 | 3818 | 8.23e-01 |
| GO:BP | GO:0072311 | glomerular epithelial cell differentiation | 1 | 17 | 8.23e-01 |
| GO:BP | GO:0006826 | iron ion transport | 6 | 40 | 8.23e-01 |
| GO:BP | GO:0006478 | peptidyl-tyrosine sulfation | 1 | 2 | 8.23e-01 |
| GO:BP | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane | 1 | 19 | 8.23e-01 |
| GO:BP | GO:0042661 | regulation of mesodermal cell fate specification | 1 | 4 | 8.23e-01 |
| GO:BP | GO:0045292 | mRNA cis splicing, via spliceosome | 1 | 26 | 8.23e-01 |
| GO:BP | GO:0046831 | regulation of RNA export from nucleus | 5 | 12 | 8.23e-01 |
| GO:BP | GO:0021590 | cerebellum maturation | 1 | 3 | 8.24e-01 |
| GO:BP | GO:0016093 | polyprenol metabolic process | 4 | 23 | 8.24e-01 |
| GO:BP | GO:0021699 | cerebellar cortex maturation | 1 | 3 | 8.24e-01 |
| GO:BP | GO:0051223 | regulation of protein transport | 17 | 404 | 8.24e-01 |
| GO:BP | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 2 | 4 | 8.24e-01 |
| GO:BP | GO:0075509 | endocytosis involved in viral entry into host cell | 4 | 11 | 8.24e-01 |
| GO:BP | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway | 2 | 5 | 8.24e-01 |
| GO:BP | GO:0061888 | regulation of astrocyte activation | 2 | 3 | 8.25e-01 |
| GO:BP | GO:0032024 | positive regulation of insulin secretion | 10 | 56 | 8.25e-01 |
| GO:BP | GO:0051791 | medium-chain fatty acid metabolic process | 2 | 9 | 8.25e-01 |
| GO:BP | GO:0070171 | negative regulation of tooth mineralization | 1 | 2 | 8.25e-01 |
| GO:BP | GO:0033007 | negative regulation of mast cell activation involved in immune response | 4 | 4 | 8.25e-01 |
| GO:BP | GO:0030239 | myofibril assembly | 27 | 66 | 8.25e-01 |
| GO:BP | GO:0019640 | glucuronate catabolic process to xylulose 5-phosphate | 2 | 4 | 8.25e-01 |
| GO:BP | GO:0001655 | urogenital system development | 3 | 49 | 8.25e-01 |
| GO:BP | GO:0051167 | xylulose 5-phosphate metabolic process | 2 | 4 | 8.25e-01 |
| GO:BP | GO:1901159 | xylulose 5-phosphate biosynthetic process | 2 | 4 | 8.25e-01 |
| GO:BP | GO:0006064 | glucuronate catabolic process | 2 | 4 | 8.25e-01 |
| GO:BP | GO:0046470 | phosphatidylcholine metabolic process | 4 | 53 | 8.25e-01 |
| GO:BP | GO:0032368 | regulation of lipid transport | 6 | 92 | 8.25e-01 |
| GO:BP | GO:0051179 | localization | 2 | 3969 | 8.25e-01 |
| GO:BP | GO:0030166 | proteoglycan biosynthetic process | 5 | 51 | 8.25e-01 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 3 | 3080 | 8.25e-01 |
| GO:BP | GO:0060428 | lung epithelium development | 6 | 30 | 8.25e-01 |
| GO:BP | GO:1903226 | positive regulation of endodermal cell differentiation | 1 | 2 | 8.25e-01 |
| GO:BP | GO:0032940 | secretion by cell | 12 | 569 | 8.25e-01 |
| GO:BP | GO:0071071 | regulation of phospholipid biosynthetic process | 8 | 15 | 8.25e-01 |
| GO:BP | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production | 2 | 3 | 8.25e-01 |
| GO:BP | GO:0033083 | regulation of immature T cell proliferation | 1 | 6 | 8.26e-01 |
| GO:BP | GO:0050747 | positive regulation of lipoprotein metabolic process | 1 | 4 | 8.26e-01 |
| GO:BP | GO:0020027 | hemoglobin metabolic process | 6 | 16 | 8.26e-01 |
| GO:BP | GO:1903061 | positive regulation of protein lipidation | 1 | 4 | 8.26e-01 |
| GO:BP | GO:1903798 | regulation of miRNA processing | 6 | 10 | 8.26e-01 |
| GO:BP | GO:0018022 | peptidyl-lysine methylation | 2 | 104 | 8.26e-01 |
| GO:BP | GO:0033084 | regulation of immature T cell proliferation in thymus | 1 | 6 | 8.26e-01 |
| GO:BP | GO:0002444 | myeloid leukocyte mediated immunity | 1 | 60 | 8.26e-01 |
| GO:BP | GO:0043652 | engulfment of apoptotic cell | 1 | 11 | 8.26e-01 |
| GO:BP | GO:0006361 | transcription initiation at RNA polymerase I promoter | 2 | 11 | 8.26e-01 |
| GO:BP | GO:0070973 | protein localization to endoplasmic reticulum exit site | 1 | 6 | 8.26e-01 |
| GO:BP | GO:0038165 | oncostatin-M-mediated signaling pathway | 1 | 4 | 8.26e-01 |
| GO:BP | GO:0043132 | NAD transport | 1 | 3 | 8.26e-01 |
| GO:BP | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development | 1 | 2 | 8.26e-01 |
| GO:BP | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 1 | 4 | 8.26e-01 |
| GO:BP | GO:0031960 | response to corticosteroid | 2 | 109 | 8.26e-01 |
| GO:BP | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway | 2 | 3 | 8.26e-01 |
| GO:BP | GO:1903282 | regulation of glutathione peroxidase activity | 1 | 1 | 8.26e-01 |
| GO:BP | GO:2000470 | positive regulation of peroxidase activity | 1 | 2 | 8.26e-01 |
| GO:BP | GO:0090276 | regulation of peptide hormone secretion | 6 | 132 | 8.26e-01 |
| GO:BP | GO:0070391 | response to lipoteichoic acid | 3 | 6 | 8.26e-01 |
| GO:BP | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone | 1 | 2 | 8.26e-01 |
| GO:BP | GO:1905447 | negative regulation of mitochondrial ATP synthesis coupled electron transport | 1 | 2 | 8.26e-01 |
| GO:BP | GO:0071223 | cellular response to lipoteichoic acid | 3 | 6 | 8.26e-01 |
| GO:BP | GO:0051621 | regulation of norepinephrine uptake | 1 | 2 | 8.26e-01 |
| GO:BP | GO:0007254 | JNK cascade | 4 | 138 | 8.26e-01 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 8 | 96 | 8.26e-01 |
| GO:BP | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction | 1 | 1 | 8.26e-01 |
| GO:BP | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction | 1 | 1 | 8.26e-01 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 2 | 24 | 8.27e-01 |
| GO:BP | GO:0060742 | epithelial cell differentiation involved in prostate gland development | 2 | 8 | 8.27e-01 |
| GO:BP | GO:0030534 | adult behavior | 4 | 92 | 8.27e-01 |
| GO:BP | GO:1904059 | regulation of locomotor rhythm | 1 | 3 | 8.27e-01 |
| GO:BP | GO:1905749 | regulation of endosome to plasma membrane protein transport | 2 | 5 | 8.27e-01 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 4 | 14 | 8.27e-01 |
| GO:BP | GO:0010706 | ganglioside biosynthetic process via lactosylceramide | 1 | 5 | 8.27e-01 |
| GO:BP | GO:0014866 | skeletal myofibril assembly | 4 | 9 | 8.27e-01 |
| GO:BP | GO:2000437 | regulation of monocyte extravasation | 2 | 4 | 8.27e-01 |
| GO:BP | GO:0002701 | negative regulation of production of molecular mediator of immune response | 1 | 21 | 8.28e-01 |
| GO:BP | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine | 1 | 3 | 8.28e-01 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 6 | 155 | 8.28e-01 |
| GO:BP | GO:0042274 | ribosomal small subunit biogenesis | 3 | 79 | 8.28e-01 |
| GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 6 | 27 | 8.28e-01 |
| GO:BP | GO:0032241 | positive regulation of nucleobase-containing compound transport | 2 | 6 | 8.28e-01 |
| GO:BP | GO:1900363 | regulation of mRNA polyadenylation | 4 | 11 | 8.28e-01 |
| GO:BP | GO:0019827 | stem cell population maintenance | 59 | 149 | 8.29e-01 |
| GO:BP | GO:0031133 | regulation of axon diameter | 1 | 4 | 8.29e-01 |
| GO:BP | GO:0002347 | response to tumor cell | 1 | 22 | 8.29e-01 |
| GO:BP | GO:0031581 | hemidesmosome assembly | 2 | 6 | 8.29e-01 |
| GO:BP | GO:0071379 | cellular response to prostaglandin stimulus | 1 | 16 | 8.29e-01 |
| GO:BP | GO:0070902 | mitochondrial tRNA pseudouridine synthesis | 1 | 2 | 8.29e-01 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 1 | 1441 | 8.29e-01 |
| GO:BP | GO:0019676 | ammonia assimilation cycle | 1 | 2 | 8.29e-01 |
| GO:BP | GO:0042450 | arginine biosynthetic process via ornithine | 1 | 1 | 8.29e-01 |
| GO:BP | GO:1901535 | regulation of DNA demethylation | 1 | 8 | 8.29e-01 |
| GO:BP | GO:0042667 | auditory receptor cell fate specification | 1 | 1 | 8.29e-01 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 19 | 395 | 8.29e-01 |
| GO:BP | GO:0035561 | regulation of chromatin binding | 3 | 20 | 8.29e-01 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 7 | 247 | 8.29e-01 |
| GO:BP | GO:2000647 | negative regulation of stem cell proliferation | 3 | 18 | 8.29e-01 |
| GO:BP | GO:0048002 | antigen processing and presentation of peptide antigen | 3 | 41 | 8.29e-01 |
| GO:BP | GO:0033028 | myeloid cell apoptotic process | 4 | 25 | 8.30e-01 |
| GO:BP | GO:0048259 | regulation of receptor-mediated endocytosis | 2 | 87 | 8.30e-01 |
| GO:BP | GO:0097021 | lymphocyte migration into lymphoid organs | 2 | 6 | 8.30e-01 |
| GO:BP | GO:0048675 | axon extension | 26 | 110 | 8.31e-01 |
| GO:BP | GO:0070475 | rRNA base methylation | 1 | 8 | 8.31e-01 |
| GO:BP | GO:1905952 | regulation of lipid localization | 4 | 112 | 8.31e-01 |
| GO:BP | GO:0045773 | positive regulation of axon extension | 1 | 33 | 8.31e-01 |
| GO:BP | GO:0006643 | membrane lipid metabolic process | 3 | 173 | 8.31e-01 |
| GO:BP | GO:0060736 | prostate gland growth | 2 | 7 | 8.31e-01 |
| GO:BP | GO:0032472 | Golgi calcium ion transport | 1 | 2 | 8.31e-01 |
| GO:BP | GO:0032468 | Golgi calcium ion homeostasis | 1 | 2 | 8.31e-01 |
| GO:BP | GO:0098629 | trans-Golgi network membrane organization | 1 | 2 | 8.31e-01 |
| GO:BP | GO:0048069 | eye pigmentation | 1 | 4 | 8.31e-01 |
| GO:BP | GO:0006405 | RNA export from nucleus | 23 | 78 | 8.31e-01 |
| GO:BP | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway | 1 | 9 | 8.31e-01 |
| GO:BP | GO:0061753 | substrate localization to autophagosome | 1 | 3 | 8.31e-01 |
| GO:BP | GO:0042350 | GDP-L-fucose biosynthetic process | 1 | 3 | 8.32e-01 |
| GO:BP | GO:1904466 | positive regulation of matrix metallopeptidase secretion | 1 | 2 | 8.32e-01 |
| GO:BP | GO:0016046 | detection of fungus | 1 | 1 | 8.32e-01 |
| GO:BP | GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1 | 2 | 8.32e-01 |
| GO:BP | GO:0070555 | response to interleukin-1 | 6 | 83 | 8.32e-01 |
| GO:BP | GO:0002841 | negative regulation of T cell mediated immune response to tumor cell | 1 | 1 | 8.32e-01 |
| GO:BP | GO:0030073 | insulin secretion | 6 | 141 | 8.32e-01 |
| GO:BP | GO:0099500 | vesicle fusion to plasma membrane | 1 | 19 | 8.32e-01 |
| GO:BP | GO:0000962 | positive regulation of mitochondrial RNA catabolic process | 1 | 3 | 8.32e-01 |
| GO:BP | GO:0048635 | negative regulation of muscle organ development | 1 | 6 | 8.33e-01 |
| GO:BP | GO:2000249 | regulation of actin cytoskeleton reorganization | 1 | 32 | 8.33e-01 |
| GO:BP | GO:0010360 | negative regulation of anion channel activity | 1 | 2 | 8.34e-01 |
| GO:BP | GO:1903960 | negative regulation of anion transmembrane transport | 1 | 2 | 8.34e-01 |
| GO:BP | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1 | 13 | 8.34e-01 |
| GO:BP | GO:0090278 | negative regulation of peptide hormone secretion | 2 | 30 | 8.34e-01 |
| GO:BP | GO:0090131 | mesenchyme migration | 1 | 4 | 8.34e-01 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 4 | 118 | 8.34e-01 |
| GO:BP | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 2 | 5 | 8.35e-01 |
| GO:BP | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress | 2 | 5 | 8.35e-01 |
| GO:BP | GO:0051311 | meiotic metaphase plate congression | 1 | 2 | 8.35e-01 |
| GO:BP | GO:1990868 | response to chemokine | 3 | 37 | 8.35e-01 |
| GO:BP | GO:0044062 | regulation of excretion | 1 | 12 | 8.35e-01 |
| GO:BP | GO:0060872 | semicircular canal development | 2 | 7 | 8.35e-01 |
| GO:BP | GO:1902932 | positive regulation of alcohol biosynthetic process | 2 | 15 | 8.35e-01 |
| GO:BP | GO:0003289 | atrial septum primum morphogenesis | 2 | 5 | 8.35e-01 |
| GO:BP | GO:1990869 | cellular response to chemokine | 3 | 37 | 8.35e-01 |
| GO:BP | GO:0003284 | septum primum development | 2 | 5 | 8.35e-01 |
| GO:BP | GO:2000253 | positive regulation of feeding behavior | 1 | 4 | 8.35e-01 |
| GO:BP | GO:0042363 | fat-soluble vitamin catabolic process | 1 | 1 | 8.35e-01 |
| GO:BP | GO:0034333 | adherens junction assembly | 6 | 13 | 8.35e-01 |
| GO:BP | GO:1902871 | positive regulation of amacrine cell differentiation | 1 | 1 | 8.35e-01 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 27 | 139 | 8.35e-01 |
| GO:BP | GO:0002791 | regulation of peptide secretion | 6 | 134 | 8.36e-01 |
| GO:BP | GO:0051238 | sequestering of metal ion | 7 | 17 | 8.36e-01 |
| GO:BP | GO:0014905 | myoblast fusion involved in skeletal muscle regeneration | 2 | 3 | 8.36e-01 |
| GO:BP | GO:0043968 | histone H2A acetylation | 9 | 22 | 8.37e-01 |
| GO:BP | GO:0043380 | regulation of memory T cell differentiation | 2 | 4 | 8.37e-01 |
| GO:BP | GO:0035766 | cell chemotaxis to fibroblast growth factor | 2 | 4 | 8.37e-01 |
| GO:BP | GO:0035768 | endothelial cell chemotaxis to fibroblast growth factor | 2 | 4 | 8.37e-01 |
| GO:BP | GO:0048588 | developmental cell growth | 50 | 192 | 8.37e-01 |
| GO:BP | GO:0032984 | protein-containing complex disassembly | 5 | 222 | 8.37e-01 |
| GO:BP | GO:2000008 | regulation of protein localization to cell surface | 1 | 37 | 8.37e-01 |
| GO:BP | GO:2000544 | regulation of endothelial cell chemotaxis to fibroblast growth factor | 2 | 4 | 8.37e-01 |
| GO:BP | GO:0050922 | negative regulation of chemotaxis | 24 | 44 | 8.37e-01 |
| GO:BP | GO:0010837 | regulation of keratinocyte proliferation | 1 | 33 | 8.37e-01 |
| GO:BP | GO:1904847 | regulation of cell chemotaxis to fibroblast growth factor | 2 | 4 | 8.37e-01 |
| GO:BP | GO:0031508 | pericentric heterochromatin formation | 1 | 3 | 8.37e-01 |
| GO:BP | GO:0051956 | negative regulation of amino acid transport | 2 | 10 | 8.37e-01 |
| GO:BP | GO:0045124 | regulation of bone resorption | 5 | 24 | 8.37e-01 |
| GO:BP | GO:0015876 | acetyl-CoA transport | 1 | 1 | 8.37e-01 |
| GO:BP | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 2 | 5 | 8.37e-01 |
| GO:BP | GO:1905323 | telomerase holoenzyme complex assembly | 2 | 6 | 8.37e-01 |
| GO:BP | GO:0007520 | myoblast fusion | 1 | 30 | 8.37e-01 |
| GO:BP | GO:1990569 | UDP-N-acetylglucosamine transmembrane transport | 1 | 6 | 8.37e-01 |
| GO:BP | GO:0038094 | Fc-gamma receptor signaling pathway | 2 | 20 | 8.37e-01 |
| GO:BP | GO:0043097 | pyrimidine nucleoside salvage | 1 | 2 | 8.37e-01 |
| GO:BP | GO:0043691 | reverse cholesterol transport | 2 | 11 | 8.37e-01 |
| GO:BP | GO:0008360 | regulation of cell shape | 1 | 126 | 8.37e-01 |
| GO:BP | GO:0001707 | mesoderm formation | 11 | 53 | 8.38e-01 |
| GO:BP | GO:0071801 | regulation of podosome assembly | 2 | 8 | 8.38e-01 |
| GO:BP | GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 1 | 2 | 8.38e-01 |
| GO:BP | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 1 | 2 | 8.39e-01 |
| GO:BP | GO:0048714 | positive regulation of oligodendrocyte differentiation | 1 | 13 | 8.39e-01 |
| GO:BP | GO:0048934 | peripheral nervous system neuron differentiation | 1 | 9 | 8.39e-01 |
| GO:BP | GO:0006704 | glucocorticoid biosynthetic process | 2 | 11 | 8.39e-01 |
| GO:BP | GO:0002730 | regulation of dendritic cell cytokine production | 3 | 10 | 8.39e-01 |
| GO:BP | GO:0002371 | dendritic cell cytokine production | 3 | 10 | 8.39e-01 |
| GO:BP | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 1 | 5 | 8.39e-01 |
| GO:BP | GO:0050433 | regulation of catecholamine secretion | 1 | 29 | 8.39e-01 |
| GO:BP | GO:0048935 | peripheral nervous system neuron development | 1 | 9 | 8.39e-01 |
| GO:BP | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation | 1 | 7 | 8.39e-01 |
| GO:BP | GO:1904844 | response to L-glutamine | 1 | 3 | 8.39e-01 |
| GO:BP | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 1 | 2 | 8.39e-01 |
| GO:BP | GO:0040034 | regulation of development, heterochronic | 2 | 8 | 8.40e-01 |
| GO:BP | GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 4 | 9 | 8.40e-01 |
| GO:BP | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 2 | 5 | 8.40e-01 |
| GO:BP | GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 1 | 4 | 8.40e-01 |
| GO:BP | GO:0034372 | very-low-density lipoprotein particle remodeling | 1 | 4 | 8.40e-01 |
| GO:BP | GO:1904751 | positive regulation of protein localization to nucleolus | 2 | 3 | 8.40e-01 |
| GO:BP | GO:0006734 | NADH metabolic process | 2 | 12 | 8.40e-01 |
| GO:BP | GO:0010894 | negative regulation of steroid biosynthetic process | 3 | 18 | 8.40e-01 |
| GO:BP | GO:2000405 | negative regulation of T cell migration | 1 | 4 | 8.40e-01 |
| GO:BP | GO:0061196 | fungiform papilla development | 1 | 5 | 8.40e-01 |
| GO:BP | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway | 2 | 7 | 8.40e-01 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 16 | 72 | 8.40e-01 |
| GO:BP | GO:0051414 | response to cortisol | 1 | 5 | 8.40e-01 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1 | 1507 | 8.41e-01 |
| GO:BP | GO:0033622 | integrin activation | 4 | 18 | 8.41e-01 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 4 | 25 | 8.41e-01 |
| GO:BP | GO:1904396 | regulation of neuromuscular junction development | 3 | 5 | 8.41e-01 |
| GO:BP | GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1 | 3 | 8.41e-01 |
| GO:BP | GO:0051124 | synaptic assembly at neuromuscular junction | 3 | 6 | 8.41e-01 |
| GO:BP | GO:0002700 | regulation of production of molecular mediator of immune response | 4 | 108 | 8.41e-01 |
| GO:BP | GO:0090087 | regulation of peptide transport | 6 | 136 | 8.41e-01 |
| GO:BP | GO:0043457 | regulation of cellular respiration | 6 | 42 | 8.41e-01 |
| GO:BP | GO:0042098 | T cell proliferation | 1 | 120 | 8.41e-01 |
| GO:BP | GO:0051896 | regulation of protein kinase B signaling | 4 | 123 | 8.41e-01 |
| GO:BP | GO:0021550 | medulla oblongata development | 1 | 2 | 8.41e-01 |
| GO:BP | GO:0030322 | stabilization of membrane potential | 1 | 6 | 8.41e-01 |
| GO:BP | GO:0015732 | prostaglandin transport | 1 | 10 | 8.41e-01 |
| GO:BP | GO:0016598 | protein arginylation | 1 | 2 | 8.41e-01 |
| GO:BP | GO:0002792 | negative regulation of peptide secretion | 2 | 31 | 8.41e-01 |
| GO:BP | GO:0098727 | maintenance of cell number | 60 | 151 | 8.41e-01 |
| GO:BP | GO:0042417 | dopamine metabolic process | 1 | 23 | 8.41e-01 |
| GO:BP | GO:0032535 | regulation of cellular component size | 10 | 305 | 8.41e-01 |
| GO:BP | GO:2001111 | positive regulation of lens epithelial cell proliferation | 1 | 1 | 8.41e-01 |
| GO:BP | GO:0097166 | lens epithelial cell proliferation | 1 | 1 | 8.41e-01 |
| GO:BP | GO:2001109 | regulation of lens epithelial cell proliferation | 1 | 1 | 8.41e-01 |
| GO:BP | GO:0019062 | virion attachment to host cell | 1 | 9 | 8.41e-01 |
| GO:BP | GO:0021524 | visceral motor neuron differentiation | 1 | 2 | 8.41e-01 |
| GO:BP | GO:0048293 | regulation of isotype switching to IgE isotypes | 1 | 5 | 8.41e-01 |
| GO:BP | GO:0048289 | isotype switching to IgE isotypes | 1 | 5 | 8.41e-01 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 4 | 512 | 8.41e-01 |
| GO:BP | GO:0006014 | D-ribose metabolic process | 1 | 3 | 8.41e-01 |
| GO:BP | GO:0021517 | ventral spinal cord development | 1 | 25 | 8.41e-01 |
| GO:BP | GO:0001975 | response to amphetamine | 2 | 22 | 8.41e-01 |
| GO:BP | GO:0061889 | negative regulation of astrocyte activation | 1 | 2 | 8.42e-01 |
| GO:BP | GO:0071109 | superior temporal gyrus development | 1 | 2 | 8.42e-01 |
| GO:BP | GO:0071461 | cellular response to redox state | 1 | 1 | 8.42e-01 |
| GO:BP | GO:0061356 | regulation of Wnt protein secretion | 1 | 4 | 8.42e-01 |
| GO:BP | GO:1903391 | regulation of adherens junction organization | 1 | 5 | 8.42e-01 |
| GO:BP | GO:0030198 | extracellular matrix organization | 5 | 233 | 8.42e-01 |
| GO:BP | GO:0044721 | protein import into peroxisome matrix, substrate release | 1 | 2 | 8.42e-01 |
| GO:BP | GO:0042069 | regulation of catecholamine metabolic process | 4 | 11 | 8.43e-01 |
| GO:BP | GO:0042053 | regulation of dopamine metabolic process | 4 | 11 | 8.43e-01 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 1 | 348 | 8.43e-01 |
| GO:BP | GO:0140245 | regulation of translation at postsynapse | 3 | 6 | 8.43e-01 |
| GO:BP | GO:0034342 | response to type III interferon | 1 | 5 | 8.43e-01 |
| GO:BP | GO:0140243 | regulation of translation at synapse | 3 | 6 | 8.43e-01 |
| GO:BP | GO:0009068 | aspartate family amino acid catabolic process | 1 | 12 | 8.43e-01 |
| GO:BP | GO:0021559 | trigeminal nerve development | 3 | 5 | 8.43e-01 |
| GO:BP | GO:0010533 | regulation of activation of Janus kinase activity | 1 | 3 | 8.43e-01 |
| GO:BP | GO:0044237 | cellular metabolic process | 2 | 6996 | 8.43e-01 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 12 | 42 | 8.43e-01 |
| GO:BP | GO:1905953 | negative regulation of lipid localization | 1 | 32 | 8.43e-01 |
| GO:BP | GO:1904871 | positive regulation of protein localization to Cajal body | 2 | 11 | 8.44e-01 |
| GO:BP | GO:0043062 | extracellular structure organization | 5 | 234 | 8.44e-01 |
| GO:BP | GO:0032964 | collagen biosynthetic process | 8 | 39 | 8.44e-01 |
| GO:BP | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 3 | 12 | 8.44e-01 |
| GO:BP | GO:1904383 | response to sodium phosphate | 3 | 5 | 8.44e-01 |
| GO:BP | GO:1904869 | regulation of protein localization to Cajal body | 2 | 11 | 8.44e-01 |
| GO:BP | GO:2000410 | regulation of thymocyte migration | 1 | 1 | 8.44e-01 |
| GO:BP | GO:2000418 | positive regulation of eosinophil migration | 1 | 1 | 8.44e-01 |
| GO:BP | GO:0010155 | regulation of proton transport | 1 | 18 | 8.44e-01 |
| GO:BP | GO:0042220 | response to cocaine | 3 | 28 | 8.44e-01 |
| GO:BP | GO:0007597 | blood coagulation, intrinsic pathway | 1 | 3 | 8.44e-01 |
| GO:BP | GO:0060711 | labyrinthine layer development | 8 | 35 | 8.44e-01 |
| GO:BP | GO:0036031 | recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex | 1 | 1 | 8.44e-01 |
| GO:BP | GO:0032677 | regulation of interleukin-8 production | 2 | 43 | 8.44e-01 |
| GO:BP | GO:0032637 | interleukin-8 production | 2 | 43 | 8.44e-01 |
| GO:BP | GO:0016578 | histone deubiquitination | 4 | 46 | 8.44e-01 |
| GO:BP | GO:0002676 | regulation of chronic inflammatory response | 1 | 2 | 8.44e-01 |
| GO:BP | GO:0045916 | negative regulation of complement activation | 3 | 8 | 8.44e-01 |
| GO:BP | GO:0017014 | protein nitrosylation | 1 | 11 | 8.44e-01 |
| GO:BP | GO:0050866 | negative regulation of cell activation | 1 | 124 | 8.44e-01 |
| GO:BP | GO:0015746 | citrate transport | 1 | 3 | 8.44e-01 |
| GO:BP | GO:0036265 | RNA (guanine-N7)-methylation | 3 | 6 | 8.44e-01 |
| GO:BP | GO:0006842 | tricarboxylic acid transport | 1 | 3 | 8.44e-01 |
| GO:BP | GO:1990044 | protein localization to lipid droplet | 1 | 4 | 8.44e-01 |
| GO:BP | GO:0002526 | acute inflammatory response | 2 | 49 | 8.44e-01 |
| GO:BP | GO:0018119 | peptidyl-cysteine S-nitrosylation | 1 | 11 | 8.44e-01 |
| GO:BP | GO:2001171 | positive regulation of ATP biosynthetic process | 1 | 10 | 8.44e-01 |
| GO:BP | GO:0042254 | ribosome biogenesis | 5 | 301 | 8.44e-01 |
| GO:BP | GO:0048710 | regulation of astrocyte differentiation | 5 | 21 | 8.44e-01 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 4 | 192 | 8.44e-01 |
| GO:BP | GO:0150003 | regulation of spontaneous synaptic transmission | 2 | 6 | 8.44e-01 |
| GO:BP | GO:0016243 | regulation of autophagosome size | 1 | 2 | 8.44e-01 |
| GO:BP | GO:2000503 | positive regulation of natural killer cell chemotaxis | 1 | 1 | 8.44e-01 |
| GO:BP | GO:0045907 | positive regulation of vasoconstriction | 1 | 15 | 8.44e-01 |
| GO:BP | GO:0001773 | myeloid dendritic cell activation | 1 | 12 | 8.44e-01 |
| GO:BP | GO:0021942 | radial glia guided migration of Purkinje cell | 1 | 3 | 8.44e-01 |
| GO:BP | GO:0035522 | monoubiquitinated histone H2A deubiquitination | 13 | 30 | 8.44e-01 |
| GO:BP | GO:0070527 | platelet aggregation | 5 | 52 | 8.44e-01 |
| GO:BP | GO:0035521 | monoubiquitinated histone deubiquitination | 13 | 30 | 8.44e-01 |
| GO:BP | GO:0001819 | positive regulation of cytokine production | 3 | 276 | 8.45e-01 |
| GO:BP | GO:0032891 | negative regulation of organic acid transport | 3 | 17 | 8.45e-01 |
| GO:BP | GO:0006935 | chemotaxis | 4 | 389 | 8.45e-01 |
| GO:BP | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport | 2 | 12 | 8.45e-01 |
| GO:BP | GO:0050432 | catecholamine secretion | 1 | 31 | 8.45e-01 |
| GO:BP | GO:0046462 | monoacylglycerol metabolic process | 2 | 8 | 8.46e-01 |
| GO:BP | GO:0009953 | dorsal/ventral pattern formation | 4 | 55 | 8.46e-01 |
| GO:BP | GO:2000653 | regulation of genetic imprinting | 2 | 4 | 8.46e-01 |
| GO:BP | GO:0002638 | negative regulation of immunoglobulin production | 2 | 5 | 8.46e-01 |
| GO:BP | GO:0097360 | chorionic trophoblast cell proliferation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0003210 | cardiac atrium formation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0048840 | otolith development | 1 | 6 | 8.46e-01 |
| GO:BP | GO:0070366 | regulation of hepatocyte differentiation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0042663 | regulation of endodermal cell fate specification | 1 | 2 | 8.46e-01 |
| GO:BP | GO:1901382 | regulation of chorionic trophoblast cell proliferation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity | 4 | 12 | 8.46e-01 |
| GO:BP | GO:0060974 | cell migration involved in heart formation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 5 | 234 | 8.46e-01 |
| GO:BP | GO:1904035 | regulation of epithelial cell apoptotic process | 1 | 71 | 8.46e-01 |
| GO:BP | GO:0002468 | dendritic cell antigen processing and presentation | 2 | 6 | 8.46e-01 |
| GO:BP | GO:0032728 | positive regulation of interferon-beta production | 12 | 29 | 8.46e-01 |
| GO:BP | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface | 2 | 3 | 8.46e-01 |
| GO:BP | GO:0042330 | taxis | 4 | 389 | 8.46e-01 |
| GO:BP | GO:1905384 | regulation of protein localization to presynapse | 1 | 2 | 8.46e-01 |
| GO:BP | GO:1905386 | positive regulation of protein localization to presynapse | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0014022 | neural plate elongation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0046427 | positive regulation of receptor signaling pathway via JAK-STAT | 1 | 21 | 8.46e-01 |
| GO:BP | GO:0022007 | convergent extension involved in neural plate elongation | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 1 | 2 | 8.46e-01 |
| GO:BP | GO:0000338 | protein deneddylation | 2 | 11 | 8.46e-01 |
| GO:BP | GO:0018126 | protein hydroxylation | 7 | 26 | 8.46e-01 |
| GO:BP | GO:0043615 | astrocyte cell migration | 2 | 6 | 8.47e-01 |
| GO:BP | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway | 1 | 10 | 8.47e-01 |
| GO:BP | GO:0019883 | antigen processing and presentation of endogenous antigen | 4 | 19 | 8.47e-01 |
| GO:BP | GO:1903224 | regulation of endodermal cell differentiation | 3 | 6 | 8.47e-01 |
| GO:BP | GO:1901386 | negative regulation of voltage-gated calcium channel activity | 3 | 13 | 8.47e-01 |
| GO:BP | GO:0097498 | endothelial tube lumen extension | 1 | 2 | 8.48e-01 |
| GO:BP | GO:0033239 | negative regulation of amine metabolic process | 2 | 2 | 8.48e-01 |
| GO:BP | GO:0000245 | spliceosomal complex assembly | 1 | 73 | 8.48e-01 |
| GO:BP | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3 | 24 | 8.49e-01 |
| GO:BP | GO:0010573 | vascular endothelial growth factor production | 2 | 23 | 8.49e-01 |
| GO:BP | GO:1901078 | negative regulation of relaxation of muscle | 1 | 4 | 8.49e-01 |
| GO:BP | GO:0002032 | desensitization of G protein-coupled receptor signaling pathway by arrestin | 1 | 2 | 8.49e-01 |
| GO:BP | GO:0061884 | regulation of mini excitatory postsynaptic potential | 1 | 2 | 8.49e-01 |
| GO:BP | GO:1904105 | positive regulation of convergent extension involved in gastrulation | 1 | 1 | 8.49e-01 |
| GO:BP | GO:0098816 | mini excitatory postsynaptic potential | 1 | 2 | 8.49e-01 |
| GO:BP | GO:1904103 | regulation of convergent extension involved in gastrulation | 1 | 1 | 8.49e-01 |
| GO:BP | GO:0061885 | positive regulation of mini excitatory postsynaptic potential | 1 | 2 | 8.49e-01 |
| GO:BP | GO:1900275 | negative regulation of phospholipase C activity | 1 | 2 | 8.49e-01 |
| GO:BP | GO:0089709 | L-histidine transmembrane transport | 2 | 5 | 8.49e-01 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1 | 1564 | 8.49e-01 |
| GO:BP | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1 | 2 | 8.49e-01 |
| GO:BP | GO:0021904 | dorsal/ventral neural tube patterning | 1 | 21 | 8.49e-01 |
| GO:BP | GO:0003422 | growth plate cartilage morphogenesis | 1 | 1 | 8.49e-01 |
| GO:BP | GO:0042445 | hormone metabolic process | 1 | 133 | 8.49e-01 |
| GO:BP | GO:0032239 | regulation of nucleobase-containing compound transport | 6 | 15 | 8.49e-01 |
| GO:BP | GO:0002826 | negative regulation of T-helper 1 type immune response | 1 | 3 | 8.49e-01 |
| GO:BP | GO:2000340 | positive regulation of chemokine (C-X-C motif) ligand 1 production | 1 | 3 | 8.49e-01 |
| GO:BP | GO:0003160 | endocardium morphogenesis | 1 | 3 | 8.49e-01 |
| GO:BP | GO:0060842 | arterial endothelial cell differentiation | 1 | 5 | 8.49e-01 |
| GO:BP | GO:0010867 | positive regulation of triglyceride biosynthetic process | 3 | 14 | 8.49e-01 |
| GO:BP | GO:0038171 | cannabinoid signaling pathway | 2 | 5 | 8.49e-01 |
| GO:BP | GO:0043950 | positive regulation of cAMP-mediated signaling | 3 | 5 | 8.49e-01 |
| GO:BP | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading | 2 | 11 | 8.49e-01 |
| GO:BP | GO:0060729 | intestinal epithelial structure maintenance | 2 | 4 | 8.49e-01 |
| GO:BP | GO:0060536 | cartilage morphogenesis | 1 | 5 | 8.49e-01 |
| GO:BP | GO:1903108 | regulation of mitochondrial transcription | 2 | 5 | 8.49e-01 |
| GO:BP | GO:0032703 | negative regulation of interleukin-2 production | 4 | 10 | 8.49e-01 |
| GO:BP | GO:0002437 | inflammatory response to antigenic stimulus | 1 | 36 | 8.49e-01 |
| GO:BP | GO:0006105 | succinate metabolic process | 2 | 5 | 8.49e-01 |
| GO:BP | GO:0006601 | creatine biosynthetic process | 1 | 2 | 8.49e-01 |
| GO:BP | GO:0110104 | mRNA alternative polyadenylation | 1 | 5 | 8.49e-01 |
| GO:BP | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 3 | 8 | 8.50e-01 |
| GO:BP | GO:1901483 | regulation of transcription factor catabolic process | 1 | 3 | 8.50e-01 |
| GO:BP | GO:1901485 | positive regulation of transcription factor catabolic process | 1 | 3 | 8.50e-01 |
| GO:BP | GO:0032715 | negative regulation of interleukin-6 production | 1 | 24 | 8.50e-01 |
| GO:BP | GO:0006528 | asparagine metabolic process | 2 | 5 | 8.50e-01 |
| GO:BP | GO:0032418 | lysosome localization | 9 | 62 | 8.50e-01 |
| GO:BP | GO:2000617 | positive regulation of histone H3-K9 acetylation | 1 | 6 | 8.50e-01 |
| GO:BP | GO:1990849 | vacuolar localization | 9 | 62 | 8.50e-01 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 5 | 232 | 8.50e-01 |
| GO:BP | GO:0045218 | zonula adherens maintenance | 1 | 3 | 8.50e-01 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 1 | 34 | 8.50e-01 |
| GO:BP | GO:0015949 | nucleobase-containing small molecule interconversion | 3 | 8 | 8.51e-01 |
| GO:BP | GO:0071418 | cellular response to amine stimulus | 1 | 2 | 8.51e-01 |
| GO:BP | GO:0060964 | regulation of miRNA-mediated gene silencing | 13 | 25 | 8.51e-01 |
| GO:BP | GO:0033687 | osteoblast proliferation | 6 | 27 | 8.51e-01 |
| GO:BP | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib | 1 | 3 | 8.51e-01 |
| GO:BP | GO:0035881 | amacrine cell differentiation | 1 | 3 | 8.51e-01 |
| GO:BP | GO:0098943 | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 1 | 2 | 8.51e-01 |
| GO:BP | GO:0048007 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 1 | 3 | 8.51e-01 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 4 | 527 | 8.51e-01 |
| GO:BP | GO:2001226 | negative regulation of chloride transport | 1 | 1 | 8.51e-01 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1 | 1602 | 8.52e-01 |
| GO:BP | GO:1901610 | positive regulation of vesicle transport along microtubule | 1 | 3 | 8.52e-01 |
| GO:BP | GO:0035801 | adrenal cortex development | 1 | 2 | 8.52e-01 |
| GO:BP | GO:0019217 | regulation of fatty acid metabolic process | 12 | 66 | 8.52e-01 |
| GO:BP | GO:0032890 | regulation of organic acid transport | 3 | 49 | 8.52e-01 |
| GO:BP | GO:0045623 | negative regulation of T-helper cell differentiation | 4 | 11 | 8.52e-01 |
| GO:BP | GO:0051712 | positive regulation of killing of cells of another organism | 1 | 2 | 8.52e-01 |
| GO:BP | GO:0002089 | lens morphogenesis in camera-type eye | 2 | 18 | 8.52e-01 |
| GO:BP | GO:0030853 | negative regulation of granulocyte differentiation | 3 | 6 | 8.53e-01 |
| GO:BP | GO:0046823 | negative regulation of nucleocytoplasmic transport | 1 | 21 | 8.53e-01 |
| GO:BP | GO:0097064 | ncRNA export from nucleus | 4 | 9 | 8.53e-01 |
| GO:BP | GO:0002038 | positive regulation of L-glutamate import across plasma membrane | 1 | 3 | 8.53e-01 |
| GO:BP | GO:0035809 | regulation of urine volume | 1 | 14 | 8.53e-01 |
| GO:BP | GO:1905219 | regulation of platelet formation | 1 | 1 | 8.53e-01 |
| GO:BP | GO:1904823 | purine nucleobase transmembrane transport | 1 | 3 | 8.53e-01 |
| GO:BP | GO:0030834 | regulation of actin filament depolymerization | 1 | 45 | 8.53e-01 |
| GO:BP | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 1 | 2 | 8.53e-01 |
| GO:BP | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | 2 | 5 | 8.53e-01 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 2 | 58 | 8.53e-01 |
| GO:BP | GO:1905221 | positive regulation of platelet formation | 1 | 1 | 8.53e-01 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 8 | 478 | 8.53e-01 |
| GO:BP | GO:0002175 | protein localization to paranode region of axon | 1 | 3 | 8.53e-01 |
| GO:BP | GO:0048745 | smooth muscle tissue development | 5 | 19 | 8.54e-01 |
| GO:BP | GO:1905906 | regulation of amyloid fibril formation | 6 | 14 | 8.54e-01 |
| GO:BP | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration | 1 | 3 | 8.54e-01 |
| GO:BP | GO:0009798 | axis specification | 2 | 63 | 8.54e-01 |
| GO:BP | GO:0043578 | nuclear matrix organization | 1 | 3 | 8.54e-01 |
| GO:BP | GO:1903003 | positive regulation of protein deubiquitination | 1 | 6 | 8.54e-01 |
| GO:BP | GO:0090292 | nuclear matrix anchoring at nuclear membrane | 1 | 3 | 8.54e-01 |
| GO:BP | GO:0120255 | olefinic compound biosynthetic process | 3 | 17 | 8.54e-01 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 4 | 531 | 8.55e-01 |
| GO:BP | GO:0048936 | peripheral nervous system neuron axonogenesis | 1 | 4 | 8.55e-01 |
| GO:BP | GO:0007586 | digestion | 2 | 60 | 8.55e-01 |
| GO:BP | GO:0035482 | gastric motility | 1 | 3 | 8.55e-01 |
| GO:BP | GO:0035026 | leading edge cell differentiation | 1 | 2 | 8.55e-01 |
| GO:BP | GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 4 | 8 | 8.55e-01 |
| GO:BP | GO:0002637 | regulation of immunoglobulin production | 1 | 43 | 8.55e-01 |
| GO:BP | GO:1904177 | regulation of adipose tissue development | 2 | 8 | 8.55e-01 |
| GO:BP | GO:0045815 | transcription initiation-coupled chromatin remodeling | 2 | 26 | 8.55e-01 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1 | 1604 | 8.55e-01 |
| GO:BP | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1 | 59 | 8.55e-01 |
| GO:BP | GO:0016485 | protein processing | 2 | 183 | 8.56e-01 |
| GO:BP | GO:1901860 | positive regulation of mitochondrial DNA metabolic process | 1 | 3 | 8.57e-01 |
| GO:BP | GO:1900119 | positive regulation of execution phase of apoptosis | 1 | 7 | 8.57e-01 |
| GO:BP | GO:0006531 | aspartate metabolic process | 3 | 4 | 8.57e-01 |
| GO:BP | GO:0019230 | proprioception | 1 | 3 | 8.57e-01 |
| GO:BP | GO:0006857 | oligopeptide transport | 4 | 5 | 8.57e-01 |
| GO:BP | GO:0035672 | oligopeptide transmembrane transport | 4 | 5 | 8.57e-01 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 11 | 55 | 8.58e-01 |
| GO:BP | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1 | 3 | 8.58e-01 |
| GO:BP | GO:0070170 | regulation of tooth mineralization | 1 | 4 | 8.59e-01 |
| GO:BP | GO:0098712 | L-glutamate import across plasma membrane | 1 | 11 | 8.59e-01 |
| GO:BP | GO:1990138 | neuron projection extension | 38 | 148 | 8.59e-01 |
| GO:BP | GO:1902475 | L-alpha-amino acid transmembrane transport | 9 | 55 | 8.59e-01 |
| GO:BP | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 2 | 66 | 8.59e-01 |
| GO:BP | GO:1900246 | positive regulation of RIG-I signaling pathway | 2 | 7 | 8.59e-01 |
| GO:BP | GO:0042660 | positive regulation of cell fate specification | 1 | 1 | 8.59e-01 |
| GO:BP | GO:1903580 | positive regulation of ATP metabolic process | 1 | 11 | 8.59e-01 |
| GO:BP | GO:0045345 | positive regulation of MHC class I biosynthetic process | 1 | 2 | 8.59e-01 |
| GO:BP | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 1 | 1 | 8.59e-01 |
| GO:BP | GO:0045777 | positive regulation of blood pressure | 2 | 17 | 8.59e-01 |
| GO:BP | GO:0061047 | positive regulation of branching involved in lung morphogenesis | 1 | 2 | 8.59e-01 |
| GO:BP | GO:1902913 | positive regulation of neuroepithelial cell differentiation | 1 | 2 | 8.59e-01 |
| GO:BP | GO:0090362 | positive regulation of platelet-derived growth factor production | 1 | 1 | 8.59e-01 |
| GO:BP | GO:0045609 | positive regulation of inner ear auditory receptor cell differentiation | 1 | 1 | 8.59e-01 |
| GO:BP | GO:0045633 | positive regulation of mechanoreceptor differentiation | 1 | 1 | 8.59e-01 |
| GO:BP | GO:2000982 | positive regulation of inner ear receptor cell differentiation | 1 | 1 | 8.59e-01 |
| GO:BP | GO:0048597 | post-embryonic camera-type eye morphogenesis | 1 | 4 | 8.59e-01 |
| GO:BP | GO:1904708 | regulation of granulosa cell apoptotic process | 1 | 2 | 8.59e-01 |
| GO:BP | GO:1901963 | regulation of cell proliferation involved in outflow tract morphogenesis | 1 | 2 | 8.59e-01 |
| GO:BP | GO:1904700 | granulosa cell apoptotic process | 1 | 2 | 8.59e-01 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 1 | 785 | 8.59e-01 |
| GO:BP | GO:1990573 | potassium ion import across plasma membrane | 5 | 31 | 8.59e-01 |
| GO:BP | GO:1903729 | regulation of plasma membrane organization | 1 | 15 | 8.59e-01 |
| GO:BP | GO:0071387 | cellular response to cortisol stimulus | 1 | 2 | 8.59e-01 |
| GO:BP | GO:1902565 | positive regulation of neutrophil activation | 1 | 1 | 8.59e-01 |
| GO:BP | GO:0002930 | trabecular meshwork development | 1 | 1 | 8.59e-01 |
| GO:BP | GO:0014052 | regulation of gamma-aminobutyric acid secretion | 1 | 5 | 8.59e-01 |
| GO:BP | GO:0070474 | positive regulation of uterine smooth muscle contraction | 1 | 4 | 8.59e-01 |
| GO:BP | GO:0050865 | regulation of cell activation | 1 | 384 | 8.60e-01 |
| GO:BP | GO:0150174 | negative regulation of phosphatidylcholine metabolic process | 1 | 2 | 8.60e-01 |
| GO:BP | GO:0140285 | endosome fission | 1 | 3 | 8.60e-01 |
| GO:BP | GO:0034343 | type III interferon production | 1 | 3 | 8.60e-01 |
| GO:BP | GO:0034344 | regulation of type III interferon production | 1 | 3 | 8.60e-01 |
| GO:BP | GO:1904894 | positive regulation of receptor signaling pathway via STAT | 1 | 22 | 8.60e-01 |
| GO:BP | GO:0035332 | positive regulation of hippo signaling | 2 | 6 | 8.60e-01 |
| GO:BP | GO:0006390 | mitochondrial transcription | 7 | 18 | 8.60e-01 |
| GO:BP | GO:0048733 | sebaceous gland development | 1 | 6 | 8.60e-01 |
| GO:BP | GO:0009880 | embryonic pattern specification | 3 | 50 | 8.60e-01 |
| GO:BP | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport | 1 | 4 | 8.60e-01 |
| GO:BP | GO:0006714 | sesquiterpenoid metabolic process | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0046724 | oxalic acid secretion | 1 | 1 | 8.61e-01 |
| GO:BP | GO:0046968 | peptide antigen transport | 1 | 1 | 8.61e-01 |
| GO:BP | GO:0010922 | positive regulation of phosphatase activity | 1 | 26 | 8.61e-01 |
| GO:BP | GO:0019605 | butyrate metabolic process | 1 | 1 | 8.61e-01 |
| GO:BP | GO:0070994 | detection of oxidative stress | 1 | 1 | 8.61e-01 |
| GO:BP | GO:0045764 | positive regulation of amino acid metabolic process | 1 | 1 | 8.61e-01 |
| GO:BP | GO:0043379 | memory T cell differentiation | 2 | 5 | 8.61e-01 |
| GO:BP | GO:1903384 | negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0050787 | detoxification of mercury ion | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0045112 | integrin biosynthetic process | 1 | 3 | 8.61e-01 |
| GO:BP | GO:1903094 | negative regulation of protein K48-linked deubiquitination | 1 | 2 | 8.61e-01 |
| GO:BP | GO:1903383 | regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 7 | 259 | 8.61e-01 |
| GO:BP | GO:2000157 | negative regulation of ubiquitin-specific protease activity | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0051595 | response to methylglyoxal | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0043306 | positive regulation of mast cell degranulation | 2 | 10 | 8.61e-01 |
| GO:BP | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide | 1 | 2 | 8.61e-01 |
| GO:BP | GO:1903181 | positive regulation of dopamine biosynthetic process | 1 | 2 | 8.61e-01 |
| GO:BP | GO:0110061 | regulation of angiotensin-activated signaling pathway | 1 | 2 | 8.61e-01 |
| GO:BP | GO:1904026 | regulation of collagen fibril organization | 1 | 6 | 8.61e-01 |
| GO:BP | GO:0033008 | positive regulation of mast cell activation involved in immune response | 2 | 10 | 8.61e-01 |
| GO:BP | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway | 1 | 4 | 8.61e-01 |
| GO:BP | GO:0031335 | regulation of sulfur amino acid metabolic process | 1 | 1 | 8.61e-01 |
| GO:BP | GO:0031554 | regulation of termination of DNA-templated transcription | 1 | 4 | 8.61e-01 |
| GO:BP | GO:0018027 | peptidyl-lysine dimethylation | 2 | 22 | 8.61e-01 |
| GO:BP | GO:1902761 | positive regulation of chondrocyte development | 1 | 1 | 8.62e-01 |
| GO:BP | GO:2001280 | positive regulation of unsaturated fatty acid biosynthetic process | 1 | 4 | 8.62e-01 |
| GO:BP | GO:0006925 | inflammatory cell apoptotic process | 2 | 15 | 8.62e-01 |
| GO:BP | GO:0030974 | thiamine pyrophosphate transmembrane transport | 1 | 1 | 8.62e-01 |
| GO:BP | GO:2000523 | regulation of T cell costimulation | 1 | 2 | 8.62e-01 |
| GO:BP | GO:0033032 | regulation of myeloid cell apoptotic process | 3 | 20 | 8.62e-01 |
| GO:BP | GO:0002250 | adaptive immune response | 1 | 218 | 8.62e-01 |
| GO:BP | GO:1990962 | xenobiotic transport across blood-brain barrier | 2 | 3 | 8.62e-01 |
| GO:BP | GO:0021515 | cell differentiation in spinal cord | 1 | 24 | 8.62e-01 |
| GO:BP | GO:0032328 | alanine transport | 7 | 14 | 8.62e-01 |
| GO:BP | GO:0043331 | response to dsRNA | 13 | 33 | 8.62e-01 |
| GO:BP | GO:2000646 | positive regulation of receptor catabolic process | 1 | 5 | 8.62e-01 |
| GO:BP | GO:0048866 | stem cell fate specification | 1 | 2 | 8.63e-01 |
| GO:BP | GO:0043170 | macromolecule metabolic process | 3 | 7069 | 8.63e-01 |
| GO:BP | GO:1905451 | positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 1 | 3 | 8.63e-01 |
| GO:BP | GO:0010721 | negative regulation of cell development | 7 | 191 | 8.63e-01 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 7 | 31 | 8.63e-01 |
| GO:BP | GO:0050778 | positive regulation of immune response | 1 | 369 | 8.63e-01 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 2 | 137 | 8.63e-01 |
| GO:BP | GO:0035929 | steroid hormone secretion | 1 | 18 | 8.63e-01 |
| GO:BP | GO:0042157 | lipoprotein metabolic process | 35 | 116 | 8.63e-01 |
| GO:BP | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining | 6 | 12 | 8.63e-01 |
| GO:BP | GO:0061046 | regulation of branching involved in lung morphogenesis | 1 | 3 | 8.63e-01 |
| GO:BP | GO:0015670 | carbon dioxide transport | 1 | 2 | 8.64e-01 |
| GO:BP | GO:1903725 | regulation of phospholipid metabolic process | 2 | 29 | 8.64e-01 |
| GO:BP | GO:0060025 | regulation of synaptic activity | 1 | 3 | 8.64e-01 |
| GO:BP | GO:0060629 | regulation of homologous chromosome segregation | 1 | 1 | 8.64e-01 |
| GO:BP | GO:0060011 | Sertoli cell proliferation | 1 | 4 | 8.65e-01 |
| GO:BP | GO:0034695 | response to prostaglandin E | 1 | 17 | 8.65e-01 |
| GO:BP | GO:0009111 | vitamin catabolic process | 1 | 3 | 8.65e-01 |
| GO:BP | GO:0048617 | embryonic foregut morphogenesis | 2 | 6 | 8.65e-01 |
| GO:BP | GO:0048856 | anatomical structure development | 3 | 4128 | 8.65e-01 |
| GO:BP | GO:1903842 | response to arsenite ion | 1 | 4 | 8.65e-01 |
| GO:BP | GO:0021626 | central nervous system maturation | 2 | 5 | 8.65e-01 |
| GO:BP | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 1 | 7 | 8.65e-01 |
| GO:BP | GO:2001225 | regulation of chloride transport | 2 | 4 | 8.65e-01 |
| GO:BP | GO:0006955 | immune response | 1 | 882 | 8.65e-01 |
| GO:BP | GO:1903843 | cellular response to arsenite ion | 1 | 4 | 8.65e-01 |
| GO:BP | GO:0050904 | diapedesis | 2 | 6 | 8.65e-01 |
| GO:BP | GO:0097581 | lamellipodium organization | 18 | 78 | 8.65e-01 |
| GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 5 | 45 | 8.65e-01 |
| GO:BP | GO:0099159 | regulation of modification of postsynaptic structure | 1 | 6 | 8.66e-01 |
| GO:BP | GO:0072178 | nephric duct morphogenesis | 1 | 8 | 8.66e-01 |
| GO:BP | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1 | 27 | 8.67e-01 |
| GO:BP | GO:1903799 | negative regulation of miRNA processing | 3 | 6 | 8.67e-01 |
| GO:BP | GO:1901842 | negative regulation of high voltage-gated calcium channel activity | 2 | 4 | 8.67e-01 |
| GO:BP | GO:0002183 | cytoplasmic translational initiation | 6 | 38 | 8.67e-01 |
| GO:BP | GO:0031532 | actin cytoskeleton reorganization | 1 | 96 | 8.67e-01 |
| GO:BP | GO:1902644 | tertiary alcohol metabolic process | 3 | 17 | 8.67e-01 |
| GO:BP | GO:0015820 | leucine transport | 1 | 10 | 8.67e-01 |
| GO:BP | GO:0038093 | Fc receptor signaling pathway | 2 | 36 | 8.67e-01 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 8 | 2270 | 8.68e-01 |
| GO:BP | GO:0022904 | respiratory electron transport chain | 1 | 104 | 8.68e-01 |
| GO:BP | GO:0045116 | protein neddylation | 1 | 26 | 8.68e-01 |
| GO:BP | GO:2000485 | regulation of glutamine transport | 1 | 2 | 8.68e-01 |
| GO:BP | GO:0089718 | amino acid import across plasma membrane | 1 | 39 | 8.68e-01 |
| GO:BP | GO:0001886 | endothelial cell morphogenesis | 5 | 10 | 8.68e-01 |
| GO:BP | GO:0032990 | cell part morphogenesis | 4 | 551 | 8.68e-01 |
| GO:BP | GO:0071529 | cementum mineralization | 1 | 3 | 8.68e-01 |
| GO:BP | GO:0016556 | mRNA modification | 1 | 29 | 8.68e-01 |
| GO:BP | GO:0070070 | proton-transporting V-type ATPase complex assembly | 1 | 7 | 8.68e-01 |
| GO:BP | GO:0009948 | anterior/posterior axis specification | 1 | 32 | 8.68e-01 |
| GO:BP | GO:0060159 | regulation of dopamine receptor signaling pathway | 1 | 7 | 8.68e-01 |
| GO:BP | GO:0048538 | thymus development | 1 | 35 | 8.68e-01 |
| GO:BP | GO:0006968 | cellular defense response | 1 | 15 | 8.68e-01 |
| GO:BP | GO:0001573 | ganglioside metabolic process | 4 | 22 | 8.68e-01 |
| GO:BP | GO:0060147 | regulation of post-transcriptional gene silencing | 14 | 28 | 8.68e-01 |
| GO:BP | GO:0010454 | negative regulation of cell fate commitment | 1 | 6 | 8.68e-01 |
| GO:BP | GO:0050427 | 3’-phosphoadenosine 5’-phosphosulfate metabolic process | 1 | 10 | 8.68e-01 |
| GO:BP | GO:1902947 | regulation of tau-protein kinase activity | 1 | 8 | 8.68e-01 |
| GO:BP | GO:0034035 | purine ribonucleoside bisphosphate metabolic process | 1 | 10 | 8.68e-01 |
| GO:BP | GO:0015780 | nucleotide-sugar transmembrane transport | 2 | 13 | 8.68e-01 |
| GO:BP | GO:1902232 | regulation of positive thymic T cell selection | 1 | 2 | 8.69e-01 |
| GO:BP | GO:0038195 | urokinase plasminogen activator signaling pathway | 1 | 2 | 8.69e-01 |
| GO:BP | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway | 1 | 1 | 8.69e-01 |
| GO:BP | GO:0019884 | antigen processing and presentation of exogenous antigen | 2 | 28 | 8.69e-01 |
| GO:BP | GO:0060437 | lung growth | 1 | 5 | 8.69e-01 |
| GO:BP | GO:0061156 | pulmonary artery morphogenesis | 3 | 7 | 8.69e-01 |
| GO:BP | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death | 1 | 9 | 8.69e-01 |
| GO:BP | GO:0046784 | viral mRNA export from host cell nucleus | 1 | 6 | 8.70e-01 |
| GO:BP | GO:0090193 | positive regulation of glomerulus development | 1 | 3 | 8.70e-01 |
| GO:BP | GO:0045117 | azole transmembrane transport | 5 | 9 | 8.70e-01 |
| GO:BP | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process | 1 | 4 | 8.70e-01 |
| GO:BP | GO:0036343 | psychomotor behavior | 1 | 2 | 8.71e-01 |
| GO:BP | GO:0014002 | astrocyte development | 1 | 27 | 8.71e-01 |
| GO:BP | GO:0010694 | positive regulation of alkaline phosphatase activity | 1 | 6 | 8.71e-01 |
| GO:BP | GO:0017185 | peptidyl-lysine hydroxylation | 3 | 9 | 8.71e-01 |
| GO:BP | GO:0042214 | terpene metabolic process | 1 | 1 | 8.71e-01 |
| GO:BP | GO:0030431 | sleep | 2 | 13 | 8.71e-01 |
| GO:BP | GO:0016116 | carotenoid metabolic process | 1 | 1 | 8.71e-01 |
| GO:BP | GO:0016108 | tetraterpenoid metabolic process | 1 | 1 | 8.71e-01 |
| GO:BP | GO:0120253 | hydrocarbon catabolic process | 1 | 1 | 8.71e-01 |
| GO:BP | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 1 | 3 | 8.71e-01 |
| GO:BP | GO:0023052 | signaling | 5 | 4141 | 8.71e-01 |
| GO:BP | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly | 1 | 6 | 8.71e-01 |
| GO:BP | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 5 | 55 | 8.71e-01 |
| GO:BP | GO:0045047 | protein targeting to ER | 1 | 49 | 8.71e-01 |
| GO:BP | GO:0071670 | smooth muscle cell chemotaxis | 1 | 6 | 8.71e-01 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 1 | 82 | 8.71e-01 |
| GO:BP | GO:0032731 | positive regulation of interleukin-1 beta production | 1 | 30 | 8.71e-01 |
| GO:BP | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration | 1 | 3 | 8.71e-01 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 34 | 2035 | 8.71e-01 |
| GO:BP | GO:0034380 | high-density lipoprotein particle assembly | 1 | 10 | 8.71e-01 |
| GO:BP | GO:0032849 | positive regulation of cellular pH reduction | 2 | 2 | 8.71e-01 |
| GO:BP | GO:1902745 | positive regulation of lamellipodium organization | 7 | 32 | 8.71e-01 |
| GO:BP | GO:0030042 | actin filament depolymerization | 1 | 50 | 8.71e-01 |
| GO:BP | GO:0003011 | involuntary skeletal muscle contraction | 1 | 3 | 8.72e-01 |
| GO:BP | GO:0030203 | glycosaminoglycan metabolic process | 9 | 87 | 8.72e-01 |
| GO:BP | GO:0018242 | protein O-linked glycosylation via serine | 1 | 7 | 8.72e-01 |
| GO:BP | GO:0061520 | Langerhans cell differentiation | 1 | 3 | 8.72e-01 |
| GO:BP | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 12 | 28 | 8.72e-01 |
| GO:BP | GO:0001732 | formation of cytoplasmic translation initiation complex | 7 | 16 | 8.72e-01 |
| GO:BP | GO:0031580 | membrane raft distribution | 1 | 3 | 8.72e-01 |
| GO:BP | GO:0007525 | somatic muscle development | 1 | 4 | 8.72e-01 |
| GO:BP | GO:0007190 | activation of adenylate cyclase activity | 1 | 13 | 8.72e-01 |
| GO:BP | GO:0010986 | positive regulation of lipoprotein particle clearance | 2 | 4 | 8.73e-01 |
| GO:BP | GO:0006370 | 7-methylguanosine mRNA capping | 1 | 7 | 8.74e-01 |
| GO:BP | GO:0045471 | response to ethanol | 1 | 73 | 8.74e-01 |
| GO:BP | GO:0120045 | stereocilium maintenance | 1 | 2 | 8.74e-01 |
| GO:BP | GO:0140291 | peptidyl-glutamate ADP-deribosylation | 1 | 3 | 8.74e-01 |
| GO:BP | GO:0071267 | L-methionine salvage | 1 | 5 | 8.74e-01 |
| GO:BP | GO:0071265 | L-methionine biosynthetic process | 1 | 5 | 8.74e-01 |
| GO:BP | GO:0046305 | alkanesulfonate biosynthetic process | 1 | 2 | 8.74e-01 |
| GO:BP | GO:0042412 | taurine biosynthetic process | 1 | 2 | 8.74e-01 |
| GO:BP | GO:0048857 | neural nucleus development | 1 | 50 | 8.74e-01 |
| GO:BP | GO:0043102 | amino acid salvage | 1 | 5 | 8.74e-01 |
| GO:BP | GO:1903288 | positive regulation of potassium ion import across plasma membrane | 2 | 7 | 8.74e-01 |
| GO:BP | GO:0001706 | endoderm formation | 5 | 46 | 8.74e-01 |
| GO:BP | GO:0002711 | positive regulation of T cell mediated immunity | 1 | 29 | 8.74e-01 |
| GO:BP | GO:0035442 | dipeptide transmembrane transport | 3 | 4 | 8.74e-01 |
| GO:BP | GO:0042938 | dipeptide transport | 3 | 4 | 8.74e-01 |
| GO:BP | GO:0000820 | regulation of glutamine family amino acid metabolic process | 3 | 5 | 8.74e-01 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 13 | 28 | 8.74e-01 |
| GO:BP | GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 3 | 4 | 8.74e-01 |
| GO:BP | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 1 | 7 | 8.74e-01 |
| GO:BP | GO:0090045 | positive regulation of deacetylase activity | 3 | 7 | 8.75e-01 |
| GO:BP | GO:0035621 | ER to Golgi ceramide transport | 1 | 3 | 8.75e-01 |
| GO:BP | GO:0014734 | skeletal muscle hypertrophy | 1 | 1 | 8.75e-01 |
| GO:BP | GO:0002456 | T cell mediated immunity | 2 | 53 | 8.75e-01 |
| GO:BP | GO:0045780 | positive regulation of bone resorption | 5 | 12 | 8.75e-01 |
| GO:BP | GO:0036123 | histone H3-K9 dimethylation | 1 | 3 | 8.75e-01 |
| GO:BP | GO:0033967 | box C/D RNA metabolic process | 1 | 3 | 8.75e-01 |
| GO:BP | GO:0000494 | box C/D RNA 3’-end processing | 1 | 3 | 8.75e-01 |
| GO:BP | GO:0071934 | thiamine transmembrane transport | 3 | 3 | 8.75e-01 |
| GO:BP | GO:0034963 | box C/D RNA processing | 1 | 3 | 8.75e-01 |
| GO:BP | GO:0042723 | thiamine-containing compound metabolic process | 3 | 4 | 8.75e-01 |
| GO:BP | GO:0002092 | positive regulation of receptor internalization | 1 | 21 | 8.75e-01 |
| GO:BP | GO:0061548 | ganglion development | 6 | 12 | 8.75e-01 |
| GO:BP | GO:0010940 | positive regulation of necrotic cell death | 1 | 13 | 8.75e-01 |
| GO:BP | GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 1 | 7 | 8.75e-01 |
| GO:BP | GO:0044650 | adhesion of symbiont to host cell | 1 | 9 | 8.76e-01 |
| GO:BP | GO:0009247 | glycolipid biosynthetic process | 7 | 61 | 8.76e-01 |
| GO:BP | GO:0019317 | fucose catabolic process | 1 | 3 | 8.76e-01 |
| GO:BP | GO:0042355 | L-fucose catabolic process | 1 | 3 | 8.76e-01 |
| GO:BP | GO:0060012 | synaptic transmission, glycinergic | 1 | 2 | 8.77e-01 |
| GO:BP | GO:0023061 | signal release | 1 | 321 | 8.77e-01 |
| GO:BP | GO:0045686 | negative regulation of glial cell differentiation | 4 | 15 | 8.77e-01 |
| GO:BP | GO:0007217 | tachykinin receptor signaling pathway | 1 | 3 | 8.77e-01 |
| GO:BP | GO:0070165 | positive regulation of adiponectin secretion | 1 | 1 | 8.77e-01 |
| GO:BP | GO:1902564 | negative regulation of neutrophil activation | 1 | 2 | 8.77e-01 |
| GO:BP | GO:0002282 | microglial cell activation involved in immune response | 1 | 1 | 8.77e-01 |
| GO:BP | GO:1903215 | negative regulation of protein targeting to mitochondrion | 1 | 3 | 8.78e-01 |
| GO:BP | GO:0060179 | male mating behavior | 1 | 5 | 8.78e-01 |
| GO:BP | GO:0072657 | protein localization to membrane | 11 | 523 | 8.78e-01 |
| GO:BP | GO:0097284 | hepatocyte apoptotic process | 5 | 17 | 8.78e-01 |
| GO:BP | GO:0009191 | ribonucleoside diphosphate catabolic process | 1 | 7 | 8.78e-01 |
| GO:BP | GO:0007549 | dosage compensation | 4 | 29 | 8.78e-01 |
| GO:BP | GO:0035066 | positive regulation of histone acetylation | 1 | 25 | 8.78e-01 |
| GO:BP | GO:0070487 | monocyte aggregation | 2 | 4 | 8.79e-01 |
| GO:BP | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway | 1 | 12 | 8.79e-01 |
| GO:BP | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy | 1 | 3 | 8.79e-01 |
| GO:BP | GO:1902988 | neurofibrillary tangle assembly | 1 | 3 | 8.79e-01 |
| GO:BP | GO:0009996 | negative regulation of cell fate specification | 2 | 4 | 8.79e-01 |
| GO:BP | GO:1990127 | intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | 1 | 2 | 8.79e-01 |
| GO:BP | GO:1902238 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | 1 | 2 | 8.79e-01 |
| GO:BP | GO:0016486 | peptide hormone processing | 8 | 27 | 8.80e-01 |
| GO:BP | GO:0002224 | toll-like receptor signaling pathway | 1 | 43 | 8.80e-01 |
| GO:BP | GO:0001945 | lymph vessel development | 5 | 22 | 8.80e-01 |
| GO:BP | GO:0090259 | regulation of retinal ganglion cell axon guidance | 1 | 3 | 8.80e-01 |
| GO:BP | GO:0070672 | response to interleukin-15 | 2 | 3 | 8.80e-01 |
| GO:BP | GO:0002363 | alpha-beta T cell lineage commitment | 4 | 11 | 8.80e-01 |
| GO:BP | GO:0007202 | activation of phospholipase C activity | 1 | 10 | 8.80e-01 |
| GO:BP | GO:0045625 | regulation of T-helper 1 cell differentiation | 2 | 5 | 8.80e-01 |
| GO:BP | GO:0061355 | Wnt protein secretion | 1 | 5 | 8.81e-01 |
| GO:BP | GO:0002036 | regulation of L-glutamate import across plasma membrane | 2 | 6 | 8.81e-01 |
| GO:BP | GO:1905686 | positive regulation of plasma membrane repair | 1 | 4 | 8.81e-01 |
| GO:BP | GO:0033688 | regulation of osteoblast proliferation | 1 | 23 | 8.81e-01 |
| GO:BP | GO:0006555 | methionine metabolic process | 1 | 13 | 8.81e-01 |
| GO:BP | GO:0010960 | magnesium ion homeostasis | 2 | 9 | 8.81e-01 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 46 | 2135 | 8.82e-01 |
| GO:BP | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 1 | 3 | 8.82e-01 |
| GO:BP | GO:0071285 | cellular response to lithium ion | 1 | 8 | 8.82e-01 |
| GO:BP | GO:0048638 | regulation of developmental growth | 8 | 258 | 8.82e-01 |
| GO:BP | GO:0046629 | gamma-delta T cell activation | 2 | 9 | 8.82e-01 |
| GO:BP | GO:0002840 | regulation of T cell mediated immune response to tumor cell | 3 | 5 | 8.82e-01 |
| GO:BP | GO:0032757 | positive regulation of interleukin-8 production | 1 | 31 | 8.83e-01 |
| GO:BP | GO:0007154 | cell communication | 5 | 4226 | 8.83e-01 |
| GO:BP | GO:0071000 | response to magnetism | 1 | 2 | 8.83e-01 |
| GO:BP | GO:0051261 | protein depolymerization | 2 | 105 | 8.83e-01 |
| GO:BP | GO:1905665 | positive regulation of calcium ion import across plasma membrane | 1 | 6 | 8.83e-01 |
| GO:BP | GO:0030047 | actin modification | 2 | 5 | 8.83e-01 |
| GO:BP | GO:0038007 | netrin-activated signaling pathway | 4 | 8 | 8.84e-01 |
| GO:BP | GO:0060440 | trachea formation | 1 | 7 | 8.84e-01 |
| GO:BP | GO:0044351 | macropinocytosis | 3 | 8 | 8.84e-01 |
| GO:BP | GO:0043616 | keratinocyte proliferation | 1 | 38 | 8.84e-01 |
| GO:BP | GO:1902743 | regulation of lamellipodium organization | 10 | 44 | 8.84e-01 |
| GO:BP | GO:0009725 | response to hormone | 18 | 642 | 8.84e-01 |
| GO:BP | GO:2000407 | regulation of T cell extravasation | 1 | 3 | 8.85e-01 |
| GO:BP | GO:0098962 | regulation of postsynaptic neurotransmitter receptor activity | 3 | 12 | 8.85e-01 |
| GO:BP | GO:0051946 | regulation of glutamate uptake involved in transmission of nerve impulse | 1 | 3 | 8.85e-01 |
| GO:BP | GO:1901881 | positive regulation of protein depolymerization | 7 | 15 | 8.85e-01 |
| GO:BP | GO:0051941 | regulation of amino acid uptake involved in synaptic transmission | 1 | 3 | 8.85e-01 |
| GO:BP | GO:0045939 | negative regulation of steroid metabolic process | 3 | 19 | 8.85e-01 |
| GO:BP | GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 1 | 2 | 8.86e-01 |
| GO:BP | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 1 | 4 | 8.86e-01 |
| GO:BP | GO:0090715 | immunological memory formation process | 2 | 6 | 8.86e-01 |
| GO:BP | GO:0010817 | regulation of hormone levels | 2 | 336 | 8.86e-01 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 1 | 37 | 8.87e-01 |
| GO:BP | GO:0033617 | mitochondrial cytochrome c oxidase assembly | 5 | 25 | 8.87e-01 |
| GO:BP | GO:0021548 | pons development | 3 | 7 | 8.87e-01 |
| GO:BP | GO:1905150 | regulation of voltage-gated sodium channel activity | 3 | 6 | 8.87e-01 |
| GO:BP | GO:0031134 | sister chromatid biorientation | 1 | 3 | 8.87e-01 |
| GO:BP | GO:1904950 | negative regulation of establishment of protein localization | 7 | 95 | 8.87e-01 |
| GO:BP | GO:0002295 | T-helper cell lineage commitment | 5 | 7 | 8.87e-01 |
| GO:BP | GO:0140253 | cell-cell fusion | 1 | 37 | 8.87e-01 |
| GO:BP | GO:1903487 | regulation of lactation | 1 | 1 | 8.87e-01 |
| GO:BP | GO:1900100 | positive regulation of plasma cell differentiation | 1 | 1 | 8.87e-01 |
| GO:BP | GO:1990418 | response to insulin-like growth factor stimulus | 1 | 2 | 8.87e-01 |
| GO:BP | GO:0072081 | specification of nephron tubule identity | 2 | 4 | 8.87e-01 |
| GO:BP | GO:0072047 | proximal/distal pattern formation involved in nephron development | 2 | 4 | 8.87e-01 |
| GO:BP | GO:0006071 | glycerol metabolic process | 1 | 12 | 8.87e-01 |
| GO:BP | GO:2000370 | positive regulation of clathrin-dependent endocytosis | 1 | 5 | 8.88e-01 |
| GO:BP | GO:0032240 | negative regulation of nucleobase-containing compound transport | 1 | 3 | 8.88e-01 |
| GO:BP | GO:2001026 | regulation of endothelial cell chemotaxis | 9 | 16 | 8.88e-01 |
| GO:BP | GO:0070370 | cellular heat acclimation | 2 | 5 | 8.88e-01 |
| GO:BP | GO:0010286 | heat acclimation | 2 | 5 | 8.88e-01 |
| GO:BP | GO:0044403 | biological process involved in symbiotic interaction | 3 | 223 | 8.88e-01 |
| GO:BP | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2 | 4 | 8.88e-01 |
| GO:BP | GO:1901896 | positive regulation of ATPase-coupled calcium transmembrane transporter activity | 2 | 6 | 8.89e-01 |
| GO:BP | GO:0043969 | histone H2B acetylation | 1 | 3 | 8.89e-01 |
| GO:BP | GO:0010430 | fatty acid omega-oxidation | 1 | 2 | 8.89e-01 |
| GO:BP | GO:0072566 | chemokine (C-X-C motif) ligand 1 production | 1 | 4 | 8.89e-01 |
| GO:BP | GO:1901877 | negative regulation of calcium ion binding | 1 | 2 | 8.89e-01 |
| GO:BP | GO:1901876 | regulation of calcium ion binding | 1 | 2 | 8.89e-01 |
| GO:BP | GO:0010591 | regulation of lamellipodium assembly | 2 | 33 | 8.89e-01 |
| GO:BP | GO:0006011 | UDP-glucose metabolic process | 1 | 6 | 8.89e-01 |
| GO:BP | GO:0071608 | macrophage inflammatory protein-1 alpha production | 1 | 3 | 8.89e-01 |
| GO:BP | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 1 | 3 | 8.89e-01 |
| GO:BP | GO:2000338 | regulation of chemokine (C-X-C motif) ligand 1 production | 1 | 4 | 8.89e-01 |
| GO:BP | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production | 1 | 3 | 8.89e-01 |
| GO:BP | GO:1904398 | positive regulation of neuromuscular junction development | 1 | 2 | 8.89e-01 |
| GO:BP | GO:0002443 | leukocyte mediated immunity | 2 | 194 | 8.90e-01 |
| GO:BP | GO:0048631 | regulation of skeletal muscle tissue growth | 2 | 7 | 8.90e-01 |
| GO:BP | GO:0033299 | secretion of lysosomal enzymes | 2 | 7 | 8.90e-01 |
| GO:BP | GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 1 | 64 | 8.90e-01 |
| GO:BP | GO:1903852 | positive regulation of cristae formation | 1 | 3 | 8.90e-01 |
| GO:BP | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway | 1 | 3 | 8.91e-01 |
| GO:BP | GO:0019477 | L-lysine catabolic process | 1 | 4 | 8.91e-01 |
| GO:BP | GO:0019474 | L-lysine catabolic process to acetyl-CoA | 1 | 4 | 8.91e-01 |
| GO:BP | GO:0046440 | L-lysine metabolic process | 1 | 4 | 8.91e-01 |
| GO:BP | GO:0019695 | choline metabolic process | 1 | 4 | 8.92e-01 |
| GO:BP | GO:0097062 | dendritic spine maintenance | 5 | 15 | 8.93e-01 |
| GO:BP | GO:0036260 | RNA capping | 9 | 20 | 8.93e-01 |
| GO:BP | GO:0097254 | renal tubular secretion | 1 | 15 | 8.93e-01 |
| GO:BP | GO:0016579 | protein deubiquitination | 1 | 129 | 8.93e-01 |
| GO:BP | GO:0070327 | thyroid hormone transport | 1 | 7 | 8.93e-01 |
| GO:BP | GO:0062028 | regulation of stress granule assembly | 2 | 5 | 8.93e-01 |
| GO:BP | GO:2000291 | regulation of myoblast proliferation | 2 | 11 | 8.93e-01 |
| GO:BP | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 28 | 72 | 8.93e-01 |
| GO:BP | GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1 | 3 | 8.93e-01 |
| GO:BP | GO:0045991 | carbon catabolite activation of transcription | 2 | 4 | 8.94e-01 |
| GO:BP | GO:0045990 | carbon catabolite regulation of transcription | 2 | 4 | 8.94e-01 |
| GO:BP | GO:0050901 | leukocyte tethering or rolling | 1 | 16 | 8.94e-01 |
| GO:BP | GO:0007599 | hemostasis | 2 | 153 | 8.94e-01 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 16 | 37 | 8.94e-01 |
| GO:BP | GO:1902459 | positive regulation of stem cell population maintenance | 7 | 44 | 8.95e-01 |
| GO:BP | GO:0046368 | GDP-L-fucose metabolic process | 1 | 4 | 8.96e-01 |
| GO:BP | GO:0002729 | positive regulation of natural killer cell cytokine production | 1 | 4 | 8.96e-01 |
| GO:BP | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 | 10 | 8.96e-01 |
| GO:BP | GO:1903963 | arachidonate transport | 1 | 11 | 8.96e-01 |
| GO:BP | GO:0050482 | arachidonic acid secretion | 1 | 11 | 8.96e-01 |
| GO:BP | GO:0071354 | cellular response to interleukin-6 | 11 | 23 | 8.96e-01 |
| GO:BP | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1 | 3 | 8.96e-01 |
| GO:BP | GO:0046958 | nonassociative learning | 2 | 6 | 8.96e-01 |
| GO:BP | GO:0060594 | mammary gland specification | 1 | 3 | 8.96e-01 |
| GO:BP | GO:0060523 | prostate epithelial cord elongation | 1 | 1 | 8.96e-01 |
| GO:BP | GO:0060648 | mammary gland bud morphogenesis | 1 | 2 | 8.96e-01 |
| GO:BP | GO:0051937 | catecholamine transport | 1 | 38 | 8.96e-01 |
| GO:BP | GO:0071549 | cellular response to dexamethasone stimulus | 9 | 24 | 8.96e-01 |
| GO:BP | GO:0021523 | somatic motor neuron differentiation | 1 | 2 | 8.96e-01 |
| GO:BP | GO:0090025 | regulation of monocyte chemotaxis | 2 | 12 | 8.96e-01 |
| GO:BP | GO:0002708 | positive regulation of lymphocyte mediated immunity | 2 | 58 | 8.96e-01 |
| GO:BP | GO:0071698 | olfactory placode development | 1 | 2 | 8.96e-01 |
| GO:BP | GO:0071699 | olfactory placode morphogenesis | 1 | 2 | 8.96e-01 |
| GO:BP | GO:0010842 | retina layer formation | 2 | 16 | 8.96e-01 |
| GO:BP | GO:0031998 | regulation of fatty acid beta-oxidation | 2 | 16 | 8.96e-01 |
| GO:BP | GO:0051799 | negative regulation of hair follicle development | 2 | 5 | 8.96e-01 |
| GO:BP | GO:0030910 | olfactory placode formation | 1 | 2 | 8.96e-01 |
| GO:BP | GO:0072672 | neutrophil extravasation | 1 | 7 | 8.96e-01 |
| GO:BP | GO:0072594 | establishment of protein localization to organelle | 6 | 422 | 8.96e-01 |
| GO:BP | GO:0018094 | protein polyglycylation | 1 | 1 | 8.97e-01 |
| GO:BP | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 1 | 12 | 8.97e-01 |
| GO:BP | GO:0014891 | striated muscle atrophy | 2 | 6 | 8.97e-01 |
| GO:BP | GO:0090083 | regulation of inclusion body assembly | 1 | 16 | 8.97e-01 |
| GO:BP | GO:0006521 | regulation of cellular amino acid metabolic process | 5 | 7 | 8.97e-01 |
| GO:BP | GO:1904054 | regulation of cholangiocyte proliferation | 1 | 2 | 8.97e-01 |
| GO:BP | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 1 | 5 | 8.97e-01 |
| GO:BP | GO:0008207 | C21-steroid hormone metabolic process | 1 | 28 | 8.97e-01 |
| GO:BP | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 4 | 10 | 8.97e-01 |
| GO:BP | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation | 1 | 3 | 8.97e-01 |
| GO:BP | GO:0060966 | regulation of gene silencing by RNA | 14 | 29 | 8.97e-01 |
| GO:BP | GO:0002019 | regulation of renal output by angiotensin | 1 | 3 | 8.97e-01 |
| GO:BP | GO:0097195 | pilomotor reflex | 1 | 2 | 8.98e-01 |
| GO:BP | GO:0060700 | regulation of ribonuclease activity | 1 | 5 | 8.98e-01 |
| GO:BP | GO:1903531 | negative regulation of secretion by cell | 1 | 99 | 8.98e-01 |
| GO:BP | GO:2001245 | regulation of phosphatidylcholine biosynthetic process | 1 | 5 | 8.98e-01 |
| GO:BP | GO:1904669 | ATP export | 1 | 1 | 8.98e-01 |
| GO:BP | GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 1 | 2 | 8.98e-01 |
| GO:BP | GO:0046649 | lymphocyte activation | 1 | 465 | 8.98e-01 |
| GO:BP | GO:1903371 | regulation of endoplasmic reticulum tubular network organization | 1 | 6 | 8.98e-01 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 1 | 123 | 8.98e-01 |
| GO:BP | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis | 1 | 7 | 8.98e-01 |
| GO:BP | GO:0046500 | S-adenosylmethionine metabolic process | 2 | 13 | 8.98e-01 |
| GO:BP | GO:0042447 | hormone catabolic process | 1 | 7 | 8.98e-01 |
| GO:BP | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 2 | 6 | 8.98e-01 |
| GO:BP | GO:0044597 | daunorubicin metabolic process | 3 | 7 | 8.98e-01 |
| GO:BP | GO:1903298 | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 2 | 6 | 8.98e-01 |
| GO:BP | GO:0097035 | regulation of membrane lipid distribution | 2 | 43 | 8.98e-01 |
| GO:BP | GO:0120317 | sperm mitochondrial sheath assembly | 2 | 2 | 8.98e-01 |
| GO:BP | GO:0060591 | chondroblast differentiation | 2 | 3 | 8.98e-01 |
| GO:BP | GO:0006807 | nitrogen compound metabolic process | 2 | 7441 | 8.99e-01 |
| GO:BP | GO:0051668 | localization within membrane | 12 | 605 | 8.99e-01 |
| GO:BP | GO:0032387 | negative regulation of intracellular transport | 3 | 49 | 9.00e-01 |
| GO:BP | GO:0071676 | negative regulation of mononuclear cell migration | 3 | 16 | 9.00e-01 |
| GO:BP | GO:0044417 | translocation of molecules into host | 1 | 7 | 9.00e-01 |
| GO:BP | GO:0035425 | autocrine signaling | 1 | 3 | 9.00e-01 |
| GO:BP | GO:0009066 | aspartate family amino acid metabolic process | 3 | 39 | 9.00e-01 |
| GO:BP | GO:0006664 | glycolipid metabolic process | 10 | 88 | 9.00e-01 |
| GO:BP | GO:0006949 | syncytium formation | 1 | 39 | 9.00e-01 |
| GO:BP | GO:0140331 | aminophospholipid translocation | 1 | 6 | 9.00e-01 |
| GO:BP | GO:0097213 | regulation of lysosomal membrane permeability | 1 | 2 | 9.00e-01 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 4 | 11 | 9.01e-01 |
| GO:BP | GO:0043244 | regulation of protein-containing complex disassembly | 2 | 113 | 9.01e-01 |
| GO:BP | GO:0030222 | eosinophil differentiation | 1 | 2 | 9.01e-01 |
| GO:BP | GO:1901984 | negative regulation of protein acetylation | 3 | 16 | 9.01e-01 |
| GO:BP | GO:0010626 | negative regulation of Schwann cell proliferation | 3 | 6 | 9.01e-01 |
| GO:BP | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 1 | 4 | 9.01e-01 |
| GO:BP | GO:0048677 | axon extension involved in regeneration | 1 | 2 | 9.01e-01 |
| GO:BP | GO:2001200 | positive regulation of dendritic cell differentiation | 1 | 3 | 9.01e-01 |
| GO:BP | GO:0048682 | sprouting of injured axon | 1 | 2 | 9.01e-01 |
| GO:BP | GO:1901608 | regulation of vesicle transport along microtubule | 1 | 4 | 9.01e-01 |
| GO:BP | GO:0001574 | ganglioside biosynthetic process | 1 | 14 | 9.01e-01 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 1 | 98 | 9.01e-01 |
| GO:BP | GO:0050689 | negative regulation of defense response to virus by host | 1 | 3 | 9.02e-01 |
| GO:BP | GO:0072194 | kidney smooth muscle tissue development | 1 | 2 | 9.02e-01 |
| GO:BP | GO:0036023 | embryonic skeletal limb joint morphogenesis | 1 | 2 | 9.02e-01 |
| GO:BP | GO:1903677 | regulation of cap-independent translational initiation | 1 | 3 | 9.02e-01 |
| GO:BP | GO:1903679 | positive regulation of cap-independent translational initiation | 1 | 3 | 9.02e-01 |
| GO:BP | GO:0001555 | oocyte growth | 1 | 2 | 9.02e-01 |
| GO:BP | GO:0061038 | uterus morphogenesis | 2 | 5 | 9.02e-01 |
| GO:BP | GO:0015718 | monocarboxylic acid transport | 7 | 90 | 9.02e-01 |
| GO:BP | GO:0051665 | membrane raft localization | 1 | 4 | 9.02e-01 |
| GO:BP | GO:1901668 | regulation of superoxide dismutase activity | 2 | 4 | 9.02e-01 |
| GO:BP | GO:0050802 | circadian sleep/wake cycle, sleep | 1 | 9 | 9.02e-01 |
| GO:BP | GO:0032722 | positive regulation of chemokine production | 1 | 32 | 9.02e-01 |
| GO:BP | GO:0031017 | exocrine pancreas development | 1 | 4 | 9.03e-01 |
| GO:BP | GO:0150172 | regulation of phosphatidylcholine metabolic process | 2 | 10 | 9.03e-01 |
| GO:BP | GO:0070098 | chemokine-mediated signaling pathway | 2 | 28 | 9.03e-01 |
| GO:BP | GO:0001923 | B-1 B cell differentiation | 1 | 3 | 9.03e-01 |
| GO:BP | GO:0019058 | viral life cycle | 1 | 244 | 9.03e-01 |
| GO:BP | GO:0030212 | hyaluronan metabolic process | 2 | 21 | 9.03e-01 |
| GO:BP | GO:0006751 | glutathione catabolic process | 1 | 5 | 9.03e-01 |
| GO:BP | GO:0045650 | negative regulation of macrophage differentiation | 2 | 5 | 9.03e-01 |
| GO:BP | GO:1904037 | positive regulation of epithelial cell apoptotic process | 4 | 26 | 9.03e-01 |
| GO:BP | GO:1900038 | negative regulation of cellular response to hypoxia | 3 | 8 | 9.04e-01 |
| GO:BP | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 3 | 11 | 9.04e-01 |
| GO:BP | GO:0120178 | steroid hormone biosynthetic process | 6 | 29 | 9.04e-01 |
| GO:BP | GO:0044788 | modulation by host of viral process | 5 | 40 | 9.04e-01 |
| GO:BP | GO:0032687 | negative regulation of interferon-alpha production | 1 | 2 | 9.04e-01 |
| GO:BP | GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 16 | 29 | 9.05e-01 |
| GO:BP | GO:1902106 | negative regulation of leukocyte differentiation | 2 | 65 | 9.05e-01 |
| GO:BP | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 2 | 11 | 9.05e-01 |
| GO:BP | GO:0120183 | positive regulation of focal adhesion disassembly | 1 | 6 | 9.06e-01 |
| GO:BP | GO:0120182 | regulation of focal adhesion disassembly | 1 | 6 | 9.06e-01 |
| GO:BP | GO:0048489 | synaptic vesicle transport | 2 | 36 | 9.06e-01 |
| GO:BP | GO:0021682 | nerve maturation | 1 | 2 | 9.06e-01 |
| GO:BP | GO:0050849 | negative regulation of calcium-mediated signaling | 8 | 15 | 9.06e-01 |
| GO:BP | GO:1903509 | liposaccharide metabolic process | 10 | 88 | 9.07e-01 |
| GO:BP | GO:0023058 | adaptation of signaling pathway | 6 | 16 | 9.07e-01 |
| GO:BP | GO:0001675 | acrosome assembly | 7 | 16 | 9.07e-01 |
| GO:BP | GO:0030050 | vesicle transport along actin filament | 7 | 13 | 9.07e-01 |
| GO:BP | GO:0019400 | alditol metabolic process | 1 | 14 | 9.07e-01 |
| GO:BP | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane | 1 | 8 | 9.07e-01 |
| GO:BP | GO:0032689 | negative regulation of type II interferon production | 1 | 16 | 9.07e-01 |
| GO:BP | GO:0010575 | positive regulation of vascular endothelial growth factor production | 3 | 18 | 9.07e-01 |
| GO:BP | GO:0090289 | regulation of osteoclast proliferation | 1 | 3 | 9.07e-01 |
| GO:BP | GO:0071485 | cellular response to absence of light | 1 | 3 | 9.07e-01 |
| GO:BP | GO:0009646 | response to absence of light | 1 | 3 | 9.07e-01 |
| GO:BP | GO:1990603 | dark adaptation | 1 | 3 | 9.07e-01 |
| GO:BP | GO:0070142 | synaptic vesicle budding | 1 | 8 | 9.07e-01 |
| GO:BP | GO:0072215 | regulation of metanephros development | 2 | 2 | 9.07e-01 |
| GO:BP | GO:0060684 | epithelial-mesenchymal cell signaling | 1 | 3 | 9.07e-01 |
| GO:BP | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 2 | 14 | 9.07e-01 |
| GO:BP | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning | 1 | 5 | 9.07e-01 |
| GO:BP | GO:1903979 | negative regulation of microglial cell activation | 2 | 5 | 9.07e-01 |
| GO:BP | GO:0010592 | positive regulation of lamellipodium assembly | 1 | 25 | 9.07e-01 |
| GO:BP | GO:2000501 | regulation of natural killer cell chemotaxis | 1 | 2 | 9.07e-01 |
| GO:BP | GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 3 | 8 | 9.08e-01 |
| GO:BP | GO:0042908 | xenobiotic transport | 10 | 30 | 9.08e-01 |
| GO:BP | GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 3 | 7 | 9.08e-01 |
| GO:BP | GO:0007214 | gamma-aminobutyric acid signaling pathway | 1 | 12 | 9.08e-01 |
| GO:BP | GO:0032732 | positive regulation of interleukin-1 production | 1 | 35 | 9.08e-01 |
| GO:BP | GO:0070472 | regulation of uterine smooth muscle contraction | 1 | 5 | 9.08e-01 |
| GO:BP | GO:0071604 | transforming growth factor beta production | 7 | 32 | 9.08e-01 |
| GO:BP | GO:1900368 | regulation of post-transcriptional gene silencing by RNA | 13 | 27 | 9.09e-01 |
| GO:BP | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 4 | 11 | 9.09e-01 |
| GO:BP | GO:0070346 | positive regulation of fat cell proliferation | 1 | 3 | 9.10e-01 |
| GO:BP | GO:0034204 | lipid translocation | 1 | 38 | 9.10e-01 |
| GO:BP | GO:0110089 | regulation of hippocampal neuron apoptotic process | 1 | 2 | 9.10e-01 |
| GO:BP | GO:0110088 | hippocampal neuron apoptotic process | 1 | 2 | 9.10e-01 |
| GO:BP | GO:0120197 | mucociliary clearance | 3 | 5 | 9.10e-01 |
| GO:BP | GO:1904340 | positive regulation of dopaminergic neuron differentiation | 1 | 3 | 9.10e-01 |
| GO:BP | GO:0090324 | negative regulation of oxidative phosphorylation | 3 | 6 | 9.10e-01 |
| GO:BP | GO:0046940 | nucleoside monophosphate phosphorylation | 4 | 9 | 9.10e-01 |
| GO:BP | GO:0030252 | growth hormone secretion | 1 | 12 | 9.10e-01 |
| GO:BP | GO:1903593 | regulation of histamine secretion by mast cell | 1 | 4 | 9.10e-01 |
| GO:BP | GO:1903595 | positive regulation of histamine secretion by mast cell | 1 | 4 | 9.10e-01 |
| GO:BP | GO:1904582 | positive regulation of intracellular mRNA localization | 1 | 3 | 9.10e-01 |
| GO:BP | GO:0071464 | cellular response to hydrostatic pressure | 1 | 3 | 9.10e-01 |
| GO:BP | GO:0060452 | positive regulation of cardiac muscle contraction | 1 | 7 | 9.10e-01 |
| GO:BP | GO:1905907 | negative regulation of amyloid fibril formation | 4 | 10 | 9.10e-01 |
| GO:BP | GO:0044029 | positive regulation of gene expression via CpG island demethylation | 1 | 3 | 9.10e-01 |
| GO:BP | GO:0090192 | regulation of glomerulus development | 1 | 4 | 9.10e-01 |
| GO:BP | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1 | 3 | 9.10e-01 |
| GO:BP | GO:0015931 | nucleobase-containing compound transport | 12 | 194 | 9.10e-01 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 36 | 726 | 9.10e-01 |
| GO:BP | GO:0006369 | termination of RNA polymerase II transcription | 3 | 8 | 9.10e-01 |
| GO:BP | GO:0048752 | semicircular canal morphogenesis | 1 | 5 | 9.10e-01 |
| GO:BP | GO:0051599 | response to hydrostatic pressure | 2 | 5 | 9.10e-01 |
| GO:BP | GO:0016043 | cellular component organization | 3 | 5076 | 9.10e-01 |
| GO:BP | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 1 | 5 | 9.11e-01 |
| GO:BP | GO:0006813 | potassium ion transport | 6 | 147 | 9.11e-01 |
| GO:BP | GO:1902499 | positive regulation of protein autoubiquitination | 1 | 2 | 9.12e-01 |
| GO:BP | GO:1903276 | regulation of sodium ion export across plasma membrane | 1 | 4 | 9.12e-01 |
| GO:BP | GO:1903278 | positive regulation of sodium ion export across plasma membrane | 1 | 4 | 9.12e-01 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 1 | 168 | 9.12e-01 |
| GO:BP | GO:0043627 | response to estrogen | 1 | 52 | 9.12e-01 |
| GO:BP | GO:1902993 | positive regulation of amyloid precursor protein catabolic process | 1 | 22 | 9.12e-01 |
| GO:BP | GO:1905155 | positive regulation of membrane invagination | 3 | 11 | 9.13e-01 |
| GO:BP | GO:0060100 | positive regulation of phagocytosis, engulfment | 3 | 11 | 9.13e-01 |
| GO:BP | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1 | 2 | 9.13e-01 |
| GO:BP | GO:2000328 | regulation of T-helper 17 cell lineage commitment | 1 | 1 | 9.13e-01 |
| GO:BP | GO:0043243 | positive regulation of protein-containing complex disassembly | 15 | 30 | 9.13e-01 |
| GO:BP | GO:0045797 | positive regulation of intestinal cholesterol absorption | 1 | 1 | 9.13e-01 |
| GO:BP | GO:0030520 | intracellular estrogen receptor signaling pathway | 18 | 41 | 9.14e-01 |
| GO:BP | GO:0061737 | leukotriene signaling pathway | 1 | 1 | 9.14e-01 |
| GO:BP | GO:0045745 | positive regulation of G protein-coupled receptor signaling pathway | 1 | 13 | 9.14e-01 |
| GO:BP | GO:1904715 | negative regulation of chaperone-mediated autophagy | 1 | 3 | 9.14e-01 |
| GO:BP | GO:0035306 | positive regulation of dephosphorylation | 11 | 47 | 9.14e-01 |
| GO:BP | GO:0032502 | developmental process | 3 | 4494 | 9.14e-01 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 4 | 121 | 9.14e-01 |
| GO:BP | GO:0044467 | glial cell-derived neurotrophic factor production | 1 | 2 | 9.14e-01 |
| GO:BP | GO:0050776 | regulation of immune response | 1 | 484 | 9.14e-01 |
| GO:BP | GO:1990809 | endoplasmic reticulum tubular network membrane organization | 1 | 4 | 9.14e-01 |
| GO:BP | GO:0060253 | negative regulation of glial cell proliferation | 1 | 13 | 9.14e-01 |
| GO:BP | GO:2000295 | regulation of hydrogen peroxide catabolic process | 1 | 2 | 9.14e-01 |
| GO:BP | GO:0051133 | regulation of NK T cell activation | 2 | 4 | 9.14e-01 |
| GO:BP | GO:0051926 | negative regulation of calcium ion transport | 3 | 45 | 9.14e-01 |
| GO:BP | GO:2000320 | negative regulation of T-helper 17 cell differentiation | 2 | 6 | 9.14e-01 |
| GO:BP | GO:0051581 | negative regulation of neurotransmitter uptake | 1 | 2 | 9.14e-01 |
| GO:BP | GO:1900166 | regulation of glial cell-derived neurotrophic factor production | 1 | 2 | 9.14e-01 |
| GO:BP | GO:0051612 | negative regulation of serotonin uptake | 1 | 2 | 9.14e-01 |
| GO:BP | GO:1900168 | positive regulation of glial cell-derived neurotrophic factor production | 1 | 2 | 9.14e-01 |
| GO:BP | GO:0070646 | protein modification by small protein removal | 1 | 147 | 9.15e-01 |
| GO:BP | GO:0018394 | peptidyl-lysine acetylation | 9 | 160 | 9.15e-01 |
| GO:BP | GO:0042478 | regulation of eye photoreceptor cell development | 1 | 1 | 9.15e-01 |
| GO:BP | GO:0006776 | vitamin A metabolic process | 2 | 3 | 9.15e-01 |
| GO:BP | GO:1903392 | negative regulation of adherens junction organization | 1 | 3 | 9.15e-01 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 2 | 2293 | 9.15e-01 |
| GO:BP | GO:1905279 | regulation of retrograde transport, endosome to Golgi | 2 | 6 | 9.15e-01 |
| GO:BP | GO:0038091 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 1 | 3 | 9.15e-01 |
| GO:BP | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway | 1 | 3 | 9.15e-01 |
| GO:BP | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 2 | 18 | 9.15e-01 |
| GO:BP | GO:2000726 | negative regulation of cardiac muscle cell differentiation | 3 | 8 | 9.15e-01 |
| GO:BP | GO:1903707 | negative regulation of hemopoiesis | 2 | 69 | 9.15e-01 |
| GO:BP | GO:0060445 | branching involved in salivary gland morphogenesis | 1 | 17 | 9.15e-01 |
| GO:BP | GO:0032743 | positive regulation of interleukin-2 production | 2 | 20 | 9.15e-01 |
| GO:BP | GO:0035701 | hematopoietic stem cell migration | 2 | 6 | 9.15e-01 |
| GO:BP | GO:0015917 | aminophospholipid transport | 3 | 8 | 9.15e-01 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 2 | 89 | 9.15e-01 |
| GO:BP | GO:1905039 | carboxylic acid transmembrane transport | 11 | 118 | 9.15e-01 |
| GO:BP | GO:0097638 | L-arginine import across plasma membrane | 2 | 4 | 9.16e-01 |
| GO:BP | GO:0097749 | membrane tubulation | 1 | 4 | 9.16e-01 |
| GO:BP | GO:0006353 | DNA-templated transcription termination | 1 | 22 | 9.16e-01 |
| GO:BP | GO:0071715 | icosanoid transport | 2 | 24 | 9.16e-01 |
| GO:BP | GO:1903412 | response to bile acid | 2 | 3 | 9.16e-01 |
| GO:BP | GO:0061589 | calcium activated phosphatidylserine scrambling | 1 | 3 | 9.16e-01 |
| GO:BP | GO:0061591 | calcium activated galactosylceramide scrambling | 1 | 2 | 9.16e-01 |
| GO:BP | GO:0021800 | cerebral cortex tangential migration | 1 | 4 | 9.16e-01 |
| GO:BP | GO:0022417 | protein maturation by protein folding | 2 | 8 | 9.17e-01 |
| GO:BP | GO:0018393 | internal peptidyl-lysine acetylation | 12 | 148 | 9.17e-01 |
| GO:BP | GO:2000297 | negative regulation of synapse maturation | 1 | 1 | 9.17e-01 |
| GO:BP | GO:0009635 | response to herbicide | 1 | 3 | 9.17e-01 |
| GO:BP | GO:0019563 | glycerol catabolic process | 1 | 5 | 9.17e-01 |
| GO:BP | GO:1902275 | regulation of chromatin organization | 4 | 49 | 9.18e-01 |
| GO:BP | GO:2000434 | regulation of protein neddylation | 6 | 19 | 9.18e-01 |
| GO:BP | GO:0030728 | ovulation | 3 | 14 | 9.18e-01 |
| GO:BP | GO:0002370 | natural killer cell cytokine production | 1 | 4 | 9.19e-01 |
| GO:BP | GO:0002727 | regulation of natural killer cell cytokine production | 1 | 4 | 9.19e-01 |
| GO:BP | GO:0050853 | B cell receptor signaling pathway | 1 | 32 | 9.19e-01 |
| GO:BP | GO:2001028 | positive regulation of endothelial cell chemotaxis | 6 | 13 | 9.19e-01 |
| GO:BP | GO:0006022 | aminoglycan metabolic process | 2 | 93 | 9.19e-01 |
| GO:BP | GO:0002001 | renin secretion into blood stream | 1 | 4 | 9.19e-01 |
| GO:BP | GO:0032729 | positive regulation of type II interferon production | 1 | 36 | 9.19e-01 |
| GO:BP | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure | 1 | 4 | 9.19e-01 |
| GO:BP | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 2 | 4 | 9.19e-01 |
| GO:BP | GO:0045627 | positive regulation of T-helper 1 cell differentiation | 1 | 3 | 9.20e-01 |
| GO:BP | GO:0140650 | radial glia-guided pyramidal neuron migration | 1 | 4 | 9.20e-01 |
| GO:BP | GO:0002920 | regulation of humoral immune response | 1 | 18 | 9.20e-01 |
| GO:BP | GO:0034142 | toll-like receptor 4 signaling pathway | 1 | 24 | 9.20e-01 |
| GO:BP | GO:0033091 | positive regulation of immature T cell proliferation | 1 | 2 | 9.20e-01 |
| GO:BP | GO:1903825 | organic acid transmembrane transport | 11 | 119 | 9.20e-01 |
| GO:BP | GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1 | 2 | 9.20e-01 |
| GO:BP | GO:1903792 | negative regulation of monoatomic anion transport | 1 | 3 | 9.20e-01 |
| GO:BP | GO:0045343 | regulation of MHC class I biosynthetic process | 1 | 3 | 9.20e-01 |
| GO:BP | GO:1903510 | mucopolysaccharide metabolic process | 1 | 74 | 9.20e-01 |
| GO:BP | GO:0031295 | T cell costimulation | 1 | 22 | 9.20e-01 |
| GO:BP | GO:0045341 | MHC class I biosynthetic process | 1 | 3 | 9.20e-01 |
| GO:BP | GO:0048227 | plasma membrane to endosome transport | 2 | 8 | 9.20e-01 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 50 | 1345 | 9.20e-01 |
| GO:BP | GO:0044406 | adhesion of symbiont to host | 1 | 10 | 9.20e-01 |
| GO:BP | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome | 4 | 13 | 9.20e-01 |
| GO:BP | GO:1905167 | positive regulation of lysosomal protein catabolic process | 1 | 4 | 9.21e-01 |
| GO:BP | GO:2001135 | regulation of endocytic recycling | 1 | 17 | 9.21e-01 |
| GO:BP | GO:0035520 | monoubiquitinated protein deubiquitination | 2 | 36 | 9.21e-01 |
| GO:BP | GO:0021562 | vestibulocochlear nerve development | 2 | 4 | 9.21e-01 |
| GO:BP | GO:0070640 | vitamin D3 metabolic process | 2 | 2 | 9.21e-01 |
| GO:BP | GO:0150007 | clathrin-dependent synaptic vesicle endocytosis | 1 | 2 | 9.21e-01 |
| GO:BP | GO:0001502 | cartilage condensation | 3 | 12 | 9.22e-01 |
| GO:BP | GO:0098609 | cell-cell adhesion | 1 | 609 | 9.22e-01 |
| GO:BP | GO:0042832 | defense response to protozoan | 3 | 10 | 9.22e-01 |
| GO:BP | GO:0045577 | regulation of B cell differentiation | 1 | 20 | 9.22e-01 |
| GO:BP | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 2 | 10 | 9.22e-01 |
| GO:BP | GO:0034694 | response to prostaglandin | 1 | 21 | 9.22e-01 |
| GO:BP | GO:0070936 | protein K48-linked ubiquitination | 1 | 66 | 9.22e-01 |
| GO:BP | GO:0046055 | dGMP catabolic process | 1 | 1 | 9.23e-01 |
| GO:BP | GO:0044211 | CTP salvage | 1 | 3 | 9.23e-01 |
| GO:BP | GO:0002082 | regulation of oxidative phosphorylation | 2 | 19 | 9.23e-01 |
| GO:BP | GO:0090026 | positive regulation of monocyte chemotaxis | 1 | 7 | 9.23e-01 |
| GO:BP | GO:0035461 | vitamin transmembrane transport | 1 | 14 | 9.23e-01 |
| GO:BP | GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 1 | 10 | 9.23e-01 |
| GO:BP | GO:0003223 | ventricular compact myocardium morphogenesis | 1 | 7 | 9.24e-01 |
| GO:BP | GO:0046596 | regulation of viral entry into host cell | 1 | 32 | 9.24e-01 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 3 | 5274 | 9.24e-01 |
| GO:BP | GO:1905244 | regulation of modification of synaptic structure | 4 | 10 | 9.24e-01 |
| GO:BP | GO:0034158 | toll-like receptor 8 signaling pathway | 1 | 3 | 9.24e-01 |
| GO:BP | GO:0050892 | intestinal absorption | 2 | 22 | 9.24e-01 |
| GO:BP | GO:0009195 | pyrimidine ribonucleoside diphosphate catabolic process | 1 | 3 | 9.25e-01 |
| GO:BP | GO:0042360 | vitamin E metabolic process | 1 | 2 | 9.25e-01 |
| GO:BP | GO:0002707 | negative regulation of lymphocyte mediated immunity | 8 | 24 | 9.25e-01 |
| GO:BP | GO:0009140 | pyrimidine nucleoside diphosphate catabolic process | 1 | 3 | 9.25e-01 |
| GO:BP | GO:0006256 | UDP catabolic process | 1 | 3 | 9.25e-01 |
| GO:BP | GO:0006475 | internal protein amino acid acetylation | 12 | 150 | 9.25e-01 |
| GO:BP | GO:1905048 | regulation of metallopeptidase activity | 6 | 14 | 9.25e-01 |
| GO:BP | GO:0002693 | positive regulation of cellular extravasation | 6 | 13 | 9.25e-01 |
| GO:BP | GO:0010863 | positive regulation of phospholipase C activity | 2 | 18 | 9.25e-01 |
| GO:BP | GO:0035723 | interleukin-15-mediated signaling pathway | 1 | 2 | 9.25e-01 |
| GO:BP | GO:0071350 | cellular response to interleukin-15 | 1 | 2 | 9.25e-01 |
| GO:BP | GO:0032371 | regulation of sterol transport | 1 | 45 | 9.25e-01 |
| GO:BP | GO:1904732 | regulation of electron transfer activity | 3 | 8 | 9.25e-01 |
| GO:BP | GO:0032374 | regulation of cholesterol transport | 1 | 45 | 9.25e-01 |
| GO:BP | GO:0002674 | negative regulation of acute inflammatory response | 1 | 5 | 9.25e-01 |
| GO:BP | GO:0021801 | cerebral cortex radial glia-guided migration | 9 | 22 | 9.26e-01 |
| GO:BP | GO:0035188 | hatching | 10 | 23 | 9.26e-01 |
| GO:BP | GO:0001835 | blastocyst hatching | 10 | 23 | 9.26e-01 |
| GO:BP | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2 | 19 | 9.26e-01 |
| GO:BP | GO:0018208 | peptidyl-proline modification | 14 | 43 | 9.26e-01 |
| GO:BP | GO:0002353 | plasma kallikrein-kinin cascade | 1 | 2 | 9.26e-01 |
| GO:BP | GO:0071684 | organism emergence from protective structure | 10 | 23 | 9.26e-01 |
| GO:BP | GO:0002254 | kinin cascade | 1 | 2 | 9.26e-01 |
| GO:BP | GO:0022030 | telencephalon glial cell migration | 9 | 22 | 9.26e-01 |
| GO:BP | GO:0048519 | negative regulation of biological process | 4 | 4045 | 9.26e-01 |
| GO:BP | GO:1904959 | regulation of cytochrome-c oxidase activity | 2 | 7 | 9.26e-01 |
| GO:BP | GO:1905526 | regulation of Golgi lumen acidification | 1 | 3 | 9.26e-01 |
| GO:BP | GO:0070471 | uterine smooth muscle contraction | 1 | 6 | 9.26e-01 |
| GO:BP | GO:0014827 | intestine smooth muscle contraction | 1 | 3 | 9.27e-01 |
| GO:BP | GO:0032989 | cellular component morphogenesis | 4 | 639 | 9.27e-01 |
| GO:BP | GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 1 | 3 | 9.27e-01 |
| GO:BP | GO:0044872 | lipoprotein localization | 2 | 15 | 9.27e-01 |
| GO:BP | GO:0072540 | T-helper 17 cell lineage commitment | 2 | 3 | 9.27e-01 |
| GO:BP | GO:0036289 | peptidyl-serine autophosphorylation | 1 | 8 | 9.27e-01 |
| GO:BP | GO:2000556 | positive regulation of T-helper 1 cell cytokine production | 1 | 2 | 9.27e-01 |
| GO:BP | GO:2000554 | regulation of T-helper 1 cell cytokine production | 1 | 2 | 9.27e-01 |
| GO:BP | GO:0035744 | T-helper 1 cell cytokine production | 1 | 2 | 9.27e-01 |
| GO:BP | GO:0008344 | adult locomotory behavior | 1 | 60 | 9.27e-01 |
| GO:BP | GO:0006030 | chitin metabolic process | 1 | 2 | 9.27e-01 |
| GO:BP | GO:0006032 | chitin catabolic process | 1 | 2 | 9.27e-01 |
| GO:BP | GO:0009134 | nucleoside diphosphate catabolic process | 3 | 9 | 9.28e-01 |
| GO:BP | GO:0006867 | asparagine transport | 1 | 3 | 9.28e-01 |
| GO:BP | GO:0015866 | ADP transport | 2 | 6 | 9.28e-01 |
| GO:BP | GO:1900148 | negative regulation of Schwann cell migration | 1 | 3 | 9.28e-01 |
| GO:BP | GO:0014012 | peripheral nervous system axon regeneration | 1 | 6 | 9.28e-01 |
| GO:BP | GO:0031294 | lymphocyte costimulation | 1 | 23 | 9.28e-01 |
| GO:BP | GO:0030647 | aminoglycoside antibiotic metabolic process | 1 | 7 | 9.28e-01 |
| GO:BP | GO:0030638 | polyketide metabolic process | 1 | 8 | 9.28e-01 |
| GO:BP | GO:0044598 | doxorubicin metabolic process | 1 | 8 | 9.28e-01 |
| GO:BP | GO:0097241 | hematopoietic stem cell migration to bone marrow | 1 | 5 | 9.28e-01 |
| GO:BP | GO:0007608 | sensory perception of smell | 1 | 16 | 9.28e-01 |
| GO:BP | GO:0034393 | positive regulation of smooth muscle cell apoptotic process | 4 | 8 | 9.29e-01 |
| GO:BP | GO:0106005 | RNA 5’-cap (guanine-N7)-methylation | 1 | 2 | 9.29e-01 |
| GO:BP | GO:1903980 | positive regulation of microglial cell activation | 1 | 2 | 9.29e-01 |
| GO:BP | GO:0002424 | T cell mediated immune response to tumor cell | 3 | 6 | 9.29e-01 |
| GO:BP | GO:1903899 | positive regulation of PERK-mediated unfolded protein response | 1 | 3 | 9.29e-01 |
| GO:BP | GO:0030259 | lipid glycosylation | 1 | 6 | 9.29e-01 |
| GO:BP | GO:0090091 | positive regulation of extracellular matrix disassembly | 3 | 6 | 9.29e-01 |
| GO:BP | GO:1905162 | regulation of phagosome maturation | 1 | 2 | 9.29e-01 |
| GO:BP | GO:0051918 | negative regulation of fibrinolysis | 5 | 8 | 9.29e-01 |
| GO:BP | GO:0022900 | electron transport chain | 6 | 142 | 9.29e-01 |
| GO:BP | GO:0035709 | memory T cell activation | 1 | 4 | 9.29e-01 |
| GO:BP | GO:0071073 | positive regulation of phospholipid biosynthetic process | 2 | 7 | 9.29e-01 |
| GO:BP | GO:0043401 | steroid hormone mediated signaling pathway | 10 | 112 | 9.30e-01 |
| GO:BP | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling | 1 | 5 | 9.30e-01 |
| GO:BP | GO:0034776 | response to histamine | 4 | 5 | 9.30e-01 |
| GO:BP | GO:0015888 | thiamine transport | 3 | 3 | 9.30e-01 |
| GO:BP | GO:1902916 | positive regulation of protein polyubiquitination | 1 | 13 | 9.30e-01 |
| GO:BP | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation | 4 | 11 | 9.30e-01 |
| GO:BP | GO:0010041 | response to iron(III) ion | 1 | 4 | 9.30e-01 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 1 | 60 | 9.30e-01 |
| GO:BP | GO:0044241 | lipid digestion | 1 | 10 | 9.30e-01 |
| GO:BP | GO:1905771 | negative regulation of mesodermal cell differentiation | 1 | 3 | 9.30e-01 |
| GO:BP | GO:0042662 | negative regulation of mesodermal cell fate specification | 1 | 3 | 9.30e-01 |
| GO:BP | GO:0035278 | miRNA-mediated gene silencing by inhibition of translation | 5 | 15 | 9.30e-01 |
| GO:BP | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 2 | 37 | 9.30e-01 |
| GO:BP | GO:0035562 | negative regulation of chromatin binding | 3 | 8 | 9.30e-01 |
| GO:BP | GO:0071800 | podosome assembly | 3 | 13 | 9.31e-01 |
| GO:BP | GO:0000966 | RNA 5’-end processing | 9 | 22 | 9.31e-01 |
| GO:BP | GO:0045656 | negative regulation of monocyte differentiation | 1 | 4 | 9.31e-01 |
| GO:BP | GO:0043353 | enucleate erythrocyte differentiation | 1 | 9 | 9.31e-01 |
| GO:BP | GO:2000272 | negative regulation of signaling receptor activity | 5 | 33 | 9.31e-01 |
| GO:BP | GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 10 | 52 | 9.31e-01 |
| GO:BP | GO:0014013 | regulation of gliogenesis | 3 | 68 | 9.32e-01 |
| GO:BP | GO:0009311 | oligosaccharide metabolic process | 10 | 43 | 9.32e-01 |
| GO:BP | GO:0006612 | protein targeting to membrane | 1 | 118 | 9.32e-01 |
| GO:BP | GO:0043382 | positive regulation of memory T cell differentiation | 1 | 3 | 9.32e-01 |
| GO:BP | GO:0097752 | regulation of DNA stability | 1 | 3 | 9.32e-01 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 1 | 220 | 9.32e-01 |
| GO:BP | GO:0045824 | negative regulation of innate immune response | 1 | 53 | 9.32e-01 |
| GO:BP | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells | 1 | 4 | 9.32e-01 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 12 | 457 | 9.32e-01 |
| GO:BP | GO:0098597 | observational learning | 2 | 5 | 9.32e-01 |
| GO:BP | GO:1903976 | negative regulation of glial cell migration | 2 | 5 | 9.32e-01 |
| GO:BP | GO:0051131 | chaperone-mediated protein complex assembly | 7 | 21 | 9.33e-01 |
| GO:BP | GO:0071798 | response to prostaglandin D | 1 | 2 | 9.33e-01 |
| GO:BP | GO:0071799 | cellular response to prostaglandin D stimulus | 1 | 2 | 9.33e-01 |
| GO:BP | GO:0032225 | regulation of synaptic transmission, dopaminergic | 1 | 5 | 9.33e-01 |
| GO:BP | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | 1 | 4 | 9.33e-01 |
| GO:BP | GO:0006578 | amino-acid betaine biosynthetic process | 2 | 5 | 9.33e-01 |
| GO:BP | GO:0045321 | leukocyte activation | 1 | 554 | 9.33e-01 |
| GO:BP | GO:1903351 | cellular response to dopamine | 1 | 47 | 9.34e-01 |
| GO:BP | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 1 | 2 | 9.34e-01 |
| GO:BP | GO:0060298 | positive regulation of sarcomere organization | 1 | 4 | 9.34e-01 |
| GO:BP | GO:0042308 | negative regulation of protein import into nucleus | 1 | 13 | 9.34e-01 |
| GO:BP | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1 | 1 | 9.34e-01 |
| GO:BP | GO:0051604 | protein maturation | 4 | 259 | 9.35e-01 |
| GO:BP | GO:0010039 | response to iron ion | 1 | 24 | 9.35e-01 |
| GO:BP | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 1 | 1 | 9.35e-01 |
| GO:BP | GO:0090258 | negative regulation of mitochondrial fission | 1 | 3 | 9.36e-01 |
| GO:BP | GO:0019740 | nitrogen utilization | 1 | 4 | 9.36e-01 |
| GO:BP | GO:0043932 | ossification involved in bone remodeling | 1 | 2 | 9.36e-01 |
| GO:BP | GO:1903350 | response to dopamine | 1 | 48 | 9.36e-01 |
| GO:BP | GO:0071803 | positive regulation of podosome assembly | 1 | 6 | 9.37e-01 |
| GO:BP | GO:0070671 | response to interleukin-12 | 2 | 6 | 9.37e-01 |
| GO:BP | GO:0002486 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1 | 3 | 9.37e-01 |
| GO:BP | GO:0051977 | lysophospholipid transport | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0032790 | ribosome disassembly | 4 | 11 | 9.37e-01 |
| GO:BP | GO:0071486 | cellular response to high light intensity | 1 | 1 | 9.37e-01 |
| GO:BP | GO:0048563 | post-embryonic animal organ morphogenesis | 1 | 8 | 9.37e-01 |
| GO:BP | GO:0002716 | negative regulation of natural killer cell mediated immunity | 2 | 10 | 9.37e-01 |
| GO:BP | GO:0031914 | negative regulation of synaptic plasticity | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0051224 | negative regulation of protein transport | 6 | 91 | 9.37e-01 |
| GO:BP | GO:0016573 | histone acetylation | 11 | 143 | 9.37e-01 |
| GO:BP | GO:0008078 | mesodermal cell migration | 2 | 3 | 9.37e-01 |
| GO:BP | GO:1900274 | regulation of phospholipase C activity | 2 | 20 | 9.37e-01 |
| GO:BP | GO:0030518 | intracellular steroid hormone receptor signaling pathway | 22 | 95 | 9.37e-01 |
| GO:BP | GO:2000317 | negative regulation of T-helper 17 type immune response | 2 | 7 | 9.37e-01 |
| GO:BP | GO:0075522 | IRES-dependent viral translational initiation | 1 | 11 | 9.37e-01 |
| GO:BP | GO:0061439 | kidney vasculature morphogenesis | 1 | 7 | 9.37e-01 |
| GO:BP | GO:0061438 | renal system vasculature morphogenesis | 1 | 7 | 9.37e-01 |
| GO:BP | GO:0070841 | inclusion body assembly | 4 | 22 | 9.37e-01 |
| GO:BP | GO:0019293 | tyrosine biosynthetic process, by oxidation of phenylalanine | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0032819 | positive regulation of natural killer cell proliferation | 1 | 4 | 9.37e-01 |
| GO:BP | GO:0006571 | tyrosine biosynthetic process | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0060839 | endothelial cell fate commitment | 1 | 7 | 9.37e-01 |
| GO:BP | GO:0009095 | aromatic amino acid family biosynthetic process, prephenate pathway | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0000965 | mitochondrial RNA 3’-end processing | 1 | 5 | 9.37e-01 |
| GO:BP | GO:0045989 | positive regulation of striated muscle contraction | 2 | 12 | 9.37e-01 |
| GO:BP | GO:0071211 | protein targeting to vacuole involved in autophagy | 1 | 4 | 9.37e-01 |
| GO:BP | GO:0010755 | regulation of plasminogen activation | 7 | 16 | 9.37e-01 |
| GO:BP | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination | 1 | 4 | 9.37e-01 |
| GO:BP | GO:1901385 | regulation of voltage-gated calcium channel activity | 6 | 29 | 9.37e-01 |
| GO:BP | GO:0006069 | ethanol oxidation | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0032489 | regulation of Cdc42 protein signal transduction | 1 | 6 | 9.37e-01 |
| GO:BP | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity | 1 | 3 | 9.37e-01 |
| GO:BP | GO:0007290 | spermatid nucleus elongation | 1 | 1 | 9.37e-01 |
| GO:BP | GO:0072017 | distal tubule development | 2 | 6 | 9.37e-01 |
| GO:BP | GO:0002921 | negative regulation of humoral immune response | 3 | 10 | 9.37e-01 |
| GO:BP | GO:0001817 | regulation of cytokine production | 6 | 447 | 9.37e-01 |
| GO:BP | GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1 | 2 | 9.37e-01 |
| GO:BP | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly | 1 | 3 | 9.37e-01 |
| GO:BP | GO:1903431 | positive regulation of cell maturation | 1 | 6 | 9.37e-01 |
| GO:BP | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose | 1 | 2 | 9.37e-01 |
| GO:BP | GO:2000857 | positive regulation of mineralocorticoid secretion | 1 | 3 | 9.37e-01 |
| GO:BP | GO:1900193 | regulation of oocyte maturation | 1 | 5 | 9.37e-01 |
| GO:BP | GO:2000860 | positive regulation of aldosterone secretion | 1 | 3 | 9.37e-01 |
| GO:BP | GO:1901164 | negative regulation of trophoblast cell migration | 1 | 4 | 9.37e-01 |
| GO:BP | GO:0002710 | negative regulation of T cell mediated immunity | 2 | 8 | 9.37e-01 |
| GO:BP | GO:0032380 | regulation of intracellular sterol transport | 1 | 6 | 9.37e-01 |
| GO:BP | GO:0001704 | formation of primary germ layer | 17 | 96 | 9.37e-01 |
| GO:BP | GO:0032383 | regulation of intracellular cholesterol transport | 1 | 6 | 9.37e-01 |
| GO:BP | GO:0044060 | regulation of endocrine process | 1 | 24 | 9.37e-01 |
| GO:BP | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1 | 39 | 9.37e-01 |
| GO:BP | GO:0035469 | determination of pancreatic left/right asymmetry | 1 | 3 | 9.37e-01 |
| GO:BP | GO:1990705 | cholangiocyte proliferation | 1 | 3 | 9.37e-01 |
| GO:BP | GO:0050434 | positive regulation of viral transcription | 1 | 3 | 9.37e-01 |
| GO:BP | GO:0002376 | immune system process | 1 | 1447 | 9.37e-01 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 2 | 47 | 9.37e-01 |
| GO:BP | GO:0072015 | podocyte development | 1 | 9 | 9.37e-01 |
| GO:BP | GO:0032413 | negative regulation of ion transmembrane transporter activity | 11 | 51 | 9.38e-01 |
| GO:BP | GO:0048545 | response to steroid hormone | 3 | 245 | 9.38e-01 |
| GO:BP | GO:0051354 | negative regulation of oxidoreductase activity | 1 | 14 | 9.38e-01 |
| GO:BP | GO:0002705 | positive regulation of leukocyte mediated immunity | 2 | 68 | 9.38e-01 |
| GO:BP | GO:1902396 | protein localization to bicellular tight junction | 1 | 3 | 9.38e-01 |
| GO:BP | GO:0006449 | regulation of translational termination | 2 | 10 | 9.38e-01 |
| GO:BP | GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 2 | 17 | 9.38e-01 |
| GO:BP | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2 | 17 | 9.38e-01 |
| GO:BP | GO:0090713 | immunological memory process | 2 | 7 | 9.38e-01 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 22 | 106 | 9.38e-01 |
| GO:BP | GO:0043330 | response to exogenous dsRNA | 10 | 27 | 9.38e-01 |
| GO:BP | GO:0051135 | positive regulation of NK T cell activation | 1 | 3 | 9.38e-01 |
| GO:BP | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 1 | 3 | 9.38e-01 |
| GO:BP | GO:0030901 | midbrain development | 3 | 69 | 9.38e-01 |
| GO:BP | GO:0090361 | regulation of platelet-derived growth factor production | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0003130 | BMP signaling pathway involved in heart induction | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0090360 | platelet-derived growth factor production | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0003133 | endodermal-mesodermal cell signaling | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0035990 | tendon cell differentiation | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0003134 | endodermal-mesodermal cell signaling involved in heart induction | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0035993 | deltoid tuberosity development | 1 | 3 | 9.38e-01 |
| GO:BP | GO:0046642 | negative regulation of alpha-beta T cell proliferation | 1 | 9 | 9.38e-01 |
| GO:BP | GO:1905310 | regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis | 1 | 3 | 9.38e-01 |
| GO:BP | GO:0048143 | astrocyte activation | 7 | 12 | 9.38e-01 |
| GO:BP | GO:0060128 | corticotropin hormone secreting cell differentiation | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0019405 | alditol catabolic process | 1 | 6 | 9.38e-01 |
| GO:BP | GO:0045620 | negative regulation of lymphocyte differentiation | 8 | 33 | 9.38e-01 |
| GO:BP | GO:0060279 | positive regulation of ovulation | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0072198 | mesenchymal cell proliferation involved in ureter development | 1 | 1 | 9.38e-01 |
| GO:BP | GO:0035992 | tendon formation | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 1 | 1 | 9.38e-01 |
| GO:BP | GO:0001816 | cytokine production | 6 | 451 | 9.38e-01 |
| GO:BP | GO:1905312 | positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis | 1 | 3 | 9.38e-01 |
| GO:BP | GO:0001562 | response to protozoan | 2 | 11 | 9.38e-01 |
| GO:BP | GO:0010958 | regulation of amino acid import across plasma membrane | 4 | 15 | 9.38e-01 |
| GO:BP | GO:1903789 | regulation of amino acid transmembrane transport | 4 | 15 | 9.38e-01 |
| GO:BP | GO:0042102 | positive regulation of T cell proliferation | 3 | 47 | 9.38e-01 |
| GO:BP | GO:2000391 | positive regulation of neutrophil extravasation | 2 | 6 | 9.38e-01 |
| GO:BP | GO:0010982 | regulation of high-density lipoprotein particle clearance | 1 | 2 | 9.38e-01 |
| GO:BP | GO:0014051 | gamma-aminobutyric acid secretion | 1 | 8 | 9.38e-01 |
| GO:BP | GO:0060259 | regulation of feeding behavior | 3 | 9 | 9.38e-01 |
| GO:BP | GO:0022401 | negative adaptation of signaling pathway | 5 | 15 | 9.38e-01 |
| GO:BP | GO:0045906 | negative regulation of vasoconstriction | 1 | 6 | 9.38e-01 |
| GO:BP | GO:0016601 | Rac protein signal transduction | 3 | 42 | 9.38e-01 |
| GO:BP | GO:0019511 | peptidyl-proline hydroxylation | 3 | 14 | 9.38e-01 |
| GO:BP | GO:0071316 | cellular response to nicotine | 2 | 4 | 9.38e-01 |
| GO:BP | GO:0046034 | ATP metabolic process | 5 | 116 | 9.38e-01 |
| GO:BP | GO:0007030 | Golgi organization | 3 | 137 | 9.39e-01 |
| GO:BP | GO:0098963 | dendritic transport of messenger ribonucleoprotein complex | 1 | 4 | 9.39e-01 |
| GO:BP | GO:0098961 | dendritic transport of ribonucleoprotein complex | 1 | 4 | 9.39e-01 |
| GO:BP | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling | 6 | 78 | 9.39e-01 |
| GO:BP | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway | 2 | 4 | 9.39e-01 |
| GO:BP | GO:0031342 | negative regulation of cell killing | 3 | 11 | 9.39e-01 |
| GO:BP | GO:0010524 | positive regulation of calcium ion transport into cytosol | 3 | 7 | 9.39e-01 |
| GO:BP | GO:0006583 | melanin biosynthetic process from tyrosine | 1 | 1 | 9.39e-01 |
| GO:BP | GO:0090425 | acinar cell differentiation | 1 | 5 | 9.39e-01 |
| GO:BP | GO:1903179 | regulation of dopamine biosynthetic process | 1 | 3 | 9.39e-01 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 1 | 581 | 9.39e-01 |
| GO:BP | GO:0048535 | lymph node development | 4 | 11 | 9.39e-01 |
| GO:BP | GO:0010624 | regulation of Schwann cell proliferation | 3 | 7 | 9.39e-01 |
| GO:BP | GO:1905205 | positive regulation of connective tissue replacement | 1 | 3 | 9.39e-01 |
| GO:BP | GO:2000036 | regulation of stem cell population maintenance | 10 | 62 | 9.39e-01 |
| GO:BP | GO:0014010 | Schwann cell proliferation | 3 | 7 | 9.39e-01 |
| GO:BP | GO:0030214 | hyaluronan catabolic process | 1 | 11 | 9.39e-01 |
| GO:BP | GO:0009441 | glycolate metabolic process | 1 | 1 | 9.39e-01 |
| GO:BP | GO:1901387 | positive regulation of voltage-gated calcium channel activity | 5 | 13 | 9.39e-01 |
| GO:BP | GO:0006091 | generation of precursor metabolites and energy | 1 | 369 | 9.39e-01 |
| GO:BP | GO:0044000 | movement in host | 1 | 138 | 9.39e-01 |
| GO:BP | GO:2000109 | regulation of macrophage apoptotic process | 1 | 6 | 9.39e-01 |
| GO:BP | GO:0110076 | negative regulation of ferroptosis | 1 | 3 | 9.39e-01 |
| GO:BP | GO:2000211 | regulation of glutamate metabolic process | 1 | 1 | 9.39e-01 |
| GO:BP | GO:0043416 | regulation of skeletal muscle tissue regeneration | 1 | 5 | 9.39e-01 |
| GO:BP | GO:0071484 | cellular response to light intensity | 2 | 4 | 9.39e-01 |
| GO:BP | GO:1903238 | positive regulation of leukocyte tethering or rolling | 1 | 5 | 9.40e-01 |
| GO:BP | GO:0062208 | positive regulation of pattern recognition receptor signaling pathway | 1 | 27 | 9.40e-01 |
| GO:BP | GO:0097052 | L-kynurenine metabolic process | 1 | 4 | 9.40e-01 |
| GO:BP | GO:0043405 | regulation of MAP kinase activity | 3 | 141 | 9.40e-01 |
| GO:BP | GO:0005984 | disaccharide metabolic process | 1 | 5 | 9.40e-01 |
| GO:BP | GO:0010984 | regulation of lipoprotein particle clearance | 3 | 12 | 9.40e-01 |
| GO:BP | GO:0072148 | epithelial cell fate commitment | 2 | 9 | 9.41e-01 |
| GO:BP | GO:1902931 | negative regulation of alcohol biosynthetic process | 1 | 10 | 9.41e-01 |
| GO:BP | GO:0016064 | immunoglobulin mediated immune response | 2 | 76 | 9.41e-01 |
| GO:BP | GO:0070741 | response to interleukin-6 | 6 | 23 | 9.41e-01 |
| GO:BP | GO:0051933 | amino acid neurotransmitter reuptake | 2 | 5 | 9.41e-01 |
| GO:BP | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules | 2 | 10 | 9.41e-01 |
| GO:BP | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 6 | 137 | 9.41e-01 |
| GO:BP | GO:0009584 | detection of visible light | 1 | 20 | 9.41e-01 |
| GO:BP | GO:0010715 | regulation of extracellular matrix disassembly | 2 | 11 | 9.41e-01 |
| GO:BP | GO:0015669 | gas transport | 1 | 6 | 9.41e-01 |
| GO:BP | GO:0060263 | regulation of respiratory burst | 3 | 10 | 9.41e-01 |
| GO:BP | GO:0015748 | organophosphate ester transport | 9 | 106 | 9.41e-01 |
| GO:BP | GO:0046888 | negative regulation of hormone secretion | 2 | 46 | 9.41e-01 |
| GO:BP | GO:0046883 | regulation of hormone secretion | 6 | 168 | 9.41e-01 |
| GO:BP | GO:0045807 | positive regulation of endocytosis | 1 | 104 | 9.41e-01 |
| GO:BP | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1 | 11 | 9.41e-01 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 1 | 220 | 9.41e-01 |
| GO:BP | GO:0010988 | regulation of low-density lipoprotein particle clearance | 2 | 8 | 9.41e-01 |
| GO:BP | GO:0035092 | sperm DNA condensation | 1 | 7 | 9.41e-01 |
| GO:BP | GO:0032971 | regulation of muscle filament sliding | 1 | 3 | 9.41e-01 |
| GO:BP | GO:0150147 | cell-cell junction disassembly | 1 | 4 | 9.41e-01 |
| GO:BP | GO:0031204 | post-translational protein targeting to membrane, translocation | 1 | 7 | 9.41e-01 |
| GO:BP | GO:0032816 | positive regulation of natural killer cell activation | 6 | 16 | 9.41e-01 |
| GO:BP | GO:0035815 | positive regulation of renal sodium excretion | 1 | 7 | 9.41e-01 |
| GO:BP | GO:0006027 | glycosaminoglycan catabolic process | 2 | 17 | 9.42e-01 |
| GO:BP | GO:0071224 | cellular response to peptidoglycan | 1 | 2 | 9.42e-01 |
| GO:BP | GO:0070901 | mitochondrial tRNA methylation | 1 | 4 | 9.42e-01 |
| GO:BP | GO:0052372 | modulation by symbiont of entry into host | 1 | 38 | 9.42e-01 |
| GO:BP | GO:0022607 | cellular component assembly | 1 | 2466 | 9.42e-01 |
| GO:BP | GO:0044238 | primary metabolic process | 2 | 7806 | 9.42e-01 |
| GO:BP | GO:0006772 | thiamine metabolic process | 1 | 2 | 9.43e-01 |
| GO:BP | GO:0051952 | regulation of amine transport | 1 | 55 | 9.43e-01 |
| GO:BP | GO:0052547 | regulation of peptidase activity | 5 | 271 | 9.43e-01 |
| GO:BP | GO:0002447 | eosinophil mediated immunity | 1 | 5 | 9.43e-01 |
| GO:BP | GO:0009048 | dosage compensation by inactivation of X chromosome | 3 | 27 | 9.43e-01 |
| GO:BP | GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7 | 18 | 9.43e-01 |
| GO:BP | GO:0032693 | negative regulation of interleukin-10 production | 1 | 7 | 9.43e-01 |
| GO:BP | GO:0019724 | B cell mediated immunity | 2 | 77 | 9.43e-01 |
| GO:BP | GO:0051140 | regulation of NK T cell proliferation | 1 | 3 | 9.44e-01 |
| GO:BP | GO:1904783 | positive regulation of NMDA glutamate receptor activity | 1 | 4 | 9.44e-01 |
| GO:BP | GO:1903241 | U2-type prespliceosome assembly | 4 | 24 | 9.44e-01 |
| GO:BP | GO:0021631 | optic nerve morphogenesis | 1 | 2 | 9.44e-01 |
| GO:BP | GO:0034470 | ncRNA processing | 10 | 400 | 9.44e-01 |
| GO:BP | GO:0002577 | regulation of antigen processing and presentation | 2 | 8 | 9.44e-01 |
| GO:BP | GO:0031999 | negative regulation of fatty acid beta-oxidation | 2 | 5 | 9.45e-01 |
| GO:BP | GO:0072683 | T cell extravasation | 2 | 8 | 9.45e-01 |
| GO:BP | GO:0002827 | positive regulation of T-helper 1 type immune response | 3 | 5 | 9.45e-01 |
| GO:BP | GO:0034162 | toll-like receptor 9 signaling pathway | 1 | 12 | 9.45e-01 |
| GO:BP | GO:0010944 | negative regulation of transcription by competitive promoter binding | 4 | 8 | 9.45e-01 |
| GO:BP | GO:0030836 | positive regulation of actin filament depolymerization | 4 | 10 | 9.45e-01 |
| GO:BP | GO:0007168 | receptor guanylyl cyclase signaling pathway | 1 | 5 | 9.46e-01 |
| GO:BP | GO:0035814 | negative regulation of renal sodium excretion | 1 | 2 | 9.46e-01 |
| GO:BP | GO:0090150 | establishment of protein localization to membrane | 2 | 250 | 9.46e-01 |
| GO:BP | GO:0010692 | regulation of alkaline phosphatase activity | 1 | 8 | 9.46e-01 |
| GO:BP | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 2 | 7 | 9.46e-01 |
| GO:BP | GO:0048521 | negative regulation of behavior | 2 | 5 | 9.47e-01 |
| GO:BP | GO:0061024 | membrane organization | 9 | 671 | 9.47e-01 |
| GO:BP | GO:0060435 | bronchiole development | 1 | 2 | 9.47e-01 |
| GO:BP | GO:0002689 | negative regulation of leukocyte chemotaxis | 1 | 10 | 9.48e-01 |
| GO:BP | GO:0042693 | muscle cell fate commitment | 3 | 11 | 9.48e-01 |
| GO:BP | GO:0032410 | negative regulation of transporter activity | 12 | 58 | 9.48e-01 |
| GO:BP | GO:0072310 | glomerular epithelial cell development | 1 | 9 | 9.48e-01 |
| GO:BP | GO:0030032 | lamellipodium assembly | 3 | 61 | 9.48e-01 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 2 | 317 | 9.48e-01 |
| GO:BP | GO:0006570 | tyrosine metabolic process | 1 | 6 | 9.48e-01 |
| GO:BP | GO:0001920 | negative regulation of receptor recycling | 1 | 3 | 9.49e-01 |
| GO:BP | GO:0001922 | B-1 B cell homeostasis | 1 | 4 | 9.49e-01 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 2 | 129 | 9.49e-01 |
| GO:BP | GO:0002697 | regulation of immune effector process | 1 | 190 | 9.49e-01 |
| GO:BP | GO:0061181 | regulation of chondrocyte development | 2 | 4 | 9.49e-01 |
| GO:BP | GO:2000110 | negative regulation of macrophage apoptotic process | 1 | 3 | 9.49e-01 |
| GO:BP | GO:0072268 | pattern specification involved in metanephros development | 1 | 4 | 9.49e-01 |
| GO:BP | GO:0072131 | kidney mesenchyme morphogenesis | 1 | 4 | 9.49e-01 |
| GO:BP | GO:0072133 | metanephric mesenchyme morphogenesis | 1 | 4 | 9.49e-01 |
| GO:BP | GO:0072180 | mesonephric duct morphogenesis | 1 | 2 | 9.49e-01 |
| GO:BP | GO:0042448 | progesterone metabolic process | 1 | 13 | 9.49e-01 |
| GO:BP | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1 | 4 | 9.49e-01 |
| GO:BP | GO:1905153 | regulation of membrane invagination | 3 | 11 | 9.49e-01 |
| GO:BP | GO:0060099 | regulation of phagocytosis, engulfment | 3 | 11 | 9.49e-01 |
| GO:BP | GO:0098743 | cell aggregation | 1 | 12 | 9.49e-01 |
| GO:BP | GO:0015874 | norepinephrine transport | 2 | 9 | 9.49e-01 |
| GO:BP | GO:0044344 | cellular response to fibroblast growth factor stimulus | 10 | 81 | 9.49e-01 |
| GO:BP | GO:1990384 | hyaloid vascular plexus regression | 2 | 3 | 9.50e-01 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 6 | 70 | 9.50e-01 |
| GO:BP | GO:0072679 | thymocyte migration | 1 | 1 | 9.50e-01 |
| GO:BP | GO:0035270 | endocrine system development | 2 | 86 | 9.50e-01 |
| GO:BP | GO:0032667 | regulation of interleukin-23 production | 2 | 6 | 9.50e-01 |
| GO:BP | GO:0032627 | interleukin-23 production | 2 | 6 | 9.50e-01 |
| GO:BP | GO:0140895 | cell surface toll-like receptor signaling pathway | 1 | 27 | 9.50e-01 |
| GO:BP | GO:0034157 | positive regulation of toll-like receptor 7 signaling pathway | 1 | 2 | 9.50e-01 |
| GO:BP | GO:0070197 | meiotic attachment of telomere to nuclear envelope | 1 | 1 | 9.50e-01 |
| GO:BP | GO:0033574 | response to testosterone | 1 | 29 | 9.50e-01 |
| GO:BP | GO:0044821 | meiotic telomere tethering at nuclear periphery | 1 | 1 | 9.50e-01 |
| GO:BP | GO:0030473 | nuclear migration along microtubule | 1 | 5 | 9.50e-01 |
| GO:BP | GO:0034398 | telomere tethering at nuclear periphery | 1 | 1 | 9.50e-01 |
| GO:BP | GO:0002753 | cytosolic pattern recognition receptor signaling pathway | 2 | 68 | 9.50e-01 |
| GO:BP | GO:0061590 | calcium activated phosphatidylcholine scrambling | 1 | 3 | 9.50e-01 |
| GO:BP | GO:0002709 | regulation of T cell mediated immunity | 1 | 39 | 9.50e-01 |
| GO:BP | GO:0032642 | regulation of chemokine production | 1 | 46 | 9.50e-01 |
| GO:BP | GO:0033005 | positive regulation of mast cell activation | 2 | 13 | 9.50e-01 |
| GO:BP | GO:0051132 | NK T cell activation | 2 | 5 | 9.50e-01 |
| GO:BP | GO:0032602 | chemokine production | 1 | 46 | 9.50e-01 |
| GO:BP | GO:0090277 | positive regulation of peptide hormone secretion | 3 | 69 | 9.51e-01 |
| GO:BP | GO:0001775 | cell activation | 1 | 655 | 9.52e-01 |
| GO:BP | GO:0007606 | sensory perception of chemical stimulus | 1 | 31 | 9.52e-01 |
| GO:BP | GO:0044272 | sulfur compound biosynthetic process | 22 | 122 | 9.52e-01 |
| GO:BP | GO:0033033 | negative regulation of myeloid cell apoptotic process | 5 | 10 | 9.53e-01 |
| GO:BP | GO:0001878 | response to yeast | 1 | 3 | 9.53e-01 |
| GO:BP | GO:0042446 | hormone biosynthetic process | 9 | 40 | 9.53e-01 |
| GO:BP | GO:0042756 | drinking behavior | 2 | 6 | 9.54e-01 |
| GO:BP | GO:0044085 | cellular component biogenesis | 1 | 2724 | 9.54e-01 |
| GO:BP | GO:0097305 | response to alcohol | 10 | 159 | 9.54e-01 |
| GO:BP | GO:2000813 | negative regulation of barbed-end actin filament capping | 1 | 3 | 9.54e-01 |
| GO:BP | GO:0021798 | forebrain dorsal/ventral pattern formation | 1 | 2 | 9.54e-01 |
| GO:BP | GO:0140367 | antibacterial innate immune response | 1 | 2 | 9.54e-01 |
| GO:BP | GO:0046907 | intracellular transport | 32 | 1453 | 9.54e-01 |
| GO:BP | GO:0008535 | respiratory chain complex IV assembly | 5 | 29 | 9.56e-01 |
| GO:BP | GO:0043316 | cytotoxic T cell degranulation | 1 | 2 | 9.56e-01 |
| GO:BP | GO:0046598 | positive regulation of viral entry into host cell | 4 | 11 | 9.56e-01 |
| GO:BP | GO:0075294 | positive regulation by symbiont of entry into host | 4 | 11 | 9.56e-01 |
| GO:BP | GO:0046884 | follicle-stimulating hormone secretion | 1 | 4 | 9.57e-01 |
| GO:BP | GO:0099515 | actin filament-based transport | 7 | 15 | 9.57e-01 |
| GO:BP | GO:1900424 | regulation of defense response to bacterium | 3 | 12 | 9.57e-01 |
| GO:BP | GO:0008594 | photoreceptor cell morphogenesis | 1 | 4 | 9.57e-01 |
| GO:BP | GO:0002793 | positive regulation of peptide secretion | 3 | 70 | 9.57e-01 |
| GO:BP | GO:0021877 | forebrain neuron fate commitment | 1 | 1 | 9.57e-01 |
| GO:BP | GO:1990051 | activation of protein kinase C activity | 1 | 3 | 9.57e-01 |
| GO:BP | GO:1903659 | regulation of complement-dependent cytotoxicity | 1 | 2 | 9.57e-01 |
| GO:BP | GO:0032496 | response to lipopolysaccharide | 2 | 178 | 9.57e-01 |
| GO:BP | GO:2001054 | negative regulation of mesenchymal cell apoptotic process | 1 | 3 | 9.58e-01 |
| GO:BP | GO:0015837 | amine transport | 1 | 56 | 9.58e-01 |
| GO:BP | GO:0034378 | chylomicron assembly | 1 | 3 | 9.58e-01 |
| GO:BP | GO:1902476 | chloride transmembrane transport | 5 | 51 | 9.58e-01 |
| GO:BP | GO:0061004 | pattern specification involved in kidney development | 3 | 6 | 9.58e-01 |
| GO:BP | GO:1904480 | positive regulation of intestinal absorption | 1 | 1 | 9.58e-01 |
| GO:BP | GO:0072048 | renal system pattern specification | 3 | 6 | 9.58e-01 |
| GO:BP | GO:1904731 | positive regulation of intestinal lipid absorption | 1 | 1 | 9.58e-01 |
| GO:BP | GO:0033004 | negative regulation of mast cell activation | 1 | 4 | 9.58e-01 |
| GO:BP | GO:0048550 | negative regulation of pinocytosis | 1 | 4 | 9.58e-01 |
| GO:BP | GO:0043301 | negative regulation of leukocyte degranulation | 1 | 5 | 9.58e-01 |
| GO:BP | GO:0008211 | glucocorticoid metabolic process | 2 | 18 | 9.58e-01 |
| GO:BP | GO:0006382 | adenosine to inosine editing | 1 | 4 | 9.58e-01 |
| GO:BP | GO:0006119 | oxidative phosphorylation | 2 | 122 | 9.59e-01 |
| GO:BP | GO:1903828 | negative regulation of protein localization | 9 | 160 | 9.59e-01 |
| GO:BP | GO:0051701 | biological process involved in interaction with host | 1 | 154 | 9.59e-01 |
| GO:BP | GO:1905564 | positive regulation of vascular endothelial cell proliferation | 4 | 15 | 9.59e-01 |
| GO:BP | GO:0014889 | muscle atrophy | 4 | 9 | 9.59e-01 |
| GO:BP | GO:2000468 | regulation of peroxidase activity | 1 | 2 | 9.59e-01 |
| GO:BP | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 1 | 2 | 9.59e-01 |
| GO:BP | GO:1901895 | negative regulation of ATPase-coupled calcium transmembrane transporter activity | 1 | 3 | 9.59e-01 |
| GO:BP | GO:0032277 | negative regulation of gonadotropin secretion | 1 | 4 | 9.59e-01 |
| GO:BP | GO:0051611 | regulation of serotonin uptake | 1 | 3 | 9.59e-01 |
| GO:BP | GO:0070857 | regulation of bile acid biosynthetic process | 3 | 7 | 9.59e-01 |
| GO:BP | GO:0048712 | negative regulation of astrocyte differentiation | 3 | 9 | 9.59e-01 |
| GO:BP | GO:0014850 | response to muscle activity | 5 | 17 | 9.59e-01 |
| GO:BP | GO:0060732 | positive regulation of inositol phosphate biosynthetic process | 1 | 5 | 9.59e-01 |
| GO:BP | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 1 | 4 | 9.59e-01 |
| GO:BP | GO:0098586 | cellular response to virus | 1 | 40 | 9.60e-01 |
| GO:BP | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 2 | 15 | 9.60e-01 |
| GO:BP | GO:0002553 | histamine secretion by mast cell | 2 | 8 | 9.60e-01 |
| GO:BP | GO:2000425 | regulation of apoptotic cell clearance | 2 | 7 | 9.60e-01 |
| GO:BP | GO:0048251 | elastic fiber assembly | 1 | 12 | 9.60e-01 |
| GO:BP | GO:0140507 | granzyme-mediated programmed cell death signaling pathway | 2 | 3 | 9.60e-01 |
| GO:BP | GO:0002349 | histamine production involved in inflammatory response | 2 | 8 | 9.60e-01 |
| GO:BP | GO:0009233 | menaquinone metabolic process | 1 | 1 | 9.60e-01 |
| GO:BP | GO:0003333 | amino acid transmembrane transport | 10 | 71 | 9.60e-01 |
| GO:BP | GO:0002441 | histamine secretion involved in inflammatory response | 2 | 8 | 9.60e-01 |
| GO:BP | GO:0048633 | positive regulation of skeletal muscle tissue growth | 1 | 6 | 9.60e-01 |
| GO:BP | GO:0045581 | negative regulation of T cell differentiation | 6 | 27 | 9.60e-01 |
| GO:BP | GO:0018243 | protein O-linked glycosylation via threonine | 2 | 7 | 9.60e-01 |
| GO:BP | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 2 | 6 | 9.60e-01 |
| GO:BP | GO:0006897 | endocytosis | 3 | 527 | 9.60e-01 |
| GO:BP | GO:0021819 | layer formation in cerebral cortex | 4 | 12 | 9.60e-01 |
| GO:BP | GO:1905247 | positive regulation of aspartic-type peptidase activity | 1 | 8 | 9.60e-01 |
| GO:BP | GO:0007492 | endoderm development | 25 | 65 | 9.61e-01 |
| GO:BP | GO:0043903 | regulation of biological process involved in symbiotic interaction | 1 | 40 | 9.61e-01 |
| GO:BP | GO:1902563 | regulation of neutrophil activation | 2 | 3 | 9.61e-01 |
| GO:BP | GO:0045851 | pH reduction | 1 | 1 | 9.61e-01 |
| GO:BP | GO:0061314 | Notch signaling involved in heart development | 1 | 9 | 9.61e-01 |
| GO:BP | GO:0072378 | blood coagulation, fibrin clot formation | 1 | 7 | 9.61e-01 |
| GO:BP | GO:0060439 | trachea morphogenesis | 1 | 7 | 9.61e-01 |
| GO:BP | GO:0010961 | intracellular magnesium ion homeostasis | 1 | 4 | 9.62e-01 |
| GO:BP | GO:0032760 | positive regulation of tumor necrosis factor production | 1 | 55 | 9.62e-01 |
| GO:BP | GO:0032817 | regulation of natural killer cell proliferation | 1 | 4 | 9.62e-01 |
| GO:BP | GO:0002835 | negative regulation of response to tumor cell | 1 | 2 | 9.62e-01 |
| GO:BP | GO:0002838 | negative regulation of immune response to tumor cell | 1 | 2 | 9.62e-01 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 21 | 1238 | 9.62e-01 |
| GO:BP | GO:0070092 | regulation of glucagon secretion | 1 | 3 | 9.62e-01 |
| GO:BP | GO:0036158 | outer dynein arm assembly | 1 | 11 | 9.62e-01 |
| GO:BP | GO:0070091 | glucagon secretion | 1 | 3 | 9.62e-01 |
| GO:BP | GO:0009312 | oligosaccharide biosynthetic process | 3 | 15 | 9.62e-01 |
| GO:BP | GO:0000470 | maturation of LSU-rRNA | 9 | 28 | 9.62e-01 |
| GO:BP | GO:0001710 | mesodermal cell fate commitment | 2 | 9 | 9.62e-01 |
| GO:BP | GO:0061092 | positive regulation of phospholipid translocation | 1 | 4 | 9.62e-01 |
| GO:BP | GO:0035696 | monocyte extravasation | 2 | 5 | 9.62e-01 |
| GO:BP | GO:0007060 | male meiosis chromosome segregation | 1 | 1 | 9.63e-01 |
| GO:BP | GO:0042026 | protein refolding | 1 | 26 | 9.63e-01 |
| GO:BP | GO:0071910 | determination of liver left/right asymmetry | 1 | 4 | 9.63e-01 |
| GO:BP | GO:0045950 | negative regulation of mitotic recombination | 1 | 2 | 9.63e-01 |
| GO:BP | GO:0031424 | keratinization | 1 | 13 | 9.63e-01 |
| GO:BP | GO:0002692 | negative regulation of cellular extravasation | 1 | 5 | 9.63e-01 |
| GO:BP | GO:0032309 | icosanoid secretion | 1 | 18 | 9.63e-01 |
| GO:BP | GO:0002704 | negative regulation of leukocyte mediated immunity | 9 | 28 | 9.63e-01 |
| GO:BP | GO:0051180 | vitamin transport | 2 | 28 | 9.63e-01 |
| GO:BP | GO:0060911 | cardiac cell fate commitment | 1 | 11 | 9.63e-01 |
| GO:BP | GO:0032369 | negative regulation of lipid transport | 2 | 20 | 9.63e-01 |
| GO:BP | GO:0071281 | cellular response to iron ion | 2 | 6 | 9.63e-01 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 1 | 389 | 9.64e-01 |
| GO:BP | GO:0072102 | glomerulus morphogenesis | 1 | 7 | 9.64e-01 |
| GO:BP | GO:0032655 | regulation of interleukin-12 production | 1 | 29 | 9.64e-01 |
| GO:BP | GO:0032615 | interleukin-12 production | 1 | 29 | 9.64e-01 |
| GO:BP | GO:0032494 | response to peptidoglycan | 2 | 5 | 9.64e-01 |
| GO:BP | GO:0150146 | cell junction disassembly | 1 | 20 | 9.64e-01 |
| GO:BP | GO:0035871 | protein K11-linked deubiquitination | 1 | 8 | 9.64e-01 |
| GO:BP | GO:0048254 | snoRNA localization | 1 | 5 | 9.64e-01 |
| GO:BP | GO:0060912 | cardiac cell fate specification | 1 | 2 | 9.65e-01 |
| GO:BP | GO:0038156 | interleukin-3-mediated signaling pathway | 1 | 1 | 9.65e-01 |
| GO:BP | GO:0045861 | negative regulation of proteolysis | 3 | 211 | 9.65e-01 |
| GO:BP | GO:0018199 | peptidyl-glutamine modification | 1 | 3 | 9.65e-01 |
| GO:BP | GO:1905563 | negative regulation of vascular endothelial cell proliferation | 1 | 5 | 9.65e-01 |
| GO:BP | GO:1905599 | positive regulation of low-density lipoprotein receptor activity | 1 | 4 | 9.65e-01 |
| GO:BP | GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 1 | 7 | 9.65e-01 |
| GO:BP | GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 1 | 19 | 9.65e-01 |
| GO:BP | GO:0140353 | lipid export from cell | 1 | 28 | 9.66e-01 |
| GO:BP | GO:0050995 | negative regulation of lipid catabolic process | 2 | 14 | 9.66e-01 |
| GO:BP | GO:0071383 | cellular response to steroid hormone stimulus | 1 | 166 | 9.66e-01 |
| GO:BP | GO:2000389 | regulation of neutrophil extravasation | 2 | 6 | 9.66e-01 |
| GO:BP | GO:0031638 | zymogen activation | 1 | 45 | 9.66e-01 |
| GO:BP | GO:0071222 | cellular response to lipopolysaccharide | 1 | 110 | 9.66e-01 |
| GO:BP | GO:0002237 | response to molecule of bacterial origin | 2 | 187 | 9.67e-01 |
| GO:BP | GO:0002434 | immune complex clearance | 1 | 1 | 9.67e-01 |
| GO:BP | GO:0090261 | positive regulation of inclusion body assembly | 1 | 5 | 9.67e-01 |
| GO:BP | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 1 | 57 | 9.67e-01 |
| GO:BP | GO:0007129 | homologous chromosome pairing at meiosis | 4 | 24 | 9.67e-01 |
| GO:BP | GO:0018205 | peptidyl-lysine modification | 3 | 336 | 9.67e-01 |
| GO:BP | GO:1905034 | regulation of antifungal innate immune response | 1 | 3 | 9.67e-01 |
| GO:BP | GO:0046942 | carboxylic acid transport | 22 | 216 | 9.67e-01 |
| GO:BP | GO:0007567 | parturition | 1 | 8 | 9.67e-01 |
| GO:BP | GO:0002829 | negative regulation of type 2 immune response | 1 | 7 | 9.67e-01 |
| GO:BP | GO:0090296 | regulation of mitochondrial DNA replication | 1 | 4 | 9.67e-01 |
| GO:BP | GO:0007155 | cell adhesion | 6 | 1012 | 9.68e-01 |
| GO:BP | GO:2000318 | positive regulation of T-helper 17 type immune response | 2 | 7 | 9.68e-01 |
| GO:BP | GO:0070667 | negative regulation of mast cell proliferation | 1 | 2 | 9.68e-01 |
| GO:BP | GO:0060335 | positive regulation of type II interferon-mediated signaling pathway | 1 | 4 | 9.68e-01 |
| GO:BP | GO:0060332 | positive regulation of response to type II interferon | 1 | 4 | 9.68e-01 |
| GO:BP | GO:0043503 | skeletal muscle fiber adaptation | 1 | 3 | 9.68e-01 |
| GO:BP | GO:1900147 | regulation of Schwann cell migration | 1 | 4 | 9.68e-01 |
| GO:BP | GO:0036135 | Schwann cell migration | 1 | 4 | 9.68e-01 |
| GO:BP | GO:0034368 | protein-lipid complex remodeling | 2 | 14 | 9.68e-01 |
| GO:BP | GO:0034369 | plasma lipoprotein particle remodeling | 2 | 14 | 9.68e-01 |
| GO:BP | GO:0015849 | organic acid transport | 22 | 217 | 9.68e-01 |
| GO:BP | GO:0043323 | positive regulation of natural killer cell degranulation | 1 | 3 | 9.69e-01 |
| GO:BP | GO:0002752 | cell surface pattern recognition receptor signaling pathway | 1 | 27 | 9.69e-01 |
| GO:BP | GO:0043321 | regulation of natural killer cell degranulation | 1 | 3 | 9.69e-01 |
| GO:BP | GO:0140052 | cellular response to oxidised low-density lipoprotein particle stimulus | 2 | 7 | 9.69e-01 |
| GO:BP | GO:0002513 | tolerance induction to self antigen | 1 | 4 | 9.69e-01 |
| GO:BP | GO:0032501 | multicellular organismal process | 1 | 4794 | 9.69e-01 |
| GO:BP | GO:0072538 | T-helper 17 type immune response | 8 | 24 | 9.69e-01 |
| GO:BP | GO:0050789 | regulation of biological process | 5 | 8061 | 9.69e-01 |
| GO:BP | GO:0002360 | T cell lineage commitment | 4 | 15 | 9.69e-01 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 1 | 38 | 9.69e-01 |
| GO:BP | GO:0035630 | bone mineralization involved in bone maturation | 2 | 6 | 9.69e-01 |
| GO:BP | GO:0060433 | bronchus development | 1 | 6 | 9.69e-01 |
| GO:BP | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 2 | 96 | 9.69e-01 |
| GO:BP | GO:0055094 | response to lipoprotein particle | 1 | 20 | 9.69e-01 |
| GO:BP | GO:0060913 | cardiac cell fate determination | 1 | 2 | 9.70e-01 |
| GO:BP | GO:1900138 | negative regulation of phospholipase A2 activity | 1 | 4 | 9.70e-01 |
| GO:BP | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 2 | 4 | 9.70e-01 |
| GO:BP | GO:0050794 | regulation of cellular process | 4 | 7552 | 9.70e-01 |
| GO:BP | GO:0008210 | estrogen metabolic process | 4 | 16 | 9.70e-01 |
| GO:BP | GO:0006869 | lipid transport | 16 | 272 | 9.70e-01 |
| GO:BP | GO:0061723 | glycophagy | 1 | 4 | 9.71e-01 |
| GO:BP | GO:0071609 | chemokine (C-C motif) ligand 5 production | 2 | 6 | 9.71e-01 |
| GO:BP | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production | 2 | 6 | 9.71e-01 |
| GO:BP | GO:1905268 | negative regulation of chromatin organization | 1 | 4 | 9.71e-01 |
| GO:BP | GO:0120262 | negative regulation of heterochromatin organization | 1 | 4 | 9.71e-01 |
| GO:BP | GO:0046887 | positive regulation of hormone secretion | 4 | 90 | 9.71e-01 |
| GO:BP | GO:1903711 | spermidine transmembrane transport | 1 | 2 | 9.71e-01 |
| GO:BP | GO:0034155 | regulation of toll-like receptor 7 signaling pathway | 1 | 2 | 9.71e-01 |
| GO:BP | GO:0031452 | negative regulation of heterochromatin formation | 1 | 4 | 9.71e-01 |
| GO:BP | GO:1902523 | positive regulation of protein K63-linked ubiquitination | 1 | 5 | 9.71e-01 |
| GO:BP | GO:0030168 | platelet activation | 7 | 91 | 9.71e-01 |
| GO:BP | GO:0043304 | regulation of mast cell degranulation | 3 | 20 | 9.71e-01 |
| GO:BP | GO:0071219 | cellular response to molecule of bacterial origin | 1 | 114 | 9.71e-01 |
| GO:BP | GO:0034138 | toll-like receptor 3 signaling pathway | 1 | 12 | 9.71e-01 |
| GO:BP | GO:1990911 | response to psychosocial stress | 1 | 2 | 9.71e-01 |
| GO:BP | GO:0010876 | lipid localization | 18 | 310 | 9.71e-01 |
| GO:BP | GO:0002025 | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | 1 | 3 | 9.71e-01 |
| GO:BP | GO:1903998 | regulation of eating behavior | 1 | 1 | 9.71e-01 |
| GO:BP | GO:0032663 | regulation of interleukin-2 production | 3 | 31 | 9.72e-01 |
| GO:BP | GO:1903891 | regulation of ATF6-mediated unfolded protein response | 1 | 4 | 9.72e-01 |
| GO:BP | GO:0032623 | interleukin-2 production | 3 | 31 | 9.72e-01 |
| GO:BP | GO:0045333 | cellular respiration | 4 | 211 | 9.72e-01 |
| GO:BP | GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 3 | 9.72e-01 |
| GO:BP | GO:1904906 | positive regulation of endothelial cell-matrix adhesion via fibronectin | 1 | 3 | 9.72e-01 |
| GO:BP | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 1 | 2 | 9.72e-01 |
| GO:BP | GO:0072086 | specification of loop of Henle identity | 1 | 3 | 9.72e-01 |
| GO:BP | GO:0044648 | histone H3-K4 dimethylation | 1 | 6 | 9.72e-01 |
| GO:BP | GO:0050975 | sensory perception of touch | 1 | 2 | 9.72e-01 |
| GO:BP | GO:0042420 | dopamine catabolic process | 1 | 5 | 9.72e-01 |
| GO:BP | GO:0045901 | positive regulation of translational elongation | 1 | 4 | 9.73e-01 |
| GO:BP | GO:0045905 | positive regulation of translational termination | 1 | 4 | 9.73e-01 |
| GO:BP | GO:0000967 | rRNA 5’-end processing | 1 | 5 | 9.73e-01 |
| GO:BP | GO:0034471 | ncRNA 5’-end processing | 1 | 5 | 9.73e-01 |
| GO:BP | GO:1905684 | regulation of plasma membrane repair | 1 | 7 | 9.73e-01 |
| GO:BP | GO:0071774 | response to fibroblast growth factor | 10 | 84 | 9.73e-01 |
| GO:BP | GO:0033690 | positive regulation of osteoblast proliferation | 1 | 10 | 9.73e-01 |
| GO:BP | GO:0000472 | endonucleolytic cleavage to generate mature 5’-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 | 5 | 9.73e-01 |
| GO:BP | GO:0035900 | response to isolation stress | 1 | 2 | 9.73e-01 |
| GO:BP | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity | 1 | 27 | 9.73e-01 |
| GO:BP | GO:0006491 | N-glycan processing | 3 | 18 | 9.73e-01 |
| GO:BP | GO:0006687 | glycosphingolipid metabolic process | 3 | 48 | 9.73e-01 |
| GO:BP | GO:0033238 | regulation of amine metabolic process | 8 | 19 | 9.73e-01 |
| GO:BP | GO:0046325 | negative regulation of glucose import | 2 | 10 | 9.73e-01 |
| GO:BP | GO:0022602 | ovulation cycle process | 10 | 37 | 9.73e-01 |
| GO:BP | GO:0045666 | positive regulation of neuron differentiation | 4 | 63 | 9.74e-01 |
| GO:BP | GO:0061588 | calcium activated phospholipid scrambling | 1 | 4 | 9.74e-01 |
| GO:BP | GO:0035812 | renal sodium excretion | 2 | 11 | 9.74e-01 |
| GO:BP | GO:0010951 | negative regulation of endopeptidase activity | 1 | 102 | 9.74e-01 |
| GO:BP | GO:0021869 | forebrain ventricular zone progenitor cell division | 1 | 2 | 9.74e-01 |
| GO:BP | GO:0000436 | carbon catabolite activation of transcription from RNA polymerase II promoter | 1 | 3 | 9.74e-01 |
| GO:BP | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter | 1 | 3 | 9.74e-01 |
| GO:BP | GO:0034112 | positive regulation of homotypic cell-cell adhesion | 1 | 10 | 9.74e-01 |
| GO:BP | GO:1905806 | regulation of synapse pruning | 2 | 5 | 9.74e-01 |
| GO:BP | GO:0071076 | RNA 3’ uridylation | 1 | 4 | 9.74e-01 |
| GO:BP | GO:0071216 | cellular response to biotic stimulus | 3 | 138 | 9.74e-01 |
| GO:BP | GO:0021859 | pyramidal neuron differentiation | 1 | 11 | 9.74e-01 |
| GO:BP | GO:0042773 | ATP synthesis coupled electron transport | 1 | 82 | 9.74e-01 |
| GO:BP | GO:0034377 | plasma lipoprotein particle assembly | 1 | 19 | 9.74e-01 |
| GO:BP | GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 1 | 82 | 9.74e-01 |
| GO:BP | GO:0048643 | positive regulation of skeletal muscle tissue development | 1 | 14 | 9.74e-01 |
| GO:BP | GO:0071599 | otic vesicle development | 4 | 10 | 9.75e-01 |
| GO:BP | GO:1901355 | response to rapamycin | 1 | 3 | 9.75e-01 |
| GO:BP | GO:0072334 | UDP-galactose transmembrane transport | 1 | 4 | 9.75e-01 |
| GO:BP | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2 | 15 | 9.75e-01 |
| GO:BP | GO:0060278 | regulation of ovulation | 1 | 2 | 9.76e-01 |
| GO:BP | GO:0018916 | nitrobenzene metabolic process | 1 | 4 | 9.76e-01 |
| GO:BP | GO:0033234 | negative regulation of protein sumoylation | 1 | 8 | 9.76e-01 |
| GO:BP | GO:0001708 | cell fate specification | 18 | 56 | 9.76e-01 |
| GO:BP | GO:0051969 | regulation of transmission of nerve impulse | 1 | 6 | 9.76e-01 |
| GO:BP | GO:0048050 | post-embryonic eye morphogenesis | 1 | 7 | 9.76e-01 |
| GO:BP | GO:0061209 | cell proliferation involved in mesonephros development | 1 | 3 | 9.76e-01 |
| GO:BP | GO:1904977 | lymphatic endothelial cell migration | 1 | 3 | 9.76e-01 |
| GO:BP | GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7 | 26 | 9.76e-01 |
| GO:BP | GO:0010593 | negative regulation of lamellipodium assembly | 1 | 2 | 9.76e-01 |
| GO:BP | GO:1904352 | positive regulation of protein catabolic process in the vacuole | 1 | 6 | 9.76e-01 |
| GO:BP | GO:0007628 | adult walking behavior | 1 | 23 | 9.76e-01 |
| GO:BP | GO:0006378 | mRNA polyadenylation | 7 | 39 | 9.76e-01 |
| GO:BP | GO:0140459 | response to Gram-positive bacterium | 1 | 3 | 9.77e-01 |
| GO:BP | GO:0097707 | ferroptosis | 1 | 4 | 9.77e-01 |
| GO:BP | GO:2000152 | regulation of ubiquitin-specific protease activity | 1 | 4 | 9.77e-01 |
| GO:BP | GO:0010452 | histone H3-K36 methylation | 1 | 5 | 9.77e-01 |
| GO:BP | GO:0035112 | genitalia morphogenesis | 1 | 5 | 9.77e-01 |
| GO:BP | GO:0001866 | NK T cell proliferation | 1 | 4 | 9.77e-01 |
| GO:BP | GO:1901671 | positive regulation of superoxide dismutase activity | 1 | 3 | 9.77e-01 |
| GO:BP | GO:0034367 | protein-containing complex remodeling | 2 | 16 | 9.77e-01 |
| GO:BP | GO:0110075 | regulation of ferroptosis | 1 | 4 | 9.77e-01 |
| GO:BP | GO:0036022 | limb joint morphogenesis | 1 | 4 | 9.77e-01 |
| GO:BP | GO:0071650 | negative regulation of chemokine (C-C motif) ligand 5 production | 1 | 3 | 9.77e-01 |
| GO:BP | GO:0033489 | cholesterol biosynthetic process via desmosterol | 1 | 4 | 9.77e-01 |
| GO:BP | GO:1904690 | positive regulation of cytoplasmic translational initiation | 1 | 5 | 9.77e-01 |
| GO:BP | GO:0033490 | cholesterol biosynthetic process via lathosterol | 1 | 4 | 9.77e-01 |
| GO:BP | GO:0002029 | desensitization of G protein-coupled receptor signaling pathway | 4 | 14 | 9.77e-01 |
| GO:BP | GO:2000316 | regulation of T-helper 17 type immune response | 6 | 16 | 9.77e-01 |
| GO:BP | GO:0014911 | positive regulation of smooth muscle cell migration | 1 | 30 | 9.77e-01 |
| GO:BP | GO:0014065 | phosphatidylinositol 3-kinase signaling | 8 | 100 | 9.77e-01 |
| GO:BP | GO:1904684 | negative regulation of metalloendopeptidase activity | 1 | 4 | 9.77e-01 |
| GO:BP | GO:0070365 | hepatocyte differentiation | 1 | 12 | 9.77e-01 |
| GO:BP | GO:0009583 | detection of light stimulus | 1 | 27 | 9.77e-01 |
| GO:BP | GO:0006026 | aminoglycan catabolic process | 2 | 19 | 9.77e-01 |
| GO:BP | GO:0014063 | negative regulation of serotonin secretion | 1 | 2 | 9.77e-01 |
| GO:BP | GO:0015914 | phospholipid transport | 5 | 75 | 9.77e-01 |
| GO:BP | GO:0030574 | collagen catabolic process | 7 | 26 | 9.77e-01 |
| GO:BP | GO:0034587 | piRNA processing | 1 | 4 | 9.78e-01 |
| GO:BP | GO:0036065 | fucosylation | 1 | 10 | 9.78e-01 |
| GO:BP | GO:0071402 | cellular response to lipoprotein particle stimulus | 5 | 23 | 9.78e-01 |
| GO:BP | GO:0032649 | regulation of type II interferon production | 1 | 52 | 9.79e-01 |
| GO:BP | GO:0002706 | regulation of lymphocyte mediated immunity | 2 | 83 | 9.79e-01 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 5 | 191 | 9.79e-01 |
| GO:BP | GO:0007596 | blood coagulation | 1 | 150 | 9.79e-01 |
| GO:BP | GO:0046174 | polyol catabolic process | 1 | 7 | 9.79e-01 |
| GO:BP | GO:0072376 | protein activation cascade | 1 | 9 | 9.79e-01 |
| GO:BP | GO:0046487 | glyoxylate metabolic process | 1 | 5 | 9.79e-01 |
| GO:BP | GO:0015671 | oxygen transport | 1 | 4 | 9.79e-01 |
| GO:BP | GO:0032609 | type II interferon production | 1 | 53 | 9.79e-01 |
| GO:BP | GO:2000319 | regulation of T-helper 17 cell differentiation | 3 | 10 | 9.80e-01 |
| GO:BP | GO:1900016 | negative regulation of cytokine production involved in inflammatory response | 6 | 13 | 9.80e-01 |
| GO:BP | GO:0035934 | corticosterone secretion | 1 | 3 | 9.80e-01 |
| GO:BP | GO:0048665 | neuron fate specification | 1 | 14 | 9.80e-01 |
| GO:BP | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly | 4 | 16 | 9.80e-01 |
| GO:BP | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 2 | 8 | 9.80e-01 |
| GO:BP | GO:0061762 | CAMKK-AMPK signaling cascade | 1 | 5 | 9.80e-01 |
| GO:BP | GO:0017004 | cytochrome complex assembly | 1 | 38 | 9.80e-01 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 4 | 18 | 9.80e-01 |
| GO:BP | GO:0007356 | thorax and anterior abdomen determination | 1 | 1 | 9.80e-01 |
| GO:BP | GO:0032490 | detection of molecule of bacterial origin | 2 | 4 | 9.81e-01 |
| GO:BP | GO:0051014 | actin filament severing | 1 | 13 | 9.81e-01 |
| GO:BP | GO:0033006 | regulation of mast cell activation involved in immune response | 3 | 21 | 9.81e-01 |
| GO:BP | GO:0050817 | coagulation | 1 | 153 | 9.81e-01 |
| GO:BP | GO:0032275 | luteinizing hormone secretion | 1 | 6 | 9.81e-01 |
| GO:BP | GO:0042989 | sequestering of actin monomers | 1 | 9 | 9.81e-01 |
| GO:BP | GO:0045050 | protein insertion into ER membrane by stop-transfer membrane-anchor sequence | 2 | 10 | 9.81e-01 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 14 | 64 | 9.81e-01 |
| GO:BP | GO:0060986 | endocrine hormone secretion | 1 | 35 | 9.82e-01 |
| GO:BP | GO:0090659 | walking behavior | 1 | 25 | 9.82e-01 |
| GO:BP | GO:2000402 | negative regulation of lymphocyte migration | 1 | 10 | 9.82e-01 |
| GO:BP | GO:0065001 | specification of axis polarity | 1 | 2 | 9.82e-01 |
| GO:BP | GO:0006790 | sulfur compound metabolic process | 3 | 248 | 9.82e-01 |
| GO:BP | GO:0010536 | positive regulation of activation of Janus kinase activity | 1 | 2 | 9.83e-01 |
| GO:BP | GO:0032847 | regulation of cellular pH reduction | 1 | 5 | 9.83e-01 |
| GO:BP | GO:0070508 | cholesterol import | 1 | 6 | 9.83e-01 |
| GO:BP | GO:0007253 | cytoplasmic sequestering of NF-kappaB | 1 | 7 | 9.83e-01 |
| GO:BP | GO:0042182 | ketone catabolic process | 3 | 9 | 9.83e-01 |
| GO:BP | GO:0042119 | neutrophil activation | 5 | 16 | 9.83e-01 |
| GO:BP | GO:0090325 | regulation of locomotion involved in locomotory behavior | 1 | 3 | 9.83e-01 |
| GO:BP | GO:0006707 | cholesterol catabolic process | 1 | 8 | 9.83e-01 |
| GO:BP | GO:0016127 | sterol catabolic process | 1 | 8 | 9.83e-01 |
| GO:BP | GO:0007216 | G protein-coupled glutamate receptor signaling pathway | 1 | 5 | 9.83e-01 |
| GO:BP | GO:0060161 | positive regulation of dopamine receptor signaling pathway | 1 | 3 | 9.83e-01 |
| GO:BP | GO:0048539 | bone marrow development | 2 | 7 | 9.83e-01 |
| GO:BP | GO:1990116 | ribosome-associated ubiquitin-dependent protein catabolic process | 1 | 5 | 9.83e-01 |
| GO:BP | GO:1903236 | regulation of leukocyte tethering or rolling | 1 | 6 | 9.83e-01 |
| GO:BP | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia | 2 | 9 | 9.83e-01 |
| GO:BP | GO:0048260 | positive regulation of receptor-mediated endocytosis | 1 | 42 | 9.83e-01 |
| GO:BP | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 1 | 1 | 9.83e-01 |
| GO:BP | GO:1903413 | cellular response to bile acid | 1 | 2 | 9.84e-01 |
| GO:BP | GO:0043320 | natural killer cell degranulation | 3 | 6 | 9.84e-01 |
| GO:BP | GO:0019614 | catechol-containing compound catabolic process | 1 | 5 | 9.84e-01 |
| GO:BP | GO:0042424 | catecholamine catabolic process | 1 | 5 | 9.84e-01 |
| GO:BP | GO:1904406 | negative regulation of nitric oxide metabolic process | 1 | 10 | 9.84e-01 |
| GO:BP | GO:0002682 | regulation of immune system process | 1 | 877 | 9.84e-01 |
| GO:BP | GO:0002832 | negative regulation of response to biotic stimulus | 2 | 88 | 9.84e-01 |
| GO:BP | GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1 | 10 | 9.84e-01 |
| GO:BP | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 1 | 4 | 9.84e-01 |
| GO:BP | GO:0002758 | innate immune response-activating signaling pathway | 5 | 122 | 9.84e-01 |
| GO:BP | GO:0043302 | positive regulation of leukocyte degranulation | 2 | 15 | 9.84e-01 |
| GO:BP | GO:0097278 | complement-dependent cytotoxicity | 3 | 4 | 9.84e-01 |
| GO:BP | GO:0099612 | protein localization to axon | 1 | 6 | 9.85e-01 |
| GO:BP | GO:0065005 | protein-lipid complex assembly | 1 | 21 | 9.85e-01 |
| GO:BP | GO:1904749 | regulation of protein localization to nucleolus | 2 | 7 | 9.85e-01 |
| GO:BP | GO:0014014 | negative regulation of gliogenesis | 2 | 26 | 9.85e-01 |
| GO:BP | GO:1900150 | regulation of defense response to fungus | 1 | 3 | 9.85e-01 |
| GO:BP | GO:0030277 | maintenance of gastrointestinal epithelium | 2 | 8 | 9.85e-01 |
| GO:BP | GO:0007501 | mesodermal cell fate specification | 1 | 5 | 9.85e-01 |
| GO:BP | GO:1902667 | regulation of axon guidance | 1 | 6 | 9.85e-01 |
| GO:BP | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation | 6 | 21 | 9.85e-01 |
| GO:BP | GO:0006907 | pinocytosis | 7 | 18 | 9.85e-01 |
| GO:BP | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation | 1 | 5 | 9.85e-01 |
| GO:BP | GO:0034660 | ncRNA metabolic process | 13 | 561 | 9.85e-01 |
| GO:BP | GO:0043631 | RNA polyadenylation | 7 | 41 | 9.85e-01 |
| GO:BP | GO:0060430 | lung saccule development | 1 | 7 | 9.86e-01 |
| GO:BP | GO:0006821 | chloride transport | 5 | 58 | 9.86e-01 |
| GO:BP | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell | 1 | 3 | 9.86e-01 |
| GO:BP | GO:0051049 | regulation of transport | 56 | 1267 | 9.86e-01 |
| GO:BP | GO:1905383 | protein localization to presynapse | 3 | 11 | 9.87e-01 |
| GO:BP | GO:0032103 | positive regulation of response to external stimulus | 19 | 337 | 9.87e-01 |
| GO:BP | GO:1901894 | regulation of ATPase-coupled calcium transmembrane transporter activity | 3 | 9 | 9.87e-01 |
| GO:BP | GO:0010519 | negative regulation of phospholipase activity | 2 | 7 | 9.87e-01 |
| GO:BP | GO:0003072 | renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | 1 | 3 | 9.87e-01 |
| GO:BP | GO:1902603 | carnitine transmembrane transport | 1 | 4 | 9.87e-01 |
| GO:BP | GO:0002034 | maintenance of blood vessel diameter homeostasis by renin-angiotensin | 1 | 3 | 9.87e-01 |
| GO:BP | GO:0065003 | protein-containing complex assembly | 9 | 1335 | 9.88e-01 |
| GO:BP | GO:0007369 | gastrulation | 7 | 146 | 9.88e-01 |
| GO:BP | GO:0045579 | positive regulation of B cell differentiation | 4 | 10 | 9.88e-01 |
| GO:BP | GO:0046636 | negative regulation of alpha-beta T cell activation | 8 | 25 | 9.88e-01 |
| GO:BP | GO:0002221 | pattern recognition receptor signaling pathway | 2 | 115 | 9.88e-01 |
| GO:BP | GO:1900037 | regulation of cellular response to hypoxia | 4 | 13 | 9.88e-01 |
| GO:BP | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1 | 3 | 9.88e-01 |
| GO:BP | GO:0071637 | regulation of monocyte chemotactic protein-1 production | 1 | 7 | 9.88e-01 |
| GO:BP | GO:0072044 | collecting duct development | 2 | 6 | 9.88e-01 |
| GO:BP | GO:0071605 | monocyte chemotactic protein-1 production | 1 | 7 | 9.88e-01 |
| GO:BP | GO:1904672 | regulation of somatic stem cell population maintenance | 1 | 6 | 9.88e-01 |
| GO:BP | GO:0022029 | telencephalon cell migration | 19 | 44 | 9.88e-01 |
| GO:BP | GO:0010756 | positive regulation of plasminogen activation | 1 | 7 | 9.88e-01 |
| GO:BP | GO:1904904 | regulation of endothelial cell-matrix adhesion via fibronectin | 1 | 3 | 9.88e-01 |
| GO:BP | GO:0060539 | diaphragm development | 2 | 5 | 9.88e-01 |
| GO:BP | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway | 1 | 4 | 9.88e-01 |
| GO:BP | GO:0010387 | COP9 signalosome assembly | 1 | 3 | 9.88e-01 |
| GO:BP | GO:0001976 | nervous system process involved in regulation of systemic arterial blood pressure | 1 | 9 | 9.88e-01 |
| GO:BP | GO:0098596 | imitative learning | 1 | 4 | 9.88e-01 |
| GO:BP | GO:0090674 | endothelial cell-matrix adhesion via fibronectin | 1 | 3 | 9.88e-01 |
| GO:BP | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2 | 6 | 9.88e-01 |
| GO:BP | GO:0043277 | apoptotic cell clearance | 1 | 35 | 9.88e-01 |
| GO:BP | GO:0042297 | vocal learning | 1 | 4 | 9.88e-01 |
| GO:BP | GO:0001821 | histamine secretion | 2 | 9 | 9.88e-01 |
| GO:BP | GO:0006754 | ATP biosynthetic process | 1 | 87 | 9.88e-01 |
| GO:BP | GO:0045576 | mast cell activation | 2 | 35 | 9.88e-01 |
| GO:BP | GO:0006868 | glutamine transport | 2 | 8 | 9.88e-01 |
| GO:BP | GO:0000165 | MAPK cascade | 14 | 556 | 9.88e-01 |
| GO:BP | GO:0042373 | vitamin K metabolic process | 2 | 6 | 9.88e-01 |
| GO:BP | GO:0021764 | amygdala development | 1 | 3 | 9.88e-01 |
| GO:BP | GO:0045059 | positive thymic T cell selection | 3 | 6 | 9.88e-01 |
| GO:BP | GO:0015986 | proton motive force-driven ATP synthesis | 19 | 66 | 9.89e-01 |
| GO:BP | GO:0048149 | behavioral response to ethanol | 2 | 5 | 9.89e-01 |
| GO:BP | GO:0034134 | toll-like receptor 2 signaling pathway | 2 | 11 | 9.89e-01 |
| GO:BP | GO:0010918 | positive regulation of mitochondrial membrane potential | 3 | 9 | 9.89e-01 |
| GO:BP | GO:0072344 | rescue of stalled ribosome | 2 | 9 | 9.90e-01 |
| GO:BP | GO:0034332 | adherens junction organization | 17 | 41 | 9.90e-01 |
| GO:BP | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1 | 13 | 9.90e-01 |
| GO:BP | GO:1901863 | positive regulation of muscle tissue development | 1 | 18 | 9.90e-01 |
| GO:BP | GO:0070918 | regulatory ncRNA processing | 21 | 47 | 9.90e-01 |
| GO:BP | GO:2001258 | negative regulation of cation channel activity | 1 | 30 | 9.90e-01 |
| GO:BP | GO:0043303 | mast cell degranulation | 1 | 30 | 9.90e-01 |
| GO:BP | GO:0009642 | response to light intensity | 1 | 11 | 9.90e-01 |
| GO:BP | GO:0002438 | acute inflammatory response to antigenic stimulus | 4 | 10 | 9.90e-01 |
| GO:BP | GO:0002675 | positive regulation of acute inflammatory response | 4 | 11 | 9.90e-01 |
| GO:BP | GO:0006886 | intracellular protein transport | 13 | 803 | 9.90e-01 |
| GO:BP | GO:0016045 | detection of bacterium | 1 | 8 | 9.90e-01 |
| GO:BP | GO:0034384 | high-density lipoprotein particle clearance | 1 | 7 | 9.90e-01 |
| GO:BP | GO:0061077 | chaperone-mediated protein folding | 17 | 65 | 9.90e-01 |
| GO:BP | GO:0007205 | protein kinase C-activating G protein-coupled receptor signaling pathway | 9 | 19 | 9.90e-01 |
| GO:BP | GO:0015980 | energy derivation by oxidation of organic compounds | 6 | 288 | 9.90e-01 |
| GO:BP | GO:0002699 | positive regulation of immune effector process | 3 | 130 | 9.90e-01 |
| GO:BP | GO:0072539 | T-helper 17 cell differentiation | 2 | 14 | 9.90e-01 |
| GO:BP | GO:0035813 | regulation of renal sodium excretion | 1 | 10 | 9.90e-01 |
| GO:BP | GO:1900736 | regulation of phospholipase C-activating G protein-coupled receptor signaling pathway | 1 | 2 | 9.90e-01 |
| GO:BP | GO:0071349 | cellular response to interleukin-12 | 1 | 5 | 9.90e-01 |
| GO:BP | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 5 | 14 | 9.90e-01 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 5 | 211 | 9.90e-01 |
| GO:BP | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1 | 15 | 9.90e-01 |
| GO:BP | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 1 | 42 | 9.90e-01 |
| GO:BP | GO:0019081 | viral translation | 1 | 18 | 9.90e-01 |
| GO:BP | GO:0042953 | lipoprotein transport | 1 | 14 | 9.91e-01 |
| GO:BP | GO:0009954 | proximal/distal pattern formation | 1 | 15 | 9.91e-01 |
| GO:BP | GO:0007289 | spermatid nucleus differentiation | 1 | 16 | 9.91e-01 |
| GO:BP | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1 | 1 | 9.91e-01 |
| GO:BP | GO:0035095 | behavioral response to nicotine | 1 | 3 | 9.91e-01 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 4 | 19 | 9.91e-01 |
| GO:BP | GO:0048557 | embryonic digestive tract morphogenesis | 1 | 8 | 9.91e-01 |
| GO:BP | GO:0042776 | proton motive force-driven mitochondrial ATP synthesis | 16 | 57 | 9.91e-01 |
| GO:BP | GO:0006688 | glycosphingolipid biosynthetic process | 1 | 25 | 9.91e-01 |
| GO:BP | GO:0022617 | extracellular matrix disassembly | 5 | 36 | 9.91e-01 |
| GO:BP | GO:1904688 | regulation of cytoplasmic translational initiation | 1 | 6 | 9.91e-01 |
| GO:BP | GO:0021957 | corticospinal tract morphogenesis | 1 | 7 | 9.91e-01 |
| GO:BP | GO:0009644 | response to high light intensity | 1 | 2 | 9.91e-01 |
| GO:BP | GO:0021885 | forebrain cell migration | 20 | 46 | 9.91e-01 |
| GO:BP | GO:0009820 | alkaloid metabolic process | 1 | 2 | 9.91e-01 |
| GO:BP | GO:0002448 | mast cell mediated immunity | 6 | 33 | 9.91e-01 |
| GO:BP | GO:0009755 | hormone-mediated signaling pathway | 23 | 139 | 9.91e-01 |
| GO:BP | GO:0010467 | gene expression | 1 | 4587 | 9.91e-01 |
| GO:BP | GO:0002820 | negative regulation of adaptive immune response | 7 | 27 | 9.91e-01 |
| GO:BP | GO:0002279 | mast cell activation involved in immune response | 1 | 31 | 9.91e-01 |
| GO:BP | GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 2 | 19 | 9.92e-01 |
| GO:BP | GO:0070613 | regulation of protein processing | 7 | 47 | 9.92e-01 |
| GO:BP | GO:0097187 | dentinogenesis | 1 | 4 | 9.92e-01 |
| GO:BP | GO:0097709 | connective tissue replacement | 2 | 8 | 9.92e-01 |
| GO:BP | GO:0007196 | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 1 | 1 | 9.92e-01 |
| GO:BP | GO:0015942 | formate metabolic process | 1 | 2 | 9.92e-01 |
| GO:BP | GO:0071286 | cellular response to magnesium ion | 1 | 3 | 9.92e-01 |
| GO:BP | GO:0002031 | G protein-coupled receptor internalization | 2 | 10 | 9.92e-01 |
| GO:BP | GO:0120252 | hydrocarbon metabolic process | 1 | 2 | 9.92e-01 |
| GO:BP | GO:0045123 | cellular extravasation | 4 | 44 | 9.92e-01 |
| GO:BP | GO:0044409 | entry into host | 17 | 113 | 9.92e-01 |
| GO:BP | GO:0043031 | negative regulation of macrophage activation | 2 | 9 | 9.92e-01 |
| GO:BP | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation | 1 | 7 | 9.92e-01 |
| GO:BP | GO:0002825 | regulation of T-helper 1 type immune response | 3 | 10 | 9.92e-01 |
| GO:BP | GO:0021794 | thalamus development | 1 | 6 | 9.93e-01 |
| GO:BP | GO:0046874 | quinolinate metabolic process | 1 | 1 | 9.93e-01 |
| GO:BP | GO:0072179 | nephric duct formation | 1 | 1 | 9.93e-01 |
| GO:BP | GO:0046668 | regulation of retinal cell programmed cell death | 1 | 2 | 9.93e-01 |
| GO:BP | GO:0015705 | iodide transport | 1 | 2 | 9.93e-01 |
| GO:BP | GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 2 | 11 | 9.93e-01 |
| GO:BP | GO:2000812 | regulation of barbed-end actin filament capping | 1 | 3 | 9.93e-01 |
| GO:BP | GO:0007260 | tyrosine phosphorylation of STAT protein | 11 | 36 | 9.93e-01 |
| GO:BP | GO:0065007 | biological regulation | 5 | 8320 | 9.93e-01 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 2 | 475 | 9.93e-01 |
| GO:BP | GO:1901317 | regulation of flagellated sperm motility | 1 | 6 | 9.93e-01 |
| GO:BP | GO:0009060 | aerobic respiration | 2 | 168 | 9.93e-01 |
| GO:BP | GO:0046718 | viral entry into host cell | 16 | 107 | 9.93e-01 |
| GO:BP | GO:1902260 | negative regulation of delayed rectifier potassium channel activity | 1 | 5 | 9.93e-01 |
| GO:BP | GO:0140206 | dipeptide import across plasma membrane | 1 | 2 | 9.93e-01 |
| GO:BP | GO:0090527 | actin filament reorganization | 2 | 10 | 9.93e-01 |
| GO:BP | GO:0015739 | sialic acid transport | 1 | 1 | 9.93e-01 |
| GO:BP | GO:0140205 | oligopeptide import across plasma membrane | 1 | 2 | 9.93e-01 |
| GO:BP | GO:0036230 | granulocyte activation | 1 | 19 | 9.93e-01 |
| GO:BP | GO:0070162 | adiponectin secretion | 1 | 4 | 9.93e-01 |
| GO:BP | GO:0070163 | regulation of adiponectin secretion | 1 | 4 | 9.93e-01 |
| GO:BP | GO:1905516 | positive regulation of fertilization | 1 | 3 | 9.93e-01 |
| GO:BP | GO:0072205 | metanephric collecting duct development | 1 | 5 | 9.94e-01 |
| GO:BP | GO:1903170 | negative regulation of calcium ion transmembrane transport | 1 | 35 | 9.94e-01 |
| GO:BP | GO:0035025 | positive regulation of Rho protein signal transduction | 1 | 22 | 9.94e-01 |
| GO:BP | GO:0002858 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 4 | 9.94e-01 |
| GO:BP | GO:0097692 | histone H3-K4 monomethylation | 1 | 8 | 9.94e-01 |
| GO:BP | GO:0032026 | response to magnesium ion | 2 | 10 | 9.94e-01 |
| GO:BP | GO:0015879 | carnitine transport | 1 | 4 | 9.94e-01 |
| GO:BP | GO:0021853 | cerebral cortex GABAergic interneuron migration | 1 | 2 | 9.94e-01 |
| GO:BP | GO:0002002 | regulation of angiotensin levels in blood | 2 | 6 | 9.95e-01 |
| GO:BP | GO:0051085 | chaperone cofactor-dependent protein refolding | 5 | 30 | 9.95e-01 |
| GO:BP | GO:0035987 | endodermal cell differentiation | 2 | 38 | 9.95e-01 |
| GO:BP | GO:0032963 | collagen metabolic process | 6 | 74 | 9.95e-01 |
| GO:BP | GO:0002886 | regulation of myeloid leukocyte mediated immunity | 6 | 34 | 9.95e-01 |
| GO:BP | GO:0016070 | RNA metabolic process | 2 | 3600 | 9.95e-01 |
| GO:BP | GO:1905245 | regulation of aspartic-type peptidase activity | 1 | 11 | 9.95e-01 |
| GO:BP | GO:0010496 | intercellular transport | 1 | 4 | 9.95e-01 |
| GO:BP | GO:0099004 | calmodulin dependent kinase signaling pathway | 1 | 6 | 9.95e-01 |
| GO:BP | GO:0150078 | positive regulation of neuroinflammatory response | 1 | 4 | 9.95e-01 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 1 | 227 | 9.95e-01 |
| GO:BP | GO:0099641 | anterograde axonal protein transport | 2 | 9 | 9.96e-01 |
| GO:BP | GO:0043933 | protein-containing complex organization | 9 | 1496 | 9.96e-01 |
| GO:BP | GO:0009595 | detection of biotic stimulus | 1 | 20 | 9.96e-01 |
| GO:BP | GO:0098664 | G protein-coupled serotonin receptor signaling pathway | 1 | 8 | 9.96e-01 |
| GO:BP | GO:0051084 | ‘de novo’ post-translational protein folding | 9 | 35 | 9.96e-01 |
| GO:BP | GO:0032274 | gonadotropin secretion | 2 | 10 | 9.97e-01 |
| GO:BP | GO:0042362 | fat-soluble vitamin biosynthetic process | 3 | 6 | 9.97e-01 |
| GO:BP | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 1 | 4 | 9.97e-01 |
| GO:BP | GO:0048663 | neuron fate commitment | 1 | 29 | 9.97e-01 |
| GO:BP | GO:0046640 | regulation of alpha-beta T cell proliferation | 7 | 23 | 9.97e-01 |
| GO:BP | GO:0032276 | regulation of gonadotropin secretion | 1 | 6 | 9.98e-01 |
| GO:BP | GO:0048536 | spleen development | 1 | 28 | 9.98e-01 |
| GO:BP | GO:0002218 | activation of innate immune response | 5 | 142 | 9.98e-01 |
| GO:BP | GO:0071384 | cellular response to corticosteroid stimulus | 1 | 47 | 9.98e-01 |
| GO:BP | GO:0022618 | ribonucleoprotein complex assembly | 1 | 203 | 9.98e-01 |
| GO:BP | GO:0007602 | phototransduction | 1 | 17 | 9.98e-01 |
| GO:BP | GO:0042632 | cholesterol homeostasis | 4 | 58 | 9.98e-01 |
| GO:BP | GO:0150079 | negative regulation of neuroinflammatory response | 2 | 6 | 9.98e-01 |
| GO:BP | GO:0071826 | ribonucleoprotein complex subunit organization | 1 | 211 | 9.98e-01 |
| GO:BP | GO:0140894 | endolysosomal toll-like receptor signaling pathway | 2 | 24 | 9.99e-01 |
| GO:BP | GO:0061535 | glutamate secretion, neurotransmission | 1 | 5 | 9.99e-01 |
| GO:BP | GO:0071702 | organic substance transport | 2 | 2116 | 9.99e-01 |
| GO:BP | GO:0055092 | sterol homeostasis | 4 | 59 | 9.99e-01 |
| GO:BP | GO:0098543 | detection of other organism | 1 | 9 | 9.99e-01 |
| GO:BP | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 10 | 34 | 9.99e-01 |
| GO:BP | GO:0048333 | mesodermal cell differentiation | 3 | 22 | 9.99e-01 |
| GO:BP | GO:0002283 | neutrophil activation involved in immune response | 1 | 7 | 9.99e-01 |
| GO:BP | GO:0042368 | vitamin D biosynthetic process | 2 | 4 | 9.99e-01 |
| GO:BP | GO:0045089 | positive regulation of innate immune response | 7 | 182 | 9.99e-01 |
| GO:BP | GO:0045332 | phospholipid translocation | 1 | 33 | 9.99e-01 |
| GO:BP | GO:0006458 | ‘de novo’ protein folding | 10 | 39 | 9.99e-01 |
| GO:BP | GO:0006457 | protein folding | 2 | 192 | 9.99e-01 |
| GO:BP | GO:0043368 | positive T cell selection | 1 | 16 | 9.99e-01 |
| GO:BP | GO:0043589 | skin morphogenesis | 2 | 10 | 9.99e-01 |
| GO:BP | GO:0007638 | mechanosensory behavior | 3 | 8 | 9.99e-01 |
| GO:BP | GO:1900426 | positive regulation of defense response to bacterium | 1 | 6 | 9.99e-01 |
| GO:BP | GO:0014823 | response to activity | 1 | 46 | 9.99e-01 |
| GO:BP | GO:0032680 | regulation of tumor necrosis factor production | 1 | 91 | 9.99e-01 |
| GO:BP | GO:0032640 | tumor necrosis factor production | 1 | 91 | 9.99e-01 |
| GO:BP | GO:2000321 | positive regulation of T-helper 17 cell differentiation | 1 | 3 | 9.99e-01 |
| GO:BP | GO:0070314 | G1 to G0 transition | 4 | 15 | 9.99e-01 |
| GO:BP | GO:0001839 | neural plate morphogenesis | 1 | 4 | 9.99e-01 |
| GO:BP | GO:0031349 | positive regulation of defense response | 1 | 251 | 9.99e-01 |
| GO:BP | GO:1903028 | positive regulation of opsonization | 1 | 1 | 9.99e-01 |
| GO:BP | GO:0070207 | protein homotrimerization | 2 | 10 | 1.00e+00 |
| GO:BP | GO:0042711 | maternal behavior | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0070206 | protein trimerization | 2 | 12 | 1.00e+00 |
| GO:BP | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 1 | 20 | 1.00e+00 |
| GO:BP | GO:0001714 | endodermal cell fate specification | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 7 | 23 | 1.00e+00 |
| GO:BP | GO:0000365 | mRNA trans splicing, via spliceosome | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0000353 | formation of quadruple SL/U4/U5/U6 snRNP | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 1 | 10 | 1.00e+00 |
| GO:BP | GO:0007343 | egg activation | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0007342 | fusion of sperm to egg plasma membrane involved in single fertilization | 2 | 4 | 1.00e+00 |
| GO:BP | GO:0099640 | axo-dendritic protein transport | 2 | 10 | 1.00e+00 |
| GO:BP | GO:0007308 | oocyte construction | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0006376 | mRNA splice site selection | 2 | 31 | 1.00e+00 |
| GO:BP | GO:0019585 | glucuronate metabolic process | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0007339 | binding of sperm to zona pellucida | 7 | 20 | 1.00e+00 |
| GO:BP | GO:0070269 | pyroptosis | 1 | 11 | 1.00e+00 |
| GO:BP | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 5 | 30 | 1.00e+00 |
| GO:BP | GO:0019646 | aerobic electron transport chain | 1 | 74 | 1.00e+00 |
| GO:BP | GO:0007338 | single fertilization | 1 | 70 | 1.00e+00 |
| GO:BP | GO:0022613 | ribonucleoprotein complex biogenesis | 1 | 453 | 1.00e+00 |
| GO:BP | GO:0101023 | vascular endothelial cell proliferation | 1 | 21 | 1.00e+00 |
| GO:BP | GO:0007320 | insemination | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0007309 | oocyte axis specification | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0003382 | epithelial cell morphogenesis | 9 | 24 | 1.00e+00 |
| GO:BP | GO:0033003 | regulation of mast cell activation | 10 | 25 | 1.00e+00 |
| GO:BP | GO:0015721 | bile acid and bile salt transport | 3 | 11 | 1.00e+00 |
| GO:BP | GO:0042730 | fibrinolysis | 5 | 15 | 1.00e+00 |
| GO:BP | GO:0060746 | parental behavior | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0045291 | mRNA trans splicing, SL addition | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0000387 | spliceosomal snRNP assembly | 1 | 45 | 1.00e+00 |
| GO:BP | GO:1903317 | regulation of protein maturation | 7 | 50 | 1.00e+00 |
| GO:BP | GO:0030299 | intestinal cholesterol absorption | 4 | 8 | 1.00e+00 |
| GO:BP | GO:0034382 | chylomicron remnant clearance | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0019336 | phenol-containing compound catabolic process | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0043046 | DNA methylation involved in gamete generation | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0032604 | granulocyte macrophage colony-stimulating factor production | 1 | 5 | 1.00e+00 |
| GO:BP | GO:2001140 | positive regulation of phospholipid transport | 2 | 11 | 1.00e+00 |
| GO:BP | GO:0034379 | very-low-density lipoprotein particle assembly | 2 | 8 | 1.00e+00 |
| GO:BP | GO:0034374 | low-density lipoprotein particle remodeling | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0006477 | protein sulfation | 1 | 6 | 1.00e+00 |
| GO:BP | GO:1905562 | regulation of vascular endothelial cell proliferation | 1 | 21 | 1.00e+00 |
| GO:BP | GO:0030300 | regulation of intestinal cholesterol absorption | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0002507 | tolerance induction | 1 | 15 | 1.00e+00 |
| GO:BP | GO:0099024 | plasma membrane invagination | 3 | 42 | 1.00e+00 |
| GO:BP | GO:0019373 | epoxygenase P450 pathway | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway | 1 | 9 | 1.00e+00 |
| GO:BP | GO:0051016 | barbed-end actin filament capping | 1 | 21 | 1.00e+00 |
| GO:BP | GO:0006396 | RNA processing | 1 | 929 | 1.00e+00 |
| GO:BP | GO:0000375 | RNA splicing, via transesterification reactions | 1 | 293 | 1.00e+00 |
| GO:BP | GO:0001914 | regulation of T cell mediated cytotoxicity | 1 | 17 | 1.00e+00 |
| GO:BP | GO:0002517 | T cell tolerance induction | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0030167 | proteoglycan catabolic process | 1 | 11 | 1.00e+00 |
| GO:BP | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 | 289 | 1.00e+00 |
| GO:BP | GO:0006397 | mRNA processing | 3 | 450 | 1.00e+00 |
| GO:BP | GO:0042791 | 5S class rRNA transcription by RNA polymerase III | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0099505 | regulation of presynaptic membrane potential | 3 | 14 | 1.00e+00 |
| GO:BP | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1 | 13 | 1.00e+00 |
| GO:BP | GO:0009593 | detection of chemical stimulus | 1 | 27 | 1.00e+00 |
| GO:BP | GO:0070486 | leukocyte aggregation | 2 | 9 | 1.00e+00 |
| GO:BP | GO:0002275 | myeloid cell activation involved in immune response | 1 | 48 | 1.00e+00 |
| GO:BP | GO:2000858 | regulation of aldosterone secretion | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste | 2 | 3 | 1.00e+00 |
| GO:BP | GO:0002503 | peptide antigen assembly with MHC class II protein complex | 2 | 4 | 1.00e+00 |
| GO:BP | GO:0042359 | vitamin D metabolic process | 3 | 9 | 1.00e+00 |
| GO:BP | GO:0008152 | metabolic process | 1 | 8518 | 1.00e+00 |
| GO:BP | GO:0008150 | biological_process | 1 | 12070 | 1.00e+00 |
| GO:BP | GO:0021554 | optic nerve development | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0032735 | positive regulation of interleukin-12 production | 7 | 19 | 1.00e+00 |
| GO:BP | GO:0021843 | substrate-independent telencephalic tangential interneuron migration | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0021830 | interneuron migration from the subpallium to the cortex | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0002423 | natural killer cell mediated immune response to tumor cell | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0006063 | uronic acid metabolic process | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0006108 | malate metabolic process | 1 | 7 | 1.00e+00 |
| GO:BP | GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 2 | 18 | 1.00e+00 |
| GO:BP | GO:0140632 | canonical inflammasome complex assembly | 1 | 23 | 1.00e+00 |
| GO:BP | GO:0021826 | substrate-independent telencephalic tangential migration | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0035036 | sperm-egg recognition | 8 | 22 | 1.00e+00 |
| GO:BP | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0048730 | epidermis morphogenesis | 2 | 20 | 1.00e+00 |
| GO:BP | GO:0042178 | xenobiotic catabolic process | 1 | 12 | 1.00e+00 |
| GO:BP | GO:0002418 | immune response to tumor cell | 3 | 12 | 1.00e+00 |
| GO:BP | GO:0050766 | positive regulation of phagocytosis | 3 | 38 | 1.00e+00 |
| GO:BP | GO:0061760 | antifungal innate immune response | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0002399 | MHC class II protein complex assembly | 2 | 4 | 1.00e+00 |
| GO:BP | GO:1990349 | gap junction-mediated intercellular transport | 1 | 2 | 1.00e+00 |
| GO:BP | GO:1900004 | negative regulation of serine-type endopeptidase activity | 1 | 4 | 1.00e+00 |
| GO:BP | GO:1900003 | regulation of serine-type endopeptidase activity | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0021762 | substantia nigra development | 1 | 41 | 1.00e+00 |
| GO:BP | GO:0001820 | serotonin secretion | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0002396 | MHC protein complex assembly | 2 | 8 | 1.00e+00 |
| GO:BP | GO:1903817 | negative regulation of voltage-gated potassium channel activity | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0035194 | ncRNA-mediated post-transcriptional gene silencing | 1 | 60 | 1.00e+00 |
| GO:BP | GO:0035195 | miRNA-mediated gene silencing | 1 | 55 | 1.00e+00 |
| GO:BP | GO:0045838 | positive regulation of membrane potential | 4 | 12 | 1.00e+00 |
| GO:BP | GO:1905920 | positive regulation of CoA-transferase activity | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0002501 | peptide antigen assembly with MHC protein complex | 2 | 8 | 1.00e+00 |
| GO:BP | GO:1900225 | regulation of NLRP3 inflammasome complex assembly | 1 | 23 | 1.00e+00 |
| GO:BP | GO:2000848 | positive regulation of corticosteroid hormone secretion | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0032981 | mitochondrial respiratory chain complex I assembly | 22 | 55 | 1.00e+00 |
| GO:BP | GO:0050913 | sensory perception of bitter taste | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0060468 | prevention of polyspermy | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0050909 | sensory perception of taste | 1 | 13 | 1.00e+00 |
| GO:BP | GO:0050907 | detection of chemical stimulus involved in sensory perception | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0008380 | RNA splicing | 3 | 419 | 1.00e+00 |
| GO:BP | GO:0050886 | endocrine process | 1 | 57 | 1.00e+00 |
| GO:BP | GO:2000846 | regulation of corticosteroid hormone secretion | 1 | 9 | 1.00e+00 |
| GO:BP | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 1 | 94 | 1.00e+00 |
| GO:BP | GO:0008343 | adult feeding behavior | 1 | 1 | 1.00e+00 |
| GO:BP | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production | 3 | 33 | 1.00e+00 |
| GO:BP | GO:2000855 | regulation of mineralocorticoid secretion | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0042421 | norepinephrine biosynthetic process | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0021514 | ventral spinal cord interneuron differentiation | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0002323 | natural killer cell activation involved in immune response | 3 | 6 | 1.00e+00 |
| GO:BP | GO:0001867 | complement activation, lectin pathway | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0002326 | B cell lineage commitment | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0001840 | neural plate development | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0008228 | opsonization | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0021860 | pyramidal neuron development | 2 | 8 | 1.00e+00 |
| GO:BP | GO:0032720 | negative regulation of tumor necrosis factor production | 3 | 32 | 1.00e+00 |
| GO:BP | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0000244 | spliceosomal tri-snRNP complex assembly | 1 | 20 | 1.00e+00 |
| GO:BP | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen | 1 | 16 | 1.00e+00 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 1 | 43 | 1.00e+00 |
| GO:BP | GO:1905918 | regulation of CoA-transferase activity | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 1 | 12 | 1.00e+00 |
| GO:BP | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1 | 22 | 1.00e+00 |
| GO:BP | GO:1905522 | negative regulation of macrophage migration | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0010257 | NADH dehydrogenase complex assembly | 22 | 55 | 1.00e+00 |
| GO:BP | GO:0009987 | cellular process | 1 | 11336 | 1.00e+00 |
| GO:BP | GO:0046666 | retinal cell programmed cell death | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0035933 | glucocorticoid secretion | 1 | 7 | 1.00e+00 |
| GO:BP | GO:0002911 | regulation of lymphocyte anergy | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0051917 | regulation of fibrinolysis | 5 | 10 | 1.00e+00 |
| GO:BP | GO:0031343 | positive regulation of cell killing | 2 | 23 | 1.00e+00 |
| GO:BP | GO:0006910 | phagocytosis, recognition | 1 | 12 | 1.00e+00 |
| GO:BP | GO:0072104 | glomerular capillary formation | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0006911 | phagocytosis, engulfment | 2 | 33 | 1.00e+00 |
| GO:BP | GO:1904936 | interneuron migration | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0002759 | regulation of antimicrobial humoral response | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0031341 | regulation of cell killing | 7 | 36 | 1.00e+00 |
| GO:BP | GO:0072103 | glomerulus vasculature morphogenesis | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0046415 | urate metabolic process | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0035989 | tendon development | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0015889 | cobalamin transport | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0002922 | positive regulation of humoral immune response | 2 | 4 | 1.00e+00 |
| GO:BP | GO:0006957 | complement activation, alternative pathway | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0031223 | auditory behavior | 2 | 6 | 1.00e+00 |
| GO:BP | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1 | 10 | 1.00e+00 |
| GO:BP | GO:0006958 | complement activation, classical pathway | 1 | 16 | 1.00e+00 |
| GO:BP | GO:1905049 | negative regulation of metallopeptidase activity | 1 | 7 | 1.00e+00 |
| GO:BP | GO:0034154 | toll-like receptor 7 signaling pathway | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0002725 | negative regulation of T cell cytokine production | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0002717 | positive regulation of natural killer cell mediated immunity | 1 | 11 | 1.00e+00 |
| GO:BP | GO:0010838 | positive regulation of keratinocyte proliferation | 1 | 9 | 1.00e+00 |
| GO:BP | GO:0002715 | regulation of natural killer cell mediated immunity | 2 | 18 | 1.00e+00 |
| GO:BP | GO:1902571 | regulation of serine-type peptidase activity | 1 | 4 | 1.00e+00 |
| GO:BP | GO:1902572 | negative regulation of serine-type peptidase activity | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0000480 | endonucleolytic cleavage in 5’-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1 | 8 | 1.00e+00 |
| GO:BP | GO:1901616 | organic hydroxy compound catabolic process | 1 | 31 | 1.00e+00 |
| GO:BP | GO:0006956 | complement activation | 2 | 23 | 1.00e+00 |
| GO:BP | GO:0016071 | mRNA metabolic process | 4 | 665 | 1.00e+00 |
| GO:BP | GO:0035932 | aldosterone secretion | 1 | 5 | 1.00e+00 |
| GO:BP | GO:1904729 | regulation of intestinal lipid absorption | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0002834 | regulation of response to tumor cell | 3 | 11 | 1.00e+00 |
| GO:BP | GO:0002833 | positive regulation of response to biotic stimulus | 7 | 192 | 1.00e+00 |
| GO:BP | GO:0080154 | regulation of fertilization | 1 | 7 | 1.00e+00 |
| GO:BP | GO:0015031 | protein transport | 35 | 1361 | 1.00e+00 |
| GO:BP | GO:0002836 | positive regulation of response to tumor cell | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0002837 | regulation of immune response to tumor cell | 3 | 10 | 1.00e+00 |
| GO:BP | GO:0031639 | plasminogen activation | 7 | 19 | 1.00e+00 |
| GO:BP | GO:0051957 | positive regulation of amino acid transport | 1 | 16 | 1.00e+00 |
| GO:BP | GO:0002839 | positive regulation of immune response to tumor cell | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0006775 | fat-soluble vitamin metabolic process | 1 | 20 | 1.00e+00 |
| GO:BP | GO:0046633 | alpha-beta T cell proliferation | 7 | 24 | 1.00e+00 |
| GO:BP | GO:0051955 | regulation of amino acid transport | 2 | 28 | 1.00e+00 |
| GO:BP | GO:2000380 | regulation of mesoderm development | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0015811 | L-cystine transport | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0051923 | sulfation | 1 | 13 | 1.00e+00 |
| GO:BP | GO:0052695 | cellular glucuronidation | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0006810 | transport | 4 | 3298 | 1.00e+00 |
| GO:BP | GO:0006706 | steroid catabolic process | 1 | 13 | 1.00e+00 |
| GO:BP | GO:0002016 | regulation of blood volume by renin-angiotensin | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0046641 | positive regulation of alpha-beta T cell proliferation | 1 | 11 | 1.00e+00 |
| GO:BP | GO:0031663 | lipopolysaccharide-mediated signaling pathway | 10 | 36 | 1.00e+00 |
| GO:BP | GO:0006068 | ethanol catabolic process | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0002003 | angiotensin maturation | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0014062 | regulation of serotonin secretion | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0014049 | positive regulation of glutamate secretion | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0014048 | regulation of glutamate secretion | 2 | 8 | 1.00e+00 |
| GO:BP | GO:0002870 | T cell anergy | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0035930 | corticosteroid hormone secretion | 2 | 12 | 1.00e+00 |
| GO:BP | GO:0035931 | mineralocorticoid secretion | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0035739 | CD4-positive, alpha-beta T cell proliferation | 2 | 12 | 1.00e+00 |
| GO:BP | GO:0002855 | regulation of natural killer cell mediated immune response to tumor cell | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0036305 | ameloblast differentiation | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0044546 | NLRP3 inflammasome complex assembly | 1 | 23 | 1.00e+00 |
| GO:BP | GO:0001990 | regulation of systemic arterial blood pressure by hormone | 1 | 22 | 1.00e+00 |
| GO:BP | GO:0046164 | alcohol catabolic process | 1 | 23 | 1.00e+00 |
| GO:BP | GO:0045058 | T cell selection | 1 | 22 | 1.00e+00 |
| GO:BP | GO:0033108 | mitochondrial respiratory chain complex assembly | 35 | 94 | 1.00e+00 |
| GO:BP | GO:0045061 | thymic T cell selection | 4 | 10 | 1.00e+00 |
| GO:BP | GO:0017038 | protein import | 1 | 7 | 1.00e+00 |
| GO:BP | GO:0017121 | plasma membrane phospholipid scrambling | 4 | 13 | 1.00e+00 |
| GO:BP | GO:0043300 | regulation of leukocyte degranulation | 3 | 27 | 1.00e+00 |
| GO:BP | GO:0043299 | leukocyte degranulation | 1 | 41 | 1.00e+00 |
| GO:BP | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0002578 | negative regulation of antigen processing and presentation | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0032429 | regulation of phospholipase A2 activity | 2 | 8 | 1.00e+00 |
| GO:BP | GO:1903027 | regulation of opsonization | 1 | 1 | 1.00e+00 |
| GO:BP | GO:0098598 | learned vocalization behavior or vocal learning | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0045088 | regulation of innate immune response | 4 | 232 | 1.00e+00 |
| GO:BP | GO:0043312 | neutrophil degranulation | 1 | 5 | 1.00e+00 |
| GO:BP | GO:0010455 | positive regulation of cell fate commitment | 1 | 1 | 1.00e+00 |
| GO:BP | GO:0071385 | cellular response to glucocorticoid stimulus | 19 | 40 | 1.00e+00 |
| GO:BP | GO:0018149 | peptide cross-linking | 1 | 14 | 1.00e+00 |
| GO:BP | GO:0000398 | mRNA splicing, via spliceosome | 1 | 289 | 1.00e+00 |
| GO:BP | GO:0045109 | intermediate filament organization | 1 | 21 | 1.00e+00 |
| GO:BP | GO:0010324 | membrane invagination | 3 | 49 | 1.00e+00 |
| GO:BP | GO:0000395 | mRNA 5’-splice site recognition | 1 | 8 | 1.00e+00 |
| GO:BP | GO:0002249 | lymphocyte anergy | 1 | 4 | 1.00e+00 |
| GO:BP | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation | 2 | 12 | 1.00e+00 |
| GO:BP | GO:0031620 | regulation of fever generation | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0007210 | serotonin receptor signaling pathway | 1 | 8 | 1.00e+00 |
| GO:BP | GO:0018279 | protein N-linked glycosylation via asparagine | 4 | 23 | 1.00e+00 |
| GO:BP | GO:0060467 | negative regulation of fertilization | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0098856 | intestinal lipid absorption | 4 | 10 | 1.00e+00 |
| GO:BP | GO:0098883 | synapse pruning | 2 | 8 | 1.00e+00 |
| GO:BP | GO:0034310 | primary alcohol catabolic process | 1 | 7 | 1.00e+00 |
| GO:BP | GO:0002703 | regulation of leukocyte mediated immunity | 2 | 118 | 1.00e+00 |
| GO:BP | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1 | 15 | 1.00e+00 |
| GO:BP | GO:0002643 | regulation of tolerance induction | 1 | 10 | 1.00e+00 |
| GO:BP | GO:0051620 | norepinephrine uptake | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0097267 | omega-hydroxylase P450 pathway | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0051608 | histamine transport | 2 | 11 | 1.00e+00 |
| GO:BP | GO:0071830 | triglyceride-rich lipoprotein particle clearance | 1 | 2 | 1.00e+00 |
| GO:BP | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 1 | 17 | 1.00e+00 |
| GO:BP | GO:0060123 | regulation of growth hormone secretion | 3 | 10 | 1.00e+00 |
| GO:BP | GO:0032306 | regulation of prostaglandin secretion | 3 | 7 | 1.00e+00 |
| GO:BP | GO:0010572 | positive regulation of platelet activation | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1 | 30 | 1.00e+00 |
| GO:BP | GO:0032308 | positive regulation of prostaglandin secretion | 3 | 6 | 1.00e+00 |
| GO:BP | GO:0002691 | regulation of cellular extravasation | 1 | 24 | 1.00e+00 |
| GO:BP | GO:0032310 | prostaglandin secretion | 3 | 8 | 1.00e+00 |
| GO:BP | GO:0071827 | plasma lipoprotein particle organization | 2 | 27 | 1.00e+00 |
| GO:BP | GO:0060124 | positive regulation of growth hormone secretion | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0098581 | detection of external biotic stimulus | 1 | 11 | 1.00e+00 |
| GO:BP | GO:0071825 | protein-lipid complex subunit organization | 2 | 29 | 1.00e+00 |
| GO:BP | GO:0031069 | hair follicle morphogenesis | 2 | 18 | 1.00e+00 |
| GO:BP | GO:0071706 | tumor necrosis factor superfamily cytokine production | 1 | 94 | 1.00e+00 |
| GO:BP | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 2 | 18 | 1.00e+00 |
| GO:BP | GO:0031047 | RNA-mediated gene silencing | 1 | 103 | 1.00e+00 |
| GO:BP | GO:0071705 | nitrogen compound transport | 31 | 1684 | 1.00e+00 |
| GO:BP | GO:0002667 | regulation of T cell anergy | 1 | 4 | 1.00e+00 |
| GO:BP | GO:0071704 | organic substance metabolic process | 1 | 8169 | 1.00e+00 |
| GO:BP | GO:0002664 | regulation of T cell tolerance induction | 1 | 6 | 1.00e+00 |
| GO:BP | GO:0060272 | embryonic skeletal joint morphogenesis | 2 | 7 | 1.00e+00 |
| GO:BP | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 4 | 30 | 1.00e+00 |
| GO:BP | GO:1904478 | regulation of intestinal absorption | 1 | 3 | 1.00e+00 |
| GO:BP | GO:0010466 | negative regulation of peptidase activity | 1 | 131 | 1.00e+00 |
| GO:BP | GO:0045026 | plasma membrane fusion | 3 | 5 | 1.00e+00 |
| GO:BP | GO:0016441 | post-transcriptional gene silencing | 1 | 65 | 1.00e+00 |
| GO:BP | GO:0006613 | cotranslational protein targeting to membrane | 1 | 35 | 1.00e+00 |
| GO:BP | GO:0006067 | ethanol metabolic process | 1 | 8 | 1.00e+00 |
| KEGG | KEGG:04115 | p53 signaling pathway | 15 | 65 | 6.44e-06 |
| KEGG | KEGG:03030 | DNA replication | 22 | 35 | 5.18e-04 |
| KEGG | KEGG:04110 | Cell cycle | 63 | 151 | 2.49e-03 |
| KEGG | KEGG:03430 | Mismatch repair | 16 | 22 | 7.67e-03 |
| KEGG | KEGG:03410 | Base excision repair | 26 | 33 | 9.65e-03 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 6 | 61 | 1.21e-02 |
| KEGG | KEGG:05034 | Alcoholism | 7 | 122 | 2.65e-02 |
| KEGG | KEGG:04217 | Necroptosis | 6 | 106 | 2.65e-02 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 2 | 20 | 2.65e-02 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 6 | 110 | 4.57e-02 |
| KEGG | KEGG:01232 | Nucleotide metabolism | 3 | 69 | 4.57e-02 |
| KEGG | KEGG:01524 | Platinum drug resistance | 21 | 65 | 4.57e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 4 | 97 | 5.85e-02 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 4 | 43 | 6.72e-02 |
| KEGG | KEGG:05216 | Thyroid cancer | 1 | 35 | 6.72e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 4 | 75 | 6.72e-02 |
| KEGG | KEGG:04210 | Apoptosis | 29 | 118 | 6.72e-02 |
| KEGG | KEGG:03440 | Homologous recombination | 10 | 39 | 6.94e-02 |
| KEGG | KEGG:05213 | Endometrial cancer | 1 | 57 | 7.89e-02 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 1 | 49 | 8.14e-02 |
| KEGG | KEGG:05214 | Glioma | 1 | 67 | 8.18e-02 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 1 | 75 | 8.18e-02 |
| KEGG | KEGG:05218 | Melanoma | 1 | 58 | 8.18e-02 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 1 | 67 | 8.18e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 1 | 84 | 8.89e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 1 | 87 | 9.14e-02 |
| KEGG | KEGG:00920 | Sulfur metabolism | 4 | 10 | 9.17e-02 |
| KEGG | KEGG:00470 | D-Amino acid metabolism | 1 | 4 | 1.05e-01 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 27 | 48 | 1.14e-01 |
| KEGG | KEGG:05226 | Gastric cancer | 1 | 117 | 1.19e-01 |
| KEGG | KEGG:05224 | Breast cancer | 1 | 117 | 1.19e-01 |
| KEGG | KEGG:04120 | Ubiquitin mediated proteolysis | 1 | 134 | 1.19e-01 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 2 | 78 | 1.25e-01 |
| KEGG | KEGG:05161 | Hepatitis B | 1 | 136 | 1.25e-01 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 1 | 145 | 1.25e-01 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 1 | 128 | 1.38e-01 |
| KEGG | KEGG:05169 | Epstein-Barr virus infection | 1 | 153 | 1.38e-01 |
| KEGG | KEGG:00480 | Glutathione metabolism | 4 | 44 | 1.59e-01 |
| KEGG | KEGG:01523 | Antifolate resistance | 8 | 24 | 2.02e-01 |
| KEGG | KEGG:00240 | Pyrimidine metabolism | 6 | 46 | 2.14e-01 |
| KEGG | KEGG:00740 | Riboflavin metabolism | 2 | 6 | 2.33e-01 |
| KEGG | KEGG:00220 | Arginine biosynthesis | 1 | 16 | 2.54e-01 |
| KEGG | KEGG:00515 | Mannose type O-glycan biosynthesis | 6 | 19 | 2.95e-01 |
| KEGG | KEGG:05200 | Pathways in cancer | 1 | 409 | 3.01e-01 |
| KEGG | KEGG:04530 | Tight junction | 5 | 137 | 3.01e-01 |
| KEGG | KEGG:04540 | Gap junction | 3 | 73 | 3.01e-01 |
| KEGG | KEGG:04916 | Melanogenesis | 20 | 77 | 3.01e-01 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 2 | 66 | 3.30e-01 |
| KEGG | KEGG:00250 | Alanine, aspartate and glutamate metabolism | 1 | 29 | 3.62e-01 |
| KEGG | KEGG:04145 | Phagosome | 5 | 99 | 3.83e-01 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 1 | 84 | 3.84e-01 |
| KEGG | KEGG:04668 | TNF signaling pathway | 22 | 87 | 4.07e-01 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 3 | 106 | 4.12e-01 |
| KEGG | KEGG:01240 | Biosynthesis of cofactors | 10 | 115 | 4.12e-01 |
| KEGG | KEGG:04710 | Circadian rhythm | 1 | 30 | 4.12e-01 |
| KEGG | KEGG:05340 | Primary immunodeficiency | 1 | 12 | 4.13e-01 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 2 | 91 | 4.39e-01 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 35 | 109 | 4.39e-01 |
| KEGG | KEGG:04978 | Mineral absorption | 2 | 42 | 4.39e-01 |
| KEGG | KEGG:04122 | Sulfur relay system | 2 | 8 | 4.39e-01 |
| KEGG | KEGG:03020 | RNA polymerase | 2 | 34 | 4.39e-01 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 2 | 49 | 4.39e-01 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 2 | 91 | 4.39e-01 |
| KEGG | KEGG:05221 | Acute myeloid leukemia | 27 | 56 | 4.44e-01 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 2 | 73 | 4.44e-01 |
| KEGG | KEGG:00670 | One carbon pool by folate | 5 | 18 | 4.44e-01 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 1 | 180 | 4.44e-01 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 1 | 62 | 4.44e-01 |
| KEGG | KEGG:00440 | Phosphonate and phosphinate metabolism | 2 | 6 | 4.44e-01 |
| KEGG | KEGG:04727 | GABAergic synapse | 2 | 55 | 4.44e-01 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 8 | 86 | 4.44e-01 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 1 | 25 | 4.44e-01 |
| KEGG | KEGG:04215 | Apoptosis - multiple species | 7 | 30 | 4.44e-01 |
| KEGG | KEGG:04218 | Cellular senescence | 8 | 145 | 4.44e-01 |
| KEGG | KEGG:03250 | Viral life cycle - HIV-1 | 28 | 56 | 4.66e-01 |
| KEGG | KEGG:04360 | Axon guidance | 1 | 162 | 4.70e-01 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 2 | 112 | 4.88e-01 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 12 | 55 | 4.88e-01 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 9 | 107 | 5.06e-01 |
| KEGG | KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection | 6 | 58 | 5.06e-01 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 4 | 157 | 5.06e-01 |
| KEGG | KEGG:05016 | Huntington disease | 5 | 256 | 5.06e-01 |
| KEGG | KEGG:03018 | RNA degradation | 2 | 74 | 5.06e-01 |
| KEGG | KEGG:05321 | Inflammatory bowel disease | 2 | 22 | 5.06e-01 |
| KEGG | KEGG:01100 | Metabolic pathways | 7 | 1146 | 5.06e-01 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 4 | 35 | 5.06e-01 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 1 | 51 | 5.06e-01 |
| KEGG | KEGG:00510 | N-Glycan biosynthesis | 1 | 48 | 5.09e-01 |
| KEGG | KEGG:05132 | Salmonella infection | 8 | 214 | 5.09e-01 |
| KEGG | KEGG:04966 | Collecting duct acid secretion | 3 | 19 | 5.09e-01 |
| KEGG | KEGG:04976 | Bile secretion | 1 | 42 | 5.09e-01 |
| KEGG | KEGG:00750 | Vitamin B6 metabolism | 1 | 5 | 5.09e-01 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 3 | 74 | 5.09e-01 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 4 | 114 | 5.09e-01 |
| KEGG | KEGG:05164 | Influenza A | 8 | 103 | 5.18e-01 |
| KEGG | KEGG:05014 | Amyotrophic lateral sclerosis | 6 | 303 | 5.26e-01 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 12 | 76 | 5.26e-01 |
| KEGG | KEGG:00524 | Neomycin, kanamycin and gentamicin biosynthesis | 1 | 4 | 5.26e-01 |
| KEGG | KEGG:04137 | Mitophagy - animal | 12 | 70 | 5.26e-01 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 44 | 74 | 5.26e-01 |
| KEGG | KEGG:04972 | Pancreatic secretion | 1 | 58 | 5.27e-01 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 3 | 46 | 5.30e-01 |
| KEGG | KEGG:04623 | Cytosolic DNA-sensing pathway | 1 | 42 | 5.45e-01 |
| KEGG | KEGG:04140 | Autophagy - animal | 20 | 133 | 5.45e-01 |
| KEGG | KEGG:01040 | Biosynthesis of unsaturated fatty acids | 7 | 24 | 5.45e-01 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 8 | 164 | 5.63e-01 |
| KEGG | KEGG:05215 | Prostate cancer | 16 | 86 | 5.64e-01 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 1 | 84 | 5.76e-01 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 22 | 135 | 5.76e-01 |
| KEGG | KEGG:05030 | Cocaine addiction | 4 | 35 | 5.76e-01 |
| KEGG | KEGG:04931 | Insulin resistance | 1 | 95 | 5.76e-01 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 2 | 172 | 5.76e-01 |
| KEGG | KEGG:05032 | Morphine addiction | 2 | 56 | 5.76e-01 |
| KEGG | KEGG:00900 | Terpenoid backbone biosynthesis | 1 | 21 | 5.76e-01 |
| KEGG | KEGG:00970 | Aminoacyl-tRNA biosynthesis | 20 | 44 | 5.76e-01 |
| KEGG | KEGG:01250 | Biosynthesis of nucleotide sugars | 3 | 35 | 5.80e-01 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 4 | 38 | 5.80e-01 |
| KEGG | KEGG:04136 | Autophagy - other | 18 | 31 | 5.84e-01 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 8 | 128 | 5.84e-01 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 4 | 56 | 5.93e-01 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 1 | 103 | 5.98e-01 |
| KEGG | KEGG:00590 | Arachidonic acid metabolism | 3 | 26 | 5.98e-01 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 2 | 53 | 5.98e-01 |
| KEGG | KEGG:05110 | Vibrio cholerae infection | 4 | 43 | 5.98e-01 |
| KEGG | KEGG:04130 | SNARE interactions in vesicular transport | 9 | 32 | 5.98e-01 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 8 | 134 | 5.98e-01 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 1 | 22 | 6.04e-01 |
| KEGG | KEGG:00600 | Sphingolipid metabolism | 5 | 44 | 6.04e-01 |
| KEGG | KEGG:04216 | Ferroptosis | 7 | 33 | 6.04e-01 |
| KEGG | KEGG:04330 | Notch signaling pathway | 31 | 51 | 6.04e-01 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 7 | 170 | 6.04e-01 |
| KEGG | KEGG:05143 | African trypanosomiasis | 3 | 16 | 6.06e-01 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 20 | 82 | 6.06e-01 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 1 | 41 | 6.06e-01 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 1 | 121 | 6.06e-01 |
| KEGG | KEGG:04146 | Peroxisome | 39 | 68 | 6.06e-01 |
| KEGG | KEGG:00592 | alpha-Linolenic acid metabolism | 3 | 10 | 6.06e-01 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 3 | 61 | 6.06e-01 |
| KEGG | KEGG:04936 | Alcoholic liver disease | 1 | 97 | 6.06e-01 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 3 | 150 | 6.06e-01 |
| KEGG | KEGG:04114 | Oocyte meiosis | 32 | 108 | 6.06e-01 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 1 | 131 | 6.06e-01 |
| KEGG | KEGG:05219 | Bladder cancer | 10 | 37 | 6.06e-01 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 1 | 20 | 6.06e-01 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 1 | 115 | 6.06e-01 |
| KEGG | KEGG:00860 | Porphyrin metabolism | 2 | 22 | 6.06e-01 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 11 | 41 | 6.06e-01 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 22 | 98 | 6.06e-01 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 3 | 151 | 6.06e-01 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 6 | 63 | 6.06e-01 |
| KEGG | KEGG:05022 | Pathways of neurodegeneration - multiple diseases | 14 | 385 | 6.06e-01 |
| KEGG | KEGG:04940 | Type I diabetes mellitus | 2 | 15 | 6.06e-01 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 12 | 50 | 6.07e-01 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 29 | 133 | 6.15e-01 |
| KEGG | KEGG:05140 | Leishmaniasis | 1 | 42 | 6.16e-01 |
| KEGG | KEGG:05033 | Nicotine addiction | 1 | 12 | 6.16e-01 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 14 | 76 | 6.30e-01 |
| KEGG | KEGG:04934 | Cushing syndrome | 23 | 121 | 6.31e-01 |
| KEGG | KEGG:04064 | NF-kappa B signaling pathway | 2 | 71 | 6.31e-01 |
| KEGG | KEGG:03022 | Basal transcription factors | 3 | 40 | 6.33e-01 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 4 | 87 | 6.33e-01 |
| KEGG | KEGG:00830 | Retinol metabolism | 1 | 16 | 6.33e-01 |
| KEGG | KEGG:00430 | Taurine and hypotaurine metabolism | 1 | 8 | 6.33e-01 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 1 | 55 | 6.33e-01 |
| KEGG | KEGG:04950 | Maturity onset diabetes of the young | 2 | 4 | 6.33e-01 |
| KEGG | KEGG:05152 | Tuberculosis | 3 | 106 | 6.33e-01 |
| KEGG | KEGG:00983 | Drug metabolism - other enzymes | 4 | 44 | 6.33e-01 |
| KEGG | KEGG:01522 | Endocrine resistance | 21 | 85 | 6.33e-01 |
| KEGG | KEGG:05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1 | 69 | 6.66e-01 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 12 | 56 | 6.66e-01 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 1 | 21 | 6.66e-01 |
| KEGG | KEGG:00520 | Amino sugar and nucleotide sugar metabolism | 3 | 46 | 6.66e-01 |
| KEGG | KEGG:04144 | Endocytosis | 4 | 232 | 6.66e-01 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 1 | 63 | 6.85e-01 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 14 | 72 | 6.85e-01 |
| KEGG | KEGG:04725 | Cholinergic synapse | 1 | 83 | 6.85e-01 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 1 | 149 | 6.85e-01 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 2 | 51 | 6.85e-01 |
| KEGG | KEGG:05416 | Viral myocarditis | 1 | 40 | 6.85e-01 |
| KEGG | KEGG:04924 | Renin secretion | 12 | 50 | 6.85e-01 |
| KEGG | KEGG:00052 | Galactose metabolism | 2 | 22 | 6.85e-01 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 1 | 64 | 6.85e-01 |
| KEGG | KEGG:00760 | Nicotinate and nicotinamide metabolism | 1 | 28 | 6.85e-01 |
| KEGG | KEGG:00790 | Folate biosynthesis | 2 | 18 | 6.85e-01 |
| KEGG | KEGG:00565 | Ether lipid metabolism | 4 | 28 | 6.85e-01 |
| KEGG | KEGG:04142 | Lysosome | 1 | 118 | 6.85e-01 |
| KEGG | KEGG:04620 | Toll-like receptor signaling pathway | 1 | 60 | 6.85e-01 |
| KEGG | KEGG:00910 | Nitrogen metabolism | 1 | 10 | 6.85e-01 |
| KEGG | KEGG:00232 | Caffeine metabolism | 1 | 1 | 6.85e-01 |
| KEGG | KEGG:04714 | Thermogenesis | 1 | 195 | 6.85e-01 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 1 | 76 | 6.85e-01 |
| KEGG | KEGG:00410 | beta-Alanine metabolism | 2 | 22 | 6.85e-01 |
| KEGG | KEGG:05145 | Toxoplasmosis | 3 | 82 | 6.91e-01 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 36 | 99 | 7.04e-01 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 1 | 67 | 7.04e-01 |
| KEGG | KEGG:00100 | Steroid biosynthesis | 11 | 17 | 7.04e-01 |
| KEGG | KEGG:00020 | Citrate cycle (TCA cycle) | 16 | 28 | 7.06e-01 |
| KEGG | KEGG:00500 | Starch and sucrose metabolism | 2 | 23 | 7.06e-01 |
| KEGG | KEGG:05020 | Prion disease | 3 | 220 | 7.06e-01 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 12 | 84 | 7.06e-01 |
| KEGG | KEGG:00120 | Primary bile acid biosynthesis | 2 | 11 | 7.06e-01 |
| KEGG | KEGG:00591 | Linoleic acid metabolism | 2 | 7 | 7.06e-01 |
| KEGG | KEGG:04911 | Insulin secretion | 12 | 64 | 7.06e-01 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 8 | 110 | 7.06e-01 |
| KEGG | KEGG:04720 | Long-term potentiation | 1 | 55 | 7.06e-01 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 4 | 104 | 7.06e-01 |
| KEGG | KEGG:02010 | ABC transporters | 13 | 29 | 7.06e-01 |
| KEGG | KEGG:05031 | Amphetamine addiction | 1 | 49 | 7.06e-01 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 3 | 240 | 7.06e-01 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 1 | 78 | 7.06e-01 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 2 | 37 | 7.06e-01 |
| KEGG | KEGG:04520 | Adherens junction | 1 | 67 | 7.08e-01 |
| KEGG | KEGG:01210 | 2-Oxocarboxylic acid metabolism | 10 | 17 | 7.08e-01 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 2 | 272 | 7.08e-01 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 9 | 48 | 7.12e-01 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 2 | 113 | 7.17e-01 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 24 | 138 | 7.17e-01 |
| KEGG | KEGG:00650 | Butanoate metabolism | 1 | 17 | 7.19e-01 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 1 | 153 | 7.27e-01 |
| KEGG | KEGG:05010 | Alzheimer disease | 4 | 315 | 7.28e-01 |
| KEGG | KEGG:05162 | Measles | 1 | 98 | 7.32e-01 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 1 | 14 | 7.35e-01 |
| KEGG | KEGG:00450 | Selenocompound metabolism | 7 | 14 | 7.35e-01 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 1 | 75 | 7.37e-01 |
| KEGG | KEGG:00630 | Glyoxylate and dicarboxylate metabolism | 4 | 25 | 7.37e-01 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 1 | 56 | 7.37e-01 |
| KEGG | KEGG:05142 | Chagas disease | 5 | 75 | 7.39e-01 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 1 | 27 | 7.39e-01 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 3 | 161 | 7.39e-01 |
| KEGG | KEGG:00785 | Lipoic acid metabolism | 1 | 3 | 7.39e-01 |
| KEGG | KEGG:03040 | Spliceosome | 38 | 132 | 7.39e-01 |
| KEGG | KEGG:00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 1 | 14 | 7.39e-01 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 6 | 165 | 7.39e-01 |
| KEGG | KEGG:04730 | Long-term depression | 12 | 42 | 7.39e-01 |
| KEGG | KEGG:05160 | Hepatitis C | 1 | 115 | 7.45e-01 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 12 | 70 | 7.45e-01 |
| KEGG | KEGG:05144 | Malaria | 1 | 20 | 7.45e-01 |
| KEGG | KEGG:04962 | Vasopressin-regulated water reabsorption | 2 | 38 | 7.51e-01 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 1 | 28 | 7.66e-01 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 1 | 88 | 7.66e-01 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 12 | 49 | 7.69e-01 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 10 | 78 | 7.69e-01 |
| KEGG | KEGG:04622 | RIG-I-like receptor signaling pathway | 3 | 49 | 7.77e-01 |
| KEGG | KEGG:04713 | Circadian entrainment | 1 | 69 | 7.77e-01 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 13 | 77 | 7.79e-01 |
| KEGG | KEGG:04014 | Ras signaling pathway | 2 | 171 | 7.79e-01 |
| KEGG | KEGG:05323 | Rheumatoid arthritis | 1 | 43 | 7.79e-01 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 8 | 65 | 7.79e-01 |
| KEGG | KEGG:04621 | NOD-like receptor signaling pathway | 1 | 117 | 7.79e-01 |
| KEGG | KEGG:00563 | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 8 | 25 | 7.79e-01 |
| KEGG | KEGG:04611 | Platelet activation | 6 | 89 | 7.79e-01 |
| KEGG | KEGG:05330 | Allograft rejection | 1 | 10 | 7.81e-01 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 1 | 98 | 7.81e-01 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 1 | 12 | 7.81e-01 |
| KEGG | KEGG:03267 | Virion - Adenovirus | 1 | 2 | 7.91e-01 |
| KEGG | KEGG:05332 | Graft-versus-host disease | 1 | 10 | 7.93e-01 |
| KEGG | KEGG:00380 | Tryptophan metabolism | 1 | 23 | 7.93e-01 |
| KEGG | KEGG:04672 | Intestinal immune network for IgA production | 1 | 12 | 7.93e-01 |
| KEGG | KEGG:04970 | Salivary secretion | 3 | 55 | 7.93e-01 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 3 | 83 | 7.93e-01 |
| KEGG | KEGG:00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 2 | 20 | 7.93e-01 |
| KEGG | KEGG:00770 | Pantothenate and CoA biosynthesis | 8 | 15 | 7.93e-01 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 3 | 79 | 7.93e-01 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 1 | 145 | 7.93e-01 |
| KEGG | KEGG:00340 | Histidine metabolism | 1 | 12 | 7.93e-01 |
| KEGG | KEGG:00000 | KEGG root term | 1 | 5558 | 7.93e-01 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 9 | 110 | 8.02e-01 |
| KEGG | KEGG:00290 | Valine, leucine and isoleucine biosynthesis | 1 | 3 | 8.02e-01 |
| KEGG | KEGG:05131 | Shigellosis | 21 | 210 | 8.03e-01 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 30 | 49 | 8.03e-01 |
| KEGG | KEGG:05012 | Parkinson disease | 3 | 226 | 8.06e-01 |
| KEGG | KEGG:03050 | Proteasome | 7 | 42 | 8.10e-01 |
| KEGG | KEGG:00062 | Fatty acid elongation | 5 | 24 | 8.12e-01 |
| KEGG | KEGG:00620 | Pyruvate metabolism | 2 | 33 | 8.12e-01 |
| KEGG | KEGG:03060 | Protein export | 5 | 23 | 8.12e-01 |
| KEGG | KEGG:00030 | Pentose phosphate pathway | 6 | 24 | 8.12e-01 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 1 | 162 | 8.12e-01 |
| KEGG | KEGG:04971 | Gastric acid secretion | 9 | 52 | 8.12e-01 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 4 | 104 | 8.15e-01 |
| KEGG | KEGG:00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3 | 13 | 8.15e-01 |
| KEGG | KEGG:05135 | Yersinia infection | 1 | 112 | 8.25e-01 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 11 | 50 | 8.26e-01 |
| KEGG | KEGG:00511 | Other glycan degradation | 3 | 16 | 8.28e-01 |
| KEGG | KEGG:05146 | Amoebiasis | 1 | 64 | 8.29e-01 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 1 | 124 | 8.37e-01 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 3 | 415 | 8.48e-01 |
| KEGG | KEGG:05320 | Autoimmune thyroid disease | 1 | 11 | 8.53e-01 |
| KEGG | KEGG:03266 | Virion - Herpesvirus | 1 | 6 | 8.55e-01 |
| KEGG | KEGG:03265 | Virion - Lyssavirus | 1 | 3 | 8.55e-01 |
| KEGG | KEGG:00310 | Lysine degradation | 1 | 59 | 8.55e-01 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 1 | 106 | 8.55e-01 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 1 | 69 | 8.60e-01 |
| KEGG | KEGG:00730 | Thiamine metabolism | 6 | 10 | 8.61e-01 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 2 | 74 | 8.72e-01 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 21 | 43 | 8.74e-01 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 2 | 179 | 8.75e-01 |
| KEGG | KEGG:00604 | Glycosphingolipid biosynthesis - ganglio series | 1 | 12 | 8.75e-01 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 9 | 176 | 8.77e-01 |
| KEGG | KEGG:00270 | Cysteine and methionine metabolism | 18 | 38 | 8.89e-01 |
| KEGG | KEGG:03450 | Non-homologous end-joining | 3 | 12 | 8.96e-01 |
| KEGG | KEGG:00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 2 | 2 | 9.06e-01 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 5 | 94 | 9.11e-01 |
| KEGG | KEGG:05133 | Pertussis | 1 | 45 | 9.12e-01 |
| KEGG | KEGG:03260 | Virion - Human immunodeficiency virus | 1 | 1 | 9.12e-01 |
| KEGG | KEGG:00640 | Propanoate metabolism | 14 | 28 | 9.14e-01 |
| KEGG | KEGG:04510 | Focal adhesion | 1 | 177 | 9.17e-01 |
| KEGG | KEGG:00780 | Biotin metabolism | 1 | 3 | 9.17e-01 |
| KEGG | KEGG:04726 | Serotonergic synapse | 1 | 63 | 9.17e-01 |
| KEGG | KEGG:04744 | Phototransduction | 1 | 12 | 9.27e-01 |
| KEGG | KEGG:00010 | Glycolysis / Gluconeogenesis | 2 | 44 | 9.29e-01 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 1 | 254 | 9.31e-01 |
| KEGG | KEGG:00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 2 | 9 | 9.34e-01 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 3 | 108 | 9.36e-01 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 4 | 31 | 9.36e-01 |
| KEGG | KEGG:00061 | Fatty acid biosynthesis | 2 | 12 | 9.37e-01 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 14 | 97 | 9.45e-01 |
| KEGG | KEGG:04929 | GnRH secretion | 5 | 53 | 9.50e-01 |
| KEGG | KEGG:00071 | Fatty acid degradation | 1 | 32 | 9.53e-01 |
| KEGG | KEGG:05204 | Chemical carcinogenesis - DNA adducts | 3 | 23 | 9.54e-01 |
| KEGG | KEGG:03015 | mRNA surveillance pathway | 26 | 86 | 9.54e-01 |
| KEGG | KEGG:05134 | Legionellosis | 4 | 39 | 9.55e-01 |
| KEGG | KEGG:04640 | Hematopoietic cell lineage | 1 | 31 | 9.61e-01 |
| KEGG | KEGG:01230 | Biosynthesis of amino acids | 6 | 60 | 9.61e-01 |
| KEGG | KEGG:04740 | Olfactory transduction | 2 | 25 | 9.61e-01 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 16 | 103 | 9.61e-01 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 19 | 142 | 9.61e-01 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 3 | 99 | 9.69e-01 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 1 | 186 | 9.96e-01 |
| KEGG | KEGG:04975 | Fat digestion and absorption | 1 | 19 | 9.96e-01 |
| KEGG | KEGG:00980 | Metabolism of xenobiotics by cytochrome P450 | 2 | 26 | 9.99e-01 |
| KEGG | KEGG:04612 | Antigen processing and presentation | 4 | 41 | 9.99e-01 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 3 | 33 | 9.99e-01 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 2 | 26 | 9.99e-01 |
| KEGG | KEGG:04742 | Taste transduction | 1 | 22 | 9.99e-01 |
| KEGG | KEGG:00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 2 | 9 | 9.99e-01 |
| KEGG | KEGG:00350 | Tyrosine metabolism | 5 | 13 | 1.00e+00 |
| KEGG | KEGG:04610 | Complement and coagulation cascades | 1 | 40 | 1.00e+00 |
| KEGG | KEGG:00260 | Glycine, serine and threonine metabolism | 14 | 31 | 1.00e+00 |
| KEGG | KEGG:03010 | Ribosome | 17 | 127 | 1.00e+00 |
| KEGG | KEGG:03008 | Ribosome biogenesis in eukaryotes | 4 | 75 | 1.00e+00 |
| KEGG | KEGG:00140 | Steroid hormone biosynthesis | 4 | 19 | 1.00e+00 |
| KEGG | KEGG:00513 | Various types of N-glycan biosynthesis | 4 | 36 | 1.00e+00 |
| KEGG | KEGG:01200 | Carbon metabolism | 2 | 98 | 1.00e+00 |
| KEGG | KEGG:05150 | Staphylococcus aureus infection | 1 | 18 | 1.00e+00 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 6 | 89 | 1.00e+00 |
| KEGG | KEGG:00982 | Drug metabolism - cytochrome P450 | 1 | 21 | 1.00e+00 |
| KEGG | KEGG:00360 | Phenylalanine metabolism | 1 | 5 | 1.00e+00 |
| KEGG | KEGG:05310 | Asthma | 1 | 3 | 1.00e+00 |
| KEGG | KEGG:00053 | Ascorbate and aldarate metabolism | 3 | 9 | 1.00e+00 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 2 | 169 | 1.00e+00 |
| KEGG | KEGG:00040 | Pentose and glucuronate interconversions | 2 | 12 | 1.00e+00 |
###Daunorubicin 3 v 24 intersection
All 187 3 hour Daun-specific genes are in the 304 genes between the two full lists of daunorubicin sigDEGs for 3 hours and 24 hours. This could possibly support the idea that Daunorubicin’s more toxic effect is related to earlier impacts on cell function. Note the enriched go terms for the 304 genes that they share. I need to see if there is a trend in EP and DX. I do see in Mito 3 hour (looked a little later).
[1] 7237
[1] 195
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 112 | 1915 | 7.05e-14 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 113 | 1991 | 2.30e-13 |
| GO:BP | GO:1903506 | regulation of nucleic acid-templated transcription | 126 | 2581 | 1.13e-10 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 126 | 2579 | 1.13e-10 |
| GO:BP | GO:0097659 | nucleic acid-templated transcription | 128 | 2684 | 1.23e-10 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 133 | 2849 | 1.23e-10 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 126 | 2598 | 1.23e-10 |
| GO:BP | GO:0006351 | DNA-templated transcription | 128 | 2683 | 1.23e-10 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 128 | 2714 | 2.39e-10 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 101 | 3015 | 7.57e-10 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 102 | 3123 | 3.16e-09 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 103 | 3174 | 3.16e-09 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 101 | 3105 | 5.02e-09 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 52 | 735 | 1.23e-08 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 99 | 3148 | 6.87e-08 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 97 | 3083 | 1.33e-07 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 98 | 3149 | 1.81e-07 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 100 | 3253 | 2.18e-07 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 107 | 3730 | 4.29e-07 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 106 | 3758 | 2.33e-06 |
| GO:BP | GO:1903507 | negative regulation of nucleic acid-templated transcription | 44 | 1011 | 4.37e-06 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 44 | 1009 | 4.37e-06 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 44 | 1020 | 5.49e-06 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 60 | 1115 | 5.49e-06 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 119 | 4330 | 6.97e-06 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 118 | 4305 | 6.97e-06 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 121 | 4440 | 8.39e-06 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 47 | 1206 | 1.69e-05 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 114 | 4465 | 4.04e-05 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 47 | 1249 | 4.84e-05 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 46 | 1215 | 6.86e-05 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 47 | 1273 | 7.96e-05 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 114 | 4537 | 9.44e-05 |
| GO:BP | GO:0010468 | regulation of gene expression | 109 | 3583 | 1.30e-04 |
| GO:BP | GO:0009058 | biosynthetic process | 114 | 4595 | 2.14e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 58 | 1780 | 7.01e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 14 | 212 | 8.69e-04 |
| GO:BP | GO:0003162 | atrioventricular node development | 3 | 8 | 1.31e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 35 | 925 | 1.58e-03 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 14 | 198 | 1.79e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 45 | 1431 | 2.89e-03 |
| GO:BP | GO:0014706 | striated muscle tissue development | 15 | 210 | 3.64e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 7 | 67 | 3.64e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 61 | 1304 | 4.13e-03 |
| GO:BP | GO:1903508 | positive regulation of nucleic acid-templated transcription | 61 | 1304 | 4.13e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 42 | 1311 | 4.49e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 48 | 1571 | 4.98e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 69 | 2425 | 5.07e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 68 | 2373 | 5.16e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 46 | 1499 | 5.40e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 48 | 1598 | 7.49e-03 |
| GO:BP | GO:0051890 | regulation of cardioblast differentiation | 3 | 7 | 9.36e-03 |
| GO:BP | GO:0003310 | pancreatic A cell differentiation | 2 | 2 | 1.18e-02 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 123 | 4640 | 1.22e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 56 | 1866 | 1.34e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 46 | 1600 | 1.35e-02 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 5 | 40 | 1.41e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 7 | 65 | 1.46e-02 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 2 | 17 | 2.11e-02 |
| GO:BP | GO:0003197 | endocardial cushion development | 5 | 42 | 2.25e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 2 | 18 | 2.27e-02 |
| GO:BP | GO:0045622 | regulation of T-helper cell differentiation | 3 | 20 | 2.29e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 3 | 49 | 2.43e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 6 | 69 | 2.54e-02 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 3 | 17 | 2.54e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 4 | 200 | 2.54e-02 |
| GO:BP | GO:0060419 | heart growth | 7 | 72 | 2.56e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 22 | 531 | 2.69e-02 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 3 | 9 | 2.69e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 6 | 79 | 2.69e-02 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 3 | 9 | 2.69e-02 |
| GO:BP | GO:0019184 | nonribosomal peptide biosynthetic process | 3 | 15 | 2.69e-02 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8 | 99 | 2.69e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 5 | 101 | 2.69e-02 |
| GO:BP | GO:0007507 | heart development | 25 | 502 | 2.69e-02 |
| GO:BP | GO:0048645 | animal organ formation | 7 | 52 | 2.69e-02 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 5 | 44 | 2.69e-02 |
| GO:BP | GO:0051891 | positive regulation of cardioblast differentiation | 2 | 6 | 2.78e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 9 | 129 | 2.78e-02 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 6 | 66 | 2.78e-02 |
| GO:BP | GO:2000121 | regulation of removal of superoxide radicals | 2 | 6 | 2.85e-02 |
| GO:BP | GO:2000320 | negative regulation of T-helper 17 cell differentiation | 2 | 6 | 2.85e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 6 | 131 | 3.00e-02 |
| GO:BP | GO:0071772 | response to BMP | 6 | 131 | 3.00e-02 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 2 | 10 | 3.00e-02 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 68 | 2648 | 3.17e-02 |
| GO:BP | GO:2000317 | negative regulation of T-helper 17 type immune response | 2 | 7 | 3.18e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 22 | 548 | 3.41e-02 |
| GO:BP | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 3 | 27 | 3.54e-02 |
| GO:BP | GO:0045603 | positive regulation of endothelial cell differentiation | 1 | 8 | 3.59e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 3 | 75 | 3.90e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 3 | 76 | 3.93e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 3 | 76 | 3.93e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 123 | 5039 | 3.95e-02 |
| GO:BP | GO:0060010 | Sertoli cell fate commitment | 1 | 1 | 4.11e-02 |
| GO:BP | GO:0001823 | mesonephros development | 3 | 77 | 4.11e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 3 | 84 | 4.11e-02 |
| GO:BP | GO:0014916 | regulation of lung blood pressure | 2 | 3 | 4.11e-02 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 71 | 2884 | 4.11e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 5 | 109 | 4.11e-02 |
| GO:BP | GO:0019827 | stem cell population maintenance | 7 | 150 | 4.19e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 9 | 227 | 4.25e-02 |
| GO:BP | GO:0033484 | cellular nitric oxide homeostasis | 1 | 3 | 4.25e-02 |
| GO:BP | GO:0060914 | heart formation | 3 | 30 | 4.25e-02 |
| GO:BP | GO:0098727 | maintenance of cell number | 7 | 152 | 4.59e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 3 | 136 | 4.80e-02 |
| GO:BP | GO:1903041 | regulation of chondrocyte hypertrophy | 1 | 1 | 4.80e-02 |
| GO:BP | GO:1903043 | positive regulation of chondrocyte hypertrophy | 1 | 1 | 4.80e-02 |
| GO:BP | GO:0035265 | organ growth | 9 | 129 | 4.80e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 4 | 34 | 4.80e-02 |
| GO:BP | GO:0045210 | FasL biosynthetic process | 1 | 1 | 4.80e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 5 | 57 | 4.82e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 12 | 229 | 4.83e-02 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 2 | 27 | 4.83e-02 |
| GO:BP | GO:1904003 | negative regulation of sebum secreting cell proliferation | 1 | 1 | 4.83e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 3 | 38 | 4.83e-02 |
| GO:BP | GO:0001701 | in utero embryonic development | 17 | 342 | 4.84e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 3 | 125 | 4.84e-02 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 4 | 34 | 4.84e-02 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 32 | 415 | 1.21e-06 |
Doxorubicin 3 hour and 24 hour
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:1904290 | negative regulation of mitotic DNA damage checkpoint | 1 | 1 | 4.04e-02 |
| GO:BP | GO:1900036 | positive regulation of cellular response to heat | 1 | 1 | 4.04e-02 |
| GO:BP | GO:1904289 | regulation of mitotic DNA damage checkpoint | 1 | 3 | 4.04e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0000278 | mitotic cell cycle | 179 | 833 | 6.42e-10 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 172 | 700 | 4.38e-09 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 66 | 193 | 4.38e-09 |
| GO:BP | GO:0000819 | sister chromatid segregation | 75 | 234 | 6.53e-09 |
| GO:BP | GO:0007059 | chromosome segregation | 103 | 378 | 1.54e-08 |
| GO:BP | GO:0045930 | negative regulation of mitotic cell cycle | 65 | 208 | 3.49e-08 |
| GO:BP | GO:0140014 | mitotic nuclear division | 50 | 264 | 3.49e-08 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 47 | 136 | 5.75e-08 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 89 | 620 | 6.11e-08 |
| GO:BP | GO:0051301 | cell division | 138 | 567 | 1.04e-07 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 55 | 180 | 2.95e-07 |
| GO:BP | GO:0051276 | chromosome organization | 89 | 543 | 1.02e-06 |
| GO:BP | GO:0051726 | regulation of cell cycle | 135 | 950 | 1.98e-06 |
| GO:BP | GO:0000280 | nuclear division | 93 | 354 | 2.14e-06 |
| GO:BP | GO:0022402 | cell cycle process | 208 | 1075 | 2.70e-06 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 84 | 287 | 2.70e-06 |
| GO:BP | GO:0007051 | spindle organization | 50 | 186 | 4.37e-06 |
| GO:BP | GO:0007052 | mitotic spindle organization | 29 | 128 | 5.58e-06 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 52 | 156 | 5.63e-06 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 11 | 18 | 7.10e-06 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 105 | 438 | 7.10e-06 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 28 | 69 | 7.10e-06 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 63 | 232 | 7.10e-06 |
| GO:BP | GO:0051225 | spindle assembly | 31 | 118 | 7.10e-06 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 19 | 42 | 7.74e-06 |
| GO:BP | GO:0048285 | organelle fission | 97 | 397 | 9.81e-06 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 39 | 118 | 1.12e-05 |
| GO:BP | GO:0007080 | mitotic metaphase plate congression | 17 | 55 | 1.31e-05 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 84 | 334 | 1.63e-05 |
| GO:BP | GO:0007049 | cell cycle | 193 | 1522 | 1.72e-05 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 69 | 270 | 2.11e-05 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 40 | 90 | 2.87e-05 |
| GO:BP | GO:0051231 | spindle elongation | 9 | 12 | 2.87e-05 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 16 | 52 | 2.91e-05 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 56 | 206 | 2.91e-05 |
| GO:BP | GO:0051304 | chromosome separation | 28 | 74 | 3.23e-05 |
| GO:BP | GO:0051256 | mitotic spindle midzone assembly | 8 | 9 | 3.36e-05 |
| GO:BP | GO:0006974 | cellular response to DNA damage stimulus | 151 | 789 | 4.69e-05 |
| GO:BP | GO:1903490 | positive regulation of mitotic cytokinesis | 7 | 7 | 5.07e-05 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 22 | 54 | 5.22e-05 |
| GO:BP | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 30 | 88 | 5.72e-05 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 20 | 46 | 6.12e-05 |
| GO:BP | GO:0051310 | metaphase plate congression | 18 | 69 | 6.14e-05 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 60 | 149 | 6.14e-05 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 14 | 44 | 6.15e-05 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 14 | 44 | 6.15e-05 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 14 | 44 | 6.15e-05 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 35 | 100 | 6.36e-05 |
| GO:BP | GO:0044774 | mitotic DNA integrity checkpoint signaling | 30 | 82 | 6.42e-05 |
| GO:BP | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 46 | 163 | 6.70e-05 |
| GO:BP | GO:0000022 | mitotic spindle elongation | 8 | 10 | 6.85e-05 |
| GO:BP | GO:0010965 | regulation of mitotic sister chromatid separation | 23 | 58 | 7.27e-05 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 14 | 45 | 7.30e-05 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 108 | 552 | 8.81e-05 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 52 | 388 | 8.96e-05 |
| GO:BP | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 30 | 89 | 9.05e-05 |
| GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 30 | 91 | 9.05e-05 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 20 | 47 | 9.17e-05 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 20 | 47 | 9.17e-05 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 20 | 47 | 9.17e-05 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 20 | 47 | 9.17e-05 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 32 | 99 | 1.09e-04 |
| GO:BP | GO:0031570 | DNA integrity checkpoint signaling | 37 | 126 | 1.11e-04 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 73 | 305 | 1.17e-04 |
| GO:BP | GO:1902412 | regulation of mitotic cytokinesis | 8 | 8 | 1.20e-04 |
| GO:BP | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 10 | 21 | 1.21e-04 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 11 | 25 | 1.42e-04 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 30 | 79 | 1.46e-04 |
| GO:BP | GO:0051306 | mitotic sister chromatid separation | 23 | 61 | 1.46e-04 |
| GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 30 | 92 | 1.55e-04 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 20 | 48 | 1.60e-04 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 20 | 48 | 1.60e-04 |
| GO:BP | GO:0051783 | regulation of nuclear division | 25 | 115 | 1.60e-04 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 93 | 413 | 1.68e-04 |
| GO:BP | GO:0006281 | DNA repair | 77 | 535 | 1.76e-04 |
| GO:BP | GO:0006541 | glutamine metabolic process | 4 | 23 | 2.23e-04 |
| GO:BP | GO:0006260 | DNA replication | 116 | 258 | 2.32e-04 |
| GO:BP | GO:0051255 | spindle midzone assembly | 8 | 12 | 2.35e-04 |
| GO:BP | GO:0044770 | cell cycle phase transition | 108 | 499 | 2.35e-04 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 22 | 57 | 2.66e-04 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 26 | 78 | 2.86e-04 |
| GO:BP | GO:0050000 | chromosome localization | 19 | 82 | 2.87e-04 |
| GO:BP | GO:0090307 | mitotic spindle assembly | 16 | 69 | 2.98e-04 |
| GO:BP | GO:0000077 | DNA damage checkpoint signaling | 33 | 118 | 3.40e-04 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 18 | 75 | 3.52e-04 |
| GO:BP | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 7 | 11 | 3.78e-04 |
| GO:BP | GO:0000281 | mitotic cytokinesis | 26 | 81 | 4.53e-04 |
| GO:BP | GO:1902425 | positive regulation of attachment of mitotic spindle microtubules to kinetochore | 6 | 8 | 4.91e-04 |
| GO:BP | GO:1902423 | regulation of attachment of mitotic spindle microtubules to kinetochore | 6 | 8 | 4.91e-04 |
| GO:BP | GO:0046037 | GMP metabolic process | 4 | 24 | 5.40e-04 |
| GO:BP | GO:0006270 | DNA replication initiation | 12 | 35 | 5.40e-04 |
| GO:BP | GO:0010212 | response to ionizing radiation | 41 | 130 | 6.35e-04 |
| GO:BP | GO:0007017 | microtubule-based process | 139 | 756 | 7.82e-04 |
| GO:BP | GO:0060236 | regulation of mitotic spindle organization | 8 | 42 | 9.20e-04 |
| GO:BP | GO:0006167 | AMP biosynthetic process | 3 | 14 | 9.44e-04 |
| GO:BP | GO:0006177 | GMP biosynthetic process | 3 | 14 | 1.17e-03 |
| GO:BP | GO:0033044 | regulation of chromosome organization | 72 | 233 | 1.69e-03 |
| GO:BP | GO:0090224 | regulation of spindle organization | 8 | 45 | 1.71e-03 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 17 | 75 | 1.83e-03 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 64 | 278 | 1.93e-03 |
| GO:BP | GO:0042770 | signal transduction in response to DNA damage | 41 | 173 | 2.45e-03 |
| GO:BP | GO:0046060 | dATP metabolic process | 2 | 3 | 2.79e-03 |
| GO:BP | GO:0009167 | purine ribonucleoside monophosphate metabolic process | 4 | 40 | 3.31e-03 |
| GO:BP | GO:0051383 | kinetochore organization | 15 | 23 | 3.46e-03 |
| GO:BP | GO:0009126 | purine nucleoside monophosphate metabolic process | 4 | 42 | 3.86e-03 |
| GO:BP | GO:0061640 | cytoskeleton-dependent cytokinesis | 29 | 103 | 3.91e-03 |
| GO:BP | GO:0007098 | centrosome cycle | 31 | 126 | 3.96e-03 |
| GO:BP | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 3 | 22 | 3.97e-03 |
| GO:BP | GO:1905820 | positive regulation of chromosome separation | 12 | 26 | 4.56e-03 |
| GO:BP | GO:0071478 | cellular response to radiation | 36 | 155 | 4.60e-03 |
| GO:BP | GO:0000086 | G2/M transition of mitotic cell cycle | 38 | 134 | 4.75e-03 |
| GO:BP | GO:0009127 | purine nucleoside monophosphate biosynthetic process | 3 | 24 | 4.91e-03 |
| GO:BP | GO:0046033 | AMP metabolic process | 3 | 22 | 4.91e-03 |
| GO:BP | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 29 | 92 | 5.48e-03 |
| GO:BP | GO:0000910 | cytokinesis | 44 | 163 | 5.71e-03 |
| GO:BP | GO:0051302 | regulation of cell division | 26 | 144 | 6.29e-03 |
| GO:BP | GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 24 | 50 | 7.05e-03 |
| GO:BP | GO:0090235 | regulation of metaphase plate congression | 7 | 13 | 7.05e-03 |
| GO:BP | GO:0071479 | cellular response to ionizing radiation | 23 | 68 | 7.06e-03 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 3 | 84 | 7.35e-03 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 11 | 36 | 7.68e-03 |
| GO:BP | GO:0044209 | AMP salvage | 2 | 5 | 7.68e-03 |
| GO:BP | GO:0032263 | GMP salvage | 2 | 4 | 7.68e-03 |
| GO:BP | GO:0009262 | deoxyribonucleotide metabolic process | 23 | 38 | 7.86e-03 |
| GO:BP | GO:0019692 | deoxyribose phosphate metabolic process | 23 | 38 | 7.86e-03 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 27 | 136 | 8.40e-03 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 54 | 264 | 8.47e-03 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 54 | 264 | 8.47e-03 |
| GO:BP | GO:0044839 | cell cycle G2/M phase transition | 40 | 148 | 8.47e-03 |
| GO:BP | GO:0046601 | positive regulation of centriole replication | 6 | 9 | 9.00e-03 |
| GO:BP | GO:0033554 | cellular response to stress | 270 | 1677 | 9.16e-03 |
| GO:BP | GO:0006979 | response to oxidative stress | 34 | 349 | 1.01e-02 |
| GO:BP | GO:0009411 | response to UV | 18 | 137 | 1.06e-02 |
| GO:BP | GO:0000076 | DNA replication checkpoint signaling | 10 | 15 | 1.12e-02 |
| GO:BP | GO:0042542 | response to hydrogen peroxide | 15 | 103 | 1.17e-02 |
| GO:BP | GO:0000302 | response to reactive oxygen species | 20 | 160 | 1.17e-02 |
| GO:BP | GO:0010332 | response to gamma radiation | 19 | 50 | 1.17e-02 |
| GO:BP | GO:0009394 | 2’-deoxyribonucleotide metabolic process | 22 | 37 | 1.18e-02 |
| GO:BP | GO:0009161 | ribonucleoside monophosphate metabolic process | 4 | 56 | 1.18e-02 |
| GO:BP | GO:0044786 | cell cycle DNA replication | 19 | 40 | 1.23e-02 |
| GO:BP | GO:0009064 | glutamine family amino acid metabolic process | 4 | 61 | 1.23e-02 |
| GO:BP | GO:0023019 | signal transduction involved in regulation of gene expression | 2 | 14 | 1.31e-02 |
| GO:BP | GO:0140694 | non-membrane-bounded organelle assembly | 23 | 355 | 1.31e-02 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 25 | 318 | 1.32e-02 |
| GO:BP | GO:0046053 | dAMP metabolic process | 2 | 5 | 1.35e-02 |
| GO:BP | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 2 | 7 | 1.35e-02 |
| GO:BP | GO:1900262 | regulation of DNA-directed DNA polymerase activity | 11 | 13 | 1.37e-02 |
| GO:BP | GO:1900264 | positive regulation of DNA-directed DNA polymerase activity | 11 | 13 | 1.37e-02 |
| GO:BP | GO:0009156 | ribonucleoside monophosphate biosynthetic process | 6 | 36 | 1.43e-02 |
| GO:BP | GO:0009314 | response to radiation | 67 | 349 | 1.47e-02 |
| GO:BP | GO:0009112 | nucleobase metabolic process | 3 | 27 | 1.47e-02 |
| GO:BP | GO:0032467 | positive regulation of cytokinesis | 15 | 33 | 1.55e-02 |
| GO:BP | GO:0090232 | positive regulation of spindle checkpoint | 6 | 12 | 1.56e-02 |
| GO:BP | GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 3 | 9 | 1.56e-02 |
| GO:BP | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 6 | 12 | 1.56e-02 |
| GO:BP | GO:0007143 | female meiotic nuclear division | 11 | 25 | 1.58e-02 |
| GO:BP | GO:0019985 | translesion synthesis | 10 | 24 | 1.58e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 75 | 1023 | 1.58e-02 |
| GO:BP | GO:0106380 | purine ribonucleotide salvage | 2 | 7 | 1.65e-02 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 12 | 15 | 1.68e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 3 | 123 | 1.88e-02 |
| GO:BP | GO:0099625 | ventricular cardiac muscle cell membrane repolarization | 6 | 21 | 1.91e-02 |
| GO:BP | GO:0030174 | regulation of DNA-templated DNA replication initiation | 7 | 14 | 1.94e-02 |
| GO:BP | GO:1902969 | mitotic DNA replication | 9 | 14 | 1.95e-02 |
| GO:BP | GO:0006301 | postreplication repair | 12 | 34 | 1.97e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 3 | 131 | 2.20e-02 |
| GO:BP | GO:0071772 | response to BMP | 3 | 131 | 2.20e-02 |
| GO:BP | GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 4 | 15 | 2.20e-02 |
| GO:BP | GO:0031297 | replication fork processing | 20 | 42 | 2.20e-02 |
| GO:BP | GO:0006284 | base-excision repair | 10 | 44 | 2.23e-02 |
| GO:BP | GO:0010032 | meiotic chromosome condensation | 4 | 6 | 2.26e-02 |
| GO:BP | GO:0040001 | establishment of mitotic spindle localization | 15 | 36 | 2.31e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 4 | 11 | 2.32e-02 |
| GO:BP | GO:1905832 | positive regulation of spindle assembly | 5 | 7 | 2.32e-02 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 47 | 136 | 2.35e-02 |
| GO:BP | GO:0044818 | mitotic G2/M transition checkpoint | 17 | 50 | 2.35e-02 |
| GO:BP | GO:1902115 | regulation of organelle assembly | 29 | 186 | 2.35e-02 |
| GO:BP | GO:0071480 | cellular response to gamma radiation | 12 | 29 | 2.35e-02 |
| GO:BP | GO:0009170 | purine deoxyribonucleoside monophosphate metabolic process | 2 | 7 | 2.35e-02 |
| GO:BP | GO:0009123 | nucleoside monophosphate metabolic process | 4 | 71 | 2.40e-02 |
| GO:BP | GO:0046599 | regulation of centriole replication | 9 | 21 | 2.50e-02 |
| GO:BP | GO:0046602 | regulation of mitotic centrosome separation | 5 | 8 | 2.52e-02 |
| GO:BP | GO:0042148 | strand invasion | 4 | 5 | 2.56e-02 |
| GO:BP | GO:1902749 | regulation of cell cycle G2/M phase transition | 29 | 102 | 2.56e-02 |
| GO:BP | GO:0009124 | nucleoside monophosphate biosynthetic process | 3 | 44 | 2.58e-02 |
| GO:BP | GO:1901976 | regulation of cell cycle checkpoint | 10 | 45 | 2.65e-02 |
| GO:BP | GO:0046129 | purine ribonucleoside biosynthetic process | 2 | 11 | 2.71e-02 |
| GO:BP | GO:0042455 | ribonucleoside biosynthetic process | 2 | 11 | 2.71e-02 |
| GO:BP | GO:0042451 | purine nucleoside biosynthetic process | 2 | 11 | 2.71e-02 |
| GO:BP | GO:0032261 | purine nucleotide salvage | 2 | 10 | 2.71e-02 |
| GO:BP | GO:0034644 | cellular response to UV | 19 | 83 | 2.72e-02 |
| GO:BP | GO:0006259 | DNA metabolic process | 108 | 890 | 2.76e-02 |
| GO:BP | GO:0006175 | dATP biosynthetic process | 1 | 1 | 2.85e-02 |
| GO:BP | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 8 | 68 | 2.87e-02 |
| GO:BP | GO:0038202 | TORC1 signaling | 39 | 56 | 3.01e-02 |
| GO:BP | GO:0140013 | meiotic nuclear division | 40 | 121 | 3.08e-02 |
| GO:BP | GO:0070925 | organelle assembly | 141 | 803 | 3.08e-02 |
| GO:BP | GO:2000233 | negative regulation of rRNA processing | 3 | 3 | 3.08e-02 |
| GO:BP | GO:0035878 | nail development | 2 | 7 | 3.11e-02 |
| GO:BP | GO:0006290 | pyrimidine dimer repair | 1 | 7 | 3.21e-02 |
| GO:BP | GO:0090329 | regulation of DNA-templated DNA replication | 28 | 54 | 3.31e-02 |
| GO:BP | GO:1905821 | positive regulation of chromosome condensation | 4 | 5 | 3.36e-02 |
| GO:BP | GO:0007079 | mitotic chromosome movement towards spindle pole | 3 | 4 | 3.36e-02 |
| GO:BP | GO:1901978 | positive regulation of cell cycle checkpoint | 7 | 19 | 3.39e-02 |
| GO:BP | GO:0033260 | nuclear DNA replication | 6 | 35 | 3.46e-02 |
| GO:BP | GO:0098869 | cellular oxidant detoxification | 6 | 66 | 3.46e-02 |
| GO:BP | GO:0032508 | DNA duplex unwinding | 19 | 75 | 3.59e-02 |
| GO:BP | GO:0034502 | protein localization to chromosome | 19 | 110 | 3.68e-02 |
| GO:BP | GO:0036166 | phenotypic switching | 4 | 7 | 3.74e-02 |
| GO:BP | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 19 | 60 | 3.80e-02 |
| GO:BP | GO:0090071 | negative regulation of ribosome biogenesis | 4 | 5 | 3.89e-02 |
| GO:BP | GO:0006268 | DNA unwinding involved in DNA replication | 10 | 22 | 3.89e-02 |
| GO:BP | GO:0071459 | protein localization to chromosome, centromeric region | 9 | 42 | 3.89e-02 |
| GO:BP | GO:1903432 | regulation of TORC1 signaling | 33 | 46 | 3.89e-02 |
| GO:BP | GO:0098880 | maintenance of postsynaptic specialization structure | 6 | 7 | 3.92e-02 |
| GO:BP | GO:0007076 | mitotic chromosome condensation | 12 | 19 | 4.00e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 5 | 21 | 4.05e-02 |
| GO:BP | GO:0006275 | regulation of DNA replication | 42 | 124 | 4.05e-02 |
| GO:BP | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization | 5 | 16 | 4.05e-02 |
| GO:BP | GO:0051299 | centrosome separation | 9 | 14 | 4.17e-02 |
| GO:BP | GO:0061642 | chemoattraction of axon | 2 | 2 | 4.29e-02 |
| GO:BP | GO:0009163 | nucleoside biosynthetic process | 2 | 15 | 4.33e-02 |
| GO:BP | GO:0034404 | nucleobase-containing small molecule biosynthetic process | 2 | 15 | 4.33e-02 |
| GO:BP | GO:0043101 | purine-containing compound salvage | 2 | 14 | 4.33e-02 |
| GO:BP | GO:0008315 | G2/MI transition of meiotic cell cycle | 4 | 5 | 4.33e-02 |
| GO:BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4 | 16 | 4.36e-02 |
| GO:BP | GO:0036462 | TRAIL-activated apoptotic signaling pathway | 6 | 10 | 4.37e-02 |
| GO:BP | GO:0085020 | protein K6-linked ubiquitination | 6 | 9 | 4.41e-02 |
| GO:BP | GO:0038101 | sequestering of nodal from receptor via nodal binding | 1 | 1 | 4.41e-02 |
| GO:BP | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress | 5 | 8 | 4.59e-02 |
| GO:BP | GO:1903376 | regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 5 | 8 | 4.59e-02 |
| GO:BP | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 1 | 2 | 4.67e-02 |
| GO:BP | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 22 | 72 | 4.67e-02 |
| GO:BP | GO:0032506 | cytokinetic process | 12 | 39 | 4.67e-02 |
| GO:BP | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 6 | 43 | 4.67e-02 |
| GO:BP | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process | 1 | 2 | 4.67e-02 |
| GO:BP | GO:0016321 | female meiosis chromosome segregation | 3 | 5 | 4.69e-02 |
| GO:BP | GO:0036297 | interstrand cross-link repair | 12 | 37 | 4.95e-02 |
| GO:BP | GO:0070914 | UV-damage excision repair | 1 | 13 | 4.99e-02 |
| KEGG | KEGG:04115 | p53 signaling pathway | 16 | 65 | 6.55e-07 |
| KEGG | KEGG:03410 | Base excision repair | 25 | 33 | 2.25e-04 |
| KEGG | KEGG:03030 | DNA replication | 15 | 35 | 2.25e-04 |
| KEGG | KEGG:03430 | Mismatch repair | 17 | 22 | 3.93e-03 |
| KEGG | KEGG:04110 | Cell cycle | 15 | 121 | 3.93e-03 |
| KEGG | KEGG:03440 | Homologous recombination | 13 | 39 | 4.07e-03 |
| KEGG | KEGG:01524 | Platinum drug resistance | 22 | 65 | 1.00e-02 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 2 | 61 | 1.19e-02 |
| KEGG | KEGG:04217 | Necroptosis | 2 | 106 | 1.58e-02 |
| KEGG | KEGG:05034 | Alcoholism | 2 | 122 | 1.79e-02 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 2 | 110 | 1.79e-02 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 14 | 48 | 3.30e-02 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 2 | 20 | 3.34e-02 |
Epirubicin
All Epi DEGs adj. p value < 0.05
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 108 | 1915 | 5.92e-24 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 109 | 1991 | 1.85e-23 |
| GO:BP | GO:1903506 | regulation of nucleic acid-templated transcription | 120 | 2581 | 8.86e-21 |
| GO:BP | GO:0097659 | nucleic acid-templated transcription | 122 | 2684 | 8.86e-21 |
| GO:BP | GO:0006351 | DNA-templated transcription | 122 | 2683 | 8.86e-21 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 120 | 2579 | 8.86e-21 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 120 | 2598 | 1.07e-20 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 122 | 2714 | 1.75e-20 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 125 | 2849 | 2.55e-20 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 129 | 3105 | 2.00e-19 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 124 | 3015 | 6.72e-18 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 124 | 3083 | 3.98e-17 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 124 | 3123 | 1.91e-16 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 124 | 3148 | 1.91e-16 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 124 | 3149 | 2.26e-16 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 124 | 3174 | 6.91e-16 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 124 | 3253 | 4.32e-15 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 131 | 3730 | 4.48e-14 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 144 | 4330 | 1.54e-13 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 130 | 3758 | 4.49e-13 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 145 | 4440 | 6.75e-13 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 141 | 4305 | 1.21e-12 |
| GO:BP | GO:0010468 | regulation of gene expression | 131 | 3583 | 2.93e-09 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 43 | 735 | 7.73e-09 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 125 | 4465 | 1.81e-08 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 50 | 1009 | 4.90e-08 |
| GO:BP | GO:1903507 | negative regulation of nucleic acid-templated transcription | 50 | 1011 | 4.98e-08 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 125 | 4537 | 5.54e-08 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 50 | 1020 | 6.71e-08 |
| GO:BP | GO:0009058 | biosynthetic process | 125 | 4595 | 1.58e-07 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 146 | 4640 | 2.72e-07 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 51 | 1115 | 3.20e-07 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 53 | 1206 | 6.42e-07 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 53 | 1249 | 2.27e-06 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 53 | 1273 | 4.22e-06 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 51 | 1215 | 4.79e-06 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 57 | 1431 | 1.11e-05 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 30 | 4047 | 2.65e-05 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 53 | 1304 | 2.72e-05 |
| GO:BP | GO:1903508 | positive regulation of nucleic acid-templated transcription | 53 | 1304 | 2.72e-05 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 53 | 1311 | 3.03e-05 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 63 | 1780 | 3.25e-05 |
| GO:BP | GO:0019222 | regulation of metabolic process | 137 | 5039 | 4.19e-05 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 59 | 1600 | 6.34e-05 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 42 | 925 | 1.44e-04 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 30 | 4503 | 1.85e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 63 | 1866 | 3.09e-04 |
| GO:BP | GO:0016070 | RNA metabolic process | 28 | 3593 | 3.16e-04 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 30 | 4616 | 3.16e-04 |
| GO:BP | GO:0019827 | stem cell population maintenance | 13 | 150 | 3.35e-04 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 30 | 4646 | 3.67e-04 |
| GO:BP | GO:0098727 | maintenance of cell number | 13 | 152 | 4.11e-04 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 54 | 1499 | 4.30e-04 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 46 | 2425 | 4.88e-04 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 30 | 4790 | 7.44e-04 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 30 | 4991 | 1.27e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 54 | 1571 | 1.87e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 49 | 1598 | 3.03e-03 |
| GO:BP | GO:1902459 | positive regulation of stem cell population maintenance | 6 | 44 | 3.03e-03 |
| GO:BP | GO:2000036 | regulation of stem cell population maintenance | 6 | 62 | 3.03e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 43 | 2373 | 3.67e-03 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 46 | 2648 | 4.12e-03 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 7 | 50 | 4.62e-03 |
| GO:BP | GO:1900034 | regulation of cellular response to heat | 4 | 16 | 5.03e-03 |
| GO:BP | GO:1904290 | negative regulation of mitotic DNA damage checkpoint | 1 | 1 | 7.52e-03 |
| GO:BP | GO:0015074 | DNA integration | 3 | 11 | 1.01e-02 |
| GO:BP | GO:0006297 | nucleotide-excision repair, DNA gap filling | 2 | 5 | 1.40e-02 |
| GO:BP | GO:0045444 | fat cell differentiation | 11 | 187 | 1.42e-02 |
| GO:BP | GO:0006473 | protein acetylation | 12 | 208 | 1.64e-02 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 9 | 126 | 1.70e-02 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 9 | 127 | 1.96e-02 |
| GO:BP | GO:1904289 | regulation of mitotic DNA damage checkpoint | 1 | 3 | 2.04e-02 |
| GO:BP | GO:1903676 | positive regulation of cap-dependent translational initiation | 1 | 1 | 2.31e-02 |
| GO:BP | GO:1903674 | regulation of cap-dependent translational initiation | 1 | 1 | 2.31e-02 |
| GO:BP | GO:0010944 | negative regulation of transcription by competitive promoter binding | 2 | 8 | 2.39e-02 |
| GO:BP | GO:0045643 | regulation of eosinophil differentiation | 1 | 1 | 2.51e-02 |
| GO:BP | GO:0045659 | negative regulation of neutrophil differentiation | 1 | 2 | 2.51e-02 |
| GO:BP | GO:0045645 | positive regulation of eosinophil differentiation | 1 | 1 | 2.51e-02 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 2 | 34 | 2.66e-02 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 46 | 2884 | 2.70e-02 |
| GO:BP | GO:0045658 | regulation of neutrophil differentiation | 1 | 2 | 3.57e-02 |
| GO:BP | GO:2000002 | negative regulation of DNA damage checkpoint | 1 | 5 | 3.57e-02 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 6 | 66 | 3.57e-02 |
| GO:BP | GO:0006968 | cellular defense response | 2 | 15 | 3.66e-02 |
| GO:BP | GO:0048538 | thymus development | 5 | 35 | 4.01e-02 |
| GO:BP | GO:0006325 | chromatin organization | 21 | 536 | 4.02e-02 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 4 | 67 | 4.33e-02 |
| GO:BP | GO:0043543 | protein acylation | 8 | 246 | 4.52e-02 |
| GO:BP | GO:0030853 | negative regulation of granulocyte differentiation | 2 | 6 | 4.61e-02 |
| GO:BP | GO:1900036 | positive regulation of cellular response to heat | 1 | 1 | 4.62e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 4 | 69 | 4.69e-02 |
| GO:BP | GO:0018394 | peptidyl-lysine acetylation | 10 | 180 | 4.69e-02 |
| GO:BP | GO:0055025 | positive regulation of cardiac muscle tissue development | 1 | 2 | 4.69e-02 |
| GO:BP | GO:0018076 | N-terminal peptidyl-lysine acetylation | 2 | 4 | 4.69e-02 |
| GO:BP | GO:0060324 | face development | 5 | 44 | 4.69e-02 |
| GO:BP | GO:0043923 | positive regulation by host of viral transcription | 3 | 17 | 4.69e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 12 | 229 | 4.87e-02 |
| GO:BP | GO:0030222 | eosinophil differentiation | 1 | 2 | 4.94e-02 |
| GO:BP | GO:1901977 | negative regulation of cell cycle checkpoint | 1 | 8 | 4.94e-02 |
| GO:BP | GO:0090721 | primary adaptive immune response involving T cells and B cells | 1 | 1 | 4.98e-02 |
| GO:BP | GO:0090720 | primary adaptive immune response | 1 | 1 | 4.98e-02 |
| GO:BP | GO:1903677 | regulation of cap-independent translational initiation | 1 | 3 | 4.98e-02 |
| GO:BP | GO:1903679 | positive regulation of cap-independent translational initiation | 1 | 3 | 4.98e-02 |
| KEGG | KEGG:05168 | Herpes simplex virus 1 infection | 31 | 415 | 7.79e-09 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0007059 | chromosome segregation | 103 | 378 | 4.04e-11 |
| GO:BP | GO:0000278 | mitotic cell cycle | 210 | 833 | 5.51e-11 |
| GO:BP | GO:0000819 | sister chromatid segregation | 70 | 234 | 1.28e-10 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 61 | 193 | 1.53e-10 |
| GO:BP | GO:1903047 | mitotic cell cycle process | 178 | 700 | 5.35e-10 |
| GO:BP | GO:0140014 | mitotic nuclear division | 44 | 264 | 6.38e-10 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 80 | 287 | 1.10e-08 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 111 | 620 | 1.10e-08 |
| GO:BP | GO:0051276 | chromosome organization | 122 | 543 | 3.28e-08 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 45 | 136 | 5.05e-08 |
| GO:BP | GO:0051726 | regulation of cell cycle | 151 | 950 | 5.99e-08 |
| GO:BP | GO:0045930 | negative regulation of mitotic cell cycle | 68 | 208 | 7.02e-08 |
| GO:BP | GO:0051301 | cell division | 129 | 567 | 8.59e-08 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 53 | 180 | 1.40e-07 |
| GO:BP | GO:0000280 | nuclear division | 115 | 354 | 3.17e-07 |
| GO:BP | GO:0022402 | cell cycle process | 165 | 1075 | 3.96e-07 |
| GO:BP | GO:0007049 | cell cycle | 217 | 1522 | 1.11e-06 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 20 | 42 | 1.82e-06 |
| GO:BP | GO:0007051 | spindle organization | 29 | 186 | 4.05e-06 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 37 | 118 | 4.34e-06 |
| GO:BP | GO:0007052 | mitotic spindle organization | 28 | 128 | 4.34e-06 |
| GO:BP | GO:0048285 | organelle fission | 119 | 397 | 5.95e-06 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 26 | 69 | 1.07e-05 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 96 | 334 | 1.07e-05 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 35 | 156 | 1.41e-05 |
| GO:BP | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 29 | 88 | 1.76e-05 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 110 | 438 | 1.78e-05 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 30 | 90 | 2.02e-05 |
| GO:BP | GO:0051225 | spindle assembly | 36 | 118 | 2.07e-05 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 65 | 270 | 3.12e-05 |
| GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 29 | 91 | 3.12e-05 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 58 | 232 | 3.12e-05 |
| GO:BP | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 29 | 89 | 3.12e-05 |
| GO:BP | GO:0007080 | mitotic metaphase plate congression | 14 | 55 | 3.28e-05 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 16 | 44 | 3.88e-05 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 16 | 44 | 3.88e-05 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 16 | 44 | 3.88e-05 |
| GO:BP | GO:0051304 | chromosome separation | 26 | 74 | 4.03e-05 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 21 | 54 | 4.43e-05 |
| GO:BP | GO:0006974 | cellular response to DNA damage stimulus | 150 | 789 | 4.43e-05 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 16 | 45 | 4.90e-05 |
| GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 29 | 92 | 5.09e-05 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 19 | 46 | 6.08e-05 |
| GO:BP | GO:0010965 | regulation of mitotic sister chromatid separation | 14 | 58 | 6.08e-05 |
| GO:BP | GO:0044774 | mitotic DNA integrity checkpoint signaling | 28 | 82 | 6.08e-05 |
| GO:BP | GO:0031570 | DNA integrity checkpoint signaling | 37 | 126 | 6.82e-05 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 11 | 18 | 7.36e-05 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 30 | 99 | 7.77e-05 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 17 | 52 | 7.77e-05 |
| GO:BP | GO:0051310 | metaphase plate congression | 15 | 69 | 7.77e-05 |
| GO:BP | GO:0051783 | regulation of nuclear division | 30 | 115 | 8.44e-05 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 16 | 47 | 9.08e-05 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 16 | 47 | 9.08e-05 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 16 | 47 | 9.08e-05 |
| GO:BP | GO:0006281 | DNA repair | 107 | 535 | 9.08e-05 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 16 | 47 | 9.08e-05 |
| GO:BP | GO:0051306 | mitotic sister chromatid separation | 14 | 61 | 9.08e-05 |
| GO:BP | GO:0006260 | DNA replication | 83 | 258 | 9.68e-05 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 54 | 149 | 1.06e-04 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 27 | 100 | 1.06e-04 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 85 | 552 | 1.10e-04 |
| GO:BP | GO:0033044 | regulation of chromosome organization | 53 | 233 | 1.24e-04 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 16 | 48 | 1.45e-04 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 16 | 48 | 1.45e-04 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 61 | 206 | 1.53e-04 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 64 | 388 | 1.60e-04 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 97 | 413 | 1.67e-04 |
| GO:BP | GO:0051231 | spindle elongation | 9 | 12 | 1.84e-04 |
| GO:BP | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 48 | 163 | 1.84e-04 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 26 | 78 | 1.84e-04 |
| GO:BP | GO:0051256 | mitotic spindle midzone assembly | 8 | 9 | 1.85e-04 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 76 | 305 | 2.00e-04 |
| GO:BP | GO:0050000 | chromosome localization | 16 | 82 | 2.21e-04 |
| GO:BP | GO:0000077 | DNA damage checkpoint signaling | 34 | 118 | 2.21e-04 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 21 | 57 | 2.21e-04 |
| GO:BP | GO:0044770 | cell cycle phase transition | 114 | 499 | 2.21e-04 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 16 | 25 | 2.55e-04 |
| GO:BP | GO:0090307 | mitotic spindle assembly | 17 | 69 | 2.87e-04 |
| GO:BP | GO:0051255 | spindle midzone assembly | 9 | 12 | 3.19e-04 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 15 | 75 | 3.67e-04 |
| GO:BP | GO:0000022 | mitotic spindle elongation | 8 | 10 | 4.44e-04 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 25 | 79 | 5.27e-04 |
| GO:BP | GO:0042770 | signal transduction in response to DNA damage | 34 | 173 | 5.54e-04 |
| GO:BP | GO:0060236 | regulation of mitotic spindle organization | 8 | 42 | 5.98e-04 |
| GO:BP | GO:0000086 | G2/M transition of mitotic cell cycle | 37 | 134 | 8.65e-04 |
| GO:BP | GO:0006275 | regulation of DNA replication | 45 | 124 | 9.91e-04 |
| GO:BP | GO:0006541 | glutamine metabolic process | 4 | 23 | 1.07e-03 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 64 | 318 | 1.08e-03 |
| GO:BP | GO:0090224 | regulation of spindle organization | 8 | 45 | 1.10e-03 |
| GO:BP | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 30 | 92 | 1.19e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 172 | 1023 | 1.21e-03 |
| GO:BP | GO:0051383 | kinetochore organization | 9 | 23 | 1.33e-03 |
| GO:BP | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 10 | 21 | 1.36e-03 |
| GO:BP | GO:0044839 | cell cycle G2/M phase transition | 39 | 148 | 1.49e-03 |
| GO:BP | GO:0006270 | DNA replication initiation | 18 | 35 | 1.61e-03 |
| GO:BP | GO:0090329 | regulation of DNA-templated DNA replication | 24 | 54 | 1.80e-03 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 15 | 36 | 2.11e-03 |
| GO:BP | GO:0051302 | regulation of cell division | 24 | 144 | 2.15e-03 |
| GO:BP | GO:0010212 | response to ionizing radiation | 35 | 130 | 2.93e-03 |
| GO:BP | GO:0006301 | postreplication repair | 11 | 34 | 3.17e-03 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 13 | 15 | 4.18e-03 |
| GO:BP | GO:0071478 | cellular response to radiation | 41 | 155 | 4.57e-03 |
| GO:BP | GO:1901976 | regulation of cell cycle checkpoint | 13 | 45 | 4.57e-03 |
| GO:BP | GO:1903490 | positive regulation of mitotic cytokinesis | 6 | 7 | 4.57e-03 |
| GO:BP | GO:1905820 | positive regulation of chromosome separation | 11 | 26 | 4.81e-03 |
| GO:BP | GO:0019985 | translesion synthesis | 9 | 24 | 4.87e-03 |
| GO:BP | GO:0000281 | mitotic cytokinesis | 17 | 81 | 5.93e-03 |
| GO:BP | GO:0009411 | response to UV | 34 | 137 | 5.93e-03 |
| GO:BP | GO:0044818 | mitotic G2/M transition checkpoint | 17 | 50 | 6.56e-03 |
| GO:BP | GO:0060623 | regulation of chromosome condensation | 6 | 9 | 7.13e-03 |
| GO:BP | GO:0007017 | microtubule-based process | 65 | 756 | 7.38e-03 |
| GO:BP | GO:1902412 | regulation of mitotic cytokinesis | 7 | 8 | 7.58e-03 |
| GO:BP | GO:0006167 | AMP biosynthetic process | 3 | 14 | 8.10e-03 |
| GO:BP | GO:0044314 | protein K27-linked ubiquitination | 8 | 8 | 8.43e-03 |
| GO:BP | GO:1902749 | regulation of cell cycle G2/M phase transition | 30 | 102 | 8.48e-03 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 4 | 84 | 8.48e-03 |
| GO:BP | GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 17 | 50 | 8.48e-03 |
| GO:BP | GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 13 | 35 | 8.85e-03 |
| GO:BP | GO:0006177 | GMP biosynthetic process | 3 | 14 | 9.58e-03 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 62 | 264 | 9.75e-03 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 62 | 264 | 9.75e-03 |
| GO:BP | GO:0036166 | phenotypic switching | 5 | 7 | 9.90e-03 |
| GO:BP | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 19 | 60 | 1.02e-02 |
| GO:BP | GO:1902425 | positive regulation of attachment of mitotic spindle microtubules to kinetochore | 6 | 8 | 1.04e-02 |
| GO:BP | GO:1902423 | regulation of attachment of mitotic spindle microtubules to kinetochore | 6 | 8 | 1.04e-02 |
| GO:BP | GO:0034644 | cellular response to UV | 23 | 83 | 1.05e-02 |
| GO:BP | GO:0046060 | dATP metabolic process | 2 | 3 | 1.05e-02 |
| GO:BP | GO:0000910 | cytokinesis | 20 | 163 | 1.10e-02 |
| GO:BP | GO:0032508 | DNA duplex unwinding | 24 | 75 | 1.11e-02 |
| GO:BP | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 7 | 11 | 1.19e-02 |
| GO:BP | GO:0044786 | cell cycle DNA replication | 18 | 40 | 1.29e-02 |
| GO:BP | GO:0009314 | response to radiation | 59 | 349 | 1.43e-02 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 70 | 278 | 1.46e-02 |
| GO:BP | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 19 | 62 | 1.49e-02 |
| GO:BP | GO:0046037 | GMP metabolic process | 4 | 24 | 1.59e-02 |
| GO:BP | GO:0046602 | regulation of mitotic centrosome separation | 6 | 8 | 1.64e-02 |
| GO:BP | GO:0140013 | meiotic nuclear division | 44 | 121 | 1.65e-02 |
| GO:BP | GO:0071897 | DNA biosynthetic process | 55 | 175 | 1.74e-02 |
| GO:BP | GO:0099625 | ventricular cardiac muscle cell membrane repolarization | 5 | 21 | 1.75e-02 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 47 | 136 | 1.75e-02 |
| GO:BP | GO:0030174 | regulation of DNA-templated DNA replication initiation | 9 | 14 | 1.80e-02 |
| GO:BP | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization | 3 | 7 | 1.91e-02 |
| GO:BP | GO:0007098 | centrosome cycle | 23 | 126 | 1.99e-02 |
| GO:BP | GO:0006259 | DNA metabolic process | 154 | 890 | 1.99e-02 |
| GO:BP | GO:0007079 | mitotic chromosome movement towards spindle pole | 3 | 4 | 2.08e-02 |
| GO:BP | GO:0071480 | cellular response to gamma radiation | 17 | 29 | 2.23e-02 |
| GO:BP | GO:0007076 | mitotic chromosome condensation | 8 | 19 | 2.25e-02 |
| GO:BP | GO:0061642 | chemoattraction of axon | 2 | 2 | 2.26e-02 |
| GO:BP | GO:0061640 | cytoskeleton-dependent cytokinesis | 20 | 103 | 2.28e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 7 | 11 | 2.35e-02 |
| GO:BP | GO:0000302 | response to reactive oxygen species | 24 | 160 | 2.35e-02 |
| GO:BP | GO:0034502 | protein localization to chromosome | 14 | 110 | 2.40e-02 |
| GO:BP | GO:0042148 | strand invasion | 4 | 5 | 2.58e-02 |
| GO:BP | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 3 | 22 | 2.78e-02 |
| GO:BP | GO:0006268 | DNA unwinding involved in DNA replication | 11 | 22 | 2.79e-02 |
| GO:BP | GO:0032263 | GMP salvage | 2 | 4 | 2.82e-02 |
| GO:BP | GO:0044209 | AMP salvage | 2 | 5 | 2.82e-02 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 24 | 136 | 2.84e-02 |
| GO:BP | GO:0032392 | DNA geometric change | 28 | 81 | 2.85e-02 |
| GO:BP | GO:0062197 | cellular response to chemical stress | 43 | 290 | 2.85e-02 |
| GO:BP | GO:0014029 | neural crest formation | 7 | 13 | 2.85e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 4 | 123 | 2.99e-02 |
| GO:BP | GO:0009064 | glutamine family amino acid metabolic process | 3 | 61 | 2.99e-02 |
| GO:BP | GO:0002227 | innate immune response in mucosa | 5 | 8 | 3.03e-02 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 9 | 21 | 3.04e-02 |
| GO:BP | GO:1902969 | mitotic DNA replication | 11 | 14 | 3.04e-02 |
| GO:BP | GO:1900264 | positive regulation of DNA-directed DNA polymerase activity | 11 | 13 | 3.13e-02 |
| GO:BP | GO:0051299 | centrosome separation | 13 | 14 | 3.13e-02 |
| GO:BP | GO:0007062 | sister chromatid cohesion | 29 | 51 | 3.13e-02 |
| GO:BP | GO:1900262 | regulation of DNA-directed DNA polymerase activity | 11 | 13 | 3.13e-02 |
| GO:BP | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 10 | 68 | 3.13e-02 |
| GO:BP | GO:0046033 | AMP metabolic process | 3 | 22 | 3.17e-02 |
| GO:BP | GO:0009127 | purine nucleoside monophosphate biosynthetic process | 3 | 24 | 3.17e-02 |
| GO:BP | GO:0034599 | cellular response to oxidative stress | 37 | 239 | 3.17e-02 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 8 | 20 | 3.17e-02 |
| GO:BP | GO:1905821 | positive regulation of chromosome condensation | 4 | 5 | 3.19e-02 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 3 | 9 | 3.19e-02 |
| GO:BP | GO:0086016 | AV node cell action potential | 3 | 9 | 3.19e-02 |
| GO:BP | GO:1905832 | positive regulation of spindle assembly | 5 | 7 | 3.19e-02 |
| GO:BP | GO:0042542 | response to hydrogen peroxide | 17 | 103 | 3.28e-02 |
| GO:BP | GO:0140694 | non-membrane-bounded organelle assembly | 63 | 355 | 3.28e-02 |
| GO:BP | GO:0060444 | branching involved in mammary gland duct morphogenesis | 12 | 20 | 3.28e-02 |
| GO:BP | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 6 | 12 | 3.28e-02 |
| GO:BP | GO:0090232 | positive regulation of spindle checkpoint | 6 | 12 | 3.28e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 4 | 131 | 3.37e-02 |
| GO:BP | GO:0071772 | response to BMP | 4 | 131 | 3.37e-02 |
| GO:BP | GO:0090235 | regulation of metaphase plate congression | 7 | 13 | 3.40e-02 |
| GO:BP | GO:0006290 | pyrimidine dimer repair | 1 | 7 | 3.41e-02 |
| GO:BP | GO:0034501 | protein localization to kinetochore | 11 | 18 | 3.49e-02 |
| GO:BP | GO:1903083 | protein localization to condensed chromosome | 11 | 18 | 3.49e-02 |
| GO:BP | GO:0006285 | base-excision repair, AP site formation | 10 | 12 | 3.54e-02 |
| GO:BP | GO:0010032 | meiotic chromosome condensation | 4 | 6 | 3.54e-02 |
| GO:BP | GO:0046601 | positive regulation of centriole replication | 8 | 9 | 3.54e-02 |
| GO:BP | GO:0006979 | response to oxidative stress | 41 | 349 | 3.54e-02 |
| GO:BP | GO:0006284 | base-excision repair | 27 | 44 | 3.63e-02 |
| GO:BP | GO:1901751 | leukotriene A4 metabolic process | 2 | 2 | 3.78e-02 |
| GO:BP | GO:0009084 | glutamine family amino acid biosynthetic process | 2 | 17 | 3.87e-02 |
| GO:BP | GO:0071103 | DNA conformation change | 22 | 88 | 3.87e-02 |
| GO:BP | GO:0046112 | nucleobase biosynthetic process | 9 | 18 | 3.91e-02 |
| GO:BP | GO:0060509 | type I pneumocyte differentiation | 8 | 8 | 3.99e-02 |
| GO:BP | GO:0033260 | nuclear DNA replication | 15 | 35 | 4.05e-02 |
| GO:BP | GO:1902115 | regulation of organelle assembly | 18 | 186 | 4.20e-02 |
| GO:BP | GO:0046053 | dAMP metabolic process | 2 | 5 | 4.50e-02 |
| GO:BP | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 2 | 7 | 4.50e-02 |
| GO:BP | GO:1990227 | paranodal junction maintenance | 1 | 2 | 4.50e-02 |
| GO:BP | GO:0051321 | meiotic cell cycle | 57 | 188 | 4.50e-02 |
| GO:BP | GO:0010332 | response to gamma radiation | 26 | 50 | 4.51e-02 |
| GO:BP | GO:0045132 | meiotic chromosome segregation | 23 | 69 | 4.76e-02 |
| GO:BP | GO:0051298 | centrosome duplication | 4 | 68 | 4.83e-02 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 10 | 75 | 5.00e-02 |
| KEGG | KEGG:04115 | p53 signaling pathway | 10 | 65 | 1.37e-05 |
| KEGG | KEGG:04110 | Cell cycle | 13 | 121 | 1.00e-04 |
| KEGG | KEGG:03410 | Base excision repair | 26 | 33 | 2.70e-04 |
| KEGG | KEGG:03030 | DNA replication | 13 | 35 | 4.66e-04 |
| KEGG | KEGG:03430 | Mismatch repair | 16 | 22 | 3.99e-03 |
| KEGG | KEGG:03440 | Homologous recombination | 11 | 39 | 7.47e-03 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 12 | 61 | 1.09e-02 |
| KEGG | KEGG:05034 | Alcoholism | 7 | 122 | 1.12e-02 |
| KEGG | KEGG:04217 | Necroptosis | 7 | 106 | 1.19e-02 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 2 | 110 | 1.96e-02 |
| KEGG | KEGG:01524 | Platinum drug resistance | 17 | 65 | 4.11e-02 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 2 | 20 | 4.86e-02 |
Epirubicin specific genes at 24 hours n= 489 genes are starting to show
some apoptosis enrichment for myeloid cells.
Mitoxantrone-specific 24 hour genes show an enrichment for DNA DSB
repair. (n=188)
Mitoxantrone DEGs (adj. p value < 0.05)
3 hour = 58 24 hour = 1327
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 33 | 2849 | 6.85e-08 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 31 | 2598 | 1.10e-07 |
| GO:BP | GO:1903506 | regulation of nucleic acid-templated transcription | 31 | 2581 | 1.10e-07 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 31 | 2579 | 1.10e-07 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 33 | 3105 | 1.30e-07 |
| GO:BP | GO:0006351 | DNA-templated transcription | 31 | 2683 | 1.30e-07 |
| GO:BP | GO:0097659 | nucleic acid-templated transcription | 31 | 2684 | 1.30e-07 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 31 | 2714 | 1.50e-07 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 32 | 3015 | 2.26e-07 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 32 | 3123 | 6.03e-07 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 32 | 3174 | 8.48e-07 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 28 | 1915 | 1.62e-06 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 31 | 3083 | 2.09e-06 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 36 | 4330 | 2.81e-06 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 31 | 3149 | 2.81e-06 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 31 | 3148 | 2.81e-06 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 28 | 1991 | 2.81e-06 |
| GO:BP | GO:0010468 | regulation of gene expression | 35 | 3583 | 4.67e-06 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 36 | 4440 | 5.49e-06 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 31 | 3253 | 5.86e-06 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 35 | 4305 | 9.38e-06 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 32 | 3730 | 1.87e-05 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 10 | 735 | 2.39e-05 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 32 | 3758 | 2.47e-05 |
| GO:BP | GO:0051890 | regulation of cardioblast differentiation | 3 | 7 | 8.49e-05 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 11 | 1115 | 8.90e-05 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 13 | 1780 | 1.13e-04 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 11 | 1206 | 1.61e-04 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 11 | 1215 | 1.86e-04 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 11 | 1249 | 2.18e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 13 | 1866 | 2.18e-04 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 11 | 1273 | 2.49e-04 |
| GO:BP | GO:1903507 | negative regulation of nucleic acid-templated transcription | 10 | 1011 | 2.86e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 10 | 1009 | 2.86e-04 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 36 | 4640 | 2.97e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 10 | 1020 | 2.97e-04 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 5 | 67 | 4.18e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 20 | 1431 | 6.36e-04 |
| GO:BP | GO:0060419 | heart growth | 5 | 72 | 9.71e-04 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 6 | 129 | 9.88e-04 |
| GO:BP | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress | 2 | 11 | 9.89e-04 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 32 | 4465 | 1.04e-03 |
| GO:BP | GO:0010002 | cardioblast differentiation | 3 | 17 | 1.14e-03 |
| GO:BP | GO:0110021 | cardiac muscle myoblast proliferation | 2 | 3 | 1.21e-03 |
| GO:BP | GO:0110022 | regulation of cardiac muscle myoblast proliferation | 2 | 3 | 1.21e-03 |
| GO:BP | GO:0110024 | positive regulation of cardiac muscle myoblast proliferation | 2 | 3 | 1.21e-03 |
| GO:BP | GO:0051891 | positive regulation of cardioblast differentiation | 2 | 6 | 1.24e-03 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 32 | 4537 | 1.35e-03 |
| GO:BP | GO:0035265 | organ growth | 6 | 129 | 1.63e-03 |
| GO:BP | GO:0016070 | RNA metabolic process | 35 | 3593 | 1.69e-03 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 3 | 23 | 1.75e-03 |
| GO:BP | GO:0019222 | regulation of metabolic process | 36 | 5039 | 1.75e-03 |
| GO:BP | GO:0009058 | biosynthetic process | 32 | 4595 | 1.75e-03 |
| GO:BP | GO:0003162 | atrioventricular node development | 2 | 8 | 1.98e-03 |
| GO:BP | GO:1905207 | regulation of cardiocyte differentiation | 3 | 24 | 1.98e-03 |
| GO:BP | GO:1903508 | positive regulation of nucleic acid-templated transcription | 18 | 1304 | 1.98e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 18 | 1304 | 1.98e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 20 | 1600 | 2.02e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 18 | 1311 | 2.02e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 5 | 101 | 2.03e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 4 | 65 | 2.09e-03 |
| GO:BP | GO:1900036 | positive regulation of cellular response to heat | 1 | 1 | 2.22e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 5 | 102 | 2.22e-03 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 36 | 4047 | 2.64e-03 |
| GO:BP | GO:0007507 | heart development | 10 | 502 | 2.74e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 4 | 50 | 2.82e-03 |
| GO:BP | GO:0043555 | regulation of translation in response to stress | 2 | 23 | 3.02e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 5 | 109 | 3.60e-03 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 2 | 24 | 3.67e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 13 | 2146 | 4.30e-03 |
| GO:BP | GO:0036302 | atrioventricular canal development | 2 | 12 | 4.30e-03 |
| GO:BP | GO:0003171 | atrioventricular valve development | 2 | 26 | 4.46e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 4 | 69 | 5.14e-03 |
| GO:BP | GO:1905209 | positive regulation of cardiocyte differentiation | 2 | 13 | 5.47e-03 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 2 | 27 | 6.04e-03 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 6 | 198 | 6.25e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 14 | 925 | 6.42e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 3 | 27 | 6.59e-03 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 10 | 478 | 6.68e-03 |
| GO:BP | GO:0072164 | mesonephric tubule development | 2 | 76 | 7.17e-03 |
| GO:BP | GO:0001657 | ureteric bud development | 2 | 75 | 7.17e-03 |
| GO:BP | GO:0003176 | aortic valve development | 2 | 31 | 7.17e-03 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 2 | 76 | 7.17e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 18 | 1499 | 7.17e-03 |
| GO:BP | GO:0060976 | coronary vasculature development | 3 | 44 | 7.17e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 13 | 2306 | 7.17e-03 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 24 | 2373 | 7.45e-03 |
| GO:BP | GO:0001823 | mesonephros development | 2 | 77 | 7.57e-03 |
| GO:BP | GO:0014706 | striated muscle tissue development | 6 | 210 | 7.73e-03 |
| GO:BP | GO:1905314 | semi-lunar valve development | 2 | 35 | 8.29e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 4 | 70 | 8.46e-03 |
| GO:BP | GO:1902010 | negative regulation of translation in response to endoplasmic reticulum stress | 1 | 1 | 9.10e-03 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 3 | 84 | 9.47e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 6 | 212 | 1.01e-02 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 3 | 45 | 1.04e-02 |
| GO:BP | GO:0003205 | cardiac chamber development | 5 | 149 | 1.04e-02 |
| GO:BP | GO:2000738 | positive regulation of stem cell differentiation | 2 | 20 | 1.08e-02 |
| GO:BP | GO:0060575 | intestinal epithelial cell differentiation | 2 | 17 | 1.08e-02 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 11 | 739 | 1.10e-02 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 18 | 1571 | 1.11e-02 |
| GO:BP | GO:0007352 | zygotic specification of dorsal/ventral axis | 1 | 2 | 1.11e-02 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 27 | 2884 | 1.16e-02 |
| GO:BP | GO:2000288 | positive regulation of myoblast proliferation | 2 | 9 | 1.16e-02 |
| GO:BP | GO:1903674 | regulation of cap-dependent translational initiation | 1 | 1 | 1.17e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 3 | 79 | 1.17e-02 |
| GO:BP | GO:1903676 | positive regulation of cap-dependent translational initiation | 1 | 1 | 1.17e-02 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 3 | 33 | 1.17e-02 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 36 | 4503 | 1.18e-02 |
| GO:BP | GO:0072073 | kidney epithelium development | 2 | 112 | 1.22e-02 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 2 | 50 | 1.22e-02 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 18 | 1598 | 1.28e-02 |
| GO:BP | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 2 | 10 | 1.31e-02 |
| GO:BP | GO:0090720 | primary adaptive immune response | 1 | 1 | 1.33e-02 |
| GO:BP | GO:0090721 | primary adaptive immune response involving T cells and B cells | 1 | 1 | 1.33e-02 |
| GO:BP | GO:0034504 | protein localization to nucleus | 6 | 274 | 1.33e-02 |
| GO:BP | GO:0048565 | digestive tract development | 3 | 91 | 1.51e-02 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 14 | 4616 | 1.60e-02 |
| GO:BP | GO:0003170 | heart valve development | 2 | 57 | 1.60e-02 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 25 | 2648 | 1.66e-02 |
| GO:BP | GO:0060537 | muscle tissue development | 7 | 340 | 1.72e-02 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 14 | 4646 | 1.72e-02 |
| GO:BP | GO:2000291 | regulation of myoblast proliferation | 2 | 11 | 1.77e-02 |
| GO:BP | GO:0055123 | digestive system development | 3 | 99 | 1.83e-02 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 23 | 2425 | 1.87e-02 |
| GO:BP | GO:0051170 | import into nucleus | 4 | 151 | 1.89e-02 |
| GO:BP | GO:1900034 | regulation of cellular response to heat | 1 | 16 | 1.89e-02 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 2 | 17 | 1.97e-02 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 2 | 34 | 1.97e-02 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 3 | 66 | 2.03e-02 |
| GO:BP | GO:0003161 | cardiac conduction system development | 2 | 34 | 2.04e-02 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 2 | 34 | 2.08e-02 |
| GO:BP | GO:2000736 | regulation of stem cell differentiation | 3 | 74 | 2.08e-02 |
| GO:BP | GO:1904003 | negative regulation of sebum secreting cell proliferation | 1 | 1 | 2.08e-02 |
| GO:BP | GO:0010991 | negative regulation of SMAD protein complex assembly | 1 | 5 | 2.08e-02 |
| GO:BP | GO:0003290 | atrial septum secundum morphogenesis | 1 | 2 | 2.08e-02 |
| GO:BP | GO:0009725 | response to hormone | 4 | 629 | 2.10e-02 |
| GO:BP | GO:0035904 | aorta development | 3 | 49 | 2.10e-02 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 2 | 36 | 2.10e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 4 | 114 | 2.10e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 3 | 123 | 2.10e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 2 | 37 | 2.10e-02 |
| GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 2 | 15 | 2.10e-02 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 14 | 4790 | 2.13e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 3 | 72 | 2.19e-02 |
| GO:BP | GO:0021756 | striatum development | 2 | 17 | 2.24e-02 |
| GO:BP | GO:0006913 | nucleocytoplasmic transport | 4 | 294 | 2.25e-02 |
| GO:BP | GO:0010990 | regulation of SMAD protein complex assembly | 1 | 6 | 2.25e-02 |
| GO:BP | GO:0051169 | nuclear transport | 4 | 294 | 2.25e-02 |
| GO:BP | GO:0032055 | negative regulation of translation in response to stress | 1 | 4 | 2.25e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 2 | 39 | 2.25e-02 |
| GO:BP | GO:0021542 | dentate gyrus development | 2 | 10 | 2.25e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 3 | 73 | 2.30e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 3 | 131 | 2.31e-02 |
| GO:BP | GO:0071772 | response to BMP | 3 | 131 | 2.31e-02 |
| GO:BP | GO:0009880 | embryonic pattern specification | 3 | 50 | 2.35e-02 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 2 | 21 | 2.35e-02 |
| GO:BP | GO:1902882 | regulation of response to oxidative stress | 2 | 77 | 2.35e-02 |
| GO:BP | GO:1903677 | regulation of cap-independent translational initiation | 1 | 3 | 2.35e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 3 | 74 | 2.35e-02 |
| GO:BP | GO:1903679 | positive regulation of cap-independent translational initiation | 1 | 3 | 2.35e-02 |
| GO:BP | GO:0009749 | response to glucose | 3 | 139 | 2.38e-02 |
| GO:BP | GO:0003301 | physiological cardiac muscle hypertrophy | 2 | 19 | 2.38e-02 |
| GO:BP | GO:0003298 | physiological muscle hypertrophy | 2 | 19 | 2.38e-02 |
| GO:BP | GO:0061049 | cell growth involved in cardiac muscle cell development | 2 | 19 | 2.38e-02 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 14 | 4991 | 2.43e-02 |
| GO:BP | GO:0009746 | response to hexose | 3 | 140 | 2.45e-02 |
| GO:BP | GO:1904504 | positive regulation of lipophagy | 1 | 5 | 2.45e-02 |
| GO:BP | GO:1904502 | regulation of lipophagy | 1 | 5 | 2.45e-02 |
| GO:BP | GO:0035054 | embryonic heart tube anterior/posterior pattern specification | 1 | 2 | 2.45e-02 |
| GO:BP | GO:0003285 | septum secundum development | 1 | 3 | 2.45e-02 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 5 | 1091 | 2.45e-02 |
| GO:BP | GO:0034284 | response to monosaccharide | 3 | 144 | 2.72e-02 |
| GO:BP | GO:2000257 | regulation of protein activation cascade | 1 | 1 | 2.87e-02 |
| GO:BP | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1 | 4 | 2.87e-02 |
| GO:BP | GO:0002190 | cap-independent translational initiation | 1 | 4 | 2.87e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 3 | 62 | 2.90e-02 |
| GO:BP | GO:2000691 | negative regulation of cardiac muscle cell myoblast differentiation | 1 | 1 | 2.95e-02 |
| GO:BP | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation | 1 | 1 | 2.95e-02 |
| GO:BP | GO:0051450 | myoblast proliferation | 2 | 17 | 2.95e-02 |
| GO:BP | GO:0003417 | growth plate cartilage development | 1 | 14 | 2.95e-02 |
| GO:BP | GO:0021544 | subpallium development | 2 | 18 | 2.97e-02 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 2 | 24 | 2.97e-02 |
| GO:BP | GO:0007493 | endodermal cell fate determination | 1 | 1 | 2.97e-02 |
| GO:BP | GO:0032912 | negative regulation of transforming growth factor beta2 production | 1 | 2 | 2.97e-02 |
| GO:BP | GO:0001949 | sebaceous gland cell differentiation | 1 | 1 | 2.97e-02 |
| GO:BP | GO:1904002 | regulation of sebum secreting cell proliferation | 1 | 1 | 2.97e-02 |
| GO:BP | GO:0003183 | mitral valve morphogenesis | 1 | 10 | 2.97e-02 |
| GO:BP | GO:1901390 | positive regulation of transforming growth factor beta activation | 1 | 2 | 2.97e-02 |
| GO:BP | GO:0010467 | gene expression | 27 | 4572 | 2.97e-02 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 10 | 659 | 2.98e-02 |
| GO:BP | GO:0072359 | circulatory system development | 10 | 879 | 3.01e-02 |
| GO:BP | GO:0045638 | negative regulation of myeloid cell differentiation | 3 | 68 | 3.01e-02 |
| GO:BP | GO:0001822 | kidney development | 2 | 244 | 3.03e-02 |
| GO:BP | GO:0061724 | lipophagy | 1 | 7 | 3.03e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 3 | 49 | 3.12e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 3 | 70 | 3.12e-02 |
| GO:BP | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress | 1 | 5 | 3.12e-02 |
| GO:BP | GO:0003174 | mitral valve development | 1 | 11 | 3.12e-02 |
| GO:BP | GO:1904690 | positive regulation of cytoplasmic translational initiation | 1 | 5 | 3.12e-02 |
| GO:BP | GO:0072001 | renal system development | 2 | 250 | 3.12e-02 |
| GO:BP | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 1 | 5 | 3.12e-02 |
| GO:BP | GO:0040007 | growth | 10 | 736 | 3.13e-02 |
| GO:BP | GO:2000647 | negative regulation of stem cell proliferation | 1 | 18 | 3.15e-02 |
| GO:BP | GO:0002089 | lens morphogenesis in camera-type eye | 2 | 18 | 3.15e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 2 | 18 | 3.15e-02 |
| GO:BP | GO:0009743 | response to carbohydrate | 3 | 163 | 3.19e-02 |
| GO:BP | GO:0009950 | dorsal/ventral axis specification | 1 | 10 | 3.19e-02 |
| GO:BP | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 1 | 12 | 3.19e-02 |
| GO:BP | GO:0072331 | signal transduction by p53 class mediator | 3 | 160 | 3.19e-02 |
| GO:BP | GO:0007183 | SMAD protein complex assembly | 1 | 12 | 3.19e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 2 | 51 | 3.21e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 2 | 52 | 3.26e-02 |
| GO:BP | GO:0003289 | atrial septum primum morphogenesis | 1 | 5 | 3.26e-02 |
| GO:BP | GO:0032331 | negative regulation of chondrocyte differentiation | 1 | 18 | 3.26e-02 |
| GO:BP | GO:0003284 | septum primum development | 1 | 5 | 3.26e-02 |
| GO:BP | GO:0048589 | developmental growth | 8 | 516 | 3.39e-02 |
| GO:BP | GO:0002194 | hepatocyte cell migration | 1 | 1 | 3.39e-02 |
| GO:BP | GO:0043049 | otic placode formation | 1 | 1 | 3.39e-02 |
| GO:BP | GO:1903898 | negative regulation of PERK-mediated unfolded protein response | 1 | 6 | 3.39e-02 |
| GO:BP | GO:1904688 | regulation of cytoplasmic translational initiation | 1 | 6 | 3.39e-02 |
| GO:BP | GO:0061114 | branching involved in pancreas morphogenesis | 1 | 1 | 3.39e-02 |
| GO:BP | GO:2000979 | positive regulation of forebrain neuron differentiation | 1 | 1 | 3.39e-02 |
| GO:BP | GO:2000178 | negative regulation of neural precursor cell proliferation | 2 | 21 | 3.42e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 2 | 127 | 3.42e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 3 | 76 | 3.42e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 1 | 22 | 3.42e-02 |
| GO:BP | GO:0034616 | response to laminar fluid shear stress | 1 | 14 | 3.42e-02 |
| GO:BP | GO:0035116 | embryonic hindlimb morphogenesis | 1 | 17 | 3.42e-02 |
| GO:BP | GO:1901031 | regulation of response to reactive oxygen species | 2 | 29 | 3.49e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 4 | 151 | 3.52e-02 |
| GO:BP | GO:1990654 | sebum secreting cell proliferation | 1 | 2 | 3.55e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 2 | 57 | 3.55e-02 |
| GO:BP | GO:0031016 | pancreas development | 3 | 52 | 3.55e-02 |
| GO:BP | GO:0061061 | muscle structure development | 8 | 543 | 3.55e-02 |
| GO:BP | GO:0061026 | cardiac muscle tissue regeneration | 1 | 6 | 3.55e-02 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 5 | 1258 | 3.55e-02 |
| GO:BP | GO:0098868 | bone growth | 1 | 23 | 3.63e-02 |
| GO:BP | GO:0061037 | negative regulation of cartilage development | 1 | 23 | 3.63e-02 |
| GO:BP | GO:0036492 | eiF2alpha phosphorylation in response to endoplasmic reticulum stress | 1 | 7 | 3.65e-02 |
| GO:BP | GO:0034605 | cellular response to heat | 1 | 51 | 3.65e-02 |
| GO:BP | GO:0002191 | cap-dependent translational initiation | 1 | 7 | 3.65e-02 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 1 | 26 | 3.69e-02 |
| GO:BP | GO:0048566 | embryonic digestive tract development | 1 | 20 | 3.77e-02 |
| GO:BP | GO:0071233 | cellular response to leucine | 1 | 10 | 3.77e-02 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 1 | 17 | 3.79e-02 |
| GO:BP | GO:0043627 | response to estrogen | 2 | 51 | 3.79e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1 | 25 | 3.79e-02 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 5 | 231 | 3.79e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 2 | 60 | 3.79e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 2 | 62 | 3.79e-02 |
| GO:BP | GO:0048048 | embryonic eye morphogenesis | 1 | 25 | 3.86e-02 |
| GO:BP | GO:0060290 | transdifferentiation | 1 | 2 | 3.86e-02 |
| GO:BP | GO:0035137 | hindlimb morphogenesis | 1 | 20 | 3.86e-02 |
| GO:BP | GO:0032056 | positive regulation of translation in response to stress | 1 | 8 | 3.90e-02 |
| GO:BP | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress | 1 | 8 | 3.90e-02 |
| GO:BP | GO:0007172 | signal complex assembly | 1 | 7 | 3.90e-02 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 2 | 32 | 3.90e-02 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 15 | 3628 | 3.99e-02 |
| GO:BP | GO:0002068 | glandular epithelial cell development | 1 | 28 | 3.99e-02 |
| GO:BP | GO:0051892 | negative regulation of cardioblast differentiation | 1 | 1 | 4.07e-02 |
| GO:BP | GO:1990253 | cellular response to leucine starvation | 1 | 13 | 4.16e-02 |
| GO:BP | GO:0032665 | regulation of interleukin-21 production | 1 | 1 | 4.16e-02 |
| GO:BP | GO:0032625 | interleukin-21 production | 1 | 1 | 4.16e-02 |
| GO:BP | GO:0060486 | club cell differentiation | 1 | 3 | 4.16e-02 |
| GO:BP | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response | 2 | 28 | 4.16e-02 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 2 | 26 | 4.16e-02 |
| GO:BP | GO:0003190 | atrioventricular valve formation | 1 | 8 | 4.16e-02 |
| GO:BP | GO:0032745 | positive regulation of interleukin-21 production | 1 | 1 | 4.16e-02 |
| GO:BP | GO:0006930 | substrate-dependent cell migration, cell extension | 1 | 8 | 4.19e-02 |
| GO:BP | GO:0080134 | regulation of response to stress | 7 | 1084 | 4.24e-02 |
| GO:BP | GO:0098751 | bone cell development | 2 | 26 | 4.30e-02 |
| GO:BP | GO:0003177 | pulmonary valve development | 1 | 20 | 4.30e-02 |
| GO:BP | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress | 1 | 10 | 4.56e-02 |
| GO:BP | GO:0043201 | response to leucine | 1 | 13 | 4.56e-02 |
| GO:BP | GO:0048617 | embryonic foregut morphogenesis | 1 | 6 | 4.56e-02 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 3 | 1141 | 4.68e-02 |
| GO:BP | GO:0007492 | endoderm development | 2 | 65 | 4.68e-02 |
| GO:BP | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 2 | 29 | 4.80e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3 | 229 | 4.82e-02 |
| GO:BP | GO:0060840 | artery development | 3 | 82 | 4.82e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 2 | 76 | 4.82e-02 |
| GO:BP | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation | 1 | 11 | 4.87e-02 |
| GO:BP | GO:1903897 | regulation of PERK-mediated unfolded protein response | 1 | 10 | 4.87e-02 |
| GO:BP | GO:0007440 | foregut morphogenesis | 1 | 7 | 4.89e-02 |
| GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 1 | 38 | 4.89e-02 |
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:1903047 | mitotic cell cycle process | 99 | 700 | 1.02e-61 |
| GO:BP | GO:0022402 | cell cycle process | 117 | 1075 | 4.84e-60 |
| GO:BP | GO:0000278 | mitotic cell cycle | 104 | 833 | 4.84e-60 |
| GO:BP | GO:0007049 | cell cycle | 133 | 1522 | 1.01e-58 |
| GO:BP | GO:0007059 | chromosome segregation | 75 | 378 | 9.96e-55 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 66 | 287 | 7.07e-51 |
| GO:BP | GO:0000280 | nuclear division | 72 | 354 | 9.04e-50 |
| GO:BP | GO:0140014 | mitotic nuclear division | 61 | 264 | 1.43e-48 |
| GO:BP | GO:0051276 | chromosome organization | 84 | 543 | 2.28e-48 |
| GO:BP | GO:0000819 | sister chromatid segregation | 57 | 234 | 1.93e-47 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 53 | 193 | 3.35e-47 |
| GO:BP | GO:0048285 | organelle fission | 72 | 397 | 6.12e-47 |
| GO:BP | GO:0051301 | cell division | 80 | 567 | 6.18e-47 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 98 | 620 | 3.56e-45 |
| GO:BP | GO:0051726 | regulation of cell cycle | 87 | 950 | 7.08e-40 |
| GO:BP | GO:0044770 | cell cycle phase transition | 76 | 499 | 4.59e-34 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 68 | 388 | 3.42e-32 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 47 | 180 | 7.73e-32 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 56 | 149 | 2.62e-30 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 69 | 438 | 1.54e-29 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 66 | 413 | 2.50e-29 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 40 | 136 | 2.93e-29 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 28 | 156 | 5.47e-29 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 26 | 118 | 5.56e-28 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 49 | 232 | 6.25e-28 |
| GO:BP | GO:0006260 | DNA replication | 70 | 258 | 7.28e-28 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 52 | 270 | 1.34e-27 |
| GO:BP | GO:0007051 | spindle organization | 26 | 186 | 2.38e-27 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 55 | 305 | 6.02e-27 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 39 | 206 | 1.69e-25 |
| GO:BP | GO:0007052 | mitotic spindle organization | 22 | 128 | 2.88e-25 |
| GO:BP | GO:0045930 | negative regulation of mitotic cell cycle | 44 | 208 | 3.93e-25 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 55 | 334 | 4.10e-25 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 49 | 552 | 5.25e-25 |
| GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 22 | 91 | 7.33e-25 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 20 | 69 | 8.92e-25 |
| GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 22 | 92 | 1.48e-24 |
| GO:BP | GO:0051304 | chromosome separation | 20 | 74 | 4.79e-24 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 22 | 99 | 9.24e-24 |
| GO:BP | GO:0006974 | cellular response to DNA damage stimulus | 109 | 789 | 1.34e-23 |
| GO:BP | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 21 | 88 | 1.44e-23 |
| GO:BP | GO:0006259 | DNA metabolic process | 85 | 890 | 1.69e-23 |
| GO:BP | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 21 | 89 | 2.87e-23 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 29 | 100 | 4.13e-23 |
| GO:BP | GO:0010965 | regulation of mitotic sister chromatid separation | 18 | 58 | 5.60e-23 |
| GO:BP | GO:0051306 | mitotic sister chromatid separation | 18 | 61 | 1.45e-22 |
| GO:BP | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 33 | 163 | 2.04e-22 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 41 | 278 | 3.32e-22 |
| GO:BP | GO:0033044 | regulation of chromosome organization | 27 | 233 | 1.07e-21 |
| GO:BP | GO:0051783 | regulation of nuclear division | 29 | 115 | 1.16e-21 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 16 | 44 | 1.27e-21 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 16 | 44 | 1.27e-21 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 16 | 44 | 1.27e-21 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 16 | 45 | 1.85e-21 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 19 | 42 | 2.30e-21 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 16 | 46 | 2.64e-21 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 16 | 47 | 5.22e-21 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 16 | 47 | 5.22e-21 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 16 | 47 | 5.22e-21 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 16 | 47 | 5.22e-21 |
| GO:BP | GO:0007017 | microtubule-based process | 41 | 756 | 8.17e-21 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 19 | 90 | 8.88e-21 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 16 | 48 | 1.00e-20 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 16 | 48 | 1.00e-20 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 16 | 52 | 2.72e-20 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 16 | 54 | 3.71e-20 |
| GO:BP | GO:0006281 | DNA repair | 81 | 535 | 5.94e-20 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 16 | 57 | 2.92e-19 |
| GO:BP | GO:0051225 | spindle assembly | 18 | 118 | 4.37e-19 |
| GO:BP | GO:0051310 | metaphase plate congression | 20 | 69 | 8.69e-19 |
| GO:BP | GO:0031570 | DNA integrity checkpoint signaling | 29 | 126 | 5.46e-18 |
| GO:BP | GO:0050000 | chromosome localization | 21 | 82 | 5.75e-18 |
| GO:BP | GO:0006270 | DNA replication initiation | 22 | 35 | 6.50e-18 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 20 | 75 | 2.32e-17 |
| GO:BP | GO:0006996 | organelle organization | 92 | 2971 | 4.16e-17 |
| GO:BP | GO:0051321 | meiotic cell cycle | 32 | 188 | 1.22e-16 |
| GO:BP | GO:0090307 | mitotic spindle assembly | 14 | 69 | 1.22e-16 |
| GO:BP | GO:0007080 | mitotic metaphase plate congression | 17 | 55 | 1.96e-16 |
| GO:BP | GO:0140694 | non-membrane-bounded organelle assembly | 23 | 355 | 2.02e-16 |
| GO:BP | GO:0090329 | regulation of DNA-templated DNA replication | 24 | 54 | 3.77e-16 |
| GO:BP | GO:0033043 | regulation of organelle organization | 41 | 1023 | 1.36e-15 |
| GO:BP | GO:0044839 | cell cycle G2/M phase transition | 35 | 148 | 1.55e-15 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 27 | 136 | 2.70e-15 |
| GO:BP | GO:0140013 | meiotic nuclear division | 26 | 121 | 2.98e-15 |
| GO:BP | GO:0000086 | G2/M transition of mitotic cell cycle | 30 | 134 | 5.76e-15 |
| GO:BP | GO:0032392 | DNA geometric change | 29 | 81 | 7.20e-15 |
| GO:BP | GO:0032508 | DNA duplex unwinding | 28 | 75 | 8.18e-15 |
| GO:BP | GO:0000077 | DNA damage checkpoint signaling | 25 | 118 | 1.58e-14 |
| GO:BP | GO:0000281 | mitotic cytokinesis | 14 | 81 | 1.97e-14 |
| GO:BP | GO:0007010 | cytoskeleton organization | 42 | 1222 | 2.79e-14 |
| GO:BP | GO:0044774 | mitotic DNA integrity checkpoint signaling | 21 | 82 | 5.71e-14 |
| GO:BP | GO:0042770 | signal transduction in response to DNA damage | 29 | 173 | 6.10e-14 |
| GO:BP | GO:0071103 | DNA conformation change | 29 | 88 | 9.60e-14 |
| GO:BP | GO:0006275 | regulation of DNA replication | 34 | 124 | 1.54e-13 |
| GO:BP | GO:0000910 | cytokinesis | 21 | 163 | 1.94e-13 |
| GO:BP | GO:0033554 | cellular response to stress | 151 | 1677 | 2.01e-13 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 20 | 78 | 2.74e-13 |
| GO:BP | GO:0045132 | meiotic chromosome segregation | 19 | 69 | 3.04e-13 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 11 | 25 | 6.92e-13 |
| GO:BP | GO:0061640 | cytoskeleton-dependent cytokinesis | 14 | 103 | 9.97e-13 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 11 | 18 | 1.77e-12 |
| GO:BP | GO:1901976 | regulation of cell cycle checkpoint | 13 | 45 | 4.46e-12 |
| GO:BP | GO:0051231 | spindle elongation | 8 | 12 | 4.54e-12 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 19 | 79 | 9.88e-12 |
| GO:BP | GO:0044786 | cell cycle DNA replication | 18 | 40 | 1.80e-11 |
| GO:BP | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 22 | 92 | 1.98e-11 |
| GO:BP | GO:0033260 | nuclear DNA replication | 17 | 35 | 2.15e-11 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 20 | 318 | 3.79e-11 |
| GO:BP | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 8 | 21 | 4.14e-11 |
| GO:BP | GO:0051256 | mitotic spindle midzone assembly | 7 | 9 | 5.90e-11 |
| GO:BP | GO:1905820 | positive regulation of chromosome separation | 10 | 26 | 7.74e-11 |
| GO:BP | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 19 | 86 | 7.87e-11 |
| GO:BP | GO:0006268 | DNA unwinding involved in DNA replication | 10 | 22 | 7.88e-11 |
| GO:BP | GO:1901989 | positive regulation of cell cycle phase transition | 21 | 103 | 7.88e-11 |
| GO:BP | GO:0051656 | establishment of organelle localization | 22 | 375 | 9.91e-11 |
| GO:BP | GO:0000022 | mitotic spindle elongation | 7 | 10 | 1.33e-10 |
| GO:BP | GO:1902749 | regulation of cell cycle G2/M phase transition | 22 | 102 | 1.74e-10 |
| GO:BP | GO:0051302 | regulation of cell division | 24 | 144 | 2.23e-10 |
| GO:BP | GO:1900264 | positive regulation of DNA-directed DNA polymerase activity | 11 | 13 | 2.48e-10 |
| GO:BP | GO:1900262 | regulation of DNA-directed DNA polymerase activity | 11 | 13 | 2.48e-10 |
| GO:BP | GO:0051383 | kinetochore organization | 9 | 23 | 3.31e-10 |
| GO:BP | GO:0051640 | organelle localization | 24 | 498 | 3.41e-10 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 23 | 113 | 3.94e-10 |
| GO:BP | GO:0051255 | spindle midzone assembly | 7 | 12 | 5.33e-10 |
| GO:BP | GO:0000727 | double-strand break repair via break-induced replication | 7 | 11 | 5.78e-10 |
| GO:BP | GO:0051052 | regulation of DNA metabolic process | 39 | 459 | 7.41e-10 |
| GO:BP | GO:0006310 | DNA recombination | 24 | 256 | 1.11e-09 |
| GO:BP | GO:0070925 | organelle assembly | 25 | 803 | 1.20e-09 |
| GO:BP | GO:0006302 | double-strand break repair | 23 | 270 | 1.30e-09 |
| GO:BP | GO:0034502 | protein localization to chromosome | 26 | 110 | 1.38e-09 |
| GO:BP | GO:0061982 | meiosis I cell cycle process | 17 | 80 | 2.59e-09 |
| GO:BP | GO:1902969 | mitotic DNA replication | 10 | 14 | 2.67e-09 |
| GO:BP | GO:0065004 | protein-DNA complex assembly | 31 | 185 | 2.72e-09 |
| GO:BP | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint | 7 | 19 | 3.51e-09 |
| GO:BP | GO:0090231 | regulation of spindle checkpoint | 7 | 19 | 3.51e-09 |
| GO:BP | GO:1903504 | regulation of mitotic spindle checkpoint | 7 | 19 | 3.51e-09 |
| GO:BP | GO:0030174 | regulation of DNA-templated DNA replication initiation | 7 | 14 | 4.17e-09 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 37 | 1947 | 6.86e-09 |
| GO:BP | GO:0034508 | centromere complex assembly | 16 | 30 | 7.37e-09 |
| GO:BP | GO:0032467 | positive regulation of cytokinesis | 12 | 33 | 7.86e-09 |
| GO:BP | GO:0007127 | meiosis I | 16 | 76 | 1.17e-08 |
| GO:BP | GO:0071824 | protein-DNA complex subunit organization | 20 | 204 | 1.23e-08 |
| GO:BP | GO:0030261 | chromosome condensation | 10 | 34 | 1.52e-08 |
| GO:BP | GO:0000724 | double-strand break repair via homologous recombination | 20 | 147 | 1.72e-08 |
| GO:BP | GO:0090224 | regulation of spindle organization | 10 | 45 | 1.86e-08 |
| GO:BP | GO:0071459 | protein localization to chromosome, centromeric region | 11 | 42 | 2.28e-08 |
| GO:BP | GO:0051653 | spindle localization | 9 | 52 | 2.35e-08 |
| GO:BP | GO:0000725 | recombinational repair | 20 | 151 | 2.55e-08 |
| GO:BP | GO:0007062 | sister chromatid cohesion | 11 | 51 | 4.52e-08 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 22 | 586 | 8.09e-08 |
| GO:BP | GO:0007143 | female meiotic nuclear division | 6 | 25 | 8.54e-08 |
| GO:BP | GO:1901970 | positive regulation of mitotic sister chromatid separation | 6 | 18 | 9.99e-08 |
| GO:BP | GO:0010212 | response to ionizing radiation | 28 | 130 | 1.11e-07 |
| GO:BP | GO:1901978 | positive regulation of cell cycle checkpoint | 6 | 19 | 1.12e-07 |
| GO:BP | GO:0060236 | regulation of mitotic spindle organization | 9 | 42 | 1.65e-07 |
| GO:BP | GO:0051293 | establishment of spindle localization | 8 | 48 | 2.87e-07 |
| GO:BP | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 13 | 87 | 3.53e-07 |
| GO:BP | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 10 | 60 | 3.98e-07 |
| GO:BP | GO:1904029 | regulation of cyclin-dependent protein kinase activity | 13 | 90 | 4.82e-07 |
| GO:BP | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 5 | 12 | 4.95e-07 |
| GO:BP | GO:0090232 | positive regulation of spindle checkpoint | 5 | 12 | 4.95e-07 |
| GO:BP | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 10 | 62 | 5.32e-07 |
| GO:BP | GO:0000076 | DNA replication checkpoint signaling | 9 | 15 | 5.39e-07 |
| GO:BP | GO:0071897 | DNA biosynthetic process | 31 | 175 | 5.53e-07 |
| GO:BP | GO:0034501 | protein localization to kinetochore | 7 | 18 | 5.70e-07 |
| GO:BP | GO:1903083 | protein localization to condensed chromosome | 7 | 18 | 5.70e-07 |
| GO:BP | GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 8 | 35 | 5.93e-07 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 9 | 15 | 6.02e-07 |
| GO:BP | GO:0040001 | establishment of mitotic spindle localization | 7 | 36 | 6.27e-07 |
| GO:BP | GO:0044818 | mitotic G2/M transition checkpoint | 9 | 50 | 7.99e-07 |
| GO:BP | GO:0071479 | cellular response to ionizing radiation | 11 | 68 | 8.20e-07 |
| GO:BP | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 9 | 27 | 8.22e-07 |
| GO:BP | GO:0007098 | centrosome cycle | 13 | 126 | 1.17e-06 |
| GO:BP | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 6 | 11 | 1.67e-06 |
| GO:BP | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 9 | 30 | 2.20e-06 |
| GO:BP | GO:0008315 | G2/MI transition of meiotic cell cycle | 5 | 5 | 2.63e-06 |
| GO:BP | GO:0007076 | mitotic chromosome condensation | 6 | 19 | 3.00e-06 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 13 | 136 | 3.38e-06 |
| GO:BP | GO:0070507 | regulation of microtubule cytoskeleton organization | 13 | 146 | 3.42e-06 |
| GO:BP | GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 12 | 50 | 3.42e-06 |
| GO:BP | GO:1903490 | positive regulation of mitotic cytokinesis | 5 | 7 | 3.65e-06 |
| GO:BP | GO:0044771 | meiotic cell cycle phase transition | 6 | 7 | 4.53e-06 |
| GO:BP | GO:0051382 | kinetochore assembly | 4 | 18 | 4.95e-06 |
| GO:BP | GO:0070192 | chromosome organization involved in meiotic cell cycle | 10 | 44 | 5.50e-06 |
| GO:BP | GO:0090235 | regulation of metaphase plate congression | 6 | 13 | 5.62e-06 |
| GO:BP | GO:0032506 | cytokinetic process | 8 | 39 | 6.94e-06 |
| GO:BP | GO:0044843 | cell cycle G1/S phase transition | 32 | 225 | 8.02e-06 |
| GO:BP | GO:1902425 | positive regulation of attachment of mitotic spindle microtubules to kinetochore | 5 | 8 | 9.15e-06 |
| GO:BP | GO:1902423 | regulation of attachment of mitotic spindle microtubules to kinetochore | 5 | 8 | 9.15e-06 |
| GO:BP | GO:1902292 | cell cycle DNA replication initiation | 5 | 5 | 9.31e-06 |
| GO:BP | GO:1902975 | mitotic DNA replication initiation | 5 | 5 | 9.31e-06 |
| GO:BP | GO:1902315 | nuclear cell cycle DNA replication initiation | 5 | 5 | 9.31e-06 |
| GO:BP | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 14 | 43 | 9.55e-06 |
| GO:BP | GO:0000212 | meiotic spindle organization | 4 | 14 | 1.60e-05 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 29 | 203 | 1.63e-05 |
| GO:BP | GO:0010332 | response to gamma radiation | 14 | 50 | 1.70e-05 |
| GO:BP | GO:0051294 | establishment of spindle orientation | 6 | 36 | 1.83e-05 |
| GO:BP | GO:0072331 | signal transduction by p53 class mediator | 29 | 160 | 1.83e-05 |
| GO:BP | GO:0051338 | regulation of transferase activity | 35 | 713 | 2.59e-05 |
| GO:BP | GO:0051781 | positive regulation of cell division | 9 | 64 | 2.73e-05 |
| GO:BP | GO:0009314 | response to radiation | 45 | 349 | 2.73e-05 |
| GO:BP | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 23 | 76 | 2.73e-05 |
| GO:BP | GO:0016321 | female meiosis chromosome segregation | 3 | 5 | 2.97e-05 |
| GO:BP | GO:1902412 | regulation of mitotic cytokinesis | 5 | 8 | 3.68e-05 |
| GO:BP | GO:0031297 | replication fork processing | 10 | 42 | 3.92e-05 |
| GO:BP | GO:1903934 | positive regulation of DNA primase activity | 5 | 5 | 4.21e-05 |
| GO:BP | GO:1903932 | regulation of DNA primase activity | 5 | 5 | 4.21e-05 |
| GO:BP | GO:2000001 | regulation of DNA damage checkpoint | 6 | 25 | 4.84e-05 |
| GO:BP | GO:0071478 | cellular response to radiation | 14 | 155 | 4.88e-05 |
| GO:BP | GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 6 | 15 | 5.07e-05 |
| GO:BP | GO:0031571 | mitotic G1 DNA damage checkpoint signaling | 9 | 27 | 5.44e-05 |
| GO:BP | GO:0032886 | regulation of microtubule-based process | 15 | 217 | 5.87e-05 |
| GO:BP | GO:0007292 | female gamete generation | 7 | 104 | 5.87e-05 |
| GO:BP | GO:1905832 | positive regulation of spindle assembly | 5 | 7 | 6.32e-05 |
| GO:BP | GO:0035825 | homologous recombination | 8 | 43 | 7.06e-05 |
| GO:BP | GO:0044819 | mitotic G1/S transition checkpoint signaling | 9 | 27 | 7.32e-05 |
| GO:BP | GO:0000132 | establishment of mitotic spindle orientation | 7 | 31 | 8.73e-05 |
| GO:BP | GO:1905821 | positive regulation of chromosome condensation | 5 | 5 | 9.48e-05 |
| GO:BP | GO:0051307 | meiotic chromosome separation | 3 | 5 | 1.16e-04 |
| GO:BP | GO:0007018 | microtubule-based movement | 11 | 296 | 1.20e-04 |
| GO:BP | GO:0044260 | cellular macromolecule metabolic process | 105 | 2777 | 1.20e-04 |
| GO:BP | GO:0090306 | meiotic spindle assembly | 3 | 8 | 1.20e-04 |
| GO:BP | GO:0071168 | protein localization to chromatin | 12 | 49 | 1.20e-04 |
| GO:BP | GO:0090169 | regulation of spindle assembly | 6 | 32 | 1.34e-04 |
| GO:BP | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 10 | 68 | 1.34e-04 |
| GO:BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 7 | 16 | 1.37e-04 |
| GO:BP | GO:0035556 | intracellular signal transduction | 51 | 2065 | 1.60e-04 |
| GO:BP | GO:0036297 | interstrand cross-link repair | 7 | 37 | 1.76e-04 |
| GO:BP | GO:0051053 | negative regulation of DNA metabolic process | 14 | 118 | 2.01e-04 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 11 | 36 | 2.38e-04 |
| GO:BP | GO:1904668 | positive regulation of ubiquitin protein ligase activity | 3 | 11 | 2.49e-04 |
| GO:BP | GO:0099607 | lateral attachment of mitotic spindle microtubules to kinetochore | 2 | 2 | 2.54e-04 |
| GO:BP | GO:0007144 | female meiosis I | 5 | 9 | 2.71e-04 |
| GO:BP | GO:0006513 | protein monoubiquitination | 12 | 83 | 2.81e-04 |
| GO:BP | GO:0140527 | reciprocal homologous recombination | 7 | 36 | 2.81e-04 |
| GO:BP | GO:0007131 | reciprocal meiotic recombination | 7 | 36 | 2.81e-04 |
| GO:BP | GO:2000104 | negative regulation of DNA-templated DNA replication | 5 | 14 | 2.87e-04 |
| GO:BP | GO:0007057 | spindle assembly involved in female meiosis I | 4 | 4 | 2.89e-04 |
| GO:BP | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 5 | 17 | 2.93e-04 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 21 | 146 | 3.35e-04 |
| GO:BP | GO:0070601 | centromeric sister chromatid cohesion | 3 | 11 | 3.46e-04 |
| GO:BP | GO:0042772 | DNA damage response, signal transduction resulting in transcription | 5 | 18 | 3.87e-04 |
| GO:BP | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 19 | 94 | 3.92e-04 |
| GO:BP | GO:1902806 | regulation of cell cycle G1/S phase transition | 23 | 166 | 4.06e-04 |
| GO:BP | GO:0007079 | mitotic chromosome movement towards spindle pole | 2 | 4 | 4.09e-04 |
| GO:BP | GO:0051054 | positive regulation of DNA metabolic process | 19 | 261 | 4.46e-04 |
| GO:BP | GO:0010032 | meiotic chromosome condensation | 5 | 6 | 4.70e-04 |
| GO:BP | GO:0009411 | response to UV | 22 | 137 | 4.84e-04 |
| GO:BP | GO:0110032 | positive regulation of G2/MI transition of meiotic cell cycle | 3 | 3 | 4.92e-04 |
| GO:BP | GO:0022616 | DNA strand elongation | 10 | 35 | 5.32e-04 |
| GO:BP | GO:0051177 | meiotic sister chromatid cohesion | 3 | 11 | 5.45e-04 |
| GO:BP | GO:0045144 | meiotic sister chromatid segregation | 3 | 11 | 5.45e-04 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 34 | 815 | 5.71e-04 |
| GO:BP | GO:0051298 | centrosome duplication | 12 | 68 | 5.82e-04 |
| GO:BP | GO:0061983 | meiosis II cell cycle process | 3 | 12 | 6.69e-04 |
| GO:BP | GO:0007135 | meiosis II | 3 | 12 | 6.69e-04 |
| GO:BP | GO:0006468 | protein phosphorylation | 43 | 1183 | 7.45e-04 |
| GO:BP | GO:0051754 | meiotic sister chromatid cohesion, centromeric | 3 | 4 | 8.76e-04 |
| GO:BP | GO:0022414 | reproductive process | 32 | 924 | 9.05e-04 |
| GO:BP | GO:1904666 | regulation of ubiquitin protein ligase activity | 4 | 24 | 9.43e-04 |
| GO:BP | GO:0051445 | regulation of meiotic cell cycle | 9 | 45 | 9.58e-04 |
| GO:BP | GO:0008156 | negative regulation of DNA replication | 6 | 26 | 9.91e-04 |
| GO:BP | GO:0000003 | reproduction | 32 | 931 | 1.00e-03 |
| GO:BP | GO:0006325 | chromatin organization | 55 | 536 | 1.01e-03 |
| GO:BP | GO:0033314 | mitotic DNA replication checkpoint signaling | 5 | 9 | 1.02e-03 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 14 | 75 | 1.08e-03 |
| GO:BP | GO:0045143 | homologous chromosome segregation | 7 | 33 | 1.13e-03 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 36 | 932 | 1.19e-03 |
| GO:BP | GO:0031399 | regulation of protein modification process | 16 | 1207 | 1.22e-03 |
| GO:BP | GO:0051438 | regulation of ubiquitin-protein transferase activity | 4 | 53 | 1.24e-03 |
| GO:BP | GO:0071480 | cellular response to gamma radiation | 5 | 29 | 1.24e-03 |
| GO:BP | GO:0031109 | microtubule polymerization or depolymerization | 7 | 117 | 1.28e-03 |
| GO:BP | GO:0051305 | chromosome movement towards spindle pole | 2 | 7 | 1.28e-03 |
| GO:BP | GO:1901993 | regulation of meiotic cell cycle phase transition | 4 | 5 | 1.29e-03 |
| GO:BP | GO:0034080 | CENP-A containing chromatin assembly | 5 | 7 | 1.33e-03 |
| GO:BP | GO:0031055 | chromatin remodeling at centromere | 5 | 7 | 1.33e-03 |
| GO:BP | GO:2000573 | positive regulation of DNA biosynthetic process | 8 | 67 | 1.40e-03 |
| GO:BP | GO:0045910 | negative regulation of DNA recombination | 7 | 31 | 1.42e-03 |
| GO:BP | GO:0110030 | regulation of G2/MI transition of meiotic cell cycle | 3 | 3 | 1.72e-03 |
| GO:BP | GO:1901995 | positive regulation of meiotic cell cycle phase transition | 3 | 3 | 1.72e-03 |
| GO:BP | GO:2000278 | regulation of DNA biosynthetic process | 11 | 111 | 1.77e-03 |
| GO:BP | GO:0000915 | actomyosin contractile ring assembly | 3 | 6 | 1.83e-03 |
| GO:BP | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 3 | 6 | 1.83e-03 |
| GO:BP | GO:0010390 | histone monoubiquitination | 7 | 35 | 1.84e-03 |
| GO:BP | GO:0007056 | spindle assembly involved in female meiosis | 3 | 5 | 1.87e-03 |
| GO:BP | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 13 | 61 | 1.90e-03 |
| GO:BP | GO:0007064 | mitotic sister chromatid cohesion | 5 | 29 | 2.07e-03 |
| GO:BP | GO:0031145 | anaphase-promoting complex-dependent catabolic process | 3 | 23 | 2.28e-03 |
| GO:BP | GO:0007099 | centriole replication | 10 | 38 | 2.38e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 19 | 457 | 2.42e-03 |
| GO:BP | GO:0006334 | nucleosome assembly | 12 | 80 | 2.79e-03 |
| GO:BP | GO:1905784 | regulation of anaphase-promoting complex-dependent catabolic process | 2 | 4 | 2.80e-03 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 18 | 432 | 3.00e-03 |
| GO:BP | GO:1902298 | cell cycle DNA replication maintenance of fidelity | 2 | 2 | 3.02e-03 |
| GO:BP | GO:1990505 | mitotic DNA replication maintenance of fidelity | 2 | 2 | 3.02e-03 |
| GO:BP | GO:0044837 | actomyosin contractile ring organization | 3 | 7 | 3.02e-03 |
| GO:BP | GO:0046601 | positive regulation of centriole replication | 4 | 9 | 3.02e-03 |
| GO:BP | GO:1990426 | mitotic recombination-dependent replication fork processing | 2 | 2 | 3.02e-03 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 11 | 437 | 3.02e-03 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 17 | 264 | 3.14e-03 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 17 | 264 | 3.14e-03 |
| GO:BP | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 3 | 14 | 3.14e-03 |
| GO:BP | GO:0071900 | regulation of protein serine/threonine kinase activity | 16 | 302 | 3.25e-03 |
| GO:BP | GO:0060623 | regulation of chromosome condensation | 4 | 9 | 3.25e-03 |
| GO:BP | GO:0071163 | DNA replication preinitiation complex assembly | 2 | 3 | 3.26e-03 |
| GO:BP | GO:0032201 | telomere maintenance via semi-conservative replication | 4 | 8 | 3.34e-03 |
| GO:BP | GO:1902410 | mitotic cytokinetic process | 4 | 23 | 3.43e-03 |
| GO:BP | GO:0043137 | DNA replication, removal of RNA primer | 3 | 4 | 3.52e-03 |
| GO:BP | GO:1904776 | regulation of protein localization to cell cortex | 3 | 8 | 3.57e-03 |
| GO:BP | GO:1905463 | negative regulation of DNA duplex unwinding | 2 | 4 | 3.59e-03 |
| GO:BP | GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 3 | 14 | 3.73e-03 |
| GO:BP | GO:1903925 | response to bisphenol A | 3 | 4 | 4.18e-03 |
| GO:BP | GO:0016310 | phosphorylation | 19 | 1443 | 4.18e-03 |
| GO:BP | GO:1903926 | cellular response to bisphenol A | 3 | 4 | 4.18e-03 |
| GO:BP | GO:1902115 | regulation of organelle assembly | 20 | 186 | 4.18e-03 |
| GO:BP | GO:0046599 | regulation of centriole replication | 6 | 21 | 4.24e-03 |
| GO:BP | GO:0097193 | intrinsic apoptotic signaling pathway | 20 | 260 | 4.26e-03 |
| GO:BP | GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 3 | 29 | 4.26e-03 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 22 | 512 | 4.41e-03 |
| GO:BP | GO:0000018 | regulation of DNA recombination | 11 | 101 | 4.42e-03 |
| GO:BP | GO:0085020 | protein K6-linked ubiquitination | 4 | 9 | 4.48e-03 |
| GO:BP | GO:0061952 | midbody abscission | 3 | 17 | 4.69e-03 |
| GO:BP | GO:0098534 | centriole assembly | 10 | 41 | 4.79e-03 |
| GO:BP | GO:0035518 | histone H2A monoubiquitination | 4 | 23 | 4.81e-03 |
| GO:BP | GO:0006566 | threonine metabolic process | 3 | 7 | 5.06e-03 |
| GO:BP | GO:1902807 | negative regulation of cell cycle G1/S phase transition | 13 | 67 | 5.14e-03 |
| GO:BP | GO:0051785 | positive regulation of nuclear division | 5 | 37 | 5.17e-03 |
| GO:BP | GO:0086016 | AV node cell action potential | 4 | 9 | 5.17e-03 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 4 | 9 | 5.17e-03 |
| GO:BP | GO:0006297 | nucleotide-excision repair, DNA gap filling | 4 | 5 | 5.18e-03 |
| GO:BP | GO:0071364 | cellular response to epidermal growth factor stimulus | 5 | 41 | 5.21e-03 |
| GO:BP | GO:0045840 | positive regulation of mitotic nuclear division | 4 | 29 | 5.25e-03 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 12 | 518 | 5.52e-03 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 13 | 743 | 5.57e-03 |
| GO:BP | GO:1905340 | regulation of protein localization to kinetochore | 2 | 4 | 5.90e-03 |
| GO:BP | GO:1905342 | positive regulation of protein localization to kinetochore | 2 | 4 | 5.90e-03 |
| GO:BP | GO:2001021 | negative regulation of response to DNA damage stimulus | 14 | 76 | 6.03e-03 |
| GO:BP | GO:2001020 | regulation of response to DNA damage stimulus | 17 | 292 | 6.17e-03 |
| GO:BP | GO:0072697 | protein localization to cell cortex | 3 | 10 | 6.27e-03 |
| GO:BP | GO:1901673 | regulation of mitotic spindle assembly | 3 | 23 | 6.27e-03 |
| GO:BP | GO:0051865 | protein autoubiquitination | 8 | 74 | 6.54e-03 |
| GO:BP | GO:2001252 | positive regulation of chromosome organization | 13 | 98 | 6.54e-03 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 17 | 97 | 6.60e-03 |
| GO:BP | GO:1901563 | response to camptothecin | 3 | 5 | 6.91e-03 |
| GO:BP | GO:0006335 | DNA replication-dependent chromatin assembly | 3 | 6 | 7.05e-03 |
| GO:BP | GO:1902808 | positive regulation of cell cycle G1/S phase transition | 7 | 52 | 7.15e-03 |
| GO:BP | GO:0007089 | traversing start control point of mitotic cell cycle | 3 | 4 | 7.41e-03 |
| GO:BP | GO:0070849 | response to epidermal growth factor | 5 | 44 | 7.57e-03 |
| GO:BP | GO:0032042 | mitochondrial DNA metabolic process | 5 | 23 | 7.70e-03 |
| GO:BP | GO:0000921 | septin ring assembly | 1 | 1 | 7.73e-03 |
| GO:BP | GO:0010824 | regulation of centrosome duplication | 8 | 44 | 7.99e-03 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 38 | 1044 | 8.21e-03 |
| GO:BP | GO:0048239 | negative regulation of DNA recombination at telomere | 2 | 2 | 8.21e-03 |
| GO:BP | GO:0072695 | regulation of DNA recombination at telomere | 2 | 2 | 8.21e-03 |
| GO:BP | GO:0051782 | negative regulation of cell division | 4 | 15 | 8.21e-03 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 38 | 1045 | 8.25e-03 |
| GO:BP | GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 4 | 21 | 8.30e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 19 | 103 | 8.30e-03 |
| GO:BP | GO:0072719 | cellular response to cisplatin | 3 | 4 | 8.33e-03 |
| GO:BP | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 6 | 42 | 8.56e-03 |
| GO:BP | GO:0070194 | synaptonemal complex disassembly | 1 | 2 | 8.99e-03 |
| GO:BP | GO:0034728 | nucleosome organization | 12 | 98 | 9.20e-03 |
| GO:BP | GO:0007019 | microtubule depolymerization | 4 | 43 | 9.50e-03 |
| GO:BP | GO:0006301 | postreplication repair | 7 | 34 | 9.55e-03 |
| GO:BP | GO:0035494 | SNARE complex disassembly | 3 | 3 | 9.75e-03 |
| GO:BP | GO:0007096 | regulation of exit from mitosis | 4 | 17 | 1.01e-02 |
| GO:BP | GO:0006290 | pyrimidine dimer repair | 1 | 7 | 1.03e-02 |
| GO:BP | GO:0086067 | AV node cell to bundle of His cell communication | 4 | 11 | 1.03e-02 |
| GO:BP | GO:0006338 | chromatin remodeling | 33 | 309 | 1.04e-02 |
| GO:BP | GO:1905462 | regulation of DNA duplex unwinding | 2 | 7 | 1.04e-02 |
| GO:BP | GO:0010165 | response to X-ray | 4 | 29 | 1.04e-02 |
| GO:BP | GO:0071139 | resolution of recombination intermediates | 4 | 6 | 1.07e-02 |
| GO:BP | GO:0006269 | DNA replication, synthesis of RNA primer | 4 | 6 | 1.07e-02 |
| GO:BP | GO:1905448 | positive regulation of mitochondrial ATP synthesis coupled electron transport | 2 | 4 | 1.17e-02 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 12 | 577 | 1.19e-02 |
| GO:BP | GO:0042148 | strand invasion | 2 | 5 | 1.22e-02 |
| GO:BP | GO:0001833 | inner cell mass cell proliferation | 6 | 14 | 1.22e-02 |
| GO:BP | GO:1900060 | negative regulation of ceramide biosynthetic process | 3 | 5 | 1.23e-02 |
| GO:BP | GO:0090737 | telomere maintenance via telomere trimming | 4 | 13 | 1.23e-02 |
| GO:BP | GO:0001325 | formation of extrachromosomal circular DNA | 4 | 13 | 1.23e-02 |
| GO:BP | GO:0090656 | t-circle formation | 4 | 13 | 1.23e-02 |
| GO:BP | GO:0045740 | positive regulation of DNA replication | 10 | 37 | 1.23e-02 |
| GO:BP | GO:0046605 | regulation of centrosome cycle | 10 | 51 | 1.28e-02 |
| GO:BP | GO:0048478 | replication fork protection | 3 | 9 | 1.28e-02 |
| GO:BP | GO:0030010 | establishment of cell polarity | 8 | 131 | 1.30e-02 |
| GO:BP | GO:0043549 | regulation of kinase activity | 23 | 598 | 1.32e-02 |
| GO:BP | GO:0032954 | regulation of cytokinetic process | 2 | 3 | 1.34e-02 |
| GO:BP | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity | 4 | 35 | 1.34e-02 |
| GO:BP | GO:0051642 | centrosome localization | 4 | 31 | 1.34e-02 |
| GO:BP | GO:0061842 | microtubule organizing center localization | 4 | 31 | 1.34e-02 |
| GO:BP | GO:0034421 | post-translational protein acetylation | 2 | 3 | 1.37e-02 |
| GO:BP | GO:1904172 | positive regulation of bleb assembly | 1 | 1 | 1.37e-02 |
| GO:BP | GO:0031106 | septin ring organization | 1 | 2 | 1.37e-02 |
| GO:BP | GO:1904170 | regulation of bleb assembly | 1 | 1 | 1.37e-02 |
| GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 4 | 45 | 1.42e-02 |
| GO:BP | GO:0046602 | regulation of mitotic centrosome separation | 2 | 8 | 1.43e-02 |
| GO:BP | GO:0033522 | histone H2A ubiquitination | 4 | 32 | 1.45e-02 |
| GO:BP | GO:0002227 | innate immune response in mucosa | 5 | 8 | 1.45e-02 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 56 | 1783 | 1.49e-02 |
| GO:BP | GO:0072757 | cellular response to camptothecin | 2 | 4 | 1.51e-02 |
| GO:BP | GO:0001556 | oocyte maturation | 7 | 23 | 1.53e-02 |
| GO:BP | GO:0022412 | cellular process involved in reproduction in multicellular organism | 7 | 248 | 1.63e-02 |
| GO:BP | GO:0016574 | histone ubiquitination | 7 | 51 | 1.66e-02 |
| GO:BP | GO:0034644 | cellular response to UV | 4 | 83 | 1.67e-02 |
| GO:BP | GO:1903671 | negative regulation of sprouting angiogenesis | 3 | 11 | 1.67e-02 |
| GO:BP | GO:0062033 | positive regulation of mitotic sister chromatid segregation | 2 | 6 | 1.69e-02 |
| GO:BP | GO:0009265 | 2’-deoxyribonucleotide biosynthetic process | 4 | 15 | 1.71e-02 |
| GO:BP | GO:0009263 | deoxyribonucleotide biosynthetic process | 4 | 15 | 1.71e-02 |
| GO:BP | GO:0046385 | deoxyribose phosphate biosynthetic process | 4 | 15 | 1.71e-02 |
| GO:BP | GO:0070914 | UV-damage excision repair | 1 | 13 | 1.72e-02 |
| GO:BP | GO:0072718 | response to cisplatin | 3 | 5 | 1.76e-02 |
| GO:BP | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 7 | 22 | 1.82e-02 |
| GO:BP | GO:0071312 | cellular response to alkaloid | 8 | 29 | 1.87e-02 |
| GO:BP | GO:0016446 | somatic hypermutation of immunoglobulin genes | 4 | 11 | 1.87e-02 |
| GO:BP | GO:0031536 | positive regulation of exit from mitosis | 2 | 4 | 2.10e-02 |
| GO:BP | GO:0090155 | negative regulation of sphingolipid biosynthetic process | 3 | 6 | 2.16e-02 |
| GO:BP | GO:0072711 | cellular response to hydroxyurea | 4 | 10 | 2.21e-02 |
| GO:BP | GO:0034198 | cellular response to amino acid starvation | 6 | 48 | 2.23e-02 |
| GO:BP | GO:0007063 | regulation of sister chromatid cohesion | 3 | 20 | 2.30e-02 |
| GO:BP | GO:0010458 | exit from mitosis | 2 | 29 | 2.36e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 11 | 630 | 2.41e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 11 | 630 | 2.41e-02 |
| GO:BP | GO:0006541 | glutamine metabolic process | 6 | 23 | 2.41e-02 |
| GO:BP | GO:0099606 | microtubule plus-end directed mitotic chromosome migration | 1 | 1 | 2.42e-02 |
| GO:BP | GO:0006903 | vesicle targeting | 11 | 61 | 2.49e-02 |
| GO:BP | GO:0010216 | maintenance of DNA methylation | 3 | 7 | 2.50e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 7 | 203 | 2.50e-02 |
| GO:BP | GO:1905446 | regulation of mitochondrial ATP synthesis coupled electron transport | 2 | 6 | 2.52e-02 |
| GO:BP | GO:0032185 | septin cytoskeleton organization | 1 | 4 | 2.52e-02 |
| GO:BP | GO:0002566 | somatic diversification of immune receptors via somatic mutation | 4 | 12 | 2.52e-02 |
| GO:BP | GO:0000002 | mitochondrial genome maintenance | 5 | 30 | 2.62e-02 |
| GO:BP | GO:0007077 | mitotic nuclear membrane disassembly | 1 | 7 | 2.63e-02 |
| GO:BP | GO:1990928 | response to amino acid starvation | 6 | 50 | 2.66e-02 |
| GO:BP | GO:0010457 | centriole-centriole cohesion | 2 | 14 | 2.67e-02 |
| GO:BP | GO:2000786 | positive regulation of autophagosome assembly | 5 | 19 | 2.79e-02 |
| GO:BP | GO:0072710 | response to hydroxyurea | 3 | 11 | 2.83e-02 |
| GO:BP | GO:0098910 | regulation of atrial cardiac muscle cell action potential | 3 | 4 | 2.84e-02 |
| GO:BP | GO:0006282 | regulation of DNA repair | 17 | 197 | 3.00e-02 |
| GO:BP | GO:0016043 | cellular component organization | 100 | 5016 | 3.08e-02 |
| GO:BP | GO:2000303 | regulation of ceramide biosynthetic process | 4 | 11 | 3.10e-02 |
| GO:BP | GO:0007100 | mitotic centrosome separation | 2 | 13 | 3.19e-02 |
| GO:BP | GO:0099022 | vesicle tethering | 7 | 31 | 3.19e-02 |
| GO:BP | GO:1904355 | positive regulation of telomere capping | 2 | 14 | 3.36e-02 |
| GO:BP | GO:0001578 | microtubule bundle formation | 4 | 79 | 3.36e-02 |
| GO:BP | GO:0051309 | female meiosis chromosome separation | 1 | 2 | 3.40e-02 |
| GO:BP | GO:2000105 | positive regulation of DNA-templated DNA replication | 4 | 14 | 3.50e-02 |
| GO:BP | GO:0043687 | post-translational protein modification | 9 | 64 | 3.61e-02 |
| GO:BP | GO:0051299 | centrosome separation | 2 | 14 | 3.62e-02 |
| GO:BP | GO:0051661 | maintenance of centrosome location | 2 | 6 | 3.64e-02 |
| GO:BP | GO:1904975 | response to bleomycin | 2 | 2 | 3.64e-02 |
| GO:BP | GO:1904976 | cellular response to bleomycin | 2 | 2 | 3.64e-02 |
| GO:BP | GO:0045007 | depurination | 1 | 4 | 3.83e-02 |
| GO:BP | GO:0006287 | base-excision repair, gap-filling | 5 | 14 | 3.86e-02 |
| GO:BP | GO:1990918 | double-strand break repair involved in meiotic recombination | 2 | 2 | 3.87e-02 |
| GO:BP | GO:0051081 | nuclear membrane disassembly | 1 | 11 | 3.92e-02 |
| GO:BP | GO:0016202 | regulation of striated muscle tissue development | 1 | 13 | 4.02e-02 |
| GO:BP | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process | 1 | 2 | 4.02e-02 |
| GO:BP | GO:0090153 | regulation of sphingolipid biosynthetic process | 4 | 12 | 4.12e-02 |
| GO:BP | GO:0090521 | podocyte cell migration | 1 | 7 | 4.12e-02 |
| GO:BP | GO:1905038 | regulation of membrane lipid metabolic process | 4 | 12 | 4.12e-02 |
| GO:BP | GO:0006312 | mitotic recombination | 4 | 23 | 4.16e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 6 | 25 | 4.17e-02 |
| GO:BP | GO:0030397 | membrane disassembly | 1 | 12 | 4.20e-02 |
| GO:BP | GO:1903416 | response to glycoside | 2 | 6 | 4.21e-02 |
| GO:BP | GO:0044090 | positive regulation of vacuole organization | 5 | 21 | 4.21e-02 |
| GO:BP | GO:0019985 | translesion synthesis | 7 | 24 | 4.21e-02 |
| GO:BP | GO:0072698 | protein localization to microtubule cytoskeleton | 4 | 52 | 4.41e-02 |
| GO:BP | GO:1905115 | regulation of lateral attachment of mitotic spindle microtubules to kinetochore | 1 | 1 | 4.49e-02 |
| GO:BP | GO:1905116 | positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore | 1 | 1 | 4.49e-02 |
| GO:BP | GO:0090435 | protein localization to nuclear envelope | 1 | 13 | 4.49e-02 |
| GO:BP | GO:0045004 | DNA replication proofreading | 2 | 2 | 4.54e-02 |
| GO:BP | GO:0051446 | positive regulation of meiotic cell cycle | 6 | 15 | 4.64e-02 |
| GO:BP | GO:0000722 | telomere maintenance via recombination | 3 | 15 | 4.64e-02 |
| GO:BP | GO:0051664 | nuclear pore localization | 3 | 4 | 4.81e-02 |
| GO:BP | GO:0071482 | cellular response to light stimulus | 4 | 96 | 4.89e-02 |
| GO:BP | GO:0044806 | G-quadruplex DNA unwinding | 3 | 7 | 4.94e-02 |
| GO:BP | GO:0021685 | cerebellar granular layer structural organization | 1 | 1 | 4.98e-02 |
| GO:BP | GO:0048634 | regulation of muscle organ development | 1 | 14 | 4.98e-02 |
| KEGG | KEGG:04110 | Cell cycle | 27 | 121 | 6.46e-22 |
| KEGG | KEGG:03030 | DNA replication | 17 | 35 | 3.55e-13 |
| KEGG | KEGG:04115 | p53 signaling pathway | 23 | 65 | 8.00e-12 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 10 | 48 | 1.45e-06 |
| KEGG | KEGG:03440 | Homologous recombination | 9 | 39 | 1.72e-05 |
| KEGG | KEGG:04114 | Oocyte meiosis | 9 | 108 | 2.47e-05 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 10 | 86 | 7.09e-05 |
| KEGG | KEGG:04218 | Cellular senescence | 12 | 145 | 7.40e-05 |
| KEGG | KEGG:03430 | Mismatch repair | 8 | 22 | 7.40e-05 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 8 | 43 | 1.34e-03 |
| KEGG | KEGG:03410 | Base excision repair | 10 | 33 | 7.77e-03 |
| KEGG | KEGG:05212 | Pancreatic cancer | 6 | 75 | 8.28e-03 |
| KEGG | KEGG:01524 | Platinum drug resistance | 6 | 65 | 1.21e-02 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 6 | 180 | 1.61e-02 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 3 | 61 | 2.75e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 7 | 109 | 4.76e-02 |
| KEGG | KEGG:05216 | Thyroid cancer | 1 | 35 | 4.84e-02 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 19 | 172 | 4.84e-02 |
AT 3 hours, the Mitoxantrone DEGs, adj. p value < 0.01, look similar to daunorubicin gene sets a 3 hours. hmmm
Venn Diagrams
All DEGs adj. p value < 0.05, 24 hour
[1] 8188
All DEGs adj. p value < 0.05, 3 hour
[1] 566
Because the 3 hour DEGs are low (expecially in Doxorubicin), we have
chosen to focus on analyzing the 24 hour DEGs for GO: BP analysis ###
Venn 3 and 24 hour sigDEGs by treatment (adj. p value <0.01)
similarities
[1] 7237
[1] 6656
[1] 6416
[1] 1174
GO analysis on 24 hour Venn, adj. p value < 0.05
[1] "Number of Doxorubicin specific DEGs, adj. P value < 0.05"[1] 355[1] "Number of All genes that respond to some condition in DEG set, adj. P value < 0.05"[1] 8368[1] "Number of No response genes in DEG set, adj. P value < 0.05"[1] 5716DDE response set
adj. P value < 0.05, intersection of DNE-DOX-EPI, excluding those in common with MTX n= 4435
no significant enrichment found! I tried going for only the I did the intersection of all AC drugs and found a list that was 6129 genes long. Below is that analysis.
of the AC genes that overlapped without Mito (n=4178) and all AC gens plus those which overlapped with Mito (n=5155), the significantly enriched GO: BP terms are the same. This may lend the idea that the specific AC set can tell us more about mechanism in AC induced cardiotoxicity.
DDEM response of 977
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:1903047 | mitotic cell cycle process | 159 | 700 | 2.42e-34 |
| GO:BP | GO:0000278 | mitotic cell cycle | 177 | 833 | 2.42e-34 |
| GO:BP | GO:0022402 | cell cycle process | 202 | 1075 | 2.53e-28 |
| GO:BP | GO:0007049 | cell cycle | 255 | 1522 | 3.47e-28 |
| GO:BP | GO:0007059 | chromosome segregation | 100 | 378 | 1.23e-27 |
| GO:BP | GO:0000070 | mitotic sister chromatid segregation | 67 | 193 | 2.14e-27 |
| GO:BP | GO:0000819 | sister chromatid segregation | 74 | 234 | 4.84e-26 |
| GO:BP | GO:0140014 | mitotic nuclear division | 78 | 264 | 1.71e-25 |
| GO:BP | GO:0051301 | cell division | 120 | 567 | 2.02e-25 |
| GO:BP | GO:0051276 | chromosome organization | 125 | 543 | 4.50e-25 |
| GO:BP | GO:0010564 | regulation of cell cycle process | 130 | 620 | 9.24e-23 |
| GO:BP | GO:0098813 | nuclear chromosome segregation | 83 | 287 | 2.38e-22 |
| GO:BP | GO:0000280 | nuclear division | 93 | 354 | 5.07e-22 |
| GO:BP | GO:0007093 | mitotic cell cycle checkpoint signaling | 51 | 136 | 2.68e-21 |
| GO:BP | GO:0000075 | cell cycle checkpoint signaling | 59 | 180 | 3.46e-21 |
| GO:BP | GO:0051726 | regulation of cell cycle | 168 | 950 | 1.80e-20 |
| GO:BP | GO:0048285 | organelle fission | 93 | 397 | 5.54e-19 |
| GO:BP | GO:0006260 | DNA replication | 70 | 258 | 7.22e-19 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 45 | 118 | 1.76e-18 |
| GO:BP | GO:0006261 | DNA-templated DNA replication | 51 | 149 | 1.76e-18 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 90 | 413 | 3.57e-18 |
| GO:BP | GO:1905818 | regulation of chromosome separation | 34 | 69 | 7.74e-18 |
| GO:BP | GO:0045930 | negative regulation of mitotic cell cycle | 60 | 208 | 8.00e-18 |
| GO:BP | GO:0044770 | cell cycle phase transition | 101 | 499 | 1.64e-17 |
| GO:BP | GO:1901988 | negative regulation of cell cycle phase transition | 63 | 232 | 3.49e-17 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 92 | 438 | 7.93e-17 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 72 | 305 | 1.28e-16 |
| GO:BP | GO:0051304 | chromosome separation | 34 | 74 | 1.28e-16 |
| GO:BP | GO:0010948 | negative regulation of cell cycle process | 68 | 270 | 1.28e-16 |
| GO:BP | GO:1901987 | regulation of cell cycle phase transition | 84 | 388 | 2.24e-16 |
| GO:BP | GO:2000816 | negative regulation of mitotic sister chromatid separation | 27 | 47 | 2.54e-16 |
| GO:BP | GO:0033048 | negative regulation of mitotic sister chromatid segregation | 27 | 47 | 2.54e-16 |
| GO:BP | GO:0033046 | negative regulation of sister chromatid segregation | 27 | 47 | 2.54e-16 |
| GO:BP | GO:0033047 | regulation of mitotic sister chromatid segregation | 28 | 52 | 4.07e-16 |
| GO:BP | GO:1901991 | negative regulation of mitotic cell cycle phase transition | 50 | 163 | 4.07e-16 |
| GO:BP | GO:0045839 | negative regulation of mitotic nuclear division | 28 | 54 | 7.28e-16 |
| GO:BP | GO:0051985 | negative regulation of chromosome segregation | 27 | 48 | 8.18e-16 |
| GO:BP | GO:1905819 | negative regulation of chromosome separation | 27 | 48 | 8.18e-16 |
| GO:BP | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 26 | 46 | 8.73e-16 |
| GO:BP | GO:0010965 | regulation of mitotic sister chromatid separation | 29 | 58 | 9.13e-16 |
| GO:BP | GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 26 | 47 | 3.09e-15 |
| GO:BP | GO:0071174 | mitotic spindle checkpoint signaling | 25 | 44 | 3.15e-15 |
| GO:BP | GO:0071173 | spindle assembly checkpoint signaling | 25 | 44 | 3.15e-15 |
| GO:BP | GO:0007094 | mitotic spindle assembly checkpoint signaling | 25 | 44 | 3.15e-15 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 37 | 99 | 3.31e-15 |
| GO:BP | GO:0051306 | mitotic sister chromatid separation | 29 | 61 | 3.98e-15 |
| GO:BP | GO:0031577 | spindle checkpoint signaling | 25 | 45 | 5.75e-15 |
| GO:BP | GO:0045786 | negative regulation of cell cycle | 72 | 334 | 6.63e-15 |
| GO:BP | GO:0007088 | regulation of mitotic nuclear division | 37 | 100 | 2.19e-14 |
| GO:BP | GO:0051784 | negative regulation of nuclear division | 28 | 57 | 2.42e-14 |
| GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 34 | 91 | 2.42e-14 |
| GO:BP | GO:0090068 | positive regulation of cell cycle process | 54 | 206 | 3.99e-14 |
| GO:BP | GO:0030071 | regulation of mitotic metaphase/anaphase transition | 32 | 88 | 5.95e-14 |
| GO:BP | GO:2001251 | negative regulation of chromosome organization | 33 | 90 | 6.13e-14 |
| GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 34 | 92 | 6.71e-14 |
| GO:BP | GO:0006974 | cellular response to DNA damage stimulus | 125 | 789 | 8.02e-14 |
| GO:BP | GO:0007051 | spindle organization | 49 | 186 | 9.37e-14 |
| GO:BP | GO:0051783 | regulation of nuclear division | 40 | 115 | 1.44e-13 |
| GO:BP | GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 32 | 89 | 1.55e-13 |
| GO:BP | GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 44 | 156 | 2.41e-13 |
| GO:BP | GO:0033044 | regulation of chromosome organization | 54 | 233 | 7.02e-13 |
| GO:BP | GO:0006259 | DNA metabolic process | 140 | 890 | 1.13e-12 |
| GO:BP | GO:0008608 | attachment of spindle microtubules to kinetochore | 21 | 42 | 1.25e-12 |
| GO:BP | GO:0007052 | mitotic spindle organization | 30 | 128 | 2.38e-12 |
| GO:BP | GO:0006281 | DNA repair | 90 | 535 | 2.09e-11 |
| GO:BP | GO:0045787 | positive regulation of cell cycle | 62 | 278 | 3.03e-11 |
| GO:BP | GO:0031570 | DNA integrity checkpoint signaling | 36 | 126 | 3.33e-11 |
| GO:BP | GO:0000281 | mitotic cytokinesis | 26 | 81 | 5.65e-11 |
| GO:BP | GO:0051225 | spindle assembly | 27 | 118 | 2.06e-10 |
| GO:BP | GO:0000226 | microtubule cytoskeleton organization | 92 | 552 | 8.91e-10 |
| GO:BP | GO:0000910 | cytokinesis | 37 | 163 | 2.87e-09 |
| GO:BP | GO:0044774 | mitotic DNA integrity checkpoint signaling | 26 | 82 | 4.05e-09 |
| GO:BP | GO:0044839 | cell cycle G2/M phase transition | 36 | 148 | 7.14e-09 |
| GO:BP | GO:0032465 | regulation of cytokinesis | 26 | 79 | 7.89e-09 |
| GO:BP | GO:0090329 | regulation of DNA-templated DNA replication | 21 | 54 | 8.49e-09 |
| GO:BP | GO:0006270 | DNA replication initiation | 17 | 35 | 1.02e-08 |
| GO:BP | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 11 | 18 | 1.06e-08 |
| GO:BP | GO:0000077 | DNA damage checkpoint signaling | 30 | 118 | 1.29e-08 |
| GO:BP | GO:0042770 | signal transduction in response to DNA damage | 39 | 173 | 1.54e-08 |
| GO:BP | GO:0051984 | positive regulation of chromosome segregation | 13 | 25 | 2.73e-08 |
| GO:BP | GO:0000086 | G2/M transition of mitotic cell cycle | 33 | 134 | 2.78e-08 |
| GO:BP | GO:1903046 | meiotic cell cycle process | 42 | 136 | 3.19e-08 |
| GO:BP | GO:0007080 | mitotic metaphase plate congression | 16 | 55 | 3.36e-08 |
| GO:BP | GO:0051255 | spindle midzone assembly | 9 | 12 | 3.75e-08 |
| GO:BP | GO:0051231 | spindle elongation | 9 | 12 | 3.75e-08 |
| GO:BP | GO:0044773 | mitotic DNA damage checkpoint signaling | 24 | 78 | 4.00e-08 |
| GO:BP | GO:0032508 | DNA duplex unwinding | 24 | 75 | 4.05e-08 |
| GO:BP | GO:0061640 | cytoskeleton-dependent cytokinesis | 26 | 103 | 4.12e-08 |
| GO:BP | GO:0006275 | regulation of DNA replication | 32 | 124 | 4.93e-08 |
| GO:BP | GO:0051310 | metaphase plate congression | 21 | 69 | 5.74e-08 |
| GO:BP | GO:0051383 | kinetochore organization | 13 | 23 | 6.24e-08 |
| GO:BP | GO:0051256 | mitotic spindle midzone assembly | 8 | 9 | 7.67e-08 |
| GO:BP | GO:0071459 | protein localization to chromosome, centromeric region | 17 | 42 | 7.96e-08 |
| GO:BP | GO:0010212 | response to ionizing radiation | 27 | 130 | 8.26e-08 |
| GO:BP | GO:0007017 | microtubule-based process | 96 | 756 | 8.26e-08 |
| GO:BP | GO:0050000 | chromosome localization | 23 | 82 | 1.77e-07 |
| GO:BP | GO:0032392 | DNA geometric change | 24 | 81 | 1.81e-07 |
| GO:BP | GO:0000022 | mitotic spindle elongation | 8 | 10 | 2.08e-07 |
| GO:BP | GO:0034502 | protein localization to chromosome | 28 | 110 | 2.58e-07 |
| GO:BP | GO:0090307 | mitotic spindle assembly | 17 | 69 | 3.92e-07 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 54 | 318 | 4.22e-07 |
| GO:BP | GO:0033043 | regulation of organelle organization | 112 | 1023 | 4.43e-07 |
| GO:BP | GO:0140013 | meiotic nuclear division | 37 | 121 | 8.28e-07 |
| GO:BP | GO:1905820 | positive regulation of chromosome separation | 12 | 26 | 9.35e-07 |
| GO:BP | GO:0051303 | establishment of chromosome localization | 21 | 75 | 1.00e-06 |
| GO:BP | GO:0071103 | DNA conformation change | 24 | 88 | 1.11e-06 |
| GO:BP | GO:1900262 | regulation of DNA-directed DNA polymerase activity | 9 | 13 | 1.18e-06 |
| GO:BP | GO:1900264 | positive regulation of DNA-directed DNA polymerase activity | 9 | 13 | 1.18e-06 |
| GO:BP | GO:0032467 | positive regulation of cytokinesis | 15 | 33 | 1.46e-06 |
| GO:BP | GO:1901976 | regulation of cell cycle checkpoint | 16 | 45 | 1.68e-06 |
| GO:BP | GO:0051052 | regulation of DNA metabolic process | 72 | 459 | 1.68e-06 |
| GO:BP | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 24 | 92 | 1.88e-06 |
| GO:BP | GO:0140694 | non-membrane-bounded organelle assembly | 54 | 355 | 2.12e-06 |
| GO:BP | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 9 | 21 | 2.27e-06 |
| GO:BP | GO:0051321 | meiotic cell cycle | 44 | 188 | 2.31e-06 |
| GO:BP | GO:0034508 | centromere complex assembly | 13 | 30 | 2.57e-06 |
| GO:BP | GO:0065004 | protein-DNA complex assembly | 40 | 185 | 2.70e-06 |
| GO:BP | GO:0010332 | response to gamma radiation | 14 | 50 | 2.88e-06 |
| GO:BP | GO:1903490 | positive regulation of mitotic cytokinesis | 6 | 7 | 3.21e-06 |
| GO:BP | GO:0034501 | protein localization to kinetochore | 10 | 18 | 3.23e-06 |
| GO:BP | GO:1903083 | protein localization to condensed chromosome | 10 | 18 | 3.23e-06 |
| GO:BP | GO:0006541 | glutamine metabolic process | 4 | 23 | 3.41e-06 |
| GO:BP | GO:1902749 | regulation of cell cycle G2/M phase transition | 25 | 102 | 3.51e-06 |
| GO:BP | GO:0051302 | regulation of cell division | 28 | 144 | 6.25e-06 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 26 | 113 | 6.31e-06 |
| GO:BP | GO:0071824 | protein-DNA complex subunit organization | 41 | 204 | 8.50e-06 |
| GO:BP | GO:0006268 | DNA unwinding involved in DNA replication | 10 | 22 | 8.51e-06 |
| GO:BP | GO:0071478 | cellular response to radiation | 28 | 155 | 8.81e-06 |
| GO:BP | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 15 | 43 | 1.28e-05 |
| GO:BP | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator | 20 | 76 | 1.90e-05 |
| GO:BP | GO:0006996 | organelle organization | 313 | 2971 | 2.09e-05 |
| GO:BP | GO:1901992 | positive regulation of mitotic cell cycle phase transition | 20 | 86 | 2.32e-05 |
| GO:BP | GO:0044786 | cell cycle DNA replication | 14 | 40 | 2.37e-05 |
| GO:BP | GO:1902969 | mitotic DNA replication | 8 | 14 | 2.73e-05 |
| GO:BP | GO:0009314 | response to radiation | 48 | 349 | 2.76e-05 |
| GO:BP | GO:0033554 | cellular response to stress | 184 | 1677 | 3.48e-05 |
| GO:BP | GO:0045132 | meiotic chromosome segregation | 20 | 69 | 4.12e-05 |
| GO:BP | GO:0090232 | positive regulation of spindle checkpoint | 7 | 12 | 4.29e-05 |
| GO:BP | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 7 | 12 | 4.29e-05 |
| GO:BP | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint | 9 | 19 | 4.63e-05 |
| GO:BP | GO:0090231 | regulation of spindle checkpoint | 9 | 19 | 4.63e-05 |
| GO:BP | GO:1903504 | regulation of mitotic spindle checkpoint | 9 | 19 | 4.63e-05 |
| GO:BP | GO:0071168 | protein localization to chromatin | 10 | 49 | 4.78e-05 |
| GO:BP | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 6 | 11 | 6.34e-05 |
| GO:BP | GO:0000727 | double-strand break repair via break-induced replication | 7 | 11 | 6.79e-05 |
| GO:BP | GO:1902412 | regulation of mitotic cytokinesis | 6 | 8 | 6.97e-05 |
| GO:BP | GO:0072331 | signal transduction by p53 class mediator | 29 | 160 | 7.78e-05 |
| GO:BP | GO:0006271 | DNA strand elongation involved in DNA replication | 8 | 15 | 7.78e-05 |
| GO:BP | GO:0007098 | centrosome cycle | 26 | 126 | 8.20e-05 |
| GO:BP | GO:1901989 | positive regulation of cell cycle phase transition | 23 | 103 | 1.05e-04 |
| GO:BP | GO:0071897 | DNA biosynthetic process | 33 | 175 | 1.05e-04 |
| GO:BP | GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 15 | 50 | 1.22e-04 |
| GO:BP | GO:0071479 | cellular response to ionizing radiation | 15 | 68 | 1.32e-04 |
| GO:BP | GO:1901978 | positive regulation of cell cycle checkpoint | 8 | 19 | 1.49e-04 |
| GO:BP | GO:0033260 | nuclear DNA replication | 12 | 35 | 1.94e-04 |
| GO:BP | GO:1902423 | regulation of attachment of mitotic spindle microtubules to kinetochore | 5 | 8 | 1.95e-04 |
| GO:BP | GO:1902425 | positive regulation of attachment of mitotic spindle microtubules to kinetochore | 5 | 8 | 1.95e-04 |
| GO:BP | GO:0008315 | G2/MI transition of meiotic cell cycle | 5 | 5 | 2.07e-04 |
| GO:BP | GO:0044818 | mitotic G2/M transition checkpoint | 14 | 50 | 2.07e-04 |
| GO:BP | GO:0000076 | DNA replication checkpoint signaling | 8 | 15 | 2.13e-04 |
| GO:BP | GO:0051656 | establishment of organelle localization | 53 | 375 | 2.16e-04 |
| GO:BP | GO:0007076 | mitotic chromosome condensation | 8 | 19 | 2.59e-04 |
| GO:BP | GO:0009064 | glutamine family amino acid metabolic process | 4 | 61 | 2.82e-04 |
| GO:BP | GO:0007062 | sister chromatid cohesion | 14 | 51 | 2.92e-04 |
| GO:BP | GO:0061982 | meiosis I cell cycle process | 25 | 80 | 3.06e-04 |
| GO:BP | GO:0006302 | double-strand break repair | 41 | 270 | 3.14e-04 |
| GO:BP | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 22 | 87 | 3.19e-04 |
| GO:BP | GO:0030174 | regulation of DNA-templated DNA replication initiation | 7 | 14 | 3.33e-04 |
| GO:BP | GO:0031023 | microtubule organizing center organization | 26 | 136 | 4.14e-04 |
| GO:BP | GO:1905832 | positive regulation of spindle assembly | 5 | 7 | 4.44e-04 |
| GO:BP | GO:0060236 | regulation of mitotic spindle organization | 10 | 42 | 4.53e-04 |
| GO:BP | GO:1904029 | regulation of cyclin-dependent protein kinase activity | 22 | 90 | 4.80e-04 |
| GO:BP | GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 11 | 35 | 4.80e-04 |
| GO:BP | GO:0090224 | regulation of spindle organization | 11 | 45 | 4.96e-04 |
| GO:BP | GO:0090235 | regulation of metaphase plate congression | 6 | 13 | 5.22e-04 |
| GO:BP | GO:0051640 | organelle localization | 63 | 498 | 5.24e-04 |
| GO:BP | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 15 | 60 | 5.75e-04 |
| GO:BP | GO:0051382 | kinetochore assembly | 8 | 18 | 6.89e-04 |
| GO:BP | GO:0044771 | meiotic cell cycle phase transition | 6 | 7 | 6.91e-04 |
| GO:BP | GO:0006310 | DNA recombination | 43 | 256 | 6.98e-04 |
| GO:BP | GO:0071480 | cellular response to gamma radiation | 8 | 29 | 7.12e-04 |
| GO:BP | GO:0000724 | double-strand break repair via homologous recombination | 27 | 147 | 7.18e-04 |
| GO:BP | GO:0010032 | meiotic chromosome condensation | 4 | 6 | 7.84e-04 |
| GO:BP | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 15 | 62 | 8.27e-04 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 35 | 264 | 8.35e-04 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 35 | 264 | 8.35e-04 |
| GO:BP | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 10 | 30 | 8.57e-04 |
| GO:BP | GO:1905821 | positive regulation of chromosome condensation | 4 | 5 | 9.07e-04 |
| GO:BP | GO:0000725 | recombinational repair | 27 | 151 | 1.06e-03 |
| GO:BP | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 20 | 94 | 1.20e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 73 | 586 | 1.24e-03 |
| GO:BP | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 4 | 6 | 1.32e-03 |
| GO:BP | GO:0000915 | actomyosin contractile ring assembly | 4 | 6 | 1.32e-03 |
| GO:BP | GO:0034644 | cellular response to UV | 14 | 83 | 1.41e-03 |
| GO:BP | GO:0030261 | chromosome condensation | 12 | 34 | 1.41e-03 |
| GO:BP | GO:0009411 | response to UV | 19 | 137 | 1.46e-03 |
| GO:BP | GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 7 | 68 | 1.46e-03 |
| GO:BP | GO:0031571 | mitotic G1 DNA damage checkpoint signaling | 9 | 27 | 1.61e-03 |
| GO:BP | GO:0000731 | DNA synthesis involved in DNA repair | 9 | 36 | 1.67e-03 |
| GO:BP | GO:0006334 | nucleosome assembly | 12 | 80 | 1.68e-03 |
| GO:BP | GO:1901970 | positive regulation of mitotic sister chromatid separation | 7 | 18 | 1.78e-03 |
| GO:BP | GO:0040001 | establishment of mitotic spindle localization | 10 | 36 | 1.80e-03 |
| GO:BP | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 9 | 27 | 2.09e-03 |
| GO:BP | GO:0044819 | mitotic G1/S transition checkpoint signaling | 9 | 27 | 2.10e-03 |
| GO:BP | GO:0006513 | protein monoubiquitination | 14 | 83 | 2.10e-03 |
| GO:BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 7 | 16 | 2.15e-03 |
| GO:BP | GO:0032506 | cytokinetic process | 9 | 39 | 2.34e-03 |
| GO:BP | GO:0061644 | protein localization to CENP-A containing chromatin | 5 | 17 | 2.35e-03 |
| GO:BP | GO:1902117 | positive regulation of organelle assembly | 15 | 75 | 2.47e-03 |
| GO:BP | GO:0044837 | actomyosin contractile ring organization | 4 | 7 | 2.75e-03 |
| GO:BP | GO:0007127 | meiosis I | 22 | 76 | 3.07e-03 |
| GO:BP | GO:0051053 | negative regulation of DNA metabolic process | 23 | 118 | 3.16e-03 |
| GO:BP | GO:0051653 | spindle localization | 12 | 52 | 3.29e-03 |
| GO:BP | GO:0002227 | innate immune response in mucosa | 4 | 8 | 3.71e-03 |
| GO:BP | GO:0034198 | cellular response to amino acid starvation | 7 | 48 | 4.15e-03 |
| GO:BP | GO:0035878 | nail development | 2 | 7 | 4.15e-03 |
| GO:BP | GO:0031297 | replication fork processing | 11 | 42 | 4.15e-03 |
| GO:BP | GO:0000302 | response to reactive oxygen species | 14 | 160 | 4.25e-03 |
| GO:BP | GO:1902292 | cell cycle DNA replication initiation | 3 | 5 | 4.37e-03 |
| GO:BP | GO:1902315 | nuclear cell cycle DNA replication initiation | 3 | 5 | 4.37e-03 |
| GO:BP | GO:1902975 | mitotic DNA replication initiation | 3 | 5 | 4.37e-03 |
| GO:BP | GO:0090169 | regulation of spindle assembly | 8 | 32 | 5.21e-03 |
| GO:BP | GO:1990928 | response to amino acid starvation | 7 | 50 | 5.21e-03 |
| GO:BP | GO:0035494 | SNARE complex disassembly | 3 | 3 | 5.33e-03 |
| GO:BP | GO:0007143 | female meiotic nuclear division | 9 | 25 | 6.20e-03 |
| GO:BP | GO:0051293 | establishment of spindle localization | 11 | 48 | 6.23e-03 |
| GO:BP | GO:0034728 | nucleosome organization | 12 | 98 | 6.32e-03 |
| GO:BP | GO:0110032 | positive regulation of G2/MI transition of meiotic cell cycle | 3 | 3 | 6.77e-03 |
| GO:BP | GO:0006301 | postreplication repair | 8 | 34 | 7.00e-03 |
| GO:BP | GO:0033314 | mitotic DNA replication checkpoint signaling | 5 | 9 | 7.00e-03 |
| GO:BP | GO:0000132 | establishment of mitotic spindle orientation | 7 | 31 | 7.75e-03 |
| GO:BP | GO:1903925 | response to bisphenol A | 3 | 4 | 7.78e-03 |
| GO:BP | GO:1903926 | cellular response to bisphenol A | 3 | 4 | 7.78e-03 |
| GO:BP | GO:0070925 | organelle assembly | 87 | 803 | 7.81e-03 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 27 | 203 | 8.07e-03 |
| GO:BP | GO:1990227 | paranodal junction maintenance | 1 | 2 | 8.41e-03 |
| GO:BP | GO:0046601 | positive regulation of centriole replication | 4 | 9 | 8.74e-03 |
| GO:BP | GO:1901605 | alpha-amino acid metabolic process | 4 | 161 | 8.82e-03 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 49 | 432 | 8.86e-03 |
| GO:BP | GO:0051294 | establishment of spindle orientation | 9 | 36 | 9.09e-03 |
| GO:BP | GO:0051781 | positive regulation of cell division | 15 | 64 | 1.03e-02 |
| GO:BP | GO:0009084 | glutamine family amino acid biosynthetic process | 2 | 17 | 1.07e-02 |
| GO:BP | GO:0072719 | cellular response to cisplatin | 3 | 4 | 1.07e-02 |
| GO:BP | GO:0007089 | traversing start control point of mitotic cell cycle | 3 | 4 | 1.10e-02 |
| GO:BP | GO:2001021 | negative regulation of response to DNA damage stimulus | 15 | 76 | 1.14e-02 |
| GO:BP | GO:0051298 | centrosome duplication | 14 | 68 | 1.14e-02 |
| GO:BP | GO:0002385 | mucosal immune response | 4 | 11 | 1.20e-02 |
| GO:BP | GO:0007057 | spindle assembly involved in female meiosis I | 3 | 4 | 1.20e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 4 | 84 | 1.37e-02 |
| GO:BP | GO:0006290 | pyrimidine dimer repair | 1 | 7 | 1.39e-02 |
| GO:BP | GO:0070192 | chromosome organization involved in meiotic cell cycle | 12 | 44 | 1.45e-02 |
| GO:BP | GO:0060623 | regulation of chromosome condensation | 4 | 9 | 1.46e-02 |
| GO:BP | GO:0019985 | translesion synthesis | 6 | 24 | 1.47e-02 |
| GO:BP | GO:0097193 | intrinsic apoptotic signaling pathway | 36 | 260 | 1.50e-02 |
| GO:BP | GO:0090306 | meiotic spindle assembly | 4 | 8 | 1.51e-02 |
| GO:BP | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 7 | 22 | 1.57e-02 |
| GO:BP | GO:0022616 | DNA strand elongation | 9 | 35 | 1.58e-02 |
| GO:BP | GO:0085020 | protein K6-linked ubiquitination | 4 | 9 | 1.58e-02 |
| GO:BP | GO:0006979 | response to oxidative stress | 21 | 349 | 1.58e-02 |
| GO:BP | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 6 | 17 | 1.59e-02 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 8 | 268 | 1.61e-02 |
| GO:BP | GO:0016446 | somatic hypermutation of immunoglobulin genes | 5 | 11 | 1.62e-02 |
| GO:BP | GO:0033209 | tumor necrosis factor-mediated signaling pathway | 4 | 77 | 1.63e-02 |
| GO:BP | GO:0002251 | organ or tissue specific immune response | 4 | 13 | 1.63e-02 |
| GO:BP | GO:2001055 | positive regulation of mesenchymal cell apoptotic process | 1 | 2 | 1.67e-02 |
| GO:BP | GO:0035880 | embryonic nail plate morphogenesis | 1 | 3 | 1.67e-02 |
| GO:BP | GO:0051795 | positive regulation of timing of catagen | 1 | 3 | 1.67e-02 |
| GO:BP | GO:1901751 | leukotriene A4 metabolic process | 2 | 2 | 1.68e-02 |
| GO:BP | GO:2001020 | regulation of response to DNA damage stimulus | 37 | 292 | 1.69e-02 |
| GO:BP | GO:0016321 | female meiosis chromosome segregation | 3 | 5 | 1.72e-02 |
| GO:BP | GO:0098910 | regulation of atrial cardiac muscle cell action potential | 3 | 4 | 1.82e-02 |
| GO:BP | GO:0036297 | interstrand cross-link repair | 8 | 37 | 1.82e-02 |
| GO:BP | GO:0023019 | signal transduction involved in regulation of gene expression | 2 | 14 | 1.98e-02 |
| GO:BP | GO:0099607 | lateral attachment of mitotic spindle microtubules to kinetochore | 2 | 2 | 1.98e-02 |
| GO:BP | GO:0071312 | cellular response to alkaloid | 8 | 29 | 2.06e-02 |
| GO:BP | GO:0042772 | DNA damage response, signal transduction resulting in transcription | 6 | 18 | 2.08e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 7 | 25 | 2.08e-02 |
| GO:BP | GO:0051794 | regulation of timing of catagen | 1 | 4 | 2.10e-02 |
| GO:BP | GO:0060364 | frontal suture morphogenesis | 1 | 4 | 2.10e-02 |
| GO:BP | GO:0110030 | regulation of G2/MI transition of meiotic cell cycle | 3 | 3 | 2.10e-02 |
| GO:BP | GO:0010824 | regulation of centrosome duplication | 9 | 44 | 2.10e-02 |
| GO:BP | GO:1901995 | positive regulation of meiotic cell cycle phase transition | 3 | 3 | 2.10e-02 |
| GO:BP | GO:0007144 | female meiosis I | 5 | 9 | 2.10e-02 |
| GO:BP | GO:0042637 | catagen | 1 | 4 | 2.10e-02 |
| GO:BP | GO:0002076 | osteoblast development | 2 | 12 | 2.15e-02 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 2 | 114 | 2.17e-02 |
| GO:BP | GO:0044843 | cell cycle G1/S phase transition | 28 | 225 | 2.17e-02 |
| GO:BP | GO:0072718 | response to cisplatin | 3 | 5 | 2.18e-02 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 7 | 679 | 2.18e-02 |
| GO:BP | GO:0000212 | meiotic spindle organization | 5 | 14 | 2.19e-02 |
| GO:BP | GO:0070914 | UV-damage excision repair | 1 | 13 | 2.22e-02 |
| GO:BP | GO:0002566 | somatic diversification of immune receptors via somatic mutation | 5 | 12 | 2.23e-02 |
| GO:BP | GO:0048818 | positive regulation of hair follicle maturation | 2 | 5 | 2.27e-02 |
| GO:BP | GO:0051782 | negative regulation of cell division | 5 | 15 | 2.27e-02 |
| GO:BP | GO:0003283 | atrial septum development | 5 | 23 | 2.29e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 20 | 146 | 2.47e-02 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 7 | 698 | 2.49e-02 |
| GO:BP | GO:0090427 | activation of meiosis | 1 | 3 | 2.50e-02 |
| GO:BP | GO:0007010 | cytoskeleton organization | 134 | 1222 | 2.56e-02 |
| GO:BP | GO:0006082 | organic acid metabolic process | 7 | 703 | 2.57e-02 |
| GO:BP | GO:0006520 | amino acid metabolic process | 4 | 234 | 2.59e-02 |
| GO:BP | GO:2000001 | regulation of DNA damage checkpoint | 7 | 25 | 2.61e-02 |
| GO:BP | GO:0035825 | homologous recombination | 10 | 43 | 2.68e-02 |
| GO:BP | GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 3 | 15 | 2.73e-02 |
| GO:BP | GO:0001833 | inner cell mass cell proliferation | 5 | 14 | 2.78e-02 |
| GO:BP | GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 2 | 2 | 2.80e-02 |
| GO:BP | GO:1903551 | regulation of extracellular exosome assembly | 3 | 6 | 2.88e-02 |
| GO:BP | GO:0032792 | negative regulation of CREB transcription factor activity | 1 | 4 | 2.90e-02 |
| GO:BP | GO:0072711 | cellular response to hydroxyurea | 4 | 10 | 2.96e-02 |
| GO:BP | GO:1904666 | regulation of ubiquitin protein ligase activity | 6 | 24 | 2.96e-02 |
| GO:BP | GO:0051754 | meiotic sister chromatid cohesion, centromeric | 3 | 4 | 2.97e-02 |
| GO:BP | GO:1901993 | regulation of meiotic cell cycle phase transition | 4 | 5 | 2.97e-02 |
| GO:BP | GO:0071482 | cellular response to light stimulus | 14 | 96 | 3.04e-02 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 6 | 20 | 3.08e-02 |
| GO:BP | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 12 | 61 | 3.13e-02 |
| GO:BP | GO:0071356 | cellular response to tumor necrosis factor | 5 | 156 | 3.21e-02 |
| GO:BP | GO:0061312 | BMP signaling pathway involved in heart development | 1 | 7 | 3.29e-02 |
| GO:BP | GO:0097012 | response to granulocyte macrophage colony-stimulating factor | 2 | 6 | 3.32e-02 |
| GO:BP | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 2 | 6 | 3.32e-02 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 10 | 155 | 3.33e-02 |
| GO:BP | GO:0072593 | reactive oxygen species metabolic process | 11 | 154 | 3.33e-02 |
| GO:BP | GO:1902010 | negative regulation of translation in response to endoplasmic reticulum stress | 1 | 1 | 3.39e-02 |
| GO:BP | GO:0035611 | protein branching point deglutamylation | 1 | 1 | 3.52e-02 |
| GO:BP | GO:0035518 | histone H2A monoubiquitination | 1 | 23 | 3.52e-02 |
| GO:BP | GO:0086016 | AV node cell action potential | 4 | 9 | 3.59e-02 |
| GO:BP | GO:0086027 | AV node cell to bundle of His cell signaling | 4 | 9 | 3.59e-02 |
| GO:BP | GO:0045617 | negative regulation of keratinocyte differentiation | 1 | 3 | 3.64e-02 |
| GO:BP | GO:2000104 | negative regulation of DNA-templated DNA replication | 5 | 14 | 3.67e-02 |
| GO:BP | GO:1904668 | positive regulation of ubiquitin protein ligase activity | 4 | 11 | 3.68e-02 |
| GO:BP | GO:0007064 | mitotic sister chromatid cohesion | 7 | 29 | 3.70e-02 |
| GO:BP | GO:0038101 | sequestering of nodal from receptor via nodal binding | 1 | 1 | 3.75e-02 |
| GO:BP | GO:0006970 | response to osmotic stress | 6 | 66 | 3.85e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 28 | 862 | 3.86e-02 |
| GO:BP | GO:0006542 | glutamine biosynthetic process | 1 | 2 | 3.86e-02 |
| GO:BP | GO:0042542 | response to hydrogen peroxide | 9 | 103 | 3.89e-02 |
| GO:BP | GO:0051438 | regulation of ubiquitin-protein transferase activity | 9 | 53 | 3.91e-02 |
| GO:BP | GO:0072710 | response to hydroxyurea | 4 | 11 | 3.92e-02 |
| GO:BP | GO:0044851 | hair cycle phase | 1 | 9 | 3.92e-02 |
| GO:BP | GO:0044848 | biological phase | 1 | 9 | 3.92e-02 |
| GO:BP | GO:0048819 | regulation of hair follicle maturation | 1 | 9 | 3.92e-02 |
| GO:BP | GO:0034312 | diol biosynthetic process | 3 | 20 | 3.92e-02 |
| GO:BP | GO:0060363 | cranial suture morphogenesis | 1 | 8 | 3.92e-02 |
| GO:BP | GO:0007056 | spindle assembly involved in female meiosis | 3 | 5 | 4.02e-02 |
| GO:BP | GO:2001170 | negative regulation of ATP biosynthetic process | 2 | 3 | 4.11e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 7 | 30 | 4.17e-02 |
| GO:BP | GO:1904975 | response to bleomycin | 2 | 2 | 4.19e-02 |
| GO:BP | GO:1904976 | cellular response to bleomycin | 2 | 2 | 4.19e-02 |
| GO:BP | GO:0006298 | mismatch repair | 7 | 29 | 4.21e-02 |
| GO:BP | GO:0034612 | response to tumor necrosis factor | 5 | 171 | 4.23e-02 |
| GO:BP | GO:0051445 | regulation of meiotic cell cycle | 11 | 45 | 4.24e-02 |
| GO:BP | GO:0021694 | cerebellar Purkinje cell layer formation | 1 | 12 | 4.24e-02 |
| GO:BP | GO:0060346 | bone trabecula formation | 1 | 9 | 4.24e-02 |
| GO:BP | GO:0071971 | extracellular exosome assembly | 3 | 6 | 4.24e-02 |
| GO:BP | GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 2 | 4 | 4.31e-02 |
| GO:BP | GO:0008544 | epidermis development | 2 | 207 | 4.36e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 4 | 123 | 4.45e-02 |
| GO:BP | GO:0033522 | histone H2A ubiquitination | 1 | 32 | 4.45e-02 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 125 | 1947 | 4.47e-02 |
| GO:BP | GO:0046605 | regulation of centrosome cycle | 9 | 51 | 4.54e-02 |
| GO:BP | GO:0019372 | lipoxygenase pathway | 3 | 5 | 4.57e-02 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 6 | 23 | 4.61e-02 |
| GO:BP | GO:0044260 | cellular macromolecule metabolic process | 262 | 2777 | 4.61e-02 |
| GO:BP | GO:0032223 | negative regulation of synaptic transmission, cholinergic | 1 | 1 | 4.61e-02 |
| GO:BP | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound | 1 | 8 | 4.61e-02 |
| GO:BP | GO:0044210 | ‘de novo’ CTP biosynthetic process | 1 | 2 | 4.61e-02 |
| GO:BP | GO:0045217 | cell-cell junction maintenance | 1 | 13 | 4.61e-02 |
| GO:BP | GO:0071619 | phosphorylation of RNA polymerase II C-terminal domain serine 2 residues | 2 | 3 | 4.65e-02 |
| GO:BP | GO:0046173 | polyol biosynthetic process | 5 | 47 | 4.71e-02 |
| GO:BP | GO:0010390 | histone monoubiquitination | 1 | 35 | 4.71e-02 |
| GO:BP | GO:0006914 | autophagy | 38 | 507 | 4.77e-02 |
| GO:BP | GO:0061919 | process utilizing autophagic mechanism | 38 | 507 | 4.77e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 11 | 151 | 4.78e-02 |
| GO:BP | GO:0060088 | auditory receptor cell stereocilium organization | 1 | 9 | 4.78e-02 |
| GO:BP | GO:0051798 | positive regulation of hair follicle development | 1 | 9 | 4.78e-02 |
| GO:BP | GO:0019731 | antibacterial humoral response | 4 | 15 | 4.81e-02 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 11 | 99 | 4.85e-02 |
| GO:BP | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 3 | 23 | 4.87e-02 |
| GO:BP | GO:0006297 | nucleotide-excision repair, DNA gap filling | 3 | 5 | 4.87e-02 |
| GO:BP | GO:0070601 | centromeric sister chromatid cohesion | 4 | 11 | 4.89e-02 |
| GO:BP | GO:0071364 | cellular response to epidermal growth factor stimulus | 5 | 41 | 4.89e-02 |
| GO:BP | GO:0008156 | negative regulation of DNA replication | 7 | 26 | 4.90e-02 |
| GO:BP | GO:0021692 | cerebellar Purkinje cell layer morphogenesis | 1 | 16 | 4.94e-02 |
| GO:BP | GO:0045683 | negative regulation of epidermis development | 1 | 6 | 4.96e-02 |
| GO:BP | GO:0061430 | bone trabecula morphogenesis | 1 | 12 | 4.96e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 3 | 440 | 4.96e-02 |
| GO:BP | GO:0045605 | negative regulation of epidermal cell differentiation | 1 | 6 | 4.96e-02 |
| GO:BP | GO:2001053 | regulation of mesenchymal cell apoptotic process | 1 | 5 | 4.96e-02 |
| GO:BP | GO:0051100 | negative regulation of binding | 2 | 136 | 4.96e-02 |
| GO:BP | GO:0046338 | phosphatidylethanolamine catabolic process | 2 | 4 | 4.96e-02 |
| GO:BP | GO:0046340 | diacylglycerol catabolic process | 2 | 3 | 4.96e-02 |
| KEGG | KEGG:04110 | Cell cycle | 35 | 121 | 1.89e-10 |
| KEGG | KEGG:04115 | p53 signaling pathway | 24 | 65 | 6.99e-09 |
| KEGG | KEGG:03030 | DNA replication | 16 | 35 | 3.09e-08 |
| KEGG | KEGG:03430 | Mismatch repair | 9 | 22 | 5.05e-04 |
| KEGG | KEGG:03440 | Homologous recombination | 10 | 39 | 1.09e-03 |
| KEGG | KEGG:05322 | Systemic lupus erythematosus | 13 | 61 | 1.09e-03 |
| KEGG | KEGG:05034 | Alcoholism | 9 | 122 | 2.23e-03 |
| KEGG | KEGG:04217 | Necroptosis | 5 | 106 | 3.64e-03 |
| KEGG | KEGG:03460 | Fanconi anemia pathway | 12 | 48 | 4.27e-03 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 5 | 110 | 4.27e-03 |
| KEGG | KEGG:04964 | Proximal tubule bicarbonate reclamation | 2 | 20 | 1.25e-02 |
| KEGG | KEGG:03420 | Nucleotide excision repair | 10 | 43 | 1.64e-02 |
| KEGG | KEGG:01524 | Platinum drug resistance | 11 | 65 | 1.97e-02 |
| KEGG | KEGG:03410 | Base excision repair | 8 | 33 | 2.64e-02 |
What I will do is take the terms from the tope three KEGG pathways and look at count changes or at FC values. Updated later.
DXspecific response (only the subset unique to Dox)
Whoa! look at the calcium things
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:2001258 | negative regulation of cation channel activity | 5 | 30 | 8.98e-03 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 8 | 95 | 8.98e-03 |
| GO:BP | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 4 | 23 | 8.98e-03 |
| GO:BP | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity | 5 | 27 | 1.11e-02 |
| GO:BP | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 3 | 10 | 1.20e-02 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 4 | 20 | 1.30e-02 |
| GO:BP | GO:0032413 | negative regulation of ion transmembrane transporter activity | 6 | 51 | 1.31e-02 |
| GO:BP | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 3 | 11 | 1.31e-02 |
| GO:BP | GO:1903170 | negative regulation of calcium ion transmembrane transport | 5 | 35 | 1.57e-02 |
| GO:BP | GO:0051284 | positive regulation of sequestering of calcium ion | 3 | 13 | 1.57e-02 |
| GO:BP | GO:0032410 | negative regulation of transporter activity | 6 | 58 | 1.57e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 4 | 25 | 1.57e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 6 | 64 | 2.11e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 4 | 27 | 2.11e-02 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 5 | 71 | 2.15e-02 |
| GO:BP | GO:0034766 | negative regulation of monoatomic ion transmembrane transport | 6 | 69 | 2.80e-02 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 4 | 28 | 2.91e-02 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 4 | 28 | 3.10e-02 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 6 | 98 | 3.15e-02 |
| GO:BP | GO:0051926 | negative regulation of calcium ion transport | 5 | 45 | 3.31e-02 |
I feel a little dumb for not remembering this results on Wednesday…. now that I ran this using the new adj. p value of < 0.05, I am more confident they are consistent. as above, I will pull the specific genes and look at logCPM of these genes soon to examine if the change is seen in the other AC genes at 24 hours.
No Response genes n=5727
| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0009100 | glycoprotein metabolic process | 174 | 317 | 4.39e-04 |
| GO:BP | GO:0022904 | respiratory electron transport chain | 67 | 103 | 5.22e-04 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 131 | 231 | 5.22e-04 |
| GO:BP | GO:0019646 | aerobic electron transport chain | 52 | 74 | 5.22e-04 |
| GO:BP | GO:0030198 | extracellular matrix organization | 130 | 230 | 5.22e-04 |
| GO:BP | GO:0043062 | extracellular structure organization | 130 | 231 | 6.06e-04 |
| GO:BP | GO:0042773 | ATP synthesis coupled electron transport | 55 | 82 | 8.58e-04 |
| GO:BP | GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 55 | 82 | 8.58e-04 |
| GO:BP | GO:0006486 | protein glycosylation | 107 | 189 | 2.71e-03 |
| GO:BP | GO:0043413 | macromolecule glycosylation | 107 | 189 | 2.71e-03 |
| GO:BP | GO:0070085 | glycosylation | 114 | 204 | 2.76e-03 |
| GO:BP | GO:0006812 | monoatomic cation transport | 323 | 668 | 3.62e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 367 | 774 | 7.37e-03 |
| GO:BP | GO:0009101 | glycoprotein biosynthetic process | 135 | 254 | 9.85e-03 |
| GO:BP | GO:0006119 | oxidative phosphorylation | 78 | 134 | 1.06e-02 |
| GO:BP | GO:0002181 | cytoplasmic translation | 88 | 155 | 1.12e-02 |
| GO:BP | GO:0022900 | electron transport chain | 81 | 141 | 1.26e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 99 | 179 | 1.35e-02 |
| GO:BP | GO:0009060 | aerobic respiration | 99 | 180 | 1.73e-02 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 54 | 89 | 3.50e-02 |
| GO:BP | GO:0030001 | metal ion transport | 269 | 563 | 3.59e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 455 | 996 | 3.59e-02 |
| GO:BP | GO:0045333 | cellular respiration | 117 | 222 | 3.59e-02 |
| GO:BP | GO:0010466 | negative regulation of peptidase activity | 83 | 149 | 3.59e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 259 | 541 | 3.75e-02 |
| GO:BP | GO:1901135 | carbohydrate derivative metabolic process | 413 | 899 | 3.99e-02 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 298 | 633 | 4.66e-02 |
| GO:BP | GO:0034645 | cellular macromolecule biosynthetic process | 468 | 1030 | 4.66e-02 |
| KEGG | KEGG:03010 | Ribosome | 84 | 127 | 6.40e-07 |
| KEGG | KEGG:05171 | Coronavirus disease - COVID-19 | 100 | 162 | 2.53e-06 |
| KEGG | KEGG:04510 | Focal adhesion | 105 | 175 | 6.34e-06 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 48 | 69 | 4.97e-05 |
| KEGG | KEGG:05415 | Diabetic cardiomyopathy | 98 | 169 | 9.70e-05 |
| KEGG | KEGG:00190 | Oxidative phosphorylation | 65 | 106 | 3.78e-04 |
| KEGG | KEGG:00531 | Glycosaminoglycan degradation | 15 | 16 | 5.15e-04 |
| KEGG | KEGG:04714 | Thermogenesis | 107 | 195 | 6.63e-04 |
| KEGG | KEGG:05012 | Parkinson disease | 120 | 226 | 1.34e-03 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 98 | 179 | 1.34e-03 |
| KEGG | KEGG:05208 | Chemical carcinogenesis - reactive oxygen species | 101 | 186 | 1.46e-03 |
| KEGG | KEGG:05020 | Prion disease | 114 | 220 | 6.11e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 129 | 254 | 6.95e-03 |
| KEGG | KEGG:05146 | Amoebiasis | 39 | 64 | 1.33e-02 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 85 | 161 | 1.36e-02 |
| KEGG | KEGG:04932 | Non-alcoholic fatty liver disease | 71 | 131 | 1.36e-02 |
| KEGG | KEGG:00000 | KEGG root term | 2295 | 5534 | 2.43e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 50 | 89 | 2.63e-02 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 87 | 170 | 3.21e-02 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 39 | 67 | 3.21e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 44 | 78 | 3.82e-02 |
##GO:BP full figure 24 DEG analysis
NULL
CVRI poster figures not run
Visualization of FC in cormotif sets
Attaching package: 'limma'The following object is masked from 'package:BiocGenerics':
plotMAcorrplot 0.92 loaded[1] TRUE
Genes of Interest log2 cpm
Genes of Interest:
Top2B
Top2A
CDKN1a
ATM
ATR
mTOR
Rictor
Raptor
RARG
expression correlation:
Loading required package: latticeLoading required package: survivalLoading required package: Formula
Attaching package: 'Hmisc'The following objects are masked from 'package:dplyr':
src, summarizeThe following objects are masked from 'package:base':
format.pval, units indv counts rldh rtnni
indv 1.00 -0.02 0.07 -0.03
counts -0.02 1.00 -0.04 -0.03
rldh 0.07 -0.04 1.00 0.71
rtnni -0.03 -0.03 0.71 1.00
n= 288
P
indv counts rldh rtnni
indv 0.7807 0.2618 0.5917
counts 0.7807 0.4772 0.5800
rldh 0.2618 0.4772 0.0000
rtnni 0.5917 0.5800 0.0000 `geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
entrezgene_id ensembl_gene_id hgnc_symbol
1 10818 ENSG00000166225 FRS2
2 51020 ENSG00000111906 HDDC2
3 23522 ENSG00000281813 KAT6B
4 23254 ENSG00000189337 KAZN
5 23030 ENSG00000127663 KDM4B
6 5916 ENSG00000172819 RARG
7 64078 ENSG00000197506 SLC28A3
8 54575 ENSG00000242515 UGT1A10
9 283337 ENSG00000139651 ZNF740`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
entrezgene_id ensembl_gene_id hgnc_symbol
1 10818 ENSG00000166225 FRS2
2 51020 ENSG00000111906 HDDC2
3 23522 ENSG00000281813 KAT6B
4 23254 ENSG00000189337 KAZN
5 23030 ENSG00000127663 KDM4B
6 5916 ENSG00000172819 RARG
7 64078 ENSG00000197506 SLC28A3
8 54575 ENSG00000242515 UGT1A10
9 283337 ENSG00000139651 ZNF740`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
entrezgene_id ensembl_gene_id hgnc_symbol
1 10818 ENSG00000166225 FRS2
2 51020 ENSG00000111906 HDDC2
3 23522 ENSG00000281813 KAT6B
4 23254 ENSG00000189337 KAZN
5 23030 ENSG00000127663 KDM4B
6 5916 ENSG00000172819 RARG
7 64078 ENSG00000197506 SLC28A3
8 54575 ENSG00000242515 UGT1A10
9 283337 ENSG00000139651 ZNF740`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
`geom_smooth()` using formula = 'y ~ x'
| time | id | ENTREZID | SYMBOL | adj.P.Val |
|---|---|---|---|---|
| 24_hours | Daunorubicin | 23254 | KAZN | 0.0000175 |
| 24_hours | Daunorubicin | 23030 | KDM4B | 0.0001975 |
| 24_hours | Daunorubicin | 283337 | ZNF740 | 0.0002275 |
| 24_hours | Daunorubicin | 10818 | FRS2 | 0.0005879 |
| 24_hours | Daunorubicin | 51020 | HDDC2 | 0.0020530 |
| 24_hours | Daunorubicin | 5916 | RARG | 0.0052878 |
| 24_hours | Doxorubicin | 10818 | FRS2 | 0.0000482 |
| 24_hours | Doxorubicin | 23254 | KAZN | 0.0001905 |
| 24_hours | Doxorubicin | 23030 | KDM4B | 0.0013753 |
| 24_hours | Doxorubicin | 51020 | HDDC2 | 0.0065896 |
| 24_hours | Doxorubicin | 283337 | ZNF740 | 0.0141077 |
| 24_hours | Doxorubicin | 64078 | SLC28A3 | 0.0292968 |
| 24_hours | Doxorubicin | 5916 | RARG | 0.0439585 |
| 24_hours | Epirubicin | 10818 | FRS2 | 0.0001665 |
| 24_hours | Epirubicin | 23254 | KAZN | 0.0007793 |
| 24_hours | Epirubicin | 51020 | HDDC2 | 0.0010982 |
| 24_hours | Epirubicin | 5916 | RARG | 0.0124123 |
| 24_hours | Epirubicin | 64078 | SLC28A3 | 0.0149064 |
| 24_hours | Epirubicin | 283337 | ZNF740 | 0.0177562 |
| 24_hours | Epirubicin | 23030 | KDM4B | 0.0236417 |
entrezgene_id ensembl_gene_id hgnc_symbol
1 10818 ENSG00000166225 FRS2
2 51020 ENSG00000111906 HDDC2
3 23522 ENSG00000281813 KAT6B
4 23254 ENSG00000189337 KAZN
5 23030 ENSG00000127663 KDM4B
6 5916 ENSG00000172819 RARG
7 64078 ENSG00000197506 SLC28A3
8 54575 ENSG00000242515 UGT1A10
9 283337 ENSG00000139651 ZNF740Kegg 24 hour heatmap
Loading required package: grid========================================
ComplexHeatmap version 2.12.1
Bioconductor page: http://bioconductor.org/packages/ComplexHeatmap/
Github page: https://github.com/jokergoo/ComplexHeatmap
Documentation: http://jokergoo.github.io/ComplexHeatmap-reference
If you use it in published research, please cite either one:
- Gu, Z. Complex heatmaps reveal patterns and correlations in multidimensional
genomic data. Bioinformatics 2016.
- Gu, Z. Complex Heatmap Visualization. iMeta 2022.
The new InteractiveComplexHeatmap package can directly export static
complex heatmaps into an interactive Shiny app with zero effort. Have a try!
This message can be suppressed by:
suppressPackageStartupMessages(library(ComplexHeatmap))
========================================
! pheatmap() has been masked by ComplexHeatmap::pheatmap(). Most of the arguments
in the original pheatmap() are identically supported in the new function. You
can still use the original function by explicitly calling pheatmap::pheatmap().
Attaching package: 'ComplexHeatmap'The following object is masked from 'package:pheatmap':
pheatmap
R version 4.2.2 (2022-10-31 ucrt)
Platform: x86_64-w64-mingw32/x64 (64-bit)
Running under: Windows 10 x64 (build 19045)
Matrix products: default
locale:
[1] LC_COLLATE=English_United States.utf8
[2] LC_CTYPE=English_United States.utf8
[3] LC_MONETARY=English_United States.utf8
[4] LC_NUMERIC=C
[5] LC_TIME=English_United States.utf8
attached base packages:
[1] grid stats graphics grDevices utils datasets methods
[8] base
other attached packages:
[1] ComplexHeatmap_2.12.1 Hmisc_4.8-0 Formula_1.2-5
[4] survival_3.5-3 lattice_0.20-45 RColorBrewer_1.1-3
[7] pheatmap_1.0.12 corrplot_0.92 limma_3.52.4
[10] paletteer_1.5.0 ggsignif_0.6.4 zoo_1.8-11
[13] rstatix_0.7.2 ggpubr_0.6.0 cowplot_1.1.1
[16] ggVennDiagram_1.2.2 scales_1.2.1 kableExtra_1.3.4
[19] gridExtra_2.3 BiocGenerics_0.42.0 gprofiler2_0.2.1
[22] lubridate_1.9.2 forcats_1.0.0 stringr_1.5.0
[25] dplyr_1.1.0 purrr_1.0.1 readr_2.1.4
[28] tidyr_1.3.0 tibble_3.1.8 ggplot2_3.4.1
[31] tidyverse_2.0.0 workflowr_1.7.0
loaded via a namespace (and not attached):
[1] circlize_0.4.15 backports_1.4.1 systemfonts_1.0.4
[4] lazyeval_0.2.2 splines_4.2.2 crosstalk_1.2.0
[7] digest_0.6.31 foreach_1.5.2 htmltools_0.5.4
[10] fansi_1.0.4 checkmate_2.1.0 magrittr_2.0.3
[13] doParallel_1.0.17 cluster_2.1.4 tzdb_0.3.0
[16] matrixStats_0.63.0 vroom_1.6.1 svglite_2.1.1
[19] timechange_0.2.0 jpeg_0.1-10 RVenn_1.1.0
[22] colorspace_2.1-0 rvest_1.0.3 xfun_0.37
[25] callr_3.7.3 crayon_1.5.2 prismatic_1.1.1
[28] jsonlite_1.8.4 iterators_1.0.14 glue_1.6.2
[31] gtable_0.3.1 webshot_0.5.4 GetoptLong_1.0.5
[34] car_3.1-1 shape_1.4.6 abind_1.4-5
[37] futile.options_1.0.1 DBI_1.1.3 Rcpp_1.0.10
[40] htmlTable_2.4.1 viridisLite_0.4.1 xtable_1.8-4
[43] clue_0.3-64 units_0.8-1 foreign_0.8-84
[46] bit_4.0.5 proxy_0.4-27 stats4_4.2.2
[49] htmlwidgets_1.6.1 httr_1.4.5 ellipsis_0.3.2
[52] pkgconfig_2.0.3 farver_2.1.1 nnet_7.3-18
[55] sass_0.4.5 deldir_1.0-6 utf8_1.2.3
[58] tidyselect_1.2.0 labeling_0.4.2 rlang_1.0.6
[61] later_1.3.0 munsell_0.5.0 tools_4.2.2
[64] cachem_1.0.7 cli_3.6.0 generics_0.1.3
[67] broom_1.0.3 evaluate_0.20 fastmap_1.1.1
[70] yaml_2.3.7 rematch2_2.1.2 processx_3.8.0
[73] knitr_1.42 bit64_4.0.5 fs_1.6.1
[76] nlme_3.1-162 whisker_0.4.1 mime_0.12
[79] formatR_1.14 xml2_1.3.3 compiler_4.2.2
[82] rstudioapi_0.14 plotly_4.10.1 png_0.1-8
[85] e1071_1.7-13 bslib_0.4.2 stringi_1.7.12
[88] highr_0.10 ps_1.7.2 futile.logger_1.4.3
[91] Matrix_1.5-3 classInt_0.4-9 vctrs_0.5.2
[94] pillar_1.8.1 lifecycle_1.0.3 GlobalOptions_0.1.2
[97] jquerylib_0.1.4 data.table_1.14.8 httpuv_1.6.9
[100] R6_2.5.1 latticeExtra_0.6-30 promises_1.2.0.1
[103] KernSmooth_2.23-20 IRanges_2.30.1 codetools_0.2-19
[106] lambda.r_1.2.4 rjson_0.2.21 rprojroot_2.0.3
[109] withr_2.5.0 S4Vectors_0.34.0 mgcv_1.8-42
[112] parallel_4.2.2 hms_1.1.2 rpart_4.1.19
[115] VennDiagram_1.7.3 class_7.3-21 rmarkdown_2.20
[118] carData_3.0-5 git2r_0.31.0 sf_1.0-9
[121] getPass_0.2-2 shiny_1.7.4 base64enc_0.1-3
[124] interp_1.1-3